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Programma
Tuesday 23rd September
8:30 Registration of SCI-DCSB and whole-
conference attendants 
9:00 – 12:45
SALA POLISSENA
SYMPOSIUM C1 (SCI-DCSB)
MOLECULAR SYSTEMS BIOLOGY
Chairmen: Mauro Fasano (Varese), Lucia Banci 
(Firenze)
09:00 Katrin Marcus (Ruhr-Universität Bochum, 
Germany)
Proteomics in neurodegenerative diseases
09:45 Pierluigi Reschiglian (Università di 
Bologna)
?????????????????????????????????????????????
biophysical characterization of biological 
systems
10:10 Maurizio Simmaco (Università di Roma La
Sapienza)
An integrated platform for clinical analysis of 
gene expression 
10:35 Coffee Break
11:00  Andreas Zanzoni ( Institute for Research
in Biomedicine, Barcelona)
Network biology: towards the comprehension 
of complex biological systems
11:45 Fulvio Magni (Università di Milano
Bicocca)
Role of mass spectrometry in protein 
biomarkers discovery: the case of renal 
clear-cell carcinoma
?????? ???????????????????????????????????
The proteome of skeletal muscle in 
neurodegenerative conditions
13:05 – 14:30 Lunch and hanging up of SCI-DCSB 
posters
14:30 – 16:00
SALA POLISSENA
SYMPOSIUM C2 (SCI-DCSB)
CHEMISTRY OF NUCLEIC ACIDS
Chairmen: Marco Franceschin (Roma), Roberto 
Purrello (Catania)
14:30 Pasquale De Santis (Università di Roma
La Sapienza)
Sequence-dependent collective properties of 
DNA and their role in biological systems 
15:00  Aldo Galeone (Università di Napoli 
Federico II)
Quadruplex DNA: structural features and 
potential applications 
15:30 Gianmaria Bonora (Università di Trieste)
PEG-addition to oligonucleotides: a story 
with a future?
16:00 – 17:30 Poster session with coffee break
17:30
SALA POLISSENA
“GASTONE DE SANTIS” AWARD
Chairmen: Gianluca Fossati (Milano), Mauro Fasano 
(Varese)
18:20 Meeting of SCI-SCSB members
Parallel meetings of the following SIB groups:
SALA VIOLANTE – PALAZZO DEI CONGRESSI
14:30 – 17:00 NEUROCHEMISTRY
  Chair: Tommaso Russo 
17:00 – 18:30 BIOGENIC AMMINES
  Chair: Antonio Toninello 
SALA GINEVRA - PALAZZO DEI CONGRESSI
14:30 – 16:30 NUTRITIONAL BIOCHEMISTRY
  Chair: Francesco Bonomi 
16:30 – 19:30 NUCLEOTIDES, NUCLEIC ACIDS,
  GENOMES
  Chair: Enrico Marinello 
SALA COSTANZA - PALAZZO DEI CONGRESSI
15:30   MEMBRANES AND BIOENERGETICS 
  Chair: Paola Palestini 
SALA  DANTE - HOTEL CRISTALLO
16:00 – 18:30 INDUSTRIAL BIOCHEMISTRY   
  AND BIOTECHNOLOGY
  Chair: Gennaro Marino 
SALA VESPUCCI - HOTEL MEDITERRANEO
15:30   CELLULAR BIOCHEMISTRY
  Chair: Giovanni Raugei 
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Wednesday 24th September
8:30 Registration of SIB attendants 
9:00 – 12:30
SALA POLISSENA
SYMPOSIUM S1 
(SIB AND SCI COMBINED SYMPOSIUM)
PROTEIN AND DRUG STRUCTURE
Chairmen: Martino Bolognesi (Milano), Mauro 
Fasano (Varese)
09:00 Alessandra Topai (Università di Roma Tor 
Vergata)
New inhibitors of metalloproteases via 
Structure/Ligand based design-case study
09:35 Claudio Luchinat (Università di Firenze)
NMR in structural biology and drug discovery
10:10 Menotti Ruvo (Università di Napoli 
Federico II)
Peptide antagonists of protein-protein 
????????????????????????????????????????????
fragments
10:30 Coffee Break
11:00 Giuseppe Zanotti (Università di Padova)
Structural and functional characterization 
????????????????????????????????????????????
pharmacological targets
11:35 Rolf Hilgenfeld (University of Lubecca,
Germany)
Structure-based discovery of new antivirals
12:10 Pierfausto Seneci (Università di Milano)
Smac Mimics-XIAP Binders: Protein-Protein 
Interaction Inhibitors from Structure-Based 
Drug Design
12:30 – 13:30 Lunch
12:30 – 13:30 removal of SCI-DCSB posters and 
?????????????????????????????????????????
13:30 – 16:00
SALA POLISSENA
SYMPOSIUM S2
SIGNAL TRANSDUCTION AND BIOMOLECULAR
TARGETS
Chairmen: Antonio de Flora (Genova), Paola 
Chiarugi (Firenze)
13:30 Marcello Allegretti (Dompé, L’Aquila)
Allosteric modulators of CXCL8 receptors
14:00 Elena Zocchi (Università di Genova)
The functional effects of the new human 
hormone abscisic acid on animal cells are 
mediated by the second messenger cyclic 
ADP-ribose
14:30 Silvia Giordano (Università di Torino)
Targeting MET in tumor and metastases: a 
matter of addiction and sensitivity
15:00 Lorenzo Pinna (Università di Padova)
Targeting CK2 as a general strategy in Signal 
Transduction Therapy
15:30  Giovanni Melillo (National Cancer 
Institute-Frederick, Maryland, USA)
Targeting hypoxic cell signaling for cancer 
therapy
16:00 – 16:30 Coffee break
16:30 – 18:00
SALA POLISSENA
SYMPOSIUM S3 
(SIB AND SCI COMBINED SYMPOSIUM)
ENVIRONMENTAL BIOTECHNOLOGY
Chairmen: Gennaro Marino (Napoli), Massimo 
Coletta (Roma)
16:30 Christopher C. R. Allen (Queen’s Univ. 
Belfast, Northern Ireland)
Dioxygenases from arene-degrading 
bacteria: Can we develop their potential for 
application in biocatalysis?
17:00 Alberto Di Donato (Università di Napoli 
Federico II)
Metabolic Engineering: a tool for 
bioremediation strategies
17:25 Fabio Fava (Università di Bologna)
Microbial reductive dehalogenation for 
the sustainable remediation of PCB-
contaminated sediments
17:50 Luigi Campanella (Università di Roma La
Sapienza)
Ecological Risk assessment by sensoristic 
approach
18:15 G. Fiorentino (Università di Napoli 
Federico II) – Selected Poster 6.1
Stress by aromatic compounds in sulfolobus 
????????????????????????????????????????????
biomonitoring
18:30 – 19:30 Poster session 1
20:00 Get together dinner
“Riccione City Eye”, panoramic terrace 
restaurant of   Palazzo dei Congressi
Thursday 25th September
08:30 – 11:00
SALA POLISSENA
SYMPOSIUM S4 
PROTEIN MISFOLDING AND ITS RELATIONSHIP
WITH DISEASE
Chairmen: Fabrizio Chiti (Firenze), Giampaolo
Merlini (Pavia)
08:30 Introduction by Giampaolo Merlini
(Policlinico San Matteo, Pavia)
08:40 Christopher M. Dobson (University of 
Cambridge)
Life on the Edge: The Nature and Origins of 
Protein Misfolding Diseases
09:05 Gennaro Esposito (Università di Udine)
?2-microglobulin refolding intermediates and 
??????????????
09:30 Vittorio Bellotti (Università di Pavia)
Misfolding and tissue localization of 
amyloidogenic proteins: complexities and 
breakthroughs
09:55 Fabrizio Tagliavini (Istituto Carlo Besta, 
Milano)
Prion protein, prion diseases and tetracyclic 
compounds
?????? ???????????????????????????????????????
Raffaele, Milano)
Protein folding and signaling in the early 
secretory apparatus
10:45 P. Polverino de Laureto (Università di 
Padova) – Selected Poster 15.60 
Characterization of oligomeric species on the 
aggregation pathway of human lysozyme
11:00 – 11:30 Coffee break
11:30 – 16:30 Election of 5 Members of the SIB 
Executive Board
11:30 – 13:00
SALA POLISSENA
SYMPOSIUM S5
EMERGING TECHNIQUES IN BIOCHEMISTRY
Chairmen: Niccolò Taddei (Firenze), Gennaro Marino 
(Napoli)
11:30 Annalisa Relini (Università di Genova)
“Seeing” at the nanoscale with the atomic 
force microscope
11:55 Piero Pucci (Università di Napoli Federico II)
Orthogonal strategies in Proteomics
12:20 Francesco Saverio Pavone (LENS, Firenze)
Manipulation and imaging of single bio-
molecules
12:45 E. Dainese (Università di Teramo) – 
Selected Poster 15.6
Small angle x-ray scattering studies reveal 
important clues for membrane binding and 
activity of fatty acid amide hydrolase (faah)
13:00 – 14.10 Lunch
13:00 – 14:10 ???????????????????????????????????
and hanging up of second set of SIB posters
14:10 – 15:00
SALA POLISSENA
ANTONINI LECTURE
Rino Rappuoli (Novartis, Siena)
The bacterial pan-genome and the global gene pool
15:00 – 18:00
SALA POLISSENA
SYMPOSIUM S6 
GENE SILENCING
Chairmen: Tommaso Russo (Napoli), Antonio De 
Flora (Genova)
15:00 John M. Denu (University of Wisconsin,
Madison, Wisconsin, USA)
Molecular functions of sirtuins
15:30 Gerry Melino (Medical Research Council, 
Leicester, UK)
miR, “stemness” & skin
16:00 Coffee break
16:30  Roberto Gherzi (Ist. Naz. per la Rierca sul 
Cancro, Genova)
KSRP, a RNA binding protein with many talents
17:00 Tommaso Russo (Università di Napoli 
Federico II)
RNA interference-based screening of genes 
involved in embryonic stem cell self-renewal 
and differentiation
17:30 Massimo Zollo (Università di Napoli 
Federico II)
miRNAs in paediatric cancer
18:00 Premio Zanichelli  e Premio Medaglia SIBBM
18:15 Assemblea dei Soci
20:30 Social Dinner
Friday 26th September
08:30 – 10:30
SALA POLISSENA
SYMPOSIUM S7 
REDOX SIGNALLING AND OXIDATIVE STRESS
Chairmen: Paola Chiarugi (Firenze), Luciana 
Avigliano (Roma)
08:30 Fatima Mechta-Grigoriou (“Stress and 
Cancer” Lab. Institut Curie - Inserm U830,
Paris)
The role of Oxidative stress in insulin 
secretion and aging
08:55 Enrico Avvedimento (Università di Napoli 
Federico II)
Oxidation-coupled transcription: histone H3 
demethylation generates an oxidation wave 
that drives estrogen-induced transcription
09:20 Franca Esposito (Università di Napoli 
Federico II)
??????????????????????????????????????????????
of a novel antiapoptotic gene involved 
in adaptation to oxidative stress and 
chemoresistance
09:45 Vittorio Calabrese (Università di Catania)
Redox regulation of cellular stress response 
in aging and neurodegenerative disorders: 
role of vitagenes
10:10 M. Donadelli (Università di Verona) 
– Selected Poster 2.33
Intracellular zinc increase inhibits p53-/-
pancreatic adenocarcinoma cell growth by 
ros/aif-mediated apoptosis
10:30 – 11:00 Coffee break
11:00 – 13:00
SALA POLISSENA
SYMPOSIUM S8
LIPIDS IN CELL COMMUNICATION AND SIGNAL 
TRANSDUCTION
Chairmen: Paola Bruni (Firenze), Bruno Venerando 
(Milano)
11:00 Laura Riboni (Università di Milano)
Cell communication in the nervous system: 
the mediator role of sphingosine-1-phosphate
11:25 Andrea Graziani (Università Piemonte 
Orientale, Novara)
Diacylglycerol kinases as switch regulators 
from diacylglycerol to phosphatidic acid-
mediated signaling: implication in cell 
signaling
11:50 Alessandro Prinetti (Università di Milano)
Sphingolipids as modulators of membrane 
signaling complexes
12:15 Daniela Corda (Mario Negri Sud, Chieti)
Cellular targets and activities of the 
glycerophosphoinositols
12:40 N. Mitro (Università di Milano and Scripps 
Res. Institute) – Selected Poster 2.43
Regulation of hepatic lipid and carboidrate 
metabolism by the liver X receptor 
13:00 – 14:00 Lunch
14:00 – 15:00 Poster Session 2
15:00 – 19:45
SALA POLISSENA
SYMPOSIUM S9
MITOCHONDRIAL FUNCTION AND
DYSFUNCTION
Chairmen: Giorgio Lenaz (Bologna), Sergio Papa (Bari)
15:00 Shinya Yoshikawa (University of Hyogo,
Japan)
Reaction mechanism of bovine 
heartcytochrome c oxidase
15:45 Paolo Bernardi (Università di Padova)
The mitochondrial permeability transition in 
pathophysiology
16:15 Paolo Sarti  (Università di Roma La
Sapienza)
Nitric oxide and control of mitochondrial 
??????????????????????????????
16:45  Alessandra Baracca (Università di 
Bologna)
Mitochondrial substrate-level phosphorylation 
improves viability of human cells with severe 
oxidative phosphorylation impairment
17:15 Coffee break
17:45 Ferdinando Palmieri (Università di Bari)
Mitochondrial membrane transport proteins 
in health and disease
18:15 Domenico De Rasmo (Università di Bari)
Regulation by cAMP dependent 
phosphorylation of mitochondrial protein 
import
??????? ????????????????????????????????????????
Raffaele, Milano)
The mitochondrial protease AFG3L2 is 
essential for development and maintenance 
of motor axon and cerebellum d
19:15 F. Pallotti (Università di Varese) – selected 
poster 12.20
Plasma Coenzyme Q10 levels in patients 
with hypercholesterolemia and high serum 
creatine kinase levels
19:30 Meeting end
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Presentazione
Il 53° Congresso Nazionale della Società Italiana di Biochimica e Biologia Molecolare che si tiene 
?? ??????????????????????????????????????????????????????????????????????????????????????????????????????????
delle numerose sessioni nelle quali è strutturato. 
??????????????????????????????????? ????????????????????????????????????????????????? ????????
Sistemi Biologici della Società Italiana di Chimica (SCI) su Molecular Systems Biology, Chemistry of 
Nucleic Acids, Protein and Drug Structure, Environmental Biotechnology.
Questi Simposi, riguardano argomenti di avanguardia per i quali fa piacere l’interesse condiviso 
??????????????????????????? ?????? ?????????????????????????? ??????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????????????-
duazione dei relatori. Le sessioni SIB spazieranno da Signal Transduction and Biomolecular Targets, 
Protein Misfolding and its Relationship with Diseases, Emerging Techniques in Biochemistry, Gene 
Silencing, Redox Signalling and Oxidative Stress, Lipids in Cell Communication and Signal Tran-
sduction, Mitochondrial Function and Dysfunction. 
????????????????????????????????????????????????????????????????????? ???????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????????
immediato futuro migliore.
Con questo spirito viviamo insieme queste belle giornate del nostro Congresso.
Sergio Papa
Presidente SIB

Speakers’ presentations 

R.1 
PROTEOMICS IN NEURODEGENERATIVE DISEASES 
Thorsten Müller, Florian Tribl, Katrin Marcus*
Department of Functional Proteomics, Ruhr University 
Bochum, Germany 
Proteomics emerged as a key technology to identify novel 
proteins, to characterize their isoforms based on 
numerous post-translational modifications, and to unravel 
protein regulation, e.g., in healthy and diseased states. 
Brain affecting diseases such as Alzheimer’s (AD) and 
Parkinson’s disease (PD) most commonly affect elderly 
people and give rise of severe and slowly progressing 
neurodegeneration. Since there is neither an effective 
pharmaceutical treatment available to cure these 
disorders, nor to reliably diagnose them at a pre-
symptomatic stage, proteomics may contribute to the 
understanding pathomechanisms of underlying 
pathomechanisms as well as the identification of new 
diagnostic biomarkers and novel therapeutic targets in the 
future.  
As with other tissues, two strategies can be 
distinguished in brain proteomics: “Mapping” approaches 
with the aim to identify the entire set of proteins within the 
sample of interest and “comparative/differential” 
proteomics aiming at the identification of key players for 
development, plasticity or disease-related changes of the 
nervous system. Examples include mapping studies in 
individual brain areas or neuronal cell types or 
comparative analysis of cerebral disorders like AD and 
PD which are thought to dramatically disturb the cellular 
proteome.  
In this talk I will focus on the application of proteomics 
on the investigation of AD and PD especially underlining 
advantages as well as limitations of some of the existing 
strategies. 
R.2 
FIELD-FLOW FRACTIONATION FOR THE ANALYSIS 
AND BIOPHYSICAL CHARACTERIZATION OF 
BIOLOGICAL SYSTEMS 
P. Reschiglian, S. Casolari, D.C. Rambaldi, B. Roda, A. 
Zattoni 
Dipartimento di Chimica “G. Ciamician”, Università di 
Bologna, Italia; pierluigi.reschiglian@unibo.it 
A technique able to separate in 5-20 minutes a broad 
range of analytes of biological interest, from proteins to 
whole cells, over a molar-mass range of 1014, and with 
relevant biophysical information obtained from retention 
parameters. This is field-flow fractionation (FFF)1, for long 
considered to be “the best-kept secret” in bioanalytical 
chemistry. In fact, over more than 30 years FFF has 
slowly evolved from a research-oriented technique to a 
well-assessed methodology. Today’s FFF is applied to 
solve real analytical problems in various biological niches. 
The key point for using FFF with biological systems is the 
“gentle” fractionation mechanism that makes “delicate” 
analytes like non-covalent protein complexes or living 
cells be separated in their native, functional state. This 
makes FFF particularly useful if the fractionated analytes 
need to be reused or further characterized. The 
development of hyphenated methods based on coupling 
FFF with uncorrelated techniques for biophysical (size, 
shape and/or mass) characterization, such as multi-angle 
laser scattering or soft-impact mass spectrometry, today 
shows to be particularly promising.  
We overview FFF basic principles and technology, 
and show applications from top-down proteome analysis2
of biological fluids and subcellular units3 to serum 
lipoprotein profiling4, from monitoring protein aggregation 
processes in prions5, amyloidic proteins or viruses to stem 
cell sorting6. These are just some examples that indicate 
the analysis under native conditions as one of the most 
representative application niches to make FFF a booming 
methodology in the study of biological systems. 
1. P. Reschiglian, A. Zattoni, B. Roda, E. Michelini, A. 
Roda. (2005) Trends Biotechnol. 23, 475-83. 
2. P. Reschiglian, M.H. Moon. “Flow field-flow 
fractionation: a pre-analytical method for proteomics J. 
of Proteomics, in press.
3. D. Kang, S. Oh, P. Reschiglian, M.H. Moon. (2008) 
Analyst 133, 505-15. 
4. D.C. Rambaldi, A. Zattoni, S. Casolari, P. Reschiglian, D. 
Roessner, C. Johann. (2007) Clin. Chem. 53, 2026-8. 
5. J.R. Silveira, G.J. Raymond, A.G. Hughson, R.E. 
Race, V.L. Sim, S.F. Hayes, B. Caughey. (2005) 
Nature 437, 257-261. 
6. P. Reschiglian, B. Roda, A. Zattoni, G.P. Bagnara. 
Patent pending PCT/EP2007/054226. 
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R.3 
AN INTEGRATED PLATFORM FOR CLINICAL 
ANALYSIS OF GENE EXPRESSION 
V. Annibali, L. Aimati, M.Borro , G. Gentile, C. Ialongo, O. 
De Luca, L. Lionetto , R. Mechelli, A. Provenza M.S. 
Torre A. De Blasi and M. Simmaco
Dipartimento Scienze Biochimiche – Diagnostica 
Molecolare Avanzata – II Facoltà di Medicina – Azienda 
Ospedaliera Sant’Andrea Università Sapienza di Roma  
(w3.uniroma1.it/biocmed2/dima) 
A farsighted interaction between the 2nd Faculty of 
Medicine and the Department of Biochemical Sciences 
“A. Rossi Fanelli” of  “Sapienza” University and 
Sant’Andrea Hospital allowed to realize, in 2001, an 
integrated system biology laboratory named “Diagnostica 
Molecolare Avanzata” (Di.M.A.), a pioneering structure 
whose mission is  to promote the development of new 
diagnostic and therapeutic strategies applying genomics 
and proteomics to clinical research. 
The wide range of activities of Di.M.A. Laboratory is 
supported by the strong synergy among different 
resources (both human and financial). 
The recent advances in molecular biology and 
biochemistry strongly influence the request of diagnostic 
laboratory analyses by clinicians and patients.  For this 
purpose, several platforms are used in a way to produce 
the more complete overview in order to offer a service of 
Personalized Medicine. 
In particular, it will be described the evaluation of 
fluoropyrimidime metabolism using a combined approach 
based on SNPs analysis by pyrosequencing and the 
effective rate of drug degradation by LC-MS/MS. 
A similar strategy is used for monitoring antipsychotic 
drugs combining genomic analysis based on an 
Affymetrix platform with the LC-MS/MS pharmacokinetic 
assay. Furthermore, the latter techniques offer a simple 
way for the evaluation of the intestinal permeability in 
pediatric and oncological patients1. Finally, proteomic 
techniques are proposed as a tool for the use of T 
lymphocytes as biosensors capable of a sensitive 
discrimination of different pathological states2.
1. Lostia AM, Lionetto L, Principessa L, Evangelisti M, 
Gamba A, Villa MP, Simmaco M.  (2008) Clin 
Biochem. 41 887-92.  
2. Borro M., Gentile G., Stigliano A., Misiti S., Toscano 
V. and Simmaco M. (2007) Clin. Exp. Immunol. 150, 
494-501. 
R.4 
NETWORK BIOLOGY: TOWARDS THE 
COMPREHENSION OF COMPLEX BIOLOGICAL 
SYSTEMS. 
A. Zanzoni
Structural and Computational Biology Programme, 
Institute for Research in Biomedicine (IRB), Barcelona, 
Spain 
Much of systems biology aims to predict the behaviour of 
biological systems on the basis of the set of molecule 
involved. Understanding the interactions between these 
molecules (proteins, DNA, RNA and small molecules) is 
therefore crucial to such efforts.  
Several genome-wide experiments have provided 
large protein-protein interaction datasets. More recently, 
given the increase in the availability of human protein 
interaction data, protein networks are progressively 
serving as implements to unveil the molecular basis of 
disease. 
A current major challenge for biology is to apply an 
integrated computational and experimental approach to 
chart, comprehend and model the properties of molecular 
networks that control the physiological and the 
pathological behaviour of the cell. 
R.5 
ROLE OF MASS SPECTROMETRY IN PROTEIN 
BIOMARKERS DISCOVERY: THE CASE OF RENAL 
CLEAR CELL CARCINOMA. 
F. Magni, C. Chinello, E. Gianazza, V. Mainini, C. 
Galbusera, M. Kienle 
Dipartimento di Medicina Sperimentale, Università di 
Milano-Bicocca, Milano, Italia 
Mass spectrometry (MS), in combination with 2DE, is 
widely used to identify a proteome profile in biological 
fluids which results to be specific for a particular disease. 
Unfortunately this approach is laborious and time 
consuming. A different approach based on the 
combination of active surface prepurification with MALDI-
TOF analysis has been described. Only a group of 
proteins present in the biological sample can be retained 
on the active surface target and detected by MALDI-TOF 
analysis (SELDI-TOF). A suitable alternative is based on 
the use of magnetic beads with activated surface 
(ClinProt) which allows pre-purification of the sample 
before mass spectrometry analysis. An example of the 
application of this approach to the renal cell carcinoma 
(RCC) will be described . 
Renal Cell Carcinoma (RCC) is one of the major 
cause of cancer death and is radio- and chemioresistant. 
Many renal masses remain asymptomatic and non-
palpable until late in the natural course of the disease. 
Therefore more than 30% of patients have metastasis 
when symptoms become evident. Biomarkers for early 
detection of RCC, for the differential diagnosis of RCC 
from benign renal lesions when imaging is not helpful, for 
prognosis and follow up are urgent.  
Serum and urine of healthy subjects (n=29) and clear 
cell RCC patients (n = 33-39) were analysed by ClinProt 
technique aimed to search possible biomarkers for early 
RCC diagnosis.  
We found in serum a cluster of three signals (marker A, 
B and C) able to discriminate patients from control subjects 
with 100 % and 90 % of specificity and sensitivity, 
respectively, in the training test and 100 % and 92.3 % in 
the external validation. Moreover, this cluster showed 100 
% sensitivity for patients at pT2 (n=5) and pT3 (n=8) and of 
85 % for pT1 patients (n=20). Markers A and C signals 
area continuously decreased from pT1 to pT3 while marker 
B increased in pT1 and pT2 reaching a plateau for pT3.  
In urine, a cluster of three different signals (marker A, B 
and C) was also able to discriminate patients from controls. 
Receiver Operating Characteristic (ROC) curve analysis 
showed  values of AUC higher than 0.9 for marker A and B, 
corresponding to sensibility of 85-90 % and specificity  of 
90 %, while marker C gave a lower AUC (0.84) 
corresponding to sensibility of 70% and specificity of 100%. 
Combination of three markers allows an improvement of 
diagnostic efficacy with specificity and sensibility of 100 % 
and 95 %, respectively, in the training test and of 100 % 
and of 85 % in the testing experiment. Efficacy of this 
cluster of signals to distinguish RCC patients grouped on 
tumour stage showed a sensibility of 100% for patients at 
pT1. Moreover one of the signal present in the cluster was 
identified as a fragment of Tamm-Horsfall Protein (THP). 
In conclusion, our data, although needing further 
validation with more patients and with different renal 
pathologies, are promising in the possibility to be used as 
multiple biomarkers for ccRCC diagnosis. 
R.6 
THE PROTEOME OF SKELETAL MUSCLE IN 
NEURODEGENERATIVE CONDITIONS 
C. Gelfi 1,2, D. Capitanio 1,2, M. Vasso1,2, C. Bendotti 3, V. 
Silani 4
1
 Department of Sciences and Biomedical Technologies, 
University of Milan, L.I.T.A., Segrate,       Milan 
2
 Institute of Molecular Bioimaging and Physiology, 
National Research Council, Segrate, Milan
3
 Lab. Molecular Neurobiology, Dept. Neurosciences, 
Mario Negri Institute for Pharmacological    Research, Via 
Eritrea, 62, Milano, Italy. 
4
Department of Neurological Sciences, University of 
Milan, Via F. Sforza 35, 20122 Milan. 
Muscular atrophy is a common feature in a 
neurodegenerative disease such as Amyotrophic Lateral 
Sclerosis (ALS). Transgenic mice overexpressing human 
mutant SOD1 gene develop progressive loss of spinal 
motor neurons with a consequent muscle atrophy and 
paralysis. The loss of muscle proteins, the differential 
changes in muscle proteome could act as signalling 
events inducing progressive damage both at the muscular 
and motoneuronal levels.  
The aims of this study was to detect markers of  primary 
events in animal models and  identify changes induced in 
muscle proteome in humans. In the present study we 
examined the proteomic profile of the gastrocnemious 
muscle from hSOD1G93A transgenic (Tg) mutant mice in the 
pre symptomatic and symptomatic stage of the disease by 
two dimensional difference in gel electrophoresis (2D-DIGE)  
and  mass spectrometry. The same proteomic approach 
was performed on gastrocnemious of 7- and 14-week-old 
wild type (NTg) mice to identify the physiological changes 
induced in muscle by ageing and  by crush of sciatic nerve 
in 14 weeks old animals.  
The same proteomic investigation was applied to 4 
patients presenting mutations in a SOD1 gene in a 
symptomatic stage of the disease; healthy age-matched 
subjects were adopted as controls.  
 Approximately 3500 spots were detected in a 3-10 
non linear pH gradient. Differential analysis of muscles at 
the early pre symptomatic age compared to NTg, 
revealed that 82 spots were significantly and differentially 
expressed in Tg hSOD1G93A versus NTg mice, 24 of them 
identified by mass spectrometry. At 14 weeks of age, 
quantitative differential analysis of Tg hSOD1G93A vs. NTg 
generated 153 differentially expressed spots, 55 were 
common to the two different disease stages, and 16 of 
them were identified. 
Among identified proteins, 8 were differentially 
expressed at 7 weeks and these changes were absent 7 
weeks later. All the proteins were mitochondrial. A total of 
7 proteins maintained the same up or down regulation 
suggesting their role as disease markers. 
Ageing induced a significant change in 95 spots, while 153 
were changed after denervation, 28 of them were common 
between ageing and crush. Only spots exclusively changed 
during disease progression or presenting differential behaviour 
from ageing and crush were taken into consideration. Overall, 
23 proteins were identified, 12 of them were not influenced by 
the ageing and denervation processes indicating these 
changes were exclusively related to disease progression. The 
remaining 11 proteins showed differential behaviour between 
pre symptomatic and symptomatic transgenic mice compared 
to ageing and denervation. 
R.7 
SEQUENCE-DEPENDENT COLLECTIVE 
PROPERTIES OF DNA AND THEIR ROLE IN 
BIOLOGICAL SYSTEMS. 
P. De Santis, A. Scipioni, G. Turchetti
Dipartimento di Chimica 
Università di Roma “La 
Sapienza” Roma, Italia 
In the present post-genomic era, DNA sequences with 
billions of informational elements are currently 
accumulating in the data banks and need to be translated 
into functional elements. The classic image of DNA, 
commonly represented as a straight rigid rod, is presently 
just an icon. The DNA chain, which was in a recent past 
considered as a simple repository of the gene information, 
is now recognized as a very complex polymorphic 
macromolecule, which plays a relevant part in the 
management of its informational content. Inside the cell, 
DNA continuously interacts with the proteins involved in 
replication, transcription, repair, and regulation processes. 
During these processes, the DNA transforms between 
packed and unpacked architectures, like that of chromatin 
or of other higher-order structures morphing into shapes 
with structural spikes alternative to the canonical B-form in 
connection with biological events. The base sequence 
encodes the dynamics of these transformations from the 
atomic to the nanometer scale length, and over higher 
spatial scales. Therefore, an important part of the DNA 
information content is not localized on the codon regions 
but is related to collective features of relatively large tracts 
of sequence. Since some years, we are investigating the 
effects of the sequence on modeling the superstructural 
properties of DNA by integrating over nano-scale the 
theoretically evaluated slight structural and electronic 
features of the different nucleotide steps along the 
sequence. Our theoretical model appears to be fully 
suitable to translate the base sequence in superstructural 
properties of DNA. It allows the prediction of the 
thermodynamic constants of the sequence dependent 
circularization reactions of DNA tracts and their writhing 
transitions from relaxed to super-coiled circular forms as 
well as the stability constants and positioning of 
nucleosomes along eukaryotic genomes in excellent 
agreement with the experiments. We have found that 
collective properties of DNAs are generally involved in 
nano-structural features and functional elements in 
genomes as well as in possible chemical evolution of 
nucleic acid informational content in prebiotic processes 
as can be speculated from the ability of inorganic surfaces 
to recognize and stabilize DNA tract of sequence. In fact, 
sequences strongly adsorbed on surface could be more 
protected against the physical-chemical injuries by the 
environment and therefore selected as "DNA phenotypes". 
1. Sampaolese B., Bergia A., Scipioni A., Zuccheri G., 
Savino M., Samorì B. and De Santis P. (2002) Proc. 
Natl. Acad. Sci. USA 99, 13566-13570. 
2. Anselmi C., De Santis P., Paparcone R., Savino M., 
Scipioni A. (2002) Biophys. Chem. 95, 23-47. 
3. Anselmi C., Bocchinfuso G., De Santis P., Savino M., 
and Scipioni A. (1999) J. Mol. Biol. 286, 1293-1301. 
4. Anselmi C., Bocchinfuso G., De Santis P., Fuà M., 
Scipioni A. and Savino M. (1998) J. Phys. Chem. B 
102 5704-5714.  
R.8 
QUADRUPLEX DNA: STRUCTURAL FEATURES AND 
POTENTIAL APPLICATIONS. 
A. Galeone, L. Mayol, G. Piccialli, A. Randazzo, G. 
Oliviero, V.  Esposito, A. Virgilio 
Dipartimento di Chimica delle Sostanze Naturali, 
Università di Napoli Federico II, Napoli, Italia 
G-quadruplexes are higher-order DNA and RNA 
structures formed by G-rich sequences based on tetrads 
of hydrogen bonded guanine bases.1 The important role 
of these structures in biological  systems relies mainly on 
three features, since they are probably (in several cases 
definitely) involved in: (i) the architecture of telomeres of 
many organisms;2 (ii) G-rich sequences that are present 
within a wide range of genes;3 (iii) the scaffolds of several 
oligonucleotide aptamers.4 G-quadruplexes are structures 
characterized by a great variability.5 Their structural 
differences involve several aspects, which are often 
mutually interconnected. For example, the relative 
orientation of the strands affects the glycosidic 
conformation (syn or anti) of the guanosine residues 
forming the scaffold of the quadruplex structure. In fact, 
each of the four possible strand arrangements, namely A4
(all strands parallel), A3B (three strand parallel and one 
antiparallel), A2B2 (two adjacent strands parallel and the 
other antiparallel) and (AB)2 (each strand running in the 
opposite direction respect to the adjacent ones),6 is 
characterized by the presence of different type of tetrad: 
all G-anti or all G-syn for A4, syn-syn-syn-anti or anti-anti-
anti-syn for A3B, syn-syn-anti-anti for A2B2 and syn-anti-
syn-anti for (AB)2. The structural variability of the 
quadruplexes has been further increased by introducing 
modification on both bases and sugar-phosphate 
backbone. In the latter frame, we have synthesized 
quadruplex forming oligonucleotides containing 8-methyl-
2’-deoxyguanosine being able to affect the syn-anti
conformational equilibrium. Furthermore, we have 
prepared and studied quadruplex structures containing a 
3’–3’ or 5’–5’ inversion of polarity site in the G-stretches 
and quadruplexes in which four strands are 
interconnected by a tetra-end linker. The structural 
features of these modified quadruplexes and their 
possible applications will be described and discussed. 
1. Burge S., Parkinson G., Hazel P., Todd A. K., Neidle 
S. (2006) Nucleic Acids Res. 34, 5402–5415. 
2. Oganesian  L., Bryan T. M. (2007) Bioessays 29, 55–
165 and references cited therein. 
3. Huppert J. (2006) in Quadruplex Nucleic Acids ed. S. 
Neidle and S. Balasubramanian, RSC Publishing, 
Cambridge, ch. 8, pp. 208–227 and references cited 
therein. 
4. Chou S.-H, Chin K.-H., Wang A. H.-J. (2005) Trends 
Biochem. Sci. 30, 231–234. 
5. Phan T., Kuryavyi V., Luu K. N., Patel D. J. and 
Dinshaw J. (2006) in Quadruplex Nucleic Acids, ed. S. 
Neidle and S. Balasubramanian, RSC Publishing, 
Cambridge, ch. 3, pp. 81–99 and references cited 
therein. 
6. Esposito V., Galeone A., Mayol L., Oliviero G., Virgilio 
A. and Randazzo L. (2007) Nucleosides, Nucleotides 
and Nucleic Acids 28, 1155-1159. 
R.9. 
PEG-ADDITION TO OLIGONUCLEOTIDES: A STORY 
WITH A FUTURE? 
G.M.Bonora
Dipartimento di Scienze Chimiche, Università di Trieste, 
Trieste, Italia 
The biological properties of synthetic oligonucleotides can 
be modified by their conjugation with polymeric moieties 
to get better cellular uptake, in vivo stability and, in 
general, more favourable pharmacological properties. 
Among the different biocompatible polymers, the 
poly(ethylene glycol) (PEG) was extensively investigated 
on the basis of its success with many proteins. 
The introduction of a large PEG chain by classical 
solid-phase procedures, as commonly used for much 
post-synthetic oligonucleotide modification, suffers from 
the phase heterogeneicity of the process that implies poor 
reactivity and unpredictable kinetic effects. To solve this 
drawback, different procedures for the PEGylation of 
synthetic oligonucleotides have been evaluates to 
ascertain the optimum level of modification achievable 
especially with large polymeric chains. The same 
procedure was applied to non-natural nucleic acid 
sequences as the PNAs. 
The presence of high-molecular weight PEGs has 
showed a minimal effect on the hybridization behaviour of 
the conjugated oligonucleotides, while a clear 
enhancement of in vivo stability and cellular permeation, 
without any adverse toxic effect, was observed. Recently, 
a PEGylated synthetic DNA sequence has been 
successfully commercialized, but other are expected to 
follow in a next future, in particular as new RNA-based 
derivatives. 
R.10 
NEW INHIBITORS OF METALLOPROTEASES VIA 
STRUCTURE/LIGAND BASED DESIGN: A CASE 
STUDY. 
A. Topai, F. Barile, C. Drago, T. Guzzo, L. Aureli, I. 
Cerbara 
C4T S.C.a r.l., via della ricerca scientifica snc, 00173 
Roma, Italia 
Matrix metalloproteinases (MMPs) are a family of 
approximately 27 Zn2+ ion-dependent endopeptidases 
which are involved in the proteolytic processing of several 
components of the extracellular matrix, such as collagens, 
proteoglycans and fibronectin as well as several cytokines 
and chemokines1.
As MMPs are involved in several pathological 
processes (cancer, arthritis, multiple sclerosis, 
cardiovascular diseases, etc), the development of 
powerful and selective inhibitors might represent an 
important therapeutic goal2.
However, recent failures of MMP inhibitors in cancer 
clinical trials have raised a question on MMPs
druggability, mostly because of their multiple and often 
contradictory role in cancer disease3.
Even though the relevance of the physiopathological 
role of MMPs is unquestionable, we need to understand 
which (and when) a MMP is actually involved in a specific 
pathological process to address the design of inhibitors 
toward a higher selectivity for different MMPs (the target 
MMP)4.
C4T carried out a drug discovery MIUR-financed 
project whose main aim was the exploitation of high-
throughput virtual screening, parallel synthesis of 
chemical libraries and in vitro screening, in order to 
discover new classes of MMP inhibitors.  
We adopted a challenging approach, studying a set of 
8 different MMPs representatives of shallow/deep-pocket 
S1’ as well as cancer target/anti-target proteases, namely 
MMP-1, MMP-2, MMP-3, MMP-8, MMP-9, MMP-12, 
MMP-13 and MMP-14.  
The aim was to identify a new series of compounds 
able to potently inhibit gelatinases and in particular MMP-2. 
An active site detailed in silico analysis, a 
pharmacophore design and a library screening from our 
virtual database were followed by rational compound 
selection based on criteria as docking scoring, physical-
chemical properties and ADMET predictions. 
This research approach let us identify different 
innovative scaffolds: a new inhibitors class active in 
nanomolar range is being patented (PCT: 
EP2008/055563) and a second group of NCEs containing 
a new Zinc Binding Group (ZBG) is being explored. 
Furthermore C4T is carrying on a novel approach for 
the identification of a potential class of MMP-13 inhibitors, 
whose main feature is an innovative no-Zinc-chelating 
mechanism of action. 
1. McQuibban G.A.; Gong J.H.; Tam E.M.; McCulloch 
C.A.; Clark-Lewis I.; Overall C.M. (2000) Science. 
289, 1202. 
2. Fingleton B. (2007) Curr. Pharm. Des. 13, 333. 
3. Coussens L.; Fingleton B.; Matrisian L.N. (2002)
Science. 295, 2387. 
4. Aureli L.; Gioia M.; Cerbara I.; Monaco S.; Fasciglione 
G.F.; Marini S.; Ascenzi P.; Topai A.; Coletta M. 
(2008) Curr Med Chem. In press. 
R.11 
NMR IN STRUCTURAL BIOLOGY AND DRUG-
DISCOVERY 
Claudio Luchinat
Università di Firenze 
ABSTRACT NOT RECEIVED 
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PEPTIDE ANTAGONISTS OF PROTEIN-PROTEIN 
INTERACTIONS IDENTIFIED BY SCREENING PROTEIN 
FRAGMENTS. 
M. Monti, A. Sandomenico, M. Sabatella, L. Tornatore, N. 
Doti, F. Viparelli, N. Dathan, C. Pedone, D. Marasco, M. 
Ruvo
Istituto di Biostrutture e Bioimmagini, CNR, and Università 
di Napoli, Federico II, via Mezzocannone, 16, 80134, 
Napoli -  Italia 
Protein tridimensional structure is the complex 
recapitulation of local and distant intramolecular forces 
that cooperatively contribute to maintain finely tuned 
energetic equilibria. Secondary structure motifs and small 
protein domains might act as building blocks that often 
can be isolated and investigated by several techniques to 
gain structural insights on the protein global structure and 
to modulate interactions with external partners.  
While a lot of progresses have been made in this field by 
using de novo designed synthetic peptides, the idea of 
using protein fragments obtained by chemical or 
enzymatic methods has been only rarely pursued. 
Enzymatic degradation of folded proteins under mild 
conditions can provide shorter polypeptides with 
preserved secondary and tertiary structures that can be 
“reminders” of the original structure and can be utilized as 
probes for structural studies and as useful tools in in vitro 
assays to identify protein-protein interaction contacts. 
Active fragments can also be used as agonists or 
antagonists of the original protein or as starting scaffolds 
for the design of more potent and selective ligands. This 
simple but effective methodology has been successfully 
applied to find out peptide antagonists of several protein-
protein interactions, allowing the identification of inhibitors 
having high efficacy and specificity. The systems studied 
include the complex between PED/PEA-15 and PLD1, 
believed to play a relevant role in the insulin resistance 
mechanism in PED/PEA-15-overexpressing tissues1,2, the 
self association of the CARD of BCL10 that mediates a 
protein oligomerisation event responsible of NF-?B
activation and cell proliferation and the self association of 
Gadd45?, a major player of the endogenous NF-?B-
mediated resistance to apoptosis in a variety of cell 
lines3,4.
1. Zhang, Y., et al., (2000) J Biol Chem 275, 35224-
35232. 
2. Viparelli, F., et al., (2008) J Biol Chem, in press. 
3. De Smaele, et al., (2001) Nature 414, 308-313. 
4. Tornatore, L.,et al., (2008) J Mol Biol 378, 97-111. 
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STRUCTURAL AND FUNCTIONAL 
CHARACTERIZATION OF HELICOBACTER PYLORI 
PROTEINS. IDENTIFICATION OF NEW 
PHARMACOLOGICAL TARGETS. 
L. Cendron, N. Barison, L. Sisinni, and G. Zanotti
Department of Chemistry, University of Padua, Italy and 
Venetian Institute of Molecular Medicine (VIMM), Padua, 
Italy 
H. pylori is a Gram-negative bacterium which establishes 
a life-long chronic infection in more than half of the human 
population. Infections are often asymptomatic, but, in an 
important minority, H. pylori causes a range of 
pathologies, including gastritis, peptic ulcers, 
adenocarcinomas and MALT lymphomas1. Several 
important factors involved in the bacterial survival and in 
the persistence of infection have been identified2. We 
have selected a pull of these H. pylori proteins, cloned, 
expressed in E. coli and purified for crystallization trials.  
In particular we have purified in high yield HP0175, a 
secreted toxin with PPIase activity that causes apoptosis 
of gastric cells3, HP1287, a homologue of Bacillus subtilis
TenA, a protein involved in the salvage of the thiamine 4.
Crystals of HP1287 have been obtained and the three-
dimensional structure determined at 2.8 Å resolution. The 
molecular model, a homotetramer with 222 symmetry, 
shows that the protein is structurally similar to the 
enzymes belonging to the TenA family. Activity tests are 
in progress. Very recently, diffraction quality crystals of 
the putative toxin HP1028 have been obtained and the 
corresponding SeMet derivative is under purification and 
crystallization trials.  
Other H. pylori relevant targets are under 
investigation, first of all some of the Cag secretion system 
major components and accessory proteins. Indeed, the 
presence of the genomic locus codifying for the Cag 
proteins, the so called cag-Pathogenicity Island (cag-PAI), 
constitutes one of the main features characterizing the 
most virulent strains1. These proteins define a peculiar 
secretion apparatus which is devoted to the major toxin 
CagA export, but also triggers a relevant proinflammatory 
response in the gastric epithelial cells. The CagZ, CagS 
and CagD structures have been solved, while crystals of 
two truncated fragments of CagV have been obtained5,6.
The structure determination is currently underway. 
1. M. Clyne , B. Dolan. And E.P. Reeves  FEMS 
Microbiol. Letters 268 (2), 135, (2007).  
2. D.N. Baldwin, B. Shepherd, P. Kraemer, M.K. Hall, 
L.K. Sycuro, D.M. Pinto-Santini, N.R. Salama Infect. 
Immun. 75,1005, (2007). 
3. C. Basak, S.K. Pathak,  A. Bhattacharyya, S. Pathak, 
J. Basu, M. Kundu J. Immunol. 174,5672, (2005). 
4. A.H. Jenkins, G. Schyns, S. Potot, G. Sun, T.P. 
Begley Nat. Chem. Biol. 3,492, (2007). 
5. L. Cendron , A. Seydel, A. Angelini, R. Battistutta and 
G. Zanotti J. Mol. Biol. 4,881, (2004).  
6. L. Cendron , E. Tasca, T. Seraglio, A. Seydel, A. 
Angelini, R. Battistutta, C. Montecucco , G. Zanotti 
Proteins 69(2),440, (2007). 
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STRUCTURE-BASED DISCOVERY OF ANTIVIRALS 
R. Hilgenfeld
Institute of Biochemistry, Center for Structural and Cell 
Biology in Medicine, University of Lübeck, Germany 
The majority of recent viral outbreaks has been caused by 
RNA viruses. Yet, for most viral infections, no causative 
therapy is available. Hence, there is an urgent need for 
discovering and developing new antivirals. For the past 
few years, my laboratory has been working on the 
structure-based design and the chemical synthesis of 
inhibitors of proteases from coronaviruses and 
picorna/enteroviruses.  
Coronaviruses have been in the spotlight since the 
SARS outbreak of the year 2003. These viruses feature the 
largest genome of all plus-stranded RNA viruses (27-31 kb 
of ssRNA). Open reading frame 1 covers 2/3 of the entire 
genome and codes for two polyproteins, pp1a and pp1ab, 
the latter of which arises through a ribosomal frameshift 
during translation. These polyproteins are processed by 
two or three viral proteases, yielding the non-structural 
proteins (Nsp1-16) required for virus replication. In most 
coronaviruses, these cleavage reactions are performed by 
three cysteine proteases, two of which are of the papain 
type (PL1pro and PL2pro) and one of the chymotrypsin type 
(Mpro). In SARS-CoV, there is only one PLpro. The main 
protease of Transmissible Gastroenteritis Virus (TGEV) 
was the first protein of any coronavirus to have its three-
dimensional structure determined1. This was followed by 
the structures of the homologous enzyme from human 
coronavirus 229E2 and from the SARS coronavirus3-5. Soon 
it became clear that the main protease is an attractive 
target for the design of anticoronaviral inhibitors. The latest 
inhibitors will be discussed, and a number of their 
complexes with the Mpro will be presented2,6-8. Also, new 
methodology will be presented for converting peptidic hits 
into non-peptidic lead compounds9.
Some of our inhibitors also exhibit an interesting 
activity against coxsackievirus B3 (CVB3) and 
caliciviruses. Hence, we have determined the crystal 
structure of the 3C protease of CVB3 and designed 
inhibitors against this target. We also characterized 
calicivirus 3C-like proteases10. Latest developments will 
be discussed. 
1. K. Anand et al. & R. Hilgenfeld: EMBO J. 21, 3213-
3224 (2002). 
2. K. Anand et al. & R. Hilgenfeld: Science 300, 1763-
1767 (2003) 
3. H. Yang et al. & R. Hilgenfeld & Z. Rao: Proc. Natl. 
Acad. Sci. USA 100, 13190-13195 (2003) 
4. J. Tan et al. & R. Hilgenfeld: J. Mol. Biol. 354, 25-40 
(2005). 
5. R. Hilgenfeld et al.: Adv. Exp. Med. Biol. 581, 585-591 
(2006). 
6. H. Yang et al.: PLoS Biol. 3, e324 (2005). 
7. K.H.G. Verschueren et al. & R. Hilgenfeld: Chem. Biol.
15, 597-606 (2008). 
8. S.I. Al-Gharabli et al. & R. Hilgenfeld & J. Rademann: 
ChemBioChem. 7, 1048-1055 (2006). 
9. M.F. Schmidt, et al. & R. Hilgenfeld & J. Rademann: 
Angew. Chem. Int. Ed. Engl. 47, 3275-3278 (2008). 
10. I. Robel, et al. & R. Hilgenfeld & J. Rohayem: J. Virol.
82, in press (2008).  
R.15 
ALLOSTERIC MODULATORS OF IL-8/CXCL8 
RECEPTORS.  
M. Allegretti
Dompè, L’Aquila 
Several allosteric modulators have been shown to 
contribute to physiological or pathophysiological 
processes, and allosteric sites represent attractive targets 
for small molecule drugs able to specifically inhibit signal 
transduction pathways induced by endogenous agonists 
rather than their interaction with the receptor as for 
orthosteric receptor antagonists. The allosteric modulation 
concept represents a largely unexploited region of the 
therapeutic chemical space, but it also poses new 
questions that invest different phases in drug discovery 
and design process, being the characterization of the 
binding mode only one of the first steps to the full 
comprehension of the specific mechanism underlying 
drug action. 
The chemokine family is a group of low molecular 
weight, multifunctional cytokines which play a primary role 
in the inflammatory response, finely regulating the 
leukocytes recruitment in the inflamed tissue and exerting 
additional functions in physiological and pathological 
conditions. Among the chemokine family, CXCL8 plays a 
key role in the activation and recruitment of neutrophils at 
the site of inflammation. CXCL8 binds two membrane 
receptors, CXCR1 and CXCR2, and in the last decade 
the physiopathological role of CXCL8 in several 
inflammatory conditions has been widely investigated. Up 
to date, a limited number of small molecular weight 
(SMW) CXCL8 inhibitors have been disclosed in the 
literature but only in recent times the first drug candidates 
have entered clinical studies aimed at the assessment of 
the therapeutic potential of this class. 
Reparixin (formerly repertaxin) and meraxin, identified 
in Dompé laboratories, are the first examples of neutral 
allosteric modulators of IL-8/CXCL8 receptors, CXCR1 
and CXCR2, with proved efficacy in several experimental 
models of IL-8/CXCL8-related acute and chronic 
pathologies. Reparixin is presently under evaluation in 
phase II clinical trials for early graft failure prevention in 
lung and kidney transplantation. The investigation on their 
mechanism of action has demonstrated a selective 
inhibition of IL-8/CXCL8-induced neutrophil migration, 
with no effect on agonist-induced receptor intracellular 
trafficking, possibly unravelling novel opportunities for 
optimized pharmacological modulation. 
Recent advances in the characterization of allosteric 
modulators of CXCL8 receptors will be discussed. 
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THE FUNCTIONAL EFFECTS OF THE NEW HUMAN 
HORMONE ABSCISIC ACID ON ANIMAL CELLS ARE 
MEDIATED BY THE SECOND MESSENGER CYCLIC 
ADP-RIBOSE. 
E. Zocchi1, S. Scarfì1, C. Ferraris1, F. Fruscione1, C. 
Fresia1, L. Guida1, S. Bruzzone1, M. Magnone1, C. Usai2,
A. Parodi1, G. Damonte1 and Antonio De Flora1
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Institute 
of Biophysics, CNR, Genova, Italy. 
Abscisic acid (ABA) is a hormone involved in pivotal 
physiological functions in higher plants, such as response 
to abiotic stress and control of seed dormancy and 
germination.  Recently, ABA was demonstrated to be 
autocrinally produced by human granulocytes and to 
stimulate granulocyte function through a signalling 
pathway involving the second messenger cyclic ADP-
ribose (cADPR)1.
Functional effects of ABA on human cells are not 
limited to granulocytes. ABA also stimulates the 
proliferation of human mesenchymal stem cells (MSC) 
and of uncommitted hemopoietic progenitors in vitro,
through a cADPR-mediated increase of the intracellular 
calcium concentration ([Ca2+]i).  
On MSC, ABA stimulates several functional activities, 
including cyclooxygenase 2-catalysed production of 
PGE2, release of several cytokines known to mediate the 
trophic and immunomodulatory properties of MSC and 
chemokinesis. ABA is produced and released by MSC 
stimulated by specific growth factors, by inflammatory 
cytokines and by lymphocyte-conditioned medium. 
Lymphocyte-stimulated human MSC produce and release 
ABA at concentrations sufficient to exert growth-
stimulatory effects on co-cultured CD34+ cells. 
On CD34+ cells, micromolar ABA induces 
transcriptional effects, which include NF-?B nuclear 
translocation and transcription of genes encoding for 
several cytokines.  
These results provide a remarkable example of 
conservation of a stress-hormone and of its second 
messenger from plants to humans and identify ABA as a 
new paracrine signal between MSC, 
inflammatory/immune cells and hemopoietic progenitors. 
1. Abscisic acid is an endogenous cytokine in human 
granulocytes with cyclic ADP-ribose as second 
messenger. Bruzzone S, Moreschi I, Usai C, Guida L, 
Damonte G, Salis A, Scarfì S, Millo E, De Flora A, 
Zocchi E. Proc Natl Acad Sci U S A  104(14):5759-64, 
2007.  
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S. Giordano., S. Corso,,V. Cepero, E. Ghiso, C. Migliore 
University of Torino Medical School, Institute for Cancer 
Research and Treatment (IRCC), Division of Molecular 
Oncology, Candiolo, Italy  
In spite of the established knowledge of the genetic 
alterations responsible for cancer onset, the genes 
promoting and maintaining the invasive/metastatic 
phenotype are still elusive. The MET proto-oncogene, 
encoding the tyrosine kinase receptor for Hepatocyte 
Growth Factor (HGF), senses unfavorable micro-
environmental conditions and drives cell invasion and 
metastasis. MET overexpression, often induced by tumor 
hypoxia, leads to constitutive activation of the receptor 
and correlates with poor prognosis. To establish the role 
of MET in the different phases of tumor progression we 
developed an inducible lentiviral delivery system of RNA 
interference. Silencing the expression of the endogenous 
MET gene in tumor cells resulted in impairment of the 
execution of the full invasive growth program in vitro, and 
of the generation of metastases in vivo. Notably, silencing 
MET in already established metastases led to their almost 
complete regression. This indicates that persistent 
expression of the MET oncogene is mandatory till the 
advanced phases of cancer progression. These findings 
can be explained by the known ability of MET to switch-off 
the apoptotic program and by its recently postulated 
contribution to the maintenance of stemness properties, 
required for the growth of metastatic colonies.  
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TARGETING CK2 AS A GENERAL STRATEGY IN 
SIGNAL TRANSDUCTION THERAPY 
Lorenzo A. Pinna
Dipartimento di Chimica Biologica dell’Università di 
Padova and Istituto Veneto di Medicina Molecolare 
(VIMM), Padova, Italy. 
In recent years a breakthrough has taken place in our 
understanding of molecular alterations underlying human 
diseases whereby most of pathological conditions are related 
to intra- and inter-cellular communication disorders. This 
gave rise to the concept of “Signal Transduction Therapy” 
(STT), a neologism coined to indicate a variety of 
approaches useful to identify and treat “signalling disorders”. 
The first choice targets in STT are protein kinases, for a 
number of reasons, notably the implication of these enzymes 
in nearly all signalling pathways, their deregulation often 
related to global diseases, and their catalytic nature, 
conferring susceptibility to low molecular weight active site-
directed specific inhibitors displaying pharmacological 
potential. Not surprisingly therefore the largest subset of the 
“druggable genome” (22%) is provided by the individual 
family of protein kinases (either Ser/Thr or Tyr specific)1,
which is encoded by less than 2% of the human genome 
(collectively referred to as the human “kinome”). Such a 
“druggable kinome” currently includes more than 150 
members of the family2 with inhibitors of many of these 
already in clinical practice or in advanced clinical trials. 
It is generally held that the pathogenic potential of protein 
kinases is conferred by their unscheduled activation, due to 
mutations and/or other genetic alterations responsible for the 
onset of specific diseases. Notable exceptions however are 
provided by a number of protein kinases whose pathogenic 
potential is not the outcome of obvious genetic alterations, 
being caused instead by their abnormally high cellular level, 
due to as yet not deciphered epigenetic events. The most 
remarkable example in this respect is provided by CK2, a 
highly pleiotropic, constitutively active Ser/Thr protein kinase 
whose level is invariably elevated in tumour cells, where it 
promotes a global anti-apoptotic and pro-survival response3,
defective susceptibility to anti-cancer agents4 and an 
accentuated multidrug resistance phenotype5. As a 
consequence cells with abnormally high CK2 levels appear 
to be positively selected by the tumour, a circumstance 
which makes CK2 an attractive target in a variety of 
neoplastic diseases where its down-regulation may abrogate 
a number of general devices exploited for tumour 
progression, even if the molecular alteration underlying the 
onset of the disease is not residing in CK2 itself. 
Based on these premises the development of selective 
cell permeable inhibitors able to attenuate CK2 activity may 
represent a “master key” useful for the treatment of a wide 
spectrum of different neoplastic disorders , rather than 
tailored for combating a specific type of cancer. 
1. Hopkins AL & Groom CR Nature Review Drug 
Discovery 1, 727-30 (2002) 
2. Visit: wwww.cellsignal.com/reference/kinase_disease.html 
3. Ahmad KA et al. Adv. Enz. Regul. (2008), doi: 
10.1016/j.advenzreg.2008.04.002 
4. Piazza FA et al. Blood (2006) 108, 1698-1707. 
5. Di Maira G et al. Oncogene (2007) 26, 6915-6926. 
Supported by AIRC and by the European Commission 
(Pro-kinase Research 503467) . 
R.19 
TARGETING HYPOXIA INDUCIBLE FACTOR 1 (HIF-1) 
FOR CANCER THERAPY.  
G. Melillo 
Developmental Therapeutics Program, SAIC Frederick 
Inc., National Cancer Institute at Frederick, Frederick, MD 
21702
Most solid tumors develop regions of low oxygen tension 
because of a tissue imbalance between oxygen supply 
and consumption. Hypoxic cancer cells are more invasive 
and metastatic, resistant to apoptosis and ultimately to 
chemo- and radiation-therapy. Failure to eliminate the 
hypoxic fraction of solid tumors is eventually associated 
with poor prognosis. Hence, the identification of survival 
pathways utilized by hypoxic cancer cells is important for 
the potential therapeutic implications and strategies to 
target hypoxic cell signaling are being actively pursued. 
HIF-1? is an attractive target for development of novel 
cancer therapeutics, in particular for its involvement in 
angiogenesis, tumor metabolism and metastasis. HIF-1 is 
not only expressed in cancer cells but also in stromal 
infiltrating cells and endothelial cells, thus representing a 
common molecular determinant of the tumor 
microenvironment. HIF-1 expression in macrophages 
regulates genes that may promote tumor growth, 
including the inducible nitric oxide synthase gene. HIF-1 
alpha expression in endothelial cells is essential for 
angiogenesis and response to growth factors. Therefore, 
HIF-1 may represent a novel target of the tumor 
microenvironment.   
Despite the increasing number of HIF-1 inhibitors 
described in the literature it is unclear which is the most 
effective way to inhibit HIF-1 and how these agents 
should be developed. Over the last few years the 
Developmental Therapeutics Program of the National 
Cancer Institute has identified several novel HIF-1?
inhibitors, including topotecan, a topoisomerase I poison 
that inhibit HIF-1? expression by a DNA-damage 
independent mechanism and echinomycin, which blocks 
HIF-1 DNA binding activity. In an effort to validate HIF-1 
inhibition in the clinic, we are conducting a clinical trial of 
oral topotecan on a 2-week schedule in patients whose 
cancers over-express HIF-1?, as assessed by IHC.  Since 
inhibition of HIF-1? alone may be insufficient to generate 
meaningful therapeutic responses we have tested the 
hypothesis that combination of HIF-1 inhibitors with 
antiangiogenic agents may have increased therapeutic 
efficacy. Results of the combination of topotecan with 
Avastin®, an anti-VEGF antibody, in xenograft models will 
be discussed. 
In conclusion, efforts should be aimed at validating 
HIF-1 inhibition in relevant animal models and in early 
clinical studies. Combination of HIF-1 inhibitors with novel 
molecular targeted agents should be explored to 
maximize the potential therapeutic effects of HIF-1 
inhibition. 
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DIOXYGENASE ENZYMES FROM ARENE-
DEGRADING BACTERIA: CAN WE DEVELOP THEIR 
POTENTIAL FOR APPLICATION IN BIOCATALYSIS? 
C. Allen, D. Boyd, L. Kulakov, N. Sharma 
School of Biological Sciences, Queen’s University of 
Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast, 
Northern Ireland, BT9 7BL. 
Arene-dioxygenase (or ring-hydroxylating dioxygenase) 
enzymes are typically found in bacteria that degrade 
aromatic hydrocarbons – including BTEX, PAHs and 
PCBs – under aerobic conditions. With these substrates 
they destabilise the aromatic ring, through incorporation 
of molecular oxygen, to yield arene cis-dihydrodiol 
metabolites. However, another significant property of 
these enzymes is their relaxed substrate specificity, and it 
has been shown that they can facilitate the 
biotransformation of a wide range of substrates to 
produce chiral alcohols of various types that can then be 
used as chiral precursors in organic synthesis (Boyd et 
al., 2001). 
Recently, we have explored the biochemical 
properties of these enzymes further, and have discovered 
a wider range of unexpected biotransformations (Boyd et 
al., 2006).  Here we discuss the implications of these 
findings – with special focus on the combination of 
dioxygenase biocatalysis with other forms of chemical 
catalysis, and on their application in ‘second generation’ 
biotransformations, where an initial biotransformation 
product is subjected to further rounds of biocatalysis with 
these enzymes. 
1. Boyd, D.R., Sharma, N.D., Allen, C.C.R. (2001). 
Aromatic dioxygenases: molecular biocatalysis and 
applications.  Current Opinion in Biotechnology, 12: 
564-573. 
2. Boyd, D.R., Sharma, N.D., Belhocine, T., Loke, P.L., 
Malone, J.F., McGregor, S., Allen, C.C.R. (2006). 
Dioxygenase-catalysed dihydroxylation of arene cis-
dihydrodiols and acetonide derivatives: a new 
approach to the synthesis of enantiopure 
tetraoxygenated arene bioproducts.  J. Chem. Soc., 
Chem. Commun., 4934-4936. 
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METABOLIC ENGINEERING: A TOOL FOR 
BIOREMEDIATION STRATEGIES. 
A. Di Donato, V. Cafaro, V. Izzo, E. Notomista, R. 
Scognamiglio, F. Alfieri, G. Bozza, F. Pennacchio.  
Department of Structural and Functional Biology, 
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Bioremediation strategies exploit the metabolic potential 
of microorganisms able to degrade pollutants. This is the 
case of Pseudomonas sp. OX1, which is able to use 
aromatic compounds like benzene, toluene, o-xylene and 
other phenols as the sole sources of carbon and energy. 
To unravel the molecular basis of this ability we have 
cloned, expressed and characterized toluene-o-xylene 
monooxygenase (ToMO) and phenol hydroxylase (PH), 
which activate aromatic hydrocarbons, and catechol 2,3 
dioxygenase (C2,3O), the “gateway” enzyme to the 
pathway that leads to molecules which enter CAC. We 
have discovered that ToMO and PH posses wide 
substrate specificity producing dihydroxylated aromatic 
compounds, which are not always substrates of C2,3O. 
For example ToMO and PH convert o-xylene, to 3,4-
dimethylcatechol - which is a good substrate of C2,3O - 
and m- and p-xylene, to 3,6- and 3,5-dimethylcatechols 
(DMC) which are not. Thus, production of these products 
is responsible for the inability of Pseudomonas sp. OX1 to 
grow on m- and p-xylene, hence impairing the 
“bioremediation potential” of the microorganism. 
Mutagenesis experiments indicate that changing 
residues 100, 103, 107, 176, 180 of ToMO A subunit 
allows to finely tune its regioselectivity. For example, 
mutant ToMO A-E103G is able to increase 3,4-DMP 
production, which is transformed by PH into 3,4-DMC, 
which can be further transformed by C2,3O. As for 
C2,3O, we have discovered that reducing the hindrance 
of residue T249 leads to a mutant which is able to bind 
3,6- and 3,5-DMC, whereas changing residues at 
positions 267 and 270 allows to increase the catalytic 
efficiency on these substrates. 
Another research line we are pursuing is the rapid 
identification, using bioinformatics tools, of new strains 
useful for bioremediation strategies. Presently, more than 
one thousand microbial genomes are being, or have 
been, sequenced. Microbial genomic databases are 
searched for proteins homologous to enzymes which 
initiate the catabolism of xenobiotics in already-known 
pathways. This allowed for the selection of four potentially 
useful strains: Ralstonia metallidurans CH34, 
Rhodobacter sphaeroides 2.4.1, Azotobacter vinelandii
OP and Silicibacter poymeroi DSS-3. A preliminary 
characterization of R. metallidurans CH34 and R. 
sphaeroides 2.4.1 has shown that they are able to 
metabolize aromatic compounds and tetrahydrofuran, 
respectively, a previously unknown ability. 
At the same time we have tried also to isolate new 
useful strains from polluted environments. Incubation of 
samples of surface seawater collected in the harbor of 
Pozzuoli - heavily polluted by fuels - with naphthalene, 
anthracene and phenanthrene, allowed to isolate several 
strains able to grow on complex mixtures of 
hydrocarbons. One of these strains, named PP1Y, is able 
to degrade methyl, ethyl, dimethyl, and trimethyl-
benzenes, biphenyl and several polyciclic aromatic 
hydrocarbons.
R.22 
MICROBIAL REDUCTIVE DEHALOGENATION FOR 
THE SUSTAINABLE REMEDIATION OF PCB-
CONTAMINATED SEDIMENTS. 
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Due to their high recalcitrance and hydrophobicity, PCBs 
are extensively accumulating in sub-surface sediments of 
freshwater and marine habitats, through which they enter 
the food chain. PCBs occurring in such sediments may  
undergo microbial reductive dechlorination, which results 
in their conversion into lower chlorinated less toxic and 
bio-accumulable congeners. The occurrence of such 
processes has been mostly observed in slurry 
microcosms of freshwater sediments suspended in 
mineral media and ascribed to bacteria of the phylum 
Chloroflexi. Recently, we detected microbial-mediated 
PCB reductive dechlorination processes in 5 marine 
sediments of Brentella Canal (Venice lagoon) suspended 
in their own site water, i.e. under geobiochemical 
conditions close to those in situ1-3.
To gain deeper insights on PCB dechlorination under 
such conditions, native microflora was sub-cultured 7 
times in sterile slurry microcosms containing decreasing 
amounts of sediment suspended in site water in the 
presence of 5 exogenous coplanar PCBs (100 mg/kg dry 
sed. each) and then of Aroclor 1254 (1 g/kg dry sed.). In 
the last two transfers, H2, short chain organic acids 
(formate, acetate, propionate and butyrate) and antibiotics 
(vancomycin, ampicillin) were monthly added to parallel 
cultures to study their effects on the dechlorination 
process. Additional microcosms without PCBs were also 
set up for each culture condition. Microbial populations 
selectively enriched under the different conditions in the 
presence and in the absence of PCBs were subjected to 
16S rDNA-DGGE analysis with universal Bacterial 
primers and primers specific for the dehalogenating 
members of the Chloroflexi phylum. 
Increasing PCB-dechlorination rates along with 
remarkable increases in sulfate-reduction and a 
progressive decline in methanogenic activity were 
observed throughout subculturing. The culture resulting 
from the last transfer displayed a marked dechlorination 
activity towards penta- through octa-chlorinated biphenyls 
of  Aroclor 1254, that were bioconverted by more than 70% 
into di-, tri- and tetra-chlorinated congeners after 30 weeks 
of incubation. DGGE analysis of 16S rRNA genes revealed 
the occurrence of a Dehaloccoccoides-like microorganism, 
having high sequence similarity with the putative PCB 
dechlorinating bacterium m-1, in all the actively PCB 
dechlorinating cultures, that was absent in all the 
corresponding PCB-free microcosms. Taken together, 
these findings suggest that reductive dehalogenation 
widely occur in situ in the Brentella Canal and that native 
Dehalococcoides-like bacteria are involved in the process. 
Thus, natural attenuation seems to be a feasible option for 
the sustainable remediation of the sediments of the Canal 
and suitable substrate mixtures able to selectively stimulate 
Dehaloccoides sp. in situ are currently sought.     
1. Fava F. et al. (2003) Chemosphere 53: 101. 
2. Fava F. et al. (2003) FEMS Microbiol. Ecol. 44: 309. 
3. Zanaroli G. et al. (2006) Biodegradation 17: 19. 
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SENSOR FOR CHEMICAL RISK 
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Sapienza” , P.Le Aldo Moro, 5; 00185 Rome - Italy. 
The traditional chemical analysis is not alway the most 
suitable way to assess the chemical risk from the 
environment where one is living. 
Generally a risk can be evaluated by integral indexes 
able to give informations not about this or that compound 
but about the integral effect of such contemporary 
presence. 
A description is here given of a preliminary approach 
to the use of a new generation solid state sensor based 
on the capacity of the sensor element to catalyze the 
photodegradation of various kinds of organic compounds 
and to monitor the consequent pH variation. The electron 
holes present in the TiO2 structure are able to trigger an 
oxidative process involving substances present in the 
environment, in particular those ones that can be 
adsorbed on it. These characteristics make titanium 
dioxide a suitable material to be used as a sensor for 
measuring environmental persistance and consequent 
risk. 
The informations are obtained by the delay to observe 
photodegradation starting from the initial irradiation and 
by the slope of the pH decrease following the beginning of 
the mineralization process announced by the acidification 
after the delay time. 
To the question about the contribution of Chemistry to 
the evaluation of human and environmental risk from 
anthropic activity , also a radical approach answer can be 
given. When we produce or use energy some of the 
energy remains segregated within secondary pathways 
molecules called radicals highly energetic and reactive 
due to the presence in their electronic structure of 
unpaired electrons which can be so or lost or coupled. As 
consequence the radicals act as reducing or oxidising 
agents. Radicals are able to attack any substrate or tissue 
so behaving as a very dangerous chemical species. 
Radicals particularly attack proteins and produce 
oxidative stress. 
All amino acid residues of proteins are potential 
targets for attack from reactive oxygen species (ROS) 
produced in the radiolysis of water; however, in only a few 
cases have the oxidation products been fully 
characterized. Moreover, under most physiological 
conditions, cysteine, methionine, arginine, lysine, proline, 
histidine, and the aromatic amino acids are primary 
targets for ROS-mediated oxidation. 
Exposure of proteins to reactive oxygen species can 
lead to the formation of protein-protein cross-linkages.   
Respiromeytric biosensor can also be successfully 
applied to chemical risk evaluation basing on the 
comparison between the respiratory capacity  of different 
cells in reference and actual conditions. 
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ORIGINS OF PROTEIN MISFOLDING 
DISEASES 
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Because proteins are involved in every chemical process 
taking place within living systems, the failure of proteins to 
fold, or to remain correctly folded, can give rise to serious 
cellular malfunctions that frequently lead to disease. One 
particularly important group of such diseases is 
associated with the aggregation of misfolded proteins into 
remarkable thread-like structures known as amyloid 
fibrils1, and includes disorders ranging from Alzheimer’s 
disease to late-onset diabetes, conditions that are 
becoming increasingly common in our aging populations. 
The manner in which the normal soluble forms of peptides 
and proteins can convert into these pathogenic amyloid 
structures is being uncovered by a wide variety of in vitro
experimental studies along with theoretical simulations 
and bioinformatics studies2. As with folding, these studies 
are increasingly being linked to events occurring in vivo
using a variety of strategies. Of particular interest are 
experiments an simulations designed to link the principles 
of misfolding and aggregation to the effects of such 
processes in model organisms such as Drosophila (the 
fruit fly). This talk will draw together some of the ideas 
that are emerging from recent work in our laboratory 
including evidence for the extremely narrow boundary 
between normal and aberrant behaviour4 and how this 
concept sheds light on the origin, current proliferation and 
potential means of prevention of many of the diseases 
associated with misfolding. 
1. Knowles et al. “Role of Intermolecular Forces in 
Defining Material Properties of Protein Nanofibrils”, 
Science 318, 1900-1903 (2007). 
2. C.M. Dobson and F. Chiti, Annu. Rev. Biochem. 75, 
333-366 (2006). 
3. Luheshi et al. “Systematic In Vivo Analysis of the 
Intrinsic Determinants of Amyloid-beta Pathogenicity”, 
PLoS Biol. 5, e290 (2007). 
4. Tartaglia et al., Trends Biochem. Soc. 32, 204-206 
(2007). 
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?2-microglobulin (? 2-m) is the nonpolymorphic light chain 
of the class-I major histocompatibility complex. The 
deposition of ? 2-m fibrils is associated to dialysis-related 
amyloidosis (Gejyo et al., 1985), a disease which arises in 
individuals with chronic renal failure following long-term 
haemodialysis treatment. Stopped-flow kinetic analysis 
(Chiti et al., 2001) could clearly reveal the occurrence of a 
long-lived intermediate of full-length ? 2-m, I2, along the 
refolding pathway characterized by a kinetic constant of 
about 10?3 s−1. The recent characterization of W60G ? 2-
m, a mutant of ? 2-m where the replacement of Trp60 
with a Gly is responsible for reduced conformational 
flexibility and dynamic association as well as for the loss 
of fibrillogenicity in TFE (Esposito et al., 2008), prompted 
us to elucidate comparatively the refolding kinetics of wild 
type and mutant–proteins at atomic definition level by 
NMR. Our analysis was thus conducted by the band 
Selective Flip Angle Short Transient (SOFAST) real time 
2D NMR method with a time resolution of few tenths of 
second. The results show that the refolding process is 
more complex than previously reported and seems to 
involve more than a single intermediate species with 
novel insights into the fibrillogenic conformation(s).  
Chiti, F., Mangione P., Andreola A., Giorgetti S., Stefani 
M., Dobson C.M., Bellotti V. and Taddei N. (2001) J. Mol. 
Biol. 307, 379-391. 
Esposito, G., Ricagno S., Corazza A., Rennella E., 
Gümral D., Mimmi M.C., Betto E., Pucillo C.E., Fogolari 
F., Viglino P., Raimondi S., Giorgetti S., Bolognesi B., 
Merlini G., Stoppini M., Bolognesi M. and Bellotti V. 
(2008) J. Mol. Biol. 378, 885-895. 
Gejyo F., Yamada T., Odani S., Nakagawa Y., Arakawa 
M., Kunitomo T., Kataoka H., Suzuki M., Hirasawa Y., 
Shirahama T., Cohen A.S. and Schmid K.(1985) 
Biochem. Biophys. Res. Commun. 129, 701-706. 
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Amyloidosis caused by β2-m offers elements of general 
interest for understanding the general mechanism of 
fibrils deposition in systemic amyloidosis. In this type of 
disease the tissue specificity of the amyloid deposition 
that is a generic clinical-pathological feature, of all the 
amyloidosis is particularly prominent. Bones, ligaments 
and synovial membranes are in fact the inescapable 
prominent target of the amyloid deposits. These peculiar 
hystopathological evidences should provide important 
clues on the elucidation of the real events occurring in 
vivo when the protein looses the monomeric globular 
structure and self aggregates into the typical cross-beta 
amyloid polymers. Combination of proteomic and 
ultramicroscopic studies provides interesting clues on the 
identification of tissue factors and characterisation of β2-
m modifications that might affect the kinetics of amyloid 
deposition. Natural amyloid fibrils accumulate in the close 
proximity of collagen fibres and in particular of those with 
the largest section. The pathognomonic cleavage at the 
sixth residues is only present when the deposit of β2-m is 
organized in the fibrillar structure.  Taking into account 
these findings we have established a method of 
fibrillogenesis in which β2-m is incubated with physiologic 
concentrations heparin, δN6-truncated β2-m and collagen 
fibres.  By this method we obtain the globular to fibrillar 
transformation in a physiologic-like environment. 
Structural transitions occurring in these conditions are 
unknown and difficult to disclose, but we have robust 
evidences suggesting that in these conditions the kinetics 
of fibrils formation is dictated by the concentration of 
soluble oligomers. The discovery of this method highlights 
the possibility that, in vivo, multiple factors might concur 
cooperatively to the protein amyloidogenesis. Availability 
of this method represents a significant step forward the 
accomplishment of research strategy aimed to identify 
new amyloid interactors suitable for pharmacological 
exploitation.  
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The prion diseases are fatal neurodegenerative disorders 
for which no effective treatment is available. A large 
number of molecules have been tested in an attempt to 
find therapeutic agents, but only a few classes of 
compounds showed any beneficial effect in in vivo and/or 
in vitro models. Studies from our group led to recognize 
that some tetracyclic compounds, such as 
iododoxorubicin and tetracyclines, are able to (i) interact 
with and revert the protease-resistance of PrPSc 
extracted from brain tissue of patients with all forms of 
CJD, cattle with BSE and rodents with experimental 
scrapie, (ii) reduce the infectivity titer in prion-
contaminated material, and (iii) prolong survival of prion-
infected animals. On this ground, a series of CJD patients 
observed at "Carlo Besta" Institute in the last five years 
received compassionate treatment with doxycycline at a 
daily oral dose of 100 mg from the time of diagnosis to 
death. The choice of this drug among others tetracyclic 
compounds effective in experimental models was based 
on the observation that doxyclycline has favorable 
kinetics, relatively good capacity to cross the blood-brain 
barrier, low toxicity and good tolerability even for 
prolonged administration. Indeed, no CJD patient 
chronically treated with this drug showed adverse 
secondary effects. The retrospective analysis revealed 
that the subjects treated with doxycycline (n=21) survived 
significantly longer than untreated patients (n=78); in 
particular, the survival time (median ± SE) was 13.0 ± 4 
months in the former and 6.0 ± 0.7 months in the latter 
(Log Rank test: p<0.001). A significant difference was still 
present when the doxycycline-treated group was 
compared to an untreated group equivalent for sex, age 
at onset and codon 129 PRNP polymorphism (treated: 
13.9 ± 3.8 months, untreated: 6.1 ± 0.5 months, p<0.01), 
which are major predictors of survival of CJD patients. 
This result, based on an open observation, is under 
verification in a randomized, double-blind study of 
doxycycline versus placebo that has been approved by 
the Italian Agency of Drug (AIFA). A positive outcome of 
this trial would activate similar studies in other 
neurodegenerative disorders due to protein misfolding 
such as Alzheimer’s disease, since the effects of 
doxycycline seem to be dependent upon a direct 
interaction with abnormal protein conformers with an 
extensive beta-sheet conformation rather than with a 
specific amino acid sequence.  
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T.Anelli°, L.Bergamelli°, M.Degano*, S.Vavassori°, 
L.Wang*, CC.Wang* and R.Sitia*
°DiBiT, Università Vita-Salute-Istituto Scientifico San 
Raffaele, Milano, Italia & *Chinese Academy of Sciences, 
Beijing, China.
The endoplasmic reticulum (ER) is a multifunctional 
organelle integrating diverse physiological tasks. Efflux of 
Ca2+ via IP3R1 is fundamental for many signalling 
processes. Moreover, suitable redox conditions must be 
maintained for oxidative protein folding and signal 
generation and tuning1. ERp44 mediates thiol-dependent 
retention in the early secretory pathway, forming mixed 
disulfides with Ero1α and Ero1β, the two main ER 
resident oxidases, and other substrate proteins through 
its conserved CRFS motif1-3. ERp44 also binds non-
covalently ERGIC-53 and IP3R1, thus concurring in the 
regulation of redox homeostasis, ER to Golgi protein 
transport and calcium signalling. Its crystal structure at a 
2.6 Å resolution reveals three thioredoxin domains, a, b 
and b’, arranged in a clover-like structure. A flexible C-
terminal tail turns back from the b’ to the a domain, 
shielding a hydrophobic pocket in domain b’ and a 
hydrophobic patch around the CRFS motif in domain a. 
Mutational and functional studies indicate that the C-
terminal tail gates the CRFS area and the adjacent 
hydrophobic pocket, dynamically regulating protein quality 
control2. The peculiar structure and subcellular 
localization of ERp44 suggest a key role of this conserved 
molecule in integrating protein transport and signalling in 
the early secretory compartment.   
1. Anelli & Sitia. 2008 EMBO J, 
2. Wang et al., 2008 EMBO Rep. 
3. Fraldi et al. 2008 Hum Mol Gen 
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“SEEING” AT THE NANOSCALE WITH THE ATOMIC 
FORCE MICROSCOPE 
A. Relini
Dipartimento di Fisica, Università di Genova, Genova, 
Italia 
Since its invention in 19861, the atomic force microscope 
(AFM) proved to be a powerful, non-invasive tool in the 
structural characterization of biological samples at the 
nanoscopic scale. This instrument employs a microscale 
cantilever with a sharp tip which probes the sample 
surface. The AFM allows operation both in air and in fluid 
environment; sample integrity can then be maintained 
under hydrated conditions. Under appropriate conditions, 
very high resolution can be attained, and, in favorable 
cases, even single biomolecules can be imaged. There is 
no need of fixation or staining procedures, which may 
affect sample morphology. Even very soft samples, which 
would be damaged by a steady contact with the tip, can 
be successfully imaged using the tapping mode, in which 
the AFM probe is oscillated, lightly tapping the sample 
surface. As samples can be maintained under controlled 
hydrated conditions, it is possible to perform in situ 
studies of processes such as assembly, polymerization, 
dissolution. Finally, the AFM can be used not only for 
imaging purposes, but also to perform force spectroscopy 
measurements, which can give information on single 
molecule rupture or stretching forces, such as those 
involved in ligand-receptor interaction or protein unfolding.  
Applications of this technique to the study of amyloid 
aggregation, protein crystals and protein/lipid membrane 
interaction will be presented. 
1. Binnig G., Quate C. F., and Gerber Ch. (1986) Phys. 
Rev. Lett. 56, 930-933. 
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ORTHOGONAL STRATEGIES IN PROTEOMICS
P. Pucci, A. Amoresano, G. Chiappetta, A. Palmese, M. 
Monti, F. Cozzolino, M. Cozzolino, G. Marino.
Dipartimento di Chimica Organica e Biochimica, 
Università Federico II di Napoli, Napoli, Italia
Following the end of the Human Genome Project, the 
biological challenge has again shifted from gene to the 
protein side, giving rise to the so-called “proteomic era”. 
Proteomics (the Science of Proteome) is a totally new 
way to look at the protein kingdom, aiming to investigate 
very complex protein mixtures within their biological 
context. Proteomic research is focused on two major 
areas, differential proteomics aimied to measure the up- 
and down-regulation of protein expression levels and 
functional proteomics, addressed to investigate protein 
functions in vivo.
In both cases, proteomic samples consist of complex 
mixtures of components that cannot be directly analysed 
without pre- fractionation by high resolution and sensitive 
techniques. Several separation methodologies have been 
developed most of which are based on two distinct 
physico-chemical properties of the sample, the so-called 
bidimensional (“orthogonal”) techniques. Among these, 
2D gel electrophoresis and 2D chromatography are 
commonly used since years.  
Besides these classical bidimensional approaches, 
new emerging mass spectrometry methodologies have 
evolved, together with high performance instruments 
capable of carrying out sophisticated experiments. These 
approaches give rise to a sort of “instrumentally driven” 
orthogonal selection of ions able to simplify the sample 
mixtures, leading to selective identification of specific 
peptides. 
Ion Mobility Spectrometry (IMS) was recently 
proposed to provides additional stages of ion separation 
before MS analysis. IMS is like a “Gas Phase 
Electrophoresis” in which the mobility of an ionised 
peptide is dependant on its Size (Shape) and Charge 
State. Since IMS separation is based on a different 
physical property from both HPLC and MS, it can provide 
an extra dimension of ion separation for the analysis of 
very complex mixtures.  
The RIGhT (Reporter Ion Generating Tag) strategy is 
based on the labelling of target residues with reagents 
capable of generating reporter ions in MS2/MS3 
experiments, such as Dansyl chloride. Fragmentation of 
dansyl derivatives shows the typical 170 m/z and 234 m/z 
ions in MSMS experiments and a diagnostic 234-170 m/z 
transition in MS3 mode. Experiments combining a 
precursor ion scan with a MS3 scan mode can then be 
tailored to selectively analyse derivatised peptides. 
Isolation of protein complexes in functional proteomics 
experiments mainly rely on (immuno)affinity procedures, 
followed by protein fractionation by SDS-PAGE and 
identification by LCMSMS. These procedures require 
extensive pre-cleaning steps to reduce false positives. 
Orthogonal methods have been proposed that integrate 
the (immuno)affinity steps with pre-fractionation of native 
complexes, as achieved by ultracentrifugation in glycerol  
or sucrose gradients, Blue Native Electrophoresis and/or 
gel filtration chromatography.  
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MANIPULATION AND IMAGING OF SINGLE BIO-
MOLECULES
Francesco S. Pavone
LENS, Università di Firenze, Firenze, Italy 
We will show some experiments in which biochemistry of 
molecule interaction is investigated at the single molecule 
level. In particular, we will show experiments where single 
DNA-protein interaction and single molecular motor 
dynamics and kinetics are investigated by means of 
optical tools. Some manipulation operations based on 
optical tweezers and magnetic tweezers will be shown, 
together with the possibility  to visualize single molecules. 
Finally, an experimental approach combining trapping and 
fluorescence detection will demonstrated the capability of 
single molecule localisation with nanometer spatial co-
localisation and 10 microsecond time resolution, allowing 
to follow in real-time single protein conformational 
dynamics. 
R.32 
MOLECULAR FUNCTIONS OF SIRTUINS. 
J. M. Denu, B. Smith, S. Lee, W. Hallows 
Department of Biomolecular Chemistry, University of 
Wisconsin, Madison, Wisconsin 
The Sir2 protein deacetylases (or Sirtuins) are an 
evolutionarily conserved family of enzymes that utilizes 
co-substrate NAD+ to deacetylate the ε-amino group of 
lysine from acetylated proteins, yielding two additional 
products nicotinamide and O-acetyl-ADP-ribose (Fig 1). 
Sirtuins have been implicated in a wide range of cellular 
processes, including pathways that affect diabetes, 
cancer, lifespan, and Parkinson’s disease.  Seven 
mammalian sirtuins (SIRT1-7) display diverse sub-cellular 
localization and have been implicated in cellular 
processes including cell survival, cell cycle regulation and 
genomic stability, fatty acid synthesis, and glucose and 
insulin homeostasis. To understand the molecular basis 
for sirtuin action, recently we have a.) probed the 
mechanism of catalysis using acetyl-lysine analog 
peptides, b.) identified metabolic enzymes as targets of 
regulation by sirtuins, and c.) determined sirtuin-specific 
changes to the mouse metabolome. The results indicate 
that mechanism-based chemical probes can be utilized to 
further our understanding of the biologial processes 
controlled by sirtuin activity1-2. The ability of SIRT1 and
SIRT3 to directly regulated the activity of key metabolic 
enzymes was demonstrated through the regulation of 
acetyl-CoA synthetases by SIRT1 and SIRT33, and the 
metabolome changes identified in the livers of Sirt3-/- 
mice. 
1. Smith, BC and Denu, JM. Mechanism-Based Inhibition 
of Sir2 Deacetylases by Thioacetyl-Lysine Peptide. 
Biochemistry. 2007, 46(50):14478-86.
2. Smith, BC and Denu, JM. Acetyl-lysine analog 
peptides as mechanistic probes of protein 
deacetylases. J Biol Chem. 2007, 282(51):37256-65. 
3. Hallows, WC, Lee, S, Denu, JM. Sirtuins deacetylate 
and activate mammalian acetyl-CoA synthetases. 
Proc Natl Acad Sci US. 2006;103(27):10230-5. 
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miR, "STEMNESS" & SKIN 
Gerry Melino
University Tor Vergata, Rome, Italy 
Although p63, similarly to its homologues p73 and p53, 
regulate apoptosis during DNA damage, shows a crucial 
role in regulating epidermal development. The activity of 
p63 depends on its steady state protein levels, and a 
number of evidence suggest that post-transcriptional 
regulation rather than transcriptional control plays a major 
role in p63 function. While p63 is important for epithelia 
formation (Candi et al. CDD 2006. 13: 1037), including 
the thymus (Candi et al. PNAS 2007. 104: 11999), p73 is 
also involved in neurodegeneration and immune 
responses. Although the tumor suppressor protein PML 
modulates p63 half-life by recruiting them to the PML-
nuclear bodies to regulate their transcriptional activities 
and thus inhibiting their degradation, the molecular 
mechanisms underlying the regulation of p63 protein 
stability remain largely unknown.  
We have identified the Hect-containing E3 (Nedd-4-
like) ubiquitin-protein ligase Aip4/ITCH as responsible for 
the proteosomal degradation of both p73 (Rossi et al. 
Embo J 2005. 24: 836) and p63 (Rossi et al. PNAS 2006. 
103: 12753).  The PY motif-containing C-terminal region 
of p73/p63 binds to the WW domain of Itch, resulting in 
ubiquitination and degradation of p73/p63.  We have also 
identified a regulator of ITCH activity, N4BP1, able to 
regulate the function of ITCH’s substrates (Oberst et al. 
PNAS 2007. 104: 11280).  On these bases, we are 
developing small molecular inhibitor of Itch able to 
regulate p73/p63 degradation and therefore their function 
in DNA damage, finely regulating apoptosis and 
chemosensitivity. 
Here, we describe the ability of p63 mutants, found in 
genetic diseases, to be regulated by Itch. We also report 
the identification of miR-203 able to target and repress 
p63, thus repressing “stemness” and allowing epithelial 
differentiation.  During keratinocyte’s differentiation the 
sudden upregulation of miR-203 causes the drastic 
reduction of DNp63 proteins, as miR-203 binds the 3’UTR 
of the trp63 transcript to regulate its translation.  This 
relationship is concerved in ES cell commitment in vitro. 
miR203 inhibit ES clonogenicity, while antagomiR-203 
enhances clonogenicity, in keeping with a role  of DNp63 
in “stemness” proliferation potential (Candi et al. PNAS 
2007. 104: 11999).   miR-203 seems to be at the interfece 
regulating the transit of epithelial cells from the 
“stemness” compartment to the differentiation 
compartment. 
R.34 
MANY FACES OF THE RNA BINDING PROTEIN KSRP
R. Gherzi, P. Briata. 
Centro Biotecnologie Avanzate (CBA) & Istituto Nazionale 
per la Ricerca sul Cancro (IST), Genova, Italy
The interaction of different protein factors with target RNA 
sequences is essential for the intricate series of events 
that determine post-transcriptional control of gene 
expression. KSRP is a single strand RNA-binding protein 
that interacts with distinct RNA sequences and is involved 
in different steps of post-transcriptional RNA life from 
splicing to transport, from cellular localization to decay. 
Many studies from our and other laboratories 
demonstrated that KSRP binds to inherently unstable 
mRNAs and target them for rapid degradation recruiting 
the ribonucleolytic enzymes. Now, we have found that 
KSRP is also implicated in an additional and unexpected 
step of post-transcriptional regulation of gene expression. 
KSRP is a component of both Drosha and Dicer 
complexes and binds with a high affinity to the terminal 
loop of a subset of miRNA precursors, critically regulates 
their maturation and, in turn, the ability of the mature 
forms to appropriately inhibit expression of target mRNAs. 
These findings reveal an unexpected mechanism that 
links KSRP to the machinery regulating maturation of a 
cohort of miRNAs, that, coupled to its role in promoting 
mRNA decay, serves to integrate specific regulatory 
programs of protein expression. 
This work has been supported by AIRC, ISS Italia-USA, e 
CIPE 2007 Regione Liguria. 
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RNA INTERFERENCE-BASED SCREENING OF GENES 
INVOLVED IN EMBRYONIC STEM CELL SELF-
RENEWAL AND DIFFERENTIATION 
T. Russo, F. Passaro, G. Aloia, L. Pastore, S. Parisi 
CEINGE biotecnologie avanzate, Università di Napoli 
Federico II, Napoli, Italy 
Loss-of-function genetics is a very powerful and effective 
tool to explore the functions of genes. In contrast to gene 
knock out obtained by genetic recombination, RNA 
interference offers a simple, rapid and quite effective 
approach to analyze the effects of gene suppression in 
cultured cells.  
We developed an assay based on the ability of mouse 
embryo stem cells (ESC) to differentiate in vitro leading to 
various neuronal populations. ESC clones, stably 
transfected with EGFP under the control of the neuron-
specific alpha1 tubulin gene promoter, show a robust 
expression of GFP starting from day 4 of differentiation.  
These clones were transfected with single plasmids 
each encoding an shRNA in 96 well plates and grown in 
differentiation conditions. At day four of differentiation the 
absence of GFP expression indicated that the 
suppression of the gene target of a specific shRNA was 
interfering with ESC differentiation. 
We have examined shRNAs targeting about 12,000 
genes and found out 80 of them that block ESC 
differentiation. 23 of these candidates have been 
validated by at least two independent shRNAs. They 
belong to three categories. The first one is that of mRNAs 
expressed in undifferentiated ES cells, whose 
concentration decreases upon differentiation. The second 
group is represented by genes that are expressed in ES 
cells, are downregulated upon the induction of 
differentiation and then reach the highest levels in fully 
differentiated cells. The last group contains several genes 
whose expression is actually unmodified before, during 
and after differentiation. 
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“miR GENES IN PAEDIATRIC CANCER” 
Massimo Zollo
1
CEINGE , Biotecnologie Avanzate, Napoli, Italia. 
2
Facoltà di Scienze Biotecnologiche, Dip.Biochimica e 
Biotecnologie Mediche, Via Pansini 5, Napoli, Italia 
Contacts: zollo@ceinge.unina.it 
The aim of my presentation is to overview the biogenesis 
of miRNAs and apply our knowledge on their expression 
in two main embryonal paediatric tumors. The first is 
derived from cerebellum in the Central Nervous System 
(MedulloBlastoma)  and the second from neural crest 
cells colonizing the adreanal medulla in the Peripheral 
Nervous System (Neuroblastoma). 
MicroRNAs (miRNAs) are small RNA of approximately 
22 nucleotides that play important regulatory roles by 
targeting mRNAs for cleavage or translational repression. 
Recent data showed that altered expression of specific 
miRNA contributes to the initiation and progression of 
cancer.  
Embryonal central nervous system tumors incidence 
is constant from infancy to 3 years of age, 
medulloblastoma (MB) accounts for 15%–20% of all 
childhood brain tumors. Children with nonmetastatic MB 
has improved considerably their survival, otherwise the 
outcomes for infants and for those with metastatic MB 
remain poor. Importantly miRNAs have been suggested in 
developmental timing, cell death, cell proliferation, and 
the patterning of the nervous system. We are applying a 
systematic analyses pipeline, including a bioinformatic 
target identification, a proof of inhibition of transcription 
and translation of target genes in vitro by luciferase 
assays and an overexpression and interference methods 
in MB cell lines, mostly identifying miRNAs with targets 
involved into specific pathways: Notch, WNT and SHH. 
We identified some miRNAs (from 
http://microrna.sanger.ac.uk/) potentially regulating target 
genes participating to these three pathways,  using the 
TaqMan (Applera, miRNA card) technology in a screening 
of 47 miRNAs in two MB cell lines, Daoy and D283Med. A 
quantitative expression analyses by Real Time PCR is 
allowing us to identify miRNAs differentially expressed 
during MB cell lines differentiation upon phenylbutirrate 
treatment. We found that several miRNAs which 
recognizes a specific region in 3’UTR sequence of 
important target genes already known to be involved in 
MB are good candidate for the validation step in vitro.
One miRNA identified is targeting HES1 protein, an 
important activator of NOTCH pathway. We highlight 
these results and speculate on their potential involvement 
in MB development. Additionally a second miRNA 
appertaining to a family of miRNAs has been found 
regulating DDL1, translating “in vitro” into an inhibition of 
this protein expression, and then either Notch1 activation 
or Notch2 signaling inhibition by its over-expression.  
Neuroblastoma (NB) is a childhood tumour derived 
from the sympathetic nervous system. It is suggested that 
it arises as a consequence of perturbed differentiation 
during the development of the sympathetic nervous 
system. In order to identify and characterize new miRNAs 
involved in NB we based our analyses on the isolation of 
new miRNAs from two independent approaches, one by 
isolating and characterizing an embryonic cDNA library of 
murine genes (Bulfone et al. 2005, Journal of 
Neuroscience), while the second strategy by analyzing 
the presence of potential miRNAs in repetitive elements 
into the genome. Following this latest approach, a novel 
miRNA, was characterized for its involvement in 
differentiation and apoptosis of human NB SH-SY5Y cells 
line, thus regulating the expression of target genes 
including IAPs (Inhibitors of Apoptosis proteins, BIRC1, 
BIRC4). We will present its functional correlation to 
neurodevelopmental processes such as neural 
differentiation and apoptosis, being a new controlling 
gene potentially involved in brain paediatric tumours. 
These approaches are then followed with “antago-mir” 
and 0-2 Methyl chemical synthesis technology thus 
resulting into impairing in vitro the miRNA function in cell 
lines, and in vivo and in ad hoc animal models 
(xenograft/orthotopic, adrenal medulla NB model). 
This study highlights the identification of a new 
miRNAs and their involvement in MB and NB cancer 
progression, and its potential use for future therapeutic 
applications. 
Acknowledgement: Grants support from AIRC, 
Associazione alla lotta del Neuroblastoma, EU-FP6 EET-
Pipeline. 
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THE ROLE OF OXIDATIVE STRESS IN INSULIN 
SECRETION AND AGING 
Fatima Mechta-Grigoriou
Institut Curie, “Stress and Cancer” Laboratory, 26, rue 
d’Ulm 75248 Paris Cedex 05 
Reactive oxygen species (or ROS) are implicated in the 
pathophysiology of various diseases, including cancer. 
JunD, a member of the AP-1 family of transcription factor, 
regulates genes involved in anti-oxidant defence and 
protects cells against ROS. Interestingly, by inhibiting 
anti-oxidant defence, junD-inactivation promotes chronic 
oxidative stress and stimulates angiogenesis. Indeed, we 
have recently uncovered a new mechanism linking 
persistent oxidative stress to enhanced angiogenesis 
(Gerald et al., 2004 ; Pouysségur and Mechta-Grigoriou, 
2006).  
Nearly sixty years ago, D. Harman proposed the “free 
radical theory of aging” correlating ROS production to 
aged-related pathologies and premature death. This 
theory suggested that endogenous ROS accumulate with 
aging and result in cumulative irreversible damages. More 
recently, several laboratories have also demonstrated that 
Insulin/IGF-1-mediated transduction pathways reduce 
lifespan in various species by stimulating energy storage 
and growth. This new theory can be referred to as “the 
endocrine theory of aging”. In agreement with its 
protective role against oxidative stress, junD-deficient 
mice (junD-/-) exhibit features of premature aging (such as 
alopecia, cachexia, cataract and sterility), develop 
cancers and die before the control littermates. junD-
deficient mice are then a model of choice for studying the 
molecular link between oxidative stress, aging and 
oncogenesis. Using these mice, we have established the 
pro-angiogenic effect of ROS in the systemic regulation of 
insulin that affects lifespan. We have then demonstrated 
that angiogenesis as a new link between two major 
theories of aging “the free radical theory” and the 
“endocrine theory”.  
Gerald, D. et al. (2004). JunD reduces tumor 
angiogenesis by protecting cells from oxidative stress. 
Cell 118, 781-794.  
Pouysségur, J. and Mechta-Grigoriou, F. (2006) Redox 
regulation of the Hypoxia Inducible Factor. Biol. Chem.
387, 1337-1346. 
Laurent G. et al., (2008). Oxidative stress contributes to 
aging by inducing pancreatic angiogenesis and insulin-
signaling.  Cell Metabolism, 7, 113-124 
R.38 
OXIDATION-COUPLED TRANSCRIPTION: 
DEMETHYLATION OF HISTONE H3 LYSINE 9 
INDUCES DNA OXIDATION AND DRIVES 
TRANSCRIPTION INITIATION BY ESTROGENS 
Enrico Avvedimento
Dipartimento di Biologia e Patologia Molecolare e  
Cellulare, Facolta’ di Medicina, Univerista’”Federico II” 
Napoli 
Covalent modifications at the N-terminal tails of 
nucleosomal histones, induced by protein complexes that 
assemble on chromatin, are required for gene 
transcription. We have analyzed the mechanism by which 
H3 histone methylations control expression of the 
estrogen-responsive bcl-2 and pS2 genes by chromatin 
immunoprecipitation analysis. DNA-bound estrogen 
receptor drives transcription by bending chromatin to 
contact the RNA polymerase II assembled 1.5 kilobases 
apart. This process is driven by receptor-targeted 
demethylation of H3 lysine 9 at both the enhancer and 
promoter sites, achieved by activation of resident LSD1 
demethylase.  
Localized demethylation produces hydrogen peroxide, 
which modifies surrounding DNA by oxidazing guanine. 
Oxidized base induces recruitment of the 8-oxoguanine-
DNA glycosylase 1 (OGG1) and topoisomerase II?,
triggering DNA cleavage and relaxation, essential for the 
assembly of the productive transcription initiation 
complex. 
By using chromatin immunoprecipitation we have 
screened promoter arrays with chromatin DNA 
immunoprecipitated with antibodies specific to estrogen 
receptor, OGG1 (8-oxoG glycosilase), Topoisomerase IIb
and LSD1. We have isolated several human promoters-
ERE regions that simultaneously recruit these proteins in 
the presence of estrogens. 
These data highlight the role of mismatch repair 
enzymes in transcription initiation and suggest a common 
evolutionary pathway between repair and transcription 
initiation. 
Cuozzo et al., 2007, PLoS Genet. 2007, 3, 1144-1162 
Perillo et al., 2008, Science;319, 202-6 
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IDENTIFICATION AND FUNCTIONAL 
CHARACTERIZATION OF A NOVEL ANTIAPOPTOTIC 
GENE INVOLVED IN ADAPTATION TO OXIDATIVE 
STRESS AND CHEMORESISTANCE. 
F. Esposito1, S. Calise1, M. Sciacovelli2, R. Sirignano1, A. 
Rasola2, and P. Bernardi2
1
Dipartimento di Biochimica e Biotecnologie Mediche, 
Università di Napoli Federico II, Naples, Italy, 
2
Dipartimento di Scienze Biomediche Sperimentali, 
Università di Padova, Padova, Italy 
TRAP1 (also known as heat shock protein 75) is a 
mitochondrial molecular chaperone homologous to 
HSP90 family members. Our previous studies 
demonstrated that: i) TRAP1 expression is increased in 
Saos-2 human osteosarcoma cells adapted to a mild 
oxidative stress by diethylmaleate, a GSH depleting 
agent1; ii) high TRAP1 levels yield cells highly resistant to 
DNA damage induced by oxidants and chemotherapeutic 
agents; iii) TRAP1 protects cells from apoptosis by platin 
derivatives2. Several observations suggest specific roles 
for this chaperone in mitochondrial physiology and 
indicate that TRAP1 may inhibit some key apoptogenic 
events in mitochondria, whose loss of regulation could 
contribute to different pathological conditions and 
phenotypes. However, molecular mechanisms involved in 
TRAP1 antiapoptotic functions have not been fully 
characterized.  
We have modulated the expression levels and sub-
cellular localization of TRAP1. TRAP1 stable knock down 
sensitized Saos-2 cells to cell death inducers acting both 
on the intrinsic pathway (oxidants, arachidonate) and on 
the extrinsic pathway to apoptosis (TNF?). Deletion of 
100 aminoacids from the N-terminus of the TRAP1 
protein (δNTRAP1) abrogated its mitochondrial 
localization, prevented the mitochondrial import of 
endogenous TRAP1, and favored apoptosis via the 
intrinsic pathway through sensitization of the 
mitochondrial permeability transition pore (PTP) to 
opening. The finding that both transient and stable 
transfectants expressing the δNTRAP1 mutant yield cells 
highly sensitive to apoptotic stimuli, suggests that the 
truncated protein, which differently from the wild type 
does not undergo phosphorylation, behaves as a 
“dominant negative” over the endogenous protein. In 
addition, we observed that TRAP1 stable transfectants, 
whose resistance to different apoptotic stimuli was widely 
demonstrated2, loose their cytoprotective function upon 
transfection with δNTRAP1 mutant.  
Taken together our observations demonstrate that 
mitochondrial TRAP1 exerts its antiapoptotic activity by 
desensitizing the permeability transition pore and define 
TRAP1 itself as a potential interactor of the PTP, thus 
expanding the range of possible combinatorial effects of 
drugs targeted to mitochondria for the treatments of 
human neoplasias and PTP-dependent diseases. 
1. N. Montesano Gesualdi, G. Chirico, M. T. Catanese,  
G. Pirozzi, and F. Esposito. Free Radical Res., 2006 
May; 40(5): 467-476. 
2. N. Montesano Gesualdi;  G. Chirico;  G. Pirozzi;  E. 
Costantino;  M. Landriscina; F. Esposito. Stress, 2007 
Nov; 10(4): 342-350. 
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REDOX REGULATION OF CELLULAR STRESS 
RESPONSE IN AGING AND NEURODEGENRATIVE 
DISORDERS: ROLE OF VITAGENES 
Vittorio Calabrese
Department of Chemistry, University of Catania, Italy 
Oxidative damage plays a crucial role in the brain aging 
process1. Induction of heat shock proteins (HSPs) is critically 
utilized by brain cells in the repair process following various 
pathogenic insults1,2. When appropriately activated, the heat 
shock response has the capability to restore cellular 
homeostasis and rebalance redox equilibrium. Activation of 
antioxidant pathways is particularly important for neural cells 
with relatively weak endogenous antioxidant defenses2. We 
have recently focused our research on the role of 
acetylcarnitine (LAC) in the defense mechanisms against 
cellular stress and neurodegeneration3. In the present study 
we investigated mRNA expression and protein synthesis of 
Hsps and the oxidant status in adult (12 months) and 
senescent (28 months) rats, and the effect of LAC treatment 
in senescent rats. mRNA and protein synthesis of Hsps 
increased in senescent rats compared to adults in all brain 
regions examined; the maximum increase was observed in 
the hippocampus followed by cerebellum, cortex, and 
striatum. Hsps increase was associated with increased 
expression and activity of carnosinase and thioredoxin 
reductase, with decreased expression of thioredoxin and with 
significant oxidative changes in glutathione redox state, as 
well as carbonyls and HNE contents. Interestingly, treatment 
with LAC resulted in a marked increase of heme oxygenase-
1 (HO-1), Hsp70, and mtSOD expression, of GSH content, 
and a decrease of HNE and protein carbonyl contents in the 
hippocampus, striatum, cortex and cerebellum. These results 
were also confirmed by in situ hybridization experiments. We 
used also a parallel redox proteomic approach4-8 to identify 
the proteins that are oxidized in aged rat brain and those 
proteins that are protected by LAC treatment. Redox 
proteomics analysis in HP and CX, brain regions in which all 
indices of oxidative modification are elevated in brain aging 
showed that the specific carbonyl levels of three proteins, 
hemoglobin (HMG), cofilin 1 (COF 1) and beta-actin (ACT), 
are significantly increased in HP of senescent rats. Carbonyl 
levels of these proteins are reduced by LAC administration in 
old rats brains. In the CX of senescent rats, the specific 
carbonyl levels of eight proteins were increased. These 
proteins are heat shock protein 70 (Hsp70), heat shock 
protein 90, (Hsp 90), glyoxylase 1 ( GOL 1), beta-actin 
(ACT), 3-mercaptopyruvate sulfurtransferase (MPST), 
peroxiredoxin 1 (PDX), phosphoribosyl pyrophosphate 
synthetase 1 (PPRPS1), and fumarase (FUM). LAC 
administration reduced the specific carbonyl levels of all 
these protein in the CX of senescent rats. The proteins 
identified in our study are involved in three processes which 
are impaired in aged brains: antioxidant defence, 
mitochondrial function and plasticity. LAC treatment might 
improve the decline of these functions. We posit that LAC 
should be considered as a potential therapeutic contributor 
for the treatment of cognitive decline in aging and age-related 
neurodegenerative disorders. In conclusion our results 
sustain a role for a redox-dependent modulation of Hsp 
expression occurring in aging brain. Notably, increased Heat 
shock protein expression, by promoting the functional 
recovery of oxidatively damaged proteins, protects brain cells 
from progressive age-related cell damage5-6. Therefore, 
therapeutic strategies focussing on acetylcarnitine treatment, 
by up-regulating HO-1 and Hsp70 signal pathways may 
represent a crucial mechanism of defence against free 
radical-induced damage of specific proteins occurring in 
aging brain and in neurodegenerative disorders7-8. This 
findings are relevant to potential pharmacological strategy 
pointing to maximize cellular stress resistance in vulnerable 
tissues such as the brain and thus providing 
neuroprotection6-10.
1. Halliwell B. (2008) Arch Biochem Biophys (epub) 
2. Calabrese et al (2007) Front Biosci 12,1107; 
3. Calabrese et al (2008) J Neurosci Res 86,1212;  
4. Calabrese et al (2007) Free Rad Biol Med  43, 160; 
5. Calabrese et al (2007) Neurochem Res 32, 757; 
6. Calabrese et al (2008) J Neurosi Res 86,1212; 
7. Calabrese et al (2008) Cell Stress Chaperon 12,299;     
8. Calabrese et al (2007) J Neurochem 101,709; 
9. Calabrese et al (2007) Nature Neurosci 8,766; 
10. Calabrese et al (2008) Neurochem Res (Epub July 16)
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Sphingosine-1-phosphate (S1P), a metabolite of 
membrane sphingolipids, has emerged as a potent 
biomediator that has important roles in the regulation of 
vital cellular processes. S1P is biosynthesized through 
the phosphorylation of sphingosine in a reaction catalyzed 
by sphingosine kinase (SK). A peculiarity of S1P as a 
signaling molecule lies in its dual action mechanism since 
it may act as a second messenger, through intracellular 
targets, and as an intercellular mediator, after interaction 
with specific subtypes of the G-protein-coupled receptor 
family (S1PR).  In the nervous system, S1P metabolism 
and S1PRs expression are regulated throughout 
development and show distinct features within specific 
cell types. A variety of extracellular stimuli, as growth 
factors, pro-inflammatory cytokines, and Ca2+ mobilizing 
stimuli, activate intracellular SK and lead to a concomitant 
rise of S1P in various neural cells.  Although S1P has 
been shown to act as an intracellular second messenger, 
its actions in the nervous system appear meanly 
mediated through interaction with specific S1P receptors, 
thus implicating it as a key mediator in cell 
communication. In fact, after binding to specific receptors, 
S1P can regulate a wide variety of biological processes in 
neurons, glial cells and brain endothelial cells. In the 
different cells of the nervous system, S1P has been 
shown to regulate cellular proliferation, shape regulation, 
migration, differentiation, neurogenesis, angiogenesis and 
survival. A key question on the role of S1P in the nervous 
system is how this bioactive sphingoid is produced in the 
extracellular milieu. In recent studies, we obtained 
evidence that different cells from the nervous system, 
including neurons, astrocytes and glioma-derived cells, 
can constitutively export S1P in the extracellular milieu, 
and various exogenous stimuli, as growth factors, phorbol 
esters and depolarizing agents, can enhance this 
secretion. Among the different cells of the nervous 
system, brain endothelial cells appear the most efficient in 
S1P secretion. In contrast to neurons and glial cells, 
these cells can also constitutively export an enzymatically 
active SK, which may play a role in producing S1P 
outside the cell. SK expression and S1P secretion by 
endothelial cells was found to be potently induced after 
conditioning with human glioma cells. 
Overall, the current data strongly support S1P as a 
crucial mediator in the dialogue among different cells in 
the nervous system, and implicate this sphingolipid in the 
regulation of physiological and pathological events in the 
nervous tissue. 
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Diacylglycerol kinase enzymes (DGKs) convert 
diacylglycerol (DG) into phosphatidic acid (PA), thus 
acting as molecular switches between DG- and PA-
mediated signalling. Consistently down-regulation of 
DGKs function enhances DG-mediated signalling in 
several cell signalling system. Conversely growth factors 
activate DGKa in different cell types. We showed that 
HGF-, VEGF- and chemokines-induced biological 
activities, including cell proliferation, migration and 
invasion, are mediated by activation DGKa (Cutrupi et al 
EMBO J 2000; Baldanzi et al. Oncogene 2004; 
Bachiocchi et al. Blood  2005; Chianale et al. Mol. Biol. 
Cell. 2007; Baldanzi et al. Oncogene, 2008).  
Growth factors-induced activation of DGKa occurs 
through tanslocation to the plasma membrane driven by 
its association with Src tyrosine kinase, requires PI(4,5)P2
hydrolysis and is independent by PI-3kinase. 
Finally we investigated the signalling pathways 
regulated by DGKa. We show that upon growth factors 
stimulation, DGKa provides a signal which is necessary 
and sufficient to recruit to the membrane  Protein Kinase 
C zeta (PKCz), an atypical PKC, and to activate it. Then 
activated membrane-bound PKCz activates several 
downstream signalling pathways, leading to Rac 
activation  through regulation of RhoGDI function, and 
activation of metalloproteases. 
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(Glyco)sphingolipids at the cell surface interact with 
plasma membrane receptors (e.g., integrin receptors and 
growth factor receptors) and adapter molecules forming 
signaling complexes that are able to influence the activity 
of signal transduction molecules oriented at the cytosolic 
surface of the plasma membrane (mainly the Src kinases 
pathway members). The function of these signaling 
complexes appears to be strictly dependent on their 
(glyco)sphingolipid composition, and likely on specific 
sphingolipid-protein interactions. From this point of view, 
particularly intriguing is the connection between 
(glyco)sphingolipids and caveolin-1, a membrane protein 
that plays multiple roles as a suppressor of tumor growth 
and metastasis in ovarian, breast and colon human 
carcinomas1.
In particular, it has been suggested a role for GM3-
regulated complexes and for GM3 synthase 
(sialyltransferase-1, SAT-1) in the control of integrin-
mediated tumor cell motility. We stably overexpressed 
SAT-1 in A2780 human ovarian carcinoma cells. All SAT-
1 transfectants were characterized by higher ganglioside 
levels and by a markedly reduced cell motility when 
compared to wild type or mock transfected A2780 cells. A 
similar reduction of cell motility has been observed in the 
phenotypic variant A2780/HPR, characterized by high 
levels of GM3 synthase. On the other hand, 
pharmacological treatments able to increase the cellular 
ganglioside levels in A2780 cells strongly inhibited their 
motility. Caveolin-1 mRNA and protein levels were 
markedly up-regulated in SAT-1 transfectants. 
Immunoprecipitation experiments showed that caveolin-1 
was associated with glycosphingolipids, c-Src and integrin 
receptor subunits. Moreover, c-Src was in a less active 
state in SAT-1 transfectants, as indicated by its increased 
phosphorylation at the carboxy-terminal tail at Tyr 527.  
These results suggest that decreased motility could be 
linked to the function of a signaling complex between 
GM3, caveolin-1 and integrins, leading to inactivation of c-
Src.  
1. Prinetti A. et al. (2008) Biochim. Biophys. Acta 1780, 
585-596 
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The glycerophosphoinositols (GPIs) are cellular products 
of phospholipase A2 and lysolipase activities on the 
membrane phosphoinositides. Their intracellular 
concentrations is in the micromolar range and can vary 
upon oncogenic transformation, cell differentiation and 
hormonal stimulation. Our studies into the formation of 
glycerophosphoinositol (GroPIns) in intact epithelial 
thyroid cells have indicated that its levels depend on 
hormonal (adrenergic and purinergic) stimulation of 
phospholipase A2IV? via a MAPK-dependent pathway. A 
glycerophosphodiester phosphodiesterase (GDE1/MIR16) 
is involved in their catabolism, which, as with their 
formation, is under hormonal regulation.  
The GPIs have diverse effects in multiple cell types. 
For instance, they induce cell proliferation in thyroid cells; 
inhibition of inflammatory responses in lymphocytes; 
changes in actin cytoskeleton organization in fibroblast, 
and reduction of the invasive potential of some tumour 
cell lines such as melanomas and breast carcinomas.  
The mechanism of action of the glycerophosphoinositol 
4-phosphate (GroPIns4P, when added exogenously), at 
least in fibroblasts, involves the activation of a signalling 
cascade that acts through the tyrosine kinase Src, PLCγ
and Ca2+/calmodulin kinase II. This results in TIAM1 
translocation to the plasma membrane, and thence to the 
formation of membrane ruffles via Rac1 activation.  
Attempts to identify molecular targets of the GPIs (through 
a proteomic approach) have led to the identification of ß-
actin, cortactin, ERK1/2, phospholipase A2 ?  and ? Pura?
all proteins that support the proposed roles of the GPIs in 
the regulation of the actin cytoskeleton and various 
signalling enzymes. Interestingly, the direct interaction of 
GroPIns with purified Pura, leads to the modulation of the 
activity of this transcription factor, indicating that these 
compounds may also act in the nucleus. 
Recent studies have focussed on inflammatory and 
immune responses, as some of the cells involved in these 
functions have potent phospholipase A2 activities that 
generate GPIs. We found that GroPIns4P enhances 
CXCR4-dependent chemotaxis in T lymphocytes. This 
activity results from the capacity of GroPIns4P to activate 
the Rho GTPase exchange factor Vav, through an Lck-
dependent pathway which also results in activation of the 
stress kinases JNK and p38. GroPIns4P was also found 
to activate with a delayed kinetics the Lck-dependent 
activation of ZAP-70, Shc and Erk1/2. These activities of 
GroPIns4P were found to be dependent on its capacity to 
inhibit cAMP production and PKA activation. In addition, a 
potent modulatory effects on the proliferation of 
lymphocyte proliferation induced by the T cell receptor 
activation was also observed. These data provide the first 
evidence of a role of GPIs as modulators of T-cell 
signaling and T cells responses.  
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Ullrich congenital muscular dystrophy (UCMD) is due to 
mutations in the genes encoding collagen VI, an 
extracellular matrix protein forming a prominent 
microfibrillar network in the endomysium of skeletal 
muscle. Myoblasts from UCMD patients display 
mitochondrial alterations and increased apoptosis due to 
inappropriate opening of the permeability transition pore 
(PTP), a mitochondrial inner membrane channel that can 
be desensitized by cyclosporin A (CsA). We will report the 
results of a pilot trial with CsA in five patients with 
collagen VI myopathies. Prior to treatment, all patients 
displayed mitochondrial dysfunction and increased 
frequency of apoptosis. Both these pathological signs 
were largely normalized after 1 month of oral CsA 
administration, which also increased muscle regeneration. 
Together with results obtained by genetic crossing of 
mouse models of muscular dystrophy with mice lacking 
cyclophilin D these findings indicate that mitochondrial 
dysfunction plays a critical role in human muscle diseases 
in vivo; and represent an important proof of principle that 
hereditary muscle diseases can be cured with proper 
drugs downstream of the genetic lesion. This is a useful 
example of how translational medicine can rapidly move 
from animal models to treatment of human diseases; and 
how mitochondrial medicine may be useful beyond the 
cure of primary mitochondrial diseases. 
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Nitric oxide (NO) controls mitochondrial respiration via the 
rapid (milliseconds) reversible inhibition of cytochrome c
oxidase (CcOX) [1, 2 and ref therein]. Two reaction 
mechanisms have been described leading to formation of 
either a relatively stable nitrosyl-derivative (CcOX-NO) or 
a more labile nitrite-derivative (CcOX-NO2
-). Both adducts 
are inhibited though with different KI, and one mechanism 
may prevail on the other depending on the turnover 
conditions and substrates concentration (cytochrome c
and O2). We have shown that under normal cell-culture 
O2 tension (∼ 270 ?M) neuroblastoma as well as lymphoid 
cells mitochondria degrade NO to nitrite, switching to 
nitrosylation upon rising the electron flux level of the 
respiratory chain at the level of CcOX [3]. Findings are 
discussed with respect to cell availability  of NO and its 
effect on the control of electron flux through the 
respiratory chain, as well as to the putative patho-
physiological relevance of the reaction of NO with 
mitochondria. 
1. Brown GC.  (2001) Biochim Biophys Acta. 1504(1): 
46-57.  
2. Sarti, P., Giuffrè, A., Barone, M.C., Forte, E., 
Mastronicola, D. and Brunori, M. (2003) Free Radicals 
in Biology and Medicine 34: 509 – 520.  
3. Masci, A., Mastronicola, D., Arese, M., Piane, M., De 
Amicis, A., Blanck, T.J.J., Chessa, L. and Sarti, P. 
(2008) Biochim Biophys Acta 1777: 66 – 73. 
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The aim of the present study was to evaluate whether 
enhanced substrate-level phosphorylation catalyzed by 
the TCA cycle succinyl-CoA synthetase increases the 
survival of cells with impaired oxidative phosphorylation 
under different conditions of energy demand.  We used 
both experimental in vitro models, in which cell lines are 
"poisoned" with specific inhibitors, and "natural" models, 
including transmitochondrial human cell lines (cybrids) 
harboring four different pathogenic mutations1. Moreover, 
we have used different cell types to better simulate the 
vulnerability of the nervous system to mitochondrial 
dysfunction. We found that human fibroblasts cultured in 
glucose-free medium and energy-challenged by 
oligomycin inhibition, had a 5 % survival at 72 h, which 
increased to 70 % when the medium was supplemented 
with α-ketoglutarate/aspartate. Similarly, homoplasmic 
cybrids carrying the 8993T?G NARP mutation were also 
protected from death (75 vs 15% survival at 72 h) by the 
supplemented medium. Significantly, the ATP content of 
cells protected by the α-ketoglutarate/aspartate 
supplement was similar to controls.  In contrast, cells with 
impaired mitochondrial protein synthesis (MERRF 
8356T?C and MELAS 3243A?G) or with rotenone-
induced complex I deficiency were not protected by the 
supplement, as shown by unaffected viability and ATP 
content. These results indicate that α-
ketoglutarate/aspartate supplementation to cells is 
especially beneficial when the impaired enzyme of 
OXPHOS is ATP synthase2, and cells are under 
conditions of high energy demand. This suggests 
potential dietary or pharmacological therapeutic 
approaches based on the supplementation of α-
ketoglutarate/aspartate to patients with impaired ATP 
production and functional respiratory chain. 
1. Pallotti F., Baracca A., Hernandez-Rosa E., Walker 
W.F., Solaini G., Lenaz G., Melzi D'Eril G.V., Dimauro 
S., Schon E.A., Davidson M.M. (2004)Biochem 
J.384,287-93. 
2. Sgarbi G., Baracca A., Lenaz G., Valentino L.M., 
Carelli V., Solaini G. (2006) Biochem J. 395,493-500. 
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The internal membrane of mitochondria contains 
numerous nuclear-coded proteins belonging to the 
mitochondrial carrier protein family that transport 
metabolites, nucleotides and coenzymes from the 
cytoplasm in the mitochondrial matrix and vice versa. The 
functional information obtained in studies with 
mitochondria and/or the reconstituted system has helped 
to gain insight into the physiological role of mitochondrial 
carriers in cell metabolism, as have tissue distribution, the 
use of knock-out mice (and/or yeast) and over-expression 
in human cell lines (or yeast) of individual carriers and 
isoforms. Furthermore, the cloning and functional 
identification of many human genes encoding 
mitochondrial carriers have led to the discovery of genetic 
defects responsible for disease and to understanding the 
symptoms of the disorders. Mutations of mitochondrial 
carrier genes involved in mitochondrial functions other 
than oxidative phosphorylation are  responsible for 
carnitine/acylcarnitine carrier deficiency, HHH syndrome, 
aspartate/glutamate isoform 2 deficiency, Amish 
microcephaly, and neonatal myoclonic epilepsy; these 
disorders are characterized by specific metabolic 
dysfunctions, depending on the physiological role of the 
affected carrier in intermediary metabolism. Defects of 
mitochondrial carriers that supply mitochondria with the 
substrates of oxidative phosphorylation, inorganic 
phosphate and ADP are responsible for diseases 
characterized by defective energy production. With the 
exception of progressive external ophthalmoplegia (PEO), 
which is an autosomal dominant disorder, all the other 
currently known diseases are autosomal recessive. 
Particular emphasis will be given to the molecular basis 
and pathogenetic mechanism of these inherited disorders.
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Most of mitochondrial protein are encoded by nuclear 
genes, translated in the cytosol and imported into 
mitochondria. It has been reported that cAMP signalling 
(via PKA) is able to promote the level of some proteins in 
mitochondria through transcriptional (Gopalakrishnan et 
al., 1994), post-transcriptional (Ginsberg et al., J. Mol. 
Biol, 2003) and post-translational (Robin et al., JBC, 
2003) regulation. 
Work is presented here on the effect of PKA mediated 
phosphorylation of the NDUFS4 and CREB proteins on 
their import, accumulation and activity in mitochondria.  
The human NDUFS4, a subunit of complex I of 
respiratory chain, has a conserved serine phosphorylation 
consensus site for PKA in the carboxy-terminal tail. The 
bovine ESSS, another subunit of complex I, has also a 
consensus serine phosphorylation site which, however, is 
absent in the human subunit. The results show that the 
accumulation in mitochondria of the mature NDUFS4 
protein is specifically promoted by PKA-catalysed 
phosphorylation of the serine at the C-terminal and 
depressed by alkaline phosphatase (AP). PKA and AP 
had no effect on the import/maturation of the ESSS 
subunit. The PKA promoting effect on the mitochondrial 
accumulation of NDUFS4 protein appears to be due 
inhibition of its retrograde diffusion into the cytosol, 
through interaction of the phosphorylated form with the 
cytosolic Hsp70 (De Rasmo et al., Cell. Sign., 2008). 
Phosphorylation of the NDUFS4 subunit can play a 
functional role in vivo in maintaining the intramitochondrial 
concentration of the mature NDUFS4 subunit at the level 
required for its assembly in complex I. This promoting 
effect of PKA can be involved in the stimulation of the 
NADH-ubiquinone oxidoreductase activity and prevention 
of mitochondrial oxygen free radical production exerted in 
vivo by cAMP in murine and human fibroblast in cultures 
(Papa et al., BBA, 2008). 
The human CREB has a PKA phosphorylable serine. 
The results indicate that CREB protein enters in isolated 
mitochondria by a classic mechanism Δ? dependent. In 
this case PKA and AP had no effect on the 
import/accumulation of the CREB protein but cytosolic 
PKA increased the transcriptional factor activity of CREB 
protein in mitochondrial matrix which resulted in an 
enhancement of mitochondrial encoded protein synthesis.  
In addition to those present in the cytosol, evidence is 
available showing the existence in the inner mitochondrial 
membrane of a pool of PKA and protein phosphatases, 
which can phosphorylate/dephosphorylate respectively 
the mitochondrial proteins in the inner mitochondrial 
compartment. Cytosolic and mitochondrial PKA and 
phosphatases can contribute to modulate the 
phosphorylation state and activity of the mitochondrial 
proteins.  
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Mitochondria harbour a conserved proteolytic system 
mediating the complete degradation of organellar 
proteins. Among the proteins composing this system 
there are paraplegin and AFG3L2, ubiquitous nuclear-
encoded mitochondrial proteins belonging to the AAA 
metalloproteases family. These proteins form high 
molecular weight hetero-oligomeric paraplegin/AFG3L2 
and AFG3L2 homo-oligomeric complexes known as m-
AAA proteases. Mutations of paraplegin cause a specific 
axonal degeneration of the upper motoneuron and, 
therefore, hereditary spastic paraplegia. We 
charaxcterized two Afg3l2 murine models: a newly-
developed null and a spontaneous mutant that we found 
carrier of a missense mutation. Contrasting with the mild 
and late onset axonal degeneration of paraplegin-
deficient mouse, Afg3l2 models display a marked 
impairment of axonal development with delayed 
myelination and poor axonal radial growth leading to 
lethality at P16.  
The increased severity of the Afg3l2 mutants is 
explained by two main molecular features that 
differentiate AFG3L2 from paraplegin: its higher neuronal 
expression and its versatile ability to support both hetero- 
and homo-oligomerization. Our data assign to AFG3L2 a 
crucial role by linking mitochondrial metabolism and 
axonal development. 
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Astrocytomas are the most common glioma, accounting 
for about half of all primary brain  tumors. Astrocytoma is 
graded as pilocytic (WHO grade I), diffuse (WHO grade 
II), anaplastic (WHO grade III), and glioblastoma 
multiforme (WHO grade IV). The progression from low- to 
high-grade astrocytoma is associated with distinct 
molecular changes that vary with other patient status 
(age, side), yet the prognosis of high-grade tumors 
remain dismal. Transglutaminase 2 (TG-2) is involved in 
the physiological regulation of cell growth, but has also 
been associated with a number of cancer-associated 
features, such as cell adhesion, metastasis and 
extracellular matrix modulation. Several studies 
undertaken with primary tumors suggest that TG-2 
expression and activity in the tumor body and surrounding 
matrix generally decreases with tumor progression, 
favoring matrix destabilization, but supporting 
angiogenesis and tumor invasion. Elevated expression 
and alternative splicing, resulting in a short isoform of TG-
2, TG-S, with more active crosslinking activity, are 
associated with increased neuronal loss in affected 
regions in the demented brain and more  
neurodegenerative disorders.  
The aim of this work is to investigate expression of 
TG-2 full-length protein and TG-S isoform and their role in 
different grade of human astroglial brain tumors. A cohort 
of 10 flash-frozen surgical specimens, obtained in adult 
patients who underwent craniotomy for microsurgical 
tumor resection, were used. These cerebral tumors has 
been histologically verified, according to the revised 
World Health Organization (WHO) classification, as 3 
glioblastoma (grade 4 WHO), 3 Anaplastic Astrocytoma 
(grade 3 WHO), and 4 Low grade Astrocytoma. We 
studied TG-1,2,3,5 and TG-S by RT-PCR, Western Blot 
and Immunohistochemistry analysis. 
Our results showed that TG-2 and TG-S are 
expressed in all grade of human astroglial brain tumors. 
In tumor/normal area TG-S may be have a crucial role in 
apoptosis phenomena inside of tumoral mass wich 
characterize astrocytomas. The up-regulation of TG2 may 
play an important role in the astrocytoma progression, 
favoring matrix destabilization, supporting angiogenesis 
and tumor invasion.  
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Chondrocyte survival is linked to cartilage integrity and 
forms of chondrocyte apoptotic death can contribute to 
cartilage degeneration in articular diseases, such as 
osteoarthritis (OA). Since growing evidence implicates 
polyamines in the control of cell death, we have been 
investigating the role of polyamine metabolism in 
chondrocyte survival and apoptosis by using specific 
polyamine biosynthesis inhibitors and, more recently, the 
symmetrically alkylated polyamine analogue N1,N11-
diethylnorspermine (DENSPM)1,2. Actually, synthetic 
polyamine analogues are currently tested as anticancer 
agents, but little information is available in literature about 
the effects of DENSPM and other polyamine analogues 
in non-tumour cells. Treatment of human C28/I2 
chondrocytes with DENSPM for up to 24 h did not reduce 
cell viability nor increase caspase activity significantly 
when given alone, but caused a caspase-3 and -9 
dependent apoptosis in chondrocytes exposed to 
cycloheximide (CHX). Previous reports indicate that 
polyamine depletion and polyamine catabolic pathways 
involving spermidine/spermine N1-acetyltransferanse 
(SSAT) and N1-acetylpolyamine oxidase (PAO) or 
spermine oxidase (SMO) may play a role in DENSPM-
induced cell death of some cancer cell lines. However 
according to the present study, DENSPM/CHX can cause 
apoptosis in chondrocytes independently of these 
pathways and polyamine levels. The addition of CHX 
together with DENSPM caused an increased uptake of 
the polyamine analogue by the cells and was associated 
with altered expression and/or phosphorylation of 
signalling proteins, i.e. MAPKs and Akt. 
This work was supported by grants from University of 
Bologna (Progetti strategici d’Ateneo 2006 and R.F.O.). 
1. I. Stanic’ et al. (2006) J. Cell. Physiol. 206, 138-46. 
2. I. Stanic’ et al. (2008) J. Cell. Physiol. 216, 153-161. 
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1.3 
INVOLVEMENT OF TRANSGLUTAMINASE IN CELL 
STRESS RESPONSE EVOKED BY HOMOCYSTEINE IN 
SH-SY5Y NEUROBLASTOMA CELLS 
S.Condello, D.Caccamo, M. Currò, N. Ferlazzo, R.Ientile 
Dip.to di Scienze Biochimiche, Fisiologiche e Nutrizione, 
Università di Messina, Messina, Italia 
Transglutaminases catalyze a Ca2+-dependent 
transamidating reaction leading to protein cross-linking or 
polyamine incorporation into protein substrates. Tissue 
transglutaminase (TG2) not only acts as a transamidating 
enzyme but is also a multifunctional protein, showing a 
complex role in cell response to different stress agents. 
Further, its involvement in apoptosis, cell differentiation, 
and inflammation, has been reported in different 
pathological conditions, such as neurodegenerative 
diseases1. However, conclusive evidence for a TG2 role 
in cell death is still lacking. Previous reports indicated that 
induction of TG2 expression by retinoic acid (RA) 
treatment or stable transfection with TG2 cDNA 
constructs did not produce any change in the rate of 
spontaneous apoptosis in human neuroblastoma SH-
SY5Y cells2. Considering that TG2 is expressed at 
different levels depending on cell differentiation state, we 
evaluated the cell response to stress conditions induced 
by homocysteine (Hcy) in undifferentiated or RA-
differentiated SH-SY5Y neuroblastoma cells. 
SH-SY5Y cells were grown in MEM/Ham’s F-12 (1:1), 
and differentiated by RA (10 ?M) treatment for 7 days in 
vitro (DIV). Then, undifferentiated and differentiated cell 
cultures were exposed to a sub-toxic concentration of Hcy 
(250 ?M) for 4 h. RT-PCR and Western blot analyses 
demonstrated that TG2 was almost undetectable in SH-
SY5Y undifferentiated cells. Instead, RA treatment resulted 
in a strong TG2 induction accompanied by the formation of 
extended neurites. Hcy exposure led to a limited TG2 de 
novo synthesis in undifferentiated cells, and only slightly 
increased TG2 levels in RA-differentiated ones.  
Further, Hcy largely increased ROS production in both 
cell culture types. This effect was associated to NF-κB
activation. In particular, the NF-?B activated levels were 
more significantly increased in undifferentiated cells 
compared with RA-differentiated ones. Notably, the 
inhibition of TG activity, with a site specific inhibitor of TG2, 
produced a reduction in NF-κB levels increased by Hcy in 
differentiated cells. Conversely, the specific NF-κB inhibition 
by SN50 suppressed Hcy-induced TG2 up-regulation in 
undifferentiated cells. In addition, Hcy treatment produced a 
more relevant increase in Hcy-induced endoplasmic 
reticulum protein (Herp) levels in RA-differentiated cells 
compared with undifferentiated ones. These data suggest 
that Hcy triggered cytosolic calcium alterations, which were 
in turn responsible for TG2 activation.  
Based on these results, TG2 up-regulation and NF-κB
activation seem to be strongly involved in cell response to 
Hcy. Further research efforts towards the identification of 
proteins modified by TG2-mediated cross-linking will be 
helpful for a better understanding of TG2 role in these 
stress conditions.  
1. Ientile et al. (2007) Amino Acids 33, 385-394. 
2. Tucholski & Johnson (2001) J. Neurochem. 81, 780–
791. 
1.4 
CARDIOPROTECTION AND ENERGY METABOLISM 
MODULATION BY 3-IODOTHYRONAMINE, A NEW 
ENDOGENOUS CHEMICAL MESSENGER 
S. Ghelardonia S. Frascarellia, G. Chiellinia, S. Ronca-
Testonia, D.K. Grandyb, T.S. Scanlanb, Riccardo Zucchia.
a
Dipartimento di Scienze dell’Uomo e dell’Ambiente, 
Università di Pisa, Pisa, Italia 
b
Department of Physiology & Pharmacology  
Oregon Health & Science University Portland, OR, USA 
3-Iodothyronamine (T1AM) is a novel endogenous thyroid 
hormone derivative that induces bradycardia and 
hypothermia in mouse and a dose-dependent negative 
inotropic effect in rat heart with IC50 on the order of 27 
?M1. T1AM hemodynamic effects are remarkably 
increased by perfusion with genistein, a tyrosine kinase 
inhibitor, and attenuated by vanadate, a tyrosine 
phosphatase inhibitor, while no changes are observed 
after treatment with inhibitors of other kinases2. In the 
present study, using the isolated and perfused rat heart 
as a model, we evaluated changes upon treatment with 
T1AM in ischemic injury, in glycogen phosphorylase (GP) 
activity, and in energy metabolism. 
Isolated rat heart were subjected to 20 min of aerobic 
perfusion, followed by 30 min of global normothermic 
ischemia and  120 min of retrograde reperfusion. 
Irreversible tissue injury was evaluated by 
triphenyltetrazolium chloride (TTC) staining. Under control 
conditions tissue injury averaged 25±2%. T1AM did not 
modify the susceptibility to ischemic injury at 12 nM 
concentration (33±4%), while it produced a significant 
protection at 120 nM and 1.2 ?M concentration (15±2% 
and 9±4%, respectively P<0.05 in both cases). The 
cardioprotective effect was blunted at higher 
concentrations, since ischemic injury averaged 18±2% and 
21±3% with 12 ?M and 25 ?M T1AM, respectively. Notably, 
T1AM did not produce any significant change in cardiac 
output nor in heart rate, if used at  120 nM or 1.2 ?M
concentration. The effects of T1AM on cardiac metabolism 
were also studied. Glucose uptake was determined by 
measuring changes in glucose concentration during 
ricirculating perfusion. Oxygen consumption was assessed 
by measuring oxygen tension with an oxygen electrode in 
the perfusate collected from the aortic and the pulmunary 
cannula. Glycogen phosphorylase activity was carried out 
spectrophotometrically in the cytosolic fraction, Although 
contractile performance was significantly depressed at 16 
?M and 25 ?M T1AM, glucose uptake was not modified 
while oxygen consumption was decreased only at 25 mM. 
In addition, perfusion with 25 ?M T1AM increased 
myocardium glycogen phosphorylase a activity. 
In conclusion, we obtained evidence of a 
cardioprotective effect of T1AM with a biphasic response, 
at concentrations which did not produce any negative 
inotropic or chronotropic action. Furthermore our findings 
suggest that T1AM may modulate energy metabolism, 
increasing oxygen consumption, if related to contractile 
performance, and glycogen phosphorylase a activity. 
1. Scanlan et al Nat. Med. (2004) 
2. Chiellini et al FASEB J. (2007) 
1.5 
EFFECT OF SPERMIDINE ON DNase I ACTIVITY 
C. Seppi, C. Balduini 
Dipartimento di Biochimica “A.Castellani”, Universitá di 
Pavia, Pavia, Italia 
The natural polyamines, putrescine, spermidine and 
spermine are ubiquitous cellular components that are 
involved in a variety of cellular functions. Polyamines are 
aliphatic molecules with amine groups distributed along 
their structure and are fully protonated at physiological 
pH. They are, therefore, polycations, a physicochemical 
feature involved in their biological effects through bonding 
by strong cation–anion interactions with different 
polyanionic macromolecules such as DNA and RNA and 
it is described that spermine and spermidine induce the 
condensation and aggregation of DNA in aqueous 
solution.  
With the aim to test if polyamines were able to protect 
DNA from digestion by endonucleases, we have 
incubated a commercial polydeoxyribonucleotide (PDRN) 
with different concentrations of spermidine. The 
spermidine-treated PDRN was then subjected to digestion 
by DNase I. Due to the molecular weight heterogeneity of 
our DNA, it was difficult to evaluate the enzyme activity by 
electrophoresis. Thus, we analyzed the activity of DNase I 
by the Kunitz assay measuring the increase of light 
absorbance induced by the DNA hydrolysis. 
The results demonstrate that at physiological 
concentration (?M) spermidine is not able to protect DNA 
from the hydrolysis by DNase I, whereas a protective 
effect was observed at 5 mM spermidine. In order to 
evaluate if in our experimental conditions the binding of 
spermidine to DNA occurs, we have analyzed the binding 
of the polyamine by measuring the formation of DNA-
aggregates and by analyzing the binding of ethidium 
bromide to DNA in the presence of spermidine. 
Our results confirm the behaviour of DNA in the 
presence of spermidine described in the literature1: the 
polycation induces first the formation of aggregates that 
disappear after a further addition of spermidine. The 
binding of spermidine was also confirmed by the ethidium 
bromide assay. At 5 mM spermidine, DNA is totally 
aggregated and the enzymatic activity of DNase is 
inhibited. It is notably that also at 1.5 mM spermidine DNA 
is totally aggregated, but at this concentration the 
polyamine is not able to inhibit the DNase activity. It is 
therefore possible that the inhibitory effect of 5 mM 
spermidine is due to an action of the polyamine on the 
enzyme, rather than to a protective role on the DNA 
molecule. This hypothesis is supported by the observation 
that the pretreatment of DNase with spermidine before 
the enzymatic assay, increases the inhibitory effect. 
On the basis of our results we can conclude that the 
binding of spermidine to DNA is not able to protect the 
macromolecule from the hydrolysis catalyzed by DNase I, 
also at concentrations of polyamine that induce the total 
aggregation of DNA.  
1. Pelta J. et al. (1996) J. Biol. Chem. 271, 5656-5662 
1.6 
DNA AGGREGATION INDUCED BY SPERMIDINE: A 
TECHNICAL NOTE 
C. Seppi, C. Balduini 
Dipartimento di Biochimica “A.Castellani”, Universitá di 
Pavia, Pavia, Italia 
DNA condensation into compact structures has received 
considerable attention in recent years due to its biological 
implications in DNA packaging in virus heads and 
chromatin as well as to understand the mechanism of 
uptake of gene vectors in living cells. Several studies 
have demonstrated the efficacy of internal proteins, 
neutral polymers, and polyamines in condensing DNA. 
The natural polyamines, putrescine, spermidine and 
spermine are aliphatic molecules with amine groups 
distributed along their structure and are fully protonated at 
physiological pH. It is described that multivalent cations 
with a charge of 3+ or greater induce the condensation 
and the aggregation of DNA in aqueous solution. With the 
aim to test if polyamines were able to protect DNA from 
digestion by endonucleases, we have incubated a 
commercial polydeoxyribonucleotide with different 
concentrations of spermidine. In order to evaluate if in our 
experimental conditions the binding of spermidine to DNA 
occurs, we have analyzed the binding of the polyamine by 
measuring the formation of DNA-aggregates and by 
analyzing the binding of ethidium bromide to DNA in the 
presence of spermidine. 
Our results confirm the behaviour of DNA in the 
presence of spermidine described in the literature1: the 
polycation induces first the formation of aggregates that 
disappear after a further addition of spermidine.  
In the course of our analysis we observed a strong pH 
enhancement in solutions containing spermidine at 
concentrations able to resolubilize the DNA aggregates. 
This alkalinization can produce a partial or complete 
deprotonation of spermidine that reduces its binding to 
DNA. On the other hand the adjustment of pH, by 
increasing the molarity of the buffer or by neutralizing the 
solutions with a strong acid, induces a rise of the ionic 
strength at values that can inhibit the formation of DNA 
aggregates.  
We suggest that these observations should be take on 
account in the discussions about the mechanisms 
underlying the resolubilization of DNA aggregates 
induced by polycations. 
1. Pelta J. et al. (1996) J. Biol. Chem. 271, 5656-5662 
1.7 
A REDOX SWITCH AND REGULATION OF ADENINE 
NUCLEOTIDE TRANSLOCASE PHOSPHORYLATION 
ARE IMPLICATED IN THE POLYAMINE EFFECTS ON 
MITOCHONDRIAL PERMEABILITY TRANSITION. 
A. Toninello, S. Grancara, E. Tibaldi, V. Battaglia, A. M. 
Brunati 
Dipartimento di Chimica Biologica, Università di Padova, 
Padova, Italia 
Activation of protein kinases within signal transduction 
pathways and modulation of oxidative stress are 
physiological processes in which polyamines exhibit an 
essential role in mitochondria1.
Polyamines are also able to prevent mitochondrial 
permeability transition (MPT), a phenomenon strictly 
related to intrinsic apoptosis. A number of evidences have 
demonstrated that MPT occurs in cultured cells and in 
vivo, however the molecular mechanism of polyamine 
action is not yet completely elucidated. Some hypothesis 
suggests that this protection, in particular spermine, 
involves the prevention of oxidative processes and/or the 
activation of protein phosphorylation at the level of key 
components of the transition pore (PTP). Spermine may 
act directly as a scavenger against the highly toxic 
hydroxyl radical or may indirectly cause an increase in 
reactive oxigen species when oxidized by polyamine 
oxidase. Indeed, polyamines are involved in signal 
transduction by activating tyrosine kinase and ERK 1/2. 
Src family kinases (SFKs) are the major players in 
mitochondrial tyrosine phosphorylation and associated in 
signal transduction from plasma membrane to 
mitochondria. The presence of SFKs in mitochondria is 
associated with the proliferative status of the cells and an 
increased level of polyamines2. Proteomic studies reveal 
a number of phosphorylated proteins in mitochondria 
which have a primary role in regulating energy 
transduction (some subunits of ATP synthase, cytocrome 
C and cytocrome C oxidase) and MPT induction (adenine 
nucleotide translocase (ANT), voltage dependent anion 
channel (VDAC), creatine kinase and esokinase). We 
found two phosphorylated tyrosines located on ANT, 
Y190 and Y194, which protrude into the channel where 
nucleotides bind for translocation3. These observations 
are consistent with the hypothesis that ANT during its 
transformation in the PTP is regulated by tyrosine 
phosphorylation. In this regard it is to take into account 
that the PTP opening is the result of two critical cysteines 
oxidation always located on ANT. In conclusion the 
induction of MPT is controlled by tyrosine phosphorylation 
and a “redox switch”, even if a connection between them 
has not been evidenced. Our results indicate that the 
protective action of polyamines against agents inducing 
MPT involve their scavenging effect and tyrosine 
phosphorylation of ANT. 
1. Toninello A., Salvi M., Mondovì B. (2004) Curr Med 
Chem 11, 2349-2374. 
2. Tibaldi E., Brunati A. M., Massimino M. L., Stringaro 
A., Colone M., Agostinelli E., Arancia G., Toninello A. 
(2008) J Cell Biochem 104, 840-849. 
3. Lewandrowski U., Sickmann A., Cesaro L., Brunati A. 
M., Toninello A., Salvi M. (2008) FEBS Lett 582, 1104-
1110. 
2.1 
ENDOCANNABINOIDS PROLONG PLATELET LIFE 
SPAN
L. Avigliano1, M. V. Catani1, V. Gasperi1,2, A. Finazzi 
Agrò1, M. Maccarrone2,3
1
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3
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Teramo, Teramo, Italia. 
The ability of endocannabinoids (ECs), like 2-
arachidonoylglycerol (2-AG) and anandamide (AEA), to 
modulate platelets functions represents an emerging field 
of interest. Indeed, ECs can act as (co-)agonist during 
platelet aggregation. It is well demonstrated that platelets 
are intrinsically programmed to die, as they express Bcl-
xL and Bak, two proteins which constitute a molecular 
clock determining platelet life span.  
Based on this background, we investigated if ECs are 
able to modulate the life/death balance in platelets.  
In the first set of experiments, we treated platelets 
from healthy donors with AEA and Meta-AEA, its not-
hydrolysable analogue, and performed viability assay and
western blot analysis.  
Platelets incubated at 37°C show decreased viability 
after 24 hours and more than 80% of MTT activity is lost 
at 48 hours. On the contrary, platelets stored at 22°C are 
stable after the same time tested.  
10-100 nM Meta-AEA increase viability of platelets, 
while higher concentrations (10-100 ?M) are not able to 
revert cell death occurring at 37°C.  Platelets incubated in 
the presence of increasing concentrations of AEA show a 
pattern similar to that observed with Meta-AEA: the most 
efficacious dose appears to be 1 ?M. Inhibition of 
intracellular AEA uptake (by the selective inhibitor 
OMDM1), as well as inhibition of AEA hydrolysis (by the 
use of the FAAH inhibitor URB597), enhance the 
protective effects of AEA, thus suggesting that it act 
extracellularly. This is further confirmed by the fact that 
arachidonic acid (AA), the major active product derived 
from AEA hydrolysis, exerts opposite effects, leading to 
cell death. 
Specific cannabinoid (CB) receptor antagonists 
(SR141716 and SR144528 for CB1 and CB2 receptors, 
respectively) inhibit Meta-AEA-mediated survival, while an 
inhibitor (IRTX) of transient receptor potential vanilloid 
type 1 (TRPV1) is ineffective. Accordingly, platelets do 
not express TRPV1, while antibodies directed against 
CB1 and CB2 receptors recognize immunoreactive 
bands. We further confirmed the involvement of CB 
receptors by the use of specific agonists for CB1 and CB2 
receptors, ACEA and JHW55, respectively.
Wortmannin, an inhibitor of PI3 kinase, abrogated 
Meta-AEA-mediated survival, thus suggesting an 
involvement of the PI3K/Akt pathway. Accordingly, Meta-
AEA dose- and time-dependently increases 
phosphorylation and activation of the pro-survival Akt 
kinase, as well as expression of the anti-apoptotic Bcl-xL; 
on the contrary, protein levels of pro-apoptotic members 
of the Bcl-2 family (Bak and Bax) are unchanged. So, 
Meta-AEA changes the Bcl-xL/Bak ratio, increasing pro-
survival factors.  
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2.2  
P2X7 OVEREXPRESSION IS RESPONSIBLE FOR THE 
INCREASED INTRACELLULAR CALCIUM AND 
FUNCTIONAL DERANGEMENT IN SCHWANN CELLS 
FROM RATS WITH CHARCOT-MARIE-TOOTH TYPE 
1A NEUROPATHY 
1S. Bruzzone, 1L. Sturla, 2F. Fiorese, 3C. Usai, 1G. Basile, 
1I. Moreschi, 2F. Benvenuto, 1E. Zocchi, 1A. De Flora, 2A. 
Schenone, 2L. Nobbio  
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3
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Charcot?Marie?Tooth (CMT) is the most frequent 
inherited neuromuscular disorder, affecting 1 person in 
2500. CMT1A, the most common form of CMT, is usually 
caused by a duplication of chromosome 17p11.2, 
containing the peripheral myelin protein-22 (PMP22) 
gene: overexpression of PMP22 in Schwann cells (SC) is 
believed to cause demyelination, although the underlying 
pathogenetic mechanisms remain unclear. Here we report 
an abnormally high basal concentration of intracellular 
calcium ([Ca2+]i) in SC from CMT1A rats. By the use of 
specific pharmacological inhibitors and through down-
regulation of expression by siRNA, we demonstrate that 
the high [Ca2+]i is caused by a PMP22-related  
overexpression of the P2X7 purinoceptor/channel leading 
to influx of extracellular Ca2+ into CMT1A SC. Correction 
of the altered [Ca2+]i in CMT1A SC restores the 
functional parameters of SC (migration, release of ciliary 
neurotrophic factor, myelination), which are typically 
defective in CMT1A SC.   
These results establish a pathogenetic link between 
high [Ca2+]i and impaired SC function in CMT1A and 
identify overexpression of P2X7 as the molecular 
mechanism underlying both abnormalities. The 
development of P2X7-inhibitors is expected to provide a 
new therapeutic strategy for treatment of CMT1A 
neuropathy. 
2.3 
ABSCISIC ACID IS AN ENDOGENOUS STIMULATOR 
OF INSULIN RELEASE FROM HUMAN PANCREATIC 
ISLETS WITH CYCLIC ADP-RIBOSE AS SECOND 
MESSENGER
S. Bruzzone1, N. Bodrato1, C. Usai2, L. Guida1, I. 
Moreschi1, R. Nano3, F. Fruscione1, M. Magnone1, S. 
Scarfi’1, A. De Flora1, E. Zocchi1
1
Department of Experimental Medicine, Section of 
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2
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3
S. Raffaele 
Scientific Institute, Milano, Italy. 
Abscisic acid (ABA) is a plant stress hormone recently 
identified as an endogenous pro-inflammatory cytokine in 
human granulocytes1. Since paracrine signaling between 
pancreatic beta cells and inflammatory cells is 
increasingly recognized as a pathogenetic mechanism in 
the metabolic syndrome and type II diabetes, we 
investigated the effect of ABA on insulin secretion. 
Nanomolar ABA concentrations induce glucose-
independent insulin release and increase glucose-
stimulated insulin secretion from RIN-m cells and from 
human pancreatic islets. The signaling cascade triggered 
by ABA in both cell types sequentially involves a pertussis 
toxin-sensitive G protein, cAMP overproduction, protein 
kinase A-mediated activation of the CD38, cyclic ADP-
ribose overproduction, eventually leading to a rise of the 
intracellular free Ca2+ concentration. ABA is rapidly 
produced and released from human islets and RIN-m 
cells stimulated with high glucose concentrations. In 
conclusion, ABA is an endogenous stimulator of insulin 
secretion in human beta cells. Autocrine production of 
ABA by pancreatic beta cells and its paracrine release by 
activated granulocytes and monocytes, suggest a 
possible role of ABA in the physiology as well as in the 
dysregulation of human insulin secretion. 
1. Bruzzone S., Moreschi I., Usai C., Guida L., Damonte 
G., Salis A., Scarfì S., Millo E., De Flora A., and 
Zocchi E. (2007) Proc. Natl. Acad. Sci. USA. 104, 
5759-5764. 
2.4 
DIACYLGLYCEROL KINASE ALPHA REGULATES 
CELL MIGRATION THROUGH PKCz, RhoGDI  AND 
RAC. 
F. Chianale, E. Rainero, C. Cianflone, V. Bettio, P. 
Porporato, M. Gaggianesi, G. Tur-Arlandis, S. Traini, G. 
Baldanzi, N. Filigheddu, A. Graziani. 
Clinical and Experimental Medicine Dept., University of 
Piemonte Orientale, Novara, Italy.  
Diacylglycerol kinase enzymes (Dgks) convert 
diacylglycerol (DG) into phosphatidic acid (PA), thus 
acting as molecular switches between DG- and PA-
mediated signalling. We previously showed that Dgka 
activation is required for VEGF-, HGF- and v-Src-induced 
cell migration of endothelial and epithelial cells, through a 
mechanism requiring Dgka phosphorylation on Tyr335 by 
Src itself (Cutrupi et al, 2000; Baldanzi et al, 2004; 
Baldanzi et al, 2007). More recently we showed that Dgka 
regulates HGF-induced membrane ruffling at the leading 
edge of migrating epithelial cells, by mediating activation 
and membrane targeting of Rac and Rac-dependent 
remodelling of actin cytoskeleton and focal contacts 
(Chianale et  al, 2007).  
We show inhere that the expression of  myristoylated 
Dgka stimulates the formation of ruffle-like structures and 
is sufficient to recruit Rac at the outer plasma membrane 
of epithelial cell colonies. In addition, we show that Dgka 
is required for HGF-induced targeting at nascent ruffles of 
GTP-bound active RacV12 mutant. Together, these 
observations suggest that Dgka provides a signal 
promoting Rac targeting at the leading edge 
independently from its GTP loading. 
Upon cell adhesion, Rac targeting to the plasma 
membrane is controlled by b1 integrin, through its 
dissociation from RhoGDI. Rac dissociation from RhoGDI 
occurs in presence of acidic lipids such as PA and PIP2,
and can be triggered by PKCz-induced threonine 
phosphorylation of RhoGDI; interestingly, PKCz is an 
atypical Protein Kinase C reported to be regulated by PA. 
Thus we investigated the hypothesis that Dgka may 
control Rac targeting through the regulation of PKCz 
and/or RhoGDI function 
We show inhere that Dgka downregulation by specific 
siRNA impairs HGF-induced recruitment at the leading 
edge of both RhoGDI and PKCz, while active myr-Dgka is 
sufficient to promote Rac, RhoGDI and PKCz recruitment 
to plasma membrane, independently from b1 integrin 
activation. Cell treatment with a specific PKCz inhibitor 
impairs both HGF- and myr-Dgka-induced Rac and 
RhoGDI targeting to the plasma membrane. Moreover, 
the expression in epithelial cells of a constitutively active 
myristoylated PKCz induces per se the formation of long 
protrusions, completely unaffected by Dgka inhibition. 
These data strongly suggest that Dgka controls PKCz 
localization and function and, consequently, RhoGDI 
recruitment and dissociation from Rac. Indeed, Dgka 
inhibition by expression of a dominat-negative mutant 
impairs HGF-induced Rac dissociation from RhoGDI.  
In conclusion, we envisage a model in which PA, 
generated by Dgka in a spatially restricted manner,  
regulates Rac function by driving membrane recruitment 
and activation of PKCz, which in turn regulates the 
dissociation of RhoGDI from Rac and finally Rac release 
and activation at the leading edge of migrating cells. 
2.5   
REACTIVE OXYGEN SPECIES HIF-1? INDUCED 
SURVIVAL IN METASTATIC MELANOMA 
M.Calvani , M. Parri, E. Giannoni, G. Comito, P. Chiarugi  
Department of Biochemical Sciences , University of 
Florence 
Hypoxia, a common feature of solid tumors, is a major 
obstacle in the development of effective cancer 
chemotherapy often decreasing the efficacy of 
chemotherapic drugs in several solid tumors. The hypoxic 
environment is able to maintain an anti-apoptotic potential 
through the activation of critical genes associated with 
drug resistance and the overexpression of prosurvival 
proteins as Bcl-2. Hypoxia inducible factor1? (HIF1?) is 
the master regulator of hypoxic response and its 
overexpression and enhanced transcriptional activity are 
linked to tumour initiation and progression by inducing 
expression of genes mediating angiogenesis and motility, 
as well as tumor metabolism and survival. Increased level 
of HIF-1? are associated with resistance to therapy in 
head and neck, ovarian, esophageal and prostate cancer, 
thus suggesting that HIF-1? is a key contributor involved 
in drug resistance acquired by hypoxia. Besides inducing 
a glycolytic shift of tumour cells, hypoxia also 
paradoxically increases the intracellular level of reactive 
oxygen species (ROS) such as superoxide and hydrogen 
peroxide. Mitochondria appear to be their main source, 
although hypoxia may affect the intracellular redox state 
through NADPH oxidase engagement by autocrine 
growth factor production. 
We observed that 1% hypoxia increases the 
resistance of human Hs29-4T metastatic melanoma to 
conventional chemotherapy with etoposide, mediating a 
signalling leading to tumor cells survival. The aim of our 
work is to identify the role of the redox   component of this 
pro-survival spur in hypoxia signalling. In melanoma cells 
hypoxia leads to a strong and sustained increase of 
intracellular ROS, indicating mitochondria as the main 
source. Mitochondria-derived ROS are both necessary 
and sufficient to stabilize and activate HIF-1? both in 
normoxic and hypoxic conditions. In addition, inhibition of 
HIF-1? with specific siRNA, as well as inhibition of ROS 
production impairing mitochondrial source (rotenone) or 
NADPH oxidase (DPI), rescues the hypoxic protection 
from etoposide-induced apoptosis. Moreover VEGF and 
VEGF receptor neutralizing antibodies fully abrogate 
hypoxia-induced survival, thus suggesting a participation 
of VEGF signalling to sustain survival. Again, removal of 
mitochondria-derived ROS abrogates VEGF downstream 
signalling and survival. We therefore propose hypoxia-
derived ROS as key modulators of the HIF-1? and VEGF-
mediated resistance to chemotherapy of metastatic 
melanoma. 
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Tumour hypoxia is linked to increased metastatic 
potential, but the molecular mechanisms coupling hypoxia 
to metastasis are poorly understood. The acquisition of a 
metastatic phenotype is often characterized by the 
activation of a transcription response, commonly called 
epithelium mesenchymal transition (EMT). Hypoxia has 
already been correlated with EMT in several cancers, 
mainly through the hypoxia inducible factor1-? (HIF1-?)
transcription factor. HIF-1?, upon decrease of oxygen 
level, transcribes several proteins responsible for the 
phenotypic conversion of cancer cells from an epithelial to 
a mesenchymal, and more motile, phenotype.  EMT leads 
to  activation of motility signals, as autocrine motility 
factor, hepatocyte growth factor and its receptor Met, the 
stem-cell-derived factor1-?, as well the decrease of cell-
cell constraints caused by decreased expression of E-
cadherin. In addition, hypoxia has been correlated with 
oxidative stress, an other condition which has been 
causally linked to EMT and to malignant transformation.  
The aim of our work is to understand the role of the redox 
component of hypoxia signalling in the EMT response of 
the Hs29-4T human metastatic melanoma cell line. 1% 
hypoxia induces a significant increase in cell spreading 
and cytoskeleton organization of melanoma cells. These 
cells respond to the hypoxic environment with an increase 
of their motility and invasiveness, likely undergoing to 
EMT, as indicated by their downregulation of E-cadherin 
and upregulation of Met. The Silencing the endogenous 
Met through an inducible lentiviral system severely 
inhibits motility and invasiveness in hypoxia. In addition, 
hypoxia is able to increase the natural tendency of 
melanoma cells to self-organize into tubular structures, a 
phenomenon commonly indicated as vasculature mimicry, 
and likely contributing to the metastatic spreading of 
these cancer cells. 1% hypoxia leads to a strong and 
sustained increase of intracellular reactive oxygen 
species (ROS), indicating mitochondria as the main 
source. Scavenging of these oxidative response using N-
acetyl cysteine (NAC) or eliminating the mitochondrial 
source with rotenone, gives rise to a strong decrease of 
the motile and invasive response to hypoxia, regulation of 
expression of Met and E-cadherin, as well the ability of 
melanoma cells to self-organize into tubular structures. 
Collectively these data point on ROS as main regulators 
of the invasive response of metastatic melanoma cells 
towards a mesenchymal phenotype during hypoxia. 
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Abscisic acid (ABA) is a phytohormone regulating 
important physiological functions in plants. We recently 
demonstrated production and release of ABA by human 
granulocytes and functional activation of these cells by 
ABA1. Thus, ABA behaves as a new pro-inflammatory 
hormone in granulocytes. Monocytes orchestrate and 
execute inflammatory and immunological processes: they 
respond to cytokines and other inflammatory stimuli by 
expressing a wide range of genes and are known to play 
a pivotal role in atherosclerosis, together with platelets 
and vascular smooth muscle cells (VSMC). Exposure of 
human monocytes to ABA evokes an intracellular Ca2+
rise through the second messenger cyclic ADP-ribose, 
leading to NF-κB activation and consequent increase of 
ciclooxygenase-2 expression and prostaglandin-E2
production, enhanced release of monocyte 
chemoattractant protein-1 (MCP-1) and of 
metalloprotease-9, all reportedly involved in the onset of 
atherosclerosis. Moreover, monocytes release ABA when 
exposed to thrombin-activated platelets, a condition 
occurring at the site of injured vascular endothelium: 
monocyte-derived ABA behaves as an autocrine and 
paracrine pro-inflammatory hormone stimulating 
monocyte migration and MCP-1 release and VSMC 
migration and proliferation. These results and detection of 
ABA in human arterial plaques identify ABA as a key 
molecule involved in the development of atherosclerosis 
and suggest a possible new target for anti-atherosclerotic 
therapy. 
1. Bruzzone S., Moreschi I., Usai C., Guida L., Damonte 
G., Salis A., Scarfì S., Millo E., De Flora A., and 
Zocchi E. (2007) Proc. Natl. Acad. Sci. USA. 104, 
5759-5764. 
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Prostate cancer is one of the main cause of male cancer 
death. However, the underlying molecular mechanisms 
contributing to prostate carcinoma progression and 
metastatic conversion are not completely clear. Recent 
studies have shown that tumor stroma is emerging as an 
active participant in tumor growth and progression. One of 
the cellular component of the reactive stroma are 
myofibroblasts, cells with de-novo acquired ability to 
synthesize large amount of extracellular matrix 
component, secrete angiogenic and pro-inflammatory 
factors and stimulate cell proliferation and invasion. Until 
now TGFβ is the only identified factor responsible for the 
fibroblast-to-myofibroblast transition. In this study our aim 
is to clarify the molecular events underlying this cellular 
transition as well as those accounting for the tumor 
invasion-promoting effect of myofibroblasts. Human 
fibroblasts (HFs) were transdifferentiated into 
myofibroblasts (MFs) by means of TGFβ? treatment. By 
incubating PC3 prostate cancer cells with conditioned 
medium (CM) from MFs or by directly co-colturing cancer 
cells with MFs, we observed a significant increase of 
cancer cell motility and invasiveness. The MF-CM 
induced a similar increase in PC3 cell motility when used 
as chemoattractant. Moreover, incubation of PC3 with 
MF-CM induced a strong increase in ROS intracellular 
level, in the expression and phosphorylation of c-Met and 
in the activation of the Src tyrosine kinase.  Interestingly, 
we observed that PC3 cells incubated with MF-CM, or 
upon co-culturing with MFs, undergo epithelial-to-
mesenchimal transition (EMT), as indicated not only by 
the activation of pro-invasive signals but also by the 
inhibition of cell-cell constraints caused by a 
downregulation of E-cadherin. Furthermore, we show 
evidence that PC3-CM is able to transdifferentiate HF in 
MFs, even if at a lesser extent with respect to what 
observed in response to TGFβ. Catalase treatment during 
HF incubation with PC3-CM abrogates their transition to 
MFs, as well as their ability to enhance cancer cell 
invasion. Collectively these data evidence a pro-invasive 
effect of MFs on prostate carcinoma cells, likely 
promoting an EMT, and suggest a role for oxidants as 
active player in PC3-promoted fibroblast 
transdifferentiation.  
2.9 
THE ROLE OF DNA-DAMAGE BINDING PROTEIN 
(DBB1), A COMPONENT OF E3 UBIQUITIN LIGASE 
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DNA damage-binding protein (DDB), also referred to as 
UV-DDB, is a heterodimer made up of the 127 kDa DDB1 
subunit and the 48 kDa DDB2 subunit. The DDB complex 
recognizes and binds some UV-damaged DNA lesions 
and is implicated in nucleotide excision repair (NER) of 
DNA damage1.
Recent studies indicate an additional role of DDB1 as 
a fundamental protein in ubiquitination mechanism. In 
fact, this protein associated with Skp2 and Cul4A is part 
of the E3 ubiquitin ligase complex and induces proteolysis 
of p27Kip1. The cyclin-dependent kinase inhibitory protein 
(CKI) p27Kip1 has been shown to play a critical role in the 
regulation of cell cycle progression. Alteration of CKI 
levels and/or functions is implicated in cell transformation 
and in growth arrest after DNA damage. Levels of p27Kip1,
in fact, are decreased in many malignant cells and down 
regulation of p27Kip1 in primary human cancers is 
mediated by accelerated proteasomal degradation of the 
protein CKI. Furthermore, there is an inverse correlation 
between the levels of p27Kip1 and Skp2 in human tumors2.
There is an extensive evidence that p27Kip1 levels are 
decreased in human melanoma cells and tissues on the 
contrary,  the role of DDB1-mediated ubiquitination and 
proteasomal degradation in down regulation of p27Kip1
levels remains to be investigated. Therefore, the aim of 
this research is to investigate the role of DDB1 in the 
turnover of p27Kip1 in human melanoma cells, in the 
cellular response to DNA damage and in senescent cells. 
In many cell types, in fact, severe DNA damage induces 
senescence and striking changes in gene expression, 
including overexpression of known cell-cycle cyclin-
dependent kinase inhibitors p21 Cip1 and p27 Kip1.
We have previously demonstrated that DDB1 is 
expressed in senescent fibroblasts at levels comparable 
to those observed in exponentially growing cells and that 
its capacity of binding to UV-damage DNA is lost in 
senescent fibroblasts. Our results, therefore, indicate that 
DDB1 in senescent cells is not able to recognize some 
UV-damaged DNA lesions and to initiate the nucleotide 
excision repair (NER).  
We used A2058, Colo 829, two melamoma cell lines, 
and BJ-hTERT cells, human foreskin fibroblasts.  
Our results show that: 
- in melamoma cells there is also an inverse 
correlation between the levels of p27Kip1 and DDB1 
- accumulation of p27Kip1 could be triggered by 
reduced or absent DDB1-dependent response to 
UV damage 
- the lack of DDB1 in ROC1/CUl4A/DDB1/Skp2 
complex could affect p27Kip1 turnover in senescent 
cells.  
1. Wittschieben B.O. and Wood R.D. (2003) DNA Repair 
2, 1065-1069 
2. Qing Li et al. (2004) J. Cutan Pathol. 31,0633-642
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Polycystic kidney disease (PKD) includes a large group 
of progressive renal disorders characterized by the 
development of renal cysts leading to end-stage renal 
disease. The most common PKDs are transmitted as 
autosomal dominant (ADPKD) and autosomal recessive 
(ARPKD) traits. The first is frequent (1:1000) and ~50% 
of patients develop renal failure by age 601, the last is a 
less frequent childhood disease (1:20000), with high 
mortality2. ADPKD is caused by loss of function of 
polycystin-1 (PC1), a large receptor protein, and of 
polycystin-2 (PC2), a Ca2+ permeable cation channel, 
interacting each other forming a receptor-channel 
complex. ARPKD is caused by mutations in PKHD1 
encoding polyductin/fibrocystin-1 (FC1), a receptor-like 
protein with a still undefined function, but interacting with 
PC2. Consistently, studies of ADPKD and ARPKD 
converge on molecular mechanisms of cystogenesis, 
including intracellular Ca2+ deregulation, eventually 
leading to increased cell proliferation, apoptosis and 
dedifferentiation3
We have investigated the putative role of PC1 and 
FC1 on intracellular Ca2+ homeostasis by comparing 
evoked Ca2+ levels and Ca2+ oscillations in HEK293
embryonal and 4/5 tubular epithelial kidney cell lines with 
knockdown of PC1 and FC1 encoding genes (PKD1 and 
PKHD1) by RNA interference.  
Either the PKD1 or PKHD1 downregulation affected 
Ca2+ homeostasis in kidney cells lines, but with different 
effects. In particular, in PC1-depleted [PC1(-)], and even 
more in FC1-depleted [FC1(-)] cells, ATP- or FBS-evoked 
Ca2+ entry was increased compared to control cells. On 
the other hand, only in PC1-depleted cells FBS-induced 
Ca2+ oscillation frequency was increased compared to 
control cells. Moreover, the increase in evoked Ca2+ in 
PC1(-) cells derived mainly from plasma membrane, 
while the increase in FC1(-) cell was associated to Ca2+
released from endoplasmic reticulum.  
In conclusion, proteins belonging to different genetic 
forms of PKD share a common effect on cytoplasmic 
evoked-Ca2+ that occurs by modulating the opening of 
different channels; this is further supported by the 
observation that loss of FC1 does not cause a variation in 
Ca2+ oscillations, nor an increase in cell proliferation 
found in PC1(-) cells, but an increase in apoptosis. These 
data suggest that abnormal Ca2+ signaling is typical of 
both PC1(-) and FC1(-) cells, but is more relevant for the 
increase in cell proliferation in the pathogenesis of 
autosomal than in the recessive form of PKD pathologies.  
1. Gabow PA. N Engl J Med. 329: 332–342, 1993. 
2. Zerres K et al. J Mol Med. 76: 303–309, 1998. 
3. Torres VE and Harris PC. J Int Med. 261:17-31, 2007. 
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Eph tyrosine kinases instruct cell for a repulsive 
behaviour, regulating cell shape, adhesion and motility. 
Beside its role during embriogenesis, neurogenesis and 
angiogenesis, EphA2 kinase is frequently upregulated in 
tumor cells of a different hystotype, including prostate, 
breast, colon and lung carcinoma, as well as melanoma. 
Moreover, the highest degree of EphA2 expression and 
activation through phosphorylation is observed in 
metastatic lesions. Although a function in both tumour 
onset and metastasis has been proposed, the role played 
by EphA2 is still debated. Here, we demonstrated that 
EphA2 re-expression in B16 murine melanoma cells, that 
use a defined mesenchymal invasion strategy, converts 
their migration style from a mesenchymal to an 
amoeboid-like, conferring a plasticity in tumor cell 
invasiveness. Amoeboid motility, originally described for 
the amoeba Dictyostelium discoidem, has been reported 
for several eukaryotic cells needing rapid movements 
through flexible and weak adhesion sites, resulting in cell 
motion depending more on the rate of cytoplasmic 
contraction and protrusion. In addition, in response to 
particular environmental cues, cancer cells can de novo
acquire an amoeboid-like motility, thus undergoing to 
what has been termed mesenchymal to amoeboid 
transition. Hence, our data propose that, in response to 
re-expression and activation of EphA2, melanoma cells 
activate a non-proteolytic invasive program which 
proceeds through the activation of cytoskeleton motility, 
the retraction of cell protrusions, a Rho-mediated 
rounding of the cell body, and squeezing among 3D 
matrix, giving rise to successful lung and peritoneal 
lymph node metastases. Our results suggest that, among 
the redundant mechanisms operating in tumour cells to 
penetrate the anatomical barriers of host tissues, EphA2 
plays a pivotal role in the adaptive switch in migration 
pattern and mechanism, defining and distinguishing 
tumour cell invasion strategies. Thus, targeting EphA2 
might represent a future approach for the therapy of 
cancer dissemination. 
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Adiponectin is a well-studied adipokine due to its insulin-
mimetic and anti-aterogenic action. The hormone is 
present in the plasma in two distinct forms (full-length and 
globular) which can associate to form more complex 
aggregates. The hormone acts mainly in liver and skeletal 
muscle where it controls both glucidic and lipids 
metabolism. Besides the well-known metabolic effects of 
adiponectin in skeletal muscle, we recently observed that 
globular adiponectin acts as a pro-differentiative agent for 
C2C12 murine myoblasts, inducing their differentiation 
and fusion into mature myofibres. These findings 
suggested that globular adiponectin could have a more 
general role in skeletal muscle physiology, rising the 
possibility that the hormone could act on muscle cells 
progenitors. To verify  this hypothesis we choose D16 
murine mesangioblasts derived from dorsal aorta as a 
cellular model endowed with skeletal muscle stemness. 
We observed that globular adiponectin induces 
mesangioblast cell proliferation, together with activation of  
p42/p44 MAPKs. In addition, globular adiponectin acts as 
a pro-survival agent for mesangioblasts, by inhibiting the 
apoptotic cascade caused by growth factor withdrawal or 
extracellular matrix detachment. In particular, Annexin V 
assay, evaluation of mitochondrial potential and caspase-
3 and-9 activities revealed a protection from apoptosis in 
globular adiponectin-treated mesangioblasts. Finally, we 
observed that the co-colture of rat L6 myoblats with 
globular adiponectin-treated mesangioblasts leads to an 
increased myogenesis as revealed by differentiation index 
and the interspecific fusion index (between L6 and D16 
cells). These findings suggests that globular adiponectin 
plays a pleiotropic role in skeletal muscle development, 
acting both on muscle cell stem cells and on myoblasts 
differentiation.  
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Aims: Apolipoprotein A-I (ApoA-I), the major 
apolipoprotein of the high density lipoprotein (HDL), 
plays key roles in the removal of cholesterol excess 
from peripheral cells, in a recognized anti-
atherosclerotic process called “reverse cholesterol 
transport” (RTC)1. In detail, it stimulates cholesterol (C) 
efflux and ApoE secretion from macrophages, and 
enhances Lecithin-Cholesterol Acyl-Transferase (LCAT) 
activity. The acute phase protein Haptoglobin (Hpt) was 
found to inhibit RCT, as binding ApoA-I and preventing 
its stimulation on LCAT. This study aimed to find out 
whether Hpt influences essential ApoA-I stimulated 
mechanisms in RCT, such as cholesterol efflux, LCAT 
activity, and ApoE secretion from macrophages. 
Methods: Monocytes were isolated from human 
buffy coats, and kept for 6 days in culture for 
differentiation into macrophages. After treatment with 
?H-C for 24 h, the cells were incubated with ApoA-I (0.04 
mg/mL), or ApoA-I plus increasing Hpt amounts (0.1-
0.75 mg/mL). After 16 h of incubation, homologous 
plasma was added as LCAT source. After further 
incubation for 16 h, supernatants were aliquoted from 
culture medium to measure their radioactivity content, 
representing the released C. Supernatant lipids were 
extracted and separated by TLC to measure the LCAT 
activity as conversion of unesterified ?H-C into C esters. 
Other macrophages, not treated with ?H-C, were 
incubated with ApoA-I (20 ?g/mL), or ApoA-I plus Hpt 
(200 ?g/mL). The supernatants of these cultures were 
collected after 16 h, and analyzed by western blotting to 
detect the amount of secreted ApoE. 
Results: Addition of Hpt to macrophages 
significantly (P<0.01) inhibited, with dose-dependent 
effect, the ApoA-I stimulation of C efflux (down to 27% 
of the control value, i.e. without Hpt), LCAT activity 
(down to 50% of the control value), and secretion of 
ApoE.  
Conclusions: Macrophages play a key role in 
atherosclerosis onset and progression, as they 
differentiate to foam cell triggering the formation of lipid 
streaks and ateromatose plaques, when RCT is 
defective. Increase in Hpt concentration, as occurring  
during inflammatory process, might impair the efficiency 
of both cholesterol efflux and LCAT activity. Moreover, 
our results also suggest that Hpt might impair 
macrophage secretion of the anti-atherosclerotic protein 
ApoE. Therefore high levels of Hpt might contribute to 
adverse cardiovascular events. 
1. Fielding C et al., (1995) J. Lipid Res 36: 211-228.
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CK2 is a highly conserved tetrameric kinase that 
phosphorylates a wide range of substrates1. In 
Saccharomyces cerevisiae CK2 is required for cell cycle 
progression both in G1 phase2-3 and in mitosis2, and it 
phosphorylates key cell cycle regulators, such as Cdc284,
Cdc375, Cdc346-7-8 and Sic19-10. Sic1 is a G1 inhibitor, 
active on the Clb5,6/Cdc28 complexes, whose activity is 
required for the onset of S phase11. Sic1 is a physiological 
relevant CK2 substrate9-10, and mutants on the CK2 
consensus site (Ser201Ala and Ser201Glu) alter cell 
growth-cell cycle coordination at the G1/S transition9.
Furthermore, we previously showed that Sic1 level and 
localization are modulated by carbon source12.
To deepen our knowledge on the role of CK2 
phosphorylation at the G1/S transition, we are focusing on 
the analysis of the phosphorylation of Sic1, as a function 
of growth conditions and cell cycle phase. To this 
purpose, we developed a system to study the in vivo
phosphorylation state of Sic1-Ser201, through 
immunopurification of Sic1 from yeast cells followed by 
LC-MS/MS analysis.  
Here we report data indicating that Sic1-Ser201 
phosphorylation is modulated by carbon source in G1 
phase; in particular, Ser201 phosphorylation is higher in 
glucose grown cells than in ethanol grown cells.  We 
further show that this difference is not due to a different 
level or localization of CK2 subunits (α, α’, β, β’) in the 
two nutritional conditions. Rather, we show that in vitro
CK2 activity (using the synthetic peptide 
RRRADDSDDDDD as a substrate) is significantly higher 
in the cell-free extract of glucose-grown cells than in that 
of ethanol-grown cells, in keeping with our data on Sic1 
phosphorylation.   
This is the first evidence of nutritional regulation of 
CK2 activity in S. cerevisiae, suggesting an involvement 
of CK2 in the nutritional modulation of the G1/S transition. 
1. Meggio and Pinna (2003) Faseb J 17, 349-368. 
2. Hanna et al. (1995) J Biol Chem 270, 25905-25914. 
3. Tripodi et al. (2007) Biochem Biophys Res Commun 
359(4), 921-7. 
4. Russo et al. (2000) Biochem J 351(1), 143-50. 
5. Bandhakavi et al. (2003) J Biol Chem 278(5), 2829-
36.  
6. Barz et al. (2006) Cell Mol Life Sci 63(18), 2183-90. 
7. Sadowski et al. (2007) Biochem J 405(3), 569-81. 
8. Coccetti et al. (2008) Cell Cycle 7(10),1391-401. 
9. Coccetti et al. (2004) Mol Microbiol 51(2), 447-60. 
10. Coccetti et al. (2006) Biochem Biophys Res Commun 
346(3), 786-93. 
11. Schwob et al. (1994) Cell 79(2), 233-44. 
12. Rossi et al. (2005) Cell Cycle 4(12), 798-807. 
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Prostate cancer is the most diagnosed cancer and the 
second leading cause of cancer deaths in men1.
Oxidative stress was involved as a causative agent in a 
number of human diseases including prostate cancer and 
epidemiological data suggested that consumption of fruits 
and vegetables might be associated with a lower incidence 
of cancer. The fruit of the Punica granatum (pomegranate) 
contains hundreds of phytochemicals and its extracts have 
recently been shown to exhibit antioxidant properties, 
thought to be due to the action of ellagic acid (2,3,7,8-
tetrahydroxy[1]-benzopyrano[5,4,3-cde][1]benzopyran-
5,10-dione) the main polyphenol present in this fruit2-4.
There is now increasing interest in the in vivo protective 
effects of natural antioxidants contained in dietary plants 
against oxidative damage caused by free radical species. 
In view of these considerations, this study investigated the 
effects of ellagic acid on LnCaP and DU145 prostatic 
cancer cell lines. BPH-1 cells were employed as non 
malignant cells. Cytodifferentiation of 
malignant/premalignant cells into more mature or normal-
like cells and apoptosis during multistep carcinogenesis are 
theoretically suitable in cancer therapy. Thus, compounds 
capable of inducing differentiation or apoptosis are 
candidate chemopreventive and/or chemotherapeutic 
agents5.The evaluation of chromogranin A levels was  used 
as  marker of neuroendocrine differentiation; since the low-
affinity nerve growth factor receptor p75 (p75 NGFR), is 
less expressed in prostatic cancer cell lines than in normal 
cells, its expression was used as marker of 
cytodifferentiation. In order to elucidate mechanisms 
involved in anticancer activity of ellagic acid, we analyzed 
by western blotting analysis the expression of different 
proteins involved in cells growth and apoptosis. In addition, 
LDH release and ROS levels were evaluated. Our data 
evidenced,  the ability of ellagic acid to reduce cell 
proliferation. In addition, our results provided morphological 
and biochemical evidence suggesting that ellagic acid is 
able to revert LnCap and DU145 cells from the 
neuroendocrine proliferating state to normal-like un-
proliferating state. Then, our study furtherly support the 
growing body of data suggesting the bioactivities of natural 
compounds and their potential impact on cancer therapy 
and on human health. 
1. A.W. Hsing, L.Tsao, S.S. Devesa. Int. Trends and 
patterns of prostate cancer incidence and mortality. 
Int. J. Cancer 2000, 85, pag. 60-67.         
2. Y.Y. Soong, P.J. Barlow. Food Chem 2006, 97, pag. 
524–530. 
3. Wang RF, Xie WD, Zhang Z, Xing DM, Ding Y, Wang 
W, Ma C, Du LJ. J Nat Prod 2004, 67, pag. 2096-
2098. 
4. S.M. Hannum. Crit Rev Food Sci Nutr 2004, 44, pag. 
1–17
5. W.K. Hong, M.B. Sporn. Science 1997, 278, pag. 
1073-1077 
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Cancer and metastatic cells communicate with endothelial 
cells (ECs) through an interactive network of cell-cell and 
cell-matrix signaling and could activate ECs by cell-cell 
contact or soluble factors. The largely undefined signal 
transduction mechanisms and cross-talk between human 
melanoma cell (HMC) lines and brain endothelial cells 
(ECs) involved in tumor cell interaction and adhesion has 
been here investigated. In immortalized rat brain EC 
cultures (GP8.3), conditioned media (CM, 48 h) prepared 
from SK-MEL28 and OCM-1 melanoma cells significantly 
enhanced EC proliferation, measured by BrdU ELISA test. 
Incubation with two kinase (PI3K/Akt and ERK1/2) 
inhibitors (wortmannin/ LY294002 mixture and PD98059, 
respectively), PLA2 activity dual blocker (AACOCF3) and 
COX-2 specific inhibitor (NS-398) caused a significant 
inhibition of cell proliferation. To clarify the role of calcium-
dependent PLA2, in addition to calcium-independent PLA2,
upon melanoma CMs, we evaluated the PLA2 protein 
expression and activation by Western blot analyses. 
Results demonstrated that, in the presence of melanoma 
CM for 24 h, ECs significantly expressed cPLA2 and iPLA2
total protein and phosphorylated form of cPLA2 at levels 
higher than controls. The increase of cPLA2 protein 
synthesis and phosphorylation may support an increase in 
cPLA2 activity
1. To investigate the possible signaling 
mechanisms by which melanoma cell CMs may mediate 
phosphorylation of the endothelial cPLA2, we next used 
the above mentioned inhibitors. Wortmannin/LY294002 
significantly inhibit stimulated expression of 
phosphorylated cPLA2 form to almost basal level. As the 
presence of melanoma CM in cultures increased cPLA2
protein synthesis in ECs, we then assessed the cPLA2
and iPLA2 mRNA levels. Melanoma CM induced a 
significant increase in endothelial cPLA2 and type VI-iPLA2
mRNAs. By confocal microscopy, activation of cPLA2,
ERK1/2, PKCα and COX-2 in perinuclear and membrane 
regions of ECs grown in CM-stimulated cultures were 
clearly observed. Since PKCα-ERK1/2 signaling mediates 
CM induced proliferation via induction of expression of 
cPLA2 activity, we electroporated exogenous cPLA2 and 
ERK1/2 antibodies, binding to corresponding intracellular 
enzyme, into ECs: both of them abrogated CM-mediated 
cell proliferation. Thus MEK-PKCα-ERK1/2 and PI3K/Akt 
survival pathways are activated in EC cultures during the 
interaction with CM from both melanoma cell lines. 
1. C.D. Anfuso et al., J. Lipid Res. 48 (2007) 782-
793.  
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Ischemia-reperfusion (IR) injury, a condition that plays an 
important role in several circumstances of clinical interest, 
is multifactorial but it is generally accepted that an 
excessive production of reactive oxygen species (ROS) 
plays a prominent role in its development1. In heart 
muscle IR has been found to induce myocyte necrosis 
and apoptosis that appear to be the prevalent mode of 
death during, respectively, the ischemic period and the 
reperfusion. The intracellular signaling pathway leading to 
cardiomyocyte death in IR are poorly understood, 
however there is evidence that the nuclear factor kappa B 
(NF-kB), a pivotal transcription factor, is rapidly activated 
by ischemia in several tissues including myocardium2.
Another pathway that might have a part in cardiomyocyte 
death during IR is that related to the c-Jun N-terminal 
kinase (JNK), which represents one of the “stress 
responsive” members of the mitogen activated protein 
kinase (MAPK) family3.
Antioxidant treatments have a critical role in cell 
protection against IR injury and many substances have 
been proposed for this purpose. In the last years growing 
interest has been addressed to curcumin, a major active 
component of the food flavor turmeric, which is extracted 
from the powdered dry rhizome of Curcuma longa Linn 
(Zingiberacee), a perennial herb widely cultivated in 
tropical regions of Asia.  
In this study we explored the effect of curcumin in 
cardiac cells subjected to a protocol simulating IR. 10 ?M
curcumin was administered prior ischemia (pre-treatment) 
or at the moment of reperfusion (post-treatment) and its 
effects were compared to those produced by a reference 
antioxidant (Trolox) used at an equal antioxidant capacity.  
IR cardiac cells showed clear signs of oxidative stress, 
impaired mitochondrial activity and a marked 
development of both necrotic and apoptotic processes; at 
the same time, increases in NF-kB nuclear translocation 
and JNK phosphorylation were observed. Curcumin pre-
treatment revealed to be the most effective in attenuating 
all the observed modifications and, in particular, in 
reducing the death of IR cells. This confirms that the 
protective effect of curcumin is not simply related to its 
antioxidant properties but involves other mechanisms, 
notably interactions in NF-kB and JNK pathways. These 
findings suggest that curcumin administration, in 
particular prior the hypoxic challenge, represents a 
promising approach to protect cardiac cells against IR 
injury.  
1. Lefer, D.J., Granger D.N. (2000) AM. J. MED. 109, 
315–323. 
2. Kis, A., Yellon, D.M., Baxter, G.F. (2003) BR. J. 
PHARMACOL. 138, 894-900. 
3. Davis, R.J. (2000) CELL. 103,239-252. 
2.18 
IDENTIFICATION OF ALTERNATIVELY SPLICED 
FORMS OF IL-6 GENE IN C2C12 CELLS. 
G. Annibalini, M. Guescini, D. Agostini, P. Sestili, C. 
Martinelli, M. Paolillo, M. Mantuano, P. Tibollo, V. Stocchi 
Dipartimento di Scienze Biomolecolari - Ist. di Ricerca 
sull’Attività Motoria, Università degli Studi di Urbino Carlo 
Bo, Italy 
Interleukin-6 (IL-6) is a pleiotropic cytokine produced and 
secreted by various cells types. The human and mouse 
IL-6 gene contains four introns and five exons. Alternative 
splicing of this gene generates three mRNAs in human: 
IL-6δ2 (deletion of exon 2), IL-6δ4 (deletion of exon 4) and 
IL-6δ2δ4 (deletion of exons 2 and 4)1. On the contrary, 
only two mRNAs were found to be expressed in different 
tissues of mouse immunized with sheep erythrocytes. 
Furthermore, these splice vatiants, involved different 
exons: IL-6δ3 (deletion of exon 3) and IL-6δ5 (partial 
deletion of exon 5)2. The biological functions of these 
isoforms are poorly studied. However in vitro receptor 
mobility shift1, reconstruction of hypothetical three-
dimension structures and analysis of interactions with 
complex receptor3 collectively suggest that these 
alternatively spliced forms could act as antagonists of IL-6 
action. 
In the present study we examined the expression of 
IL-6 isoforms in C2C12. In addition to full-length IL-6 (640 
bp), we detected three different PCR bands both in 
myoblasts and myotubes. Sequencing of the 
corresponding PCR bands confirmed the presence of the 
two isoforms also saw in vivo in mouse: IL-6δ3 (526 bp) 
and IL-6δ5 (582 bp)2. Furthermore, this analysis, revealed 
a novel splice variant, IL-6δ3δ5 representing IL-6 lacking 
both exons 3 and the firsts 58 bp of exon 5 (468 bp). The 
amount  of the various PCR products differed 
considerably. In particular the intensity of the full-length 
IL-6, IL-6δ5, IL-6δ3 and IL-6δ3δ5 bands was, respectively, 
hight, intermediate, low and very low intense. Analysis of 
the hypothetical structure and prediction of interactions 
with IL-6 receptors suggest that, all these isoforms, in 
different manner, could act as antagonists of IL-6 action. 
For example, the most expressed isoform IL-6δ5, retain 
the banding site for the second gp130 monomer but lost 
the E-helix and D-helix possibly losing the ability to 
interact with IL-6R and the first gp130 monomer. 
Therefore the formation of functional IL-6-receptor 
complex is likely to be impeded. The presence of splice 
variants of IL-6 gene in unstimulated myoblasts and 
myotubes suggest that the expression of these isoforms 
wasn’t strictly related to inflammatory process, as 
reported in immunized mouse2, and underline the 
importance to study what functional roles these variants 
play in muscle physiology. 
1. Bihl M. P., et al. 2002 Am J Respir Cell Mol Biol 27 
48-56 
2. Yatsenko O. P., et al. 2004 Cytokine 28 190-6 
3. Denessiouk K. A., et al. 2008 Proteins 71 751-70 
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Stretch-activated channels (SACs) regulate trans-
membrane currents providing cation and Ca2+ entry 
pathways, which have important regulatory roles in many 
cell processes1. Little is known on the physiological 
functions of SACs in skeletal muscle cells. In the present 
study we investigate whether a member of the TRP 
channel family (TRPC1) can be activated by mechanical 
stretch and whether it can be an effector of the pro-
myogenic factor, sphingosine 1-phosphate (S1P) in 
C2C12 myoblasts.  
Using short interfering RNA and whole-cell patch-
clamp, we provided the first experimental evidence that 
TRPC1 can be activated by mechanical stretch in C2C12 
myoblasts. Interestingly, by immunoprecipitation 
experiments we found that the physical interaction 
between actin-formed stress fiber and focal adhesion 
kinase as well as TRPC1 was enhanced by the bioactive 
lipid and significantly reduced by the Rho kinase inhibitor 
Y-27632, and the myosin II ATPase inhibitor blebbistatin. 
Moreover, TRPC1 expression was potentiated by the 
treatment with S1P and appeared to be essential for the 
skeletal muscle differentiation elicited by the bioactive 
lipid.  
These findings demonstrate the existence of a 
structural coupling between actin filaments and plasma 
membrane and of a tensional force generated by S1P-
induced SF contraction, that, in turn, contribute to 
sarcolemma stretching and SAC activation in myoblastic 
cells. Furthermore, beside to identify a novel effector in 
the signalling pathway of S1P leading to the phenotypic 
maturation of myoblasts, these data offer new possible 
targets for therapeutic intervention in those pathologies in 
which alterations of cation concentration appears to be 
crucially involved, such as muscle dystrophy. 
1. Ingber DE. FASEB J. 2006, 20: 811-827. Review. 
Grants from Fondazione Cassa di Risparmio di Pistoia e 
Pescia, MIUR ex-60% (to EM, FF;LF) 
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Various apoptotic stimuli increase PS synthesis1-3 and it 
has been proposed that this event participates to PS 
exposure1, 2. However, the reduction of PS synthesis 
observed in macrophages induced to apoptosis by Group 
B Streptococcus (GBS)4, seems in contrast with this 
possibility. Here we investigated on the correlation 
between apoptosis and PS synthesis in another 
experimental model, represented by MOLT-4 induced to 
apoptosis by Cr(VI)5. PS synthesis has been evaluated, 
as usually done, from the incorporation of [3H]serine into 
PS. Apoptosis level and PS exposure were measured in 
parallel samples using propidium iodide and annexin V 
binding, respectively. Treatment of cells with Cr(VI) 
reduced PS radioactivity in a dose- and time-dependent 
manner that well correlated to the level of cell apoptosis. 
Cr(VI)-treatment reduced also conversion of newly 
synthesised PS to phosphatidylethanolamine (PE), a 
reaction catalysed by an enzyme located in mitochondria. 
The decrease of cellular [3H]PS and [3H]PE in Cr(VI)-
treated cells appeared not due to a greater release of 
radioactive membrane vesicles in the medium. Thus, the 
response to the apoptotic stimulus was similar to that 
observed in GBS-infected macrophages4. In GBS-induced 
apoptosis, some pro-apoptotic proteins are released from 
the mitochondria6. Here, we evaluated the release of 
cytochrome c (cyt c) and of AIF from mitochondria after 
6h treatment with 200 ?M Cr(VI) (50% annexin V positive 
cells; 50% decrease of PS radioactivity). Western blotting 
analysis for cyt c and AIF in crude mitochondria fraction 
and in the post-mitochondrial supernatant7 demonstrated 
that the two proteins were not released from mitochondria 
of apoptotic cells.  
1. Aussel C. et al. (1998) FEBS Lett. 431, 195–198 
2. Yu A. et al. (2000) Biochim. Biophys. Acta 1487, 296-
308
3. Buratta S. et al. (2000) Mol. Cell. Biochem. 211: 61-67 
4. Buratta S. et al. (2002) FEBS Lett. 520, 68-72 
5. Gambelunghe A. et al. (2006) J. Occup. Environ. Med. 
48, 319-25. 
6. Fettucciari K. et al. (2006) J. Immunol. 176, 7542-56. 
7. Liu F.T. et al. (2003) Biochim. Biophys. Res. 
Commun. 310: 956-962 
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Adaptation to oxidative stress can be considered a good tool 
to study molecular mechanisms involved in 
chemoresistance. In fact many anticancer agents, mainly 
platin derivatives, anthracyclines and other anti-neoplastics 
drugs induce cell death through generation of reactive 
oxygen species. However, cancer chemotherapy is often 
unsuccessful for the intrinsic or acquired cell drug resistance. 
We demonstrated that expression of TRAP1, a 
mitochondrial chaperone, is significantly up-regulated in 
Saos-2 osteosarcoma cells chronically adapted to grow in 
mild oxidizing conditions, induced by diethylmaleate 
(DEM), a GSH depletor1, and this correlates with a 
phenotype more resistant to H2O2-induced DNA damage 
and to apoptosis2. Furthermore TRAP1 is recently 
described as a component of a mitochondrial pathway 
selectively up-regulated in tumor cells, which antagonizes 
the proapoptotic activity of cyclophilin D and is 
responsible for maintenance of mitochondria integrity, 
thus favoring cell survival. Interestingly, novel antagonists 
of TRAP1/ ATPase activity causes sudden collapse of 
mitochondrial function and selective tumor cell death, 
suggesting that this pathway may represent a novel 
molecular target to improve anticancer therapy. 
Since expression of inducible heat shock proteins  
correlates with increased resistance to apoptosis induced 
by a wide range of cytotoxic agents, we evaluated 
whether the up-regulation of TRAP1  expression may 
represent a mechanism responsible for resistance to 
chemotherapy in HT29 human colorectal carcinoma cells. 
A comparison of TRAP1 mRNA expression between 
DEM-adapted and chemoresistant cells demonstrates 
that TRAP1 mRNA levels are similarly induced in HT29 
cell resistant to 5-fluorouracil and oxaliplatin2.
Furthermore cell growth analysis by MTT dye assay, upon 
exposure of DEM-adapted Saos-2 cells and TRAP1 
stable clones to 5-fluorouracil, demonstrated a direct 
correlation between TRAP1 expression and cell survival. 
Finally flow cytometric analysis of HT29 cells transiently 
overexpressing TRAP1, treated with 5-fluorouracil or 
oxaliplatin, demonstrated the TRAP1 protection from 
apoptosis. These results suggest that the increased 
expression of TRAP1 observed in human colorectal 
carcinomas could be part of a pro-survival pathway 
responsible for resistance to 5-fluorouracil and oxaliplatin-
based chemotherapy. In addition a preliminary finding of 
increased TRAP1 expression in some colorectal cancer 
specimens suggests that TRAP1 may represent a novel 
molecular target in cancer theraphy. 
1. N. Montesano Gesualdi, G. Chirico, M. T. Catanese,  
G. Pirozzi, and F. Esposito. Free Radical Res., 2006 
May; 40(5): 467-476. 
2. N. Montesano Gesualdi;  G. Chirico;  G. Pirozzi;  E. 
Costantino;  M. Landriscina; F. Esposito. Stress, 2007 
Nov; 10(4): 342-350. 
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Cancer cells are characterized by a high rate of glycolysis 
with production of lactate even in presence of oxygen, 
and by a reduced rate of aerobic respiration, the so-called 
Warburg effect (Warburg 1956). Nevertheless, the role of 
mitochondrial changes in cancer has not been 
unambiguously defined. We have used a system of K-ras-
transformed fibroblasts (Chiaradonna et al 2005) in 
comparison with immortalized normal counterparts (NIH-
3T3) to evaluate functional bioenergetic changes 
dependent upon ras oncogene activation. Cell viability 
was studied under different glycolytic conditions by 
changing daily the substrate-enrichment of the culture 
medium: 25 mM glucose and 5 mM galactose both in 
presence of 110 mg/l pyruvate were chosen. K-ras 
transformed cells have normal growth in high glucose, 
being higher the growing rate with respect to wild-type 
cells. At variance, decreasing the glucose content (and 
glycolysis rate) K-ras transformed cells grow much slower 
than the wild-type cells. Interestingly, ras-transformed 
fibroblasts grown in both glucose and glucose free 
medium have decreased ATP content and decreased 
expression of several mitochondrial genes related to 
oxidative phosphorylation, including genes encoding for 
cytochrome oxidase and ATP synthase subunits. 
We have investigated bioenergetic parameters in 
digitonin-permeabilized cells grown in glucose medium. 
Contrary to succinate as substrate, glutamate/malate 
energized K-Ras transformed cells, resulted strongly 
depressed in both State 3 respiration and ATP synthesis 
rate. We have further measured the redox activity of 
Complex I (as rotenone-sensitive NADH dehydrogenase) 
in isolated mitochondria and a significant reduction of 
activity was shown in the transformed cells; the decrease 
of Complex I activity was in the range of NADH-
dependent respiration decrease. 
These data demonstrate that the decreased ATP 
synthesis and respiration rate are not the result of 
changes pertaining to either ATP synthase or cytochrome 
oxidase, but of alterations occurring at the level of 
respiratory Complex I. Since Complex I subunits had 
shown no change in the gene expression study of 
Chiaradonna et al (2006), we are currently investigating 
the content and supramolecular organization of OXPHOS 
complexes by polyacrylamide gel electrophoresis and 
western blotting. 
Warburg O. (1956) Science 123, 309-314.  
Chiaradonna F, Magnani C, Sacco E, Manzoni R, 
Alberghina L, Vanoni M. (2005) Biochem. Soc. Trans.  33, 
297-299  
Chiaradonna F., Gaglio D, Vanoni M, Alberghina L. 
(2006) Biochim. Biophys. Acta 1757, 1338-1356 
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The secretory pathway of plants is a highly complex system 
concerned with the manufacture, quality control and 
transport of various polymers. Errors in transcription, 
translation and inefficient folding are among the many 
factors that can contribute to the accumulation of misfolded 
or unassembled polypeptides within the secretory pathway. 
These proteins are potentially very damaging and must 
therefore be eliminated. This was initially assumed to 
involve degradation in lytic vacuoles following targeting or 
autophagy. However, it was later demonstrated that the 
plant endoplasmic reticulum (ER) is endowed with a 
system that allows the retrotranslocation of terminally 
misfolded or orphan proteins to the cytosol where these 
selected substrates can then be degraded1. This quality 
control pathway known as ER-associated protein 
degradation (ERAD) is well described in mammalian cells, 
where it typically involves delivery of the selected proteins 
to dislocation machineries in the membrane, substrate 
recognition on the cytosolic plane of the membrane brought 
about by the ubiquitination machinery, extraction from the 
membrane and degradation by proteasomes. These events 
are tightly coupled such that it is normally very difficult to 
visualise a retrotranslocated substrate unless proteasomes 
are inhibited. Although several different ERAD substrates 
have now been described in plants, so far we are almost 
completely ignorant not only of the range of plant proteins 
that undergo ERAD, but of how many endogenous proteins 
are devoted to the disposal of ER proteins. Of note, over 
1300 genes (5% of the Arabidopsis proteome) are devoted 
to the selective breakdown of proteins by the extensive 
ubiquitin/26S proteasome pathway in plant cells, but 
virtually nothing is known about these components in 
relation to ERAD, nor of the overall impact of this pathway 
relative to alternative disposal mechanisms. Addressing 
these important questions until now has been extremely 
difficult due to the limited information concerning both the 
biochemical properties of plant proteasomes and the 
activity of proteasome inhibitors in living plant cells. For this 
reason we characterized the cleavage specificities of 
proteasomes in protoplasts extracts of Nicotiana tabacum
using fluorogenic substrates specific for the main peptidase 
activities of 26S particles. Furthermore, we evaluated the in 
vitro sensibility of these activities to several reversible and 
irreversible inhibitors widely used to inhibit mammalian and 
yeast proteasomes. Finally we measured the extent of 
proteasomal inhibition reached in vivo by administration of 
these inhibitors to protoplasts cultures. Based upon these 
results, we plan to develop more effective protocols of 
proteasomal in vitro and in vivo inhibition that will facilitate 
further study on ERAD in plants cells. 
1. Di Cola A. et al. (2001) PNAS 98, 14726-14731. 
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Cellular prion protein (PrPc) is a ubiquitous glycoprotein. It 
is localized at the cell surface via a 
glycosylphosphatidylinositol (GPI) anchor, and its 
physiological role is poorly characterized. It has been 
suggested that PrPc participates in synaptic structure, 
neurite formation, copper metabolism, and signal 
transduction1. It also has a protective role in 
neurodegeneration due to oxidative stress2. Several 
cellular partners of PrPc have been proposed, but no 
functional ligand of PrPc has yet been identified clearly. 
Antibody cross-linking has been used to identify PrPc
induced signalling pathways, revealing a caveolin-
dependent coupling of PrPc to the tyrosine kinase Fyn3. In 
this study we detailed the intracellular events induced by 
PrPc antibody-mediated cross-linking in PC12 cells. We 
found a Fyn-dependent activation of the Ras-Raf 
pathway, which leads to a rapid and transient 
phosphorylation of Erk1/2. In addition, this activation 
cascade relies on the engagement of integrins, and 
involves FAK activation. We demonstrated the tyrosine 
phosphorylation of caveolin-1 and paxillin as a 
consequence of PrPc stimulation, and showed that 
phosphocaveolin-1 scaffolds and coordinates protein 
complexes involved in PrPc-dependent signalling. 
Moreover, we found that caveolin-1 phosphorylation, like 
paxillin phosphorylation, is a mechanism for recruiting the 
C-terminal Srk kinase (Csk) to the plasma membrane and 
inactivating Fyn, so as to terminate cell signalling. 
Furthermore our data support a significant role for PrPc as 
a response mediator in neuritogenesis. In fact cells grown 
in the presence of the anti-PrPc antibody clearly show 
neurite extensions, which are not visible in control cells. 
Acknowledgements: Work supported by FIRB 2003-
project RBNE03FMCJ_007, grant to G. Manao 
1. Linden R, Martins VR, Prado MA, Cammarota M, 
Izquierdo I, Brentani RR (2008) Physiol Rev 88(2):673-
728. 
2. Milhavet O, and Lehmann S (2002) Brain Res. Brain 
Res. Rev. 38: 328-339. 
3. Mouillet-Richard S, Ermonval M, Chebassier C, 
Laplanche JL, Lehmann S, Launay JM, Kellermann O 
(2000) Science 289:1925–1928. 
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Intestinal subepithelial myofibroblasts (ISEMF), present at 
the interface between enterocytes and the lamina propria 
mediate information flow between epithelium and the 
mesenchymal elements by secreting various cytokines, 
growth factor and inflammatory mediators. An excessive 
production of pro-inflammatory cytokines in the intestinal 
mucosa plays an important role in the pathogenesis and 
complications of inflammatory bowel disease (IBD). In fact, 
a deregulation of cytokine secretion occurs in intestine of 
these patients. The antioxidants affect the cytokine 
synthesis in response to appropriate stimuli with the 
involvement of MAP-kinases (MAPKs) and GSH levels 
decrease in the intestinal mucosa of IBD patients1. For this 
purpose we have evaluated the role of p38 and ERK1/2 
MAPKs in the redox regulation of the production of IL-6 an 
IL-8, involved in the onset of acute inflammation, in a 
human intestinal myofibroblast cell line, 18Co. These cells 
were stimulated in different experimental conditions for 24 h 
with lipopolysaccaride (LPS), N-formyl-methionyl-leucyl-
phenylalanine (fMLP) and tumor necrosis factor (TNF?), 
important mediators regulating IL production. The culture 
medium was used to assay IL-6 and IL-8 by ELISA Kits. 
GSH and GSSG levels were measured by HPLC method 
and phosphorylation of p38 and ERK1/2 MAPKs was 
performed by Western blot analysis. 
A relationship between the cytokine synthesis and 
GSH/GSSG ratio has been demonstrated in 18Co cells. 
In fact, the decrease of this ratio, by inhibiting GSH 
synthesis with buthionine sulfoximine (BSO), induced an 
increase in the IL-8 and IL-6 production. The subsequent 
stimulation of BSO treated cells with LPS, TNF? and 
fMLP induced a further and significant increase of ILs 
production both respect to BSO treated cells and to 
untreated but stimulated cells. On the contrary, the N-
acetylcysteine (NAC) addition to cells in which BSO was 
or not removed, by washing with PBS, restored both the 
GSH/GSSG ratio and the synthesis of interleukins to the 
normal values. BSO induced also a significant 
phosphorylation of p38 and ERK1/2 and this effect was 
abolished by NAC treatment. ILs production has been 
detected also in the presence of specific inhibitors of 
MAPKs to evaluate their physiological role in this process. 
Inhibition of MAPK pathways abrogated the increased 
release of interleukins in BSO treated and stimulated 
cells.  These results show that the decreased GSH/GSSG 
ratio levels measured in the intestinal mucosa of IBD 
patients can be responsible of the increased cytokine 
production that occurs in these patients. This study shows 
also that this effect is mediated by activation of p38 and 
ERK1/2 MAPKs.  
1. Iantomasi T et al. Biochem Med Metab Biol 
1994;53:87-91 
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Introduction: Previous results have demonstrated that 
PDGF receptor (PDGFr) is redox regulated in NIH3T3 
fibroblasts and that Sphingosine 1-phosphate (S1P) 
stimulation induces activation of NADPH oxidase and 
production of H2O2
1,2. S1P belongs to groups of platelet-
derived lipid mediators regulating various biological 
processes. Extracellular S1P acts through specific G-protein 
coupled receptors (GPCRs) in various cells including 
NIH3T3 fibroblasts. In these cells, intracellular S1P is also 
related to PDGF mitogenic signalling as second messenger 
and to PDGF-induced cell motility by autocrin mechanisms 
of S1P receptors stimulation. S1P and some GPCRs 
ligands transactivate receptor tyrosine kinase (RTK) with 
important effects downstream the signalling pathways, even 
if S1P-stimulated transactivation of RTK has not been well 
studied. Methods: Cell culture, transfection experiments, 
western blot analysis were performed as reported in the 
reference2. Results: Previously, we demonstrated in 
NIH3T3 fibroblasts that S1P is able to activate tyrosine 
phosphorylation of PDGF receptor (PDGFr) and this effect 
is mediated by H2O2 production. Concentration- and time-
dependent PDGFr tyrosine phosphorylation after S1P 
stimulation have been demonstrated and this effect was 
obtained in the presence of vanadate, specific inhibitor of 
tyrosine phosphatase that increased tyrosine 
phosphorylation. Similar results were obtained after cell 
stimulation by dihydro-S1P, S1P analogue that binds 
GPCRs and differently to S1P acts only as extracellular 
mediator. Phosphorylation of tyrosine 857 essential for the 
full activation and regulation of PDGFr kinase activity was 
also observed in S1P stimulated cells. Experiments 
performed by pertussis toxin (PTX), which specifically 
inhibits GPCRs, demonstrated that S1P-induced PDGFr 
transactivation occurred through GPCRs. Moreover, the 
specificity of this event was also determined. S1P-induced 
PDGFr transactivation was mediated by c-Src kinase 
activation with the involvement of H2O2 production. This has 
been demonstrated in cells treated with specific inhibitors of 
c-Src or PDGFr tyrosine kinase and with catalase. 
Effectively, c-Src kinase activation and H2O2 production 
induced by S1P stimulation occur upstream of PDGFr 
transactivation2. Finally, it has been demonstrated that 
PDGFr transactivation contributes to ERK1/2 activation and 
NIH3T3 fibroblasts proliferation due to S1P stimulation. 
Conclusions: Taken together, these results show that 
H2O2 production and c-Srk kinase activation are involved 
in a possible redox regulation of PDGFr transactivation 
induced by S1P and this event can contribute to 
downstream activation of ERK1/2 and cell proliferation. 
1. S.Catarzi et al., BBA, 1745, 166-175, 2005 
2. S.Catarzi et al., BBA, 1770, 872-883, 2007 
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Respiration is controlled by NO1 and by the 
electrochemical potential gradient at the level of 
cytochrome c oxidase. Two different mechanisms of 
inhibition by NO have been proved to be active in vitro,
using the enzyme purified in detergent solution or in intact 
cells2. Similar cell lines (lymphoid cells) appeared more 
susceptible to one mechanism or the other, depending on 
the concentration of cytochrome c in the cell3
MATERIALS AND METHODS 
NO- and O2-amperometric measurements have been 
carried out in parallel and compared to the available rapid 
mixing spectroscopic results. 
RESULTS & CONCLUSION 
At high concentration of cytochrome c2+, NO inhibits 
the enzyme in competition with O2 by binding to heme 
a3
2+ (nitrosyl complex), whereas at low [cytochrome c2+]
NO is oxidized to nitrite, possibly by reacting with the 
CuB
2+. In both cases cytochrome oxidase is transiently 
inhibited; the inhibition is reversible, and the enzyme fully 
recovers activity in the presence of O2 and reductants 
either by releasing NO or ejecting nitrite in the bulk phase.  
We are presently studying, by Metabolic Control 
Analysis (MCA), the behaviour of a human liver 
carcinoma cell line (HepG2). The effect of the NO 
inhibition on the control coefficient of cytochrome c
oxidase has been compared to that of the electrochemical 
potential gradient modulated by ionophores.
1. Brown, G.C. Biochim Biophys Acta. (2001),1504:46-
57
2. Mastronicola, D. et al. Cell. Mol. Life Sci. (2003) 60, 
1752-1759  
3. Masci, A. et al. Biochim Biophys Acta. (2008), 1777:6
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The GPR17 receptor, which is specifically activated by 
both uracil nucleotides and cystenil-leukotriene ligands 
and is mainly coupled to Gi-q protein 1, has been recently 
identified as a dualistic receptor with a phylogenetic 
position between P2Y and CysLT receptors. Purinergic 
signalling, having a important role in cell proliferation, 
migration and differentiation, has been recently involved 
in the control of mitogenic signalling activated by growth 
factor receptors (GFR) 2. Vascular endothelial growth 
factor (VEGF) has neurotrophic and neuroprotective 
effects on neuronal and glial cells, thus stimulating the 
proliferation and survival of neural stem cells. 
The aim of this work was to evaluate the GPR17 
expression and involvement in neuronal differentiation-
proliferation and its functional interaction with VEGFR in 
rat pheocromocytoma PC12 cells, as a neuronal model. 
Because of Nerve growth factor (NGF, 100 ng/ml) 
induces cell differentiation in sympathetic neurons, PC12 
cells were grown in medium containing NGF (100 ng/ml) 
for different times (0-10 days). 
The GPR17 expression levels were evaluated by RT-
PCR and immunocytochemistry experiments. PC12 cells, 
at different NGF treatment days, were exposed to GPR17 
agonists UDP-glucose and LTD4 for 24h, with or without 
VEGF (100ng/ml): then the MTS vitality assay was 
performed to assess cell proliferation. The levels of ERK 
? activation were also evaluated after cell exposure to 
GPR17 agonists and/or VEGF. 
Experimental data showed that GPR17 receptor 
wasexpressed in PC12 cells in the early stages of 
differentiation: anyway its expression was highest after 10 
days of neuronal differentiation (in serum-free conditions), 
in accordance to the dynamic expression of purinergic 
receptors during brain development. 
The VEGF and both UDP-glucose and LTD4 
significantly increased cell viability. UDP-glucose 
increases PC12 cell proliferation but had no synergic 
effects with VEGF. On the contrary, LTD4 increases 
PC12 cell proliferation and has a synergic effects with 
VEGF, at concentration within 5 nM. UDP-glucose and 
LTD4 effects on PC12 cell proliferation seem to be 
mediated by the activation of ERK1/2. 
The results obtained show promising perspectives for 
the employment of GPR17 receptor as a new target for 
therapeutic approach in brain damage and repair. 
1. Ciana P. et al. (2006) EMBO J, 25, 4615-4627. 
2. Franke H. and Illes P. (2006) Pharmacol Ther, 109, 
297-324. 
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In the current bibliography “normoxia” is generally 
referred to an oxygen concentration of 20%, instead, 
physiological oxygen tension is highly variable in different 
tissues but nevertheless it’s very different from that of the 
atmospheric pressure. It has been calculated that oxygen 
tension is about 13% in the pulmonary alveoli and 7% in 
the peripheral capillaries. Hence, considering both tissue 
oxygen consumption and diffusion, an oxygen tension of 
about 1-3% is conceivable for most tissues. 
In our working model we considered 1% oxygen 
tension as a physiological condition for NIH-3T3 cells, 
whereas we consider 20% an hyperoxic condition, to 
which a tissue could be exposed in particular conditions 
such as a wound. 
Our data show that a low oxygen tension (1%) causes 
a reduced proliferation rate in NIH3T3 cells with respect 
to that grown at 20% oxygen tension, in response both to 
serum and to PDGF-BB stimulation. In addition we found 
that cells kept at low oxygen tension show a reduced 
migration capability with respect to NIH-3T3 in 20% 
oxygen atmosphere upon PDGF-BB stimulation.  
We found that the exposition of NIH-3T3 cell to 1% 
oxygen tension for several days progressively reduce, 
through a post-transcriptional mechanism, the expression 
of PDGF receptor leading both to a weak cell proliferation 
response to high dose of PDGF-BB (30 ng/ml) and to a 
reduced cell migration at low PDGF-BB dose (2 ng/ml).  
We have tested also the behavior of transformed cells, 
in particular melanoma cells from primary tumor (A375) 
and from metastasis (HS29), in the presence of 1% 
oxygen tension and we have found that they show an 
higher proliferation rate respect to that kept at 20% 
oxygen.  
The opposite behavior of normal and transformed 
cells at low, physiological, oxygen tension may lead to the 
idea that, while for normal cells the low oxygen tension is 
a condition that contribute to the cellular quiescence of an 
adult tissue, for cancer cells the 1% oxygen tension gave 
instead a selective advantage both in terms of 
proliferation and migration. In this view cancers cells 
subvert what is normally a quiescent condition in a pro-
proliferative one, acquiring a selective advantage over the 
other non transformed cells in the tissue. A logical 
consequence of this idea is that the changing in 
the.oxygen-dependence response is one of the step 
(together with loss of apoptotic control, loss in cell 
proliferation control, loss of contact inhibition, etc) on the 
long route to cellular transformation.  
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NEW SMALL MOLECULE ANTAGONISTS TO 
PROTEASE-ACTIVATED RECEPTOR-1 (PAR-1): 
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Protease-activated receptors (PARs) belonging to the large 
G protein-coupled receptors family (GPCRs) are activated 
by proteolytic cleavage of their amino-terminal extracellular 
domain, thus exposing a new amino-terminal sequence 
that functions as a tethered ligand to activate them. PAR-1, 
the first member of this unique GPCR subfamily to be 
cloned, responds to a selected group of serine proteases 
including thrombin, plasmin, factor Xa, activated protein C, 
and matrix metalloprotease-1. The cellular effects of 
thrombin, are largely, but not exclusively, mediated via the 
activation of PARs (PAR-1, PAR-3, and PAR-4) among 
which PAR-1 is a high-affinity receptor and the major 
effector of thrombin signaling in platelets and endothelial 
cells. Through activation of PAR-1, thrombin is the most 
potent stimulus for platelet activation and initiates 
inflammatory and tissue repair responses1. Thus, PAR-1 
represents an important target for antagonist drugs which 
will be able to block the cellular effect of thrombin, including 
platelet activation, without inhibiting fibrin formation or 
platelet activation by other activators. To date, few PAR-1-
targeting agents have been developed and tested in limited 
disease models such as thrombosis, and experimental liver 
fibrosis 2,3. Recently, a panel of small molecules, which 
compete for binding at the carboxyl terminus of activated 
PAR-1 with a high affinity peptide mimicking the carboxyl 
terminal G?q, have been identified. One of these 
compound, Q94, inhibits thrombin receptor-activating 
peptide (TRAP) induced calcium current in a concentration 
dependent manner and blocks PAR-1-mediated CC-
chemokine (CCL2) production in mouse lung fibroblasts4.
Here, we examined the effects of four compounds 
which inhibit G?q peptide binding to activated PAR-1 
(similarly to Q94) on intracellular calcium increase 
induced by PAR-1 stimulation in HMEC-1. The purpose of 
this preliminary investigation was to identify potent 
allosteric antagonists which selectively interfere with Gq-
mediated PAR-1 signalling.  
All compounds caused either a modest or marked shift 
to the right of thrombin concentration-response curves 
and an evident reduction of thrombin maximal efficacy. 
Among the four compounds, compound PAR-1-0190 was 
the effective in reducing calcium transient with a complete 
block of the response at 10 ?M. This compound has a 
molecular structure which is similar to that of Q94 while 
the other three compounds have quite different molecular 
structures. PAR-1-0190 and Q94 may represent leader 
molecules to design new selective allosteric antagonists 
of PAR-1.  
1. Coughlin SR. (2005) J Thromb Haemost. 3: 1800-
1814. 
2. Derian CK et al. (2003) J Pharmacol Exp Ther. 304: 
855-861.  
3. Fiorucci S et al. (2004) Hepatology. 39: 365-375. 
4. Deng X et al. (2008) Mol Biol Cell. 19: 2520-2533. 
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In this work we assessed the antiproliferative activity of 
new synthesized imidazo-indolinone-derivatives in cancer 
cells. As preliminary screening the antitumor activity of 
the whole series of compounds was evaluated according 
to the protocols available at the National Cancer Institute 
of Bethesda. Compound 24 is the most potent of the 
series, particularly it is active against colon carcinoma cell 
lines. In order to investigate its  mechanism of action, we 
first examined the effect on the cell cycle profile of HT-29 
colon carcinoma cells. The cells were incubated for 24h in 
the presence of compound 24 at concentrations ranging 
from 0.5 to 2?M, afterward the analysis of DNA profiles 
was performed by flow cytometry. The results revealed 
that the molecule under test caused a dose-dependent 
accumulation of HT-29 cells in the G2/M phase. A similar 
effect was obtained with vincristine, used as a reference 
compound because in its structure it contains an indolic 
nucleus. 
A cellular event strictly correlated with cell cycle 
progression is represented by the induction of ornithine 
decarboxylase (ODC), the limiting enzyme for the 
biosynthesis of polyamines, that are absolutely required 
for cell proliferation. It is known that ODC inhibitors can 
interfere with the cell cycle at G1-S and G2-M transitions. 
The ODC activity was measured after cell treatment and it 
was observed a dose-dependent inhibition of enzymatic 
activity.  
Next we examined the effect of the molecule on 
cellular microtubule networks by using 
immunofluorescence techniques. The microtubules 
exhibit normal arrangement and organization in control 
HT-29. However, after treatment with compound 24, an 
increase of cellular tubulin condensation was detected, 
indicating cytoskeleton reorganization, together with a 
great number of mitotic spindles. These observations 
suggested that compound 24 arrested the cells in the 
mitotic process similarly to vincristine. Morphological 
studies performed by using 4',6-diamidino-2-phenylindole 
(DAPI) staining revealed condensed chromatin along with 
fragmented nuclei, suggestive of activation of apoptosis. 
Following 48h of cycle arrest, the activity of caspase 
proteases acting on the amino acid sequence Asp-Glu-
Val-Asp (DEVD) began to increase, confirming the onset 
of apoptosis. 
We can conclude that the effect of the very active 
compound 24 in HT-29 cells, is associated with a block in 
cell cycle progression, together with inhibition of ODC. As 
expected, the arrest of the cell cycle is then followed by a 
late induction of apoptosis, with activation of caspase 
proteases. The results obtained show that compound 24
can interfere with proliferation of colon cancer cells by 
multiple mechanisms and that it could be a promising 
candidate as an antitumor drug toward colon carcinoma. 
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The endogenous lipoperoxidation product 9-
hydroxystearic acid (9HSA) is an inhibitor of HDAC1 and 
its administration to HT29, a colon adenocarcinoma cell 
line, induces a proliferative arrest mediated by a direct 
activation of the p21 WAF 1 gene, bypassing p53 1. In a 
recent work the interaction of 9-HSA with the catalytic site 
of the 3D model of HDAC1 has been tested with a 
docking procedure. Noticeably, when interacting with the 
catalytic site, the (R)-9-enantiomer is more stable than the 
(S) one: in fact the energies of interaction are -8.45 
kcal/mol and -1.97 kcal/mol for the (R) and (S) isomer, 
respectively, and the estimated free energies of binding 
are -6.31 kcal/mol and +4.98 kcal/mol for (R) and (S), 
respectively 2. In this study (R) and (S)-9HSA were 
isolated and their biological activity tested in HT29. After 
24 h of growth HT29 cells were treated with 50 ?M of (R) 
or (S)-9HSA and then permeabilized by incubation with a 
solution of RNase and propidium iodide (PI). PI 
fluorescence was analyzed with a flow cytometer Epics 
Elite (Coulter), and cell cycle analyses  were performed 
by M Cycle (Verity) and MODFIT 5.0 software. 
A concentration of 50 ?M (S)-9HSA induced a growth 
arrest in G0/ G1. At the same concentration (R)-9-HSA 
showed a more remarkable antiproliferative effect, 
resulting in a increase of cells in G0/ G1. To asses the 
effects of (R)- and (S)-9HSA on histone deacetylase 1 
(HDAC1) HDAC2 and HDAC3 activity, HDACs were 
immunoprecipitated from HT29 cells and their catalytic 
activity were assayed by using [3H] acetate as the 
substrate. The amount of [3H] acetate released by 
deacetylase was expressed as cpm/mg protein. In 
presence of (R)-9HSA a drastic reduction of percentage 
of [3H] acetate released was observed, showing a 
stronger inhibitor effect on HDAC1, HDAC2 and HDAC3 
activity than the S isomer.  
1. Calonghi N. et al. (2004) BBRC 314:138-142. 
2. Calonghi N. et al. (2005) J. Lipid Res. 46: 1596-1603. 
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Pancreatic cancer is characterized by high frequency 
mutations in TP53, K-RAS, P16, and DPC4 genes. 
Despite advances in the understanding of the molecular 
biology, prognosis of this cancer remains dismal with a 5-
year survival of less than 5% and the gold standard 
chemotherapy with gemcitabine is largely ineffective. 
Zinc is an important modulator of various cellular activities 
with both catalytic and structural roles. It is the cofactor of 
over 300 enzymes and is involved in the stabilization of 
the three-dimensional structure of many proteins, 
including more than 100 transcription factors containing 
zinc finger domains. Owing to these critical roles, the 
cellular homeostasis of zinc ions is strictly controlled at 
different levels by cell membrane zinc transporters, 
metallothionein sequestration, and storing in intracellular 
compartments called “zincosomes”. Although zinc is an 
essential element, its excess induces apoptosis in 
different cell lines involving mitochondrial injury and 
oxidative stress production.  
In this work we show that treatment with non-toxic 
doses of zinc in association to the ionophore compound 
pyrrolidine dithiocarbamate (PDTC) inhibits p53-/-
pancreatic cancer cell growth much more efficiently than 
gemcitabine, the gold standard chemotherapeutic agent 
for pancreatic cancer. Both the metal chelator N,N,N’,N’-
tetrakis(2-pyridylmethyl)ethylenediamine and the radical 
scavenger N-acetyl-L-cysteine are able to recover cell 
growth inhibition by Zn/PDTC, demonstrating that this 
effect depends on the increased levels of intracellular zinc
and of reactive oxygen species (ROS). Zn/PDTC 
treatment induces a strong apoptotic cell death that is 
associated to ROS-dependent nuclear translocation of the 
mitochondrial factor AIF, but not to the regulation of 
apoptotic genes and caspase activation. Primary 
fibroblasts are more resistant than pancreatic cancer cells 
to Zn/PDTC treatment and exhibit a lower basal and 
Zn/PDTC-induced enhancement of intracellular zinc. We 
show that Zn/PDTC induces p53 proteasomal 
degradation and that the proteasome inhibitor MG132 
further increases fibroblast growth inhibition by Zn/PDTC, 
suggesting that p53 degradation plays an important role 
in fibroblast resistance to Zn/PDTC. 
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The efficacy of doxorubicin in the treatment of cancer is 
limited by its side effects and by the onset of drug 
resistance. Reversing such resistance could allow the 
decrease of the dose necessary to eradicate the tumor, 
thus diminishing the toxicity of the drug. We transfected 
doxorubicin-sensitive (HT29) and doxorubicin-resistant 
(HT29-dx) human colon cancer cells with RhoA small 
interfering RNA. The subsequent decrease of RhoA 
protein was associated with the increased sensitivity to 
doxorubicin in HT29 cells and the complete reversion of 
doxorubicin resistance in HT29-dx cells. RhoA silencing 
increased the activation of the nuclear factor-kappa B 
pathway, inducing the transcription and the activity of 
nitric oxide synthase. This led to the tyrosine nitration of 
the multidrug resistance protein 3 transporter (MRP3), 
and contributed to a reduced doxorubicin efflux. Moreover 
RhoA silencing decreased the ATPase activity of P-
glycoprotein (Pgp) in HT29 and HT29-dx cells, as a 
consequence of the reduced expression of Pgp. RhoA 
silencing, by acting as an upstream controller of both 
MRP3 nitration and Pgp expression, was effective to 
reverse the toxicity and accumulation of doxorubicin in 
both HT29 and HT29-dx cells. Therefore we suggest that 
inactivating RhoA has potential clinical applications and 
might in the future become part of a gene therapy 
protocol. 
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In higher eukaryotes, transcriptional processes regulated 
by nucleoproteins complexes, called enhanceosomes, 
play a critical role in the integration of cellular signalling 
information. In this context the STAT3-dependent 
enhanceosome is particularly interesting. The signal 
transducer and activator of transcription-3, a 
cytoplasmatic latent transcription factor, is a point of 
convergence for numerous oncogenic signalling 
pathways. STAT3, constitutively activated in several 
cancer cells, up-regulates the expression of numerous 
genes, involved in promoting tumor cell proliferation, 
angiogenesis, metastasis and cell survival. 
This research is focused on the influence of diverse 
extracellular signals on the composition of nuclear multi-
protein complex STAT3 specific. 
Melanoma cell (M14) is our cellular model of choice, 
because STAT3 is constitutively activated by src but is 
also responsive to stimulation by cytokine (IL-6 
100ng/ml), and growth factors (EGF100ng/ml). 
To characterize the STAT3-containing complexes we 
performed experiments in vitro, such as DNA affinity 
assay, and in vivo such as CoIP (Co-
Immunoprecipitation); the proteins complexes so purified, 
were analyzed by SDS-PAGE followed either by 
Coomassie staining and mass-spectroscopy analysis, or 
by Western blotting with specific antibodies. The results 
obtained showed that the interaction between STAT3 and 
its co-activators is strongly dependent on the signalling 
pathways. 
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Some neurological disorders due to defective cholesterol 
metabolism and characterized by abnormal accumulation 
of unesterified cholesterol (Niemann Pick type C1, NPC1) 
or sterols (cerebrotendinous xantomathosis, CTX) are 
also characterized by glia activation and increased 
expression of inflammatory markers. Astrocytes and 
microglia possess a repertoire of sterol hydroxylases 
belonging to the superfamily of cytochrome P450s (CYPs) 
enzymes, which catalyze multiple hydroxylations of 
cholesterol. It has been shown recently that the metabolic 
conversion of cholesterol to hydroxylated derivatives that 
can be easily eliminated through the blood-brain barrier is 
critical to maintain cholesterol homeostasis and intact 
brain functions. 
We have recently found that sterol hydroxylases are 
differently expressed in astrocytes and microglia, along 
with other genes involved in cholesterol homeostasis and 
their expression may be modulated at the level of gene 
transcription. 
Aim of the present study was to better characterize the 
effects of an inflammatory stimulus (LPS) and cholesterol 
accumulation on the expression of genes involved in 
cholesterol metabolism and activation in glial cells.  
To this end purified cultures of primary rat astrocytes 
and microglia were challenged with 5 ng/ml LPS for 4 h or 
loaded with 20 ?g/ml cholesterol  for 24 h. Gene 
expression was evaluated by real time RT PCR and 
activation was measured as release of biologically active 
Tnf-α.
We found that sterol 27-hydroxylase (Cyp27a1) is the 
only sterol hydroxylase to be up-regulated by LPS in both 
astrocytes and microglia. The induction of Cyp27a1 
mRNA is maximal at 4 h and appears to be kinetically 
slower than the up-regulation of Tnf-α
The levels of Cyp27a1 protein do not change rapidly 
suggesting a dissociation between transcription and 
translation. The preliminary observation that biochemical 
inhibition of the p38 MAPK can partially prevent the action 
of LPS on Cyp27a1 suggest that p38 substrates are likely 
involved in the LPS-dependent transcriptional regulation 
of this gene. 
On the other side cholesterol loading reduces 
mitochondrial functionality (assessed by means of MTT 
test) and increases the mRNA levels of Tnf-α in primary 
astrocytes. In the same conditions we observed reduced 
expression of some sterol hydroxylases (Cyp46a1 and 
Cyp7b1) but not of Cyp27a1. 
Our results suggest that Cyp27a1 may be a crucial 
gene in the innate immunity response of glial cells and a 
possible link between cholesterol homeostasis and the 
inflammatory process. 
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ERp57/GRP58, a member of the protein disulfide 
isomerase (PDIs) family and also a glucose-regulated 
protein, is induced by a variety of cellular stress 
conditions. ERp57 is mainly located in the endoplasmic 
reticulum, but it has also been found in other cellular 
compartments1, where its function is still unclear. 
In order to identify a possible correlation between the 
stress-response and the nuclear location and function of 
ERp57, we identified ERp57-bound DNA fragments by 
means of ChIP experiments on HeLa cells2.
The features of these DNA sequences, i.e. proximity 
of MAR regions and homology to the non-coding regions 
of orthologue genes of mouse or rat and DNAse 
hypersensitivity, are compatible with a gene expression 
regulatory function. Considering the nature of the genes 
concerned, one of which codes for a DNA repair protein 
(i.e. MSH6), we suggest that at least part of the 
mechanism of action of ERp57 takes place through the 
regulation of these, and possibly others still unidentified, 
stress-response genes. 
Moreover, in M14 melanoma cells we found that the 
STAT3-ERp57 complex is also present in the nucleus, 
and that its nuclear import is strongly favoured by the 
activation of STAT3 induced by IL-6. Furthermore, ERp57 
is associated with a number of STAT3-bound enhancers3.
In order to understand the functions of ERp57 in the 
nucleus, we have exploited an RNAi strategy. The 
silencing of the protein ERp57 has an effect on the 
expression of genes identified by ChIP experiments (i.e. 
MSH6, TMEM, ETS1). 
In addition, the inhibition of ERp57 expression is 
accompanied by the decrease of the expression of the 
STAT3-dependent genes. Evidence will be presented 
showing that the importance of ERp57 is not due to (or 
not limited to) the impairment of the nuclear import of 
STAT3. 
Together these results suggest that this protein is 
involved in a variety of nuclear processes. 
1. Turano C, Coppari S, Altieri F, Ferraro A. (2002) J Cell 
Physiol. 193,154-163. Review. 
2. Chichiarelli S, Ferraro A, Altieri F, Eufemi M, Coppari 
S, Grillo C, Arcangeli V, Turano C. (2007) J Cell 
Physiol. 210,343-51. 
3. Eufemi M, Coppari S, Altieri F, Grillo C, Ferraro A, 
Turano C. (2004) Biochem Biophys Res Commun. 
323,1306-12. 
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The functional association between transmembrane 
receptors in order to finely regulate cell activities is well 
established.  
In the past years, during a search for protein interactors of 
the vascular specific tyrosine kinase receptor Tie-2 we 
identified, among many candidates, another 
trasmembrane protein, Neurexin (NRXN). This protein 
had been studied exclusively in the nervous system 
where it localizes at the pre-synaptic side of chemical 
synapses. Based on the published data, NRXN and Tie-2 
were expressed in different anatomical districts, and 
physical interaction between these two membrane-bound 
proteins was impossible to conceive. Since Vascular 
Biology is our main interest, we decided to investigate if 
Neurexin, as many other neuronal proteins, was 
expressed in the vascular system. We demonstrated that, 
among others, immature blood vessels of the chick 
embryo produce NRXN in the entire span of their 
developing wall (including the endothelial  lining that 
expresses  Tie-2).  
At this stage we were in the right conditions to verify 
the initial hypothesis, i.e. that NRXN and Tie-2 can 
physically interact. As a first approach we overexpressed 
both proteins in a non-endothelial cell line and we verified 
that in these conditions NRXN and Tie-2 exist in stable 
preformed complexes. To improve the physiological 
significance of our data, we next moved to chirurgically 
excised arteries from chick embryos at day 18 of 
development,    as a model   to study the interaction. In 
these vessels Tie-2 is expressed preferentially by the 
endothelial layer while NRXN expression covers both the 
endothelial and the most luminal layers of vascular 
smooth muscle cells. In this setting we were also able to 
demonstrate that   NRXN and Tie-2 form endogenous 
complexes. The best conditions to maintain this 
interaction were found after a set up phase of the 
extraction efficiency with   buffers containing different 
detergents /cations. Moreover, we found that the optimal 
procedure to reveal the complex was to 
immunoprecipitate   NRXN and immunoblot the resulting 
precipitate with the anti Tie-2 antibody. We believe that 
this could be explained by the fact that, in the arteries, 
Tie-2 is produced at least in a ten times greater amount 
than NRXN.  
The findings here described strongly sustain the 
possibility that NRXN, a synaptic/vascular protein, 
exploits the Tie-2-initiated pathway   to   affect blood 
vessel biology. In fact, Tie-2 is one the few essential 
vascular players.  At this stage we are investing to 
analyse the molecular/cellular mechanisms and the 
functions of this interaction in the vascular system. We 
are also planning to identify what part of Neurexin is 
needed for Tie2- binding by using mutational analysis. 
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The differential diagnosis of the thyroid nodule includes 
numerous entities, non-neoplastic and neoplastic, benign 
and malignant and not infrequently pose diagnostic and 
treatment difficulties. 
The use of fine needle aspiration cytology (FNAC) has 
significantly improved the ability to identify specific high-
risk disorders and to facilitate their management in an 
expeditious and cost-effective manner but the follicular-
derived neoplasms (adenoma, carcinoma and the 
follicular variant of papillary carcinoma) manifest 
overlapping cytomorphologic features. 
The purpose of this research was to identify novel 
genes that can be targeted as diagnostic and clinical 
markers of indifferentiated thyroid tumours.  
Human thyroid carcinoma cell lines utilized in this 
study were obtained from primary thyroid neoplasms 
through biopsy and from FNAC, with the informed 
consent of the patients (Centro Telesforo), and cultivated 
at the Department of Pathology and Experimental 
Medicine and Clinic, University of Udine. 
Analysis were performed using western blotting and 
real-time PCR. PCR-based methods offer a simpler and 
practical approach to quantify gene expression also with 
limited amounts of material. 
Moreover, data reported so far demonstrated that 
H2O2 is crucial for the generation of thyroid hormones but 
is a potential source of reactive oxygen intermediates. 
These can lead to DNA damage if antioxidant defences 
are inadequate. Therefore, in this study we examined the 
effect of H2O2 on ARO, WRO and NPAP cells with the 
aim to investigate changes in the level of expression of 
selected genes (by real-time PCR) and a different cellular 
distribution of selected protein targets (by western 
blotting). 
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Stimulation of  primary T cells by engagement of the 
TCR-CD3 complex along with the coreceptor  CD28 
initiates signal transduction cascades that lead to the 
activation of  NF-AT, NF-kB and AP1  transcription factors 
required for cytokine production and cell proliferation.  
This event is associated with the degradation of the 
cyclin-dependent kinase inhibitor p27kip1 by the 26S 
proteasome  following its ubiquitination  by the ubiquitin 
ligase SCFskp2-cks1 (1). SCF complexes are  RING type 
ubiquitin ligases  that consist of  Cul1, Rbx, Skp1 and a 
member of the F-box protein family. The RING domain 
containing protein Rbx1 together with Cul1 form a 
catalytic core complex that recruits a ubiquitin conjugating 
enzyme; the variable F-box protein  binds the substrate 
and Skp1 serves as an adapter that links the F-box 
protein to Cul1. Skp2 and its cofactor Cks1B are the 
substrate binding subunits of the SCFskp2-cks1 ubiquitin 
ligase (2).
In the aim to differentiate between NF-?B-dependent 
and NF-?B-independent events occurring during  T-
lymphocytes activation,  the effects of the inhibition of  
NF-kB pathway on the stability of p27kip1 and the 
expression of  Skp2 and Cks1B following activation of 
resting T-lymphocytes  were evaluated. 
Resting T -lymphocytes were isolated from buffy coats 
of  healthy donors by density gradient cetrifugation on 
Lymphoprep followed by immunopurification. Cells were 
maintained at 37°C in a 5% CO2 humidified atmosphere in 
a medium supplemented with 10 mM HEPES, 1mM  
glutamine, 1 mM sodium  pyruvate, 50 UI/ml penicillin, 50 
?g/ml streptomycin and amphotericin A  T-lymphocytes  
were activated by incubation in the presence of 
immobilized anti-CD3 + anti-CD28 antibodies in the 
absence and in the presence of  inhibitors of NF-?B
activation.  At the end of incubation cells were lysed and  
mRNA  and protein expression was evaluated by qRT-
PCR and  western immunoblotting, respectively.  
Activation of resting T-lymphocytes  with immobilized 
antibodies against CD3 + CD28  caused  a significant 
number of cells entering cell cycle. Following a 48h 
stimulation, around  23% of cells  were S phase.   Cell 
cycle entry was accompanied by  decreased levels of 
p27kip1. Analysis of  Skp2 and Cks1B expression revealed   
increased levels of Skp2 and Cks1B both at the mRNA 
and protein levels. Activation of resting T-lymphocytes in 
the presence of inhibitors of NF-?B pathway determined a 
decrease in the number of  cells entering  cell cycle which 
was accompanied  by a decrease of Skp2 and Cks1 at 
the protein but not at the mRNA level.  In these conditions 
the down regulation of  p27kip1 was instead unaltered. 
1. Sherr, C.J. and Roberts J.M. (1999) Genes & Dev. 13, 
1501-1512. 
2. Hao, B. et al. (2005) Mol. Cell 20, 9-19.
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Chromatin structure is mainly regulated by histone post-
translational modifications. In particular, histone lysine 
acetylation is modulated by the opposing activity of two 
enzyme classes, namely histone deacetylases (HDACs) 
and histone acetyl-transferases (HATs).  
Aberrant levels of HDACs have been reported in most 
human malignancies, leading to the identification of 
HDACs as one of the promising targets for cancer 
treatment. In this regard, many HDAC inhibitors have 
been developed in the last few years, some of them being 
in late-phase clinical trials as new antineoplastic drugs. 
Current studies are aimed to improve inhibitor selectivity 
on HDAC isoenzymes, resulting in more restricted 
therapeutic targets and lower cell toxicity. 
In this study, MC1855, a new class I HDAC selective 
inhibitor, has been tested in HT29 human colon cancer 
cells. MTT assay was performed to determine MC1855 
IC50, and the effects on HT29 proliferation were analysed 
by flow cytometry. MC1855 negatively affects HT29 
growth with a 24h IC50 in the range 1.2 - 5.7 ?M. The 
treatment with 5 ?M MC1855 induced a strong growth 
arrest characterized by an increase of cells in the G2/M 
phase of cell cycle.  
This antiproliferative effect is mediated by the 
induction of the p21WAF1 gene, analysed by semi-
quantitative PCR.  In addition 24 hours administration of 
MC1855 resulted in the induction of the proapoptotic 
protein Bax, as revealed by confocal microscopy. In 
addition, histones extracted from HT29 cells treated with 
this inhibitor were characterized by liquid–
chromatography coupled to mass spectrometry1 in order 
to determine genome-wide histone post-translational 
modifications. The observed molecular events were found 
to be associated to a diffuse histone hyperacetylation 
status, covering histone classes H2-A, H2-B, H3 and H4. 
These data indicate MC1855 as a new potential 
HDAC inhibitor, its administration causing an interesting 
antiproliferative effect in colon cancer cells, and the  
growth arrest seems to be associated to a broad histone 
hyperacetylation. 
1. M. Naldi et al. (2006) J Chromatogr A 1129(1):73-81. 
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Naphtoquinones and anthraquinones have a wide 
spectrum of anticancer activity: they covalently bind to 
and intercalate into DNA, inhibit DNA replication and RNA 
transcription, act as DNA topoisomerase II poisons, 
produce oxidative stress, induce DNA breakage and 
chromosomal aberrations. Moreover quinones, such as 
emodin and shikonin, are able to modulate receptor 
tyrosine kinase (RTK) activity, an innovative molecular 
target for successful mechanism-based cancer 
therapies1,2. RTKs are mediators of cellular proliferation
and their mutations are often associated with hyperplasia 
and tumor development. Targeted inhibition of RTKs has 
thereby become an attractive therapeutic strategy in the 
treatment of cancer, and has resulted in several small-
molecule RTK inhibitors recently approved for clinical use 
worldwide. Polyamines have long been associated with 
cell growth and cancer: their important roles in 
angiogenesis and invasion have recently been identified, 
and now polyamine analogues are being developed as 
anticancer drugs to target polyamine metabolic enzymes 
and inhibit polyamine biosynthesis. Besides by 
modulating cell growth, some analogues also play an 
important role in cell apoptosis by regulating gene 
expression. Therefore, following the concept that a library 
built on the basis of selected natural products should yield 
better hits at a higher rate than classical compound 
libraries, we planned to design a small library combining 
aromatic quinone scaffolds with polyamines, varying from 
diamines to triamines and tetramine, as potential new 
chemical entities against cancer. We recently reported 
preliminary biological results showing that such a 
polyaminoquinone derivative designed following this 
rationale, FR18, shows cytotoxic activity in a human colon 
carcinoma cell line by activating apoptosis. A library of 24 
derivatives designed by combining two natural products-
derived fragments was prepared and tested to determine 
their anticancer potential in HT29 colon cancer cells. All 
library members inhibit cell proliferation as measured by 
MTT mitochondrial functional assay, with IC50 values in 
the 1-100 ?M range. We recently reported preliminary 
biological results showing that such a polyaminoquinone 
derivative designed following this rationale, FR18, shows 
cytotoxic activity in a human colon carcinoma cell line by 
activating apoptosis. This finding further encouraged us to 
perform SAR studies, synthesizing a focused 
polyaminoquinone library. Herein, to our knowledge, we 
report the first parallel synthesis with a polymer assisted 
purification of a polyamine-quinone conjugates library 
together with their antiproliferative properties. 
1. Lloyd, D. G et al (2006) Drug Discov. Today, 11, 149-
159. 
2. Koehn, F. E et al. (2005) Nat. Rev. Drug Discov., 4, 
206-220. 
2.43   
REGULATION OF HEPATIC LIPID AND 
CARBOHYDRATE METABOLISM BY THE LIVER X 
RECEPTOR  
N. Mitro1,2,3, P.A. Mak3, L. Vargas3, C. Godio1, V. Molteni3,
A. Kreusch3, E. De Fabiani1, D. Caruso1 and E. Saez2,3.
1
Dipartimento di Scienze Farmacologiche, Università degli 
studi di Milano, Milano, Italia. 
2
Chemical Physiology Department, The Scripps Research 
Institute, La Jolla, California, USA. 
3
Genomics Institute of the Novartis Research Foundation, 
San Diego, California, USA. 
Nuclear receptors are ligand-activated transcription 
factors that modulate gene expression in response to 
endocrine and environmental signals.  Members of the 
family that work as heterodimers with the Retinoid X 
Receptor (RXR) have emerged as sensors of various 
dietary components, including lipids, fatty acids, retinoids, 
vitamins, cholesterol, bile acids, and xenobiotics.   
The Liver X Receptors (LXR alpha and beta) are 
nuclear receptors that are activated by oxidized forms of 
cholesterol (oxysterols).  They serve as sensors of 
intracellular accumulation of pathogenic cholesterol, 
activating a program of gene expression aimed at 
removing harmful levels of cholesterol.  In addition to their 
role in regulation of cholesterol homeostasis, recent 
studies have demonstrated that the LXRs also coordinate 
carbohydrate and lipid metabolism in the liver and that 
they modulate expression of key genes in glucose 
metabolism.  The liver plays a central role in glucose 
homeostasis, as it has the distinct ability to produce and 
consume glucose.  Upon feeding, glucose influx triggers 
gene expression changes in hepatocytes to suppress 
endogenous glucose production and convert excess 
glucose into glycogen, or fatty acids to be stored in 
adipose tissue.  This process is controlled by insulin.  In 
addition to stimulating pancreatic insulin release, glucose 
also regulates the activity of Carbohydrate Responsive 
Element Binding Protein (ChREBP), a transcription factor 
that modulates lipogenesis.  
We recently described another mechanism whereby 
glucose determines its fate: we showed that glucose 
binds and stimulates the transcriptional activity of the 
Liver X Receptors.  D-glucose binds and activates both 
LXRs at physiological concentrations expected in the 
liver, inducing expression of LXR target genes with similar 
efficacy to oxysterols.  Cholesterol homeostasis genes 
that require LXR for expression are upregulated in liver 
and intestine of fasted mice re-fed with a glucose diet, 
suggesting that glucose is an endogenous LXR ligand.  
Our results suggest that LXR acts as a transcriptional 
switch that integrates hepatic glucose metabolism and 
fatty acid synthesis: excess glucose is sensed by the 
same transcription factor responsible for control of fatty 
acid synthesis. 
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Thrombopoietin (TPO) and IL-16, combined with a 
conventional cocktail composed of Flt3L, GM-CSF, IL-4 
and TNF-alpha ? direct the differentiation of human 
CD34+hematopoietic stem cells toward the development 
of tolerogenic dendritic cells. However, the molecular 
mechanisms by which dendritic cells are shifted away 
from an immune stimulatory phenotype are largely 
undefined. 
Here, we report that TPO+IL-16-mediated signaling 
leads to STAT3 phosphorylation and drives specific 
down-regulation of cathepsins S and D, two members of 
the pool of proteases involved in antigen presentation. 
Expression of these enzymes is finely time-controlled at 
both transcriptional and post-transcriptional levels, and 
apparently linked to a concerted modulation of the 
endogenous cathepsin inhibitor cystatin C. Notably, 
CD34+cells induced to differentiate toward the alloreactive 
pathway by the cytokine cocktail lacking TPO+IL-16 
switched the course of dendritic cell differentiation from 
immunity into tolerance when either cathepsin gene was 
silenced via RNA interference. Knockdown cells displayed 
markedly reduced levels of MHC-II, decreased efficacy in 
antigen uptake and impairment of stimulatory activity 
toward autologous CD4+T cells comparable to those 
resulting from TPO+IL-16 treatment. 
Thus, cathepsins S and D enforce a biochemical 
checkpoint within the immunosuppressive pathway 
elicited by TPO+IL-16, suggesting that either enzyme may 
be targeted for cell manipulation aimed at 
immunotherapy.
Acknowledgements: Ministero della Salute, RF-UMB-
2006-339457; Fondazione Cassa di Risparmio di Perugia, 
2007.0149.020 
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Tumor cells were shown to release, both in vitro and in 
vivo, “vesicles” that vehicle several proteins involved in 
cell-cell and cell-matrix interactions. An interesting 
challenge is the characterization of the protein content of 
such vesicles that may increase the understanding of 
their potential roles in vivo.
8701-BC, a continuous line of breast carcinoma cells, 
was shown to release “membrane vesicles” with a 
diameter ranging from 100 to 1000 nm and playing a role 
in tumor progression mechanisms. On the other hand, 
production of “exosomes”, smaller vesicles known to be 
involved in immune response activation, had not been 
revealed. 
The first goal of this study was to separate different 
vesicle populations from 8701-BC cell conditioned 
medium. To this aim, after two low speed centrifugations 
performed to remove cells and cell debris, the medium 
was differentially centrifuged. Western analysis, carried 
out using specific antibodies, revealed that the 15,000xg 
pelletted fraction contains ?1-integrin, a protein which had 
been shown to be clustered in membrane vesicles shed 
by 8701-BC cells1, but not Hsc70, a protein found in 
exosomes2, 3. On the contrary, Hsc70 is detectable while 
?1-integrin is not present in the fraction obtained by a 
further centrifugation at 100,000xg of 15,000xg 
supernatant. Moreover, the absence of Cytochrom C in 
both fractions excludes the contamination with apoptotic 
vesicles. These results suggested that 8701-BC cells 
release both membrane vesicles and exosomes and that 
their separation can be achieved by differential 
centrifugation. 
Then, to analyze the whole protein content of the 
vesicle preparations, a proteomic approach was chosen. 
Protein 2D-PAGE analysis of the different fractions was 
performed and the resulting gel images were analyzed in 
silico, using ImageMaster 2D Platinum software. 
The preliminary comparative proteomic analysis 
revealed a set of protein spots differently abundant in the 
vesicle fractions. These data strongly encourage for 
further investigation using 2D-PAGE coupled with MS-
MALDI-TOF analysis which could help to elucidate 
physiological roles of the two different kinds of vesicles. 
1. Dolo V, Ginestra A, Cassarà D, Violini S, Lucania G, 
Torrisi MR, Nagase H, Canevari S, Pavan A, Vittorelli 
ML. (1998) Cancer Res. 58(19): 4468-74.
2. Hegmans J, Bard M, Hemmes A, Luider T, Kleijmeer 
M, Prins JB, Zitvogel L, Burgers S, Hoogsteden H, 
and Lambrecht B. (2004) Amer. J. Pathol. 164, 1807-
1815. 
3. Choi DS, Lee JM, Park GW, Lim HW, Bang JY, Kim 
YK, Kwon KH, Kwon HJ, Kim KP, and Gho YS. 
(2007). J Prot Res. 6, 4646-4655. 
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Ovarian cancer remains one of the most difficult 
gynaecologic cancers to treat, owing to its aggressive 
biology and high relapse rate, as well as the toxic side 
effects of available chemotherapeutic agents used 
against this recurrent disease. Therefore, it is important to 
develop new antiproliferative molecules with fewer side 
effects and superior pharmacological properties. 
Among anticancer agents, those that target 
microtubules constitute one of the most effective classes 
of chemotherapeutics employed for survival prolongation 
in the advanced state of the disease. Most of them, such 
as Vinca alkaloid (Vincristine, Vinblastine) or the semi-
synthetic ones (Vinolrebine), contain in their structure an 
indolic nucleus, responsible for the therapeutic activity. 
These drugs are used extensively for the treatment of a 
wide variety of human cancers, including ovarian, 
prostate, NSCLC, and breast cancers. 
In a previous work we investigated the antitumor 
activity of a new class of indole-derivatives towards 60 
different human cancer cell lines1. In particular we noted 
that compound 3l, (3E)-3-{[2-chloro-1-(4-chlorophenyl)-5-
methoxy-6-methyl-1H -indol-3-yl]methylene}-5-hydroxy-6-
methyl-1,3-dihydro-2H -indol-2-one, was able to induce a 
strong and irreversible cytostatic effect without showing 
any cytotoxicity in human ovarian carcinoma cells, 
IGROV-1 1.
The aim of this work is to characterize the biochemical 
pathway by which the new indole-derivative produces 
growth inhibition in IGROV-1 cells. 
Firstly to assess whether 3l interferes with the cell 
cycle progression we performed flow cytometric studies: 
treated cells showed a marked increase in the G0/G1 
peak with respect to controls (89% vs 66%). 
In order to identify the molecular target of the 
compound we followed its cellular internalization, by 
monitoring the concentration in the IGROV-1 nuclear 
fractions for 48 hrs. A method based on LC-ESI-MS was 
developed for the quantitative determination of the 
molecule under test in the cellular samples. The analysis 
revealed that drug localizes in the nucleus starting from 6 
hrs after treatment , where it remains for 48 hrs. 
These preliminary results indicate a correlation 
between the cell cycle arrest and accumulation of 3l in the 
nuclear compartment for 48 hrs. Further studies are in 
progress to investigate whether the compound brings 
about  posttranslational modifications, such as 
phosphorylation and acetylation, of nuclear protein 
involved in the control of the cell cycle. 
1. Andreani A, et al.(2007) J Med Chem. 50(14), 3167-
72
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Human malignancies of all kinds show alterations in the 
epigenetic features, indicating that all cancer patients 
could potentially benefit from epigenetic therapy. In 
particular, an high activity of histone deacetylases 
(HDACs) causes epigenetic alterations associated with a 
genome-wide histone hypoacetylation. Consequently, 
HDAC non selective inhibitors have entered late-phase 
clinical trials as new antineoplastic drugs. However they 
can cause contradictory effects by inhibiting different 
isoforms at the same time. Selective HDAC inhibitors 
could be in principle able to avoid these situations and 
also result less toxic. 
The goal of the present work has been the study of a 
possible correlation between the degree of histone post-
translational modification and the effects caused by 
treatment with HDAC I selective (MS275, MC1855), Class 
II HDAC selective (MC 1568)1 and non selective (SAHA) 
HDACs inhibitors. This correlation along with the whole 
analysis of the histones isoforms, could afford a mean to 
better understand the mechanisms of action of new, more 
potent, and selective HDAC inhibitors directly on the cells.  
Following our previous studies2, liquid –
chromatography coupled to mass spectrometry was 
applied to characterize histones and their post-
translational modifications in HT29 cells after time and 
concentration dependent treatment with HDAC inhibitors.  
The results were correlated to the power of HDAC 
inhibition, the effects on the cell cycle, and protein 
expression. The most important results were that MC 
1568 produced only a modest H4 hyperacetylation even 
at high doses (50 ?M), was ineffective on the other 
histones, and resulted non cytotoxic. In order to have 
cytotoxic effects therefore HDACs inhibitors must inhibit 
HDAC class I. In fact we observed that, besides H4, 
SAHA (non selective) and MC1855 (class I HDAC 
selective) induced a generalized histone hyperacetylation 
when administered at 50 ?M, and were found to be 
cytotoxic. Levels of intermediate inhibition of H4, H3, 
H2A, and H2B as those obtained after treatment with 
MS275 produced only less marked effects on the cell 
cycle by inducing a G0/G1 arrest. It can be concluded that 
the sole H4 hyperacetylation does not cause cell death. 
1. Mai et al. (2005) J. Med. Chem. 48:3344–3353.  
2. M. Naldi et al. (2006) J Chromatogr A 1129(1):73-81. 
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A growing body of evidence indicates that growth factors 
stimulate ROS production in a variety of cell types 
through receptor-transducing pathways, although the 
detailed mechanism is poorly understood [1]. Growth 
factor-induced ROS production seems to be necessary 
for optimal propagation of mitogenic signals in neoplastic 
proliferation and for glucose transport activation. 
Malignant cells are known to have accelerated 
metabolism, high glucose requirement and thus increased 
glucose uptake rate. 
In this study we show that in the human acute myeloid 
leukaemia (AML) cell line M07e the growth factor IL-3 
induced ROS formation and stimulated the synthesis of 
glucose transporter 1 and of the cytosolic NAD(P)H 
oxidase subunit p47phox. In fact, both intracellular ROS 
content and glucose transport activity were decreased by 
inhibitors of plasma membrane ROS sources such as 
diphenylene iodonium and apocynin. Among the catalytic 
subunits implicated in NAD(P)H oxidase activity, M07e 
cells express the phagocytic gp91phox protein (Nox2). 
The inhibition of ROS generation with NAD(P)H oxidase 
inhibitors stimulated apoptosis in leukaemia cells as 
confirmed by typical internucleosomal DNA fragmentation 
and effector caspase activation. Similar effects on ROS 
content, glucose transport modulation and apoptosis 
induction were also shown by the incubation with receptor 
tyrosine kinase inhibitors, such as anti-leukaemic drugs 
blocking the stem cell factor receptor c-kit. In fact, IL-3 
seems to transmodulate c-kit phosphorylation. The 
receptor tyrosine kinase c-kit is essential for the 
development of normal hematopoietic cells and has been 
proposed to play a functional role in acute myeloid 
leukemia. Binding of the c-kit ligand SCF initiates a signal 
transduction cascade including receptor 
autophosphorylation and subsequent phosphorylation of 
intracellular substrates. Therefore, we could speculate 
that a receptor transmodulation or receptor trans-
phosphorylation occurs in the context of leukaemia cell 
growth responses to individual cytokines. Otherwise, an 
autocrine SCF production could occur, as shown in most 
AML cells. 
The results suggest that ROS production induced by 
IL-3 via NAD(P)H oxidase protects leukaemia cells from 
apoptosis. Opposing to this mechanism may play an 
important role in acute myeloid leukaemia treatment, thus 
representing a novel therapeutic strategy. 
This work has been supported by MIUR (PRIN) and 
Fondazione Cassa di Risparmio di Cento (Italy) 
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Protein tyrosine phosphorylation plays a key role in the 
generation of signals necessary for different cellular 
events such as growth, migration and invasion of normal 
and malignant cells. Recent studies have assessed the 
role of low molecular weight protein tyrosine phosphatase 
(LMW-PTP) in cell transformation and tumour onset and 
progression, observing a significant increase in LMW-PTP 
mRNA and protein expression in different human tumors 
and in particular in breast and colon cancer1,2 and 3.
Moreover, its enhanced expression is generally 
prognostic of a more aggressive cancer. Negative 
modulation of LMW-PTP expression leads to profound 
changes in cell motility, possibly due also to LMW-PTP-
dependent Src Tyr-phosphorylation. LMW-PTP 
modulation seems also to influence apoptosis. Finally, we 
believe that the analysis of the pattern of expression of a 
very large repertoire of genes will contribute to clarify the 
role of LMW-PTP in tumorigenesis. Our aim is to evaluate 
how LMW-PTP could play a role in modulating cell 
transformation, trying to understand the cause-effect 
relationship between expression level of LMW-PTP and 
tumorigenesis, using whole genome expression 
approach, such as microarray techniques, in combination 
with ectopic LMW-PTP modulation. Moreover, we are 
also analyzing the phenotypic changes in cell adhesion 
and motility induced by LMW-PTP modulation.  Whole 
genome expression analysis are currently performed with 
microarray techniques in MCF10A cells where expression 
of LMW-PTP has been modulated by either transient 
ectopic expression or with RNAi-induced silencing, to 
increase or decrease LMW-PTP expression in the cell. 
Results must be yet statistically analyzed and evaluations 
will be available soon. In the same experimental 
conditions it was possible to observe  that LMW-PTP 
silencing leads to a strong increase in cell motility, 
observed already after 12 hours, using a on-plate wound-
ealing assay. A crucial parameter such as 
phosphorylation of the activatorial Tyr416 of Src protein 
was also evaluated: Src specific phosphorylation shows a 
2-fold increase, possibly due to a direct action of LMW-
PTP. Moreover, MMC2 metallo-protease expression is 
markedly induced (about 5-fold) by LMW-PTP negative 
modulation. Evidences suggests that in these conditions 
there is also a partial protection from anoikis induced by 
detachment of the cells from extra-cellular matrix.  
1. Chiarugi, P. et al., (2004)  Oncogene  23(22):3905-14. 
2. Malentacchi F et al., (2005) Biochem. Biophys. Res. 
Commun., 334: 875-83. 
3. Marzocchini et al., (2008), Int.J.Cancer 122(7), 1675-
1678. 
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BACKGROUND AND AIM. Proteins undergo in vivo
spontaneous post-biosynthetic deamidation/isomerization 
of asparagines, generating L-isoaspartyl residues. Such 
alterations slowly occur during aging processes and are 
dramatically increased by physical-chemical stresses 
brought to living cells. Deamidated-isomerized proteins 
are often structurally altered and functionally impaired. 
The isospartyl protein carboxyl-O-methyltransferase 
(PCMT; EC 2.1.1.77) initiates the repair of the isopeptide 
bond at the isoaspartyl site. In line with the role of PCMT 
in the maintenance of protein structural stability upon cell 
stress, preliminary results speak in favor of the 
involvement of this enzyme in the apoptosis processes.   
Aim of this project is to shed light on the role of PCMT in 
apoptosis and to clarify the relevant mechanism(s) 
involved.  
METHODS. Endothelial cells from porcine aorta (PAE) 
were transfected with pcDNA3.1 expression plasmid, 
carrying human wild type PCMT or its antisense or 
various mutants. Cells were then subject to oxidative 
stress induced by H2O2 concentrations (0.1 - 0.5 mM 
range). Apoptosis was monitored by: A) DNA 
fragmentation assay; B) Western blotting, using anti-
PARP and anti-caspase3 antibodies; C) FACS analysis 
(propidium iodide staining). PCMT substrates were 
purified through proteomics, using human recombinant 
PCMT as a byte coupled to SulfoSbed, followed by mass 
spectrometry.   
RESULTS. 1) PAE cells overexpressing the“wild type” 
human PCMT are resistant to apoptosis. 2) This is 
specifically due to the methyltransferase activity, since 
negative dominant mutants are devoid of any 
antiapoptotic effect. 3) Transfection with antisense PCMT
induces high sensitivity to apoptosis even at low H2O2
concentrations. 4) Cells transfected with either antisense 
PCMT or mutants accumulate unrepaired highly 
deamidated-isomerized proteins, upon oxidative stress. 5) 
The mechanism for apoptosis is mediated by activation of 
the caspase3/PARP common pathway. 6) Proteomics 
allowed the identification of Hsp70, Hsp90 and Bcl-xL as 
PCMT substrates involved in apoptosis. In particular Bcl-
xL is an antiapoptotic protein which has been previously 
described to undergo deamidation in vivo.
CONCLUSIONS. PCMT is involved in the regulation 
of cell response to proapoptotic stimuli such as oxidative 
stress. The mechanism of this protection involves methyl 
esterification of specific isoaspartyl residues derived from 
asparaginyl deamidation. We propose that PCMT repairs 
the deamidated forms of key anti-apoptotic proteins thus 
preserving their structural stability and biological function.  
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Neuroblastoma is the most common extra cranial solid 
cancer in childhood. The difficulty with neuroblastoma lies 
in early diagnosis. Unfortunately, it’s normally diagnosed 
when the disease had metastasized to other parts of the 
body (bones, lymph nodes, skin and liver). If the 
neuroblastoma is found in time, treatment is often very 
successful. The prognosis is not so good in the later 
stages, however. In about 90% of neuroblastomas, 
elevated levels of catecholamines or their metabolites are 
found in the urine or blood.  
Vanilmandelic acid (VMA, 4-hydroxy-3-
methoxymandelic) and homovanillic acid (4-hydroxy-3-
methoxy- phenylacetic, HVA) are the main acidic 
catabolites of norepinephrine and dopamine, respectively, 
and are excreted in urine. The concentrations of these 
metabolites increase significantly in neurological 
disorders so that  HVA and VMA are exploited as 
biological markers of neuroblastoma. 
The main goal of the present work was to develop a 
method for the rapid quantitative analysis of VMA, HVA in 
urine samples using multi-detection techniques as HPLC–
ESI- MS/MS, HPLC-UV and HPLC-FLD. 
The high selectivity and sensitivity of tandem MS and 
fluorescence make these techniques suitable for 
determination of low concentrations of metabolites in 
complex matrices, such as urine. The developed methods 
use mandelic acid as internal standard (IS), both for the 
evaluation of recovery and assessment of ionization 
efficiency towards these metabolites. In parallel a 
qualitative analysis of VMA was also pursued. In fact, it is 
very interesting to observe that  in the  catabolic pathways 
of L-noradrenaline and L-adrenaline, the stereocenter 
configuration of some metabolites is not specified, 
particularly for VMA. For this reason, an attempt to 
identify if this molecule is present as unique enantiomer, 
racemic mixture or enantiomeric excess “in vivo” in the 
human organism was also made. To resolve the VMA 
standard racemic mixture the indirect resolution strategy 
was used. This method is based upon diastereomers 
formation by reaction with a chiral tagging reagent. This 
way their HPLC separation using an achiral stationary 
phase is possible, exploiting the different physicochemical 
properties of the diastereomers. 
2.52    
OSTEOBLAST RESPONSE TO MECHANICAL 
STRESSES IN VITRO IN THE PRESENCE OF 
ESTRADIOL 
B Cerboni, C Alessandrini1, T Doldo2, V Micheli, G 
Pierucci, G Nardi, S Sestini 
DipartimentI: Biologia Molecolare, Scienze Biomediche
1
,
Scienze Odontostomatologiche
2
. Università di Siena, 
Siena, Italia 
Bone remodelling is the result of different factors, such as 
piezoelectric responses, prostaglandin production, intra- 
and extra-cellular biochemical factors stimulated by 
natural or applied mechanical forces, whose efficiency is 
a very important topic in orthodontics. It is well known that 
tooth movement is due to both strain and compression 
forces, whose dimension and duration are crucial to 
obtain good and quick clinical results. Sexual hormones 
are also active on the bone cycle: estrogen deficiency, for 
instance, leads to increased bone resorption due to 
inhibition of osteoclast apoptosis and to decreased bone 
production1.
In this study, we attempted to evaluate the effect of 
strain forces on osteoblast-like SaOS-2 cell line in the 
presence or absence of estradiol, to evaluate the action of 
these two different variables taken together. 
We subjected SaOS-2 cells to mechanical strains 
caused by two types of continuous forces (1: slow, 
consisting in 2 hours of stress and 2 hours of rest, 2: very 
slow, consisting in 24 hours of stress followed by 24 
hours of rest) or by interrupted forces (consisting in 20 
seconds of stress, 20 seconds of rest for 1 hour) in the 
presence and in the absence of estradiol. The method to 
stress the cells is a modification of that of Hasegawa2.
Cells were seeded in six well plates, in transwells which 
are provided with transparent, permeable and reversibly 
deformable bottom. To stress the cells, a template with a 
convex surface was placed under the transwells. ALP 
activity was assayed as a marker of osteoblast 
differentiation by colorimetric method. In the estradiol 
absence, ALP activity decreased following stress though 
not significantly, demonstrating a weak stop signal in cell 
differentiation. The activity didn’t change after the rest 
period in type 1 stress, while it showed a significant 
increase of 52% in type 2 stress, thus suggesting that 
long stress is a stimulus to osteoblast differentiation.  
Incubation of cells in the presence of estradiol caused 
a 45% increase of ALP activity with respect to control 
cells; such increase, even if in different amount, is always 
present in all the experimental conditions. ALP activity 
increased significantly in interrupted stress after the rest 
(58% with respect to non stressed cells). No significant 
variations are shown after both types of continuous 
stresses. Continuous long time stress seems thus to be 
the optimal condition for bone remodelling, nevertheless 
interrupted stress applied to osteoblasts in the presence 
of estradiol, caused the highest ALP activation.  
This different behaviour shown in the presence or 
absence of hormones suggests dentists that this factor 
must be taken into account when using orthodontic 
appliance in subjects with different hormonal conditions. 
1. Manolagas SC. et al. (2002) Recent Prog Horm 
Res.57, 385-409 
2. Hasegawa S. et al. (1985) Calcif. Tissue Int. 37,431-
436
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Cellular senescence is a special form of permanent 
growth arrest that is considered a tumor suppressor 
mechanism and an alternative to apoptosis, as well as a 
possible contributor to tissue aging. Various stimuli, 
including dysfunctional telomers, sublethal oxidative 
stress, DNA damage and activation of certain oncogenes, 
trigger cellular senescence that is usually controlled by 
p53 and p16-retinoblastoma (p16-Rb) tumor suppressor 
pathways.  
Accumulation of senescent cells has been viewed for 
a long time as potential cause of aging and recent 
evidences support the hypothesis that this phenomenon 
may contribute to aging not only by accumulation in vivo
of senescent cells in different tissues, but also by 
reducing the regenerative potential of the tissues, as a 
consequence of the stem cell senescence. The cellular 
senescence is characterized not only by the appearance 
of several markers, but also by modifications of gene 
expression pattern.  
We previously reported that young human embryo 
fibroblasts (IMR90) exposed for few days to low doses of 
the GSH-depleting agent DEM, acquire the senescent 
phenotype1.
A recently identified class of short (20-23 nucleotides) 
non-coding RNAs, that act as “regulators” at post-
transcriptional level, are the microRNAs (miRNAs). 
miRNAs suppress gene expression via imperfect base 
pairing to the 3’ untranslated region of target mRNAs, 
leading to repression of protein production or, in some 
cases, to mRNA degradation. Since recent studies 
indicate that miRNAs affect a broad spectrum of biological 
activities including development, proliferation, apoptosis 
and cancer, we have investigated whether the miRNAs 
have a role in the induction of cellular senescence 
provoked by mild and chronic oxidative stress. We 
performed a microarray analysis for 380 known human 
miRNAs, by using as probes RNAs from normal and 
DEM-treated young IMR90. Preliminary results show that 
4 miRNAs are up-regulated in IMR90 exposed to DEM; 
validation of these results by real time PCR will be 
presented. 
1. Faraonio R., Pane F., Intrieri M., Russo T., and 
Cimino F. (2002) Cell Death Differ 9: 862-64 
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Biochemical biomarkers are of particular value as they 
represent sublethal changes resulting from individual 
exposure to pesticides. Organophosphorous insecticides 
(OPs) bind covalently to the active site of 
acetylcholinesterase (AChE) and measurement of AChE 
activity represents an obvious biochemical biomarker to 
detect OP exposure. On the other hand, exposure to 
insecticides is expected to produce a series of 
biochemical changes, including not only decreased level 
of target enzymes, but also an increased level of 
enzymes involved in the biotransformation pathway and a 
disturbance of the normal physiology and energetic 
metabolism of the animal1. To our knowledge no studies 
have been performed on the role of metabolic 
intermediates and/or end-products as biochemical 
biomarkers. 
In this study we measured the metabolites 
concentration in freshwater macroinvertebrates exposed 
to OPs under laboratory conditions. Then we examined 
these metabolites in natural communities exposed to OPs 
and other pesticides. Laboratory studies were performed 
on midge larvae (Chironomus riparius), a well known 
sentinel organism for freshwater ecosystems. During a 
survey of metabolite concentrations in C. riparius larvae 
exposed to insecticides we found unusual high 
concentration of alanine in animals treated with 
fenitrothion (FT) which increased up to 7-fold the basal 
level. This phenomenon was accompanied by decreased 
trehalose, pyruvate and glutamate and increase of 
transaminase activity. These effects were not detected 
when animal were exposed to carbamate insecticides, 
suggesting that metabolic response elicited by FT could 
by related to oxidative stress induced by this compound 
as documented in literature.  
Metabolite analysis was then applied to a field research 
which included biochemical analysis of several freshwater 
macroinvertebrates collected from Meolo River, a site 
exposed to agricultural pollution (in particular OPs, 
herbicides and fungicides), and Upper Livenza River, a 
low pollution reference site. Animals collected from Meolo 
River displayed lower AChE activities and higher alanine 
concentration compared to Livenza and a metabolic 
pattern compatible with exposure to OPs similar to that 
described from laboratory studies. Alanine determination 
is confirmed as a valuable biochemical biomarker to OPs 
exposure. 
1. Callaghan et al. (2001) Ecotoxicol. Environ. Saf. 50, 
19-24. 
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Serotonin (5-HT) has not been detected in all trombocytes 
of fishes but in teleost it has been shown to regulate the 
hypothalamic-pituitary-interrenal activity and the secretion 
of plasma cortisol in response to different stressors1.
European sea bass Dicentrarchus labrax is subjected to 
different rearing conditions, that may affect production, 
product quality, but mainly fish physiological functions and 
welfare. In order to investigate the effects of different 
anaesthetics in reducing the stress related to handling and 
in affecting fish metabolism, plasma 5-HT with tryptophan 
(Try) and cortisol levels were measured in D. labrax,
without anaesthesia and with anaesthesia using tricaine 
methanesulphonate (MS-222), 2-phenoxyethanol (2-PE) 
and cloves oil. Fish (n. 5, mean weight ± D.S. 82 ± 15 g)  
were caught from off-shore cages and transferred to a tank 
of water (150 l). Sampling was done without anaesthetic 
(Group I, control) after 31 days acclimation in aquarium to 
21,0 °C, pH 7,35. Fish (n. 15, mean weight ± D.S. 61 ± 11 
g), reared in aquarium, were anaesthetized before 
sampling with MS 222 (50 mg/l) (Group II), 2-PE (0,4 ml/l) 
(Group III), cloves oil (0,04 ml/l) (Group IV). All fishes were 
exposed to anaesthetic for a medium time of 7-8 min. 
Blood, in heparin, was taken from caudal vessel. PCV, 
plasma glucose, TPP, TG, TCho (spectrophotometer) were 
analysed. Cortisol levels were determined in duplicate by 
EIA kit (Radim). Plasma samples were added to standard 
N-Methylserotonin and protein precipitation reagent, vortex-
mixed, incubated at 4°C and centrifugated.  The surnatant 
was analysed by HPLC and electrochemical detector. In 
Group I plasma 5-HT leves are very low, comparable to 
those reported by Rubio2. Blood variables are similar in 
Group II,III,IV; Glucose, PCV, TPP levels are comparable 
to control, suggesting that the anaesthetics did not affect 
the biochemical status of fishes, while TG and TCho 
concentrations are significatively lower owing to 
maintenance diet. Increased cortisol levels owing to all 
anaesthetics are directly related to time exposure. As in 
other species subjected to handling3 cloves oil is less 
effective than MS-222 in reducing cortisol responses. 5-HT 
and Try values show similar trend. Plasma 5-HT levels are 
strongly increasing only in Group II. Try levels in Group III 
and IV are comparable to control values while in Group II 
are significatively higher vs. Group I and IV (P<0,01) and 
Group III (P<0,05). The results obtained support the 
hypothesis that the anaesthetic MS 222 probably interact 
with brain serotoninergic system, thus inducing an increase 
of plasma 5-HT and Try levels. 
1. Winberg S. et al. (1997) Neuroscience Letters 230, 
113-116    
2. Rubio V.C. et al. (2006) Physiol. & Behav. 87, 7-15. 
3. Sink T.D. et al. (2007) North American Journal 
Fisheries Management 27(1),156-161 
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The cathelicidin family of host defence peptides is 
regarded as an important component of the host innate 
immune system. Its members are synthesized as 
precursors with a characteristic N-terminal cathelin-like 
domain, well conserved also in evolutionary distant 
vertebrates, and with cationic C-terminal regions, carrying 
the active antimicrobial peptide, with considerable 
sequence diversity. Cathelicidin-related proteins were 
found in mammals, birds, primitive vertebrate Atlantic 
hagfish and most recently also in ray-finned fish such as 
rainbow trout and atlantic salmon1,2.
By using genomic PCR amplifications, RT-PCR tissue 
analyses, and peptide chemical synthesis, we have here 
investigated and characterized the cathelicidin family in 
different salmonid ans osmerid species such as brown 
trout (Salmo trutta fario), brook trout (Salvelinus 
fontinalis), grayling (Thymallus thymallus) and rainbow 
smelt (Osmerus mordax).
With few exceptions, two different genes, CATH-1 and 
CATH-2, were found in each species, with almost 
identical cathelin-like domains and largely varied cationic 
C-terminal domains. Unique hallmarks were found in all 
these peptides: the presence of a high number of Gly and 
Ser residues, which collocate them in a novel distinctive 
group of antimicrobial peptides, and the presence of a six-
amino-acid repeated sequence, detected in a variable 
copy number among the different cathelicidins, which 
reflects the existence of a genetically unstable region 
similarly to that found in some mammalian cathelicidin 
genes. RT-PCR assays indicate that salmonid 
cathelicidins are expressed in a wide range of tissues in 
healthy fish, including head and trunk kidney, spleen, 
gills, skin, stomach and brain. Some of the C-terminal 
peptides have been chemically synthesized and used to 
investigate their spectrum of antibacterial activity against 
a number of bacterial fish pathogens.  
1. Tomasinsig L. and Zanetti M. (2005) Curr. Protein 
Pept. Sci. 6, 23-34. 
2. Chang C.I. et al. (2006) Antimicrob. Agents 
Chemother. 50, 185-195. 
3.4 
STRUCTURAL CHARACTERIZATION OF SILICATEIN 
FROM THE MARINE SPONGE PETROSIA FICIFORMIS
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Cerrano2, U. Benatti4, G. Damonte3
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Silicateins, members of the cathepsin L family, are 
enzymes that have been shown to be involved in the 
biosynthesis/condensation of biosilica in spicules from 
Demospongiae (phylum Porifera). Axial filaments from P. 
ficiformis spicules have been extensively analyzed by 
mass spectrometry. Preliminary MALDI-MS experiments 
on the intact protein samples showed a complex group of 
signals in the 22.9-24.2 KDa range, clearly indicating an 
high degree of heterogeneity in the silicateins family. 
Further bottom-up analysis with tandem mass sequencing 
were thus performed on both the whole sample and on 
the 1D electrophoresis bands. Peptides deriving from 
proteolytic digestions where separated by reversed-phase 
chromatography and analyzed by Nanospray-MS/MS. 
The previously published sequence of silicatein beta 
deduced from P. ficiformis cDNA has been completely 
confirmed except for a single point mutation (a valine 
instead of a leucine). Functional silicatein sequence 
begins with H2N-LPETVD, but strong evidences of a 
significant degree of methylation of the N-terminus were 
collected in tandem mass sequencing experiments. 
Extensive use of manual interpretation of tandem mass 
data of smaller chimotryptic peptides proved to be a 
crucial breakthrough in silicatein analysis. Several post 
translational modifications were detected in our 
experiments. Three phosphorylation sites Tyr 97, Ser 213 
and Ser 66 were found. Experiments have been planned 
in order to assess the correct grade of phosphorylation. 
Preliminary results show that phosphorylated/non 
phosphorylated ratio roughly ranges from 5 (S213)  to 
20% (Y97) . It should nevertheless be noted that the 
reported phosporylations are those surviving the HF 
extraction procedure and might not correctly represent the 
correct amount of phosphorylation of silicatein in its 
natural conditions inside spicules. Other relevant 
modifications were an extensively oxidized histidine at 
H15 and the  modified thyonyl group of Cys 157 to cisteic 
acid. The elucidation of details on silicatein structure and 
its post-translational modifications are essential to better 
understand the mechanism of biosilica precipitation and 
its nanoscale organisation and it will allow a future employ 
of these peculiar proteins as biotechnological devices for 
the realisation of shapes and dimensions controlled silica 
particles suitable for microelectronics and 
nanotechnology. 
3.5 
FUNCTIONAL METAPROTEOME ANALYSIS OF 
MICROBIAL POPULATIONS IN ENRICHMENT 
CULTURES ON POLYCYCLIC AROMATIC 
HYDROCARBONS
A. Magini1, E. Federici2, L. Urbanelli1, M. A. Giubilei1, B. 
Tancini1, F. Trivelli1, G. Cenci2, C. Emiliani1
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2 Department of Cellular and Environmental Biology, 
University of Perugia, Italy.  
A better understanding of microbial ecology would lead to 
clarify the essential processes mediated by 
microrganisms such as bioremediation of polluted sites. A 
variety of tools, such as nucleic acid-based methods, 
have been used in the past to gain insights into genetic 
structure and diversity of environmental microbial 
populations (metagenome). However, knowledge of 
genetic structure of microbial community does not help to 
acquire useful information on functional pattern such as 
metabolic capacity, population dynamics, and 
physiological responses to changeable environmental 
conditions. To overcome this limit, the large-scale study of 
whole community expressed proteins (metaproteome) 
has the potential to yield insights into the functional role of 
the microbial components in ecosystems.  
In  this study we performed a parallel analysis of the 
metagenome and the metaproteome of enrichment 
cultures established using an historically contaminated 
soil as inoculum and naphthalene or phenantrene as sole 
carbon source. Denaturing gradient gel electrophoresis 
(DGGE) fingerprinting of 16S rRNA genes indicated that 
enrichment cultures presented a lower microbial 
biodiversity than the soil used as inoculum but, 
surprisingly, the bacterial communities in the polycyclic 
aromatic hydrocarbons (PAH)-amended cultures were 
highly similar to the control cultures. On the contrary, 
Real-Time PCR quantification of PAH catabolic genes, 
namely the upper-pathway naphthalene dioxygenase 
gene (nahAc) and the lower-pathway catechol 2,3-
dioxygenase gene (C23O), indicated that strains 
harboring PAH catabolic genes, and thus potentially 
capable of PAH degradation, were enriched in the 
cultures treated with PAHs, and in particular with 
naphthalene. Entire proteome of cultured bacterial 
communities was separated by two-dimensional gel 
electrophoresis using the 3-10 pH range. Spot analysis, 
performed using specific software, highlighted  
quantitative and qualitative differences in the protein 
expression pattern of PAH-treated cultures with respect to 
the control. PAH treatment induced a strong increase of 
the total number of expressed proteins, 505 and 452 
spots in naphthalene and phenantrene cultures, 
respectively, compared to 361 spots in control cultures. 
Interestingly, naphthalene and phenantrene treated 
cultures shared 88 treatment-specifc proteins. Moreover, 
the number of spots that showed no significant 
quantitative differences were higher in phenantrene 
respected to naphthalene cultures, confirming Real-Time 
PCR results. In conclusion we can emphasize as 
metagenome and metaproteome characterization of 
complex microbial communities can provide useful 
information to link their genetic structures with their 
functions in the environment. 
3.6 
MURINE PULMONARY INFLAMMATORY RESPONSE 
FOLLOWING INSTILLATION  OF SIZE-
FRACTIONATED TYRE PARTICLES (TP) 
 F. Farina, P. Mantecca,  G. Sancini, E. Moschini, M. 
Gualtieri, G. Miserocchi, M. Camatini2 and P. 
Palestini1
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Epidemiological studies have demonstrated associations 
between acute exposure to elevated levels of particulate 
matter (PM) and increased risk of cardiopulmonary 
disease. PM is composed of an inert carbonaceous core 
covered by layers of adsorbed pollutant molecules. 
Attention has been focused on one component of the 
respirable fraction, the tyre derived particles (TP which 
represent 8-10% of PM10  and  2.5 % of  PM2.5). In a 
recent in-vitro study we demonstrated that organic extract 
of TP causes disassembling of the alveolar plasma 
membrane at discrete points and causes deregulation of 
caveolae/rafts expression (Beretta et al, 2007), while  the 
lung  inflammatory response evoked by  TP in-vivo, is still 
unknown.   
Therefore, we evaluated the pro-inflammatory 
potential effects induced by size-fractionated TP (10 ?m) 
intratracheally instilled. TP morphology and 
characterization were performed by  transmission electron 
microscopy. Male BALB/c mice (7-8 week-old) were 
intratracheally instilled with microsprayer syringe (Penn 
Century) with 10 (TP1), 100 (TP2), 200 ?g (TP3) of TD10 
in 100 ?l of saline 0.01% Tween 20, or 100 ?l of saline 
0.01% Tween 20 (Control). After 24 h, 10 mice from each 
group were euthanized, the trachea was cannulated and 
the lungs were lavaged 3 times with 0.6 ml of saline. The 
resulting lavage (BAL) was centrifuged 1500 g, 15 min, 4 
°C.  Total cells were counted using Trypan blue; cell 
aliquots were smeared on slides using Cytospin and 
stained with Diff-Quik for differential count. The 
supernatant was assayed for total proteins, LDH, MIP2, 
TNF? ?-Glucoronidase, Alkaline Phosphatase, SOD and 
total GSH. 
TP present the typical shape of tyre debris: the 10?m
TP are mainly distributed under the dimension of 10?m
(more than 90%).Biochemical analyses, cell number and 
cell type of  BAL didn’t show significant differences in 
comparison with control. Conversely, TP2 dose induced 
significant increase in the number of total cells and in 
particular in polymorphonuclear (PMNs) percentage (70% 
compared to 29% in control). Biochemical analysis 
revealed  an increase in alkaline phosphatase activity 
(correlated to increase of PMNs and marker of alveolar 
cells type II damage)and MIP2 level, but no change in 
LDH,  ?-Glucoronidase, SOD, GSH and TNF?. The 
highest dose  TP3 produced a marked increase in PMNs 
percentage (up to 80 %), ?-glucoronidase and LDH. 
Among all the tested parameters, the most sensitive end-
point appeared to be the PMNs number in the BAL, which 
was significantly elevated in a dose-dependent way. The 
other parameters monitored, such as anti-oxidant 
enzymes and proinflammatory cytokines appeared to be 
less indicator systems, almost at the end time analyzed 
Supported by EPRI project 2008  “ Effects of tire particles 
on in-vivo system” to M. Camatini.  
4.1 
NUTRITIONAL MODULATION OF IL-23 RECEPTOR AS 
POTENTIAL REGULATOR OF BOWEL 
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Recent immunologic advances have established that T 
cells and inflammatory cytokines play a pivotal role in 
inflammatory bowel disease (IBD)1. Particularly, Crohn’s 
disease is associated with high levels of interleukin-23 
(IL-23) secretion2, mucosal interleukin-17 (IL-17) 
expression and serum IL-173.
IL-23 is a newly discovered member of the interleukin-
12-related cytokine family. IL-23 is primarily involved in 
the differentiation of pathogenic T cells, which are 
characterized by the production of the pro-inflammatory 
IL-17.  
Controlling the expression/production of IL-23 and IL-
17 is an approach that would allow the development of 
novel therapeutic and nutritional tools in human IBDs. In 
fact, diverse micronutrients are believed to exert their 
effects through modulation of the expression of genes 
related to inflammation. 
In humans, the functional IL-23 receptor complex is 
predominantly expressed on activated/memory T cells, T-
cell clones, and natural killer cell lines4.
In this study we established whether Kit 225 cells 
might be a suitable model system for investigating 
nutritional modulation of IL-23 pathway. Kit 225 are 
interleukin-2-dependent human T cells derived from 
chronic lymphocytic leukemia. The expression of IL-23 
receptor in this cells was evaluated with quantitative real 
time PCR and Caco-2 cell line was used as comparison. 
Once established IL-23 receptor complex expression in 
our model system, we evaluated its effect on the 
expression and release of some cytokines, in the 
presence or absence of IL-23 stimuli. 
Future experiments will elucidate whether specific 
micronutrients can modulate IL-23 receptor activity, 
therefore reducing IBDs incidence or symptoms. This 
nutrigenomic approach appear essential for the 
developing of immunonutrition as optimal new therapy. 
1. Marx J. (2007) Science 315(5808): 33-35. 
2. Fuss I.J., et al. (2006) Inflamm Bowel Dis 12(1): 9-15. 
3. Fujino S., et al. (2003) Gut 52(1): 65-70. 
4. Langrish C.L., et al. (2004) Immunol Rev 202: 96-105. 
4.2 
PRO-APOPTOTIC EFFECTS OF ORIGANUM 
VULGARE IN HUMAN COLON CANCER CACO2 
CELLS
I. Savini, R. Arnone, M.V. Catani, L. Avigliano 
Dept. Experimental Medicine & Biochemical Sciences, 
University of Rome Tor Vergata, Rome, Italy.  
Oregano spice is widely used in Mediterranean diet, 
which is associated with a low risk for colon cancer. 
Although the medicinal benefits of oregano, such as the 
antioxidant, anti-inflammatory and antimicrobial activities, 
are well known, nonetheless only few data are available 
on its effect in cancer prevention, especially concerning 
the mechanisms of action. Here, we investigated the 
effects of Origanum vulgare ethanolic extract on cell 
proliferation, redox balance and apoptosis of the human 
colon cancer Caco2 cell line and compared them with 
normal human primary fibroblasts.  
We found that 500 ?g/ml oregano extract led to growth 
arrest and cell death of Caco2 cells, without harming 
normal cells, through a mechanism involving the 
expression of biochemical hallmarks of apoptosis and 
alteration of redox state. Oregano led to activation of pro-
caspase-3, as indicated by the increase in the expression 
of 17 kDa cleavage product, which in turn promoted 
cleavage of full-length PARP to its 89 kDa fragment. To 
gain insight into the mechanism of action, we analyzed 
the activation of caspases and regulators, involved either 
in the death receptor or mitochondrial pathways. 
Treatment of Caco2 cells with oregano induced 
processing of pro-caspase 8: the cleaved, active fragment 
p18 was significantly increased (4 fold) after treatment 
with oregano , thus suggesting an involvement of the 
death receptor-dependent signalling. Oregano also 
activated the intrinsic apoptotic pathway: after a 24 hours 
incubation, the expression of APAF-1 increased of 1.6 
fold, while the expression of pro-caspase-9 decreased of 
0.48 fold. Expression of pro- or anti-apoptotic members of 
the Bcl-2 family also appeared to be modulated: oregano 
increased protein levels of pro-apoptotic Bak, while down-
regulating the expression of anti-apoptotic Bcl-xL. 
Furthermore, oregano promoted a perturbation in the 
mitochondrial membrane potential, as measured by 
uptake of the fluorescent dye JC-1, thus corroborating its 
influence on the death mitochondrial pathway. Despite its 
antioxidant capacity (2.4 mmol of Trolox equivalent/g of 
oregano extract dry weight) oregano lowered total 
glutathione levels and increased the content of its 
oxidised form, when added to cultures.  
In conclusion, our data suggest a scientific basis for 
oregano spice involvement in prevention of cancer. 
Recently, the pro-oxidant action of phenolic compounds 
present in spices seems to explain their preferential 
cytotoxicity towards cancer cells. The amounts of extract 
used in our experiments were derived from about 2.5 mg 
of dried leaves, quantities far less than those normally 
found in the diet. Therefore, the anti-tumoral effects 
described in this study are easy to reach in a 
Mediterranean diet. 
4.3 
POLYUNSATURATED FATTY ACIDS IN THE 
CONTROL OF CHOLESTEROL AND TRYGLICERIDE 
SYNTHESIS: ROLE OF SREBP 
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The plasma triglyceride and cholesterol-lowering effect is 
considered an important one among other possible 
contributing factors for the protecting activity of 
polyunsaturated fatty acids (PUFAs) in cardiovascular 
diseases. Both cholesterol and fatty acids biosynthetic 
processes are controlled by a common family of 
transcription factors indicated as sterol regulatory element 
binding proteins (SREBPs). SREBPs are intrinsically 
bound to endoplasmic reticulum membranes and must be 
escorted to the Golgi apparatus, where proteases liberate 
mature forms of SREBPs. Once released, mature 
SREBPs translocate to the nucleus to bind to the SRE 
(sterol response element) in the promoter regions of key 
genes of lipid metabolism. The proteolytic processing of 
SREBPs is regulated by free cholesterol intracellular 
concentration. When sterol concetration is high SREBP is 
confined into the endoplasmatic reticulum, when it is low 
cellular SREBP moves to activation in the Golgi, and the 
mature and active form of SREBP is released.  
In this study, we evaluated the effect of the 
supplementation of different fatty acids to the culture 
medium of HepG2 cells on SREBP-mediated gene 
regulation. HepG2 cells were transfected with the SRE-
luciferase (SRE-luc) gene, and SRE-luc activity 
determined after supplementation with scalar 
concentrations of n-6 and n-3 PUFAs. Modification of cell 
fatty acid composition was also determined by 
gascromatography. Furthermore, to evidence whether an 
increase of free cholesterol intracellular concentration 
could participate to the proteolytic regulation of SREBP 
activity, the distribution of free cholesterol within cell after 
PUFAs supplementation was assessed by fluorescence 
microscopy, in the absence/presence of U18666A, a 
pharmacological molecule that blocks cholesterol 
translocation. 
All supplemented PUFAs caused a significant 
reduction of SRE-luc activity, let us hypothesize a 
consequent reduction in the expression of genes related 
to fatty acids and cholesterol biosynthesis. PUFAs added 
to the culture medium were not only remarkably 
incorporated into cell lipids, but also converted into their 
longer and more unsaturated metabolites. Filipin staining 
showed free cholesterol distribution in both plasma 
membrane and cytosol. Free cholesterol transport was 
clearly blocked by the addition of  U18666A, but when the 
pharmacological molecule was added to EPA 
supplemented cells, a free cholesterol translocation was 
still present. This result suggest an EPA-induced 
cholesterol release from plasma membrane to cytosol. 
Our data may improve knowledge of the mechanisms 
by which fatty acids control fatty acid and cholesterol 
synthesis, and provide insight into the development of 
new therapeutic strategies for a better management of 
lipid metabolism. 
4.4 
SUPPLEMENTATION WITH ISOFLAVONES: 
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Consumption of soy products has been correlated to a 
lower incidence of different diseases such as CVD, 
hormone-related cancers and osteoporosis, that has been 
partially attributed to isoflavone intake1-3. The aim of this 
study was to investigate the metabolic effects of isoflavone 
(IF) supplementation in healthy women. A dietary 
intervention with isoflavone supplements was performed in 
8 healthy women under a free diet (age 29 ± 8, BMI 22 ± 
3), selected by a specific selection criteria. Volunteers were 
supplemented with 80 mg/d of total isoflavones (42 mg 
genistein, 30 mg daidzein and 8 mg glycitein) for 6 months 
followed by 2 months of suspension.  
At the beginning (T=0), after 2 (T=1), 4 (T=2) and 6 
(T=3) months of treatment and after the suspension  
(T=4) samples of blood were collected. Plasma 
concentrations of isoflavones (genistein and daidzein), 
variables of antioxidant status like total antioxidant 
capacity (TEAC, Lag-time), plasma vitamin status (α-
tocopherol, retinol, ascorbic acid); markers of oxidative 
stress  like erythrocytes membrane fluidity (fluorescence 
anisotropy) and susceptibility of DNA against induced 
oxidative stress (comet assay); serum lipid profile 
(concentration of triglyceride, total cholesterol, HDL 
cholesterol and LDL cholesterol) were analysed.  
Statistical analysis were performed by ANOVA test for 
repeated measure.  
Plasma concentrations of isoflavones significantly 
increased according to dietary intervention suggesting a 
good compliance of volunteers to the protocol.  Markers 
of plasma antioxidant capacity show a trend (not 
significant)  toward an increase at T=2 and T=3 and a 
return to the basal level at T=4. Plasma concentrations of 
vitamins show a variability possibly related to  different 
dietary habit within the experimental period (ascorbic 
acid). Regarding membrane status we observed a 
significant increase of fluidity at T=2 T=3 with respect to 
the basal level and final point (p<0.05). DNA susceptibility 
against induced oxidative stress (H2O2) was significantly 
decreased due to dietary intervention (p<0.05), showing a 
significant inverse correlation between DNA damage and 
plasma IF concentration (p<0.01).  Finally, the analyses of 
serum lipid profile pointed out a positive effect of IF on 
LDL cholesterol (significantly decreased at T=3, p<0.05), 
while other variables were not affected.  
The obtained results suggest a positive effect of  IF 
supplementation in healthy young women against 
oxidative stress evaluated by measurement of membrane 
fluidity and DNA oxidative damage. These results support 
that the healthy  effect ascribed to soy consumption could 
be at least partially related to the antioxidant potential of 
isoflavones.  
1. Keys A  Cambridge Mass: Harvard University Press 1980 
2. Setchell KD et al Am J Clin Nutr 2003;78:593S 
3. Peeters PH et al Breast Cancer Res Treat 2003;77:171 
4.5 
KINETICS OF THE LIPOPEROXYL RADICAL-
SCAVENGING REACTION OF BETANIN AND 
BETANIDIN IN SOLUTION. 
Allegra M., Pawlicka K., Gentile C., Tesoriere L., Livrea 
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ROS-mediated damage to membranes and lipoproteins is 
involved in the initiation and/or progress of a number of 
diseases including atherosclerosis, coronary hearth 
disease and cancer. Betacyanins, water-soluble 
nitrogenous pigments formed by condensation of 
betalamic acid with cyclo-DOPA or cyclo-DOPA 
derivatives, are dietary bioavailable phytochemicals 
whose antioxidant effects have been recently reported in 
LDL and RBCs both in vitro and ex vivo experiments1,2.
In this work we studied the reaction between betanin, 
the main dietary betacyanin, and its aglycone, betanidin, 
with lipoperoxyl radicals generated by azoinitiator-induced 
oxidation of methyl linoleate in methanol, and identified 
the oxidation products of the pigments to clarify the anti-
radical reaction mechanism. 
Betanin, in the range 1-50 ?M, behaved as a retarder 
of the lipid peroxidation causing a concentration-
dependent decrement of the propagation rate and 
generating betalamic acid. Consumption rate of betanin 
was linearly related to its amount (r2=0.98), suggesting 
adverse autoxidation reactions.  
Betanidin behaved as a chain-terminating lipoperoxyl 
radical scavenger as effective as α-tocopherol, with a 
calculated inhibition constant of 1.23 x 105 M-1s-1 and a 
stoichiometric factor of 1.99. Its oxidation product was 
identified as betanidin o-quinone.  
Betanin is characterised by a monophenol structure 
whereas betanidin is an o-diphenol. A mechanism can be 
proposed in which phenoxyl radicals generated from 
betanin following reaction with peroxyl radicals cause 
autooxidation and cleavage of the molecule. On the other 
hand, the two orthohydroxyls in the phenol moiety of 
betanidin, while remarkably increasing their reactivity, 
affect betacyanin transformation. The aryloxyl radical 
formed following reaction with lipoperoxyl radicals can 
suffer a dismutation to produce betanidin quinone and re-
generate betanidin.  
Our results contribute to elucidate the chemical basis 
of the known antioxidant action of the betacyanin 
pigments. 
1. Tesoriere L., Butera D., D’arpa D. Di Gaudio F., 
Allegra M., Gentile C., Livrea M.A. (2003) Free Rad. 
Res. 37, 689-696  
2. Tesoriere L., Butera D., Allegra M., Fazzari M., Livrea 
M.A. (2005) J. Agric. Food Chem. 53, 1266-1270. 
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Ascorbic acid has a fundamental role for preservation and 
correct maintenance of living organism. Close to its well 
known antioxidant properties, it is an unreplaceable 
cofactors of enzymatic reaction. Many organisms 
biosynthesize L-ascorbic acid, but other have the need to 
introduce this fundamental vitamin with the vegetables. 
One of the main problems involving ascorbic acid 
assimilation is correlated to its instability and degradation 
into biologically inactive compounds. As reported in 
Barreca et al.1 trehalose preserves ascorbic acid against 
thermal degradation. In this work we analyses the 
protective influences of the sugar on antioxidant 
properties of ascorbic acid.  500 ?M ascorbic acid solution 
was incubated at 25°C and at 60°C in presence or 
absence of 1.0 M trehalose for 20 minute. After 
incubation, the vitamin solution were analyzed by UV-
Visible spectroscopy. The free radical scavenging effect 
of compounds was assessed by using the stable free 
radical 2,2-diphenyl-1-picrylhydrazyl. Ascorbic acid alone 
or plus trehalose, at a concentration ranging from l to 100 
?M, in a final volume of 3.0 ml, was mixed with 80 ?M
DPPH in methanol. The changes in absorbance at 517 
nm was monitored over 30 min. DPPH concentration in 
the cuvette has been chose to give absorbance values 
less than 1.0. UV-Visible spectroscopy did not reveal 
significant changes in major absorbance band of ascorbic 
acid, in presence of trehalose. Otherwise a remarkable 
decrease in the same band intensity was observed for 
solution incubated at 60°C without sugar. The antioxidant 
assay showed that absorbance of DPPH alone did not 
change over all the period of the experiments. The results 
obtained with ascorbic acid alone or plus trehalose 1.0 M, 
after incubation for 20 min a 25°C, are the same for both 
solution, inducing a rapid decrease of absorbance at 517 
nm. The efficient concentration (EC50)  obtained was the 
same for both solution  (6.55 ?M). After incubation for 20 
min at 60°C, the results obtained in presence of 1.0 M 
trehalose are superimposable with the curves at 25°C, 
while ascorbic acid alone showed very little antioxidant 
potency. The antioxidant potentials of pure vitamin C and 
vitamin C plus trehalose were the same irrespective of the 
sugar concentration, indicating that vitamin solution could 
play an effective role as radical scavenger. The same test 
shows also that at 60°C the presence of trehalose 
preserves ascorbic acid scavenger potency, presenting a 
biological activity equivalent to the pure L-ascorbic acid. 
Otherwise at 60°C ascorbic acid solution looses nearly 
completely this capacity.     
1. E. Bellocco, D. Barreca, G. Laganà, U. Leuzzi, F. 
Migliardo, G. Galli, A. Galtieri, L. Minutoli, F. 
Squadrito. Neutron Scattering and HPLC Study on L-
Ascorbic Acid and its Degradation. Chemical Physics 
345, 191-195, 2008. 
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Abstract: Allium sativum L., commonly known as garlic, 
belong to Alliaceae family. It grows wild in areas where it 
has become naturalised; it probably descended from the 
species Allium longicuspis, which grows wild in south-
western Asia.  Garlic has been used as both food and 
medicine in many cultures for thousands of years, and 
represents a popular herbal remedies.  It’s claimed to 
help prevent heart disease, reduces cholesterol and 
cancer risk by neutralizing dietary mutagens and free 
radicals, significantly inhibits abnormal platelet 
aggregation and oxidation of LDL and VLDL cholesterol, 
helps to remove iron and other toxic heavy metals from 
the body, protects neurons from aging damage, boosts 
immune function and lower blood pressure in some 
people1. Allium sativum may also possess cancer-fighting 
properties due to the presence of allylic sulfur compounds 
such as diallyl disulfide, believed to be an anticarcinogen 
and allicin, a powerful antibiotic and anti-fungal 
compound. It is major component include: alliin, ajoene, 
vitamins, minerals and flavonoids. In our work we focused 
attention on protein fraction of garlic extract. We 
examined protein content and its potential antioxidant 
activity and capacity to inhibit tyrosynase activity. Garlic 
bulb were homogenate into powder in a chilly mortar. 
Protein were precipitated by salts and suspended with 
buffer. Protein content were estimated by Bradford assay. 
Radical scavenging activity were analyzed, in function of 
protein concentration, against the free stable radical 2,2-
diphenyl-1-picrylhydrazyl (DPPH). The measurement of 
the reductive ability was evaluated by ferric 
reducing/antioxidant power.    
Antioxidant assay shows the potentiality of protein 
extract precipitated by salts, to eliminated DPPH radical 
species. Useful information arise also by salts 
precipitation at different salts ratio (20, 30, 40, 60, 80 and 
100%).  Ferric reducing/antioxidant power assay reveals 
that about 40% of total garlic extract reducing activity is 
attributable to protein fraction. This last shows also 
tyrosynase inhibitory that is function of its activity. Results 
underline the importance of garlic protein fraction not only 
for feeding but also for commercial preservation utility. 
1. Lawson LD. Garlic: a review of its medicinal effects 
and indicated active compounds. In: Lawson LD, 
Bauer R, eds. Phytomedicines of Europe: Chemistry 
and Biological Activity. Washington, D. C.: American 
Chemical Society; 1998:177-209. 
4.8 
ANTIOXIDANT ACTIVITY IS INCREASED IN XENOPUS
EMBRYOS DEVELOPED IN SIMULATED 
MICROGRAVITY 
M. Negroni, G. Montorfano, P. Corsetto, P. Berselli, S. 
Zava, B. Berra  and A. M. Rizzo 
Institute of General Physiology and Biochemistry “G. 
Esposito”,  University o f Milan 
The operation of the space station and the human 
exploitation of the space will require long duration 
missions, characterized by two condition that can 
negatively impact on human health: microgravity and 
space radiations .  
In the human organism, solar radiation or low 
wavelength electromagnetic radiations (such as gamma 
rays) from the Earth or space environment can split water 
to generate the hydroxyl radical, which can initiate chain 
reactions leading to lipid peroxidation. These reactive free 
radicals (ROS) can react with the non-radical molecules, 
leading to oxidative damage of lipids, proteins and DNA, 
involved in various diseases, such as cancer, cell 
degeneration, and inflammation.  
In this view radiation constitutes the most important 
hazard for humans during long-term space flights. 
Radiation protection is therefore mandatory to safeguard 
the well-being of astronauts or jet crew and to prevent the 
occurrence of future damage.  
The aim of this experiment was to determine if 
microgravity might influence endogenous antioxidant 
systems so modifying the ability of living organisms to 
counteract to space radiation. 
Xenopus laevis embryos of different ages were 
exposed to simulated microgravity using a Random 
Positioning Machine (RPM). Changes of liquid were 
performed daily. Morphology and enzymatic activities 
were measured.  
As previously described embryos exposed to 
microgravity have axial malformations. For what 
biochemical assays concern it can be definitively 
conclude that: ?g (RPM) did not cause an increase of 
mortality compared with controls. The exposure of 
embryos to RPM for 3 days caused an activation of HSP-
60 and HSP-70; longer periods of incubation did not 
cause the same effect. When the embryos developed in 
simulated ?g it was possible to observe an increase of 
activity of glutathione (GSH) related enzymes. Also  GSH 
content wwas increased after exposure to RPM. These 
might result in a higher resistance to stress, such as 
anoxia or perhaps radiation induced oxidative stress. 
This Work is supported by Italian Space Agency 
A.S.I., MoMa –ASSC Grant to A. M. Rizzo 
4.9 
LONG CHAIN PUFAS OMEGA-3 INCORPORATION IN 
CELL MEMBRANE MICRODOMAINS  OF BREAST 
CANCER CELLS  
Paola Corsetto, Gigliola Montorfano, Manuela Negroni, 
Angela M. Rizzo and Bruno Berra  
Institute of General Physiology and Biochemistry “G. 
Esposito”, University of Milan via D. Trentacoste 2, 
20134, Milano, Italy. 
Long chain PUFAs are important molecules for 
membrane order and function; they can also modify 
inflammation-inducible cytokines production, regulation of 
eicosanoid production, plasma TAG synthesis,  blood 
pressure, and gene-expression.  
Furthermore omega-3 have been hypothesized to 
influence colorectal carcinogenesis through many 
mechanisms (e.g. inhibiting COX2, increasing apoptosis, 
reducing angiogenesis). In breast cancer, 
supplementation with DHA synergistically enhances 
taxane cytotoxicity, down regulate HER-2/neu (c-erbB-2) 
oncogene expression, modifies the production of the 
heparansulfate syndecan1, suggesting a gene-nutrient 
interaction of critical importance for mammary 
carcinogenesis and supporting the hypothesis that 
omega-3 can be used as modulators of cancer cell 
chemo-sensitivity. 
Aim of the study was to evaluate the  effects of 
supplementation of AA, EPA and DHA in two lines of 
human breast cancer cells characterized by different 
expression of ER receptor. The fatty acid are all  
incorporated in cell membrane phospholipids with 
different specificity.  
Moreover after treatments fatty acids are partially 
metabolized from both cell lines. In particular EPA is 
promptly converted to DPA,; DHA is partially re-converted 
in EPA while AA is integrated without being further 
metabolized. 
However both omega-3 fatty acids induced cell 
apoptosis, with different degree and sensitivity, while AA 
increased cell proliferation in both cell lines. 
Further studies will investigate the role of membrane 
changes induced by omega-3 fatty acid in micro domain 
function and signal transduction related to cancer cell 
proliferation.  
This work was supported by FIRST from UNIMI and 
Nutra-Snack EU VI PQ to AM Rizzo and B Berra 
4.10 
EFFECT OF POTASSIUM METABISULFITE IN HUMAN 
FIBROBLASTS 
C. Bietolini1, G. Cardinali2, L. Corte2, L. Roscini1,2, A.
Magini1, V. Ciccarone1, B. Tancini1, F. Trivelli1, C.
Emiliani1
1 Department of Experimental Medicine and Biochemical 
Sciences, University of Perugia, Italy. 
2 Department of Applied Biology – Microbiology.  
Potassium metabisulfite (E224) is used as an 
antimicrobial substance in many kinds of foods. 
Potassium metabisulfite (PMB) is a sulfite that is 
chemically very similar to sodium metabisulfite (SMB), 
and is sometimes used interchangeably [The Ministry of 
Agriculture, 2004]. Both PMB and SMB are converted in 
aqueous solution to bisulfate and sulfur dioxide. Sulfites 
are often used as preservatives in wines to prevent 
spoilage and oxidation, dried fruits, dried potato products, 
biscuits and chocolate, jam, and sausage and salami. 
Since potassium metabisulfite is a widely used 
preservative in food industry, it may be of interest to 
investigate the effects of this substance on cultured 
animal cells. On this regard, it has been recently 
demonstrated that PMB had genotoxic and cytotoxic 
effects on human peripheral lymphocytes1.
In this study Human Dermal Fibroblasts (HDF) were 
treated with different concentrations (150, 300 and 600 
mg/ml) of potassium metabisulfite and the effects on 
cellular growth and protein expression pattern were 
analyzed at various intervals of time. Our results clearly 
indicated that the highest dose of PMB caused a dramatic 
cell death from one day of incubation. Nevertheless, a 
significant decrease on cell growth was observed even at 
low concentrations of the sulfite. SDS-PAGE of cell 
extracts revealed a substantial increase on the amount of 
a 70 KD protein in all samples. 2D electrophoresis 
analysis reveal extensive changes on protein expression 
pattern of treated cells compared to the control and will be 
used to identify target proteins by mass spectrometry 
(MS). Overhall results demonstrate that PMB has 
dramatic effect on human cultured cells and its use as 
food preservative should be carefully assessed.  
1. A.Y. Kocaman et al. Environmental and Molecular 
Mutagenesis (2008) 49, 276-282  
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AUTOCATALYTIC AND MITOCHONDRIA-ASSISTED 
FLAVINYLATION OF RECOMBINANT RAT 
DIMETHYLGLYCINE DEHYDROGENASE.
C. Brizio1, S. Iametti2, F. Bonomi2, P. Ferranti3, E. 
Gianazza4, M. Barile1
1
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The mitochondrial matrix located dimethylglycine 
dehydrogenase (Me2GlyDH, EC 1.5.99.2) is a key 
enzyme of folate one-carbon metabolism and choline 
catabolism, which covalently binds FAD via a histidyl(N3)-
(8α)FAD linkage. Like most mitochondrial proteins, 
Me2GlyDH is synthesized in the cytosol as a higher 
molecular weight precursor protein containing an N-
terminal mitochondrial targeting peptide, which is 
removed on protein import inside the organelle by the 
mitochondrial processing peptidase (MPP). 
Both the mature (mMe2GlyDH) and the precursor 
(pMe2GlyDH) forms of rat Me2GlyDH have been produced 
in Escherichia  coli, purified in both their  apo- and holo-
forms and identified by ESI-MS/MS1, 2.
Purified recombinant holo-mMe2GlyDH and holo-
pMe2GlyDH show typical flavoprotein absorbance 
spectra, with a main peak at 277 nm and two minor peaks 
at about 349 and 457 nm. They exhibit an enzymatic 
specific activity  (240 nmol/min/ mg protein at 30 °C , pH 
7.0) similar to that of the native enzyme and are in a 
folded state, as demonstrated by circular dichroism (CD) 
analysis. Underflavinylated forms of Me2GlyDH perform a 
70-80% lower specific activity. Trypsin-resistance 
experiments and CD analysis indicate that apo-
mMe2GlyDH is mostly in an unfolded state.  
In vitro flavinylation experiments demonstrate that: i) 
covalent attachment of FAD to recombinant apoenzyme 
can slowly proceed autocatalytically, without third 
reactants; ii) the removal of mitochondrial presequence 
from apo-pMe2GlyDH by MPP is not required for covalent 
autoflavinylation; iii) addition of proteins from 
mitochondrial matrix to apo-Me2GlyDH  strongly  
accelerates holoenzyme formation, allowing for a total 
recovery of a fully flavinylated enzymatically active 
holoenzyme. 
These results allow to rule out the existence of a 
mitochondrial holoenzyme synthetase. A proposal for an 
alternative flavinylation pathway involving mitochondrial 
proteins will be presented in this communication. 
This work was supported by Grant from MIUR (FIRB 
2003, project RBNE03B8KK) to MB. 
1. Brizio C., et al. (2004) Protein Expr. Purif. 37, 434-
442.  
2. Brizio C., et al. (2008) Int. J. Biol. Macromol. 42, 455-
462.  
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BODY FAT DISTRIBUTION MAY INFLUENCE BOTH 
LIPIDEMIC AND OXIDATIVE PROFILES IN WOMEN. 
RESULTS OF CROSS-SECTIONAL STUDY  
C. Cervellati1, M. Pedriali2, G. Pascale2, C. Castaldini2, G. 
La Marca1, P. Christodoulou1, A. Guariento1, G. 
Bonaccorsi2, C.M. Bergamini1, F. S. Pansini2, F. Casali3
1
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Università di Ferrara 
2
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Centro Di Servizio e Ricerca per lo Studio della 
Menopausa e dell’Osteoporosi, Universita’  di Ferrara 
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Laboratorio Analisi, Ospedale di Stato di San Marino 
Visceral-abdominal adiposity, a widely recognized 
cardiovascular disease (CVD) risk factor, is frequently 
associated with atherogenic dyslipidemia1. The Reactive 
Oxygen Species (ROS)-mediated oxidative modification 
of LDL cholesterol is implicated in the etiopathogenesis of 
several forms of CVD. 
We evaluated the interrelationships among Body Fat 
Distribution assessed by Dual Energy X-Ray 
absorptiometry (DXA), oxidant (hydroperoxides) and 
antioxidant (total antioxidants, Uric Acid and Thiols) 
markers and lipidic profile (Total, LDL and HDL 
cholesterol, Tryglicerides): This cross-sectional study was 
based on a sample of 132 healthy women.  
We found significant correlations between abdominal 
fat  and LDL cholesterol (r = 0.300, p<0.05), LDL/HDL  
ratio (r = 0.339, p<0.001),  tryglicerides (r = 0.267, 
p<0.001)  and HDL cholesterol (r = -0.199, p<0.05). Total 
and abdominal fat,  were significantly correlated with total 
antioxidants (r = 0.257, p<0.01 and 0.259, p<0.01 
respectively) due to the essential contribute of Uric Acid, 
the highest concentrated endogen antioxidants of human 
organism, which is mostly associated with fat stored in 
abdomen (r= 0.371, p<0.001). Hydroperoxides only 
showed a positive correlation with fat localized on legs (r 
= 0.226, p<0.01). All association persisted after adjusting 
for age values. Finally, no significant associations 
between any components of lipid profile and antioxidant 
and oxidant markers were discovered. 
Our results are consistent with a possible influence of 
body fat distribution on two well known CVD risk factors 
as dyslipidemia and Oxidative Stress. It is confirmed that 
the fat stored in abdomen is mostly linked to an enhanced 
LDL/HDL  ratio. This relationship has been explained as 
one of the principal reason why abdominal-visceral fat is 
considered a key player in the development of type 2 
diabetes and atherogenesis. Interestingly legs fat mass, 
widely considered much less harmful  than abdominal, 
shows to be positively correlated with systemic Oxidative 
Stress. This last result may open new perspectives in the 
comprehension of  mechanisms involved in the 
generation of ROS.  
1. You T, et. al. The Metabolic Syndrome in obese 
postmenopausal women: relationship to body 
composition, visceral fat and inflammation. J Clin. 
Endo. & Met. 2004; 89 (1): 5517-5522. 
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POSSIBLE ROLE OF OXIDATIVE STRESS IN THE 
PATHOGENESIS OF CHRONIC VENOUS 
INSUFFICIENCY. PRELIMINARY RESULTS OF A 
POPULATION STUDY 
C. Cervellati, E. Franzoni, E. Masotti, E. Cremonini, A. 
Guariento, C.M. Bergamini 
Dipartimento di Biochimica e Biologia Molecolare, 
Università di Ferrara 
BACKGROUND: It is now appreciated that Oxidative 
Stress (OS) is involved in the pathogenesis of the lesions in 
certain chronic arterial diseases (as in atherosclerosis)1. In 
contrast, little information  is available on the  implication of 
oxidant species in pathologies affecting the venous system. 
OBJECTIVES:  The aim of our population study was to 
evaluate whether OS could have role in the onset of 
chronic venous insufficiency (CVI), one of the most spread 
and severe venous diseases. 
METHODS: For this study we have selected 2 samples of 
women from a total of 350 patients attending a Vascular 
Surgery Clinics: the first group included 71 women devoid 
of any type of pharmacologic intervention; the second 
consisted of 65 subjects who either intensively or 
occasionally used medicals. Both samples were 
subdivided in 3 groups: healthy; patients with varicose 
veins; and patients with diagnosed CVI.  Sera from all 
subjects were employed for colorimetric assessment of 
Oxidant Power (PO) given by hydroperoxides 
concentration measured by D-Roms test and total 
antioxidant power (TAP), determined through a ferric 
reduction (FRAP) technique.   
 RESULTS: In the first sample a slight, but not significant 
(p>0.05), increase in Oxidant and Antioxidant power is 
observed in ill with respect to healthy subjects. The 
average values of both parameters are higher in patients 
with CVI than those with varixes. The use of medications 
appears to indistinctly increase PO (p<0.001) in healthy, 
varixes and CVI groups while the increment in TAP is only 
significant in CVI patients.  
DISCUSSION: Our preliminary results are not consistent 
with an implication of OS in pathogenesis of CVI. Indeed, 
the progression of venous disease, from the mild varicous 
veins to the severe CVI is not accompanied by an 
increase of OS. Interestingly, the use of medicals for the 
cure of this venous disease seems to improve the 
antioxidant defense.  
1. Behl C. et. al.  Molecular Pharmacology 1997; 
51:535–41 
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PERIPHERAL BLOOD LEUKOCYTES. 
Betti M1,2, Mazzini F1,3, Floridi A1, Canonico B2, Luchetti 
F2, Piroddi M1, Pilolli F1, Aisa MC1 and Galli F1.
1
Dipartimento di Medicina Interna, Sezione di Biochimica 
Applicata e Scienze della Nutrizione, Perugia, 
2
Dipartimento di Scienze dell’Uomo, Ambiente e Natura, 
Università degli Studi di Urbino “Carlo Bo”, 
3
Dipartimento 
di Chimica e Chimica Industriale, Università di Pisa.  
A growing body of evidence is accumulating on the possible 
use of vitamin E analogues as anti-cancer compounds. The 
succinyl ester of ?-tocopherol (α-T) tocopheryl succinate (α-
TS) and the ether-linked acetic acid analogue, namely α-TEA, 
are considered the prototypes of the anti-cancer analogues of 
vitamin E. Actually they are potent pro-apoptotic agents for 
human cancer cells in vivo and in vitro in that stimulate the 
mitochondrial pathway of apoptosis and ROS generation. Only 
recently amide derivatives of α-T (TNH) have been produced 
and biological evaluations of these analogues are awaited. In 
this study we used a systematic in vitro drug screening 
approach to investigate a series of synthetic vitamin E 
analogues that include esters and ethers based on α-TS and 
α-TEA structures, and a series of TNHs that are derived from 
the basic structure of amino-tocopherol. The analogues were 
based on the condensation of the hydroxyl group in position 6’ 
of the chroman ring with proper cyclic anhydrides and 
carboxylic acids providing succinic, maleic, fumaric and 
benzoic acids. Di and poly-halogenated amide derivatives of 
these acids were also prepared. Cell viability was investigated 
using MTT assay and cell death was assessed by 
cytofluorimetry. The test compounds were assessed for anti-
cancer activity in the concentration range 0.1 – 10 ?M using 
C6 murine glioma cells; peripheral blood mononuclear cells 
(PBMC) from healthy donors were used a non-cancerous cells 
to test the specificity of the anti-cancer activity. The four natural 
forms of vitamin E (namely α−, β−, γ−, δ−Toc) served as 
reference compounds. The main evidence provided by this 
study was that α-TS and α-TEA were confirmed to behave as 
strong pro-apoptotic analogues with IC50 values for the cell 
growth inhibition < 0.1 ?M, but both of them showed low 
specificity. As far as it concerns cell viability, α-TEA produced 
a higher IC50 value than α-TS and a better apoptotic/necrotic 
ratio. The same findings were obtained for γ-TEA. In 
comparison with TS and TEA, TNHs and the other ether and 
ester derivatives investigated in this study were less effective 
in reducing C6 cell viability, but were also effective pro-
apoptotic agents and showed higher specificity of activity. 
Intriguingly, TNH2 was one of the most active compounds. 
The different types of dicarboxylic acid used to functionalize 
the chroman group of α-T do not seem to influence 
significantly the activity of the test compounds, apart from the 
presence of a phenol group that significantly increased activity 
and specificity of TEA analogues. In conclusion, when tested 
in C6 glioma cells, α-TS and α- or γ-TEA are strong, but 
unspecific, in vitro anticancer agents. Other synthetic 
analogues such as TNHs and ether-linked benzoic acid 
analogues show a higher specificity to activity ratio, and thus 
are good candidates for the use in further pre-clinical 
evaluations. 
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MATERNAL SUPPLEMENTATION WITH HIGH DOSES 
OF α-TOCOPHEROL INFLUENCES HIPPOCAMPAL 
PKC ACTIVITY OF RAT OFFSPRING.  
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Vitamin E is considered important to sustain foetal 
development and thus it is commonly recommended as a 
supplement during pregnancy. The net placental transfer 
of vitamin E, however, appears to be low and this has 
stimulated to use relatively high doses to maximize the 
delivery to foetal tissues. The effects of vitamin E 
supplementation on gene expression and signaling 
pathways of foetal tissues remain unexplored. Dietary 
loads of vitamin E as α-tocopherol (α-Toc) have been 
reported to affect neuronal plasticity and protein kinase C 
(PKC) signalling in adult rat hippocampus, and PKC is 
involved in a variety of developmental processes of CNS.  
Based on this background, we investigated in rats the 
effects that the maternal supplementation with high doses 
of α-Toc may exert on PKC activity of offspring 
developing hippocampus. Moreover, we assessed the 
bioavailability of the supplemental vitamin E in the 
mothers and offspring measuring  α-Toc levels in liver 
and brain tissues.  
The results showed that PKC inhibition was highest at 
bird, when PKC activity was virtually abolished (-95% 
respect to controls). Thus, p-PKC levels remained 
significantly reduced during the span of hippocampal 
maturation, with significant differences between 
supplemented and control offspring. These differences in 
offspring PKC activity decreased with age (-75% until 14 
days, and then -50% at 21 days of age) and disappeared 
in adulthood (i.e. after 60 days). These changes showed 
a correlation with the changes of liver vitamin E in the 
mother and offspring, but this correlation was much less 
evident when brain vitamin E was assessed. 
This study shows that maternal exposure to high 
doses of ?-Toc during pregnancy and lactation in rat 
causes a massive even if transient inhibition of PKC 
activity in offspring developing hippocampus. 
4.16 
DISTRIBUTION OF HOMOCYSTEINE AND CYSTEINE 
IN PLASMA LIPOPROTEIN FRACTIONS 
M.C. Gueli 
Dipartimento di Scienze Biochimiche, Università di 
Palermo, Palermo, Italia 
S-thiolation of plasma proteins have been detected in 
healthy humans, in patients with cardiovascular diseases 
and it is a recurrent phenomenon in oxidative stress 
elicited by reactive oxygen species. The low-molecular-
weight aminothiols homocysteine (Hcy) and cysteine 
(Cys) can exist in the plasma either free or bound to thiol-
combining groups, many of which are present in proteins 
(Pb), particularly albumin. 
Recent studies have demonstrated that also plasma 
lipoproteins (LP) are susceptible to form disulfide-linked 
products with Hcy and Cys and that the N-
homocysteinylation is accompanied by structural and 
functional alteration and could increase the atherogenicity 
of LDL. However, the mechanism through which Hcy 
contributes to these abnormalities remains however still 
undefined.  
In order to ascertain the link between physiologic thiols 
and lipoproteins (LP), we determined simultaneously the 
distribution of Hcy and Cys, in vivo, bound to different 
plasma protein fractions by disulfide linkage. Human 
VLDL, LDL, HDL and LPDS (lipoprotein-free protein 
fraction) were obtained from plasma of normolipemic 
subjects volunteers (University workers) prepared by 
differential ultracentrifugation. The purity of the isolated 
subfractions were controlled by electrophoresis on 
agarose gel and no significant albumin content was found 
in the isolated lipoprotein fractions. The Hcy and Cys 
bound to single plasma protein fraction was calculated as 
difference between total and free aminothiols. Hcy and 
Cys in plasma and in lipoprotein fractions were analyzed 
by the HPLC method1.
Protein-bound Hcy and Cys (Pb-Hcy and Pb-Cys) (9.10 
and 196.79 ?mol/L, respectively) represents about 76% 
and 79% of total plasma Hcy and Cys (11.98 and 249.33 
?mol/L, respectively). The absolute Pb-Hcy and Pb-Cys 
distribution between the single LP fractions was as 
follows (?mol/L): VLDL=0.59 (6.4%) and 36.78 (18.7%) 
respectively; LDL=0.77 (8.5%) and 9.13 (4.6%) 
respectively; HDL=1.44 (15.8%) and 6.63 (3.4%) 
respectively; LPDS=6.30 (69.3%) and 144.24 (73.3) 
respectively. The Hcy and Cys/protein ratios in each 
single LP fraction (nmol/mg of protein) suggest a higher 
binding capacity for Hcy and Cys by VLDL and LDL 
probably due to their content in Apo B.  
The detection of all aminothiols (Hcy, Cys, Cys-Gly, GSH) 
linked to Apo B may be important to understand the 
mechanisms of thiol-disulfide exchange reactions and to 
evaluate if this binding may have a complex role in 
promoting lipoprotein oxidation or structural and/or 
functional modifications in lipoprotein thiolation both in 
vivo and in vitro.  
1. Gueli et al. (2000) IBTS 15:167 
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SULFORAPHANE MODULATES NRF2/ARE PATHWAY 
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Sulforaphane (SF), a naturally occurring isothiocyanate 
abundant in Cruciferous vegetables, has gained attention 
as a potential chemopreventive compound1 thanks to its 
ability to induce several classes of genes implicated in 
reactive oxygen species (ROS) and electrophiles 
detoxification. Antioxidant responsive element (ARE)-
mediated gene induction is a pivotal mechanism of 
cellular defence against the toxicity of electrophiles and 
ROS. The transcription factor NF-E2-related factor-2 
(Nrf2), is essential for the up-regulation of these genes. 
Nrf2 phosphorylation by protein kinases such as Akt 
kinase, extracellular-signal-regulated kinase (ERK), c-Jun 
NH2-terminal kinase (JNK) and protein kinase C (PKC) 
influence the activation of the Nrf2/ARE pathway2, 3.
Recently, we have demonstrated that SF elicits 
cardioprotective activity by up-regulating a battery of 
antioxidants and phase II enzymes4. The aim of this study 
was to verify SF mechanism of action leading to 
cardioprotection by investigating the effect of SF 
treatment on Nrf2 activation in primary cultures of 
neonatal rat cardiomyocytes. In particular we focused our 
attention on the ability of SF to activate different mitogen–
activated protein kinases (MAPK) related to Nrf2 
translocation to the nucleus.  
Cultured rat cardiomyocytes, prepared and grown as 
previously reported5, were supplemented with 5 ?M SF 
for different times. Western blot analyses of Nrf2, 
phsopho-p38, phospho-JNK, phospho-Akt, phospho-
ERK1/2 were performed using specific antibodies and 
following the manufacturer’s recommended protocols. 
Nrf2 translocation to the nucleus was evaluated by 
immunoblotting of different cellular fractions. The 
expression of Nrf2 was determined by RT-PCR.  
SF was able to modulate MAPK phosphorylation and Nrf2 
translocation to the nucleus. This translocation was 
blocked by cell treatment with specific MAPK inhibitors 
demonstrating that Nrf2 activation is mediated by these 
pathways. SF was also able to up-regulate Nrf2 
expression. So, the cardioprotective activity of SF could 
be ascribed to its ability to modulate both MAPK signaling 
pathways and Nrf2 expression. 
This research was supported by MIUR-COFIN and 
Fondazione del Monte di Bologna e Ravenna 
1. Y. Zhang, et al. (1992) Proc Natl Acad Sci U S A. 89, 
2399-403. 
2. J. D. Hayes, et al. (2001) Cancer Lett. 174, 103-13. 
3. T. Nguyen, et al. (2004) Free Radic Biol Med. 37, 433-
41. 
4. C. Angeloni, et al. (2007) Proc Nutr Soc. 66, 111A. 
5. S. Hrelia, et al. (2002) Biochim Biophys Acta. 1567, 
150-6. 
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In mammals, species lifespan can vary by more than 100 
fold (shrew 2 years, bowhead whale 211 years).  Despite 
considerable research, the cellular mechanisms that 
make this variation possible remain unclear. In regard to 
these mechanisms, several predictions can be made. 
First, they must impact fundamental biochemical 
processes. Second, they would be expected to be related 
to structural differences between species at the cellular 
level. Furthermore, the goal would be to find significant 
correlation between cellular differences and the life span 
magnitude. As a tool to investigate these mechanisms, 
we have developed a series of skin fibroblast cell lines 
derived from mammalian species with a wide variation in 
lifespan (man, cow, bat, dog, mouse etc.).  Using these 
lines, we have previously shown that the reported 
dependence of replicative capacity on longevity1 is most 
likely due to the dependence of replicative capacity on 
body mass, which is itself correlated with longevity2.
Therefore, comparative studies of longevity must address 
the influence of body mass. 
The fact that DNA-PKcs and Ku 80 ablation in mice 
reduces average lifespan approximately 25% and 50% 
respectively and that Ku 80 null mice display symptoms of 
premature aging supports the potential role of these 
nuclear proteins in the aging process. DNA-PKcs and Ku 
are key proteins in double strand damage recognition. So 
we tested the capacity of skin fibroblast nuclear extracts 
from different mammalian species to bind DNA double 
strand breaks using an electrophoresis super-shift 
method that we have previously developed and that is 
now widely used in the field of DNA damage/repair3. Our 
results indicate that Ku-dependant DNA double strand 
break recognition increases exponentially with longevity 
and suggest that an enhanced ability to detect critical 
DNA damage may be a key requirement for longevity. 
1. Rohme, D., Evidence for a relationship between 
longevity of mammalian species and life spans of 
normal fibroblasts in vitro and erythrocytes in vivo.
Proc Natl Acad Sci U S A, 1981. 78(8): p. 5009-13. 
2. Lorenzini, A., et al., Cellular replicative capacity 
correlates primarily with species body mass not 
longevity. Mech Ageing Dev, 2005. 126(10): p. 1130-
3. 
3. Getts, R.C. and T.D. Stamato, Absence of a Ku-like 
DNA end binding activity in the xrs double-strand DNA 
repair-deficient mutant. J Biol Chem, 1994. 269(23): p. 
15981-4. 
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Acute, exhaustive exercises lead to a burst of reactive 
oxygen species (ROS) generation that increases the 
GSSG/GSH ratio in plasma1, and causes structural 
damage to muscle cells as evidenced by an increase in 
plasma activity of cytosolic enzymes such as lactate 
dehydrogenase (LDH) and creatine kinase. Acute 
exhaustive exercise can be considered an interesting 
model of oxidative stress and muscle damage. To prevent 
and counteract ROS generation and oxidative stress 
during exercise, many studies have been focused on the 
use of natural compounds with ROS scavenging 
properties acting as direct antioxidants, but the overall 
results are still inconclusive. In this study we have 
investigated the possibility to counteract exhaustive 
exercise induced oxidative stress and muscle damage in 
rats by treating animals with sulforaphane (SF). SF is a 
naturally occurring isothiocyanate present in the human 
diet and originating from the ingestion of Cruciferous 
vegetables. SF is known to induce phase 2 enzymes with 
antioxidant properties in many tissues, but no data are 
still available on skeletal muscle tissues. In our study 
male Wistar rats (age 4 months, weight 230±20g) were 
treated every 24 hours with SF (25 mg/kg bw i.p.) for 
three days before undergoing an acute exhaustive 
exercise protocol. The exercise protocol consisted in 
running on a treadmill at 24 m/min and 7% gradient. 
Exhaustion was defined as the point at which the animals 
failed to get off the shock grid and thus had to be 
manually repositioned to the front of the treadmill on three 
consecutive occasions. Animals were sacrificed and LDH 
activity was determined on plasma samples. The activities 
of phase 2 enzymes such as NAD(P)H:quinone 
oxidoreductase (NQO1), glutathione-S-transferase (GST),  
glutathione reductase (GR), glutathione peroxidase 
(GPx),  thioredoxin reductase (TR) and superoxide 
dismutase (SOD) and catalase (CAT) were evaluated in 
homogenates from freshly excised vastus lateralis 
skeletal muscle. SF treatment significantly induced the 
activity of NQO1, GST and GR in skeletal muscle tissues, 
with no effect on GPx, TR, SOD and CAT activities. 
Upregulation of phase 2 enzymes correlated with a 
decrease in oxidative damage in muscles, as evidenced 
by a significant decrease in LDH release in plasma after 
SF treatment. Our data, for the first time, demonstrate 
that SF could play a critical role in the modulation of 
muscle redox environment leading to the prevention of 
exhaustive exercise induced muscle damage. These 
results suggest that SF could become an interesting 
natural compound in the development of a dietary 
intervention that promotes oxidant scavenging through 
phase 2 protein induction and in the development of new 
dietary supplements for physical active people. 
Research supported by Fondazione del Monte di BO e 
RA
1. Sastre J et al. Am J Physiol. 1992;263:R992-995 
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Although the beneficial effects of olive oil consumption on 
human health are widely recognized, the functions and 
the mechanisms through which specific components of 
olive oil exert their effects still need to be fully deciphered. 
Although in vivo studies suggest that these compounds 
are responsible for the anti-inflammatory and anti-
atherosclerotic actions of olive oil, less is known on the 
direct effects and mechanisms of action of these 
molecules in circulating cells. Monocytes participate in the 
early stages of atherosclerosis and, by expressing several 
molecules, including metalloproteinases (MMPs), 
contribute to amplify the inflammatory response. 
With the aim of elucidating the mechanisms through 
which olive oil-derived phenols are beneficial on markers 
related to cardiovascular diseases, we investigated the 
effects of an olive oil phenolic extract (PE) and the main 
individual phenolic compounds (PCs, namely oleuropein 
aglycone, apigenin, luteolin, tyrosol, and hydroxytyrosol) 
on the modulation of MMP-9 in monocytes. 
We found that PE significantly counteracts the effect 
of TNF-α on the expression and secretion of MMP-9. 
Oleuropein aglycone resulted to be active at the 
concentrations found in PE although other compounds 
probably contribute to the activity exhibited by the extract. 
We demonstrated that the PE acts at the transcriptional 
level preventing the stimulation of MMP-9 promoter 
activity. Finally, we found that the effect of PE on gene 
expression is ascribable to impairment of NF-kB 
signalling. 
We assayed individual compounds present in PE that 
could contribute to the biological activity. Our findings 
regarding the ability of both flavonoids to down-regulate 
the MMP-9 promoter and to attenuate the NF-kB-driven 
transcription are much higher than those found in the PE 
used in our experiments thus excluding a role of these 
compounds in the effects exerted by the PE. 
In the present study we clearly demonstrated that PE 
inhibits MMP-9 expression thus supporting the hypothesis 
that inhibition of proteolytic activity by PCs could be, at 
least in part, responsible for the reduction of invasiveness 
of tumour cells. 
In this context our study elucidates some of the 
molecular mechanisms through which olive oil, a phenolic 
rich source, can be beneficial to human health, as widely 
demonstrated by in vivo studies. 
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Chamomile, prepared with dried flowers from Matricaria 
recutita L., is one of the most commonly consumed herbal 
tea. The drug is used for the treatment of gastrointestinal 
complaints (minor spasms, epigastric distensions, gastritis 
and gastric inflammation). Several classes of bio-active 
compounds have been identified in the extracts of 
chamomile including phenolic acids, coumarins and 
flavonoids such as the glycosides of apigenin, quercetin, 
patuletin, luteolin and several derivatives1. Several 
studies showed that chamomile infusions possess a 
protective effect on gastritis and gastric ulcer2-3, but the 
mechanisms involved in this effect are not well 
established. Matrix metalloproteases (MMPs) and 
neutrophils elastase (NE) are proteases that degrade 
extracellular matrix in physiological and pathological 
conditions. Since MMPs and NE are involved in gastric 
inflammation, the aim of this work was the evaluation of 
the effect of chamomile infusions of dried capitula (CFI) 
and sifted (SFI) flowers on MMP-9 and NE, and the 
identification of the compounds responsible for the 
observed effect. Each infusion was analyzed by LC-
MS/MS in order to verify whether compositional 
differences affected biological activity. 
Analysis of CFI and SFI by LC-MS/MS showed a 
complex profile. The compounds unequivocally identified 
were the flavonoids apigenin-7-O-glucoside (api7glu), 
luteolin-7-O-glucoside (lut7glu), patuletin-7-O-glucoside 
(pat7glu) and hyperoside (hyp). Api7glu was more 
abundant in CFI than in SFI, whereas the opposite was 
for lut7glu. Pat7glu was the most abundant in both the 
infusions, whereas hyp was the lowest. 
CFI and SFI inhibited enzymatic activity of MMP-9 
catalytic domain in a concentration-dependent manner. At 
1500 ?g/ml the inhibition was 28 % and 55 % for CFI and 
SFI, respectively. Api7glu and lut7glu (10 ?M) showed an 
inhibitory activity of 40 % and 30 %, respectively, 
demonstrating their contribute to the effect of the 
infusions. The inhibitory effect of CFI and SFI was 
confirmed on MMP-9 released by human 
adenocarcinoma cells (AGS cells). CFI was able to inhibit 
MMP-9 secretion from AGS cells (85 % at 1500 ?g/ml). 
The inhibitory effect of the infusions on NE was also 
tested. Concentration-response curves were performed 
and IC50 of CFI and SFI on NE were 369,2 ?g/ml and 
536,7 ?g/ml, respectively. The individual compounds that 
showed an inhibitory effect on NE activity were api7glu 
(IC50 74,3 ?M), lut7glu (IC50 8,6 ?M), pat7glu (IC50 10,4 
?M), and chlorogenic acid (IC50 31,3 ?M). 
In conclusion, the present study shows some 
biochemical mechanism of action for the effect of 
chamomile infusions and supports the use of chamomile 
in the treatment of gastrointestinal inflammation. 
1. McKay D. Phytotherapy Research 2006, 20, 519-530. 
2. Achterrath-Tuckermann U. Planta Med 39: 38-50. 
3. Ceska O. Fitoterapia 1992. 63, 387-394. 
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Elevated serum homocysteine (Hcy) levels represent an 
independent cardiovascular risk factor and may contribute 
to the pathogenesis of atherosclerosis by altering 
endothelial functions.1.
The mechanism of Hcy-induced cell adhesion has 
been investigated2. In particular, we have recently 
demonstrated that the lowering of intracellular adenosine 
concentration is responsible for Hcy-induced increased 
adhesiveness of EA.hy 926 cells. In 
hyperhomocysteinemia, indeed, the Hcy-induced reversal 
of S-adenosylhomocysteine (AdoHcy) hydrolase reaction 
causes the increase of the intracellular formation of 
AdoHcy at the expense of free intracellular adenosine. 
This event results in a lowering of extracellular adenosine, 
and likely in an impairment of the adenosine-related 
signal transduction. 
Olive oil polyphenols, because of their powerful 
antioxidant activities, modulate several cardiovascular risk 
factors and contribute to the low incidence of 
cardiovascular diseases in the Mediterranean Area3. To 
examine the effect olive oil polyphenols on Hcy-induced 
endothelial dysfunction, and to elucidate if their protective 
effects are strictly related to their scavenging activities, 
structurally related phenolic compounds, endowed with 
different scavenging activities, have been selected and 
assayed for their ability in reducing the Hcy-induced 
monocyte adhesion as well as cell surface expression of 
intercellular adhesion molecule-1 (ICAM-1), in EA.hy 926 
cells. The tested compounds include hydroxytyrosol 
(Dopet) and its in vivo metabolite homovanillyl alcohol 
(Mopet), sharing the same antioxidant properties. Tyrosol, 
the Dopet monophenolic analogue, devoid of antioxidant 
activity, has also been assayed. Our data indicate that 
Dopet and Mopet significantly and equally reduce cell 
adhesion and ICAM-1 expression, starting from a 
concentration as low as 0.75 ?M. Also tyrosol appears 
protective, although to a less extent. Similar results have 
been obtained testing hydroxycinnamic acid derivatives, 
including caffeic, ferulic and p-coumaric acid. Taken 
together, our results indicate that in our model system the 
tested olive oil phenolic compounds are able to affect the 
specific Hcy-activated signalling, which results in ICAM-1 
expression, through redox-independent mechanisms that 
remain to be elucidated. 
1. Herrmann W., Herrmann M., Rima O., (2007). Curr. 
Drug Metab. 8, 17-31. 
2. Cacciapuoti G., Manna C., Napoli D., Zappia V., 
Porcelli M. (2007). FEBS Lett. 581, 4567-4570. 
3. Pérez-Jiménez F, Ruano J, Perez-Martinez P, Lopez-
Segura F, Lopez-Miranda. (2007). J. Mol Nutr Food 
Res.;51, 1199-208. 
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Consumption of fruit and vegetables has been recognized 
to be of great importance in the Mediterranean diet, 
because of health benefits against inflammation and 
various chronic diseases. Healthy properties are due to 
the presence of some vitamins, minerals, fiber and 
phytochemicals. Among the latter, polyphenols, 
widespread in the plant kingdom, are known for their 
redox and antioxidant properties1.
Peaches are important as table fruit, as well as 
ingredient largely utilized in the confectionery industry. 
Though a few studies reported about the antioxidant 
potential of some peach varieties in solution, the 
antioxidant activity in biological environments has not 
been investigated yet.  
The antioxidant capacities of methanolic extracts of 
peel and flesh of seven sicilian peach cultivars in solution, 
have been assessed using TEAC (Trolox Equivalent 
Antioxidant Capacity), and TAA (Total Antioxidant 
Activity) assay. Metal-dependent lipid membrane 
oxidation of bovine liver microsomes, measured as 
TBARS, was assessed only for the flesh. The total 
phenols were determined by a spectrophotometric 
enzymatic method. 
The TEAC values ranged 1.2 – 9.5 and 2 – 6.4 (?mol 
Trolox / g fresh weight), and the TAA values ranged 12.9 
– 98.3 and 33.4 – 60.3 (mg GAE / 100 g fresh weight) for 
flesh and peel, respectively. Guglielmina and Daniela 
cultivars showed the highest values of TEAC and TAA.   
A strong correlation was verified between total 
phenolics and antioxidant capacities expressed as either 
TEAC or TAA of flesh (vs TEAC r2 = 0.98; vs TAA r2 =
0.96) and peel (vs TEAC r2 = 0.92; vs TAA r2 = 0.96). 
Flesh extracts from all cultivars , at a concentration 
1mg fresh weight/ mL assay mixture, inhibited TBARS 
formation in microsomes in the range of 10 – 90 %. Only 
Fair Line cultivar needed 10 mg fresh weight/ mL assay 
mixture to show an inhibition of 25%.  
1. Rice-Evans, C. A.; Miller, N. J.; Paganga, G. 
Antioxidant properties of phenolic compounds. Trends 
Plant Sci. 1997; 2: 152-159. 
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Mitochondria are the cellular site at which many 
flavoproteins are located, where they act as 
dehydrogenases and oxidases in co-operation with the 
riboflavin-derived redox cofactors FMN and FAD. We 
demonstrated the existence of a mitochondrial FAD 
synthesising pathway starting from imported riboflavin 
both in rat1 and yeast2 and  proposed that, besides 
working as traditional cofactors, riboflavin/riboflavin 
metabolites may play a direct role in 
transcriptional/translational regulation of apo-flavoprotein 
expression, both in humans3 and in yeasts4. In the aim to 
elucidate the mode by which mitochondria maintain the 
proper level of FAD, we overproduced in E. coli, identified 
and purified two human isoforms of FAD synthetase (EC 
2.7.7.2), the enzyme which adenylates FMN to FAD, 
produced from two different transcript variants of  FLAD1 
gene5, 6. Transcript variant 1 encodes a 587-amino acid 
protein with a predicted molecular mass of 65.3 kDa 
(hFADS1), and the second variant encodes a 490-amino 
acid protein with a predicted molecular mass of 54.2 kDa 
(hFADS2), which lacks an N-terminal region of 97 amino 
acids present in hFADS1.  Analysis using protein 
prediction programs showed that hFADS1 contains an N-
terminal mitochondrial targeting sequence (17 residues, 
molecular mass 2.1 KDa).  Here we report mitochondrial 
import assays aimed to directly prove the mitochondrial 
localisation of hFADS1p. For this purpose, the cDNA 
encoding hFADS1 was cloned into the pCMVTNTTM
vector and used as template in the coupled 
transcription/translation rabbit reticulocyte lysate system. 
One main [35S]-Met labelled product migrating at about 
63 kDa on SDS-PAGE was generated and processed to 
an about 2 kDa faster band upon incubation with freshly 
isolated rat liver mitochondria. The import of the protein 
into mitochondria was demonstrated by the protection 
from digestion by externally added trypsin. hFADS1p 
processing was inhibited by the uncoupler 
carbonylcyanide p-trifluoromethoxyphenylhydrazone 
(FCCP), as expected for a process depending on 
mitochondrial membrane potential. The same 
experiments were carried out with the in vitro translated 
hFADS2 protein, starting from pCMVTNTTM–hFADS2 
plasmid. hFADS2p was neither  processed by nor 
imported into isolated mitochondria. These results 
represent the first direct demonstration that hFADS1 
transcript encodes for the mitochondrial FAD synthetase. 
1. Barile M., et al. (2000) Eur. J. Biochem. 267, 4888-
4900. 
2. Bafunno V., et al. (2004) J. Biol. Chem. 279, 95-102. 
3. Gianazza E., et al. (2006) Electrophoresis 27, 1182-98 
4. Giancaspero  T.A.,et al. (2008) FEBS J. 275, 1103-17. 
5. Brizio C., et al. (2006) Biochem Biophys Res 
Commun. 344,1008-1016.  
6. Galluccio, M. (2007) Protein Expr Purif. 52, 175-81. 
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Quantitative real-time PCR addresses the evident 
requirement for quantitative data analysis in molecular 
medicine, biotechnology, microbiology and diagnostics1.
Although, the cycle-threshold (Ct) method is the present 
“gold standard”, it is far from being a standard assay. 
Uniform reaction efficiency among samples is the most 
important assumption of this method. Nevertheless, some 
authors have reported that it may not be correct and a 
slight PCR efficiency decrease of about 4% could result in 
an error of up to 400% using the Ct method2. This 
reaction efficiency decrease may be caused by inhibiting 
agents used during nucleic acid extraction or copurified 
from the biological sample. We propose a new method 
(Cy0) that does not require the assumption of equal 
reaction efficiency between unknowns and standard 
curve. 
The Cy0 method is based on the fit of Richards’ 
equation to real-time PCR data by nonlinear regression in 
order to obtain the best fit estimators of reaction 
parameters. Subsequently, these parameters were used 
to calculate the Cy0 value that minimizes the dependence 
of its value on PCR kinetic. 
The Ct, second derivative (Cp), sigmoidal curve fitting 
method (SCF) and Cy0 methods were compared using 
two criteria: precision and accuracy. Our results 
demonstrated that, in presence of optimal amplification 
conditions, the Cy0 method showed the same 
effectiveness respect to the Ct and Cp methods. 
However, when PCR efficiency was slightly decreased, 
lowering amplification mix quantity or adding a biological 
inhibitor such as IgG, the Ct, Cp and SCF methods were 
markedly impaired while the Cy0 method gave 
significantly more accurate and precise results.
These data demonstrate that Cy0 represents a valid 
alternative to the standard methods for obtaining a 
reliable and precise nucleic acid quantification even in 
sub-optimal amplification conditions overcoming 
quantitative inaccuracy due to slight amplification 
inhibition. 
1. Bustin, S.A. and R. Mueller. Clin Sci (Lond), 2005. 
109(4): p. 365-79. 
2. Ramakers, C., et al. Neurosci Lett, 2003. 339(1): p. 
62-6. 
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XYLab: AN INTERACTIVE PLOTTING TOOL FOR 
MIXED MULTIVARIATE DATA OBSERVATION AND 
INTERPRETATION.  
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Studi di Firenze, viale Morgagni 50, 50134 Firenze, Italia. 
The correct display of data is often a key point for 
interpreting the results of experimental procedures. 
Multivariate data sets suffer from the problem of 
representation, since a dimensionality above 3 is beyond 
the capability of plotting programs. Moreover, non 
numerical variables such as protein annotations are 
usually fundamental for a full comprehension of biological 
data. Here we present a novel interactive XY plotter 
(XYLab) designed to take the full control of large datasets 
containing mixed-type variables, provided with an intuitive 
data management, a powerful labelling system and other 
features aimed at facilitating data interpretation and sub-
setting1.
The XYLab loads data from simple column-based 
tables to build up an XY scatter plot with per-point pop-up 
labels. The plot area is controlled by three easily 
accessible selectors, named “X”, “Y” and “Lab” since 
columns containing numerical variables are automatically 
detected and used to feed the first two selectors, while 
the latter may also contain non-plottable variables such 
as text-based ones. 
XYLab is aimed at offering to the user an easy-
handling, fast and full control of what to plot and which 
labels to show: a simple change in the variable choice 
from the selectors makes an update of the plot with 
automatic rescaling and optimization. This allows to 
visually explore a number of data trends and interrelations 
in minutes. 
XYLab takes full control over its labels. In fact, we 
implemented a “search-in-plot” procedure: we introduced 
a text box that is read before plotting the points and that 
may contain a query directed against the variable 
selected in the “Lab” selector. Such query can be 
verbose, acting on text-based labels, or numerical (e.g. 
greater/lesser than), acting on numerical labels. All the 
positive matches are scored directly in the plot by 
changing the point appearance, without affecting their 
position in the Cartesian space.  
Another peculiar aspect of the XYLab is a sub-setting 
mechanism that we called “select-and-paste”. Being the 
plot an interactive area, the user can draw a rectangle in 
a region containing interesting points and all the 
associated features are automatically visualized in a 
dedicated program area, ready to be exported. Thus, the 
plot itself guides the data selection and avoids the tedious 
task to look at the full data table to trace-back the desired 
information. 
In conclusion, the XYLab offers a simple and intuitive 
plotting interface aimed at the rapid interpretation of large 
multivariate datasets in which text and numbers have a 
comparable importance. 
The program, along with its manual and a test dataset, 
is available at www4.unifi.it/scibio/bioinfo/XYLab.html 
1. Ramazzotti M. et al, Bioinformation 2008 2(9):392-
394. 
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REGULATION AND BIOMONITORING.  
G. Fiorentino, R. Ronca, A. Vitale, S. Bartolucci 
Dipartimento di Biologia Strutturale e Funzionale, 
Università degli Studi di Napoli Federico II, Napoli, Italia 
Most of the archaeal microbial cells, the third domain of 
life, are adapted to grow in extreme environments not 
only regarding temperature but also pH, ionic strength 
and the presence of high concentrations of detergents 
and organic solvents. As all living cells, they possess a 
wide variety of finely regulated biochemical systems to 
defend from environmental stress and, in fact, they own in 
their genomes regulative sequences responsive to 
different stress agents1. Generally, the response can be 
initiated by binding of transcription factors to particular 
ligands, such as environmental signals.  
The thermophilic archaeon S. solfataricus responds to 
stress by aromatic compounds increasing the expression 
of a MarR-like operon and of an alcohol dehydrogenase 
gene (Sso2536adh)2. The system involves the MarR 
family transcription factor BldR, which binds to its own 
promoter inducing auto-activation and increasing the 
coexpressed drug export permease level. BldR also binds 
to the Sso2536 promoter stimulating the gene 
transcription, the accumulation of the ADH enzyme, and 
hence the enzyme-catalyzed conversion of the aldehydes 
to the less toxic alcohols3. A homologue of Bldr, Bldr2, 
has been recently characterised. DNA binding assays 
demonstrated that this protein is indeed a transcription 
factor. Biochemical characterization, as well as 
transcriptional analyses, suggested that Bldr2  could be 
also involved in the detoxification/catabolism of aromatic 
aldehydes.  
Knowledge of the molecular mechanisms underlying 
this stress response has revealed crucial to set up a 
microbial sensing device for the measurement of water-
dissolved aromatic aldehydes. The biosensor is an E coli
strain expressing the GFP under the control of the 
responsive Sso2536 promoter, and the gene for the 
sensor protein BldR. 
1. Pedone E, Bartolucci S and Fiorentino G. (2004) Front 
Biosci, 9:2909-26. 
2. Fiorentino G, Cannio R, Rossi M, Bartolucci S. (2003) 
J Bacteriol., 185, 3926-34.  
3. Fiorentino G., Ronca R., Cannio R., Rossi M., and 
Bartolucci S. (2007) J Bacteriol.,  20, 7351-60. 
6.2 
TOLUIDINE BLUE-MEDIATED PHOTODYNAMIC 
EFFECTS ON STAPHYLOCOCCAL BIOFILMS 
A. Di Poto1, M. S. Sbarra1, L. Visai1,2, P. Speziale1
1
Dipartimento di Biochimica “A. Castellani”, Università di 
Pavia, Pavia, Italia 
 2
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Staphylococci are important causes of nosocomial and 
medical-device-related infections. They often form 
biofilms, sessile communities of microcolonies encased in 
an extracellular matrix that adhere to biomedical implants 
or damaged tissue. Infections associated with biofilms are 
difficult to treat; sessile bacteria in biofilms are more 
resistant to antibiotics than their planktonic counterparts. 
Photodynamic treatment (PDT) has been proposed as an 
alternative approach for the inactivation of bacteria in 
biofilms.  
In this study, we have investigated the effect of the 
photodynamic action of toluidine blue O (TBO) on the 
viability and structure of biofilms of Staphylococcus 
epidermidis and of a methicillin-resistant Staphylococcus 
aureus strain.  
Significant inactivation of cells was observed when 
staphylococcal biofilms were exposed to TBO and laser 
simultaneously. The effect was found to be light dose 
dependent. Confocal Laser Scanning Microscopic study 
suggested damage to bacterial cell membranes in 
photodynamically treated biofilms. In addition, Scanning 
Electron Microscopy provided direct evidence for the 
disruption of biofilm structure and a decrease in cell 
numbers in photodynamically treated biofilms. 
Furthermore, the treatment of biofilms with tetrasodium 
EDTA followed by PDT enhanced the photodynamic 
efficacy of TBO in S. epidermidis, but not in S. aureus,
biofilm. The results suggest that photodynamic treatment 
may be a useful approach for the inactivation of 
staphylococcal biofilms adhering to solid surfaces of 
medical implants. 
This work was partially funded by a grant from the 
Italian Ministero della Salute (identification code RF-IOR-
2006-349032; Opportunistic bacteria in orthopaedic 
implant infections: new strategies of molecular and gene 
therapies) and by the Italian Ministero dell’Istruzione, 
dell’Universita` e della Ricerca, IDEE PROGETTUALI 
(Grandi Programmi Strategici, Decreto Ministeriale 24695, 
Protocollo RBIPO6FH7J). 
53rd National Meeting of the Italian Society of Biochemistry and Molecular Biology (SIB) and National Meeting of Chemistry of Biological 
Systems Italian Chemical Society (SCI - Section CSB) : Palazzo dei Congressi di Riccione 23rd - 26th  September 2008, ISBN 978-88-
8453-820-8 (print), ISBN 978-88-8453-821-5 (online), ©2008 Firenze University Press
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Plants have their own networks of defence against 
pathogens that include a vast array of proteins and other 
organic molecules produced during pathogen attack: 
pathogenesis-related proteins (PR proteins), defensins, 
ribosome-inactivating proteins (RIP), lipid-transfer proteins 
(LTP), killer proteins (KP), protease inhibitors (PI), etc. (1). 
Recombinant DNA technology is currently being used in 
agriculture to create genetically modified plants which 
result more resistant to pathogen infections. In order to 
provide a more effective strategy in plant disease control, 
we designed a bifunctional chimeric molecule containing 
two different protein modules: PD-L4, type 1 ribosome-
inactivating protein (RIP) and a subtilisin/chymotrypsin 
inhibitor (WSCI). PD-L4 is a monomeric protein (Mr about 
30k), isolated from Phytolacca dioica L. leaves that 
hydrolyzes the N-glycosidic bond of a specific adenosine 
in the major rRNA and acts as toxic or antiviral agent (2). 
WSCI is a small protein (Mr 8,126.3k), isolated from 
Triticum aestivum, capable to inhibit bacterial subtilisin 
and pancreatic chymotrypsin as well as to interfere with 
proteolytic activities present in the midgut of some 
phytophagous insect larvae (3). pd-l4-cDNA and wsci-
cDNA  have been isolated and cloned in E. coli expression 
vectors (2, 4). Here we report on: i) the strategy used to 
clone a genetic cassette, containing the cDNAs of PD-L4 
and WSCI separated by a double strand oligonucleotide 
linker, in the pGEX-2T expression vector; ii) the 
expression of the recombinant chimeric protein into E. coli
BL21-DE3 strain; iii) the characterization of the 
recombinant product. 
1. Chandrashekar A. and Satyanarayana K.V. (2006) J. 
Cereal Sci. 44, 287-304. 
2. Di Maro, A., Valbonesi, P., Bolognesi, A., Stirpe, F., De 
Luca, P., Siniscalco Gigliano, G., Gaudio, L., Delli 
Bovi, P., Ferranti, P., Malorni, A. and Parente, A. 
(1999) Planta 208, 125-131.  
3. Poerio, E., Di Gennaro, S., Di Maro, A., Farisei, F., 
Ferranti, P. and Parente, A. (2003) Biol. Chem. 384,
295-304.  
4. Di Gennaro, S., Ficca, A.G., Panichi, D. and Poerio, E. 
(2005) Biol.Chem. 386, 383-389. 
6.4 
CONJUGATES BETWEEN FOOD PROTEINS AND 
MAGNETIC NANOPARTICLES: PRODUCTION AND 
PROPERTIES 
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Ferraretto2, R. Hempelmann3
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Advances in processes for producing nanostructured 
materials have made possible the production of magnetic 
nanosupports with potential applications in the 
biochemical and biotechnological fields. This kind of 
support is generally synthesized by encapsulating 
magnetic materials within a polymer layer. The interest for 
magnetic nanosupports is not only limited to the obvious 
ease of their separation under micro- and nanofluidic 
conditions. Most relevant is the fact that nanostructures 
can be conjugated to biologically active molecules, 
including hormones, antibodies, drugs, and various 
peptides, taken up by cells, and circulated among tissues 
expressing their cognate receptors. Given their intrinsic 
magnetism, magnetic nanoparticles may be used as 
tracers in NMR and MRI experiments, and are easily 
detectable in standard transmission electron microscopy. 
This work is aimed at producing and characterizing 
conjugates between magnetic nanoparticles and bioactive 
proteins, and at assessing their use as biological tracers 
(for instance in monitoring the intracellular and/or intra-
tissutal path of bioactive molecules of food origin), and 
their suitability for controlling enzyme activity in a number 
of applications. 
Dextran-coated iron oxide nanoparticles were modified in 
order to obtain an activated coating which allowed the 
covalent binding of different bioactive proteins through simple 
chemical procedures. Proteins considered in our studies 
included food allergens, enzymes, and antibodies to food 
proteins. Dot blotting with specific antibodies, followed by 
immunoenzymatic detection of the bound antibodies, 
demonstrated the actual presence of these allergenic 
proteins on the conjugated nanoparticles. As a further test of 
protein immobilization, immunoprecipitation experiments 
were performed to demonstrate the coupling of the proteins 
to the functionalized dextran-coated nanoparticles. Both 
immunological approaches confirmed the suitability of our 
immobilization strategy. 
We also prepared conjugates between analytical-grade 
trypsin and dextran-coated nanoparticles, and assessed 
the immobilized enzyme activity on synthetic substrates. 
These experiments led us to estimate the coupling yield of 
our coupling approach, which compares with those 
reported in the literature for equivalent procedures1.
Preliminary tests aimed at assessing the citotoxicity of 
unmodified dextran-coated nanoparticles showed that the 
viability of differentiated HT-29 cells, from a human 
adenocarcinoma cell line, after various times of incubation 
with the nanoparticles was close to that of control 
untreated cells, suggesting full biocompatibility of the 
unmodified particles with this peculiar cell line. 
1. Kouassi G. K., and Irudayaraj J. (2006) Journal of 
Nanobiotechnology, 4, 8. 
6.5 
GENETIC VARIABILITY ANALYSIS OF APULIA SHEEP 
BREEDS BY USING MICROSATELLITES. 
L. Siculella, F. Damiano, P. Priore and G.V. Gnoni 
Laboratory of Biochemistry and Molecular Biology, 
Department of Biological and Environmental Science and 
Technologies, University of Salento, Lecce-Italy 
The dramatic contraction of autochthonous sheep breeds 
increased the need for native genetic resource 
conservation. Infact, the local sheep breeds, 
characterized by a limited size, strictly depend on the 
maintenance of genetic differences. Conservation of 
genetic diversity and resistance to disease are of great 
importance in animal science and the analysis of breed 
genotype can supply the basis for conservation programs. 
The drastic decrease in the Moscia Leccese breed, even 
more in the Altamurana breed (<500 animals), among the 
Apulia native genotypes (provinces of Bari and Lecce), 
focused attention to the possibility of genetics protection 
of these races. 
The genetic variability and genetic distance of sheep 
populations Altamurana (AL), Moscia Leccese (ML), Delle 
Langhe (DL), Sarda (S), Massese (M) and Bergamasca (B) 
were analyzed. In this study, 8 microsatellite molecular 
markers (OarCP49, FCB11, OarAE129, FCB304, 
INRA063, MAF214, CSRD247 e HSC) were used. These 
microsatellites were amplified by multiplex-PCR and 
analyzed for genetic variability and genetic distance among 
individuals having a scrapie ARR/ARR genotype.  
161 individuals were analyzed: 49 AL (46 of them with 
a ARR/ARR scrapie resistent genotype), 17 ML, 34 S, 18 
DL, 28 M e 15 B. ML, S, DL, M e B individuals were not 
consanguineous and belong to different sheep herds. 
Allele frequencies, the average allele number per 
population, observed  (Hobs) and expected average 
heterozygosity (Hexp), genetic distances and Hardy-
Weinberg equilibrium  were analyzed with GENETIX 4.05 
and FSTAT softwares. Genetic relationships among the 
breeds were analyzed by the factorial correspondence 
analysis (AFC). Genetic distance among individuals within 
populations, based on common alleles, was analyzed with 
MICROSAT software.  
A total of 130 alleles was detected across the 8 loci. 
The average number of alleles per locus observed was: 
AL=8.8, DL= 6.5, M=9.0, S=9.6, ML=6.9, B=7.0. 
Average values of expected (H exp) and observed (H 
obs) heterozygosity were respectively: AL=0.747± 0.10 
and AL=0.701± 0.07; DL=0.671± 0.15 and DL=0.619± 
0.18; M=0.749 ± 0.08 and M=0.695 ± 0.09; S=0.719 ± 
0.10 and S=0.665 ± 0.14, ML=0.743 ± 0.07 and 
ML=0.694 ± 0.11; B=0.755 ± 0.06 and B=0.808 ± 0.09. 
The reduction of intrapopulation heterozigosity Fis
was 0.0741±0.01 and revealed an excess of homozigotes 
with respect to Hardy-Weinberg equilibrium condition. The 
total heterozigosity reduction Fit was 0.134±0.01. The 
reduction of interpopulation heterozigosity was 
0.065±0.01 and, on the basis of Wright classification, it 
denotes a low differentiation among the studied 
populations. On the basis of the AFC analysis, DL e AL 
populations were the most primitive with respect to the 
other populations and they have a probably common 
origin, whereas S e M populations have a recent origin.  
This study was supported by a grant from Interreg IIIA 
Grecia-Italia Asse 2- Misura 2.1 Project Animalpromed. 
6.6 
FUNGAL LIGNINOLYTIC ENZYMES IN TEXTILE 
INDUSTRIAL WASTE DEPURATION 
F. Balestri, S. Di Gregorio, L. Mariotti, V.Matteini, 
M.G.Tozzi and R. Lorenzi. 
Dipartimento di Biologia, Università di Pisa, Pisa, Italia 
Synthetic dyes find application in different industrial 
divisions including textile. These compounds result to be 
recalcitrant to degradation and toxic to higher animals 
becoming of environmental concern in case of release in 
aquifers. Physico-chemical treatment methods (e.g. 
electrolysis, sonication or ozonization) which bring to the 
complete destruction of dye molecules are somewhat 
unsuccessful, very expensive and producing large 
amounts of toxic wastes which are difficult to dispose of.  
Many representatives of different classes of synthetic 
dyes, have been subjected to discoloration by fungi, in 
particular, the ligninolytic basidiomycetes have received 
extensive attention due to their powerful lignin-
degradating extracellular enzymatic systems1: laccases 
and peroxidases. 
Laccase (Lc) is a blue oxidase capable of oxiding 
phenols and aromatic amines. Lignin peroxidase (LiP) is 
characterized by its ability to oxidize high-redox-potential 
aromatic compounds and manganese peroxidase (MnP) 
by Mn2+ oxidation, Mn3+ chelates acting as diffusing 
oxidizers. Versatile peroxidase combines the catalytic 
properties of the two above peroxidases. These enzymes 
are also able to decolorized several industrial dyes. The 
ligninolytic basidiomycetes are edible and their industrial 
treatment produces a significant amount of spent 
mushroom substrate (SMS), still characterized by high 
levels of residual enzymatic activity.  
We have demonstrated that the SMS and the 
extracellular culture fluid derived from the spent 
mushroom substrate of the lignolitic basidiomycete 
Pleurotus Ostreatus were able to decolorize the synthetic 
diazo-dye reactive Black DM 5594, trade name “Lanasol” 
black, and the synthetic dye acid blue “Follone” and 
“Follone” complete recipe. The enzymatic assays on the 
extracellular culture fluid of Pleurotus Ostreatus, revealed 
that laccases are predominant on the manganese and 
versatile peroxidase, while no lignine peroxidase activity 
was found. The optimum pH was 4 with ABTS as 
substrate. The laccase stability to pH indicated that this 
enzyme was stable in a range of pH 4-9. The laccase 
stability to temperature indicated that the enzyme is 
stable until 60 ºC. To shed light on the potential toxicity of 
commercial azo dyes, we have used a human epithelial 
cell line (WISH) for the cytotoxicity tests and feeds of 
some common plants for the germinability tests. The azo 
reactive dyes Lanasol red, black, blue and yellow are 
toxic for cells and feed plants.  On the other hand these 
azo reactive dyes pre treated with SMS, have lost their 
toxic effect on the cells and for the feed plants. The azo 
acid dyes, blue, red and yellow Follone and a real waste 
water deriving from a local textile manufacturer are no 
toxic for cells and feeds as observed for the azo reactive 
dyes. 
1. Wesemberg, D. (2003) Biotechnol Adv. 22(1-2):161-
87.  
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Mucins are the major glycoprotein components of the 
mucous that coats the surfaces of cells lining the 
respiratory, digestive, and urogenital tracts. Their function 
is to protect epithelial cells from infection, dehydration, 
and physical or chemical injury. In the eye, corneal and 
conjunctival epithelia produce hydrophilic mucins that 
hold tears onto the ocular surface. Eye pathologies, as 
dry eye syndrome can be associated to mucin alterations. 
Dry eye is associated with tear film deficiency, owing to 
insufficient supply or excessive loss, and anomalous tear 
composition. One of the essential functions of the tear film 
is to lubricate the ocular surface during blinking and eye 
movement. The eyes are constantly in motion, and the 
ocular surface is delicate; without adequate lubrication, 
ocular surface damage occurs and symptoms of 
discomfort develop or increase. Ocular lubrication is also 
essential for contact lens wearers, which utilize artificial 
tears to increase both lubrication and retention of the tear 
film. A general feature of artificial tears is their high 
viscosity which should increase the residence of the 
substance on the ocular surface. However, the high 
viscosity may lead up to inconveniences such as sticky 
feeling and solidification. In this regard, a strategy to 
antagonize the discomfort of dry eye is the use of low 
viscosity polysaccharidic molecules that may endure on 
the ocular surface without unpleasant disadvantages. 
Arabinogalactan (AG), a natural polysaccharide present in 
conifers of the genus Larix (Larch), was recently shown to 
exert a corneal protective action.  
This study is devoted to assess mucoadhesive 
properties of purified AG (supplied by Opocrin) by 
evaluating its ability to interact with mucins through gel 
filtration chromatography. The methodological approach 
is based on the shift possibly occurring in the elution 
profile of a ligand when subjected to gel filtration 
chromatography in the presence of the target and on the 
measurement of the ligand bound to the target while 
emerging from a chromatographic column equilibrated 
with different ligand concentrations. 
Mucin (MUC1) from bovine submaxillary glands and 
AG display, when chromatographed separately on a 
Sephacryl S300 column, well distinct elution peaks. A 
significant change in the elution profile of AG, compatible 
with a transient coelution of the two molecular species, is 
observed when the polysaccharide is chromatographed 
together with mucin. On the contrary, no effect is exerted 
on the elution profile of AG by different proteins and 
glycoproteins with molecular mass comparable with 
mucin. Frontal gel chromatographic approach, performed 
with MUC1 (1 mg of protein/ml) and AG at concentrations 
ranging from 0.06 to 0,23 mg/ml allowed to assess the 
effectiveness of the interaction process. 
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There is increasing interest in new biomaterials and new 
culture methods for bone tissue engineering, in order to 
produce, in vitro, living constructs able to integrate in the 
surrounding tissue. Static culture environments suffer 
from limited diffusion and often result in inhomogeneous 
cell and extracellular matrix distribution. In order to 
overcome the drawbacks associated with static culture 
systems, several bioreactors have been designed1.
Using an electromagnetic bioreactor (magnetic field 
intensity, 2 mT; frequency, 75 Hz), we investigated the 
effects of electromagnetic stimulation on SAOS-2 human 
osteoblasts seeded onto a 3D titanium alloy scaffold. In 
comparison with control conditions, the electromagnetic 
stimulation caused increased surface coating with 
decorin, type I and III collagen, osteopontin, osteocalcin, 
osteonectin, alkaline phosphatase and fibronectin. The 
immunolocalization of the above proteins showed their 
co-localization in the cell-rich areas. RT-PCR analysis 
revealed the electromagnetically up-regulated 
transcription specific for the foregoing matrix proteins and 
for the growth factor TGF-b. Furthermore, the sample 
exposed to an electromagnetic bioreactor showed an 
higher cell proliferation as confirmed by the measurement 
of DNA content and SEM observations.  In order to 
overcome the total immunocompatibility with the patient, 
the use of mesenchymal stem cells (MSCs) could be 
promising. For this purpose, human bone marrow-derived 
MSCs (BMMSCs) were isolated from adult patient and 
their osteogenic potential was evaluated onto the same 
3D titanium alloy scaffold in terms of cell adhesion, 
proliferation and differentiation in static conditions. We will 
be setting the same experiment with BMMSCs evaluating 
the effects of an electromagnetic stimulation.  
The use of an electromagnetic bioreactor aims at 
obtaining the surface modification of the 3D scaffolds  in 
terms of cell colonization and coating with calcified matrix; 
in this way the superficially modified biomaterial could be 
used, in clinical applications, as an implant for bone 
repair.  
1. Fassina L, Saino E, Visai L, Silvani G, Cusella De 
Angelis MG, Mazzini G, Benazzo F, Magenes G. 
Electromagnetic enhancement of a culture of human 
SAOS-2 osteoblasts seeded onto titanium fiber-mesh 
scaffolds. J Biomed Mater Res A. 2008 Jan 15. 
8.1 
ANTIOXIDANT ACTIVITY OF OLEA EUROPAEA 
DERIVATIVES 
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At the present time it is easy to observe an increasing 
interest for the utilization of natural products as opposed 
to synthetic ones. The drug, food and cosmetic industry 
mostly use synthetic phenolic compounds with the aim of 
scavenging free radicals. In the cosmetic industry, in 
particular, these compounds are used to delay the skin 
ageing process. 
Grape, olive and orange are fruits rich in antioxidants 
which are poorly exploited by the industry1-4.
Persuing our interest in the field of natural antioxidant 
discovery, we have evaluated “in vitro” in different 
experimental models (Erythrocytes, Phosphatidylcholine 
liposomes, DPPH) the radical scavenging activity of raw 
extracts coming from manufacturing process of olive oil5.
The products exhibit a marked antioxidant activity with 
an IC50 ranging from 1 to 5 mg/ml which is largely over to 
that of vitamin E. 
In addition the compounds show a sinergistic 
interaction with this important antioxidant contained in 
olive oil.. 
This research was supported by MURST (60% and ex 
40%) Ministero dell'Università e della Ricerca Scientifica. 
1. M.T. Huang, C.T. Ho, C.Y. Lee and. Phenolic 
compounds in food and their effects on health II. ACS 
Symposium Series 507, Washinton. DC 1992. 
2. Zouari N. Decolorization of olive oil mill effluent by 
physical and chemical treatment prior to anaerobic 
digestion. J Chem Technol Biotechnol 1998; 73: 297-
303. 
3. Vassilev N, Vassileva M, Azcon R, Fenice M, Federici 
F, Barea J M. Fertilizing effect of microbially treated 
olive mill wastewater on Trifolium plants. Bioresour 
Technol 1998; 66: 133-137. 
4. Paredes C, Bernal MP, Cegarra J, Roig A. Bio-
degradation of olive mill wastewater sludge by its co-
composting with agricultural wastes. Bioresour 
Technol. 2002;85(1):1-8. 
5. C. Anselmi, M. Andreassi, M. Centini, R. Maffei 
Facino, M. Carini. "Miscela ad elevata attività 
antiossidante sinergica e radical scavenging di origine 
vegetale e suo procedimento di produzione" Domanda 
di Brevetto n. FI 2000A000223 del 9/11/2000.  
8.2 
NEW APPROACHES TO THE EXPANDED NEWBORN 
SCREENING PROGRAMS BY TANDEM MASS 
SPECTROMETRY: REDUCTION OF FALSE-POSITIVES 
FOR C5, C5OH, C6DC. 
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The expansion of newborn screening programs has 
increased the number of newborns diagnosed with inborn 
errors of metabolism in the presymptomatic phase but it has 
also increased false-positive results. False positive results are 
costly for Public Health Resources and causes unnecessary 
parental stress. We report an update on the latest 
developments in the expanded newborn screening programs. 
Acyl-carnitines C5, C5OH, C6DC are one of the analytes 
most frequently responsible for false-positive results. We 
developed a rapid liquid chromatography-tandem mass 
spectrometry (LC-MS/MS) method that identifies free acids 
and glicine derivatives: 3-idroxisovaleryl-acids (3-OH-IVA), 2-
idroxisovaleryl-acids (2-OH-IVA), 3- MethylcrotonylGlycine 
(3MCCGly), Isovalerylglycine (IVAGly), PropionylGlycine 
(C3Gly), 3-idroxMethyl-Glutaric acid (3-OH-3-MetGlut), 3-
Methyl-Glutaconic acid (3-MetGlutac), Lactic acid (LA), 
Metylmalonic acid (MMA), Succinyl acid (Suc) and 
TiglylGlycine (TiglilGly) in blood spots thus reducing false-
positive rates due to C5, C5OH, C6DC during expanded 
newborn screening programs. We studied newborn screening 
spots from 92 healthy controls; 28 from false positives for 
abnormal C5, C5OH, C6DC and 23 from inborn truly affected. 
Analytical method consists of chromatographic separation on 
a C6-Phenyl column of an extracted 3.2 mm dried blood spot 
and injection into triple quadrupole mass spectrometer 
equipped with a Turbo Ion Spray Ionization Source. Specific 
Multiple Reaction Monitoring were carried out and labelled 
isotopic reagent were used as an internal standard. No 
derivatization is required and total analysis time is 5 minutes 
per sample. Intra- and interassay imprecision data were 
3.5%-8% and 3.2%-6% for MMA. Limit of detection and limit 
of quantitation were 0.01 and 0.05 micromol/L, respectively, 
for C3Gly and IVAGLy. The recoveries were 92.9%-106.1%. 
No deterioration was noted on the columns after 500 
chromatographic runs. The application of this method as 
second tier test allows to reduce false-positive results, the 
retesting and the consequent recalls inborn. In addition, the 
test allows us to diagnose with greater certainty diseases like 
Isovaleric acidemia (IVA), 3-Methylcrotonyl-CoA carboxylase 
deficiency or MethylcrotonylGlicinurie (MCC), Biotinidase 
(BIO) because on the other hand, false-negative cases have 
been reported by several newborn screening laboratories. We 
found that in experimental conditions developed specifically is 
that the following picture of metabolic alteration: 
∞ IVA increase 3-OH-IVA, IVAGly 
∞ MCG increase 3-OH-IVA, 3MCCGly 
∞ BIO increase 3-OH-IVA, IVAGly, C3Gly 
CONCLUSIONS: This method has the potential to 
markedly reduce false-positive results and the associated 
costs and anxiety. It may also be suitable for diagnosing 
and routinely monitoring blood spots IVA, BIO, MCC. 
1. Oglesbee D. et al., Clinical Chemistry (2008), 54: 542 
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8.3 
EFFECTS OF HISTONE DEACETYLASE INHIBITORS 
ON ENERGY METABOLISM
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Scotti, D. Caruso, M. Crestani, E. De Fabiani 
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Recent experimental evidences reported in the literature 
have revealed that the control of metabolic pathways 
occurs at the transcriptional level also through epigenetic 
mechanisms, and particularly by chromatin remodeling. 
Previous results obtained in our laboratory showed that 
the treatment with histone deacetylase inhibitors (HDACi) 
induces the increase in CYP7A1 gene expression, a key 
actor in cholesterol homeostasis, in mice and the 
reduction in plasma cholesterol level. In addition we 
observed a net decreased concentration of serum 
triglycerides and of body weight, despite increased food 
intake. 
Collectively, these changes could be due to increased 
fatty acid oxidation, altered fatty acid synthesis or 
increased energy expenditure. The aim of this work was 
to analyze the mechanisms underlying HDACi effects in 
the liver and in the muscle fibers, which are deeply 
involved in the regulation of the energy metabolism.  
We first analyzed in the liver of treated mice the 
expression levels of relevant genes and we observed a 
general increase in mRNA levels of genes involved in lipid 
catabolism and its regulation, like LCAD, Fatty acid 
traslocase (CD36) and  Apolipoprotein CII (ApoC-II), while 
we found decreased mRNA levels of ACC1, the rate 
limiting enzyme in lipogenesis. Interestingly, we observed 
a strong up-regulation of PGC-1?, a key player in 
mammalian energy metabolism involved in mitochondrial 
biogenesis. These data can also explain the net decrease 
in the triglyceride content observed in the liver of mice 
treated with HDACi. 
Also in C2C12 myotubes, a murine model of muscle 
fibers we observed a strong increased expression of 
PGC-1? after HDACi treatment, which could contribute to 
improved oxidative ability. We observed in fact the 
upregulation of important genes involved in oxidative 
phosphorylation (Cyt C) and in lipolysis (MCAD, VLCAD) 
and CD36 in treated myotubes. Western Blot analysis 
also revealed that HDACi transiently increased AMPK 
phosphorylation, a signal that disappeared after several 
hours of treatment. We also reported an increased mRNA 
level of the insulin dependent glucose transporter GLUT4, 
whose expression and traslocation can be regulated by 
PGC-1α and AMPK. 
These results suggest that HDACi treatment mimics 
an energetic stress condition to which cells respond with 
an increased demand of energy substrates, increased 
oxidation rate and enhancing mitochondrial biogenesis. 
Administration of HDACi to mice fed high-fat diet, a 
model of insulin resistance, improves glucose tolerance 
test, thus suggesting that HDACi may be effective in 
reducing hyperglycemia. 
In conclusion, HDACi reveal that the acetylation state 
of histones and other DNA associated proteins has a key 
role in the trascriptional regulation of genes involved in 
energy metabolism and therefore could be valuable tools 
to study molecular mechanisms implicated in metabolic 
diseases. 
8.4 
PHARMACOLOGICAL POTENTIAL OF INHIBITORS OF 
6-PHOSPHOGLUCONATE DEHYDROGENASE FROM 
T. brucei: DIFFERENTIATION OF SUBSTRATE 
ANALOGUES FROM REACTION-INTERMEDIATE 
ANALOGUES BY ISOTHERMAL TITRATION 
CALORIMETRY 
S. Hanau, K. Montin, M. Magnani, F. Dallocchio 
Dipartimento di Biochimica e Biologia Molecolare, 
Università di Ferrara, Ferrara, Italia 
6-Phosphogluconate dehydrogenase (6PGDH) is a 
validated target to develop new drugs against African 
trypanosomiasis. Kinetic assays have shown that 4-
phospho-D-erythronate (4PE) and 5-phospho-D-ribonate 
(5PR) are substrate competitive inhibitors with Ki under 
the Km for 6PG and a good selectivity for the parasite 
enzyme compared to the mammalian 6PGDH. The 
binding of the inhibitors has been further characterized by 
isothermal titration calorimetry (ITC) and, while the Kd of 
5PR was found equal to the Ki (1.35 ?M), the Kd for 4PE 
was found much higher than the Ki (2.86 ?M versus 0.13 
?M). The difference between the two inhibitors is larger 
but reversed in the ternary complexes with either NADP 
and NADPH. The number of NADP binding sites in the 
ternary complex with 4PE and 5PR is one per dimer, as it 
is in the ternary complex of the enzyme with 6PG and the 
nonoxidizing coenzyme analogue 3-amino-pyridine 
adenine dinucleotide phosphate. Thus the enzyme 
functions in a asymmetric way as 6PGDH from other 
species. However, while in the presence of 5PR NADP 
shows the same Kd observed in the binary complex, in the 
presence of 4PE the Kd decreases by two orders of 
magnitude, from 7.54 ?M to 43 nM. The same difference 
is observed in the binding of NADPH, whose Kd slightly 
increases in the presence of 5PR and decreases from 
1.05 ?M to 20 nM in the presence of 4PE. The binding of 
4PE to the enzyme-NADP complex shows two sequential 
binding sites, the first site with Kd 177 nM, very close to 
the Ki value of the inhibitor determined kinetically, and the 
second site with Kd in the ?M range as in the binary 
complex. The observed half-site reactivity toward NADP 
means that the coenzyme at high concentration acts as a 
competitive inhibitor toward the 4PE. The 177 nM Kd is so 
an apparent Kd, while the true Kd is 17.7 nM. We conclude 
that 5PR simply mimics the substrate and supports the 
conformational changes accompanying the formation of 
the ternary complex, while 4PE is an analogue of the 
tightly bound, high-energy intermediate of the reaction.  
The large decrease of the Kd observed also in the 
presence of NADPH suggests that the 4PE could be an 
inhibitor more effective under physiological conditions, 
where NADPH concentrations are high, rather than in the 
in vitro assay performed in the absence of NADPH. Thus 
4PE appears a lead compound in development of 
compounds with better pharmacological properties.  The 
main obstacle in the use of phosphorylated sugar 
analogues as therapeutic agents is the impossibility to 
cross the cell membrane. However a recent report shows 
that chemical modification of the phosphate group can 
overcome this obstacle. 
8.5 
USE OF HUMAN RECOMBINANT PROLIDASE TO 
INVESTIGATE THE ENZYME ACTIVE SITE. 
A. Lupi1, S. Alleva2, V. Minicozzi2, S. Morante2, F. 
Stellato2, E. Campari1, R. Gioia1, A. Profumo3, A. Rossi1,
G. Cetta1, R. Tenni1, A. Forlino1
1
Dipartimento di Biochimica “A. Castellani”, Università di 
Pavia, Pavia, Italia 
2
Dipartimento di Fisica, Università di Roma “Tor Vergata”, 
Roma, Italia 
3
Dipartimento di Chimica, Università di Pavia, Pavia, Italia 
Introduction. The latest stage of protein catabolism, 
particularly of those molecules rich in imino acids such as 
collagens, requires the activity of prolidase, the only Mn2+
dependent metalloenzyme that cleaves the 
iminodipeptides containing a C-terminal proline or 
hydroxyproline. Mutations in the prolidase gene (PEPD) 
cause the recessive connective tissue disorder Prolidase 
Deficiency. Beside its intracellular functions, prolidase has 
an antitoxic effect against some organophosphorus 
molecules, can be used in dietary industry as bitterness 
reducing agent and recently has been used as target 
enzyme for specific melanoma prodrug activation.  
Results. We recently generated recombinant human 
prolidase characterized by substrate specificity, optimum 
pH and temperature of activity and ion dependence 
similar to the endogenous enzyme1. In solution 
recombinant prolidase, with or without Mn2+ activation, is 
present mainly (80-99%) as homodimer of 123 kDa as 
determined by gel filtration chromatography. ICP mass 
spectrometry revealed the predominant presence of Mn 
and Zn. While the presence of Mn2+ ions was expected, 
the presence of Zn2+ was surprising and the two metals 
were detected at a well defined concentration ratio in 
several preparations: [Prolidase dimer]: [Mn]=1:1 and 
[Prolidase dimer]:[Zn]=1:4. The five-fold metal 
coordination is in disagreement with the published data 
available on prolidase enzyme in other organisms 
containing only four metal binding sites, but confirms a X-
Ray diffraction experiment performed on human prolidase 
which is reported to bind five Na+ ions. X-Ray Absorption 
Spectroscopy (XAS) study of the metal binding site 
structure of the prolidase was also performed. A 
preliminary analysis of XAS data confirmed that the 
dimeric protein in solution is capable of binding Zn2+ ions 
and Mn2+ ion. Our data showed two more likely situations: 
first one with Zn in A1, A2 and C3 metal sites while Mn 
was in site B1; the second with Zn in A1, B1 and A2 sites 
while Mn was in C2 site.  
Conclusion. The complete analysis of XAS data 
could clarify whether the two sites belonging to the same 
monomer are both omo-loaded (Zn2+-Zn2+) or whether 
instead one is omo- and the second one etero- (Zn2+-
Mn2+) and where is the binding site for an eventual fifth 
ion. 
Supported by MIUR 2006 (Grant n. 2006050235),  
Fondazione Cariplo to A.R.. 
1. Lupi A., Della Torre S., Campari E., Tenni R., Cetta 
G., Rossi A. and Forlino A. (2006) FEBS J. 273, 5466-
5478. 
8.6 
THE COMBINED MUTATION OF INTERFACIAL AND 
ACTIVE-SITE RESIDUES OF TREPONEMA 
DENTICOLA CYSTALYSIN LEADS TO A FOLDED PLP-
BOUND MONOMER 
R. Montioli(a), B. Cellini(a), A. Paiardini(b), M. Bertoldi(a)
and C. Borri Voltattorni(a) 
(a)Department of Morphological-Biomedical Sciences, 
Section of Biological Chemistry, University of Verona, 
Strada Le Grazie, 8, 37134 Verona, Italy (b)Department of 
Biochemical Sciences “A. Rossi Fanelli”, University “La 
Sapienza”, 00185 Rome, Italy 
Cystalysin is a dimeric pyridoxal 5’-phosphate dependent 
lyase produced by the oral pathogen Treponema 
denticola1. Recent studies have evidenced that apo- and 
holo-cystalysin exhibit dramatic structural differences and 
that PLP strongly influences the dimerization properties of 
the enzyme2,3. Site-directed mutagenesis experiments 
have been undertaken with the aim of getting a folded 
monomeric form of the enzyme suitable for investigating 
the role of the coenzyme on the associative/dissociative 
process of cystalysin. Based on molecular modelling 
analyses, the interfacial residues L57 and L62, as well as 
the Y64* residue, hydrogen-bonded to the PLP-
phosphate, have been mutated to alanine. The L57A, 
L62A, Y64*A, L57A/L62A, L57A/Y64*A, 
L57A/L62A/Y64*A variants have been constructed, 
expressed and purified. By size-exclusion 
chromatography, the effects of the mutations on the 
quaternary structure of apo- and holo-cystalysin have 
been elucidated. The results indicate that L57A mutation, 
more that L62A mutation, affects the quaternary structure 
of apocystalysin, while the Y64*A mutation only interferes 
with holocystalysin dimerization. Moreover, the L57A 
mutant, which is monomeric in the apo-form and 
dimerizes in the presence of PLP, has been chosen as a 
model to investigate the effect of coenzyme binding on 
the dimerization process. Data show that i) the L57A 
monomer is able to bind PLP, even if with an affinity lower 
than that of the dimer; ii) PLP induces the association of 
monomers in a slow-equilibrium process with a rate which 
parallels that of the regain of lyase activity. Finally, by a 
combination of the three mutations, a stable PLP-bound 
monomeric form of cystalysin has been generated. Kinetic 
analyses of this mutant indicate that: i) the lyase, 
racemase and D-alanine half-transaminase activities are 
suppressed in the monomer; ii) monomeric cystalysin 
retains an L-alanine half-transaminase activity whose 
catalytic efficiency value is increased by ~2-fold with 
respect to that of the wild-type enzyme. 
1. Chu L., Holt S.G., Microb. Pathog., 16(3), 197-212 
(1994) 
2. Cellini B., Montioli R., Bossi A., Bertoldi M., Laurents 
D.V., Borri Voltattorni C., Arch. Biochem. Biophys. 
455(1), 31-39 (2006) 
3. Cellini B., Bertoldi M., Montioli R., Laurents D.V., 
Paiardini A., Borri Voltattorni C., Biochemistry 45(47), 
14140-14154 (2006) 
8.7 
CYSTATHIONINE GAMMA-LYASE IN BOVINE LENS  
R. Moschini, E. Calvani, A. Del Corso, M. Cappiello, U. 
Mura. 
Dipartimento di Biologia, Università di Pisa, Pisa, Italia 
The relevance of proper glutathione (GSH) levels in 
maintaining lens transparency is well assessed. Cysteine 
(Cys) represents the limiting amino acid for the synthesis 
of GSH and its availability is controlled by the flux through 
the transulfuration pathway. This metabolic route allows 
the conversion of methionine into Cys and is composed of 
two sequential steps catalyzed by cystathionine beta-
synthase and cystathionine gamma-lyase (CGL), 
respectively.  
CGL, a PLP-dependent enzyme, catalyses the rate 
limiting step of the transulfuration pathway, i.e. the 
conversion of L-cystathionine into L-Cys. CGL has been 
shown to be essential in liver and kidney for an adequate 
supply of Cys for GSH synthesis, thus its deficiency plays 
a key role in GSH depletion in several physiological and 
pathological situations. Recently, it has been shown that 
the transulfuration pathway exists also in the lens and that 
can be up regulated in oxidative conditions. Moreover, it 
has been hypothized that CGL activity may be particularly 
relevant for Cys availability in the aging lens. Despite this 
potential crucial role of CGL in affecting the redox 
potential of the lens, very limited information is available 
on the CGL from lens. This study is devoted to the 
isolation of CGL from bovine lens, in order to perform a 
characterization of the enzyme, useful to disclose 
features of the enzyme able to modulate Cys availability 
for GSH synthesis.  
Extremely low levels of CGL activity are detectable in 
bovine lens crude extracts, in which the Western blot 
analysis reveals the presence of a single protein cross-
reactive with anti-CGL antibody, with a molecular weight, 
in denaturing and reducing conditions, of approximately 
25 KDa. It is worth noting that, in the same conditions, 
CGL from sources different from bovine lens is detected 
as a 40 KDa band. After partial purification of the crude 
extract, also a 40 KDa band, cross-reactive with anti-CGL 
antibody becomes detectable. The enzyme activity seems 
to be associated only with the latter molecular species. 
The two CGL proteins can be completely separated by 
hydrophobic interaction chromatography, and their further 
characterization reveals that their molecular weight in 
native conditions is compatible with a homotetrameric 
structure.  
A well detectable CGL activity can be measured in 
cultured bovine lens epithelial cells. The measured 
specific activity results two orders of magnitude higher 
than what observed in the whole lens. Moreover in 
epithelial cells only the 40KDa cross-reactive band is 
present.  
The possibilities that in lens CGL undergoes limited 
proteolysis catalyzed by proteolytic activities not present 
(or present at low levels) in the epithelial cells, or that 
oxidative modifications occurring on CGL makes the 
enzyme susceptible to proteolysis, have been 
investigated. 
8.8 
STREPTOZOTOCIN-INDUCED DIABETES REDUCES 
ACTIVITY AND EXPRESSION OF MITOCHONDRIAL 
CITRATE CARRIER IN RAT LIVER. 
P. Priore, A. Giudetti, G. Gnoni 
Laboratory of Biochemistry, Department of Biological and 
Environmental Sciences and Technologies, University of 
Salento, 73100 Lecce, Italy 
Diabetes mellitus is characterized by substantial 
alterations in hepatic intermediary metabolism. In diabetic 
state, reduced enzyme activities in the glycolytic and 
pentose phosphate pathways together with an increase in 
gluconeogenic, glycogenolytic and lipolytic pathways 
were observed1. In absolute insulin deficiency, the plasma 
concentration and turnover of fatty acids increase, 
whereas de novo fatty acid synthesis and proportion of 
fatty acyl-CoA that is esterified as opposed to oxidized, 
decrease1. Lipogenesis requires cooperation between 
mitochondrial and cytoplasmic enzymes and involves 
fluxes of metabolites across mitochondrial membranes2.
Citrate carrier (CiC), an integral protein of the inner 
mitochondrial membrane, plays an important role in 
hepatic intermediary metabolism, translocating 
mitochondrial citrate into the cytosol, where it supplies 
acetyl-CoA for de novo fatty acid and cholesterol 
syntheses. The aim of the present work was to investigate 
the effect of streptozotocin-induced diabetes on 
mitochondrial CiC activity and expression in rat liver and 
to characterize the molecular step(s) of this hormonal 
modulation. The rate of citrate transport was reduced by 
~35% in mitochondria from diabetic versus control rats. 
Kinetic studies in diabetic mitochondria showed a 
reduction in the Vmax and almost unchanged CiC Km
value. Diabetes led to changes in mitochondrial 
membrane fatty acid composition. In particular, a 
noticeable decrease in arachidonic acid (C20:4, n-6) and 
a simultaneous increase in docosahexaenoic acid (C22:6, 
n-3) was detected in mitochondria from diabetic animals. 
In the latters, linoleic acid (C18:2, n-6) level significantly 
accumulated. In spite of these changes there was no 
significant variation in the sum of saturated and 
unsaturated fatty acids and in their unsaturation index. 
Mitochondrial phospholipid composition was not 
significantly affected, while an increase in the cholesterol 
amount and in the cholesterol/phospholipid ratio was 
observed. To deeply investigate into the mechanism 
responsible for the reduced CiC activity in diabetic state, 
molecular studies were performed. RNase protection 
assay and Western blotting analysis indicated that both 
hepatic CiC mRNA accumulation and protein level 
decreased similarly to the CiC activity. The reduced 
mRNA level and the lower content of the mitochondrial 
CiC protein, might account for the decline of CiC activity 
in diabetic animals. In the latters, CiC activity and 
expression changed in covariance with those of de novo
fatty acid synthesis enzymes.  
1. Postic C. , Dentin R. , Girard J. (2004) Diabetes Met. 
30: 398-408. 
2. Rossmeisl M., Syrovy I., Baumruk F., Flachs P., 
Janovska P., Kopecky J. (2000) FASEB J. 14: 1793-
1800. 
8.9 
SILDENAFIL INHIBITS THE ROS PRODUCTION BY 
XANTHINE OXIDASE 
G. Taibi1, G. Carruba2 , L. Cocciadiferro2, A. Cucchiara3,
and C.M. A. Nicotra1
1
Dipartimento di Oncologia Sperimentale e Applicazioni 
Cliniche, Università di Palermo, Via del Vespro 129, 
90127 Palermo, Italia. 
2
Laboratorio di Oncologia 
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Civico, Palermo. 
3
Dipartimento di Scienze per la 
Promozione della Salute, Università di Palermo, Via del 
Vespro 129, 90127 Palermo, Italia
Xanthine oxidase (XO) catalyzes the hydroxylation of a 
wide variety of substrates, including purines, pirimidines, 
pterins d aldehydes, to acids1. At relatively high oxygen 
pressure, it generates reactive oxygen species (ROS) as 
superoxides and hydroxyl radicals. The XO, detected in 
endothelial and epithelial cell outer surface, has been 
involved in ischemia/reperfusion injury1,2. Furthermore, 
XO-ROS production has been implicated in chronic 
hearth failure, inflammatory diseases, LDL oxidation, 
atherosclerosis, hypertension, cancer, aging1.
Allopurinol, a hypoxanthine analogue developed as 
xanthine oxidase inhibitor 30 years ago, and oxypurinol, 
its oxidation product, have proved to be effective in the 
treatment of these conditions both in experimental 
animals and human clinical trials1. Recent studies have 
shown the significant benefits of sildenafil, an inhibitor of 
type 5 phosphodiesterase, in patients with pulmonary 
hypertension, and an endothelium enhancing effect in 
preconditioning prior to ischemia/reperfusion3,4. As 
allopurinol/oxypurinol and sildenafil exhibit a marked 
structural analogy, we assayed the effect of this drug on 
the purified enzyme and in human prostatic cell cultures. 
The 80-100% inhibition of the ROS production by the 
enzyme bound to the external membrane of prostatic cells 
suggests that this mechanism may be of primary 
importance for the protective effects of the drug on 
epithelial cells. 
1. Harrison R. (2006) Int Dairy J. 16, 546-554  
2. Rouquette M, Page S, Bryant R, Benboubetra M, 
Stevens CR, Blake DR. (1998) FEBS Lett. 426, 397-
401
3. Sastry BKS, Narasimhan C, Reddy NK, et al. (2004) J 
Am Coll Cardiol. 43, 1149-1153  
4. Gori T, Sicuro S, Dragoni S, et al. (2005) Circulation 
111, 742-746 
9.1 
PROTEOGLYCAN UNDERSULFATION OF THE 
GROWTH PLATE IN A SULFATE TRANSPORTER 
KNOCK-IN MOUSE 
M. Facchini1, B. Gualeni1, M. Viola2, A. Passi2, A. Forlino1,
F. Pecora1, G. Cetta1, A. Rossi1
1
Dipartimento di Biochimica “A. Castellani”, Università di 
Pavia, Pavia 
2
Dipartimento di Scienze Biomediche Sperimentali e 
Cliniche, Università degli Studi dell’Insubria, Varese 
Mutations in the diastrophic dysplasia sulfate transporter 
(DTDST or SLC26A2) cause a family of recessively 
inherited chondrodysplasias including, in order of 
decreasing severity, achondrogenesis 1B, 
atelosteogenesis 2, diastrophic dysplasia (DTD) and a 
recessive form of multiple epiphyseal dysplasia. The gene 
encodes a widely distributed sulfate/chloride antiporter of 
the cell membrane. Its function is crucial for the uptake of 
inorganic sulfate, which is needed for sulfation of the 
glycosaminoglycan (GAG) chains of proteoglycans (PGs). 
We have already demonstrated undersulfation of GAGs in 
articular cartilage from patients and from a dtd mouse 
model generated in our laboratory. However, cartilage 
sulfation at the growth plate level has never been 
measured due to the low amount of tissue available and 
the difficulties in isolating this small area.  
In this work we measured PG sulfation of the growth 
plate on mutant dtd and wild-type mice and we checked 
whether undersulfation affects chondrocyte proliferation. 
The growth plate was obtained from sections of the 
tibia of 2 and 3 weeks old mice by manual 
microdissection and disaccharides, released  from PGs 
after enzymatic digestion, were labeled with a fluorescent 
dye and analysed by FACE (fluorophore assisted 
carbohydrate electrophoresis) or reverse phase HPLC. 
Results obtained with both techniques demonstrated a 
significant undersulfation of the dtd growth plates 
compared to those of wild-type animals. 
Chondrocyte proliferation was measured in 3 weeks 
old mutants and wild-type mice injected intraperitoneally 
with bromodeoxyuridine (BrdU). Animals were sacrificed 2 
hours after injection. BrdU incorporated during the 
labeling time into replicating cells was detected by 
immunohistochemistry on the tibia growth plate. Our 
results demonstrate a significant decrease of chondrocyte 
proliferation  in the growth plate of mutant 3 weeks old 
mice compared to wild type animals, demonstrating that 
PG undersulfation affects chondrocyte 
proliferation/differentiation causing reduced bone growth. 
This work was supported by grants from Telethon-Italy 
(grant no. GGP06076) and the European Community 
(FP6, “EuroGrow” project, LSHM-CT-2007-037471). 
53rd National Meeting of the Italian Society of Biochemistry and Molecular Biology (SIB) and National Meeting of Chemistry of Biological 
Systems Italian Chemical Society (SCI - Section CSB) : Palazzo dei Congressi di Riccione 23rd - 26th  September 2008, ISBN 978-88-
8453-820-8 (print), ISBN 978-88-8453-821-5 (online), ©2008 Firenze University Press
9.2 
EXPRESSION AND SUBCELLULAR LOCALIZATION 
OF SIALIDASE NEU3 IN MDCK CELLS. 
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Among the four different forms of mammalian sialidases, 
Neu3 is characterized by its high substrate specificity 
toward gangliosides and by its association to cellular 
membranes. Moreover, Neu3 is known to co-fractionate 
with caveolin-1, indicating its presence inside lipid rafts. 
Recently we demonstrated that Neu3 behaves as a 
peripheral membrane protein and, in COS7 and HeLa 
cells, is associated with the extracellular leaflet of the 
plasma membrane and co-localizes with markers of the 
endocytic route1. The latter observation suggests that the 
protein cycles between the plasma membrane and the 
endosomal compartment.  
Under specific growth conditions, MDCK cells can 
differentiate into a polarized cellular monolayer where the 
plasma membrane can be distinguished into an apical 
and a basolateral domain. Interestingly, the protein and 
lipid composition of the two domains is different and 
unique. Thus, in MDCK cells protein delivery to the apical 
or basolateral membranes is a specifically controlled 
cellular mechanism. 
We expressed Neu3 in MDCK cells by stable 
transfection of the murine form of the protein and 
characterized transfectants by immunofluorescence and 
confocal microscopy analysis. As expected, indirect 
immunofluorescence experiments demonstrate that in 
non-polarized MDCK cells Neu3 localizes at the plasma 
membrane and in endosomes, with a specific enrichment 
of the protein at the cell-cell contact areas. When MDCK 
cells were allowed to polarize, Neu3 was detected only at 
the basolateral domain and, more specifically, at the 
lateral side of the membrane where cell-cell interactions 
take place. Moreover, intracellular vesicular structures 
labeled for Neu3 were found, especially enriched at the 
basal portion of the polarized monolayer. Association of 
Neu3 to lipid rafts was also investigated. When MDCK 
cells were grown in a non-polarized system a small, 
though significant, amount of Neu3 was found in light 
Optiprep density gradient fractions, corresponding to the 
microdomains enriched fractions. Analysis of the 
distribution of the protein after polarization showed that 
Neu3 does not co-fractionates with caveolin-1 positive 
light fractions.  
Our results suggest that Neu3 undergoes specific 
mechanisms of delivery to the basolateral membrane of 
polarized cells. Whether the plasma membrane and the 
endosomal pools of the protein are in a dynamic 
equilibrium remains to be investigated. Experiments are in 
progress in our laboratory in order to identify possible 
mechanisms that regulate Neu3 delivery to the cell 
surface and exposure to the cell-cell contact areas.  
1. Zanchetti G. et al. (2007) Biochem. J., 408, 211–219. 
9.3 
PURIFIED HUMAN GLYCOSAMINOGLYCANS 
REDUCED NF-kB ACTIVATION, PRO-INFLAMMATORY 
CYTOKINE PRODUCTION AND APOPTOSIS INDUCED 
BY LPS IN MOUSE CHONDROCYTES. 
G. M. Campo, A. Avenoso, S. Campo, A. D’Ascola, P. 
Traina, D. Samà,  A. Calatroni. 
Department of Biochemical, Physiological and Nutritional 
Sciences, University of  Messina,  Messina, Italy 
Chondroitinsulphates (CS) are the main glycosaminoglycan 
(GAGs) component in human organism, and  of plasma 
GAGs. A significant increase, with respect to normal values, 
of plasma GAG concentration was observed in patients with 
different types of diseases, although the meaning of the 
change is still unclear1. CS may modulate inflammatory 
responses and ,especially chondroitin-4-sulphate (C4S) 
exerts antioxidant activity2. Interleukin 1beta (IL-1β),
interleukin-6 (IL-6), tumor necrosis-alpha (TNF-α), and 
interferon-gamma (IFN-γ)  are pro-inflammatory cytokines 
that play an important role in immune regulation and 
inflammatory processes by inducing the expression of many 
effector proteins, such as cytokines/chemokines, inducible 
nitric oxide synthetase (iNOS) and matrix metalloproteinases 
(MMPs)3. Excessive and/or dysregulated activity of these 
mediators is associated with tissue destruction and cell 
death. Nitric oxide (NO) is spontaneously produced by 
chondocytes in osteoarthritis, and contributes to progressive 
cartilage degradation4.
The aim of this study was to evaluate the effects of 
GAGs, purified from normal human plasma, on reducing 
inflammation in a model of LPS-induced increase in pro-
inflammatory cytokines in mouse articular chondrocyte 
cultures. Chondrocyte stimulation with LPS  for 24 hours 
generated high TNF-α, IL-1β, IL-6, IFN-γ gene expression 
and their related protein levels, nuclear factor kB (NF-kB) 
activation, IkBα phosphorylation and apoptosis evaluated 
by the increase in caspase-3 expression and its related 
protein amount. LPS treatment generated also high 
concentrations of iNOS and the detrimental oxidant 
species NO evaluated in terms of nitrites and nitrates.  
Purified human GAGs, at three different doses, 
reduced inflammatory cytokines and iNOS produced by 
chondrocytes at mRNA and protein levels, blocked NF-kB 
activation and cytoplasmatic IkBα phosphorylation, limited 
cell death by inhibiting apoptosis, and finally reduced the 
NO concentrations. By capillary electrophoresis analysis 
of purified human plasma GAGs unsaturated 
disaccharides,  C4S was  identified as the main 
component. The positive modulatory effect exerted by  
plasma GAGs on all considered parameters may be due 
to its efficiency to bind protein structures thereby exerting 
an inhibitory activity. These results further support the 
hypothesis that circulating GAGs may function as 
immunomodulators and their increased release and 
degradation could be a biological response that acts to 
modulate inflammation during disease.    
1. Raman R. et al. (2005) Chem Biol, 12, 267-77. 
2. Campo G.M. et al. (2006) Adv. Pharmacol., 53, 417. 
3. Herrington C. and Hall P. (2008)  J Pathol.,  214, 123. 
4. Vuolteenaho K. et al. (2007) Scand. J. Rheumatol., 36, 
247. 
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Although the pathogenesis of acute cirrhosis is not fully 
understood, it is clear that ROS play a key role in 
pathological changes in the liver1. Carbon tetrachloride 
(CCl4), a hepatotoxin, has been used extensively to 
induce liver injury in various animal models. The 
experimentally induced cirrhotic response by CCl4 in rats 
and mice has been shown to be similar to human 
cirrhosis of the liver2.
The up-regulation of the nuclear factor kB (NF-kB) has 
been implicated in the pathogenesis of several diseases, 
including inflammation and liver diseases. Animal models of 
acute hepatic damage  support a role for NF-kB in the 
development and progression of cirrhosis. Although oxidants 
are commonly considered to exert their effects via direct toxic 
action on target cells, recent findings suggest their 
contributory role in gene induction. NF-kB may be activated 
by low levels of ROS and inhibited by antioxidants3.   
Glycosaminoglycans (GAGs), especially chondroitin-
4-sulphate (C4S), show antioxidant activity 4.
Aim of this study is to investigate whether the 
administration of C4S, besides exerting antioxidant 
activity, is able to modulate NF-kB and apoptosis 
activation in CCl4-induced liver injury in mice.  
Acute toxic hepatitis was induced in mice by an 
intraperitoneal injection of 1.0 ml/kg of CCl4 in mineral oil. 
Varying doses of C4S were administered intraperitoneally 
1 h before, 6 and 12 h after CCl4 injection. 24 h after CCl4
injection, the mice were sacrificed and biochemical and 
histological analysis performed.   
CCl4 injection produced: marked elevation of alanine 
and aspartate aminotransferases; hepatic membrane lipid 
peroxidation, assayed by 8-isoprostane levels; depletion 
of the antioxidants GSH and SOD activity; NF-kB 
translocation and reduction of IkBα;  increase in 
metalloproteinase(MMP)-2, MMP-9, caspase-3 and 
caspase-7 gene expression and their related protein; 
induction of liver polymorphonuclear infiltration, evaluated 
by elastase assay, and hepatic cell disruption.  
C4S administration: inhibited lipid peroxidation; 
blocked NF-kB activation and IkBα protein loss; reduced 
mRNA MMPs and caspase expression and their related 
protein; restored endogenous antioxidants; limited hepatic 
polymorphonuclear accumulation and hepatic damage.  
This study is a further confirmation that the antioxidant 
effect of C4S, and show that C4S is able to inhibit NF-kB 
and apoptosis activation, due to the CS induced decrease 
of  ROS production.  
1. Wu D. et al.,  J. Gastroenterol. Hepatol. (2006) 21, 
Suppl.3,S26-29. 
2. Weiler-Normann C. et al., (2007) Z. Gastroenterol. 45, 
43-50. 
3. Kundu J.K. et al. (2006) Biochem. Pharm..72 :1506-
15. 
4. Campo G.M. et al., (2006) Mini Rev. Med. Chem. 6, 
1311-20. 
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Neuroblastoma is a highly malignant tumour derived from 
neural crest cells that accounts for approximately 50 % of 
childhood cancer death. Among several typical genetic 
changes of this disease, the amplification of the oncogene 
MYCN is significantly associated to a poor prognosis1. In 
this report, we demonstrated that the expression of the 
long form of the sialidase Neu4 (Neu4L) is connected to 
the distorted control of proliferation characteristic of 
neuroblastoma and, in particular synergizes with MYCN 
to accelerate the G1/S phase progression.  
The human neuroblastoma SK-N-BE cell line, known 
to possess MYCN amplification, was transfected with 
Neu4L cDNA. The first important consequence was a 
marked acceleration of the proliferation rate assessed by 
an increase of [3H]thymidine incorporation (+ 45%) and 
by cell count for up to 4 days (+ 36%). After cell 
synchronization through serum deprivation, Neu4-L over-
expressing SK-N-BE cells failed to block in the G1 phase, 
in contrast to mock cells and proceeded, massively, to the 
S phase. Important alterations concerning the expression 
of the main molecules which rule the transition into the S 
phase could explain the bypassing of the G1/S 
checkpoint: the activation of MAPK cascade, the 
decrease of the cyclin dependent kinase (CDK) inhibitor 
p21 and p27, the activation of CDK2, and the 
phosphorylation of Rb. These events triggered the 
transcription of key S-phase-promoting genes such as 
cyclin A1 (+ 83%) and cyclin E (+ 61%). Significantly, also 
the expression of MYCN resulted to be more expressed 
(+ 36%). The direct substrates of Neu4L in SK-N-BE cells 
seem to be soluble glycoproteins in the range of 60 kDa. 
Therefore, the expression of Neu4L in neuroblastoma 
cells could synergize and further enhance MYCN cell 
cycle alteration, through the desialylation of key 
glycoproteins which possibly concur to regulate the MEK-
ERK axis. These findings suggest that Neu4L expression 
is directly correlated to the malignancy degree of 
neuroblastoma. 
1. Brodeur GM (2003) Nat Rev Cancer. 3, 203-16 
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Post translational modifications of proteins are considered 
to be one of the major determinants regarding the 
complexity of higher organisms1. More than 200 different 
types of post translational modi-fications are known2 of 
which only a limited number   are reversible and important 
for the regulation of biological processes. Among these 
modifications, the most studied is protein phosphorylation. 
The aim of the present investigation was to identify the 
main differentially expressed phosphoproteins in   human 
erythroleukemia cells (K562) upon treatment with       
AZT, the first anti-retroviral drug approved and yet used in 
combined AIDS therapy3. For this purpose we used K562 
cells untreated (control), or exposed to 20 ?M AZT for 3 h. 
This drug concentration was chosen because is higher 
but not far from that found in the blood of AIDS patients 
under AZT therapy. In addition, AZT concen-tration and 
treatment time were selected also to enhance the 
changes of new proteins under drug exposure to obtain 
the major differences between control and treated 
samples without affecting  cells growth and cell viability. 
Then, by using specific biotinylated mAb  (anti-phospho-
serine, anti-phosphothreonine, anti-phosphotyrosine) and 
by means of ELISA, FACS, and confocal micro-scopy a 
generalized screen was performed on the O-
phosphorylation level. In particular, the main results we 
obtained are the following: 
a) an increase of O-phosphorylation level in K562 
AZT-treated cells when analyzed by ELISA was observed 
(about 20%). However, after cells permeabilization, as 
FACS and confocal microscopy analyses revealed, the 
increase was mainly due to the intracellular phospho-
proteins; in fact,  AZT-treated but non-permeabilized cells 
showed a decrease of surface O-phosphorylation (about 
12%).   
b) proteomic analysis based on two-dimensional gel 
electrophoresis  and subsequent protein identification by 
MALDI-ToF-MS, evidenced 27 phosphoproteins diffe-
rentially expressed in AZT-treated K562 cells (up- or 
downregulated). Many of the differentially expressed 
proteins found in this study may be associated with 
important cellular activities such as protein biosynthesis, 
folding and degradation, energetic metabolism, cyto-
skeleton motility, nucleotide biosynthesis and salvage, 
detoxification and redox processes and signal trans-
duction.  
Thus, many protein components of relevant cellular 
metabolic processes may be involved in AZT treatment of 
HIV-affected patients. Our findings also indicate that the 
proteomic approach could represent a simple and useful 
tool for monitoring cellular AZT response(s) which could 
be employed as a potentially useful implement in the 
management of HIV patients under antiretroviral therapy. 
1. Venter J. C. et. al. (2001)  Science 291, 1304-1351. 
2. http://www.abrf.org/index.cfm/dm.home?AvgMass=all. 
3. Mitsuya H. et al. (1985) PNAS 82, 7096-7100. 
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Sialidases or neuraminidases (EC 3.2.1.18) are enzymes 
widely distributed in nature from viruses to vertebrates. 
They play a key role in the metabolism of 
sialoglycoconjugates. In particular, they are able to 
remove sialic acid residues from gangliosides, 
sialoglycoproteins and sialoligosaccharides. It is 
becoming more and more evident that the partial 
desialylation of senescent erythrocyte membrane 
sialoglycoconjugates constitutes a primary or preliminary 
signal for erythrophagocytosis. The removal of sialic acid 
from the sialoglycoconjugates is assumed to be promoted 
by the sialidases present on the membranes. The 
presence of two sialidases in human erythrocytes has 
been previously reported. One acts optimally at acidic pH 
(4.2-4.7) and the other at neutral pH. In order to identify 
the exact nature of these two sialidases and the enzyme-
membrane leaflet interaction, we incubated the 
erythrocyte membranes with different solutions. We 
obtained interesting results when we treated the 
membranes with 0,1 M sodium carbonate buffer pH 11,5. 
In literature it is reported that sodium carbonate treatment 
is one of the methods used to discriminate between 
peripheral and integral cell membrane proteins (Fujiki et 
al., 1982). The sodium carbonate treatment led to the 
release of 50% acidic sialidase into the supernatant, 
whereas the neutral sialidase remained totally in the 
pellet. Our results suggest that only alkaline pH is 
responsible for the release of this sialidase from the 
membrane and that the enzyme is a peripheral protein. 
Then we analyzed the stability of the acidic sialidase 
released after the treatment: the enzymatic activity 
decreases by 40% after 24 h at 4°C. The enzyme looses 
25% of its activity after the first freeze-thaw cycle, while 
seems to be stable after the other five freeze-thaw cycles. 
The released enzyme has been analyzed also using 
polyclonal anti-Neu1 antibodies. The western blot 
analyses reveal that Neu1 sialidase is present on the 
erythrocyte membranes and that the alkaline treatment 
causes the partial release of this sialidase from the 
membranes. This is the first evidence of the presence on 
erythrocyte membranes of Neu1 sialidase, an enzyme 
that is usually located in a multienzymatic complex in the 
lysosomes of mammalian cells. So we investigated if the 
multienzymatic complex was present on erythrocyte 
membranes using antibodies against the other  
components of the complex. Our results suggest that 
Neu1 sialidase is alone on the erythrocyte membrane and 
it does not need the other complex components to 
expound its enzymatic activity. 
Fujiki et al., (1982), The Journal of Cell Biology 93, 97-
102
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Chronic myeloid leukaemia (CML) is a paradigmatic 
example of neoplasia in which a differentiation arrest 
occurs during the myeloid lineage and a highly 
proliferative malignant clone originates1. In the context of 
cancer disease and differentiation, an ever-increasing 
interest is being focused on sialidases and 
sialoglycoconjugates since alterations in these fields are 
directly interconnected to neoplastic transformation2. In 
particular, the plasma-membrane associated sialidase 
Neu3 over-expression, reported in several tumours, is  
linked  to apoptosis resistance phenomena. In this report, 
we demonstrated that the silencing of Neu3 in the CML 
K562 cells decreases proliferation rate and apoptosis 
resistance in favour of a differentiation process. 
K562 cells were transduced with a shRNA targeting 
the coding region of Neu3, inserted in a lentiviral vector. 
Neu3 silencing (-70 % as protein content and – 93 %, as 
catalytic activity) gave rise to significant events. First of 
all, cyclin D2 and Myc were much less expressed (- 40 % 
and – 30 %, respectively) while p21 increased (+ 60 %); 
as consequence, cell growth and [3H]thymidine 
incorporation (- 47 %) diminished. Apoptosis resistance 
toward chemotherapeutic molecules such as etoposide 
and staurosporine decreased, accordingly to a concurrent 
decrease of the anti-apoptotic protein Bcl2 (- 30 %) and to 
an increase of the pro-apoptotic proteins Bax and Bad (+ 
17 % and + 32 %, respectively). Moreover, K562 cells 
became able to differentiate toward the megakaryocytic 
lineage as proved by the appearance of the 
megakaryocytic markers CD10, CD44, CD41, CD61. This 
important cascade of events was triggered by the 
activation of the signalling pathways PLC-b2, PKC, RAF, 
ERK1/2, RSK90, and JNK. The molecular connection 
between Neu3 silencing and the activation of PLC-b2 has 
to be searched in the significant increase of GM3 (+ 81 
%), as demonstrated by the treatment of K562 cells with 
brefeldin A which simulated a GM3-rich conformation. 
Therefore, these results indicate that Neu3 plays a 
decisive role in CML and could be an interesting target for 
developing therapeutic strategies. 
1. Deninger MW et al (2000) Blood 96, 3343-56 
2. Miyagi T et al (2004) Glycoconj. J. 20, 189-98 
9.9 
NEU3 SIALIDASE STRICTLY MODULATES GM3 
LEVELS IN SKELETAL MYOBLASTS C2C12 THUS 
FAVORING THEIR DIFFERENTIATION AND 
PROTECTING THEM FROM APOPTOSIS 
G. Palazzoloa,b, L. Anastasiaa,b,*, N. Papinia,b, F. 
Colazzoa,b, C. Tringalia, L. Dileoa,b, M. Piccolia,b, E. 
Confortia,b, C. Sitziaa,b, E. Montic, M. Sampaolesid,e, G. 
Tettamantib, and B. Venerandoa,b,#
a
Department of Medical Chemistry, Biochemistry and 
Biotechnology, University of Milan, Milan, Italy. 
b
Laboratory of Stem Cells for Tissue Engineering, IRCCS 
Policlinico San Donato, San Donato Milanese (Milano), 
Italy. 
c
Department of Biomedical and Biotechnological 
Sciences, University of Brescia, Brescia, Italy. 
d
Stem Cell 
Research Institute, University Hospital Gasthuisberg, 
Leuven, Belgium. 
e
Department of Experimental Medicine, 
University of Pavia, Pavia, Italy; *luigi.anastasia@unimi.it; 
#
bruno.venerando@unimi.it 
Membrane-bound sialidase NEU3, often referred to as the 
“ganglioside sialidase”, has a critical regulatory function 
on the sialoglycosphingolipid pattern of the cell 
membrane, with an anti-apoptotic function, especially in 
cancer cells.  Although other sialidases have been shown 
to be involved in skeletal muscle differentiation, the role of 
NEU3 had yet to be disclosed.  Nevertheless, NEU3 
involvement seems quite plausible, as the enzyme has a 
critical regulatory function on the sialo-glycosphingolipid 
pattern of the cell plasma membrane.  For instance, 
NEU3 of COS7 cells is able to modify the sialo-
glycosphingolipid pattern of adjacent cells, supporting its 
involvement in cell-cell interactions1.  On these bases, we 
decided to investigate the effects of NEU3 on muscle 
differentiation by constitutively silencing NEU3 with small 
interference RNA (shRNA), using murine C2C12 
myoblasts as the cell model.  Our results show that: (a) 
the induced down-regulation of the enzyme in murine 
myoblasts C2C12 completely inhibited their ability to enter 
the differentiation process; (b) upon induction of 
differentiation, or when grown to confluence, NEU3-
silenced myoblasts underwent a massive apoptotic cell 
death; (c) NEU3 silencing caused EGFR inhibition and 
down-regulation due to the increased levels of 
endogenous ganglioside GM3; (d) supplementation of 
GM3 in the culture medium of wild-type C2C12 strongly 
reduced their differentiation capability; (e) NEU3-silenced 
myoblasts, when co-cultured with wild-type C2C12, re-
acquired the capability to differentiate and fused to form 
MHC-expressing myotubes. 
1. N. Papini et al. J Biol Chem. 279 (2004) 16989-95. 
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Lysosomal a-D-mannosidase (EC 3.2.1.24) is an 
exoglycosidase involved in the ordered degradation of N-
linked oligosaccharides. Lack of a-D-mannosidase activity 
leads to the lysosomal storage disorder a-mannosidosis 
(MIM No 248500), characterized by neurological 
symptoms. Abnormal levels of a-D-mannosidase activity 
have been previously reported in some pathological 
conditions, such as cancer (Hakomori S., PNAS 99: 
10231–3) and neurological disorders. We observed that 
a-D mannosidase enzymatic activity is high in blasts from 
Acute Myeloid Leukaemia (AML) M2 and M3 subtype 
patients, and in cell lines derived from a AML-M2 patient, 
such as HL60. Gene expression analysis demonstrated 
increased levels of MAN2B1 transcript in HL60, as 
compared to HEK cells used as non leukaemic control. To 
elucidate molecular events underlying human lysosomal 
a-D-mannosidase expression, we characterized a-D-
mannosidase promoter. Regulatory regions crucial for 
promoter activity were determined by reporter gene assay 
in HEK cells and highest promoter activity was found in 
the region -101/-53 with respect to the first ATG. 
Mutational analysis confirmed that this region was of 
basic importance for MAN2B1 gene promoter activity. 
Electrophoretic mobility-shift assays demonstrated that 
Sp1 bound to this sequence in both HEK and HL60 cells 
but in HL60 other transcription factors binding upstream 
are responsible of the increased level of a-D-
mannosidase transcript. 
1. Emiliani C., Martino S., L. Stirling J.L., Maras B., 
Orlacchio A. (1995)  Biochem. J. 305: 363-6. 
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Ras is a monomeric GTPase which transduces signals 
from membrane receptors to downstream effectors, thus 
regulating transcription factors state of activation. Several 
Ras mutants have been characterized. In particular, 
RasV12 is a constitutively active Ras protein, while 
double mutants RasV12S35, RasV12G37 and 
RasV12C40 are loss of function mutants that maintain the 
ability to activate specific downstream effectors, i.e. 
MAPK, RalGEF and PI3K respectively. Previous 
investigations showed that active Ras up-regulates 
lysosomal glycohydrolases a-D-mannosidase, b-D-
galattosidase and b-D-hexosaminidase in human primary 
fibroblasts. To investigate signal transduction pathways 
linking Ras activation to lysosomal enzymes activity, we 
prepared plasmid and retroviral vector constructs 
encoding RasV12, RasV12S35, RasV12G37 and 
RasV12C40 to express transgenes in a transient and 
stable manner. We tested these constructs in different 
human cell lines, fully differentiated (fibroblasts),  
immortalized (HEK, HUDE) and of tumor origin (MCF7). 
Transfected cells were analysed for their lysosomal 
glycoidrolases activity content with fluorogenic substrates 
(4MU-a-mann, 4MU-GlcNAc, 4MU-b-gal). Results 
demonstrated that lysosomal glycohydrolases were 
differently regulated. a-D-mannosidase activity was 
significantly increased only in primary fibroblasts over 
expressing RasV12 while b-D-galactosidase and b-D-
hexosaminidase activity was specifically up regulated by 
double mutants in a cell model depending manner. Taken 
together, these evidences demonstrated that lysosomal 
enzyme activity is regulated by Ras activation through 
specific signaling pathways in different cell models. 
Interestingly, they show that Ras oncogene double 
mutants mainly affect the activity of b-D-galactosidase 
and b-D-hexosaminidase, both involved in 
glycosphingolipid catabolism.  
1. Emiliani C., Urbanelli L., Racanicchi L., Orlacchio A., 
Pelicci G., Sorbi S., Bernardi G., Orlacchio A. (2003) 
J. Biol. Chem 278: 38453–60.  
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Toll-like receptors (TLRs) ligand activation elicits 
production of pro-inflammatory cytokines. The role of 
TLRs in the exacerbation of the inflammatory response 
has been postulated.  TLR-4 has a key role in the 
inflammation induced by lipopolysaccharide (LPS). TLR-4 
activation by LPS involves many adapters, as the myeloid 
differentiation primary response protein (MyD88) and the 
tumor necrosis factor receptor-associated factor 6 
(TRAF6), involving the phosphorylation of several kinases 
that in turn led to liberation of nuclear factor kB (NF-
kB)/Rel family members into the nucleus. Chain 
fragments of acid glycosaminoglycans (GAGs) 
hyaluronan (HA) and heparan sulphate (HS) are also 
ligands able to activate TLR-4 1,2.
Both HA and HS, and other GAGs, as chondroitin-4-
sulphate (C4S) and chondroitin-6-sulphate (C6S), are 
suggested to protect cells from oxidative stress3. It was 
also reported that HA and C4S were able to reduce cell 
damage by inhibiting the NF-kB and apoptosis4,5.
The aim of this study was to investigate whether 
GAGs may exert anti-inflammatory activity due to an 
antagonist effect on TLR-4 receptor in a model of LPS-
induced increase of pro-inflammatory cytokines in mouse 
articular chondrocyte cultures. 
 Chondrocyte stimulation with LPS for 24 hours 
increased TLR-4, MyD88 and TRAF6 mRNA expression 
and their related proteins, induced NF-kB activation and 
generated high levels of tumor necrosis factor alpha 
(TNF-α), interleukin beta (IL-1β), and the inducible nitric 
oxide synthase (iNOS), evaluated in terms of gene 
expression and protein production.  
The treatment of chondrocytes with two different doses 
(25 and 50 ?g/ml) of HA, C4S, C6S and HS produced 
various effects: HA reduced MyD88 and TRAF6 levels and 
NF-kB activation with the higher dose only, and exerted a 
very low anti-inflammatory effect; C4S, and to less extent 
C6S,  significantly inhibited MyD88, TRAF6 production and 
NF-kB activation and the inflammation mediators TNF-α  and 
IL-β;  iNOS expression and activity were also significantly 
reduced;  HS, like C4S, was able to significantly reduce 
MyD88, TRAF6 and NF-kB activation and inflammation. The 
use of a specific TLR-4 blocking antibody confirmed these 
results, suggesting that the inhibitory effect exerted by GAGs 
on NF-kB activation may follow the block of TLR-4. Since 
GAGs are able to bind a variety of biological molecules, 
especially proteins, the block of TLR-4, together with their 
antioxidant activity and an eventual direct inhibition of NF-kB, 
may represent a further step of GAG fine modulation of the 
inflammatory mechanism. 
1. Johnson G,B,  et al.(2002)  J Immunol., 168, 5233-9. 
2. Termeer C. et al. (2002)  J Exp Med, 195, 99-111. 
3. Campo G.M. et al. (2004) Glycoconj. J. 20, 133-41. 
4. Campo G.M. et al. (2008) Mol. Cell Biochem. 311,167-77.   
5. Jomphe C.et al. (2008) Basic Clin. Pharm. 
Toxicol.102,59-65. 
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Hyaluronan (HA) plays a dynamic regulation during 
inflammation1. In its native state, HA exists as high molecular 
weight (MW) polymer, in excess of 106 Da. However, shorter 
HA chains are frequently found, with different biological 
effects on cells and tissues. Low MW HA showed  high 
inflammatory activity, while high MW HA a marked anti-
inflammatory effect2,3. HA fragments elicit the expression of 
pro-inflammatory cytokines, inducible nitric oxide synthase 
(iNOS) and metalloproteases (MMPs) through a mechanism 
involving the cell-surface receptor for HA, CD44. The CD44 
stimulation activates protein kinase C (PKC) family that in 
turn activates the transcriptional nuclear factor kB (NF-kB), 
responsible of the expression of  inflammation mediators 
such as tumor necrosis factor alpha (TNF-α), interleukin beta 
(IL-β) and iNOS4. CD44 interaction with its ligands strongly 
depends upon PKC which modulates the phosphorylation 
state of CD44 and the various anchoring proteins5. The aim 
of this study was to investigate the effects of HA at different 
MW (50, 1000 and 5000 kDa) on inflammation and 
especially on PKC expression in a model of phorbol 12-
myristate 13-acetate (PMA) -induced PKC/inflammation in 
mouse articular chondrocyte cultures.   
High CD44 and PKCδδ and PKCη mRNA and their 
related proteins levels were found in chondrocytes 24 
hours after PMA treatment. NF-kB up-regulation, and 
increased levels of TNF-α, MMP-13 and iNOS gene 
expression and their related protein production were also 
induced by the PMA stimulation.  
The treatment of chondrocytes with HA at various MW 
(two doses for each MW, 0.15 and 0.30 mg/ml) produced 
different effects: low MW HA up-regulated CD44 
expression, increased  PKCδδ and PKCη mRNA levels and 
protein production, and enhanced the inflammatory 
activity in untreated chondrocytes; while in PMA-treated 
cells it increased CD44, PKCδd ? PKCη, NF-kB, TNF-α,
MMP-13, and iNOS with enhancement of PMA effects; 
medium MW HA did not exert any inflammatory activity in 
untreated chondrocytes and was unable to reduce PMA 
effects;  high MW HA had no effect in untreated 
chondrocytes while it reduced PKCδd ? PKCη, NF-kB 
activation and all the inflammatory mediators stimulated 
by PMA treatment. The use of a specific CD44 blocking 
antibody supported the results.  
These data confirm the multifactorial role played by HA in 
living organisms and especially its regulatory effect exerted 
at different states of aggregation. The HA stimulation/block of 
CD44 during inflammation needs to be taken into account to 
develop  new strategies against inflammation.  
1. Taylor K.R. and Gallo R.L. (2006) FASEB J. 20, 9-22. 
2. McKee C.M. et al. (1997) J Biol Chem, 272, 8013-8. 
3. Bollyky P.L. et al. (2007) J Immunol. 179, 744-7.  
4. Lesley J. and Hyman R. (1998) Front Biosci. 3, d616-
30. 
5. Larsson  C. (2006) Cell Signal, 18, 276-84. 
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STREPTO-COCCUS INFECTION OF PERITONEAL 
MACROPHAGES
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Group B Streptococcus (GBS), a pathogen involved in 
serious neonatal infections, has evolved different 
strategies to evade immune defences of host organisms. 
For example, interaction of GBS with macrophages 
causes defects in membrane permeability, massive 
increase in intracellular calcium and apoptosis, paralleled 
by profound changes in protein expression.  
In order to investigate proteome alterations induced in 
this host-pathogen model, mouse peritoneal 
macrophages (3 x 106 cells) were infected either with 
active 3 x 108 GBS cells or with heat-inactivated GBS. 
Non infected macrophages, incubated in the same 
conditions, were used as control cultures (C). 
After two hours, macrophages were recovered and 
repeatedly washed with PBS. Macrophage proteins, 
solubilised in a small volume of aqueous solution 
containing chaotropes and amphionic detergent, were 
separated by two-dimensional electrophoresis (2DE). 
Preliminary tests were performed to demonstrate that 
contamination of protein preparations by streptococcal 
proteins was negligible using the solubilisation procedure 
outlined.  
Sypro-Ruby stained gel images obtained from three 
separate experiments were analysed by using a 
dedicated software (PD-Quest, BioRad). After 
normalisation, matching polypeptide spots whose 
intensity was significantly different (p<0.05 Kruskal-Wallis 
test) in the three experimental groups were submitted to 
trypsinisation and identified by LC-MS/MS.  
The expression of 74 spots, corresponding to 61 
unique proteins, was significantly affected by the 
interaction with GBS.  
The identified proteins were clustered according to 
Gene Ontology (GO) categories by using web tools for 
functional annotation (Babelomics, DAVID Bioinformatics 
Resources) with the aim of  identifying common pathways 
involved in cell-pathogen interaction. 
About 30% of the polypeptides whose expression was 
changed in macrophages following GBS infection, are 
subunits of mitochondrial proteins.  
Significant alterations of the expression of proteins 
involved in regulation of metabolic processes were 
induced by co-culturing macrophages with GBS. The 
abundance of selected enzymes and coenzymes involved 
in glucose and carboxylic acid metabolism was 
significantly lowered in GBS-infected macrophages. 
In addition, DNA-binding proteins and proteins 
involved in nucleocytoplasmic traffic as well as proteins 
implicated in intracellular signalling cascades, cell 
communication, intracellular transport, cytoskeletal 
organisation, antioxidant defense, calcium-binding and 
apoptosis were differentially expressed in GBS-infected 
macrophages and controls. 
10.2 
A FAST MUTAGENESIS APPROACH TO BYPASS 
INTERNAL AMBER STOP CODONS IN scFvs AND 
PURIFY RECOMBINANT ANTIBODIES  
M. Ramazzotti, F. Niccheri, M.Berardi, M. Belli, D. 
Degl’Innocenti 
Dipartimento di Scienze Biochimiche, Università degli 
Studi di Firenze, viale Morgagni 50, 50134 Firenze, Italia. 
Single chain fragment variable (scFv) antibodies are a 
great tool for understanding the immunological properties 
of molecules. They have been developed in the form of 
phage displayed proteins, allowing to rapidly select a 
battery of mono-specific and structure sensitive probes 
against the antigen of interests starting from a library of 
randomized Ig molecules containing hundreds of billions 
of individuals. The most recent and frequently used scFv 
libraries are the Tomlinson I+J one, available at 
www.geneservice.co.uk and based on a human 
framework. The selection is made possible in amber-
suppressor E.coli strains (e.g TG1) that allows to bypass 
an amber stop codon between the coding sequences of 
the scFv and a specific protein of the phage envelope, 
generating a phage displayed fusion protein. After the 
biopanning, a simple infection by the selected phages of 
E.coli amber-sensitive strains allows to express  and 
purify an scFv molecule in the form of a soluble protein of 
about 27 KDa. 
From the time of their development a number of cases 
have been reported1,2 in which additional amber stop 
codons have been found inside the scFv molecules (a 
natural and never obscured consequence of the 
maturation of the randomized libraries inside amber 
suppressor stains), leading to the impossibility  of 
switching to soluble scFv purification in amber sensitive 
stains. 
Here we report a simple and fast solution that allowed 
us to bypass internal amber stop codons and to express 
up to three milligrams/liter of soluble and fully functional 
scFv antibody. 
Our procedure is based on the mutagenesis of the 
amber stop codon dividing scFv and pIII-phage protein 
from amber (TAG) to normal (TAA) stop codon. This 
single point mutagenesis is made by a couple of primers 
that can be considered as universal for the Tomlinson 
library, being the mutagenised region conserved in all the 
library sequence. We then transformed the mutagenised 
vector into XL1-Blue amber-suppressor strain (supplied 
by the mutagenesis kit from Stratagene) and induced, 
after proper set up of the conditions, the scFv over-
expression with IPTG. Protein purification was with Ni-
NTA affinity columns after sonication based bacterial 
lysis.     
When tested by SDS-PAGE, western blot, dot blot, 
and ELISA, the purified scFv proved to be integer, stable 
and well performing as those resulting from classic 
expression protocols. 
1. Wu S et al., Journal of Immunological Methods 318 
(2007) 95–101 
2. Barderas et al. Journal of Immunological Methods 312 
(2006) 182–189 
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EFFECT OF pH ON MMP-9 RELEASE BY LPS-
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Acidosis and alkalosis are complications that may be 
causes of poor prognosis in critically ill patients. In 
particular, the mortality rate of patients that go under 
alkalosis conditions is greater than that in acidosis. 
Certain neutrophil responses can be affected by 
changes in the external pH: extracellular acidic conditions 
enhance neutrophil proinflammatory responses triggered 
by conventional agonists1.
Neutrophils have different kind of granules: primary 
granules are Myeloperoxidase (MPO) positive and MMP-
9 negative; secondary granules contain lactoferrin, a little 
amount of MMP-9 and other molecules; tertiary granules 
contain the larger amount of MMP-9. The aim of this 
study is to verify if MMP-9 released by stimulated 
neutrophils may be higher in extracellular alkalosis 
respect acidosis conditions. This may have implications in 
severity of alkalosis and acidosis. 
Neutrophils were isolated from buffycoats of healthy 
subjects by dextran sedimentation and Ficoll-Hypaque 
gradient centrifugation. Contaminating RBC were 
removed by hypotonic lysis. Cell pellets were 
resuspended in NaCl 0.9% and than counted. 2x106 cells 
were placed in bicarbonate-buffered RPMI 1640 medium 
at various pH (7.0 to 7.8) with 1% heat-inactivated FBS 
and LPS 10 ?g/ml and placed at 37 °C for 30 minutes; 
conditioned mediums were collected and stored at –80 °C 
until MMP-9 assay. Total MMP-9 was measured using 
commercially Activity Assay System.  
Extracellular acidosis and alkalosis enhance 
neutrophil proinflammatory response. We have studied 
the release of MPO and MMP-9 “in vitro” in the pH range 
from 7.0 to 7.8. After LPS-stimulation, MPO released 
doesn’t show significative difference in the pH range 
studied. Instead, the amount of MMP-9 released 
increases both under acidic and basic conditions 
(P<0.001) compared to physiological pH (7.4). 
Furthermore, the amount of MMP-9 released at basic pH 
is greater than that released at acidic pH (P<0.001).We 
have also analysed the pH dependence of MMP-9 
proteolytic activity. We have observed that in the pH 
range from 7.0 to 7.8 MMP-9 shows an higher activity 
when the pH is over 7.4 (physiological pH). 
Neutrophil response to a proinfammatory stimulus is 
differentially affected by the environmental pH. While the 
release of primary granules seems to be insensitive to the 
analysed pH, the release of tertiary granules is sensitive 
to small pH changes and in particular when the pH shifts 
to slightly basic conditions. 
The increased release of MMP-9 at higher pH together 
with its proteolytic activity dependence from the pH suggest 
that MMP-9 could be one of the adverse factors in the 
prognosis of alkalosis and acidosis conditions. 
1. Trevani et al., Extracellular acidification induces 
human neutrophil activation. Journal of Immunology
62: 4849-4857; 1999 
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BY SPECIFIC RECEPTOR AGONIST. 
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Autosomal Dominant Polycystic Kidney Disease (ADPKD) 
is mainly caused by mutations in the PKD1 gene 
encoding for polycystin-1 (PC1). PC1 is a large G?protein 
coupled receptor of the plasma membrane, playing 
important roles in cell-cell, cell-matrix interactions and 
signalling pathways. Between these latter, Ca2+ and
cAMP signalling are particularly involved in the abnormal 
cell proliferation typical of PKD kidney cysts. In particular, 
ADPKD cystic cells respond to cAMP with increased cell 
proliferation through activation of the b-Raf/ERK 
pathway1, and reduction of cAMP has been reported to 
normalize cell growth in cystic cells1. On the other hand, 
we have found that abnormally increased Ca2+ levels and 
oscillations result in increased cell proliferation, via 
PKCalpha and NFAT signalling, in PC1-depleted HEK293 
cells and in PKD1-mutated cystic cell lines2. Thus, the 
discovery of molecules capable to inhibit the adenylyl 
cyclase (AC) or to normalize Ca2+ signals could function 
as new therapeutic agents for the ADPKD treatment.  
Here we demonstrate that the PKD1 knockdown by 
siRNA in HEK293 cells is also associated to modulation 
of A3 adenosine receptor expression, which are G-protein 
coupled receptors that negatively modulate AC activity. In 
particular, in PC1-depleted HEK293 cells as well as in 
PKD1-mutated cystic cells, we have found a significant 
increase in the expression of A3 adenosine receptors. 
This A3R increase caused a bigger inhibition of AC 
activity, after treatment with the selective agonist Cl-IB-
MECA, in PC1-depleted than in control cells. 
Consistently, the Cl-IB-MECA stimulation, induced a 
higher reduction of cell proliferation in PC1-depleted cells 
compared to normal cells. The reduction of cell growth by 
Cl-IB-MECA treatment is associated to increase of 
p21WAF1 expression and reduction in ERK1/2 kinase 
activity. Interestingly, the effects on ERK1/2 are reverted 
by the A3 receptor antagonist, supporting the role of these 
receptors in the growth inhibition. Cl-IB-MECA could be, 
therefore, considered an interesting molecule in ADPKD 
treatment.
1. Calvet JP. (2008) Clin J Am Soc Nephrol. 
2. Aguiari G. et al.  (2008) Cell Prolif. 41(3):554-73 
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DAMAGE AND CELL DEATH IN KERATINOCYTES 
FROM PERILESIONAL SKIN IN VITILIGO 
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Vitiligo is a chronic acquired hypomelanotic disorder 
affecting 0,5%-2% of the world population. The two major 
pathogenetic hypotheses are focused on immune-
mediated or toxic-mediated cell damage primarily directed 
on melanocytes. Recent experimental data underline the
complex interactions that exist between melanocytes and 
other cells found in the skin. Among these cells, 
keratinocytes are able to influence both the survival and 
the functional activity of melanocytes. 
Oxidative stress has been suggested to be the initial 
pathogenetic event in melanocyte degeneration1 with 
H2O2 accumulation in the epidermis of patients with active 
disease. Defective recycling of tetrahydrobiopterin has 
been reported in vitiligo epidermis, associated to the 
intracellular production of H2O2. In addition, an alteration 
in the antioxidant pattern, with a significant reduction of 
catalase activity, has been demonstrated in both lesional 
and non lesional epidermis of patients2, as well as in 
melanocytes. However, the antioxidant imbalance has 
been confirmed also in peripheral blood mononuclear 
cells of active vitiligo patients; it was correlated to an 
increased intracellular production of reactive oxygen 
species and appeared to be due to a mitochondrial 
impairment3. These findings support the concept of a 
possible systemic oxidative stress in vitiligo. 
In order to gain insights on the involvement of 
oxidative stress in the pathogenesis of vitiligo, we have 
grown cultures of keratinocytes from lesional, perilesional 
and healthy skin, evaluating the presence of oxidative 
damage and apoptotic markers in the cells.  
Results indicate that keratinocytes from perilesional 
skin show the features of damaged cells. Pretreatment 
with antioxidants inhibited caspase activation, increased 
total antioxidant capacity, repressed intracellular ROS 
generation, lipid peroxidation and ameliorated 
mitochondrial activity.  
Our data, besides considering the achromic patch as 
the terminal event of a chain of biological processes 
which take place in the perilesional skin, give to 
keratinocytes a role of primary importance in vitiligo 
development. We suggest that the presence of an 
imbalance in the oxidant-antioxidant system might play a 
role in the pathogenesis of vitiligo and support the 
concept that free radical-mediated damage may be the 
initial pathogenic event in melanocyte degeneration in 
generalized vitiligo.  
1. Schallreuter K.U., Wood J.M., Pittelkow M.R., et al.
(1994) SCIENCE 263, 1444-1446. 
2. Schallreuter K.U., Wood J.M., Berger J. (1991) J. 
INVEST. DERMATOL. 97, 1081-1085. 
3. Dell’Anna M.L., Maresca V., Briganti S., et al. (2001)
J. INVEST. DERMATOL. 117,908-813. 
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CYTOSTATIC EFFECT INDUCED BY 2-
CHLOROADENOSINE SENSITISES PC3 CELLS TO 
DOCETAXEL. 
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2-Chloroadenosine (2-CADO) is an adenosine analog 
capable of inducing apoptosis in several cell lines by 
acting either via adenosine receptors or via uptake that is 
followed by metabolic transformations leading to 
nucleotide analogs. DNA-directed nucleotide analogs are 
antimetabolites effective in the treatment of a variety of 
malignancies. Docetaxel-based chemotherapy is the only 
treatment that demonstrated an overall survival benefit in 
men with hormone refractory prostate cancer.  The study 
showed that 2-CADO inhibits the growth of PC3 cells, 
through a mechanism involving cellular uptake. The 
nucleoside analog induces apoptosis and accumulation of 
cells in the  S-phase of the cell cycle. 2-CADO pre-
treatment followed by docetaxel at subclinical dosage 
reduces the viability of either PC3 or LNCaP while it does
not enhance docetaxel-induced cytotoxicity in adherent 
non-neoplastic HECV suggesting that the treatment is 
effective for prostate cancer cells independently on their 
androgen sensitiveness. Down-regulation of PAR-1 gene 
expression results in a slightly lower metastatic potential, 
whereas up-regulation of IL-23 induces the activation of 
the immune system. On the whole the results suggest a 
beneficial cytotoxic effect of 2-CADO and Docetaxel in 
PC3 cells and the information gathered from this 
experimental study might be exploited to design clinical 
polytherapeutic protocols for the management of prostate 
cancer. 
11.4 
PROTEASOMES ARE NOT A TARGET OF 
DOXORUBICIN IN FELINE-INJECTION SITE 
SARCOMA
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Doxorubicin is a potent anti-cancer agent of the 
anthracycline family widely used in the chemotherapeutic 
treatment of different tumors. The exact mechanism by 
which Doxorubicin induces death of neoplastic cells 
remains to be fully elucidated. Although anthracycline can 
exert cytotoxic action by directly liberating free oxygen 
radicals, Doxorubicin was also shown to bind and inhibit 
proteasomes. Notably, proteasomal inhibition is known to 
induce apoptosis of rapidly proliferating cells and, 
consistent with this notion, proteasome inhibitors are 
emerging as powerful tools against many tumors, 
especially plasma cell malignancies. Since recent work 
from our lab demonstrated an enhanced expression and 
activities of immunoproteasomes in feline injection-site 
sarcoma (FISS)1, a spontaneously occurring tumor of cats 
that is an informative model for the study of tumour 
biology in other species, including humans, we undertook 
this study to assess if clinical Doxorubicin treatment 
induces modulation of proteasomes level and functions in 
vivo. To this end, we measured proteasomal subunits 
expression levels and catalytic activities in tissue extracts 
from primary fibrosarcoma lesions and related healthy 
subcutis of nine cats affected by FISS who received two 
Doxorubicin treatments 31 and 10 days before surgery. 
By this approach we demonstrated that the enhanced 
immunoproteasomal expression and enzymatic activity 
characteristic of FISS is not at all affected by standard 
Doxorubicin administration. This unexpected finding might 
account for the reported low clinical effectiveness of such 
a treatment in FISS and provides the rationale for 
developing new therapeutic protocols aimed at achieving 
a better proteasomal inhibition in this and others poorly 
Doxorubicin-sensitive tumors. 
1. Cerruti F., Martano M., Petterino C., Bollo E., Morello 
E., Bruno R., Buracco P. and Cascio P. Enhanced 
expression of γ-interferon induced antigen processing 
machinery components in a spontaneously occurring 
cancer. (2007) Neoplasia 9, 960-969. 
11.5 
NEW LOW CALCEMIC VITAMIN D ANALOGS:  
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The natural hormone, 1α,25-dihydroxyvitamin D3 and its 
analog in the ergosterol series, i.e. 1α,25-
dihydroxyvitamin D2 are known to be highly potent 
regulators of calcium homeostasis in animals and 
humans, and their activity in cellular differentiation has 
also been established1. Many structural analogs of these 
metabolites have been prepared and tested, including 1α-
hydroxyvitamin D3, 1α-hydroxyvitamin D2, various side 
chain homologated vitamins and fluorinated analogs. 
Some of these compounds exhibit an interesting 
separation of activities in cell differentiation and calcium 
regulation. This difference in activity may be useful in the 
treatment of a variety of diseases such as renal 
osteodystrophy, vitamin D-resistant rickets, osteoporosis, 
psoriasis, and certain malignancies. 
We describe here the synthesis and the biological 
profile of a small series of new 2-methylene-19-nor-
1a,25(OH)2D3 compounds: RR-22 (20R,25R), SOR-
1(20S,25R), REN (20R,25S) and SS-22 (20S,25S),
structurally  characterized by the presence of a methylene 
substituent at the carbon 2 (C-2), a hydroxyl substituent 
attached to the 25-position (C-25) in the side chain, the 
methyl group normally located at the 26 position (C-26) in 
the side chain replaced with a hydrogen atom and a 
double bond located between carbon atoms 22 and 23 
(C-22 and C-23) in the side chain. 
In order to synthesize these new 2-methylene-19,26-
dinor-22E-1a,25(OH)2D3 compounds, we have taken 
advantage of the Lythgoe-type Wittig-Horner coupling 
approach, which we have previously used in the 
preparation of other 2-substituted 19-norvitamins2.
When tested in vitro these new 2-methylene-19,26-
dinor-22E-1a,25(OH)2D3 compounds bind to the vitamin D 
nuclear receptor (VDR), and their binding is comparable 
to 1a,25(OH)2D3, they are equally active as 1a,25(OH)2D3
in inducing differentiation of HL-60 cells as well as in 
stimulating 24-hydroxylase transcription. Importantly, they 
all have limited calcemic activity when measured in vivo,
either by intestinal calcium transport or bone calcium 
mobilization, at equimolar quantities or even when given 
at consistently higher dosages as compared to 
1a,25(OH)2D3.
Accordingly, they may find use in the treatment of a 
large variety of diseases, such as autoimmune diseases, 
secondary hyperparathyroidism and cancer. 
1. Ostrem P. et al., Proc. Natl. Acad. Sci. USA, 84, 2610 
(1987). 
2. Sicinski R. et al., J. Med. Chem. 37(22):3730 (1994). 
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Introduction: It is well-known that anti-inflammatory drugs 
are usually carboxylic acids in which the carboxylate group 
is available for metal–ligand interactions; the formation of 
such complexes has been hypothesized to play a role to 
develop and enhance the pharmacological properties of the 
drug1. Surface Enhanced Raman Spectroscopy (SERS) 
technique, with an enhancement up to 106 of the intensity 
of Raman spectra, gives the opportunity to study the 
mechanism of the action of a drug at concentrations 
mimicking the physiological condition. In the present paper 
we present a SERS study on four non-steroidal anti-
inflammatory drugs (NSAIDs), namely the Na salts of 
Ibuprofen, Tolmetin, Piroxicam and Diclofenac, both alone 
and in presence of Co++ and Zn++ ions, at concentrations 
lower than 500 ppm.  
Materials and METHODS: Raman spectra were 
obtained using a Jasco NRS-2000C instrument. All 
spectra were recorded using the 514.5 nm [Ar+] line and 
the laser power on the samples was 15 mW. The systems 
investigated by SERS technique consisted in solutions 
containing both NSAID and the metal ion in a Ag colloidal 
suspension, resulting from the controlled hydroxylammine 
reduction of silver nitrate. 
RESULTS: All SERS spectra exhibited intense bands 
in the region 1350 - 1600 cm-1, due to vibrational modes 
of the aromatic ring and to the asymmetrical and 
symmetrical stretching of COO- group. It should be noted 
that the overall feature of the spectra changes noticeably 
comparing the Raman spectra of NSAIDs concentrated 
solutions with the SERS spectra of NSAIDs adsorbed on 
the Ag colloidal suspension. The differences are mainly 
due to the presence of highly polarizable groups that are 
strongly adsorbed on the metal surface. As a 
consequence, only the bands related to the groups 
directly interacting with the Ag surface are enhanced. On 
the contrary, the general feature of the SERS spectra 
does not change noticeably after the addition of an 
equimolar concentration of Zn++ and Co++ ions. In fact, the 
Δ?  (?asCCO- - ?sCOO-) deduced from SERS spectra 
appear to be, 161 cm-1 for Na-ibuprofen; 158 cm-1 for Zn-
Ibuprofen and 155 cm-1 for Co-Ibuprofen. Similar results 
were observed in other NSAIDs, were the Δ? difference 
was always within 10 cm-1. Moreover, the SERS low 
frequency region (? < 600 cm-1) does not exhibit 
noticeable differences before and after the metal ions 
addition. 
The experimental data seemed to support the 
hypothesis that both with Na+ ion as well as with  divalent 
Co++ and Zn++ ions, at the low concentration considered, 
the formation of the same monomeric monodentate 
structure prevailed, reshuffling thus the role of the metal 
complex formation to enhance the therapeutic activity. 
1. C. Dendrinou-Samara et al., J. Inorg. Biochem. 71  
(1998) 171. 
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In the last years a growing interest has arisen in the 
application of proteomic approach to discover additional 
biomarkers in many types of cancer but at this time not 
even one proteomic study has been performed regard to 
the search of biomarkers in parathyroid diseases. 
Particularly, parathyroid carcinoma is a rare cause of 
parathyroid hormone dependent hypercalcaemia (PTHP) 
with incidence value in PTHP patients less than 1 % of 
cases. However, the diagnosis of a parathyroid 
malignancy is notoriously difficult to make on both gross 
and histological examination. It is often impossible to 
distinguish between benign and malignant disease 
without clear evidence that the tumor is invasive. Local or 
distant metastases firmly establish the diagnosis of 
parathyroid malignancy. However at this stage cure is 
impossible. Until now, no genetic or proteic markers that 
reliably distinguish carcinoma from adenoma have been 
identified.  Recently, different reports have demonstrated 
in parathyroid carcinoma the presence of mutations of 
HRPT2 tumor suppressor gene in patients affected by 
parathyroid carcinoma and a loss of immunoreactivity to 
parafibromin, the protein encoded by HRPT2.  
In the present work, for the first time, proteomic 
analysis has been performed to obtain the parathyroid 
tissue protein map of adenoma. All patients included in 
the study have been submitted to a surgical procedure to 
remove hyperplastic gland. Fifteen patients were enrolled 
in the study and were classified in three groups 
depending of their calcaemia levels.  The proteins profile 
of parathyroid tissue was obtained for each sample by 
two-dimensional electrophoresis (2DE) in a non linear  
range of pH 3-10. About 1050 proteins spots have been 
detected by analysis Image Master 2D platinum software, 
while comparison of each group of pathological samples 
with  respect to  controls (normal parathyroid) showed 
qualitative and quantitative differences of protein 
expression.
Our preliminary results demonstrate the applicability of 
a proteomic approach in the study of parathyroid diseases 
and suggest it as a start point to investigate, the presence 
of potential markers implicated in parathyroid cancer 
progression.  
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Colorectal cancer is the third commonest cause of 
cancer-related death in the western world. Early diagnosis 
and surgical treatment ensure a five-year survival of 70-
90%. It is essential to understand the genetic factors and 
molecular mechanisms that, together with life-style 
related risk factors, cause the development of 
adenomatous polyps and their malignant transformation. 
Molecular diagnostics in cancer patients can be useful for 
prognostic assay and for monitoring response to therapy. 
In this study, we used qRT-PCR to evaluate expression of 
four enzymes of purine metabolism in human intestinal 
biopsy specimens. The enzymes were adenosine kinase 
(AdK: EC 2.7.1.20), adenylate kinase (MK: EC 2.7.4.3), 
adenosine deaminase (ADA: E.C. 3.5.4.4) and 
5’nucleotidase (5’N: E.C. 3.1.3.5). The above quoted 
enzymes are involved in the biosynthesis, interconversion 
and degradation of purine compounds and play important 
functional roles in the life of the cells. The former 
contributes to the steady-state maintenance of adenosine, 
the well known cytoprotective functions of which include 
stimulation of angiogenesis and inhibition of inflammatory 
reactions. 5’N is considered to be a key enzyme in the 
generation of adenosine, a potential vasodilator; ADA 
seems to be associated with the differentiation of 
epithelial cells; MK equilibrates the adenylate energy 
charge and AdK, together with ADA, controls adenosine 
concentration. The four enzymes may play major roles in 
tumor progression and their expression may be a 
sufficiently accurate prognostic indicator for individual 
colorectal cancer patients. 
We analysed 30 patients (15 males and 15 females, 
age 48-82 years) classified according to cancer location 
and TNM staging. Fragments of neoplastic and normal-
appearing mucosa close to (less than 3 cm) and distant 
from (at least 10 cm) the tumour were removed during 
surgical resection and immediately placed in RNA-later 
solution. Quantitative mRNA expression levels were 
normalized against the reference gene ?-actine, which 
showed minimal variation between paired normal colon 
and cancer tissue and the analysis for relative gene 
expression was carried out using the 2-DDCt method. 
The obtained results clearly show that AdK1, ADA and 
5’N gene expression were significantly higher in cancer 
tissues than in normal-appearing mucosa, while MK did 
not vary; a similar trend was previously observed 
assaying the enzymatic activity of the enzymes in the 
same pathology2. AdK significantly vary according to 
tumor position and with the progression of the disease. 
These interesting findings represent a novel approach to 
monitoring tumor progression and contribute to enlarge 
our knowledge on purine metabolism in cancer. 
1. Giglioni S. et al. (2008) Nucleosides Nucleotides and 
Nucleic Acids, in press. 
2. Vannoni D. et al. (2004) Med Oncol.; 21(2):187-95. 
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The efficacy of antiplatelet therapy to prevent 
cardiovascular and athero-thrombotic events in patients 
underwent percutaneous coronary intervention (PCI) has 
been demonstrated by different clinical trials. 
Nevertheless at this time 10-20% of patients treated with 
clopidogrel and/or aspirin seems to not take advantage 
from this therapy and occur in thrombotic events in the 
first year of follow-up. This phenomenon, that has been 
called “resistance”, usually is connected with a persistent 
hyper-activation at platelet level. 
With the aim to investigate the potential causes of this 
“resistance” and the physiopathological mechanisms 
responsible of platelet function, in this study, for the first 
time, we used a proteomic approach to compare 
expression changes in protein patterns of platelets from 
patients with stable coronary ischemic disease before PCI 
(T0), 12 h after 600 mg of clopidogrel (T1) and 24 h after 
PCI (T2). 
Twenty patients with stable angina taking aspirin (100 
mg/die) for at last a month were enrolled in the study. 
Blood samples from patients were collected and 
processed to obtain platelet isolation and purification. The 
proteins profile of platelets was obtained for each sample 
by two-dimensional electrophoresis (2DE) and the 
difference of proteins expression of platelets obtained 
from patients at different times was evaluated using 
Image-Master 2D Platinum. Approximately 1000 protein 
spots on each gel using an ammoniacal-silver staining 
were detected. Quantitative and qualitative differences 
were found from comparison of synthetic gels obtained 
from each group. Our results suggest that the platelet 
proteomic profile can be used not only to evaluate the 
platelet activation state and the potential drug target 
proteins but also to investigate the mechanisms 
responsible of the antiplatelet drugs “resistance”. 
11.10 
DEHYDROEPIANDROSTERONE INHIBITS PLATELET 
AGGREGATION WITH A  cGMP-DEPENDENT 
MECHANISM 
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Dehydroepiandrosterone (DHEA) and its sulfate ester 
(DHEA-S) are the major circulating steroid hormones in 
humans and serve as precursors to both androgens and 
estrogens. Epidemiological studies suggest that high 
concentrations of DHEA(S) play a protective role against 
atherosclerosis and coronary artery disease. Accordingly, 
in vitro DHEA(S) stimulates NO production by endothelial 
cells, and platelets from DHEA treated patients contain a 
higher amount of cGMP, marker of platelet inhibition. 
Pioneering studies showed that DHEA(S) inhibited 
arachidonate-dependent platelet aggregation. The aim of 
this study was to investigate in vitro the effect of DHEA(S) 
on human platelets and to characterize the signal 
transduction pathways involved. Gel-filtreted platelets 
were incubated with different concentrations of DHEA-S 
or pre-incubated with DHEA-S and then stimulated with 
different doses of agonists.  We found that DHEA-S 
inhibited the aggregation induced by thrombin in a dose-
dependent manner. This effect was due to DHEA and not 
to DHEA-S, as demonstrated by the treatment of platelets 
with the sulphatase inhibitor Estrone Sulphamate that 
prevented the DHEA-dependent inhibition of aggregation 
of thrombin-stimulated platelets. The signal transduction 
pathways triggered in human platelets by DHEA were 
investigated in immunoblotting experiments. We found 
that DHEA caused inhibition of thrombin-induced 
activation of ERK1/2 and Akt, however this effect was 
observed only when DHEA was added to platelets few 
seconds before thrombin and not for longer treatment of 
platelets with the hormone. DHEA caused in platelets a 
rapid and dose-dependent VASP phosphorylation on 
Ser239, but not on Ser157. This finding suggests that 
DHEA activates guanyly cyclase and cGMP-dependent 
PKG in platelets, presumably with a NO-dependent 
mechanism. In fact in DHEA-S-treated platelets a 
significant increase of cGMP was detected, whilst 
intracellular cAMP levels remained unchanged with 
respect to the control. However, the NOS inhibitors L-
NMMA and L-NAME did not prevent DHEA-dependent 
inhibition of platelet aggregation, therefore DHEA caused 
activation of guanyly cyclase with a different mechanism. 
This evidence requires more investigation, however we 
have found that in DHEA-S-treated platelets occurred the 
activation of Src that recently has been proposed  as a 
mechanism alternative to NO to activate guanyly cyclase 
in platelets (1). In conclusion, our results indicate that in 
human platelets DHEA plays an anti-aggregating role 
acting through a cGMP-dependent signal transduction 
pathway.  
Gambaryan S. et al. (2008) Journal of Thrombosis 
and Haemostasis (in press).  
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Oral squamous cell carcinoma (OSCC) is the most 
frequent malignant tumour of the oral cavity with about 
30,000 new cases and 8,000 related deaths per year in 
the United States. Despite refinement of surgical 
techniques and adjuvant therapies, the mortality rate of 
OSCC has shown little improvement over the last three 
decades. The optimal management of cervical lymph 
node metastases is very important to improve survival, 
and the identification of reliable and clinically applicable 
markers which allow their preoperative detection is 
crucial.  
In the present study, we wished to focus on the 
expression of genes critical in the drug metabolism 
process, namely on Nicotinamide N-Methyltransferase 
(NNMT), enzyme belonging to Phase II Metabolizing 
Enzymes and involved in the biotransformation and 
detoxification of many xenobiotics. To explore the 
involvement of  NNMT in OSCC, we analysed the enzyme 
expression in paired tumour (T) and non-tumour (NT) 
tissues obtained at surgery by  semiquantitative RT-PCR, 
Real-Time PCR, western blot and immunohistochemical 
analyses. Compared with normal mucosa, OSCC exhibited 
significantly increased expression of NNMT in 11 of 22 (50 
%) examined patients. Interestingly, NNMT was 
upregulated in most  of the favourable OSCCs (N 0), while 
no marked NNMT expression alterations  between tumour 
and normal mucosa were detected in most of the 
unfavourable OSCCs (N+). Both, pT and pathological 
staging showed an inverse correlation with NNMT mRNA 
levels, and a significant negative association of the amount 
of NNMT expressed by tumour tissue compared to the 
adjacent normal mucosa was found with metastasis 1. To 
observe the effect of NNMT silencing on cell proliferation 
and cell cycle distribution, four shRNA plasmid vectors 
against NNMT were constructed and transfected into 
human oral cancer cell line PE/CA-PJ15. NNMT down-
regulation was detected by Real-Time PCR and western 
blot analysis. The cell proliferation inhibition was 
determined by MTT and soft agar colony formation assays; 
cell cycle distribution and apoptosis were examined by flow 
cytometry. ShRNA vectors targeted against NNMT 
efficiently suppressed gene expression, showing inhibition 
rates around 70 %, observed at both the mRNA and protein 
levels. The shRNA-mediated gene silencing of NNMT 
resulted in a significant rise in apoptosis rate. 
The present data support the hypothesis that the 
enzyme plays a role in tumour expansion, and NNMT 
expression level measurements would provide a rapid 
and useful method of identifying patients at high risk of 
lymph node metastases. Therefore, NNMT may have 
potential as a new prognostic marker, and its inhibition 
could represent a possible molecular approach to the 
treatment of OSCC. 
1. Sartini D et al. (2007) MOL MED 13, 415-421. 
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STREPTOZOTOCIN-INDUCED DIABETES AFFECTS 
TWO REGULATIVE STEPS OF THE CITRATE 
CARRIER GENE EXPRESSION IN RAT LIVER 
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The present study was focused on defining how 
streptozotocin (STZ)-induced diabetes down-regulates 
mitochondrial citrate carrier (CiC) activity and expression 
in rat liver. CiC, an integral protein of the inner 
mitochondrial membrane, plays an important role in 
intermediary metabolism catalyzing the transport of 
acetyl-CoA, primer for both fatty acid and cholesterol 
syntheses, from mitochondria to the cytosol. Male Wistar 
rats (150-200 g) were used throughout this study. 
Diabetes was induced by a single intraperitoneal (i.p.) 
injection to rats of buffered solution of STZ at a dosage of 
70 mg/kg b.w. We showed that in the diabetic rats CiC 
activity was significantly reduced in covariance with those 
of lipogenic enzymes. CiC kinetic characterization 
indicated that diabetes decreased Vmax of this transport 
without affecting Km.
CiC activity, assayed as in1, significantly decreased in 
diabetic rats (approx. 35%)  as compared to control 
animals. The molecular mechanism for the diabetes-
induced CiC modulation was then investigated. We found 
that the decreased CiC activity observed in diabetic 
animals can be most likely ascribed to a lower content of 
both CiC immunoreactive protein and mRNA, measured 
as in1 by RNase protection assays (RPA) and Western 
blotting analysis, respectively. CiC expression changed in 
parallel with those of de novo fatty acid synthesis 
enzymes.  Adenine Nucleotide Translocase, isoform 2 
(ANT2) and porin showed different behaviour.   
The estimated half-life of CiC mRNA was the same in 
the hepatocytes from diabetic and control rats, whereas 
the transcriptional rate of CiC mRNA, tested by nuclear 
run-on assay, decreased by about 30% in the nuclei from 
diabetic vs control rats. In addition, RPA showed that in 
the nuclei of diabetic rats the splicing of CiC RNA is 
affected.  
Finally, the ratio polyadenylated/unpolyadenylated CiC 
RNA as well as the length of the CiC RNA poly(A) tail 
were similar in diabetic and control rats.  
Overall these results suggest that: i) reduced mRNA 
level and the lower content of the mitochondrial CiC 
protein, might account for the decline of CiC activity in 
diabetic animals; ii) CiC expression is affected by 
diabetes at transcriptional and post-transcriptional level; 
iii) diabetes exerts a gene specific effect. 
1. Siculella, L. et al (2006) J. Biol. Chem. 281: 19072-
19080. 
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The mitochondrial DNA (mtDNA) encoded subunit of 
NADH dehydrogenase ND5 is a the largest mitochondrial 
complex I gene and has turned out to be a hotspot for 
mutations in several mitochondrial pathologies including 
Leber hereditary optic neuropathy (LHON)1.
Herein, we present the genetic characterization of a 
patient with an unusual clinical association of optic 
subatrophy and nephropathy. Total DNA was extracted 
from peripheral blood lymphocytes, fibroblasts and skin 
biopsy. The presence of the LHON primary mutations 
(11778/ND4, 3460/ND1, and 14484/ND6) was evaluated 
by RFLP-PCR. Automated sequencing by ABI Prism 310 
Analyzer was performed on overlapping PCR products 
encompassing the entire mtDNA. Haplogroup was 
defined by sequencing analysis. PCR-RFLP assays were 
developed to quantify the novel ND5 mutations versus 
wild-type mtDNA. Skin biopsy was obtained from patient 
to cultivate fibroblast. After excluding the presence of 
primary LHON mutations in the proband, sequencing of 
the entire mtDNA revealed two nucleotide changes, 
A13528G and C13565T, both present also in the mother 
and sister. The same association of ND5 mutations has 
recently been reported in a MELAS patient3.
We present a novel genotype/phenotype correlation in 
a patient who harbors two ND5 mutations on a 
haplogroup U4b mtDNA, suggesting that the overall 
mtDNA background may modulate the penetrance and 
affect the significance of specific mutations. We are 
investigating the enzymatic activities and the membrane 
potential in fibroblasts and transmitochondrial cybrids to 
evaluate the role of the ND5 variants in affecting the 
mitochondrial metabolism. 
1. Taylor et al. Eur. J. Hum. Genet. 2002; 10 (2), 141–
144
2. Liolitsa et al., Ann. Neurol. 2003; 53 (1), 128–132. 
3. McKenzie M. et al., J Biol Chem. 2007; 
282(51):36845-52 
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Introduction. Leber Hereditary Optic Neuropathy (LHON) 
is a maternally inherited disorder characterized by loss of 
central vision and optic atrophy, affecting most frequently 
young males. Classical LHON phenotype is associated to 
three primary mitochondrial DNA (mtDNA) mutations 
mostly homoplasmic in ND1, ND4 and ND6 genes, 
encoding for complex I subunits of respiratory chain1. The 
syndromic form of this mitochondrial disorder, referred to 
as LHON “plus” phenotype, can occur with variable 
involvement of peripheral and central nervous systems 
and of cardiac and skeletal muscle. It has been 
hypothesized that the 3460/ND1 primary mutation, when 
associated with specific cytochrome b (cytb) variants, 
may contribute to the clinical expression of LHON “plus” 
phenotype2. In the present work we report on a 3460 
LHON plus family, characterized by mental retardation 
and epilepsy as extra-ocular features. 
Material and Methods. Total DNA samples were 
extracted from peripheral blood lymphocytes. LHON 
mutations was screened by RFLP-PCR analysis. 
Haplogroup assignment was carried out by sequencing of 
mitochondrial marker regions by ABI PRISM 310 
sequencing analysis system. 
Results and Conclusion. Family members harbour the 
3460 mutation partly in homoplasmy and partly in 
heteroplasmy according to the severity of symptoms. 
Polymorphisms analysis assigned our family to the 
haplougroup U4. Cytb gene sequence revealed the 
presence of the T15693C variant. Sequencing of the 
entire mtDNA will be performed on skeletal muscle biopsy 
from the proband to evaluate other possible variants in 
mitochondrial genes acting synergistically with the 
3460/ND1 mutation. 
1. Carelli V. et al. Prog Retin Eye Res 2004; 23:53-89; 
2. La Morgia C. et al. Neurology 2008; 70(10):762-70. 
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The mitochondrial oxoglutarate carrier (OGC) catalyzes 
the transport of 2-oxoglutarate across the mitochondrial 
inner membrane in exchange for malate, or other 
dicarboxylates, and belongs to a large family of related 
transport proteins called the mitochondrial carrier family 
(MCF). The primary structures of the family members are 
made up of three tandemly-repeated homologous 
domains of about 100 amino acids in length, each 
containing a characteristic sequence motif and two 
hydrophobic stretches1. No 3D structure is available for 
OGC yet, but several spectroscopic and functional studies 
have unveiled some of its features. An important 
contribution to the description of the structural 
characteristics of MCF has been provided by EM studies 
on two dimensional crystals of yeast ADP/ATP carrier 
(AAC)2 and by elucidation of the crystal structure of 
bovine AAC3. The OGC seems to be folded into 6 
transmembrane segments too in the inner mitochondrial 
membrane. Site directed spin-labeling (SDSL) has been 
used to probe the structural and dynamic features of 
residues comprising the sixth transmembrane segment of 
the mitochondrial oxoglutarate carrier. Starting from a 
functional carrier, where cysteines have been replaced by 
serines, 18 consecutive residues (from G281 to I298) 
have been mutated to cysteine and subsequently labeled 
with a thiol-selective nitroxide probe. The labeled 
proteins, reconstituted into liposomes, have been 
assayed for their transport activity and analyzed with 
continuous-wave electron paramagnetic resonance. 
Linewidth analysis, that is correlated to local probe 
mobility, indicates a well defined periodicity of the whole 
segment from G281 to I298, indicating that it has an a-
helical structure. Saturation behaviour, in presence of 
paramagnetic perturbants of different hydrophobicities, 
allow the definition of the polarity of the individual 
residues and to assign their orientation with respect to the 
lipid bilayer or to the water accessible translocation 
channel. Comparison of the EPR data, homology model 
and activity data indicate that the segment is made by an 
a-helix, accommodated in an amphipathic environment, 
partially distorted in the middle at the level of L289, 
probably because of the presence of a proline residue 
(P291). The C-terminal region of the segment is less 
restrained and more flexible than the N-terminus. 
This work puts together another piece of the puzzle in 
the quest for elucidating the structure-function relationship 
of the mitochondrial oxoglutarate carrier. 
1. Palmieri F. (2004) Pflugers Arch. 447, 689–709. 
2. Kunji E.R. and Harding M. (2003) J. Biol. Chem. 278, 
36985-36988. 
3. Pebay-Peyroula E. Dahout-Gonzalez C. Kahn R. 
Trézéguet V. Lauquin G.J. Brandolin G. (2003) Nature 
426, 39-44. 
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Introduction: The effect of amphiphilic non-steroidal anti-
inflammatory drugs (NSAIDs), like Ibuprofen (Ibu) a white 
insoluble powder with pKa = 4.31, on liposomal bilayer as 
biomembrane model, plays a crucial role in understanding 
their mechanism at the molecular level1. To explain their 
activity and correlate it with the chemico-physical 
properties of the drug, the thermal behaviour of the 
hydrated multilamellar vesicles (liposomes) of 
dimyristoylphosphatidylcholine (DMPC) in the presence of 
increasing amounts of both Ibu as well of its Na-salt (Na-
Ibu) have been studied at pH = 3.0 and at pH = 7.0 by 
means of Differential Scanning Calorimetry (DSC) 
technique. 
Materials and METHODS: Liposomes were prepared 
by mixing the appropriate amount of  Ibu or Na-Ibu with 
DMPC in a NaCl 0.9 % w/w solution buffered at the 
request pH value up to a final lipid concentration of about 
20 % w/w. DSC scans were performed on a Mettler-
Toledo DSC 821e calorimeter at a heating rate of 
2.0°C/min. 
RESULTS: The results on Ibu/DMPC liposomes at pH = 
3.0 show significant Tm decrease and a ΔT1/2 increase when 
Ibu si added, suggesting that the hydrophobic core is 
strongly affected by the presence of the drug unionized 
molecules. Moreover, in the samples where Ibu content is 20 
% w/w, the transition disappeared. The ΔH behaviour is more 
complex; indeed initially, up a 2.0 % w/w of added 
substance, it increases and successively, up to 20 % w/w Ibu 
content, its values decreased lineally. On the contrary, the 
measurements on the Ibu/DMPC systems at pH = 7.0 
showed noticeably lower values both in Tm decrease as well 
as in ΔT1/2 increase, suggesting that the hydrophobic core is 
not so strongly affected by the presence of Ibu as it was at 
pH = 3.0.  Moreover the transition is present at any Ibu 
concentration up to 30 % w/w and also ΔH increased up to 
20 % w/w system, decreasing only in the most concentrated 
Ibu containing sample (30 % w/w). Similar results were 
obtained starting from the very soluble Na-Ibu salt. 
The data suggest that the interaction Ibu-liposomes is 
strongly pH-dependent, suggesting that at pH lower than 
pKa the interaction involves mainly the deeper part of the 
bilayer. On the contrary, when pH is greater than pKa, the 
setting up of strong electrostatic interactions between the 
negative ion on Ibu molecule and the polar moiety of the 
lipid localize the interaction on the external part of the 
bilayer. Moreover, the obtaining of the same results even 
starting from Na-Ibu water solution, confirm the capability 
of the of liposomes to strip the drug molecules out from 
water and concentrate within the bilayer. 
The perturbing effect of Ibu on the membrane 
structure would alter, indirectly, the function of the 
membrane proteins, whose function is highly dependent 
on the membrane structure. 
1. H. Lygre et al.,Acta Odontol. Scand. 61 (2003) 303. 
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OPA1 is an intra mitochondrial dynamin showed to be a 
major regulator of pleiotropic mechanisms associated to 
mitochondrial inner and outer membrane dynamics1.
Eight OPA1 isoforms resulting from alternative splicing 
combinations of exon 4, 4b and 5b have been described. 
The different spliced exons encode domains included in 
the N-terminal region and contribute to determine OPA1 
functions2.
Similarly to its yeast orthologue protein mitochondrial 
genome maintenance-1 (Mgm1), OPA1 is relevant for 
mitochondrial network dynamics and for cristae 
structuring3, 4. But to date, there is no clue suggesting that 
OPA1, as Mgm1, might be involved in human 
mitochondrial DNA maintenance5.
Using a siRNA approach, cell biology and quantitative 
PCR, and analysing HeLa cells, we show that a specific 
OPA1 isoform is involved in mtDNA maintenance. 
Silencing of this variant is responsible for mtDNA 
depletion and its abundance correlate to the amount of 
mtDNA. Furthermore this variant is responsible for mtDNA 
distribution into the mitochondrial network. Interestingly 
we evidenced that the N-terminal region of OPA1 is 
important for this function.  
So, in addition to the recent discovery linking mutation 
of OPA1 GTPase domain to mtDNA deletion6,7, our data 
suggest that mutation in OPA1 can be responsible for 
mtDNA depletion syndromes, and that OPA1 plays a 
fundamental role in mitochondrial genome maintenance. 
1. Chen et al., 2005, Hum. Mol. Genet. 14: 283-289 
2. Olichon et al., 2007, Cell Death Differ. 14: 682-692 
3. Olichon et al., 2003, J. Biol. Chem. 278: 7743-7746 
4. Frezza et al., 2006, Cell 26: 177-189 
5. Herlan et al., 2003, J. Biol. Chem. 278: 27781-27788 
6. Amati-Bonneau et al. 2008, Brain 131: 338-351 
7. Hudson et al., 2008, Brain 131: 329-337 
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Bcl-2 protects cells from apoptosis and necrosis, although 
the molecular mechanisms by which it mediates cell 
survival are not well defined. Bcl-2 can regulate the 
mitochondrial metabolism and its overexpression has 
been reported to significantly improve oxidative 
phosphorylation in cells bearing pathogenic mitochondrial 
DNA mutations1.
Furthermore, Bcl-2 was shown to display an 
antioxidant action, inhibiting mitochondrial dysfunction 
and cell death elicited by GSH-depleting reagents2.
Finally, Bcl-2 has also been reported to stabilize 
microtubule network3.
Here we have investigated the effect of Bcl-2 
overexpression in XTC.UC1 cells bearing a disruptive 
mutation in the ND1 subunit of complex I leading to a 
severe energetic impairment4. When forced to use 
exclusively oxidative phosphorylation for energy 
production by inhibiting glycolysis, these cells triggered a 
caspase-independent cell death pathway, which was 
associated to a significant imbalance in glutathione 
homeostasis and a cleavage of the actin cytoskeleton. 
Overexpression of the antiapoptotic Bcl-2 protein 
significantly increased the level of endogenous reduced 
glutathione, thus preventing its oxidation after the 
metabolic stress. Furthermore, Bcl-2 completely inhibited 
actin cleavage and increased cell adhesion, but was 
unable to improve cellular viability. Similar effects were 
obtained when XTC.UC1 cells were incubated with 
exogenous GSH. We hence propose that Bcl-2 can 
safeguard actin cytoskeleton stability through an 
antioxidant function. 
1. Manfredi et al. 2003, J. Biol. Chem. 278, 5639-5645. 
2. Zimmermann et al., 2007, J. Biol. Chem. 282, 29296-
29304. 
3. Haldar et al. 1997, Cancer Res. 57, 229-233. 
4. Bonora et al., 2006, Cancer Res. 66, 6087-6095 
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Lipid rafts (LRs) are detergent-resistant microdomains 
containing glycosphingolipids, cholesterol and 
glycosylphosphatidylinositol-linked proteins; they seems 
to be actively involved in many cellular processes 
including signal transduction, apoptosis, cell adhesion 
and migration1.
Membrane lipid rafts may represent the important 
functional platforms by which redox signals are produced 
and transmitted in response to various agonists or stimuli. 
In addition, a new concept is emerging that could be used 
to define the interactions or amplification of both redox 
signalling and lipid raft-associated signalling. This concept 
is characterized by redox-mediated feed forward 
amplification in lipid platforms. It is proposed that lipid 
rafts are formed in response to various stimuli; NAD(P)H 
oxidase subunits are aggregated or recruited in these 
platforms, increasing Nox activity. Superoxide and 
hydrogen peroxide generation could induce various 
regulatory activities, for instance the induction of further 
lipid-raft platforms formation. 
The aim of our study is to probe the involvement of 
lipid rafts in the modulation of the glucose transporter 
Glut1 and NAD(P)H oxidase activities of human acute 
leukaemia cells, where a direct correlation between Nox-
derived ROS and glucose uptake is already established, 
as we previously published2,3.
At first, we performed a sucrose density gradient 
centrifugation of the cell lysates, and collected the 
subcellular fractions. Flotillin-2, which is strongly 
associated with LRs, was considered as the LRs marker 
protein1.
To investigate the potential functional role of LRs in 
the regulation of NAD(P)H oxidase and Glut1 activities, 
methyl-β-Cyclodextrin, a well-established cholesterol 
depleting reagent, was used to disrupt lipid rafts. 
Our findings suggest that the important role played by 
Nox-derived ROS in the regulation of glucose uptake and 
proliferation of leukaemia cells could likely occur through 
the control of lipid-raft-associated signalling and therefore 
they may hint at novel targets for cancer treatment. 
1. Pike LJ J Lipid Res. (2003) 44(4):655-67. 
2. Fiorentini D, Prata C, Maraldi T, Zambonin L, Bonsi L, 
Hakim G, Landi L. Free Radic Biol Med. (2004) 
37(9):1402-1411. 
3. Prata C, Maraldi T, Fiorentini D, Zambonin L, Hakim 
G, Landi L. Free Radic Res. (2008) 42(5):405-414. 
This work has been supported by MIUR (PRIN) and 
Fondazione Cassa di Risparmio di Cento (Italy) 
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Introduction: The cellular metabolism has to adapt to 
several changes for energetic demand. In this work, the 
effects of serum modulation upon signal transduction 
systems (NF-kB and c-Jun pathways), respiratory chain 
protein expression, enzymes activity and ROS generation 
in human fibroblasts, were studied. 
Material and Methods: Cells were serum starved 3 
days to induce metabolic quiescence and to synchronize 
cell cycle as shown by growth curve analysis. 
Reintroduction of serum in the culture medium was 
followed by functional changes which appeared to be 
associated with transcriptional and post-translational 
events. The possible involvement of cAMP signalling, was 
analysed using PKA inhibitor H89. 
Results: Results show that serum starvation caused a 
significant inactivation of NF-kB pathway. Confocal 
microscopy analysis revealed that NF-kB migrated from 
cytosol to nucleus after 1 hour of serum induction; c-Jun, 
instead, showed an opposite behaviour. 
Time-course measurement of enzymatic activities (6, 
12, 24, 48 hours) of citrate synthase and respiratory chain 
complexes I and IV in serum-induced cells showed an 
increase in complex I activity after 24 hours. Western-blot 
analysis in both whole cell lysate and in mitoplast fraction 
resolved by Blue native/ SDS PAGE showed that  the 
increased activity was accompanied by an enhanced 
expression of complex I subunits (39 kDa and GRIM 19) 
after 24 hours. 
In serum-induced cells treated with H89 we found no 
induction of complex I subunits, showing a role of NF-kB 
pathway in complex I subunits expression which is under 
control of growth factors and cAMP cascade. In fact is 
reported that NF-kB phosphorylation by PKA was 
essential for NF-kB transactivation and DNA binding. 
Conclusions: The early activation of NF-kB, which was 
obtained with serum induction treatment, promotes cell 
survival, cell growth and also interfere with ROS induction 
and JNK signalling. NF-kB pathway may regulate 
complex I activities and biogenesis, possibles by 
enhancing Tfam transcription cAMP signal can play a role 
in regulation of complex I activity both at transcriptional 
level as well as post-translational. 
1. Herzig R. and Scarpulla R.C. (2000). J. Biol. Chem. 
275, 13134–13141. 
2. Bubici C. et al. (2004). Cell Cycle. 3(12), 1524-1529. 
3. Papa S. et al. (2004). Cell Death and Differ. 13(5): 
712–729. 
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INTRODUCTION. D-AKAP1 (also known as AKAP1, S-
AKAP84, AKAP121 and AKAP149) focuses distinct 
signalling events by binding and targeting cAMP-
dependent protein kinase (PKA), protein tyrosine 
phosphatase (PTPD1), and mRNA1,2; variation in the N-
terminus can alter the localization of D-AKAP1 to either 
ER or mitochondria thereby changing the distribution of 
PKA in the cell3,4.
It is note that AKAP149, AKAP121, and AKAP84 arise 
from a single gene by alternative mRNA splicing through 
a fine mechanism of gene expression1,5. In the present 
work, we show a preliminary study on the expression of 
this gene and the localization of protein in different 
subfractions of HeLa and HepG2 cells.  
METHODS. HeLa and HepG2 cells were grown in 
supplemented DMEM. Total RNA was extracted and 
reverse transcribed. RT-PCR was performed with specific 
primer. To silencing D-Akap1 gene, cells were transfected 
with four plasmid pLKO.1-puro clones that allow 
expression of four different shRNAs. Proteins 
AKAP121/149 and AKAP84 were analyzed by Western 
blot with specific antibodies. 
RESULTS AND DISCUSSION. D-Akap1 gene 
produces only the transcript encoding for the protein 
AKAP121/149. RT-PCR showed, infact, that the transcript 
corresponding to AKAP121/AKAP149 was expressed at 
significantly level in the cells analyzed. On the contrary, 
low level of the transcript corresponding to AKAP84, was 
detected. In addition, western blotting analysis, revealed 
only the AKAP121/149 protein band in both HeLa and 
HepG2 cell lines, which is associated to the mithocondrial 
membranes. Silencing showed that this protein is 
essential for the viability of both cell lines. 
Further investigations will be direct to elucidate the 
role of AKAP proteins on the mitochondrial function. 
1. Chen Q., et al. J. Biol. Chem. (1997); 272, 15247-
51527
2. Livigni A., et al. Molec Biology of the Cell (2006); 17, 
263-271 
3. Sardanelli A.M., et al. FEBS Lett. (2006); 
580(24):5690-5696 
4. Ma Y., Taylor S.S. J Biol Chem. (2008); 
283(17):11743-51 
5. Carlucci A., et al. EMBO J. (2008); 27(7):1073-84 
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INTRODUCTION. Genetic deficiency of complex I is a 
most frequent case of inborn mitochondrial disease. This 
study reports the cases of three patients with pathological 
deficiency of complex I. The first patient has a 
pathological intronic mutation IVS1nt-1,G >A in the ndufs4
gene, which causes the transcription of a shorter mRNA, 
without the exon 2, non coding for a functioning protein. 
The other two patients, K and C, have no pathological 
mutations in all 46 CI subunits nor in CI assembly factors 
known at the moment.  
In these patients we have analyzed the assembly 
state, the protein profile and the activity of complex I. 
METHODS: All measurements and analysis were 
carried out on patient fibroblasts. Respiratory complexes 
activities were assayed as in2;  protein content of 
respiratory chain was evaluated by BN/SDS PAGE of 
mitoplast fraction as described in2; mitochondrial 
proteolysis was analyzed by LSCM following the 
degradation of calpain-specific substrate SLLVY-AMC1.
RESULTS: 2D electrophoresis showed in patient ndufs4
IVS1nt-1,G >A the lost of a normally assembled CI and a 
small amount of CI subcomplex (39kDa, 20kDa and Grim-
19), while patients K and C have a significant decrease of 
the content of normally assembled and immunodetectable 
complex I (39kDa, 20kDa, 17kDa) which was more severe in 
one of two brothers (patient C). In all patients, a marked 
decrease of complex I activity was found, in particular patient
ndufs4 IVS1nt-1,G >A CI activity was almost lacking. 
While for ndufs4 IVS1nt-1,G >A patient the lost of the 
enzymatic activity was attributable to the missing of the wild 
type NDUF4 protein, causing CI misassembly, for patient K 
and C the  explanation was more difficult. Treatment of 
patients K and C cell culture with protease inhibitors 
prevented the decrease of the assembled complex I and 
restored the enzymatic activity. Using the peptide probe 
SLVVY-AMC, whose fluorescence emission of proteolytic 
product is used to measure the activity of calpains and other 
chemotrypsin-like enzymes, we found a significant 
production of the fluorescent proteolytic product of the probe 
essentially localized at the mitochondrial level. This data 
indicated that the decrease of the functional and structural 
level of complex I in the two patients can be due to an 
enhanced proteolytic cleavage of the complex, even if further 
investigations are necessary to identify the gene responsible 
for the decreased stability of complex I. These data indicate 
that genetic and pathogenetic mechanisms of hereditary 
dysfunction of complex I can be divided in two types. The 
first type includes mutations in assembly factors and in 
structural subunits, both mitochondrial and nuclear, the 
second type, mutations or altered functioning of proteases, 
causing compex I instability. 
1. D. D. Arrington et al. (2006). Am J Physiol Cell Physiol 
291:1159-1171. 
2. Iuso el al. (2006). J.Biol. Chem. 281:10374-10380. 
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Introduction. The N-arachidonyl-amino acids (NAAAs) are 
a recently characterized family of arachidonic acid 
derivatives that include N-arachidonyl-glycine (NA-Gly), 
N-arachidonyl-alanine (NA-L-Ala) and N-arachidonyl-γ-
aminobutyric acid (NA-GABA). These compounds are 
structurally related to anandamide (arachidonyl-
ethanolamine) which is considered an endogenous ligand 
of cannabinoid receptor. NA-Gly is present at relatively 
high levels in the spinal cord, small intestine, kidneys and 
at lower, but remarkable, levels in testes, lungs and liver. 
This wide distribution suggests multiple functions, in 
addition to the reported anti-inflammatory and pain 
suppression action (Huang et al, J. Biol. Chem. 276, 
2001, 42639-44). Here we report on the interaction of NA-
Gly with isolated rat liver mitochondria. 
Materials and methods. The respiratory activity of liver 
mitochondria was measured polarographically with a 
Clark-type electrode. The membrane potential in intact 
mitochondria was measured following the safranin-O 
fluorescence quenching at 525 nm (excitation), 575 nm 
(emission). ROS production was detected 
spectrofluorimetrically using  the oxidation-sensitive dye 
DCF-DA. 
Results. Micromolar concentrations of NA-Gly cause: 
i) a substantial increase of state 4 respiration with both 
glutamate + malate and succinate as substrate; ii) a 
decrease of ADP or CCCP stimulated respiration with a 
consequent drop of the respiratory control ratio. The 
membrane potential generated by either succinate 
oxidation or ATP hydrolysis was only weakly dissipated 
by NA-Gly concentrations increasing state 4 respiration. 
Experiments are also presented showing that NA-Gly 
caused a respiration dependent large ROS production 
and cytochrome c release. 
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Introduction The cAMP cascade regulates a variety of 
cellular processes such as the utilization of glycogen and 
lipid stores, neuronal activity, transcription of specific 
genes, cell proliferation, differentiation and death. It has 
been shown that the increasing of cellular cAMP in 
various serum-limited (SL) cell cultures stimulates the 
complex I activity and reverts ROS accumulation1.
Oxidative stress can regulate protein thiols redox state 
and it is reported that the complex I activity is also 
modulated by glutathionylation. In this work we 
investigated the modulation of complex I activity by 
modulation of β-adrenergic signalling pathway and we 
examined the involvement of glutathionylation in cAMP-
dependent complex I activity and ROS removing effect. 
Materials and methods The NADH–UQ 
oxidoreductase and cytochrome c oxidase activities were 
determined spectrophotometrically. ROS production was 
measured by DCF-DA. Glutathionylation was analyzed 
using GSH-antibody.  
Results and Discussion The activation of the β-
adrenergic receptor by isoproterenol (ISO) reverted the 
accumulation of H2O2 and depression of complex I activity 
in serum-limited fibroblasts (NHDF-neo). Treatment of 
cardiomyocytes H9c2 with isoproterenol promotes 
complex I activity and basal ROS reduction; pre-exposure 
of H9c2 to β1-blocker metoprolol abolished this effect. 
Howewer, direct treatment with β-blockers metoprolol and 
propranolol promoted enhanced complex I activity and 
ROS reduction, probably due to their antioxidant activity2.
The analysis by 2D-electrophoresis of the complex I 
subunits in mitoplast isolated from NHDF-neo cells in 
exponential growth phase, serum limited and serum 
limited treated with bcAMP with anti-GSH antibody 
revealed that the glutathionylation not influence cAMP 
activation of complex I. In conclusion our data show that 
the activation of complex I and prevention of oxygen free 
radicals production is not due to changes in the 
glutathionylation of the complex. On the other hand these 
effects of cAMP can be associated with phosphorylation 
of structural subunits of complex I.   
1. Piccoli, C. et al (2006) FEBS Lett. 580: 4539–4543. 
2. Gomes, A. et al (2006) Bioorganic & Medicinal 
Chemistry 14: 4568–4577. 
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INTRODUCTION: All-trans-retinoic acid (RA), a 
metabolite of vitamin A, binds to specific nuclear 
receptors, induces expression of various genes, and 
inhibits growth of certain types of cancer1-2. The product 
of the gene GRIM 19 is a component of complex I that is 
essential for the assembly of complex I and the integrity 
of the whole mitochondrial electron transfer chain3-4. In 
this work the effect of all-trans-retinoic acid (ATRA) on 
cellular growth and complex I activity, of human 
keratinocytes are presented. 
MATERIAL AND METHODS: Cells were treated up to 
72 hours with 20?M ATRA and/or protease inhibitors. The 
dynamics of complex assembly was examined using 2D 
Blue Native/SDS PAGE of mitoplasts from cultured cells. 
RESULTS AND DISCUSSION: Keratinocytes 
treatment with RA resulted in a strong depression of cells 
growth. A decrease of the catalytic activity of NADH-UQ 
oxidoreductase in RA treated cells was also found. 
Cytocrome c oxidase and citrate synthase activities were 
not affected by RA treatment. 
2D Blue-Native/SDS PAGE of mitoplast fraction 
revealed, on the other hand,  significant increase in the 
level of GRIM-19 as well as of the overall complex I. Cell 
treatment  with RA had no effect on the level of complex 
III, IV and V. 
Treatment with protease inhibitors resulted in an 
electrophoretic pattern similar to that of retinoic acid 
treatment. The present result indicate that the enhanced 
level of the GRIM-19 and depression of complex I activity 
caused by ATRA result from defective proteolytic 
degradation of damage unproductive subunits of the 
complex. The consequence of complex I increased 
stability and decreased turnover could lead to the 
accumulation of an “aged” enzyme exhibiting lower 
functional activity. Balance between life and death might 
depend on the ability of the cells to sustain activation of 
transcription factor of the NF-kB family5. We observed 
activation of NF-kB by retinoid acid which could lead to an 
extension of the cellular life possibly related to JNK 
deactivation. 
1. Kunee, G.A. et al. 1993. Nutr. Cancer, 20: 61-70.   
2. Papa F. et al. 2007. Int. J. Imm. Pharm., 20(4):719-29. 
3. Huang G. et al. 2004. Mol Cell Biol., 24(19):8447-56.  
4. Lu H.,Cao X. 2008. Mol. Biol. Cell., 19(5):1893-902. 
5. Huang G. et al. 2007. Cell Death Differ., 14(2):327-37. 
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Studies of the last 15 years showed the presence in 
plasmamembrane of lipid domains, restricted areas 
having lipid and protein composition different from the 
environment. Two types of lipid microdomains coexist in 
non-neural cells: caveolae, flask-shaped invaginations of 
plasma membrane rich in caveolin (cav-1) and lipid rafts, 
highly dynamic heterogeneous structures rich in 
cholesterol and GPI-anchored proteins. In different 
mammalian species, in sperm plasma membrane coexist 
both type of microdomains and a recent work (Cross, 
2004) shows their role in “capacitation”, process 
indispensable for sperm maturation. This process is also 
regulated by receptors like CBR1 (cannabinoid receptor 
1) and VR1 (vanilloid receptor 1), that respond to 
endocannabinoids. 
The aim of this work was to investigate lipid 
microdomains organization in sperm during capacitation 
in order to assess if their molecular composition, in 
particular CBR1 and VR1 receptors, changes. 
Semen samples were collected from 3 boars of 
proven fertility. After remove of seminal plasma, the 
sperm sample was immediately processed for 
biochemical analysis (NC sperm) or was diluted in TCM 
199 to a final concentration of 2x108 spermatozoa/ml to 
reach in-vitro capacitation (C sperm). The incubation was 
carried out at 38.5°C in 5% CO2 humidified atmosphere 
for up to 4 h. Successively the detergent-resistant 
membrane fraction (DRM), that includes caveolae and 
lipid rafts, was prepared (Palestini et al., 2000). We 
determined the protein content in DRM by SDS-PAGE 
followed by WB and lipid composition (Cholesterol and 
GM1) by TLC. 
The total protein content in DRM increase after 
capacitation but the protein markers of  microdomains, 
cav-1, CD55 and flot-2 are not enriched in DRM, and 
these proteins are present also in the other fractions of 
the gradient. We found an acrosomal marker in different 
fractions of  the gradient, including DRM, indicating that 
this distribution is the cause of the presence of cav-1, flot-
2 and CD55 in all the gradient fractions. CB1 and VR1 are 
present in DRM and their content increase after 
capacitation, suggesting a shift of CBR1 and VR1 from 
fluid membrane areas to domains. Conversely, the total 
amount of cholesterol and GM1, after capacitation, 
decreases significantly in DRM. The modification of DRM 
in sperm plasma membrane after capacitation and in 
particular the increase in endocannabinoid receptors, 
indicate an important role of these microdomains in 
signalling events that induce capacitation. Moreover, it is 
possible that these series of events are extended also to 
the acrosomal membrane, like it is testified from the 
variation in DRM of the acrosine amount. In conclusion, it 
is possible to suppose that the DRM molecule reshaping 
has a crucial function in the fusion process between 
plasma membrane and acrosome, crucial phase and real 
functional end-point of the capacitation. 
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Uncoupling proteins (UCPs) are carrier proteins that 
uncouple the electron transport chain from ATP synthesis 
localized in the inner mitochondrial membrane. Five UCP 
homologues (UCP1–UCP5) are present in mammals1.
Apart from UCP1, which is involved in thermogenesis, the 
physiological role of UCP isoforms is unclear. UCP3 has 
recently been implicated in fatty acid transport and 
metabolism. In fact, it promotes β-oxidation and reduces 
their storage. Therefore, UCP3 has been proposed as a 
candidate gene for susceptibility to obesity2. Thus far, no 
data have been reported about UCP3 mutations 
associated to obesity in humans. We recently identified 
four novel mutations in the heterozygous state in 200 
severely obese (BMI-SDS>2.5) children with early-onset 
obesity (<4 y) living in Southern Italy: three missense 
mutations V56M, A111V, V192I, and one non-sense 
mutation, Q252X, that generates a truncated protein. 
Here we report preliminary results of an in vitro functional 
analysis of the V56M, V192I and Q252X mutant proteins.
Constructs expressing human UCP3 cDNA wt and 
mutants were transiently transfected in HEK 293 cells, 
which lack endogenous UCP3. Wt and mutant UCP3 
proteins were correctly localized in mitochondria as 
assayed by western blotting experiments. The activity of 
wt and mutant UCP3 was indirectly measured by 
incubating cells with a 100 ?M palmitic acid mix 
containing 16.7 ?Ci/ml of 3H-labeled palmitic acid for 2 h 
with and without mitochondrial fatty acid oxidation 
inhibitors. 3H-labeled water, produced by palmitate 
oxidation, was collected and counted in a scintillation 
counter (3). Mutants V192I and Q252X retained only 40% 
of wt protein activity and V56M only 20%. Interestingly, 
children carrying mutations V192I and Q252X had a 
higher respiratory quotient at rest (0.9 and 1.05 
respectively) than obese children without UCP3 mutations 
(0.85). Therefore, it appears that carbohydrates are used 
more than fatty acids in the metabolic mixture. 
Furthermore, children carrying mutations V56M and 
Q252X have mild steatosis, which suggests an increase 
in fat storage. Further experiments are underway to better 
clarify the involvement of UCP3 in fat storage. 
1. Yu XX et al. FASEB J (2000);14:1611-18 
2. Hesselink MK et al. Obes Res (2003);11:1429-43 
3. Narayan SB et al. Clin Chem (2005);51:644-46 
Grants: Regione Campania (G.R. 20/12/2004 N. 2495, LR 
n. 5/2002); Ministero Istruzione Università e Ricerca 
Rome (PRIN 2004); Fondazione SDN-IRCCS, Napoli, 
Italia 
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Besides the “liquid state” model for the organization of the 
respiratory chain, depicting the redox enzymes as 
complexes independently embedded in the lipid 
membrane bilayer, another condition can be envisaged 
based on direct channelling between the redox enzymes 
(“solid state”) since stable multicomplex units have been 
observed in several mitochondrial species1.
Considering the lack of functional data, here we report 
our efforts to understand the physiological implications of 
the existence of supercomplexes. Particularly, we 
address the problem in mitochondria (POM) from freshly 
harvested potato tubers (Solanum tuberosum) by 
focusing on the kinetic properties of the respiratory 
complexes involved in the NADH- and succinate-
dependent respiration.  
For the first time, we show that all the enzyme steps in 
the rotenone-sensitive respiratory machinery in POM 
exert the same metabolic control and that their flux 
coefficients are close to unity (1.0, 1.1, 1.2 for Complex I, 
Complex III and Complex IV, respectively) therefore we 
can demonstrate that, contrarily to animal mitochondria2,
the respiratory complexes behave as a functional 
supramolecular unit where, according to the principles of 
the Metabolic Control Analysis3, also Complex IV 
molecules are included. Furthermore, we discuss the 
presence of alternative dehydrogenases as functionally 
independent components not comprised in the 
supercomplex assembly. 
1. Lenaz, G., and Genova, M. L. (2007) Kinetics of 
integrated electron transfer in the mitochondrial 
respiratory chain: random collisions vs. solid state 
electron channeling. Am. J. Physiol. Cell Physiol. 292, 
C1221-1239. 
2. Bianchi, C., Genova, M. L., Parenti Castelli, G., Lenaz, 
G. (2004) The mitochondrial respiratory chain is 
partially organized in a supercomplex assembly: 
kinetic evidence using flux control analysis. J Biol 
Chem. 279, 36562-36569. 
3. Kholodenko, N. B., and Westerhoff, H.V. (1993) 
Metabolic channelling and control of the flux. FEBS
Lett. 320, 71-74. 
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CHANGES IN MEMBRANE PHOSPHOLIPIDS 
COMPOSITION AFFECT ABETA PEPTIDE TOXICITY 
ON NEURONAL CELL .
E. Cazzaniga, A. Bulbarelli, E. Lonati, M. Masserini 
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Milano Bicocca, Monza (MI), Italia 
Biochemically, Alzheimer’s disease is characterized by 
the formation of plaques of Abeta that participates to the 
progressive deterioration of memory, language and other 
cognitive functions which lead to dementia. A number of 
observations indicate that the primary target of amyloid 
peptide (Abeta) is neuronal cell membrane and specific 
lipids, e.g. ganglioside GM11. Alteration of the ratio 
cholesterol/phospholipids are involved in membrane-
peptide interactions, including peptide insertion, 
cytotoxicity, and pore formation2. In vitro experiments 
using atomic force microscopy and transmission electron 
microscopy indicate that the interaction with the 
membrane lipids induces a structural change of the 
peptide, from mature fibrils into soluble oligomers3,
influencing membrane fluidity and neurodegeneration. 
Recently, it has been reported that Abeta (1-42) 
oligomers inhibit neuronal viability 10-fold more than fibrils 
and 40-fold more than unaggregated peptide4. In this 
context, the comprehension of Abeta-lipid interaction 
mechanisms would be useful to develop strategies 
against Abeta toxicity to prevent neuronal damage.  
Experiments of immunochromatography on lipids 
extracted from SH-SY5Y human neuroblastoma cells 
showed that phosphatidylethanolamine (PE) is able to 
bind oligomeric Abeta 1-42 more efficiently than other 
membrane phospholipids, suggesting that this 
phospholipid could be involved in Abeta/membrane 
interaction and toxicity. Therefore, inhibition of the specific 
PE biosynthetic pathway may affect the poisonous effects 
of the peptide on neuronal cells. Exploiting this 
hypothesis, choline and phosphocholine were tested as 
inhibitors of PE biosyntesis. Experiments were carried out 
on SH-SY5Y human neuroblastoma cells differentiated for 
5 days with retinoic acid. Cells were treated for 6, 16 or 
24 hours with 1 mM or 2.5 mM choline or 0.5 mM or 1 mM 
phosphocholine. A statistically significant (p <0.05) 
reduction of PE level (42%) was obtained with 2.5 mM 
choline treatment after 24 hours, without affecting cell 
viability (data obtained by MTT test) and slightly affecting 
PC level. On the other side, treatment with 
phosphocholine did not show alteration in PC and PE 
levels. Noteworthy, cells treated with 5 ?? Abeta 1-42 
showed a decrease of cell viability of 48%, against a 
value of 31%  when pre-treated with 2.5 mM choline. 
Such treatment or membrane lipid modulation by 
assumption of food rich in choline (liver, cauliflower, 
brown bread, yolk, peanuts) or soy lecithin supplements, 
could reduce the toxicity of the peptide. 
1. Yanagisawa et al., BBA 2007 
2. Shang-Rong Ji et al, JBC 2002 
3. Widenbrandt et al., Biophys J 2006 
4. Stine et al., JBC 2003 
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STRUCTURAL STUDIES ON THE HUMAN ABCC6 
TRANSPORTER
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The human ABCC6, formerly called MRP6, is a member 
of the adenosine triphosphate-binding cassette (ABC) 
gene superfamily1.  The exact function and natural 
substrate(s) of ABCC6 are currently unknown. Mutations 
in ABCC6 gene cause Pxeudoxanthoma elasticum (PXE), 
an autosomal recessive disorder of the connective tissue 
characterized by progressive calcification of elastic 
structures in the skin, the eyes and the cardiovascular 
system2.
The proteins of this superfamily are involved in active 
transport of a wide variety of substrates, including 
aminoacids, lipids, peptides, saccharides and drugs, into 
and out of the cell and in the intracellular compartment. 
The structure of these proteins includes two 
transmembrane domains not much conserved, TMD1 and 
TMD2 that bind substrates, and two hydrofilic domains, 
NBD1 and NBD2, able to bind and hydrolyze ATP. The 
MRP6 protein, as some other transporters belonging to 
the subfamily ABCC, contains an additional sequence 
(TMD0) in the N-terminal region of about two hundred 
residues. The function of TMD0 remains poorly defined. 
In this report, the structure of the N-terminal region and 
the NBD1 domain was investigated.  To study the 
structure and the function of TMD0, the polypeptide 
sequence corresponding to the aminoacids 1-102 of  N-
terminal region have been synthesized by recombinant 
DNA technology. CD spectroscopy showed a strong 
tendency of the N terminal region to assume an ?-helical 
conformation in hydrophobic solutions and in micelles, 
suggesting a transmembrane localization for this 
sequence. The ATP binding to the NBD1 domain was 
also studied. 
1. Dean M. et al., Journal of Lipid Research, 2001 
2. Le Saux O. et al., Nature, 2000 
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In the last ten years a great attention has been paid to the 
interaction of nitric oxide (NO) with the respiratory chain 
activity, essentially after reports showing the existence of 
a specific mitochondrial nitric oxide synthase (mtNOS) 
distinct from the well known three isoforms: endothelial 
(eNOS), neuronal (nNOS) and inducible (iNOS). 
Moreover, different research groups have questioned the 
existence of an mtNOS. In our lab we have characterized 
the activity of the cytosolic NADH/cyto-c system, an 
electron transport pathway additional to that of the 
respiratory chain. In isolated liver mitochondria the 
addition of a catalytic amount of cytochrome c (cyto-c) 
activates this system which promotes the oxidation of 
NADH-dependent substrates added outside and 
generates an electrochemical proton gradient useful for 
ATP synthesis. 
This report describes the effect of NO on the activity of 
the cytosolic NADH/cyto-c system. Our original research 
program was aimed to compare the effect of NO 
generated inside the mitochondria by mtNOS to that of 
NO added to the incubation medium. Since we were 
unable to promote any mtNOS activity, the data obtained 
with NO generated by the dissociation of GSNO or added 
as water solutions saturated with gaseous NO molecules, 
are presented. The inhibition of NADH/cyto-c system by 
NO is reversible, is fully recovered as NO is completely 
metabolised and can be ascribed essentially to NO 
interaction with the cytochrome oxidase (Cox), as 
suggested by the data obtained with intact and solubilized 
mitochondria. A direct interaction of NO with the free 
molecules of cyto-c with the formation of a quite stable 
adduct, has been also found. This interaction, at least in 
part, may contribute to the overall inhibition of Cox 
observed in the presence of NO. At constant oxygen 
concentration, increasing NO up to 12 micro molar the 
time life of inhibition state increases but the entity of 
inhibition remains the same. This is consistent with an 
inhibitory mechanism of “all or nothing” type. In the 
presence of NO, Cox preferentially works as NO oxidase 
rather than as cyto-c oxidase, behaving as an efficient 
“NO scavenger”. On the metabolic point of view, this 
opens a new scenario on the role and function of NO/Cox 
interaction. Very relevant is also the finding that the 
membrane potential generated by the oxidation of 
exogenous NADH is not affected by a relatively low 
concentration of NO, while the oxidation rate is strongly 
inhibited. Thus we suggest that this behaviour could be 
correlated to the protective effect observed in the 
presence of NO in the ischemia reperfusion injury. 
12.18 
STRUCTURAL STUDIES ON THE HUMAN MRP6 
MF. Armentano, F.Bisaccia 
Dipartimento di Chimica, Università degli Studi della 
Basilicata, Italia 
The MRP6  is codified from the ABCC6 gene,  a member 
of the adenosine triphosphate-binding cassette (ABC) 
gene superfamily . The proteins of this family are involved 
in active transport of intracellular compounds to the 
extracellular environment. Mutations in ABCC6 cause 
Pxeudoxanthoma elasticum (PXE), an autosomal 
recessive disorder of the connective tissue characterized 
by progressive calcification of elastic structures in the 
skin, the eyes and the cardiovascular system.  
The structure of these proteins includes two 
transmembrane domains, TMS1 and TMS2, not much 
conserved, that bind the substrates, and two hydrofilic 
domains, NBD1 and NBD2, able to bind ATP. The MRP6 
protein, as some other transporters belonging to this 
family, contains an additional sequence in the N-terminal 
region of about three hundred residues, perhaps 
responsible of a regulatory function. To study the 
structure of this protein, some short sequences, 
corresponding to the N-terminal and the NBD1 regions, 
have been synthesized by recombinant DNA technology 
and/or chemical synthesis. CD spectroscopy showed a 
strong tendency of the N terminal region to assume an ?-
helical conformation in hydrophobic solutions and in 
micelles, suggesting a transmembrane localization for this 
sequence. 
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Visual transduction in retinal rod Outer Segments (OS) is 
an energy demanding process for which ATP supply is 
not yet clarified. Toward the goal of increasing our 
understanding of the molecular basis of OS energetic 
metabolism, we have presented a comprehensive 
proteomic study of purified rod disks. Proteins involved in 
vision as well as mitochondria-specific proteins not known 
to be part of the disk, were identified (respiratory chain 
complexes I to IV and oxidative phosphorylation complex 
V (F1Fo-ATP synthase). Results suggested that F1Fo-ATP 
synthase is catalytically active on disk surface. We also 
reported that the OS selectively stains with mitochondrial 
vital dyes, by an ex vivo technique on living retinas.  
Now we report a consistent ATP synthesis by purified 
bovine disks which accounts for about 200 ?M ATP/sec, 
sufficient for the phototransduction energy need. ATP 
synthesis was inhibited by mitochondrial ATP synthase 
inhibitors (oligomycin, nigericin, DCCD, Antimycin A). 
Inhibition by oligomycin and nigericin, suggests that disk 
ATP synthase employs a transmembrane electrochemical 
proton potential difference to synthesize ATP. The 
presence of a proton gradient across disks is also 
demonstrated by fluorescence quenching experiments of 
Rhodamine 123. Moreover, Rhodamine 123 selectively 
stained OS in a whole living retina, ex vivo. The four 
respiratory chain complexes display an activity 
comparable to that of mitochondria and are sensitive to 
the common inhibitors, such as Antimycin A, Rotenone or 
KCN. Moreover, intact disks consume oxygen when are 
energized  with NADH or succinate, at a rate similar to 
that of mitochondria. All the above results suggest that 
ATP is generated through oxidative phosphorylation in 
these organelles, that are devoid of mitochondria, likely 
by a recruitment of mitochondrial proteins, but not 
mitochondria.  
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EFFECTS OF PEROXYNITRITE ON LCAT ACTIVITY IN 
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AIMS: The enzyme Lecithin-Cholesterol Acyl-Transferase 
(LCAT) produces cholesteryl esters (CE) in plasma but its 
activity in cerebrospinal fluid (CSF), although detected, has 
not yet been characterized. LCAT, secreted by hepatocytes 
and neuroglial cells, might play an important role in brain 
cholesterol transport. Oxidative stress severely affects 
brain function, and might impair LCAT activity. Peroxynitrite 
is a major oxidant in CSF, and the footprint of its attack to 
proteins is represented by 3-Nitrotyrosine (NT) formation. 
The aims of this work were to asses whether peroxynitrite 
can affect LCAT activity in CSF.  
METHODS:. CSF samples from healthy donors were 
processed by SDS-PAGE and Western Blotting (WB), 
and the membrane was stained with rabbit anti-NT IgG. 
Digital images were analyzed by the Gel-Pro Analyser 
software (Media Cybernetics, Silver Spring, MA), and the 
band intensities were recorded as peaks on a 
densitogram. The LCAT activity ex vivo,  represented by 
the ratio of CE with unesterified cholesterol (C) in HDL1,
was determined in  the HDL-like fraction of CSF by 
measuring the C levels before and after saponification. 
LCAT assays in vitro (using liposomes containing ApoE3 
for stimulation, and tritiated C as substrate) were carried 
out with/without 100 ?M 3-Morpholinosydnonimine 
hydrochloride (SIN, peroxynitrite donor of peroxynitrite) as 
published2.
RESULTS: Two CSF samples with the same amount 
of protein (namely A and B) were analyzed for their NT 
level, and CE/C ratio. Densitometry of WB patterns 
indicated 1.5-fold higher NT level in A. CE/C was higher 
in A than in B (1.5± 0.01 and 0.82± 0.03 respectively). 
LCAT activity in vitro was 4.82 or 1.87 units in the 
absence or presence of SIN, respectively. This result 
indicates that peroxynitrite damages the enzyme activity 
in vitro 
DISCUSSION: 
We here report preliminary data showing that, in CSF, 
higher C esterification might be associated to lower NT 
formation. This result is supported by the finding of 
decreased LCAT activity by peroxynitrite in vitro. It can 
thus be hypothesised that peroxynitrite, produced under 
conditions of oxidative stress such as those associated to 
neurodegeneration, might impair lipoprotein-mediated C 
removal from brain. LCAT-dependent C transport might 
actually play a crucial role for neuron function, when C 
accumulates in the plasma membrane by reduced 
hydroxylation and causes ß-amyloid release in CSF. 
1. Cigliano L et al, (2001) Steroids 66: 889-896. 
2. Chen CH et al., (1982)  J Lipid Res. 23, 680-691. 
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The aim of present investigation was to study the effects 
of dexamethasone (DEX) or estradiol (E2) on proliferation 
and differentiation of rat bone marrow mesenchymal stem 
cells (MSCs) in culture, evaluating by western blotting and 
immunocitochemical analysis some specific neural 
proliferative and differentiative markers. MSCs are 
multipotent cells in the bone marrow stromal line, known 
for their potential to differentiate into several types of 
cells. 
MSCs were harvested from bone marrow of femurs of 
4 to 8 month-old rats. Cytofluorimetric analysis revealed 
that MSCs were negative for CD45, CD34 and positive for 
CD90, CD105. 
After 24h starvation period, MSC cultures were treated 
for 48h with DEX 10-9 M or E2 5 x 10
-9 M. Qualitative and 
quantitative analysis were performed by 
immunocytochemical and western blot analysis 
respectively for nestin, neurofilament, ?-tubulin and MAP-
kinase. 
Our results show an enhancement of the above 
mentioned neural markers and MAP-Kinase in MSCs 
cultures treated with DEX. E2-treatment increased MAP-
Kinase and ?-tubulin expression, but it decreased nestin 
and neurofilament expression. 
Collectively, our results indicate that DEX induces an 
up regulation of some neural protein expression indicating 
an its possible role played on differentiation of these 
MSCs to neural line. In addition, it shows an involvement 
on signal transduction patways. On the contrary, E2
treatment induces up and down modulation of nestin, 
neurofilament, ?-tubulin and MAP-kinase expression. 
Moreover, are in progress experiments on DEX-growth 
factors crosstalk on GFAP, vimentin, nestin, PARP and 
MAP-Kinase expression in astroglial cell cultures at 15 
DIV, in order to compare the different effects evaluated in 
both in vitro models. 
53rd National Meeting of the Italian Society of Biochemistry and Molecular Biology (SIB) and National Meeting of Chemistry of Biological 
Systems Italian Chemical Society (SCI - Section CSB) : Palazzo dei Congressi di Riccione 23rd - 26th  September 2008, ISBN 978-88-
8453-820-8 (print), ISBN 978-88-8453-821-5 (online), ©2008 Firenze University Press
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Anandamide (arachidonoylethanolamide, AEA) acts as 
endogenous agonist of both cannabinoid and vanilloid 
receptors. During the last two decades, its metabolic 
pathways and biological activity have been extensively 
investigated and relatively well-characterized. In contrast, 
the effective nature and mechanism of AEA transport 
remain at present a controversial and still unsolved issue. 
We have reported the characterization of a biotinylated 
analogue of AEA (b-AEA), that has the same lipophilicity 
of the parent compound. In addition, by means of 
biochemical assays and fluorescence microscopy, we 
have shown that b-AEA is accumulated inside the cells in 
a way superimposable on that of AEA. Conversely, b-AEA 
doesn’t interact nor interfere with the other components of 
the endocannabinoid system, i.e. type-1 and type-2 
cannabinoid receptors, vanilloid receptor, AEA synthetase 
(NAPE-PLD) or AEA hydrolase (FAAH). Taken together, 
our data suggest that b-AEA could be a very useful probe 
for visualizing the accumulation and intracellular 
distribution of this endocannabinoid.
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INTRODUCTION: A large body of evidences have 
indicated a relevant protective properties of carnosine and 
trehalose against many antioxidative stress conditions. 
The neuropeptide carnosine (?-alanyl-L-histidine), is 
involved in many processes of cellular defence such as 
inhibition of protein cross-linking and glycation, metal 
chelation, free radicals and NO detoxification1.
The disaccharide trehalose is produced in large 
amounts under stress conditions and can counteract 
protein mysfolding and aggregation in neurodegenerative 
disorders. 
In the present study we examined L and D- carnosine 
and trehalose effect against NO induced cell death in 
primary rat astroglial cell cultures treated with 
lipopolysaccharide (LPS) and interferon gamma (INFγ).
To better evaluate the molecular mechanism underlying 
the role of carnosine and trehalose we measured cell 
viability, nitrite production and the LDH release. PARP 
expression was also determined to verify its involvement 
in the mechanisms of protection and/or cell death during 
proinflammatory commitment.  
MATERIALS AND METHODS: Interferon-γ (100U/ml) 
and lipopolysaccharide (LPS 1 ?g/ml) were used to 
induce iNOS dependent stress conditions in primary rat 
astroglial cell cultures with or without carnosine and 
trehalose (20mM). 
RESULTS aAND DISCUSSION: An increase of nitrite 
production and LDH release and a decrease of cell 
viability (MTT) after 24 or 48 hrs of LPS and INF-γ
treatment was observed. Carnosine as well trehalose 
addition separately or tougether was able to decrease 
nitrite and LDH release and to increase cell viability in a 
dose-response manner. Apart the NO binding activity of 
carnosine, such effect is also attributable to the observed  
PARP 1 and 2 down-regulation by carnosine and 
trehalose treatment under stress conditions. 
In the same experimental conditions D-carnosine a 
“synthetic peptide” shows a more remarkable effect, than 
L-carnosine. This result can be attributed to the effect of 
carnosinase activity wich is able to hydrolize the L- 
carnosine brt not D-carnosine.The data obtained suggest 
that, beside the antioxidant role of carnosine and 
trehalose, these molecules can also modify the PARPs 
expression pathway. Such hypothesis is under further 
investigation to better understand such critical step of 
many neurodegenerative disorders2.
1. V. Nicoletti et al, 2007 J. of Neuroscience Research 
vol 85, 2239-2245  
2. V. Spina-Purrello et al, 2008 Neurochemical Research 
Submitted for publication 
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Several lines of evidence suggest a relationship between 
the aggregation state of amyloid ? peptides and their  
ability to promote cell degeneration in vitro, an aspect 
which might also govern their toxicity in vivo1. The very 
toxic A?(25-35) is the shortest peptide sequence that 
retains a biological activity comparable with that of full-
length A?(1-42)2. This fragment differs from all the other 
commonly studied ?-amyloid peptides because of its 
extremely rapid aggregation properties so that it cannot be 
studied with conventional electrophoretic techniques3.
Mounting evidence shows that synthetic A?, in an 
aggregated state is toxic to neurons in cultures. The 
assembly phenomenon is dependent on pH, concentration, 
and incubation time in solution. Several A? fragments have 
been reported to form such assemblies, but only those that 
include a substantial portion of a transmembrane sequence 
assemble into aggregates that are stable at pH 7.4 and 
resistant to disruption by SDS.  We provided the first 
information on the very rapid aggregation of A?(25-35) in 
water at pH 7.4. Adopting UV-Vis spectroscopy, Congo 
Red spectrophotometry and thioflavin-T fluorimetry, we 
were able to quantify in water the role of initial solvent in 
determining the aggregation rate, extent and, thanks to 
thioflavin-T data, modality of A?(25-35) self-assembly to 
form stable insoluble aggregates. Moreover, the 
percentage of A?(25-35) aggregation at 37°C in water was 
evaluated by UV-Vis spectroscopy and we assessed that it 
reached 37% of aggregation in 30 minutes of incubation, 
far higher than the aggregation percentages of the very 
amyloidogenic A?(1-42) peptide. A?(25-35) aggregation 
tendency was then confirmed by the evaluation of its 
percentage of sedimentation. Congruently with aggregation 
quantification, A?(25-35) showed the highest sedimentation 
percentage (56%) respecting to the reference A?(1-42) 
peptide (24%). The basic understanding of the modality of 
A?(25-35) self-assembly will help to comprehend the 
pathway and key steps of A? association. 
1. Gazit E: Self-assembled peptide nanostructures: the 
design of molecular building blocks and their 
technological utilization. Chem Soc Rev. 2007
;36(8):1263-9.  
2. Clementi M.E., Misti F.: Substitution of methionine 35 
inhibits apoptotic effects of A?(31-35) and A?(25-35) 
fragments of amyloid-? protein in PC12 cells. Med Sci 
Monit. 2005;11(11):BR381-5. 
3. Picke C.J. et al.: Neurodegeneration induced by ?-
amyloid peptides in vitro: the role of peptide assembly 
state., J Neurosci. 1993;13(4):1676-87. 
13.6 
TSPO EXPRESSION ON MURINE MODEL OF OBESITY
L. Schmid1, A. Pirone2, L. Betti1, L. Fabbrini1, M. Lanza1,
L. Palego 1, G. Mascia1,  C. Lenzi2, O. Fabiani2, G. 
Giannaccini1, A. Lucacchini1
1
Department of Psychiatry, Neurobiology, Pharmacology 
and Biotechnology, University of Pisa
2
Department of Animal Productions, Section of Anatomy, 
University of Pisa 
The ob/ob murine line, mutant for leptin gene, represents 
a good experimental model to study several pathologies 
as diabetes and obesity. The ob/ob mouse is obese, 
hyperphagic, hyperinsulinemic and become significantly 
hyperglycaemic during stress, presumably as a direct 
consequence of leptin deficiency at hypothalamic level. In 
fact, leptin stimulates melanotropic hormone (? MSH) 
release, inhibits food intake, increases parasympathetic 
nervous system tone and energy expenditure; on the 
other hand, it inhibits neuropeptide Y (NPY) release, that 
increases parasympathetic tone, appetite and reduces 
energy consumption.  
Ob/ob mice lack these functions at hypothalamic level. 
In particular, these mice present an adrenal hypertrophy 
and increased corticosteroid secretion during diurnal 
rhythms. One consequence of increased glucocorticoids 
is a diminished muscle glucose uptake. An increased 
serum cholesterol, associated to a moderate 
hypertryglicemia is also observed in ob/ob mice. 
TSPO (translocation protein or PBR - peripheral 
benzodiazepine receptor) is richly expressed in tissues 
producing steroids, implying that one of its main functions 
is represented by regulation of the synthesis process of 
these hormones. 
Cytoplasmic cholesterol binds with high affinity to 
TSPO and this interaction is involved on cholesterol 
transport inside  mitochondria: its translocation from outer 
to inner mitochondrial membrane is the rate determining 
step in the whole synthesis process. 
Therefore, our aim was to evaluate TSPO expression 
in mutant ob/ob mice in comparison with wild-type ones to 
individuate a possible translocator alteration, associated 
with the hypercolesterolemic status of  the murine leptin 
mutant.  
TSPO expression was evaluated either in central 
nervous system or in periphery, by means of [3H]PK11195 
binding assay, carried out on brain and kidney 
membranes. 
A significant statistical increase of [3H]PK11195 Bmax 
values (maximal receptor density) was evidenced in the 
brain of mutant ob/ob mice without significant alterations 
of Kd values (dissociation constant); by contrast, there 
were no significant variations of either  [3H]PK11195 
Bmax or Kd in kidneys of both control or leptin mutant 
mice. 
These results showing an increased TSPO expression 
in mutant mouse brain need further investigations by 
autoradiographic tecniques, which will evidence the 
translocator localization and distribution in the different 
cerebral areas. 
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PIN1: A NEW OUTLOOK IN THE STUDY OF 
ALZHEIMER’S DISEASE  
E. Lonati, E. Cazzaniga, M. Masserini and A. Bulbarelli.
Dipartimento di Medicina Sperimentale, Università  di 
Milano-Bicocca, Monza, Italia. 
Alzheimer’s disease (AD) is characterized by extracellular 
plaques deposits of amyloid-beta (Aβ) oligomers and 
intracellular hyper-phosphorylated microtubule-binding 
protein Tau neurofibrillary tangles (NFTs). Recent data 
suggest that Pin1, a peptidyl-prolyl cis/trans isomerase, 
might be involved in AD pathogenesis, because of its role 
in Tau and APP (beta-amyloid precursor protein) cis/trans
isomerisation on Ser(P)/Thr(P)-Pro sequences. Pin1 may 
take part in promoting APP cleavage by ?-secretase 
rather than the amiloydogenic pathway1. Moreover, it has 
been demonstrated that Pin1 is implicated in oxidative 
stress-induced Tau dephosphorylation2 on Thr231 by 
protein phosphatase 2A (PP2A). The Thr231 residue 
plays a critical regulatory role because its phosphorylation 
greatly diminishes the ability of Tau to bind and stabilize 
microtubules in the cell3. Since oxidative stress is an early 
event in AD pathogenesis, we investigated the Pin1 
involvement in modulation of tau phosphorylation in rat 
cultured hippocampal cells after exposition to β-amyloid 
oligomers.  
Hippocampal neurons cultured for 7-8 days are 
treated with Aβ (1-42) oligomers4 2,5 ?M for different 
times (up to 24 hours). Western blotting analysis revealed 
that Tau phosphorylation level on Thr231 seems to 
decrease after 3-8 hours of 2,5 ?M Aβ (1-42) oligomers 
treatment, increasing again in 24 hours of exposition, 
although we observe caspases activation and 40% of cell 
apoptotic death within 24 hours. The early Tau 
dephosphorylation event observed may probably due to 
protein isomerisation by Pin1, since that Aβ-induced Tau 
phosphorylation is recovered by pre-treatment with a 
specific Pin1 inhibitor (juglone 10 ?M). Furthmore, in cells 
pre-treated with okadaic acid (20nM), that mainly inhibits 
PP2A, TauThr231 results hyper-phosphorylated, suggesting 
a correlation between Pin1 and PP2A activity. 
Additionally, we established that, after A? treatment, 
some of other Tau phosphorylation sites under 
Gsk3?/PP2A regulation (Ser199, Ser396) undergo to 
dephosphorylation  indirectly induced by Pin1 activity. 
Taken together, these results suggest an intriguing 
hypothesis of Pin1 direct  involvement in early 
mechanisms activated during Aβ-induced cytotoxic insult 
and modulating Tau phosphorylation state.  
1. Pastorino et al.,(2006) Nature 440, 528-534  
2. Galas et al., (2006) J. Biol. Chem. 28,19296-19304  
3. Hamdane et al., (2003) J. Biol. Chem. 278, 34026-
34034
4. Stine et al., (2001) J. Biol. Chem. 278,11612-11622 
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Sporadic Amyotrophic Lateral Sclerosis (sALS) is a 
progressive disorder ending into voluntary muscle 
paralysis caused by selective and progressive death of 
motor neurons in brain and spinal cord, the reason of 
which is still poorly known. Cytoplasmic ubiquitin-positive 
round or skein-like inclusions are a hallmark of sALS. 
TDP-43, a 43 kDa nuclear protein involved in gene 
expression and RNA splicing regulation, was uncovered 
to be a component of these inclusions in which it is 
described to exist in the native form, as a 43 kDa protein, 
and in a variety of high molecular mass derivatives 
predictive of its abnormal distribution as a protein tagged 
with ubiquitin polymers1.
We were interested in going in deep into the nature 
and subcellular distribution of TDP-43 in sALS. Brain 
frontal cortex (FC) and spinal cord (SP) autoptic 
specimens from three heavily affected patients and three 
age-matched neurologically healthy subjects were 
evaluated by western-immunoblotting carried out on a 
cleared cytoplasmic fraction and a pellet enriched in the 
nuclear fraction and the insoluble inclusions (hereafter 
called nuclear pellet) using TDP-43 and ubiquitin selective 
antibodies. An immunohistochemical analysis on formalin-
fixed, paraffin-embedded tissue sections was performed 
in parallel on 30 other sALS cases. 
Biochemically, in FC and SP of controls TDP-43 was 
distributed exclusively as a nuclear protein and only as a 43 
kDa protein; surprisingly in FC and SP of sALS it was 
expressed in the cytoplasmic fraction, that was free from 
inclusions, in which it was easily appreciable not only as 43 
kDa full length protein but even as high molecular mass 
derivatives tagged with various ubiquitin monomers; in the 
nuclear pellet, in addition to the normal 43 kDa form, TDP-
43, here too, was clearly expressed as a highly ubiquitinated 
abnormal component. Immunohistochemically, in the sALS 
cytoplasm TDP-43 was distributed diffusely as well as inside 
insoluble aggregates. 
These dysfunctions highlight a perturbation of nuclear 
trafficking and/or solubility of TDP-43 ending into loss of 
the nuclear functions and gain of the cytoplasmic ones, 
both exerting a negative impact on neuron metabolic 
activity and lastly vitality. 
1. Buratti E. and Baralle F.E. (2008) Front Biosci 13, 
867-878. 
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Alzheimer's disease (AD), an age-related 
neurodegenerative disorder, is characterized clinically by a 
progressive loss of memory and cognitive functions. 
Neuropathologically, AD is defined by the accumulation of 
extracellular amyloid protein deposited senile plaques and 
intracellular neurofibrillary tangles made of abnormal and 
hyperphosphorylated tau protein, regionalized neuronal 
death and loss of synaptic connections within selective 
brain regions. Mild Cognitive Impairment (MCI) is generally 
referred to the transitional zone between normal cognitive 
aging and early dementia or clinically probable AD. Protein 
glycosylation is one of the most common post-translational 
modifications of proteins in eukaryotes. It is critical to 
growth control, cell migration, cell adhesiveness, tissue 
differentiation and inflammatory reaction cascades. Protein 
glycosylation modifies the processing of several key 
proteins involved in the molecular pathogenesis of AD. We 
employed a proteomic approach coupled to lectin-affinity 
chromatography, using two different lectin Con A and 
WGA, to elucidate possible differential expression in the 
total pattern of glycoproteins in AD and MCI hippocampus 
compared to age-matched control. This technique allows to 
focus the interest only to glycosilated proteins identifying 
which might be involved in the pathogenesis and the 
progression of the AD. We show many differences in 
glycoproteins expression, which demonstrate the alteration 
of several cellular systems, molecular pathways or 
processes during AD development. Alterations on γ-
enolase and glutamate dehydrogenase suggest an 
impairment of energy metabolism pathway both in MCI and 
AD, as previously reported1. Downregulation of  both GRP 
78 (glucose related protein 78) and GRP 94, HSP90 and ?-
glucosidase indicates an impairment of the protein folding 
machinery in MCI and AD. Moreover we show that also 
neuron arrangement undergoes to several changes as 
indexed by the alteration of structural and neuronal growth 
proteins (TPM 2-3, DRP-2, 14-3-3) in MCI and AD and of 
synaptic vesicles trafficking in MCI (XAP-4). In conclusion, 
our data enrich previous knowledge on the molecular 
mechanisms involved in the onset,  progression and 
pathogenesis of AD and provide a contribute to explain the 
biological events that may lead MCI patients to progress to 
AD. 
1. Reed T, Perluigi M, Sultana R, Pierce WM, Klein JB, 
Turner DM, Coccia R, Markesbery WR, Butterfield DA. 
Neurobiol Dis. 30:107-20. 2008  
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Increasing evidence supports the notion that reduction of 
cellular expression and activity of antioxidant proteins and 
the resulting increase of oxidative stress are fundamental 
causes in the aging processes and neurodegenerative 
diseases. Several conditions including protein, lipid or 
glucose oxidation disrupt redox homeostasis and lead to 
accumulation of unfolded or misfolded proteins in aging 
brain. To cope with the accumulation of misfolded 
proteins and to activate the repair processes, the central 
nervous system has evolved the conserved mechanism of 
unfolded protein responce. One of the main intracellular 
redox systems involved is the vitagene system1.
Vitagenes encode for cytoprotective heat shock proteins 
(Hsp) Hsp70 and heme oxygenase-1, as well as 
thioredoxin reductase (TRXred).  
In the present study, we investigated, in rats 12 (adult) 
and 28 (senescent) months old, the role of Hsp 
expression on aging-induced changes in the antioxidant 
redox status. In the brain, expression of Hsp72 and HO-1 
increased with age. The maximum induction was 
observed in the hippocampus and substantia nigra (SN) 
followed by cerebellum, cortex, septum and striatum. We 
also evaluated levels of expression of Hsp90, thioredoxin 
and TRXred as function of aging process and we 
observed in senescent rats compared to adults a 
significant decrease of Hsp90 in the cortex and 
cerebellum, an increase in the SN, while no significant 
changes were found in septum, striatum and 
hippocampus between senescent and adult animals. 
TRXred activity and expression was elevated in 
senescent rats compared to adults in all brain regions 
examined while the protein expression of thioredoxin 
decreased in all brain regions but the SN and cerebellum. 
We used a redox proteomics approach to identify proteins 
which are oxidatively modified as a specific target  in the 
hippocampus of senenscent rats compared with adults. 
Many of these are energy-related proteins such as 
pyruvate kinase, ATP synthase, aldosase, creatine kinase 
and alpha-enolase. The oxidative modification of these 
enzymes likely leads to their inactivation. These results 
are in line with current literature data showing that free 
radical damage and decreased energy production are 
characteristic hallmarks of the aging process.  We posit 
that increase of Hsp expression might promote functional 
recovery of oxidatively damaged proteins thus protecting 
neural cells from progressive age-related damage.  
Conceivably, heat shock signal pathway by increasing 
cellular stress resistance may represent a crucial vitagene 
controlled mechanism operating against free radical-
induced damage occurring in aging brain and in 
neurodegenerative disorders. 
1. Calabrese V. et al. (2007) Nature Neuroscience 8, 
766-775. 
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The relaxin 3 (Rln3) is a neurotransmitter abundantly 
expressed in a restricted cell group of brainstem region, 
known as the nucleus incertus (NI)1; this neuron cluster is 
positioned in a behavior control network that integrates 
information related to memory, attentional state and 
stress response2. To date, the role of rln3 has been only 
investigated in mammalian species. In our study  we 
analyzed rln3 expression in the brain of a non-mammalian 
vertebrate, zebrafish, which has emerged as vertebrate 
model for genetic, molecular and behavioral studies. We 
demonstrated, by whole mount in situ hybridization 
experiments, that, at late pharyngula period, two discrete 
symmetric rln3-expressing cell groups are present in 
developing zebrafish brain in the midbrain tegmentum 
region. This restricted signal was still evident later in 
developing embryos. These cell clusters are distributed 
latero-dorsally to the central midbrain tegmentum in the 
putative periaqueductal gray matter (PAG). The 
expression of zebrafish rln3 gene in the putative PAG 
neurons is very appealing since these neurons have been 
correlated to the production of vocal communication, 
which is an important feature for social behaviour3.
Interestingly, starting from larval stage, a new more 
posterior signal was detected in a smaller cell group in 
tegmentum/medulla region. We hypothesize that this cell 
cluster might correspond to mammalian NI, reporting the 
first molecular evidence of existence of nucleus incertus 
in fish. We support our hypothesis comparing the 
anatomical position of rln3-expressing cells and dorsal 
raphe neurons finding the same anatomical relationship 
reported in rat brain. NI acts in a complex control network 
together with other neural components such as locus 
coeruleus and raphe nuclei that are emerging sites of the 
brainstem neural circuitry involved in stress response. 
Our analyses, based on double in situ hybridization 
experiments using rln3 antisense riboprobe and marker 
genes for locus coeruleus and raphe nuclei, indicate that 
these brainstem circuitries, could take place shortly after 
hatching, when the embryo starts to interact with the 
environment and is easily accessible to behavioural 
studies. In conclusion, our findings provide the basis to 
analyze the involvement of Rln3 peptide and of PAG and 
NI in different neural mechanisms in early life stage of a 
vertebrate model organism. 
1. Tanaka M., Iijima N., Miyamoto Y., Fukusumi S., Itoh 
Y., Ozawa H., Ibata Y. (2005) Eur J Neurosci 21,1659-
1670.  
2. Olucha-Bordonau FE, Teruel V, Barcia-Gonzalez J, 
Ruiz-Torner A, Valverde-Navarro AA. (2003) J Comp 
Neurol 464:62-97.   
3. Kittelberger JM, Land BR, Bass AH. (2006) J 
Neurophysiol 96:71-85. 
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Among the brain tumors, the glioblastoma multiforme 
(GBM) is the most incurable form of cancer. It is defined by 
uncontrolled proliferation, infiltration, propensity for 
necrosis, robust angiogenesis and resistance to apoptosis. 
Despite surgery, radiotherapy and chemotherapy, the 
prognosis of GMB patients is very poor. New findings in 
this field will be fundamental to develop targeted therapies 
against this untreatable cancer. 
The mitochondrial permeability transition (MPT), due 
to the opening of a multiprotein pore (MPTP) shows a 
central role in mediating cell death. Moreover, some of 
the MPTP components are selectively up-regulated in 
cancer, such as the TSPO and ANT proteins. 
Mitochondria-directed cytotoxic agents, combined with 
traditional chemotherapy, could be emerging tools to fight 
GBM. 
We planned to extend the knowledge about the 
therapy combination of the MPT-inducing drugs and the 
traditional chemotherapy, with the aim to improve the 
GMB therapeutic protocols. 
The ability to induce cell death of MPT-inducing 
agents, selected among those targeting the TSPO and 
ANT proteins, has been tested in murine and human 
glioma cells by MTS assay. Moreover, the induction of 
MPT has been tested, assaying the mitochondrial 
potential, using the specific fluorescent probe JC1 and the 
apoptosis has been investigated by cytochrome C release 
and DNA fragmentation assays and electron microscopy. 
Our results indicated the ability of the tested TSPO 
and ANT drugs to trigger cell death in murine and human 
glioblastoma cell lines as a consequence of MPT 
induction, and such drugs were also potently effective in 
glioma cells resistant to the usual chemotherapy drugs. 
Studies are undergoing to test MPT-inducing agents, or 
combination of MPT-inducing agents and conventional 
chemotherapy drugs, on GMB cells. 
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L-3,4-dihydroxyphenylalanine (L-DOPA) alone or in 
combination with a peripheral dopa decarboxylase 
inhibitor (DDI) is the most effective therapeutic agent to 
improve motor function in most of patients with 
Parkinson's disease (PPD). However, chronic L-DOPA 
therapy is associated with of side-effects arising 
particularly during long-term therapy. Only a small 
percentage of an exogenous dose of L-DOPA is 
converted into dopamine (DA) in the brain. The majority is 
either decarboxylated in peripheral tissues by aromatic 
amino acid decarboxylase (AAD) to DA, which does not 
cross the blood-brain barrier, or is O-methylated by 
catechol-O-methyltransferase (COMT) in both peripheral 
and brain tissue to yield 3-O-methyldopa (3-OMD). To 
effectively raise brain DA levels, a large amount of L-
DOPA must be administered, often in  an oral dose. It has 
been reported that such large doses of L-DOPA can 
significantly affect sulphur amino acid metabolite levels. 
During long-term clinical practice, the decarboxylation of 
L-DOPA is inhibited, the role of COMT is accentuated and 
circulating L-DOPA is largely converted into 3-OMD. 
Therefore, O-methylation of L-DOPA to 3-OMD is linked 
with conversion of SAM to S-adenosylhomocysteine 
(SAH). SAH is split into adenosine and Hcy.  
We evaluated the impact of long-term application of L-
DOPA/DDI formulations on plasma methionine (MET), 
SAM, SAH and tHcy levels in PPD. 
Patients were from the Institute of Neuropsychiatry, 
Palermo University. All patients entering the study were 
examined by neurologists to confirm or exclude the 
diagnosis of Parkinson’s disease. There were 10 PPD 
treated with L-DOPA/DDI formulation and 10 healthy 
controls. Peripheral blood samples were taken in the 
morning after the subjects had fasted and were off 
medication for at least 12 hrs. Thus we avoided impact of 
acute L-DOPA/DDI intake. Plasma tHcy and sulphur 
metabolite levels were determined by high-performance 
liquid chromatography (HPLC) as reported. 
The levels of MET and SAM (approximately 1.21 and 
1.32 fold, respectively) in the treated PPD were 
significantly lower than in the controls while the levels of 
tHcy (mean 16.6 ?mol/L; SD 4.4) were higher compared 
with controls (mean 9.8 ?mol/L; SD 3.4). No significant 
differences in SAH levels appeared.  
Based on these findings, we hypothesized that 
another consequence of high-dose e/or long-term L-
DOPA administration might be hyperhomocysteinaemia 
and may also represent a risk factor for both ischaemic 
heart and cerebrovascular disease in treated PPD. 
Besides, the resulting hyperhomocysteinaemia might be 
increased if L-DOPA therapy is superimposed on a 
condition known to impair Hcy metabolism, such an 
enzyme defect or B/acid folic vitamin deficiency.  
1. Wise C.K. et al. (1995) J Liq Chromatogr 18, 2005-
2017; 2. Gueli et al. (2000) IBTS 15:167. 
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Sporadic IBM (s-IBM) is the most common muscle 
disease beginning after age 50, which leads to severe 
disability. There is increasing evidence that free-radical 
toxicity may participate in the IBM pathogenesis. 
Indicators of oxidative stress, as well as enzymes 
participating in the cellular defense against oxidative 
stress, are accumulated in IBM muscle fibers. 
Mitochondrial abnormalities shown to be more prevalent 
in s-IBM than in other inflammatory myopathies. 
Reducted expression of adenine nucleotide translocator 
(ANT1), mitochondrial protein involved in the response to 
oxidative stress, has been associated with reactive oxigen 
species (ROS) production in muscular cell. The products 
of irreversible non-enzymatic glycation and oxidation have 
been termed advanced glycation end products (AGEs). 
Through their capacity to form cross-links and to liberate 
reactive oxygen intermediates, AGEs and their receptors 
(RAGE) can induce cellular damage.  Recently it has 
been demonstrated that RAGE-NF-?B pathway is 
involved in proinflammatory pathomechanism and in 
muscle fiber regeneration in inflammatory myopathies. 
Our study want to analyze oxidative stress markers, 
ANT1 and RAGE-NF-kB pathway in s-IBM.  
On muscle samples of five patients with s-IBM, five 
patients with polymyositis (PM) and five normal controls 
were done the following studies: immunocytochemistry  
for activated  NF-?B; electrophoretic mobility shift assay 
(EMSA) of NF-?B DNA binding activity; western blot 
studies of RAGE and ANT1; hydrogen peroxide (HP), 
peroxidase and glutathione peroxidase (GPx) assays. 
Nuclear immunoreactivity for NF-?B, NF-?B-DNA binding 
activity, increased RAGE and GPx expression were found 
in muscle specimens from s-IBM and PM patients, 
whereas ANT1 reduction was present in s-IBM in 
comparision with PM and normal controls. 
ANT1 reduction, high GPx activity and RAGE-NF-kB 
pathway activation indicate a redox system alteration in s-
IBM. 
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Inflammation is an important component in the 
pathogenesis of many diseases of different origin. In most 
cases, the role of inflammation is a natural response to 
injury, and an important mechanism for healing and tissue 
repair. However, the immuno-response can either be 
inadequate or overwhelming, leading to direct injury or 
severe host disease. This is the case of several 
lysosomal storage disorders, such as GM2 
gangliosidosis, where the inflammation is one of the most 
important features of neurodegeneration within the central 
nervous system (CNS). Using GM2 gangliosidosis as a 
neurodegenerative diseases model1 we are exploring how 
the inflammation is related to the metabolic storage 
disorder.In particular, we investigated whether the genetic 
defects in the HEX (HEXA and HEXB) genes, which lead 
to the absence of Hexosaminidase (Hex) isoenzymes in 
GM2 gangliosidosis, are involved in an altered immuno-
response.  
To this end, we generated an in vitro model of human 
CD1a+ Dendritic Cells (DCs) knockdown for HEX genes. 
Our data demonstrated that the HEXA and HEXB gene 
expression have a 90 and 85 percent of inhibition 
respectively after siRNAs transfection of WT-CD1a+DCs. 
These results have a direct correspondence for the level 
of inhibition of the Hex activity in these cells. More 
importantly, using a specific fluorescent BRDU-MLR for 
the T-cell proliferation assay, we found that the HEX-
knockdown CD1a+-DCs express a tolerogenic-like 
phenotype and were unable to activate the T 
lymphocytes. As, these results are in agreement with 
highly reduction of the Hex activity that we observed in 
tolerogenic DCs generated in vitro from hematopoietic 
stem cells, we suggest a role for the enzyme within the 
cell-mediated immuno-response which is therefore likely 
linked to inflammatory processes during GM2 
gangliosidosis. 
1. Martino S. et al. Hum.Mol.Genet. 2005;14:2113-23.  
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Brain functioning requires a lot of energy to restore and 
maintain its electro-physiological activity. It represents 
only 2-3% of the body weight, but its energy consumption 
is more than 20% of that of the whole organism. This is 
quite surprising because the mitochondrial density in 
brain is very low. Several Authors suggest that part of the 
energy may be supplied by the glia. Our attention has 
focused on myelin, the multilayered membrane 
protein/lipid structure surrounding axons, because there is 
growing evidence that it also has a neuro-trophic role. In 
fact, in demyelinising  diseases like Multiple Sclerosis, the 
loss of myelin causes an axonal necrosis, cause of the 
neurological disability.  
Following a challenging hypothesis that the aerobic 
production of ATP for axons takes place in myelin sheath, 
we conducted experiments on isolated myelin vesicles 
(IMV) obtained according to the method of Norton ad 
Poduslo. By semiquantitative WB analysis, biochemical 
assays and TEM and confocal microscopy techniques,  
we have observed that IMV: i) are able to consume 
oxygen when are energized  with NADH and Succinate; ii) 
display a proton gradient on their surface;  iii) contain Fo-
F1 ATP Synthase and all the four respiration chain 
complexes, which are catalytically active and are 
sensitive to the common inhibitors, such as Olygomicine, 
Rotenone or KCN. The extent of mitochondrial 
contamination was assessed by semiquantitative WB with 
an Ab against ANT, TIM and TOM (proteins typical of the 
mitochondrial membranes) and by biochemical assay of 
Adenylate Kinase Isoform 3 (AK3,a typical matrix protein). 
ANT, TIM and TOM as well as AK3 activity were absent in 
IMV. 
These data suggest that the whole redox chain is 
present in myelin sheath and that it is catalytically active 
in aerobic ATP production, functional to the high energy 
demands of CNS. Moreover this basic study will be 
pivotal for shedding some light on the etiophatogenesis of 
many demyelinating diseases.  
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pLG72 BINDING TO D-AMINO ACID OXIDASE 
MODULATES D-SERINE CONCENTRATION IN HUMAN 
BRAIN. 
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In the past few years, the identification of relatively high 
concentration of glial derived D-serine shed new light on 
the role played by the flavoenzyme D-amino acid oxidase 
(DAAO). In several regions of the brain, the 
gliotransmitter D-serine acts as an endogenous allosteric 
modulator of the NMDA receptors. Since in brain DAAO is 
mainly expressed in astrocytes surrounding the synapses, 
this flavoenzyme has been proposed to regulate the 
synaptic concentration of D-serine, and thus indirectly to 
modulate glutamatergic neurotransmission. According to 
this proposal, it was not surprising that the genes coding 
for human DAAO (hDAAO) and its putative interactor 
pLG72 have been linked to the predisposition to 
schizophrenia1, which onset has been related to an 
altered functionality of  NMDA receptors. 
We investigated the regulation of hDAAO exerted by 
pLG72 by using different approaches. In human brain 
cortex, immunohistochemical analyses revealed that both 
proteins are expressed in astrocytes, where they most 
likely interact, considering their partial overlapping 
subcellular distribution and their co-immunoprecipitation. 
The specific in vitro interaction of the two proteins (as was 
demonstrated by different techniques) yields a ∼200 kDa 
complex composed by 2 hDAAO homodimers and 2 
pLG72 molecules. The binding of pLG72 did not affect the 
kinetic properties and FAD binding ability of hDAAO, but 
resulted in the modification of its tertiary structure and in a 
time-dependent loss of activity. We then demonstrated 
that overexpression of hDAAO in human glioblastoma 
cells decreases the cellular level of D-serine, an effect 
which is nulled when pLG72 is co-expressed. These 
evidences strongly indicate that pLG72 acts as a negative 
effector of hDAAO. 
Thus, we propose a molecular mechanism by which 
hDAAO and pLG72 are involved in schizophrenia 
susceptibility: an increase of hDAAO activity (e.g. due to 
the anomalous hypoexpression of pLG72 under 
pathological conditions) yields to a decrease of D-serine 
released at the synapse and, as a result, to the 
hypofunction of NMDA receptors2. The elucidation of the 
role played by hDAAO and pLG72 in such a complex 
psychiatric disorder and the availability of the hDAAO-
pLG72 complex will provide an ideal system to test small 
molecules with potential therapeutic application. 
This work was supported by a grant from Fondazione 
Cariplo to L.P. 
1. Chumakov I. et al. (2002) PNAS. 99 :13675-13680. 
2. Sacchi S. et al. (2008) JBC. In press. 
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Amyotrophic Lateral Sclerosis (ALS) is an adult-onset 
neurodegenerative disorder characterized by death of 
motor neurons in the spinal cord. Approximately 90% of 
ALS cases are sporadic (SALS), while only a minority of 
cases shows a familiar inheritance (FALS). FALS is 
mainly caused by missense mutations in the gene
encoding superoxide dismutase 1 (SOD1), an enzyme 
catalyzing the conversion of harmful superoxide radicals 
to hydrogen peroxide and oxygen. 
It has been reported that oxidative damage plays a 
fundamental role not only in FALS, but also in SALS 
pathogenesis. 
In proteins, L-asparaginyl residues flanked by small, 
non-bulky residues are subject to deamidation, a 
spontaneous post-translational modification generating L-
isoaspartyl abnormal derivatives (IsoAsp), in turn 
responsible for structural and functional protein impairment. 
Under physiological conditions, isoAsp residues are 
recognized by protein L-isoaspartate (D-aspartate) O-
methyltransferase (PIMT; EC 2.1.1.77), an enzyme 
involved in the repair of the damaged proteins. This protein 
is ubiquitous in all human tissues, but is more active in red 
blood cells (RBC), where the deamidation rate increases 
with aging and in response to oxidative stress. Owing to its 
kinetic features, PIMT’s activity is highly sensitive to any 
significant alteration of transmethylation potential, a useful 
index of the propensity to transfer methyl groups from 
AdoMet. This value is expressed as the ratio 
AdoMet/AdoHcy, being AdoMet the methyl donor and 
AdoHcy a powerful methyltransferase inhibitor. 
The present project aims to investigate the possible 
effect of oxidative injury, one of the main pathogenetic 
factors involved in SALS, on the efficiency of 
transmethylation reactions. 
We found that methyl esterification of RBC membrane 
proteins is significantly increased in SALS patients, 
compared to healthy controls. This result indicates that an 
accumulation of abnormal IsoAsp residues occurs in vivo
in these patients, presumably as a consequence of the 
oxidative microenvironment. 
In addition, the intracellular concentration of AdoMet in 
SALS patients is 50% reduced compared to healthy 
controls. As a consequence, [AdoMet]/[AdoHcy] ratio is 
significantly decreased in the patients. This strong 
reduction might contribute to the accumulation of IsoAsp 
residues through the impairment of PIMT-mediated repair 
process. Moreover, an alteration in DNA methylation, an 
epigenetic modification involved in gene expression 
regulation, can be hypothesized, owing to the high 
sensitivity DNA methyltrasferases to variations of 
transmethylation potential. The possible reactivation of 
genes whose expression is allele-specific and 
methylation-dependent (genes X-inactivated or imprinted) 
is currently under investigation. 
13.19 
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AN EXPERIMENTAL MODEL OF NERVE CRUSH 
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Peripheral neuropathy due to trauma of nerves is one of 
the common functional deficits in road and domestic 
accidents. Different therapeutic approaches are now 
available to promote the regeneration of damaged nerve, 
but a satisfactory management to ensure a full restoration 
of peripheral nerve after trauma is not yet available. 
Using an experimental protocol in which crush injury 
was applied 1 cm above the bifurcation of the rat sciatic 
nerve for 20 seconds, we have evaluated whether 
neuroactive steroid levels as well as biochemical (i.e., 
myelin proteins and Na+,K+ ATPase pump) and functional 
(nociceptive response to thermal stimulation and walking 
track test) parameters were affected. By means of liquid 
chromatography coupled to tandem mass spectrometry, 
we here demonstrate that the levels of neuroactive 
steroids such as pregnenolone (PREG), progesterone (P) 
and testosterone (T) and their  reduced metabolites (i.e., 
dihydroprogesterone, DHP, and tetrahydroprogesterone 
and dihydrotestosterone, DHT, respectively) present in 
injured sciatic nerve were significantly decreased with 
respect to those in control. The drop of DHP and DHT 
levels in crushed sciatic nerve does not seem to be the 
consequence of the reduced levels of the general 
precursor PREG, since the levels of P and T (i.e., their 
direct precursors) were not significantly affected. A 
possible hypothesis could be an impairment of the 
enzyme devoted to their synthesis (i.e., the enzyme 5?-
reductase). In agreement with this hypothesis, we here 
observe that the mRNA levels of this enzyme were 
significantly decreased in crushed sciatic nerve. Crush 
nerve lesion is also able to induce other biochemical 
alterations, such as a decrease of myelin protein gene 
expression and an increase of Na+,K+ ATPase activity 
and expression of its catalytic subunits. Moreover, 
nociceptive and motor functions are deeply altered in 
crush animals. 
Altogether these findings represent an important 
background to analyze whether treatment with 
neuroactive steroids might counteract functional and 
biochemical parameters affected in this experimental 
model.  
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The 18 kDa mitochondrial Translocator Protein (TSPO) is 
constitutively expressed in central and peripheral tissues. 
It is associated with a plethora of biological functions, 
such as cholesterol transport, steroidogenesis, cellular 
proliferation, apoptosis. Many studies reported its up-
regulation in several forms of cancer, with a positive 
correlation between TSPO level and the grade of 
malignancy. For such reason, TSPO has become an 
interesting target in molecular imaging (i.e. PET, 
fluorescence microscopy and cytofluorimetry). 
We aimed to develop new fluorescent or radio-labeled 
ligands targeting TSPO to create new imaging tools that 
can make easier to study TSPO expression and function 
in tumor cells. 
Previously, we described a series of N,N-dialkyl-(2-
phenylindol-3-yl)glyoxylamides as potent and selective 
TSPO ligands1. Pursuing our interest in this field, we 
obtained new indolylglyoxylamides as molecular probes 
labelled with a fluorescent moiety or with a Positron 
Emitter Carbon-11. 
The fluorescent probes were obtained by linking the 
norbornadiene (NBD) moiety to the N-alkyl chain, and 
were monitored at the mitochondrial level in glioma cells 
to verify the specific TSPO labelling. Instead, to obtain the 
TSPO radioligands, the indolylglyoxylamides bearing a 
methyl group on the indole N-1 were synthesized and 
tested for their biological activity by radiobinding assays, 
showing high affinity for the TSPO. Such results make 
these compounds good candidates to be labelled with 
Carbon-11. 
In conclusion, both fluorescent and radiolabelled 
indolylglyoxylamides are new molecules targeting this 
protein as promising imaging tools for cancer. 
1. Primofiore G et al., J Med Chem 2004, 47, 1852. 
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Increasing evidence supports the idea that the initial 
events of A? oligomerization and cytotoxicity in 
Alzheimer’s disease involve the interaction of amyloid A?-
derived diffusible ligands (ADDLs) with the cell 
membrane, indicating lipid rafts, ordered membrane 
microdomains enriched in cholesterol, sphingolipids and 
gangliosides, as likely primary interaction sites of ADDLs. 
To shed further light to the relation between A? oligomer 
interaction with the cell membrane and cytotoxicity, we 
investigated the dependence on membrane cholesterol 
content of ADDLs binding to lipid rafts in human 
neuroblastoma cells and in primary fibroblasts from 
familial Alzheimer’s patients. In particular, confocal laser 
microscopy analysis showed that A?1-42 oligomers 
markedly interact with plasma membrane rafts and that 
A?1-42 oligomer- monosialoganglioside GM1 interaction 
was prevented by a moderate membrane cholesterol 
enrichment. Moreover, anisotropy fluorescence 
measurements of flotillin-1-positive rafts purified by 
sucrose density gradient suggested that the cholesterol 
content is inversely correlated with membrane 
perturbation by A?1-42 ADDLs. Finally, membrane 
microdomain morphology and size were imaged by 
Atomic Force Microscopy (AFM), before and after the 
exposure to monomeric and aggregated forms of A?.
Contact mode AFM images of lipid rafts in liquid showed 
that ADDLs induce changes in raft morphology with the 
appearence of large pores. The pore size and depth were 
significantly reduced in cholesterol-enriched rafts, 
suggesting that cholesterol protects against amyloid-
induced membrane damage at the lipid raft level by 
modifying raft physicochemical features.
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EXTRACELLULAR UPTAKE OF AMYLOID BETA 
AGGREGATES BY A CLATHRIN-DEPENDENT, RAFT-
MEDIATED MECHANISM. 
M. Zampagni, C. Cecchi, A. Pensalfini, M. Becatti, E. 
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A leading theory on the molecular basis of amyloid toxicity 
considers that prefibrillar unstable assemblies interact 
with cell membranes destroying their ordered structure. 
Although considerable evidence indicates that 
extracellular A? contributes to the intracellular pool of A?,
the mechanisms involved in A? uptake by neurons are 
poorly understood. Recent evidence suggests that 
amyloid A?-derived diffusible ligands (ADDLs) interact 
with the amyloid precursor protein (APP) present at the 
cell surface, which acts as a ligand of its own precursor to 
enhance APP complex formation, resulting in a cell death-
related signal. To shed further light to the relation 
between A? oligomer interaction with the cell membrane 
and cytotoxicity, we investigated the dependence on APP 
distribution in the plasma membranes of A? aggregate 
binding to lipid rafts, ordered membrane microdomains 
enriched in cholesterol, in human neuroblastoma cells. 
Confocal laser microscopy analysis showed that ADDLs 
markedly interact with plasma membrane rafts. Moreover, 
anisotropy fluorescence measurements of flotillin-1-
positive rafts purified by sucrose density gradient 
suggested that the APP content is significantly correlated 
with membrane perturbation by ADDLs. Finally, confocal 
microscopy studies suggested a caveolae-independent, 
clathrin-dependent, raft-mediated mechanism of 
extracellular ADDLs internalization inside neuronal cells, 
thus implying lipid rafts as contributors not only to A?
biogenesis and accumulation but also to extracellular A?
uptake. 
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Poly(ADP-ribose)polymerases (PARPs) are members of a 
family of enzymes that utilize nicotinamide adenine 
dinucleotide as substrate to form large ADP-ribose 
polymers (PAR) in the nucleus. PAR has a very short 
half-life due to its rapid degradation by poly(ADP-ribose) 
glycohydrolase. PARP-1 is involved in DNA repair and in 
maintenance of genome stability. Futhermore, it is 
becoming increasingly clear that the regulation by 
poly(ADP-ribosylation) contributes to a wide range of 
cellular functions. PARP-1 mediates acute neuronal cell 
death induced by a variety of insults including cerebral 
ischemia, parkinsonian neurotoxins and CNS trauma. The 
regulation of PAR metabolism by specific inhibitors has 
generated important insight into poly(ADP-ribosylation) 
functions and highlighted the therapeutic potential of 
PARP inhibitors in human diseases.  
The PARP inhibitor capacity of  a new 4-
chinazolidonic derivative MC2050, has been 
characterized by evaluating enzyme activity both “in vitro” 
and in SH-SY5Y neuroblastoma cell line. Its effect has 
also been assessed in a cellular model which mimicks 
Alzheimer’s degeneration, i.e. SH-SY5Y cells treated with 
Abeta 25-35 fragment. 
The data obtained in vitro by PARP activity 
colorimetric kit (Trevigen) indicate that the new compound 
is highly active in the micromolar range (IC50 = 50 
microM) compared to other well known inhibitors, chosen 
as reference drugs. In addition MC2050 is a more potent 
inhibitor than 3-ABA and PJ34 when assayed in SH-SY5Y 
cells. Cell viability assays revealed also that this 
compound is not cytotoxic at the tested concentrations.  
When the SH-SY5Y cells were pretreated with 10 
microM Abeta 25-35, the level of endogenous PARP 
activity increased up to 40% within 24 hours. In the 
presence of MC2050 enhancement of PARP activity 
seems to be blunted.  
These results indicate that MC2050 is able to inhibit 
PARP probably by binding to the active site of the 
enzyme. Regulation of PARP activity may be a useful 
therapeutic intervention to reduce neurodegenerative 
damage. 
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PYRIMIDINE NUCLEOSIDE TRIPHOSPHATES ARE 
MAINTAINED AT HIGH LEVELS DURING MASSIVE 
ATP BREAKDOWN INDUCED BY ANOXIC-LIKE 
CONDITIONS IN CENTRAL NERVOUS SYSTEM 
CELLS. 
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ATP is the primary high-energy phosphate compound 
produced by catabolism, in the processes of glycolysis 
and oxidative phosphorylation. In normoxic cells, its 
average concentration is 3 to 5 mM1, depending on cell 
type and cell metabolic condition. A set of at least 100 
kinases, including nucleoside-, nucleoside monophospho-
, and nucleoside diphospho-kinases, then carry 
phosphoryl groups to other purine and pyrimidine free 
nucleosides and nucleotides, to form the other three main 
nucleoside triphosphates: GTP, UTP, and CTP. For these 
three ribonucleotides, the average cellular concentration 
is about one order of magnitude lower than that of ATP. It 
is a widely accepted tenet in neurobiology that, under 
normoxic conditions, intracellular nucleoside triphosphate 
levels are rigorously protected. However, in such events 
as ischemia or anoxia, massive ATP breakdown occurs. 
In this communication we present evidence that both in 
“post-mitochondrial” brain cell extracts, and in oligomycin-
treated human astrocytoma cell line (ADF), the 
breakdown of ATP2,3 is not accompanied by a 
concomitant breakdown of UTP and CTP.  
The time courses of UTP and CTP breakdown, as 
catalyzed by rat brain extracts, were followed in the 
absence and in the presence of ATP, at physiological 
concentrations of the three nucleotides. In the absence of 
ATP, 0.6 mM UTP was rapidly broken down to UMP, 
uridine, and uracil, and CTP was broken down to CMP, 
cytidine, uridine and uracil (in the order). The addition of 
3.6 mM ATP, almost completely prevented UTP and CTP 
breakdown. Strikingly, only when the concentration of 
ATP fell down around the Km values of nucleoside mono- 
and di-phosphokinases, UTP and CTP started to be 
broken down. The results obtained with brain extracts
were sustained by experiments performed with cultured 
cells. In fact, the incubation of ADF cells with oligomycin, 
which inhibits oxidative phosphorylation, causes ATP 
breakdown at a more rapid rate as compared to CTP 
breakdown. 
Our results suggest that nervous system cells have 
the capacity to maintain pyrimidine nucleotides at a high 
degree of phosphorylation, at least during the first anoxic 
stages, to avoid that certain nucleotides are lost, and to 
achieve better reperfusion recovery. 
1. Traut, T.W. (1994) Mol. Cell. Biochem. 140, 1-22. 
2. Barsotti,C. and Ipata, P.L. (2004) Int. J. Biochem. Cell 
Biol. 36, 2214-2225. 
3. Barsotti, C., Tozzi, M.G. and Ipata, P.L. (2002) J. Biol. 
Chem. 277, 9865-9869. 
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Human cytidine deaminase (CDA) consists of four 
identical subunits (4 x 14,900 Da) with one active site per 
subunit. The four active sites, which lie at the subunit 
interface, operate independently and each subunit is 
equipped with a zinc atom that is involved in the covalent 
addition of water to cytidine, followed by elimination of 
ammonia1. Molecular modelling studies on human CDA2
and the crystal structure of the tetrameric B. subtilis CDA3
indicated that a complicate set of intersubunit interactions 
contributes to the building of  the active site in each 
monomer. In this work the role exerted of the residue 
Y33, in the subunit interface and in the active site of 
human CDA was investigated. Y33 residue is part of a 
conserved region (32PYSHF36) in most tetrameric CDAs 
and it was supposed to be close to the active site in the 
CDA tertiary structure3. To verify this hypothesis on the 
purified  Y33G mutant CDA, a kinetic study was 
performed and the effect of temperature on the protein 
activity and stability was also investigated.  
The kinetic parameters calculated in presence of 
cytidine, deoxycytidine, azacytidine and cytosine 
arabinoside (Ara-C) revealed that deoxycytidine was the 
best substrate for Y33G whereas the Km value for 
cytidine and azacytidine was higher with respect to the 
wild-type CDA. The Vmax was significantly lower, 
indicating that the substitution of a tyrosine with a glycine 
had a dramatic effect on catalysis efficiency. Ara-C, an 
analog used in chemotherapy as antileukemic agent, was 
not recognized as substrate by the Y33G. The ability of a 
number of nucleosides and nucleotides to inhibit the 
mutant enzyme Y33G was tested, obtaining a lower Ki 
value with respect to the wild type CDA.  
Differently to wild-type CDA1, Y33G is a thermolable 
enzyme with optimal temperature around 40°C and a rapid 
decrease of enzymatic activity at 50°C due to protein 
denaturation. The temperature dependence of Vmax and 
Km values of Y33G mutant was analysed by using the 
empirical Arrhenius equation and the van’t Hoff equation. 
The energy activation (Ea) value calculated for the mutant 
enzyme was 13,812 kcal/mol whereas for the wild type 
CDA  the Ea was 9,038 kcal/mol. From these data it may 
be supposed that Y33G mutant CDA introduces strong 
interactions with the ligands (in particular deoxycytidine and 
inhibitors) as confirmed by its higher negative enthalpic 
value with respect to the wild-type enzyme. On the other 
hand Y33G mutant enzyme has difficulty to convert the 
substrate into the product because of the increasing Ea 
value that leads to a decrease of the Vmax value  with 
respect to the wild-type CDA. 
1. Vincenzetti S. et al., (2008) Proteins: Structure, 
Function and Bioinformatics. 70, 144-156. 
2. Costanzi S.  et al (2006) J. Mol. Graph. Model. 25, 
10–16. 
3. Johansson E. et al,  (2002) Biochemistry. 41, 2563–
2570. 
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The presence of mycovirus dsRNAs has been detected in 
cherry leaves showing symptoms of Chlorotic Rusty Spot 
disease (CCRS)1. In previous communications we 
provided evidence that the fungus T. wiesneri might be a 
possible host of that mycovirus because it is invariably 
present not only in affected but also in healthy leaves and 
also in immature buds2. We show here detailed location of 
T. wiesneri in cherry bud structures and provide evidence 
that mycotic Chrysovirus is an early presence in leaf 
areas that later will show the chlorotic rusty disease. 
Leaves and buds of cherry trees were collected from 
plants closely inspected to detect the initial symptoms of 
CCRS. Samples were analysed for fungi presence by 
PCR amplification and sequencing of both 18S rDNA and 
ITS1 and ITS2 spacer segments. Mycovirus presence 
was revealed by RT-PCR amplification of 4 different 
segments corresponding to the 4 genomic dsRNAs of 
Chrysovirus. Analyses were performed on presumptive 
rusty spots and on adjacent areas of each leaf to 
establish possible boundaries of virus presence. 
PCR results have confirmed the previous identification 
of Taphrina wiesneri as the most frequent fungus on 
cherry tree tissues2. Analyses of Chrysovirus dsRNAs 
have demonstrated its presence, at high titer, on leaves 
that showed faint spots of only early chlorotic 
modification, presumed to evolve in rusty spots. Similar 
analyses, on the closely adjacent areas of the leaf, and 
on its vascular conducts, gave negative results for virus 
genome. Also fungi collected and cultivated from the 
exterior of the affected areas of the leaf were negative for 
virus presence. 
In conclusion, present data demonstrate that the 
Chrysovirus dsRNAs is a very early symptom of CCRS. 
The virus is detected neither in areas of the same leaf 
where chlorosis is not evident nor in its vascular tissues. It 
seems that there is an initial rapid burst of virus 
production and that this occurs only in a host fungus that 
is inside the leaf since no virus is detected in fungi 
collected and cultivated from the outer side of the affected 
regions of the same analysed leaves. 
It is possible that the virus host, is a fungus that 
penetrates the leaf with no evidence of external growth, 
cycling between fallen and new leaves. It is also possible 
that the virus might infect specific areas of leaves using 
as a host a fungus that is already present in the leaf, 
transforming it into a pathogen. Studies will be made to 
investigate on these alternatives. 
1. Kozlakidis Z. et al (2006) J.Gen.Vir 87, 3113-3117 
2. del Gaudio R. et al (2007) IJB special issue Abst. 
14.12, pg.163 
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PHOSPHODIESTERASES ACTIVITY EVALUATION IN 
STEM CELLS OF THE HUMAN PERIODONTAL 
LIGAMENT (PDL-MSCs) 
L. D’Alessandro, M. Paludi, D. Vitale, S. Di Marco, M. 
Iannetti, O. Trubiani and G. Spoto 
Department of Stomatology and Oral Sciences, “G. 
D’Annunzio” University, 66013 Chieti, Italy. 
Mesenchymal stem cells (MSCs) are multipotent, capable 
of developing into mesenchymal, bony, cartilaginous, 
muscular and connective tissues. 
Even thus bone marrow represents an excellent 
source of mesenchymal stem cells, adult stem cells can 
be harvested in large quantities from several organs and 
tissues like the umbilical cord, blood, dental pulp, 
periodontal ligament, amniotic fluid. One interesting and 
promising source of adult stem cells is the periodontal 
ligament (PDL).PDL does not only have a role in 
sustaining the teeth, but it also contributes to their 
trophism. Diseases which affect the periodontal tissues 
are the most frequent causes of teeth loss, which is the 
result of the destruction of the tissues which support the 
teeth (PDL, cementum, gingiva and alveolar bone)2. As a 
consequence of these phenomena the reconstruction of a 
healthy periodontium is the basis of periodontal therapy.  
Given that cyclic nucleotide signaling regulates a wide 
variety of cellular functions, it is not surprising that cyclic 
nucleotide phosphodiesterases are represented by a 
large superfamily of enzymes. PDEs have a modular 
architecture, with a conserved catalytic domain proximal 
to the carboxyl terminus and regulatory domains or motifs 
often near the amino terminus. 1
The aim of our work was to trace the cAMP and cGMP 
dependent phosphodiesterases activity and cyclic nucleotides 
levels in stem cells obtained from PDL during their osteogenic 
differentiation process. The PDL-MSCs were obtained and 
cultured in MSCM medium (Cambrex Company, Walkersville 
MD 21793-0127) according to the manufacturer’s directions 
provided (Trubiani et al. 2005). Cyclic nucleotides levels and 
the enzymatic reaction for cAMP/cGMP PDE assay were 
carried out using the method of Spoto et al.2006, with minor 
variations, by reverse-phase HPLC. The samples were 
organized into control stem cells (undifferentiated) and three 
groups of inducted stem cells: after 1 week, 2 weeks and 4 
weeks. We achieved an interesting result concerning the 
cAMP PDE activity which shows a bell-shaped trend graph 
reaching its maximum at 2 weeks. Meanwhile cAMP level 
increases rapidly reaching its maximum value at one week 
and after PDE activity decreases below basal levels. Contrarily 
to our expectations, no implication of cGMP and  cGMP PDE 
activity were detected during the differentiation process. The 
work demonstrates that cyclic AMP and cAMP PDE enzymatic 
activity are crucial steps in the differentiation process of the 
human stem cell.  
cAMP Phosphodiesterase Activity Evaluation in Human 
Carcinoma of Salivary Glands. Nucleosides Nucleotides 
Nucleic Acids. (2006) 25: 1113-1117 
1. A family of cAMP-binding proteins that directly activate 
Rap1 Science 1998, 2275-2279
2. Regenerative potential of human periodontal ligament 
derived stem cells on three-dimensional biomaterials: 
A morphological report 
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DIFFERENT EXPRESSION OF NICOTINAMIDE 
MONONUCLEOTIDE ADENYLYLTRANSFERASE  
ISOZYMES IN NORMAL AND PATHOLOGICAL 
TISSUES AND CELL LINES. 
M. Di Stefano1, S. Scotti1, L. Galassi1, F. Mazzola1, A. 
Poloni2 and G. Magni1
(
1
) Istituto di Biotecnologie Biochimiche, (
2
) Clinica di 
Ematologia, Università Politecnica delle Marche, Ancona, 
Italia 
Nicotinamide mononucleotide adenylyltransferase 
(NMNAT) is the central enzyme of the NAD biosynthetic 
pathway, catalyzing the transfer of the adenylyl moiety of 
ATP to NMN and leading to the formation of NAD.  
Three human NMNAT isozymes, differing for the 
oligomeric state, subcellular localization and catalytic 
properties have been identified and characterized: 
NMNAT1 has an hexameric organization and is a nuclear 
protein; NMNAT2 is monomeric and is localized in the 
Golgi complex; NMNAT3 is a tetrameric mitochondrial 
protein. 
By using a discrimination assay developed in our 
laboratory, we have been able to assess the individual 
isozymes contribution to NAD formation and, 
consequently, to determine their relative amounts in cell 
lines and tissues1.
The mRNA and protein expression profiles, 
determined by RT real-time PCR and Western blotting, 
respectively, validate our protocol, in that in the cell lines 
and tissues analyzed the distinctive presence or absence 
of each isozymes perfectly matched. 
The results show that, in all extracts, the three 
isozymes are not simultaneously present and do not 
equally contribute to NAD formation. Indeed, NMNAT1 is 
ubiquitously expressed, while NMNAT2 and NMNAT3 
show a tissue-specific expression.  
For example, in brain NMNAT3 is not detectable, 
whereas NMNAT2 predominates. Instead, in addition to 
the predominance of NMNAT1, NMNAT3 is present in 
liver tissue and in the hepatic cell line HepG2.  
Our discrimination assay applied to red blood cells 
(RBCs) indicates that, unexpectedly, mitochondrial 
isozyme 3 largely exceeds the presence of isozyme 1 
whereas isozyme 2 is absent. Moreover, NMNAT total 
activity is higher in younger RBCs, with NMNAT3 
exceeding NMNAT1 in all different-aged RBCs. 
An interesting correlation between NMNAT isozymes 
expression and pathological conditions was found in white 
blood cells (WBCs): total NMNAT activity is significantly 
higher in lymphocytes B of B-cell chronic lymphocytic 
leukemia patients than in normal lymphocytes B, and 
NMNAT3 seems to be exclusively expressed in the 
tumoral lymphocytes. 
The results described in this presentation could be 
exploited for the identification of NMNAT isozymes as 
putative tumoral markers. 
1. Sorci L, Cimadamore F, Scotti S, Petrelli R, 
Cappellacci L, Franchetti P, Orsomando G and Magni 
G. Biochemistry 2007, 46: 4912-4922. 
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EVALUATION OF BIOMARKERS IN PATIENTS WITH 
HAND OSTEOARTHRITIS
L.D. Kozaci1, O.F. Sendur2, P. Ruggeri3, N. Franceschini3
1
Dept. Biochemistry, Faculty of Medicine, Adnan 
Menderes University, Aydin, Turkey
2
Dept. Physical Therapy and Rehabilitation, Faculty of 
Medicine, Adnan Menderes University, Aydin, Turkey
3
Dept. Sciences and Biomedical Technologies, Faculty of 
Biotechnologies, University of L’Aquila, L’Aquila, Italy 
Osteoarthritis (OA) is a common chronic joint disease with 
pain, functional impairment and radiographic changes at 
joints involved. In post-menopausal women, hand OA is 
the most common form, with a higher frequency of 
erosive type. Various clinical and radiographic criteria are 
used to classify and predict the progression of the 
disease but a gold standard definition has not yet been 
achieved. Usually, affected hand joints evolve from space 
reduction leading to swollen and painful periarticular 
tissue to formation of osteophytes and nodules with bone 
erosion in some patients. Objective of this study was to 
evaluate the performance of some biochemical markers in 
comparison to the radiographic assessment. MMPs (1, 3 
and 13), TIMP-1, cathepsin B and COMP were measured 
in serum samples (n= 70). OA patients were divided into 
subgroups as: erosive (n=10) and nodular (n=40), on the 
basis of radiographs taken at the time of their enrolment.  
Healthy volunteers were chosen as controls (n= 20). 
Routine biochemical tests, ESR, CRP and total blood 
cells count were assayed on blood withdrawn and sera 
stored at -80°C for further analyses.  
Preliminary data obtained by means of zymography, 
fluorometric and immunoenzymatic techniques show that 
MMP-1 content is significantly increased in nodular OA; 
whereas MMP-3 is markedly increased in erosive form. 
ESR levels were high compared to controls in both forms 
of OA.  
Belhorn LR, Hess EV. Semin Arthritis Rheum (1993) 22, 
298-306 
Kozaci LD, Buttle DJ, Hollander AP. Arthritis Rheum. 
1997, 40, 164-74 
Kozaci LD, Brown CJ, Adcocks C, Galloway A, Hollander 
AP, Buttle DJ. Mol. Pathol. 2008, 51, 282-286 
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ALA147THR SUBSTITUTION IN TSPO IS 
ASSOCIATED TO ADULT SEPARATION ANXIETY IN 
PATIENTS WITH DEPRESSION  
P. Gabellonia, B. Costab, S. Pinia, M. Abellia G.B. 
Cassanoa, C. Martinia.
aDepartment of Psychiatry, Neurobiology, Pharmacology 
and Biotechnology, University of  Pisa, Pisa, Italy. 
bDepartment of Human Morphology and Applied Biology, 
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Although anxiety disorders are heritable, their genetic and 
phenotypic complexity has made the identification of 
susceptibility genes difficult. In animal models, separation 
distress has been repeatedly shown to induce profound 
and irreversible alterations in neurosteroid-mediated 
central mechanisms controlling HPA activity and aberrant 
behaviours indicating increased anxiety1.
A well-validated anxiety animal model is represented 
by rats that have been subjected to chronic maternal 
separation. 
A human condition that might share some of those 
mechanisms described in animals is adult separation 
anxiety. We evidenced a reduction of expression levels of 
Translocator Protein (TSPO), the key protein of the first-
limiting step of neurosteoid biosynthesis, in individuals 
with adult separation anxiety2. In this study, we sought to 
test whether two allelic variants of TSPO gene, 439G>A 
and 485G>A single nucleotide polymorphisms (SNPs), 
were associated with the presence of adult separation 
anxiety in patients with a principal diagnosis of bipolar 
disorder or major depression. 
A case-control study was performed in 182 patients 
and 190 controls. With regards to 485G>A SNP, analysis 
did not elicit any association with adult separation anxiety. 
For 439G>A, a risk to develop adult separation anxiety 
was evidenced for A allele carriers. This SNP is likely to 
have a functional effect, because it codes for the 
aminoacidic change of Ala 147 in Thr.  This aminoacidic 
position is in CRAC domain of TSPO, that is responsible 
for the uptake and translocation of cholesterol into 
mitochondria. Substitution of a non-polar aminoacid with a 
polar aminoacid might determine an alteration of 
cholesterol translocation that is the first rate-determining 
step in neurosteroid biosynthesis. A carriers showed 
significantly higher total scores on the scale for adult 
separation anxiety than patients with GG genotype. Our 
findings suggest that the A-allele of 439G>A SNP might 
be implicated in pathophysiology of adult separation 
anxiety. 
1. Ladd CO, Owens MJ, Nemeroff CB. (1996) 
Endocrinology 137, 1212-1218. 
2. Chelli B, Pini S, Abelli M, Cardini A, Lari L, Muti M et 
al. (2008) Eur Neuropsychopharmacol 18, 249-254 
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A GENE EXPRESSION STUDY FOR B-CELL CHRONIC 
LYMPHOCYTIC LEUKEMIA 
E. Marinello, V.Tommassini, F. Carlucci, B. Pisano, A. 
Tabucchi  
Dipartimento di Medicina Interna, Scienze Endocrino-
Metaboliche e Biochimica, Sez. Biochimica, Università 
degli Studi di Siena, Siena, Italia 
B-CLL is the most frequent type of leukemia in the 
Western countries. The disease is most common among 
the elderly with a peak of incidence over 60 years. B-CLL 
follows a variable course both overall survival times and 
symptoms during disease course.  
There is evidence that the accumulation of lympocytes 
in peripheral blood and bone marrow is due to a cell 
resistance to apoptosis rather than to high proliferative 
cells.  
The analysis of  gene expression profiling through 
microarray technology, in lymphocytes of patients with B-
CLL, has revealed a number of biochemical and 
biomolecular changes. Particularly affected are the 
mechanisms of apoptosis, membrane signal transduction, 
the expression of interleukins, the activity of certain 
purinic metabolism enzymes and those involved in the 
responses to oxidative stress. 
In our study peripheral blood lymphocytes were 
isolated by gradient density centrifugation and B cells 
were separated by immunomagnetic procedure. Total 
RNA was extracted and microarray analysis was 
performed by Ocimum Hybridization Service (Netherland).  
Under the Customer Service was developed a chip 
consists of 50 genes coding for proteins involved in the 
processes mentioned above. Moreover, the presence or 
absence of programmed cell death in leukemic cells  was 
determined by the study of enzyme activity of caspase 3 
and protein-tyrosine phosphatase (PTP), the presence of 
fragmented DNA was determined by gel electrophoresis 
of agarose. 
Preliminary results identified many genes of purine 
metabolism with different expression from controls. The 
expression of 17 of 50 genes studied is altered (34% of 
genes on the chip). Their expression is increased or 
reduced by at least two times compared to control. 
Among de novo enzymes, the Gairs-Airs-Gart complex 
was overexpressed and IMP dehydrogenase seemed 
underexpressed. Of salvage pathway enzymes, APRT 
revealed underexpression, but HGPRT was unchanged. 
Ecto-5’-nucleotidase (CD73) was underexpressed in 
agreement with the low enzymatic activity, determined 
during our studies. 
Since extracellular adenosine induces apoptosis via 
A2b receptors, enzymes such as CD73 involved in 
extracellular adenosine release could play a role in B-CLL 
cell resistance to apoptosis. 
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LEVELS OF HOMOCYSTEINE AND TRANSAMINASE
E. Marinello, L. Terzuoli, R. Zanaboni, B. Porcelli, M.G. 
Coppola, A. Cito, R. Pagani 
Dipartimento di Medicina Interna, Scienze Endocrino-
Metaboliche e Biochimica, Sezione di Biochimica, 
Università di Siena, Siena, Italia
Recent epidemiologic studies1-2 have shown that 
homocysteine (Hcy), a sulfur-containing amino acid 
formed during the metabolism of methionine, is a risk 
factor of atherosclerosis, myocardial infarction, stroke, 
thrombosis, chronic kidney disease and cognitive 
impairment in various neurological diseases. Therefore, 
hyperhomocysteinemia is associated with a lot of 
diseases, but it has not been clarified exactly which 
mechanism is responsible for occurence disease.  
Between possible negative effects of Hcy can also 
count taking away of free pyridoxal-phosphate (PLP) or 
PLP bound with enzymes, alterated the enzymatic activity.  
In previous our study3 we examined the effects of 
different aminothiols on enzymatic activity of PLP 
dependent enzymes. These sulfurated substances 
strongly inhibited enzymatic activity.  
The aim of this study is to assess the relationship 
between level of Hcy and two enzymes: aspartate 
transaminase (AST 2.6.1.1) and alanine transaminase 
(ALT 2.6.1.2). These two enzymes are characterized by 
the presence of PLP and its participation in catalysis. The 
PLP coenzyme is covalently bound to the ε-amino group 
of lysine 258. It provides the characteristic absorption 
spectra with a major absorption peak at 390 nm.  
PLP reacts chemically with Hcy to give 2-(3-hydroxy-
5-phosphoryloxymethyl-2-methyl-pyridyl-D-tetrahydro-1,3-
thiazine-1-carboxylic acid4. During reaction the original 
absorption maxima shift to 330 nm to formation of new 
substance. In this way we can evaluate adduct formed.  
To demonstrate inhibition of AST and ALT by 
homocysteine, we evaluate enzymatic activity, monitored 
via decrease in E340 in the presence and absence of 
different concentration of Hcy.  
AST mixtures in final volume 1 ml: 12 mM aspartate; 2 
mM α-ketoglutarate; 0.1 M potassium phosphate buffer 
pH 7.3; 0.15 mM NADH; 0.1 U malato dehydrogenase. It 
was prewarmed to 37 °C in a cuvette for 10 min. For one 
experiment, to this mixture added 0.05 U AST.  
ALT mixtures in final volume 1 ml: 4 mM alanine; 16 
mM α-ketoglutarate; 0.1 M potassium phosphate buffer 
pH 7.3; 0.15 mM NADH; 0.1 U LDH. It was prewarmed to 
37 °C in a cuvette for 10 min. For one experiment, to this 
mixture added 0.05 U ALT.  
For inhibition experiment, added different aliquot of 
Hcy (3.8 - 7.6 - 15.2 ?moles). 
Hcy don’t inhibit the activity of two enzyme considered, at 
difference of cysteine and analogous aminothiols3. Hcy, in 
total plasma elevated concentration, can be involved in many 
interactions, but don’t interfere with two important enzymes, 
the transaminase, frequently assayed in clinical laboratories. 
1. Thambyrajah J. et al. (2000) Eur. Heart J. 21, 967-974.  
2. Folstein M. et al. (2007) Am. J. Psychiatry 164, 861-
867.  
3. Pagani R. et al. (1994) BBA 1204, 250-256. 
4. Okumura K. et al. (1967) Vitamins 35, 301-307. 
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IDENTIFICATION OF INOSINE NUCLEOTIDES IN 
CELLULAR RNA BY AN HPLC-LINKED METHOD: 
POSSIBLE UTILIZATION IN THE STUDY OF mRNA 
EDITING   
A.. Guerrini, G. Jacomelli, M.R. Corradi, M. Bertelli, G. 
Pompucci, V. Micheli 
Dipartimento di Biologia Molecolare – Università di Siena 
The presence of IMP in mRNA is due to the action of a 
specific class of RNA-adenosine deaminases (ADAR), 
present in different forms indicated as ADAR1, ADAR2 
and ADAR3. ADARs share the common characteristic of 
converting specific mRNA adenosine nucleotides into 
inosine ones by hydrolysis of the amine group. The 
mutated nucleotide is recognized as a guanosine 
nucleotide during translation, thus changing the triplet and 
often coding for a different aminoacid. This process, 
indicated as A-to-I RNA editing, leads to mutated proteins 
often resulting in significant functional consequences. 
RNA editing represents a finely regulated mechanism 
changing the readout of a gene within the primary RNA 
transcript.. ADARs are mainly expressed in nervous 
tissue and are known to edit mRNA of specific membrane 
receptors (e.g. glutamate and serotonine) thus modulating 
signal transduction.  
Molecular approach is usually used to detect RNA editing; 
this study presents a biochemical HPLC-linked method for 
qualitative and quantitative detection of IMP from RNA.  
Up to 1 mg RNA extracted from different biological 
sources (human blood;human and animal cell lines 
:HELA, 3T3, ADF, medulloblastoma) was hydrolysed by 
Nuclease P1 from Penicillum Citrinum (Sigma), releasing 
5’ phosphate nucleosides. Incubation was conducted in 
tris-HCl buffer pH 7,5, supplied with ZnCl2 as an enzyme 
stabilizer, either at 37°C (up to 150 mins) or 50°C (60 
mins). Protein-free perchloric extracts of assay mixtures 
were brought to neutrality and processed by RF-HPLC. 
Elution was conducted according to a modification of 
previously described methods [V. Micheli et al., Life Sci, 
1999]. Gradient elution using 0.1M KH2PO4 containing 
6mM TBA, pH 5,5 (eluant A) and methanol (eluant B) 
allowed the complete separation of released AMP, IMP, 
GMP, UMP and CMP in 12 minutes. Concentration and 
percent amount of each nucleotide could be calculated. 
IMP was only detectable in RNA from one blood sample, 
but not in other cells; IMP recovery reliability was checked 
by added internal standard in all samples.  
A-to-I RNA editing is known to follow specific events, 
such as cell differentiation [A.Barbon et al., Mol Brain 
Res, 2003] and may be altered in pathological processes 
[S. Kwak, et al., J Mol Med 2005]. The described method 
was demonstrated to be reliable in isolating and 
quantifying IMP from RNA, when present. This technique 
might provide a quick and unexpensive support to 
molecular investigations, particularly as a screening 
diagnostic tool. Investigations are in progress concerning 
disorders in which A-to-I editing is known or suspected to 
be altered, such as schizofrenia, Alzheimer and 
Huntington diseases, epilepsy and depression [C.M. 
Niswender et al., Neuropsychopharmacology, 2001] 
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MECHANISTIC STUDIES ON STRUCTURE AND 
FUNCTION OF CYTOSOLIC 5’-NUCLEOTIDASE (cN-II): 
EFFECTOR SITES AND SUBUNITS INTERACTION. 
R. Pesi, M.G. Careddu, S. Allegrini, E. Lazzari, G. Orsini, 
F. Zucchi , MG. Tozzi 
Dipartimento di Biologia, Università di Pisa, Pisa, Italia. 
CN-II is a bifunctional enzyme ubiquitously expressed in 
human tissues, with the highest levels of activity being 
expressed in several pathological conditions. CN-II shows 
a complex regulation system and the ability to catalyze 
both hydrolase and phosphotransferase activities. Both 
cN-II activities are involved in the regulation of 
intracellular availability of purine compounds1 and in the 
activation/inactivation processes of antiviral and 
antitumoral purine prodrugs2. CN-II is activated by ATP, 
ADP (high energy charge) and inhibited by phosphate3.
Hypotheses have been advanced that activators promote 
subunits aggregation . 
Site-directed mutagenesis allowed us to identify the 
catalytic motif and to assign cN-II as a member of HAD 
superfamily4. Recently, crystal structure of cN-II has been 
described5. Authors indicate the presence of two effector 
sites based on the interaction with adenosine. In order to 
unravel the specificity of each site for the several 
compounds involved in cN-II regulation, we constructed 3 
point mutants for putative effector sites and two point 
mutants for the site of interface between subunits. 
Preliminary results indicate that diadenosine 
tetraphosphate acts through interaction with both sites, 
while ATP seems to interact only with site 2. Site- directed 
mutagenesis on residues involved in subunit aggregation 
strongly affects the conformation of active site as judged 
by the alteration of Km for phosphotransferase substrate 
inosine. 
1. Ipata PL and Tozzi MG (2006) Purinergic Signalling 2, 
669-675. 
2. Galmarini CM et al (2003) Leuk Lymphoma 44, 1105-
1111. 
3. Pesi R. et al (1994) Arch. Biochem. Biophys. 312, 75-
80. 
4. Allegrini S. et al. (2004) Eur. J. Biochem. 271, 4881-
4891. 
5. Wallden K et al. (2007) J.B.C. 282 (24) 17828-17836.
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MECHANISTIC STUDIES ON STRUCTURE AND 
FUNCTION OF CYTOSOLIC 5’-NUCLEOTIDASE: 
POINT MUTANT Y55G. 
R. Pesi, M.G. Careddu, S. Allegrini, D. Filoni, E. Piccinini, 
M.G. Tozzi 
Dipartimento di Biologia, Università di Pisa, Pisa, Italia. 
CN-II is a bifunctional enzyme ubiquitously expressed in 
human tissues, with the highest levels of activity being 
expressed in several pathological conditions. CN-II shows 
a complex regulation system and the ability to catalyze 
both hydrolase and phosphotransferase activities. Both 
cN-II activities are involved in the regulation of 
intracellular availability of purine compounds1 and in the 
activation, inactivation processes of antiviral and 
antitumoral purine prodrugs2. CN-II is activated by ATP, 
ADP (high energy charge) and inhibited by phosphate3.
Site-directed mutagenesis allowed us to identify the 
catalytic motif and to assign cN-II as a member of HAD 
superfamily4. All members of the HAD superfamily share 
four highly conserved motifs in their otherwise dissimilar 
sequences, and similar structural folding with an ?/? core 
domain in which the active site is formed by four loops 
and a small cap domain for substrate recognition.  
Sequence alignment of cN-II with other members of 
5’-nucleotidases family suggested that the first conserved 
motif is involved not only in the formation of a covalent 
intermediate with phosphate but also in the transfer of the 
bound phosphate to a nucleoside acceptor. We, 
therefore, decided to generate a point mutant substituting 
a tyrosine residue in position 55 with a glycine. In fact, 
members of the family devoid of phosphotransferase 
activity possess a glycine in the corresponding position. 
The ability of the point mutant to operate a phosphate 
transfer was measured as function of several parameters 
such as the presence of activators, inhibitors and in 
combination (energy charge in the presence or absence 
of phosphate). Our results indicate that the mutant 
possess a very poor phosphotransferase activity, while 
every other kinetic characteristics of the enzyme remain 
unaltered. 
1. Ipata PL and Tozzi MG (2006) Purinergic Signalling 2, 
669-675. 
2. Galmarini CM et al (2003) Leuk Lymphoma 44, 1105-
1111. 
3. Pesi R. et al (1994) Arch. Biochem. Biophys. 312, 75-
80. 
4. Allegrini S., et al. (2004) Eur J. Biochem 271, 4881-
4891. 
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CHARACTERIZATION OF THE TRANSCRIPTIONAL 
REGULATOR OF THE NRTR FAMILY CONTROLLING 
NAD SALVAGE IN γ-PROTEOBACTERIA  
C. Mancini, L. Galeazzi, J. De Ingeniis, A. Amici, N. 
Raffaelli 
Istituto di Biotecnologie Biochimiche, Università 
Politecnica delle Marche, Ancona, Italia 
By using comparative genomic techniques to analyze 
conserved NAD biosynthetic operons we have recently  
identified a new family of Nudix-related transcriptional 
regulators (NrtR) in a broad range of bacteria1. NrtRs contain 
an N-terminal domain homologous to ADP-ribose (ADPR) 
pyrophosphatase of the Nudix family and a C-terminal 
domain which adopts a winged-helix turn helix fold found in 
many prokaryotic transcription factors1. While the Nudix 
domain is likely responsible for a specific binding of an 
effector molecule, the C-terminal domain binds to the 
operator sites of the regulated genes. The NrtR-binding sites 
were predicted in a variety of bacterial genomes, allowing in 
silico reconstruction of NrtR regulons that primarily include 
genes involved in various aspects of NAD metabolism1.
In some γ-proteobacteria, including Shewanella 
oneidensis, NrtR is predicted to control transcription of the 
prs-nadV operon, involved in nicotinamide (Nam) 
recycling to NAD. The operon codes for the PRPP 
synthesizing enzyme (Prs) and Nam 
phosphoribosyltransferase (NadV), which catalyzes the 
transfer of the phosphoribosyl moiety of PRPP to Nam 
forming NMN, the direct NAD precursor. Combination of 
prs and nadV into one functional unit would allow NMN 
synthesis from Nam, providing at the same time the 
phosphoribosyl donor PRPP. In order to functionally 
characterize Shewanella oneidensis NrtR (soNrtR), the 
corresponding gene has been cloned and over-expressed 
in E. coli. The specific binding of the regulator to the 
predicted DNA sites in  the upstream region of the prs-
nadV operon was demonstrated by both  electrophoresis 
mobility shift assay (EMSA) and  a fluorescence based 
thermal shift assay. The regulator was found to be a 
repressor, as revealed by assaying its effect on prs-nadV
operon transcription in vitro with σ70-saturated RNA 
polymerase from E. coli, following quantification of the 
resulting transcript by RT-mediated real-time PCR. The 
thermal shift assay was also used to analyze the binding 
of soNrtR to various NAD metabolites. The regulator 
showed the highest binding affinity (17 ?M) towards 
ADPR, phospho-ADPR and NAADP. These molecules 
were also the most effective in suppressing in vitro
binding of NrtR to its DNA target sequence and in 
preventing  the repressive effect of NrtR on transcription.  
The effect of ADPR on soNrtR suggests that the 
regulator might control NAD biosynthesis by sensing 
intracellular ADPR levels. Accumulation of ADPR in the cell 
might be interpreted as a signal to replenish NAD pool, as 
ADPR is formed together with Nam from the enzymatic 
hydrolysis of NAD. Binding of ADPR to NrtR would promote 
dissociation of NrtR-DNA complex, leading to derepression 
of NAD biosynthetic genes transcription. In vivo functional 
studies are in progress to verify this model. 
1. Rodionov DA, Ingeniis JD, Mancini C, Cimadamore F, 
Zhang H, Osterman AL, Raffaelli (2008)  Nucleic Acid 
Research 36, 2047-59 
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DIHYDROFOLATE REDUCTASE BY SPERMINE 
G. S. De Fronzo, M. R. Carradori, P. Natalini, S. 
Vincenzetti, V. Polzonetti, L. Signorello, A. Vita, and S. 
Pucciarelli. 
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Multiple intermediates and conformations are general 
characteristics of enzyme catalysis and allosteric 
regulation. Dihidrofolate reductase (EC 1.5.1.3), an 
enzyme ultimately involved in DNA biosynthesis, is 
recognized to possess structural features able to guide 
the substrate (dihydrofolate) and cofactor (NADPH) 
through the preferred catalytic pathway by specific active 
site conformational changes, modulated by long range 
interloop interactions1. In this study we examined the 
modulatory effect of natural polyamines (putrescine, 
spermidine and spermine) on the enzymatic activity of 
dihydrofolate reductase overexpressed and purified from 
E. coli. Polyamines are charged molecules essential for 
cell life and found to be involved in many biological 
processes like cell growth, regulation of gene expression 
and cell signalling2. Many molecular aspects of 
polyamines function remain still to be clarified; the aim of 
this study was to investigate a possible role of polyamines 
as regulators of cell cycle by directly interacting with the 
key enzyme of folate metabolism, and directly involved in 
nucleotide biosynthesis. The results reported by our study 
shown a partial inhibition effect exerted by spermine on 
dihydrofolate reductase from E. coli at pH 7.3 and 30 °C. 
Partial inhibition can be interpreted as the conversion of 
the enzyme from a fast to a slow kinetic form, still able to 
catalyze the transformation of the substrate to product, 
even if at lower rate. From the fractional-velocity plots, 
spermine resulted to behave as a partial non-competitive 
inhibitor of E. coli DHFR with respect to dihydrofolate, with 
a Ki of 335 ?M. Analysis of the temperature dependence 
of the catalytic constant in presence of spermine 
confirmed the effect of the polyamine in increasing the 
activation energy of the reaction catalyzed by 
dihydrofolate reductase. The structural aspects of the 
partial inhibition of DHFR by spermine have been 
analyzed by performing a pH screening of the inhibitory 
effect. Our data clearly demonstrate that the spermine 
does modulate the enzymatic activity of dihydrofolate 
reductase from E. coli by stabilizing, through weak 
interactions, a kinetically slower conformation of the 
protein. This kind of enzymatic modulatory effect is worth 
to be investigated in order to understand cellular 
signalling regulation and to design new multi-target drugs. 
1. Jason R. Schnell, H. Jane Dyson, and Peter E. Wright. 
(2004) Structure, dynamics and catalytic function of 
dihydrofolate reductase. Annu. Rev. Biophys. Biomol. 
Struct. 33: 119-140 
2. T. Thomas and T. J. Thomas. (2001) Polyamines in 
cell growth and cell death: molecular mechanisms and 
therapeutic applications. CMLS, Cellular and 
Molecular Life Sciences 58: 244-258 
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Despite its strict anaerobic nature, M. acetivorans
genome hosts genes that can be related to O2
metabolism; among these, an open reading frame 
encodes for a “protoglobin” (NP_617780; Pgb). Pgbs are 
single domain heme proteins of ~195 amino acids, related 
to the N-terminal domain of archaeal and bacterial globin 
coupled sensor proteins (GCS)1-3.
Sequence comparisons indicate that Pgbs, despite 
their 30-35% larger size, are structurally related to the 
single chain hemoglobins (composed of about 150 amino 
acids, folded into a 3-on-3 a-helical sandwich,12-16% 
residue identity to Pgbs), and to the heme-based 
aerotaxis transducer sensor domain of Bacillus subtilis
GCS. Pgbs bind O2, CO, and NO reversibly in vitro. 
Although functional and evolutionary issues are openly 
debated1-3, Pgb may facilitate O2 detoxification in vivo 
promoting electron transfer to O2, or may act as CO 
sensor/supplier in methanogenesis. 
We report here the 1.3 Å crystal structure of 
oxygenated M. acetivorans protoglobin, together with first 
insight into its ligand binding properties4. We show that 
Pgbs are composed of a single heme-binding domain 
strongly related in tertiary and quaternary structure to the 
N-terminal domain of archaeal and bacterial GCSs. 
Furthermore, contrary to all known globins, protoglobin-
specific loops and a N-terminal extension completely bury 
the heme within the protein matrix. Structural modulation 
of the globin fold in Pgb translates into entirely new 
access routes to the heme, which is granted by 
protoglobin-specific apolar tunnels reaching the heme 
distal site from locations at the B/G and B/E helix 
interfaces.  
The high experimental resolution of the Pgb structure 
provides unequivocal evidence of substantial distortion in 
the porphyrin ring system, which suggests a proactive 
role of Pgb in modulating heme reactivity (e.g. chemical 
and photophysical properties, axial ligand affinity, O2 off-
rates, redox potentials) providing a mechanism for 
differentiating between CO and O2 binding. 
1. Freitas T.A.K. et al. (2004) Proc. Natl. Acad. Sci. USA 
101, 6675-6680. 
2. Vinogradov S.N. et al. (2006) BMC Evol. Biol. 6, 31. 
3. Vinogradov S.N. et al. (2007) GENE 398, 132-142. 
4. Nardini M. et al. (2008) EMBO Reports 9, 157-163. 
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ON THE OLIGOMERIZATION STATE OF THE 
SCAFFOLDING PROTEIN GEPHYRIN. 
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Recent studies have revealed the importance of lateral 
diffusion on the plasmamembrane for the regulation of 
neurotransmitter receptor number at synapses, and thus 
for the modulation of synaptic strength. Great attention 
has been especially paid to factors underlying the 
confinement and clustering of the receptors, i.e. the 
cytoplasmic scaffolding proteins present at the 
postsynaptic terminal. Among these, gephyrin has a 
major role in anchoring and stabilizing the glycine 
receptor (GlyR) at inhibitory postsynaptic sites. Isolated 
N- and C-terminal domains (G and E) of gephyrin can 
form trimers and dimers, respectively, and thus contribute 
to the formation of sub-membranous gephyrin clusters 
found at synapses.  
Here, we investigate how the expression of constructs 
able to modify the oligomerization state of gephyrin can 
affect GlyR dynamics. These constructs include the 
isolated E and G domains, and a natural gephyrin splice 
variant that has a decreased propensity to form trimers. 
Experiments were carried out in spinal cord neurons and 
COS7 cells. A reduction of the size and number of 
gephyrin-GlyR clusters was found in both cell types 
expressing the various constructs. To determine the 
dynamic properties of gephyrin and the constructs, 
fluorescence recovery after photobleaching (FRAP) of 
mRFP and YFP tagged proteins was performed in spinal 
cord neurons. Although the different constructs have 
relatively fast rates of recovery, they do not alter the 
exchange rate of wild-type gephyrin. This result shows 
that gephyrin and the constructs are at steady state and 
the remaining clusters are mainly constituted by full-
length gephyrin. The GlyR was immunochemically bound 
to quantum dots (QDs), very small and photostable 
fluorescent probes, and real-time SPT was used to 
analyze the mobility of the receptor. We demonstrate that 
gephyrin-GlyR complexes are present in the extra-
synaptic compartment. The presence of isolated G and E 
domains can interfere with gephyrin oligomerization and 
increase the mobility of these complexes. Over-
expression of the variant results in a similar increase in 
the lateral diffusion of GlyR.  
We therefore provide direct evidence that the 
reduction in the amount of synaptic GlyR following 
expression of the gephyrin variant results from the 
formation of extra-synaptic gephyrin-GlyR complexes, 
which diffuse freely in the plasmamembrane. These 
findings may implicate the variant in the endogenous 
regulation of GlyR dynamics and trafficking. The 
oligomerization properties of gephyrin not only contribute 
to the formation of gephyrin clusters, but also affect the 
lateral diffusion of the glycine receptor in the extra-
synaptic compartment. 
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Characterized rhodanese-like proteins in vitro catalyse 
the transfer of a sulfur atom from a suitable sulfur donor 
(e. g. thiosulfate for rhodaneses) to cyanide, with 
concurrent formation of thiocyanate1. Genome 
sequencing analysis has clustered at least 3000 proteins 
in the rhodanese domain homology superfamily (Pfam 
Acc. N.: PF00581). The physiological role of these 
proteins is still elusive, although in vitro studies with rat 
mercaptopyruvate sulfurtransferase2, and proteomic 
analyses3-4 pointed to a possible relevance of specific 
rhodanese-like proteins in processes related to oxidative 
events. 
Among the redundant rhodanese-like proteins of 
Azotobacter vinelandii, the tandem domain protein RhdA 
contains an active-site motif not commonly found in 
rhodanese-domain proteins. Preliminary phenotypic 
characterization of an A. vinelandii mutant strain in which 
rhdA was deleted, evidenced that RhdA protected Fe-S 
enzymes that are easy targets for oxidative damage5.
To explore a possible role of RhdA in maintaining 
redox homeostasis in A. vinelandii, the expression of 
RhdA was evaluated in cell cultures grown under 
conditions of induced oxidative stress. The analyses of 
mRNA for RhdA and immunodetectable RhdA were 
performed in RNA extracts and in crude extracts  of A. 
vinelandii cell cultures grown either in the absence 
(control samples) or in the presence of  the oxidative 
agent phenazine methosulfate (15 ?M). A two-step 
Reverse Transcription PCR (RT-PCR) was used for 
semiquantification of rhdA mRNA. We found that rhdA
transcript was more abundant (2-fold) in A. vinelandii cells 
grown under oxidative stress conditions than in control 
growth conditions. Western blot analyses with anti-RhdA 
antibody did not revealed an increase of RhdA protein in 
conditions of induced oxidative stress. A possible 
modification involving the RhdA Cys230 catalytic thiol was 
suggested by measurements of the thiosulfate:cyanide 
sulfurtransferase activity in extracts from PMS-treated  
cells. 
Taken together, these results support the hypothesis 
that RhdA helps A. vinelandii in maintaining cellular redox 
balance, and that  events related to sulphur redox 
chemistry could increase oxidative-induced RhdA 
turnover.  
1. Westley et al. (1983) Fundam. Appl, Toxicol. 3, 377-
382. 
2. Nagahara et al. (2007) J. Biol. Chem. 282, 1561-1569. 
3. Santos et al. (2004) Proteomics 4, 2640-2652. 
4. Krivobok et al. (2003) J. Bacteriol. 185, 3828-3841. 
5. Cereda et al. (2007) FEBS Letters 581, 1625-1630. 
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Mycobacterium tuberculosis NADPH-ferredoxin reductase 
(NFR or FprA)1, is a FAD-containing oxidoreductase, 
homologous to mammalian adrenodoxin reductase (AdR). 
The bacterial enzyme has been proposed to play a major 
role in the lipid metabolism of the pathogen, as a source 
of reduced ferredoxin(s) to sustain the activity of its 
several cytochrome P450s. 
The resolution of the crystal structure2 of NFR allowed 
us to identify two ionisable residues (D161 and E211) 
located in the active site and potentially involved in 
catalysis of hydride transfer. In order to evaluate the role 
of these residues, we produced six variants of the 
enzyme carrying various single point mutations (E211A, 
E211D, E211Q, D161A, D161E, D161N). All NFR forms 
were overproduced in E. coli
We were able to isolate all E211 mutants in 
holoenzyme form. Their functional characterization 
indicated that E211 plays a significant but non-essential 
role in substrate binding, resulting in a moderate 
contribution to catalysis. On the contrary, the variants 
carrying a substitution at position 161 could only be 
isolated as apoenzymes. Indeed, all D161 variants 
undergo loss of FAD prosthetic group during purification, 
making impossible any kinetic characterization. Moreover, 
attempts to reconstitute the holoenzyme adding 
exogenous FAD were unsuccessful. These results 
indicate a critical role for the D161 side chain in the 
stabilization of the NFR native conformation and in FAD 
binding. 
Since the side chain of D161 forms a salt bridge with 
R164, it was argued that replacement of the former 
residue with a neutral one, could induce a reorganization 
of the orphan Arg side-chain, resulting in destabilization of 
the native conformation. Thus, two additional NFR 
variants were produced, carrying either a single mutation 
(R164A) or a double mutation (D161A/R164A). Both 
mutants turned out to be highly unstable, suggesting that 
both member of the ionic couple D161/R164 are critical 
for the stability of the enzyme. These results indicate that 
most of the ionisable residues located at active site of 
NFR are more important for maintaining the native 
conformation of the enzyme than for its catalytic activity. 
1. Fischer F. et al. (2002) Eur. J. Biochem. 269, 3005-
3013. 
2. Bossi R.T. et al. (2002) Biochemistry 41, 8807-8818. 
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Apicomplexan parasites harbor a specific organelle, 
named apicoplast, which is related to plant non-
photosynthetic plastids and displays a plant-like 
metabolism. The apicoplast has been shown to contain 
typical vegetal proteins, such as ferredoxin–NADP+
reductase (FNR) and ferredoxin (Fd)1-2. Both proteins 
from Plasmodium falciparum (PfFNR and PfFd) have 
been produced in recombinant form and characterized3.
The PfFNR/PfFd couple was shown to be catalytically 
active in vitro yielding reducing power to support the 
activity of LytB4, the last enzyme of the biosynthetic 
pathway for isoprenoid precursors, a known site of action 
of antiplasmodial compounds. On this basis, PfFNR has 
been proposed as a possible target for new antimalarial 
drugs2.
The three-dimensional structure of PfFNR has been 
determined by X-ray crystallography3. Compared to other 
plastidic-type FNRs, PfFNR displays a significantly lower 
catalytic efficiency and lower selectivity against NADH. 
These functional features are probably the consequence 
of the lack of protein positive charges stabilizing the 2’-
phosphate of the bound substrate. NADP(H) binding to 
PfFNR occurs through an induced-fit mechanism never 
observed in other FNRs. The conformational changes 
induced by binding to the enzyme of 2’-P-AMP, a NADP+
analogue, includes the partial unwinding of an ?-helix 
localized in the NADP+-binding domain. Furthermore, the 
binding of NADP+ triggers the formation of a disulfide-
stabilized homodimer resulting in the inactivation of 
PfFNR. This process, observed in vitro, could represent a 
physiologic mechanism regulating the enzyme activity. 
Structure-based design of PfFNR inhibitors is in progress 
and has already yielded some active compounds, with 
inhibitory constants in the range of micromolar or lower. 
1. Pandini V. et al. (2002) J. Biol. Chem. 277, 48463-
48471
2. Seeber F. et al. (2005) Curr. Phar. Des. 11, 3159-
7312
3. Milani et al. (2007) J. Mol. Biol. 367, 501-513 
4. Röhrich R.C. et al. (2005) FEBS Lett. 579, 6433-6438 
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Amides, esters, and ethers of long-chain polyunsaturated 
fatty acids, collectively referred to as “endocannabinoids”, 
represent a growing family of lipid signaling mediators found 
in several tissues with a wide variety of biological actions. 
The main members of this group of molecules are 
anandamide (N-arachidonoylethanolamine, AEA) and 2-
arachidonoylglycerol. Fatty acid amide hydrolase (FAAH) is 
a typically membrane enzyme that catalyzes the conversion 
of AEA into arachidonic acid and ethanolamine, thus 
terminating the signaling of this endocannabinoid1. The 
homodimeric structure of FAAH has been deducted as a 
biological unit from the crystallographic structure of a mutant 
rat enzyme (DTM-FAAH), a catalytically active form still able 
to bind the membranes even if missing the a-helices mainly 
responsible for this interaction. Until now, direct information 
on FAAH aggregation state in solution and in the presence of 
inhibitors, substrate analogues, or lipids is still lacking. 
In this study we analyzed the oligomerization state of 
DTM-FAAH in solution by small angle X-ray scattering 
(SAXS). We found that, among several effectors, high 
concentrations of Tris buffer (? 0.5 M) are able to stabilize 
monodisperse oligomers. Data analysis shows that these 
oligomeric structures have a value of radius of gyration of 
129±13 Å, as calculated from the p(r) function (in 
accordance with the Guinier analysis) and a value of the 
maximum dimension of the particle (Dmax) of about 410±10 
Å. Superimposing the crystallographic unit of FAAH (pdb 
entry 1MT5.pdb), which is an octamer of dimers, to the low 
resolution DAM model of our oligomers, we observed that 
these last are composed of three octamers revealing an 
unprecedented oligomerization state of FAAH in solution. 
Furthermore, we studied the structural effects of different 
FAAH inhibitors observing an increase of the 
oligomerization state of the protein in the presence of these 
molecules. Then we paralleled this structural information 
with a functional analysis of the enzyme investigating the 
role of these inhibitors in modulating the membrane 
association of FAAH using both fluorescence resonance 
energy transfer measurements (FRET) and Laurdan 
fluorescence. Taken together, the complementary 
information collected allowed to understand the molecular 
mechanisms leading to FAAH function. It also revealed the 
presence of an unprecedented oligomerization state of 
FAAH and a key role of inhibitors in favouring the subunit-
subunit interactions that may impair the FAAH activity. 
1. Mei G. Di Venere A. Gasperi V. Nicolai E. Masuda K. 
R. Finazzi Agrò A. Cravatt B. F. and Maccarrone M. 
(2007) J. Biol. Chem. 282, 3829-3836. 
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Lipoxygenases are non-heme, non-sulfur iron containing 
enzymes that catalyze the dioxygenation of polyunsatured 
fatty acids containing one or more pentadiene systems to 
the corresponding hydroperoxy derivatives. Structural 
studies in solution of the mammalian and plant enzyme 
revealed that the latter has a more stable and compact 
conformation1. As yet, metal atom extraction, 
reconstitution and substitution with vicariate metals have 
not been successfully applied to soybean lipoxygenase-1, 
because of the highly buried position of the iron atom 
within the active site. Tryptic digestion of lipoxygenase-1 
and the subsequent isolation of the 60 kDa C-terminal 
region allowed to generate a “mini-lipoxygenase-1 
(miniLOX)” that retains the catalytically active iron, but in 
a more accessible position2. In this study, we investigated 
by near-UV-circular dichroism and fluorescence 
spectroscopies the structural and functional effects of iron 
removal, reconstitution and vicariation in miniLOX. 
Moreover, we report the kinetic analysis and the 
membrane binding ability of the apo- and metal-
substituted forms of miniLOX, using fluorescence 
resonance energy transfer and monolamellar vesicles. 
Taken together, these data demonstrate an 
unprecedented structural role of iron, which is involved 
not only in the catalytic activity but also in the membrane 
binding ability of lipoxygenase-1. 
1. Dainese E. Sabatucci A. van Zadelhoff G. Angelucci 
C. B. Vachette P., Veldink G. Finazzi Agrò A. and 
Maccarrone M. (2005). J. Mol. Biol. 349, 143-152. 
2. Maccarrone M. Salucci M. L. van Zadelhoff G. 
Malatesta F. Veldink, G. Vliegenthart J. F. and Finazzi 
Agrò A. (2001). Biochemistry 40, 6819-6827. 
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Carcinogenesis is a multistep process associated with 
accumulated genetic alterations in somatic cells.  
Reactive oxygen species (ROS) may participate in the 
multistage carcinogenesis from initiation to malignant 
conversion by causing oxidative DNA damage and 
mutations in proto-oncogenes and tumour suppressor 
genes, and by activating signal transduction pathways1.
Since many human neoplasms have shown significant 
changes in superoxide dismutase (SOD) and catalase 
(CAT), we have investigated them in healthy gastric 
tissues respect to  adenocarcinoma,  Helicobacter pilory
(HP), autoimmune-atrophic-gastritis (AAG) and chronic 
gastritis (CG) mucosa. 
MnSOD activity significantly increased in 
adenocarcinoma, CG and HP tissues respect to healthy 
control. Cu/ZnSOD was significantly lower in 
adenocarcinoma and HP tissues respect to healthy 
control. Parallel MnSOD activity, with respect to 
Cu/ZnSOD, is 3-4 fold higher in HP and tumours samples 
respectively. Relatively to the expression, MnSOD and 
Cu/ZnSOD are significantly more expressed in 
adenocarcinoma and HP tissues and less expressed in 
CG tissues respect to control group. A significant 
decrease in CAT activity in adenocarcinoma and HP 
tissues was observed. 
SODs are correlated with the degree of cancer 
differentiation but their biological significance in gastric 
cells is unclear2. Indeed only MnSOD is associated with 
poor survival in carcinoma patients suggesting different 
regulatory mechanisms between SODs isoforms. In 
conclusion our data suggest a specific condition of stress 
in HP and cancer and partially in CG tissues due to SOD 
increase and low levels of CAT. This state establishes an 
apoptotic intracellular environment  characterized by 
several mutations, cell transformations and cancer, 
confirming the importance to detect an early signal 
involved in neoplasms development. 
1. Cerruti P. et al (1994) Environ. Health Perspect. 
102(10): 123-129. 
2. Kim J.J. et al (2002) Phatobiol. 70:353-360. 
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Nowadays there is a strong interest in partly folded or even 
fully disordered or natively unfolded proteins, since these 
protein states can have a role in the proper functioning of 
proteins1. However, the analysis of protein structural disorder 
is quite problematic and, to this aim, physicochemical and 
computational techniques for identifying and characterizing 
protein conformational disorder are being explored2. In a 
series of papers from our laboratory we have demonstrated 
that limited proteolysis experiments can be successfully used 
to probe conformational features of proteins. This approach 
relies on the fact that the sites of limited proteolysis along a 
polypeptide chain are characterised by enhanced backbone 
flexibility and, therefore, proteolytic probes can pinpoint the 
sites of local unfolding or protein disorder in a protein chain. 
The first indication that limited proteolysis correlates with 
protein locall dynamics was established by us two decades 
ago using thermolysin as an experimental test3.
We have successfully used the limited proteolysis 
technique for the analysis of the molecular features of 
several partly folded proteins and, in particular, for the 
identification of disordered regions within otherwise folded 
globular proteins. A striking correlation was found 
between sites of limited proteolysis and sites of enhanced 
chain flexibility of the polypeptide chain, this last 
evaluated by the crystallographically determined B-factor. 
In crystal structures of proteins, the B-factor reflects the 
uncertainty in atom positions in the 3D protein model and 
often represents the combined effects of thermal 
vibrations and static disorder. When plotted against 
residue number, B-factor values provide a graphic image 
of the degree of mobility existing along the polypeptide 
chain.  
We have now found that limited proteolysis very often 
occurs at chain regions characterized by missing electron 
density, thus indicating unfolding of these regions. In 
general, a clear-cut correlation exists between sites of 
limited proteolysis and sites of flexibility/disorder in a 
dozen of proteins for which the crystallographic structure 
is known. Here, we show only a couple of examples, but 
the generality of the approach has been substantiated 
with a dozen of protein systems.  
We conclude that limited proteolysis is a very useful 
and reliable experimental technique that can detect sites 
of disorder in proteins, thus complementing the results 
that can be obtained by the use of other physicochemical 
(X-ray, NMR, hydrogen-deuterium exchange) and 
computational approaches.  
1. Uversky, V. N., et al. (2005) J. Mol. Recognit. 18, 
343–384. 
2. Tompa, P. (2002) Trends Biochem. Sci. 27, 527–533. 
3. Fontana, A., et al. (1986) Biochemistry 25, 1847–
1851. 
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NAD is an essential molecule in all living organisms. In 
many eubacteria, including several pathogens, the first 
two steps in the de novo synthesis of this important 
cofactor are catalyzed by the so called quinolinate 
synthase complex made by L-aspartate oxidase (NadB) 
and quinolinate synthase (NadA). Despite the important 
role played by these two enzymes in NAD metabolism, 
many of their biochemical and structural properties are 
still largely unknown. In the present study we cloned, 
over-expressed and  characterized NadA and NadB from 
B. subtilis, one of the best studied bacteria and a model 
for low-G-C Gram-positive bacteria including pathogens. 
Our data add new information regarding the NadA 
cofactor and the interaction between NadA and NadB. In 
particular, it is demonstrated that the cofactor for NadA 
from B. subtilis is a [4Fe-4S] cluster and for the first time 
the cysteines involved in the cluster binding are identified. 
All together the data suggest that in NadA from B. subtilis
the [4Fe-4S] cluster is coordinated by three highly 
conserved cysteine residues (C110, C230, C320) 
suggesting that NadA presents a new non canonical 
binding motif that, based on sequence alignment studies, 
may be common to all the quinolinate synthases from 
different sources. Moreover, the results show for the first 
time that the interaction between NadA and NadB is not 
species-specific and that the integrity of the Fe-S cluster 
may be important for the binding of iminoaspartate to 
NadA. 
15.11 
PROTEOMIC ANALYSIS OF XENOPUS EMBRYOS 
EXPOSED TO SIMULATED MICROGRAVITY 
S. Nonnis1, L. Pagliato1, A. Negri1, M. Negroni 2 , S. 
Ronchi1, A.M. Rizzo2 , G . Tedeschi1
1
D.I.P.A.V. - Section of Biochemistry, University of Milano, 
Via Celoria 10, 20100 Milano, Italy  
2
I.F.G.C.B – University of Milano, via Trentacoste 2, 
20134 MIlano, Italy 
Exposure to space-flight environment, notably 
microgravity and radiations, can induce rapid changes in 
living systems that are similar to changes occurring during 
ageing. Indeed ageing and life in space are both 
associated with the same undesirable effects on normal 
physiological processes, such as increased stress 
hormones, altered musculoskeletal system structure and 
function, altered inflammatory response and mitochondrial 
function with increased oxidative stress. Because of 
special requirements, only few animal systems are 
suitable for space experiments. In particular, we decided 
to use Xenopus laevis as a model, because it is a 
vertebrate and the embryos possess some of the 
advantages of both animal and cells systems. They are 
easily produced in large number by in vitro fertilisation, 
can be kept in Petri dishes, develop at room temperature 
in fresh water and do not need to be fed during the first 
few days of development. 
Xenopus embryos of different ages (3 and 6 days) 
were exposed to simulated microgravity for different 
periods; morphology and enzymatic activities were 
measured after the treatment revealing that the embryos 
exposed to microgravity have axial malformations and a 
potentiation of GSH system (see poster by AM Rizzo et 
al.). To better investigate the proteins involved in this 
process, a proteomic approach was applied. Two-
dimensional protein maps were obtained for head and 
tails of Xenopus embryos exposed to microgravity (RPM). 
Two-dimensional map of Xenopus embryos grown in 
normal condition was kept as a control (CTR).  
In details: frozen embryos were suspended in 500 ?l
of lysis buffer (15 mM Tris-HCl at pH 6.8 plus 150 ?g
PMSF) on ice. Mechanical lysis was done with a Potter 
homogenizer, the soluble fraction obtained was diluted 
with 500 ?l of lysis buffer. To delipidate the sample, 1 ml 
of Freon was added, after vigorous stirring the material 
was centrifuged at 4°C for 15 min a 15000 rpm. The 
upper material was recovered, the protein content dosed 
by BCA-assay and then precipitated with cold acetone on 
ice. After 30 min of incubation, the precipitate was 
collected and stored at -80°C until use. 
For 2D-PAGE each fraction was resuspended in an 
appropriate volume of sample buffer (1% DTE, 4% 
CHAPS, 8 M Urea, 35 mM Tris and a trace of 
bromophenol blue). For analytical purposes, 200 ?g of 
protein were loaded on each IPG strip (pH 3-10 NL, 18 
cm). 1 mg was loaded for semipreparative 2DE. For the 
first dimension the total voltage applied was 74.65 kV at 
9°C; the second dimension was performed at 40 mA per 
gel at 9°C. The gels obtained were visualized by silver or 
blue colloidal staining. All the spots that appeared to be 
different between CTR gels and RPM gels were 
destained and digested with trypsin at 37°C for mass 
spectrometry identification.  
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Over the years protease inhibitors (PIs) have been 
established as an effective natural protective system of 
plants. Their use as an alternative natural source of drugs 
for the treatment of some medical conditions is of growing 
interest. 
The aqueous protein extract of Mucuna pruriens 
seeds has been reported to be active against Echis 
carinatus snake venom. It is reported that it contain the 
kunitz-type of serine protease inhibitor1.
Snake venom is made up of a complex mixture of 
toxins, amongst which are metalloproteases and serine 
proteases. These components has been studied over the 
years. 
As a continuation of our efforts to fully elucidate the 
anti-snake venom properties of Mucuna pruriens, we 
studied the anti-protease activity of MPE against venom 
proteases and compare them with standard  proteases 
like trypsin and chymotrypsin. We compared the reduction 
in enzymatic activity after incubation of these enzymes 
with the extract. Spectrophotometric assay using 
chromogenic substrates was used to measure the kinetics 
and level of inhibition of these proteases. 
Protein–Protein interaction of standard proteases (1:1 
molar ratio) leading to formation of complexes was 
studied, after pre-incubation of 30, 60 and 120 minutes 
with MPE. Elution  profiles were monitored based on 
absorbance at 280nm.  
The anti-protease activity of MPE against snake 
venom proteases was again studied using in vitro 
incubation assay. In this case, three incubation mixtures 
were prepared one containing ecarin and prothrombin; 
the second, P and prothrombin, and the third had a 2 ?l of 
a 1 hr pre-incubated mixture of P and ecarin (equivalent 
to 0.1 ?g P and 0.1 ?g ecarin) and of  prothrombin. All 
mixtures were incubation for 1 hr at 37°C. The mixtures 
were then separated on SDS-PAGE. 
Zymography was also employed to study anti-
protease activity of MPE against venom proteases after 1 
hr pre-incubation of venom protease with MPE. 
In conclusion, using different experimental approach 
we observed that our Mucuna pruriens seed extract 
contains protease inhibitor that interacts with Echis 
carinatus venom proteases.  
1. Guerranti R., Aguiyi J.C., Ogueli I.G., Onorati G, Neri 
S., Rosati F., Del Buono F.,   Lampariello R., Pagani 
R., Marinello E. Biochem. Biophys Res Commun. 
2004 Oct 15; 323 (2):484-90. 
15.13 
PROTEOMIC ANALYSIS AS NEW RESEARCH TO 
IDENTIFY VULNERABLE PLAQUE 
R. Pagani (1) , I. Ciari (1), C. Felici (1), L. Terzuoli (1), G. 
de Donato (2), M. Giubbolini (2), C. Setacci (2), C. Banfi 
(3), M. Brioschi (3), E. Tremoli (3), B. Porcelli (1) 
(1) Dipartimento di Medicina Interna, Scienze Endocrino-
Metabioliche e Biochimica, Università degli Studi di Siena, 
Siena, Italia 
(2) Unità di Chirurgia Vascolare ed Endovascolare, 
Università degli Studi di Siena, Siena, Italia 
 (3) Dipartimento di Scienze Farmacologiche, Università 
degli Studi di Milano, Milano, Italia  
The non-invasive recognition of a vulnerable plaque at an 
early stage and before an acute clinical event is very 
difficult.  
In such an early stage markers that play a 
fundamental role in the formation and progression of a 
plaque would be appropriate, but for this type of study 
proteomic analysis of the plaque as a whole is still 
difficult, due to its heterogeneous cellular composition and 
abundance of plasma proteins. In a previous study1, we 
proposed a new strategy for studying plaque proteomes, 
which makes it possible to select the proteins exclusive to 
plaques, by constructing a synthetic reference gel. The 
aim of this study is to verify the possibility of comparing a 
sample of interest from a carotid plaque with the synthetic 
reference gel. 
Samples of different types of carotid artery plaque 
were obtained from 10 patients (4 symptomatic, average 
age 74years) after carotid endarterectomy. We matched 
the spots of the synthetic gel of the plaque pool with the 
spots of the removed carotid plaque pool, in order to only 
select spots exclusive to plaques from the 2D-
electrophoresis of the plaque pool. We selected some 
spots from among the exclusive ones and identified them 
by mass spectrometry(MS). 
Among the spots exclusive to the plaque pool, as first 
approach, were identified by MS six proteins: haptoglobin-
related protein, superoxide dismutase, AMBP protein, 
Rho GDP-dissociation inhibitor1, tropomyosin alpha-4 
and osteoglycin. Some of these proteins are involved in 
transport, others take part in elimination of toxic radicals, 
others are metabolic enzymes or structural proteins. 
We proposed a new strategy for studying plaque 
proteome, which makes it possible to select the proteins 
exclusive to plaques via the construction of a synthetic 
reference gel. The results presented are an example of 
the application of this new approach, demonstrating that 
the reference gel makes it possible to select only the 
spots exclusive to plaques in any sample of interest. This 
new approach could identify novel markers of lesions 
which could be associated with plaque instability. 
1. Terzuoli L., Felici C., Ciari I., Guerranti R., Pagani R., 
Marinello E. and Porcelli B. (2007) Int J 
Immnunopathol Pharmacol 20:637-642.  
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Mycobacterium tuberculosis glutamyl-tRNA synthetase 
(Mt-GluRS) is an essential enzyme which provides Glu-
tRNAGlu for protein biosynthesis and for that of δ-
aminolevulinic acid (ALA), the first common precursor of 
tetrapyrrole biosynthesis.  
Soluble recombinant protein was obtained in large 
amounts and purified to homogeneity. The catalytic 
properties of Mt-GluRS are being investigated using the 
well characterized  E. coli GluRS (Ec-GluRS) as a 
reference in order to highlight peculiar properties of the M. 
tuberculosis enzyme. The steady-state kinetic parameters 
of Mt-GluRS reaction were found to be similar to those 
exhibited by other GluRS  except for a higher value of the 
Km for L-Glu (2.7 mM instead of 0.1 mM for Ec-GluRS). 
The enzyme reaction mechanism and the Glu-AMP 
intermediate formation was studied by using a 
colorimetric method for pyrophosphate (PPi) detection, 
[3H]-labelled ATP and chromatographic separation of 
reaction components and by monitoring the [32P]-PPi-ATP 
exchange reaction. Mt-GluRS was shown to catalyze the 
formation of Glu-AMP only in the presence of bound 
tRNAGlu as reported for GluRS from other sources. 
Among the several GluRS substrate and product analogs 
tested, only the reaction product PPi and the Glu-AMP 
analog glutamol-AMP (GOM) had an effect on GluRS 
activity.  PPi was a non competitive inhibitor with respect 
to ATP, in agreement with the observed [32P]-PPi-ATP 
exchange. GOM was a competitive inhibitor with respect 
to both L-Glu and ATP (Ki 3.9 and 1.5 ?M, respectively) 
suggesting random binding of these substrates to the 
enzyme•tRNA complex. At variance with other GluRS, Mt-
GluRS was found to catalyze the hydrolysis of ATP to 
ADP+Pi in the absence of tRNA and Glu, although at a 
rate of 5.1 min-1, corresponding to only 4% of the turnover 
rate of the physiological reaction. 
Analysis of M. tuberculosis genome revealed the 
absence of genes encoding Gln-tRNAGln synthetase 
indicating that Mt-GluRS belongs to the class of the non 
discriminating GluRS, which misacylate tRNAGln with L-Glu 
forming Glu-tRNAGln. The misacylation is corrected by the 
specific amidotransferase generating Gln-tRNAGln. Genes 
encoding the amidotransferase have indeed been identified 
in M. tuberculosis genome. However, the overexpression of 
Mt-GluRS in E. coli, which expresses a Gln-tRNAGln
synthetase and lacks the amidotransferase, was not toxic, 
raising the question of the tRNA specificity of Mt-GluRS. 
Genome analyses indicated that in M. tuberculosis ALA 
is formed from Glu-tRNAGlu by glutamyl-tRNA reductase 
(GluTR), in the presence of NADPH, and glutamate 1-
semialdehyde aminomutase in the so-called C5 pathway. 
Thus, we tested the hypothesis of the possible formation of 
a complex between GluRS and GluTR, which would 
commit Glu-tRNAGlu to tetrapyrrole biosynthesis as 
opposed to protein synthesis. By affinity chromatography 
with immobilized His-tagged forms of GluRS or of GluTR as 
the bait to fish out the second enzyme, we obtained data 
consistent with complex formation. 
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Several studies have shown that fatty acids can induce 
the formation of toxic aggregates in some amyloidogenic 
proteins involved in neurodegenerative diseases. In 
particular, it has been demonstrated that oleic acid (OA) 
can induce the formation of oligomers in proteins such as 
tau1, superoxide dismutase2 and amyloid ?-peptide3.
Here, we have studied the interaction of OA with horse 
heart apomyoglobin (apoMb), which is not related to any 
pathology. This single chain and disulfide-free 153-
residue protein is extensively used since decades as a 
model for studies of protein structure, folding, misfolding 
and aggregation. The interaction of OA with apoMb (1:10 
molar ratio) leads to the formation of an apoMb/OA 
complex given by protein oligomers, as evidenced by 
protein cross-linking experiments with glutaraldehyde 
followed by SDS-PAGE. Indeed, cross-linked oligomers of 
apoMb are formed in the presence of OA, while apoMb 
alone does not form oligomers. Far-UV circular dichroism 
spectroscopy measurements indicated that apoMb 
maintains a highly helical conformation in the presence of 
OA. We tested the toxicity of the apoMb/OA complex on 
Jurkat cells and we have found that the protein complex 
causes cell death by an apoptosis-like mechanism. 
Conversely, the protein is not active when tested alone 
and OA shows a much reduced toxicity. Of interest, it has 
been demonstrated previously that OA can induce cellular 
toxicity by an apoptosis-like mechanism4. Our results 
suggest that the interaction of OA with apoMb strongly 
enhance the water solubility of the otherwise insoluble 
fatty acid, thus leading to a significant enhancement of its 
intrinsic apoptotic activity3. We suggest that the 
apoMb/OA complex acts as a delivery system of the toxic 
fatty acid to the cell. This mechanism could explain also 
the previously reported toxicity of OA complexes with 
other proteins, including those with human and bovine a-
lactalbumin (LA)5. We conclude that the toxic effect for 
tumor cells of the OA/LA complex previously reported6 is 
not protein-specific and we suggest that other proteins 
can display similar toxic effects if combined in an OA 
complex.  
1. Kim, Y. J., Nakatomi, R., Akagi, T., Hashikawa, T., 
and Takahashi, R. (2005) J. Biol. Chem. 280, 21515–
21521. 
2. Wilson, D. M., and Binder, L. I. (1997) Am. J. Pathol. 
150, 2181–2195. 
3. Barghorn, S., et al. (2005) J. Neurochem. 95, 834–
847. 
4. Cury-Boaventura, M. F., Pompeia, C., and Curi, R. 
(2004) Clin. Nutr. 23, 721–732. 
5. Svensson, M., et al. (1999) J. Biol. Chem. 274, 6388–
6396. 
6. Mok, K. H., et al. (2007) Biochem. Biophys. Res. 
Commun. 354, 1–7. 
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Iron is an essential element to all organisms but is both 
poorly available and potentially toxic in the presence of 
oxygen. Bacteria have evolved various mechanisms to 
counter the problems imposed by the chemistry of this metal 
and thereby to achieve effective iron homeostasis. Highly 
efficient iron acquisition systems are used to scavenge this 
metal from the environment under iron-restricted conditions. 
Bacteria possess iron storage proteins, ferritin and 
bacterioferritin, that provide intracellular iron reserves to meet 
the metabolic requirements. Dps proteins (DNA-binding 
proteins from starved cells) also possess iron storage 
capacity, but primarily protect bacteria and their 
macromolecules against iron-induced oxidative damage. 
Dps proteins are homododecamers belonging to the ferritin 
superfamily, assembled into hollow spheres. The protection 
against oxidative damage is achieved by binding Fe(II) at the 
ferroxidase centers and oxidizing it with H2O2. Fe(III) 
produced is stored in the protein cavity. Some members of 
the Dps protein family, for example E.coli Dps, are able to 
physically bind DNA by means the formation of electrostatic 
interactions1.
The occurrence of oxygenic photosynthesis in 
cyanobacteria entails an increased formation of reactive 
oxygen species as a result of the photosynthetic transport of 
electrons, such that photosystems I and II are main targets of 
photodamage. Possibly, in accordance with the increased 
requirement of antioxidant activity, the thermophilic 
cyanobacterium Thermosynechococcus elongatus 
possesses two Dps proteins, Dps-Te and DpsA-Te2. The two 
T. elongates Dps proteins have been cloned in E.coli and 
characterized in terms of X-ray crystal structure, ferroxidase 
catalytic properties and thermo-stability. 
The Dps-Te and DpsA-Te sequences were compared; 
the alignment shows that the Dps-Te ferroxidase site is 
composed by the “canonical” conserved amino acidic 
residues (2 His, 1 Asp, 1 Glu) whereas the DpsA-Te one 
presents a unique feature (3 His, 1 Glu). This peculiarity was 
confirmed by the crystal structures and finds its functional 
manifestation in the iron oxidation. Typically in Dps proteins 
oxidation kinetics by H2O2 is 100-fold then by O2, but in 
DpsA-Te the preference for H2O2 is ? 3-fold. In accordance 
with their extremophilic bacterial source, Dps-Te and DpsA-
Te show an increased thermostability relative to mesophilic 
Dps proteins by adopting similar strategies. 
In perspective, the expression profile of the two T. 
elongatus proteins under several growth conditions and 
their localization will be evaluated to elucidate the specific 
role of the two Dps proteins in the physiology of this 
thermophilic cyanobacterium. 
1. Chiancone E., Ceci P., Ilari A., Ribacchi F., Stefanini 
S.(2004) BioMetals 17, 197–202,  
2. Franceschini S., Ceci P., Alaleona F., Chiancone E., 
Ilari A. (2006) FEBS Journal 273, 4913–4928 
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Beta-lactoglobulin (BLG) belongs to the lipocalin 
superfamily. Its three-dimensional structure is 
characterized by antiparallel β-strands arranged to form a 
barrel-shaped cavity in which hydrophobic ligands can be 
lodged1. The protein can bind naturally occurring 
molecules, as well as other non polar molecules in 
multiple binding-sites2. In view of the resistance of the 
protein to acid denaturation and to proteolysis, this 
feature is of great interest from a pharmacological point of 
view. 
The binding of two different molecules, fluvastatin and 
flurbiprofen, to BLG was assessed by ESI-MS and NMR 
at different pH values. The stability of the BLG-fluvastatin 
and BLG-flurbiprofen complexes were compared with that 
of BLG bound to one of its natural ligands, palmitic acid. 
The binding of the two drugs or of palmitic acid to BLG did 
not change the secondary and tertiary structure of the 
protein, as detected by CD and tryptophan fluorescence, 
but influenced the sensitivity of BLG towards chemical 
and physical denaturation. Although thermal stability data 
could not be obtained for fluvastatin-loaded BLG as a 
consequence of the thermal instability of the drug, 
fluvastatin had a protective effect towards urea 
denaturation of BLG in a similar fashion to the protection 
exerted by the natural ligand (palmitic acid), that improves 
stability of BLG towards both thermal and chemical 
denaturation3. On the contrary, BLG-bound flurbiprofen 
does not protect toward thermal denaturation, suggesting 
that the binding of this drug involves a different region of 
the protein. Competition experiments, carried out by ESI-
MS at different pH values and order of addition, clearly 
shows that palmitic acid and fluvastatin compete for the 
binding site in the central calyx, thus leading to improved 
structural stability, whereas flurbiprofen binds to a 
different site, as indicated by the lack of competition with 
the natural ligand and of stabilizing effects. 
Besides pointing out the versatility of this class of 
proteins as almost-universal and multi-site carriers for 
hydrophobes, these results are of practical interest as 
they indicate a possible use of BLG (and, possibly, of 
related lipocalins) as a "protective agent" for easing the 
delivery of unstable/insoluble drugs. 
This work was supported from FIRBRBNE03B8KK; 
FIRST, University of Milan 
1. Monaco H.L., Zanotti G., Spadon P., Bolognesi M., 
Sawyer L., Eliopoulos E.E. (1987) J Mol Biol. 20, 695-
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3. Beringhelli T., Eberini I., Galliano M., Pedoto A., 
Perduca M., Sportiello A., Fontana E., Monaco H.L., 
Gianazza E. (2002) Biochemistry. 41, 15415-15422. 
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Trehalose is essential for organism survival under extreme 
stress conditions, so the molecular mechanism 
characterization of trehalose protection is fundamental for 
its biotecnological application. A lot of study  statement that 
bioprotective effect of sugar could be due to molecular, 
physiological and structure complex interaction between 
bynary (sugar-water) and ternary (sugar-macromolecules-
water) complexes. In fact, trehalose influences markedly 
dynamic and structural water properties, creating a more 
rigid unit, capable to protect macromolecular structure by 
an elaborate mechanism of adaptation1. To date interesting 
for hydrophilic protective glass grows as function of their 
pharmaceutical, technological and industrial utilization. The 
mechanisms that hide under this type of stabilization are 
very complicated and  involve, for example, protein reaction 
dynamics and solvent viscosities. In our work we try to 
analyze and correlate the results obtained in presence of 
trehalose, glycerol, and trehalose-glycerol solution at 
different ratio on ornithine transcarbamoylase (OCT), in 
function of medium viscosity and activity determination. As 
previously reported in our works1-2, OCT thermal 
stabilization process is markedly influenced by the 
presence of 0.5 M trehalose solution. So we further 
increase disaccharide concentration (up to 1.0M) and mix 
with glycerol at the same concentration in different ratio. 
Kinematic viscosities of 1.0 M trealose plus 0.2 mg/ml OCT 
solution is higher than that of the same concentration of 
glycerol one. In the mix of trealose and glycerol solution 
plus 0.2 mg/ml OCT, the increase in % of the glycerol 
solution cause a decrease of kinematic viscosities up to 
100 % of this solution. Viscosities determinations reveal the 
first unexpected result when we mix 95% 1.0 M trehalose 
plus 5% 1.0 M glycerol and 0.2 mg/ml OCT. The kinematic 
viscosities of solution increase and exceed trehalose one.  
So we analyzed the influences of these different solution on 
thermal OCT stabilization at 68°C. 1.0 M trehalose solution 
shows the high stabilization activity, while all the other 
solution show little effects, including the mix 95% 1.0 M 
trehalose plus 5% 1.0M glycerol. The presence of both 
glycerol and trehalose in solution induced markedly 
changes in properties solution, without further increase 
stabilization effects of trehalose alone.  
1. E. Bellocco, G. Laganà, D. Barreca, S. Ficarra, E. 
Tellone, S. Magazù, C. Branca, A. Kotyk, A. Galtieri 
and U. Lezzi. “Role of Polyols  in Thermal Inactivation 
of Ornithine Transcarbamoylase”  Physiological 
Research, Vol. 54 (4), pp 395-402, 2005 
2. D. Barreca , E. Bellocco , G. Lagana` , U. Leuzzi , S. 
Magazu` , F. Migliardo , A. Galtieri. Spectroscopic 
investigation of structure-breakers and structure-
makers on ornithine carbamoyltransferase. Food 
Chemistry 106, 1438-1442, 2008. 
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Dps (DNA binding proteins from starved cells) proteins 
are involved in regulating the cellular response to 
oxidative stress in bacteria. Dps proteins are 9-10 nm 
shell-like structures composed by twelve identical 
subunits arranged with 23 symmetry. This in turn gives 
rise to three different environments along the symmetry 
axes of the molecule. The two-fold symmetry interface 
contains residues that form the catalytic centers for the 
detoxification of iron and hydrogen peroxide. The three-
fold “ferritin-like” interface is characterized by negatively 
charged pores that traverse the protein shell and 
resemble those formed at the 3-fold channels in ferritins, 
whereas the “Dps like” interface is unique to Dps proteins 
and contains smaller channels (Ilari et al., 2000). 
In ferritins, the three-fold pores represent the route for 
iron entry into the protein cavity and for the opposite 
process, namely the release of iron from the core 
(Stefanini et al., 1989, Liu et al., 2003). It is not known 
whether the “ferritin-like” pores have the same role in Dps 
proteins. On this basis, the present work focusses on the 
function of “ferritin-like” pores in the Dps protein from the 
Gram-positive bacterium, Listeria innocua. In L. innocua 
Dps (LiDps) the three-fold pores are lined by three 
aspartate residues, D121, D126 and D130. The 
comparison of Dps primary sequences shows that D130 
is highly conserved (80%) within the protein family, 
whereas D121 and D126 are poorly conserved. A set of 
site-specific mutants (D121N, D126N, D130N and 
D121N-D126N-D130N) has been utilized to study 
specifically the role of the pore aspartate in the 
management of iron by LiDps. When the pores are 
altered by the mutation of aspartate residues, in particular 
D130, the iron binding, oxidation and mineralization 
processes are slowed down significantly, less so the iron 
release process. Thus, the presence of negative charges 
and of well-defined electrostatic gradients in the pore area 
is required for a correct protein function.
1. Ilari A, Stefanini S, Chiancone E, Tsernoglou D. The 
dodecameric ferritin from Listeria innocua contains a 
novel intersubunit iron-binding site. (2000) Nat Struct 
Biol. 7:38-43. 
2. Stefanini S, Desideri A, Vecchini P, Drakenberg T, 
Chiancone E. Identification of the iron entry channels 
in apoferritin. Chemical modification and 
spectroscopic studies. (1989) Biochemistry 28:378-82. 
3. Liu X, Jin W, Theil EC. Opening protein pores with 
chaotropes enhances Fe reduction and chelation of 
Fe from the ferritin biomineral. (2003) Proc Natl Acad 
Sci 100:3653-3658. 
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Hen egg white lysozyme (EC 3.2.1.17),  is a 129-residue 
protein stabilized by four disulfide bonds. It has two 
domains, rich in ? and β structure, respectively. Molecular 
weight of lysozyme is an approximately 14.7 kDa. 
Lysozyme is widespread in animals and plants. It is found 
in mammalian secretions and tissues, saliva, tears, milk, 
cervical mucus, leucocytes, kidneys and in egg white. The 
residues of glutamic acid 35 (Glu35) and aspartate 52 
(Asp52) have been found to be critical to the activity of 
this enzyme1. There has been interest in lysozyme as a 
"natural" antibiotic and as an aid in the diagnosis of 
disease. Measurements of a hydrogen-deuterium (H/D) 
exchange between peptide backbone amides and solvent 
provide considerable insight into the protein folding and 
structure. The H/D exchange rate is closely related to its 
local environment. In general, a protein in a tightly folded 
conformation has fewer protons available for deuteration, 
than the same protein in an unfolded state. Since the 
deuteration increases the molecular mass of a protein 
electrospray mass spectrometry is a useful technique to 
monitor the H/D exchange. We attempted to use  mass 
spectrometry to study lysozyme conformation changes by 
H/D exchange in different condition, in absence and in 
presence of trehalose. Lysozyme (2 mg/ml) was 
denatured in 6 M deuterated GuDCl in D2O for 1 h to 
permit exchange of all labile peptide and side-chain 
hydrogens for deuterons in absence or in presence of 0.5 
M trehalose. At different time points in the rate study, 
aliquots were removed to carry out of H/D exchange 
experiments, the exchange is quenched, and samples 
analyzed by ESI-MS/MS. Samples were introduced to the  
ionization source of the mass spectrometer an infusion 
syringe pump. Hydrogen exchange labeling experiments 
monitored by ESI MS were carried out to identify more 
clearly the origin of the effects of added trehalose on the 
denaturation kinetics of lysozyme. The native positive-ion 
Esi mass spectrum of lysozyme (scan-range m/z 900-
2000) shows a Gaussian-type distribution of multiply 
charged ions ranging from m/z 1302.3 to 1789.4. In 
particular, ESI-MS/MS spectrum is characterized by three 
abundant ions at m/z of 1432.3, 1591.1 and 1789.4 and 
attributed to the +10, +9 and +8 multicharged ions of 
native protein. H/D exchange was remarkably influenced 
by trehalose presence. This results were also supported 
by UV-visible spectroscopy, which indicate the formation 
of a more compact protein structure in presence of 
trehalose.  
1. Vocadlo, D. J.; Davies, G. J.; Laine, R.; Withers, S. G. 
Nature 2001, 412, 835 
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Evidence is accumulating that normally folded proteins 
retain a significant tendency to form amyloid fibrils 
through a direct assembly of monomers in their native-like 
conformation1. However, the factors promoting such 
processes are not yet well understood. The 
acylphosphatase from Sulfolobus solfataricus (Sso AcP) 
aggregates under conditions in which a native-like state is 
initially populated2. Aggregation occurs in two phases. In 
a first step aggregates form in which the monomers 
maintain their native-like topology3. In a second phase 
these early aggregates convert into amyloid-like 
protofibrils3. An unstructured N-terminal segment and an 
edge β-strand were previously shown to play a major role 
in the process4. In this work, using kinetic experiments on 
a set Sso AcP variants and a set of peptides 
corresponding to the unstructured N-terminal segment of 
the protein, we show that the major event of the first step 
is the establishment of an inter-molecular interaction 
between the unstructured segment of one Sso AcP 
molecule and the globular unit of another molecule. 
Control experiments show that this interaction is 
determined by the primary sequence of the unstructured 
segment and not by its physico-chemical properties. 
Experiments of aggregation carried out with Sso AcP 
dimers in which two edge β-strands or two unstructured 
segments are forced to interact are in agreement with an 
inter-molecular interaction between unstructured segment 
and β-strand 4. Possible destabilizing effects induced by 
the N-terminal segment on the globular unit do not seem 
to play any role in the aggregation process. Moreover, we 
show that the conversion of the initial aggregates into 
amyloid-like protofibrils is an intra-molecular process in 
which the Sso AcP molecules undergo conformational 
modifications from a native-like fold to an amyloid-like 
fold. The obtained results allow the formulation of a model 
for the assembly of Sso AcP into amyloid-like aggregates 
at a molecular level. 
1. Richardson J. S. and Richardson D. C. (2002) Proc. 
Natl. Acad. Sci. U. S. A. 99, 2754-2759. 
2. Plakoutsi G., Taddei N., Stefani M. and Chiti F. (2004) 
J. Biol. Chem. 279, 14111-14119. 
3. Plakoutsi G., Bemporad F., Calamai M., Taddei N., 
Dobson C. M. and Chiti F. (2005) J. Mol. Biol. 351, 
910-922. 
4. Plakoutsi G., Bemporad F., Monti M., Pagnozzi D., 
Pucci P. and Chiti F. (2006) Structure 14, 993-1001. 
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Two types of cholinesterases are present in vertebrates: 
Acetylcholinesterase (AChE) and Butyrylcholinesterase 
(BChE). AChE plays an important role in the synaptic 
transmission. BChE is found in blood serum, CNS and 
other tissues, and, together with AChE is one of the most 
used enzymes to monitor organophosphorous and 
carbamate environmental pollutants. Moreover, it was 
suggested its possible involvement in neural function and, 
as AChE, a possible role in neurodegenerative disorders, 
such as Alzheimer’s disease (AD)1. Recent studies 
indicated increased plasma and RBC activities of BChE 
and AChE in several low grade systemic inflammatory 
conditions2, and it was suggested that these enzymes 
could be markers of inflammation2. Palmitoylethanolamide 
(PEA) is an endogenous lipid that is thought to be 
involved in endogenous protective mechanisms of 
inflammatory response. It is present in a large variety of 
tissues, included brain and blood, and a significant 
increase of its levels was found in pathological conditions, 
such as inflammation3. Although the presence of 
cholinesterases and PEA in the same tissues raises the 
hypothesis of their possible interaction, no studies have 
been performed on this field.  The current study examines 
the possible effect of PEA on BChE structural and kinetic 
features. It was demonstrated that Arrhenius plots of 
BChE-catalysed  hydrolysis of esters presents a break at  
18-22°C4 that was related to the presence of two different 
BChE active forms on  both sides of the break. This break 
was attributed to a temperature-induced conformational 
change of the active site gorge in the transition state 
[ES]4, but is not related to any overall conformation 
alteration. Human BChE purified in our laboratory 
presents similar kinetic features, with a break in the range 
19.6°-22.2°C. Arrhenius plot of Trp  fluorescence intensity 
measurements, shows a break at similar temperatures 
(Ea was about 17 kJ/mol, and about 10.5 kJ/mol below 
and above the break, respectively), indicating  that the 
fluorescence of  BChE Trp  are sensitive to the 
conformational change induced by temperature on the 
active site gorge, and that this conformational 
modification is not induced by the binding of the 
substrate. The same measurements performed in the 
presence of 5 ?M PEA show a slight increase of Ea, more 
evident below the transition temperature, suggesting that 
PEA can interact with the two different active forms of 
BChE, but likely with different affinity.  
1. Darvesh, S., Hopkins, D.A. and Geula, C. (2003) Nat. 
Rev. Neurosci.  4,131-138 
2. Das U.N. (2007) Med.Sci.Monit. 13,RA214-221 
3. Lambert D.M. et al. (2002) Curr.Med.Chem. 9,663-674 
4. Weingand-Ziadè A. et al. (1999) Eur. 
.Biochem.264:327-335 
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Specific targeting of tumor-associated antigens that are 
selectively expressed or over-expressed by tumor cells is 
the goal of modern cancer therapy aimed at overcoming 
the non-specific toxicity of most anticancer drugs. 
Qualitative and quantitative expression of tumor-
associated antigens varies among different tumors and 
patients, resulting in highly variable responses to targeted 
therapies. For a selective tumor therapy to be effective, 
tumor diagnosis should provide information on the 
expression of the targeted antigen in each patient, thus 
enabling prediction of the possible efficiency of a 
personalized therapy. In order to translate tumor 
diagnostic information into reliable prognostic data, the 
molecules used for tumor tracing –either in vivo or ex 
vivo- should be as close as possible to those used for 
therapy. 
Antibodies and small molecules have been used as 
targeting agents, and both have limits and advantages. 
We demonstrate here that oligo-branched peptides can 
be efficient tumor-targeting agents that combine the 
advantages of antibodies and small molecules. They 
allow multimeric binding, despite a much lower molecular 
weight compared to antibodies, and can be easily 
synthesized and chemically modified, like small 
molecules. Moreover, oligo-branched peptides are 
extremely resistant to proteases and peptidases1, 2.
We produced tetra-branched peptides targeting the 
neurotensin (NT) receptors, which are over-expressed in 
a number of human tumors. Tetra-branched peptides 
were used either for spotlighting tumor cells or for killing 
them, by simply exchanging the functional moiety that can 
be coupled to a conserved targeting core3.
Fluorophore-conjugated branched NT peptides allow 
discrimination between tumor and healthy tissues in 
human biopsies from colon and pancreas 
adenocarcinomas and can be used to measure tumor 
versus healthy peptide binding in each patient, giving an 
indication of the possible efficiency of an NT-mediated 
therapy. The same NT branched molecules, when 
conjugated to drugs, allow selective tumor cell killing and 
also allow by-passing drug resistance in colon, pancreas 
and prostate tumor cell lines. 
The approach proved promising for the personalized 
therapy of tumors that over-express NT receptors, such 
as colon, pancreas and prostate carcinoma, and might be 
applied to many different tumor targets. 
1. Bracci  L. et al. (2003) J Biol Chem. 278, 46590-5 
2. Falciani C. et al. (2007) Chem Biol Drug Des. 69, 216-
21. 
3. Falciani C. et al. (2007) Mol Cancer Ther. 6, 2441-8. 
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Recent reports indicate that the oligomers that precede 
the formation of well-defined fibrils play a critical role in 
the pathogenesis of protein deposition diseases, at least 
in the case of neuropathic disorders1. Nevertheless, the 
structural elucidation of such species remains elusive, 
because their dynamic and metastable nature prevents 
the use of high resolution techniques.  
Oligomers by the N-terminal domain of HypF from E. coli
(HypF-N) were prepared using two distinct protocols, i.e. at 
low pH and in the presence of 330 mM sodium chloride; and 
at pH 5.5 and in the presence of 12% (v/v) trifluoroethanol2,3.
The resulting aggregates consist of spherical oligomers 
having a height of 3.0 nm, as revealed by atomic force 
microscopy, an extensive b-sheet structure and the ability to 
bind the Thioflavin T dye. When the two kinds of aggregates 
were tested for their possible citotoxic effects on cultured SH-
SY5Y cells, only those formed at pH 5.5 and in the presence 
of trifluoroethanol resulted to be toxic. 
The excimer forming fluorescence probe pyrene-
maleimide was thus used to monitor the structure of the 
protofibrils formed under the two sets of conditions. 
Excimers form when two pyrene moieties stack each 
other within 4-10 Å of distance and result in a broadened 
pyrene emission spectrum with a new peak or shoulder in 
the 450-470 nm region4. Thus, by conjugating the dye to a 
polypeptide chain one can investigate inter-chain 
interactions. HypF-N variants carrying a single cysteine 
residue located at different positions of the polypeptide 
chain were selectively labeled with the probe and 
incubated for four hours at 25 °C under the two sets of 
conditions, in order to monitor the pyrene emission 
spectrum after the formation of protofibrillar aggregates.  
Residues located in three regions of the sequence 
(approximately 25-34, 55-59 and 75-87) have been found 
to give rise to a significant excimer signal when labeled 
with the probe, indicating that such regions contribute to 
the structure of the protofibrillar aggregates and form 
inter-chain interactions in the protofibrils. These regions 
correspond to the three major peaks of the hydropathy 
profile of HypF-N. Nevertheless, the extent of the 
tendency to form excimers at pH 5.5 with 12% 
trifluoroethanol is lower, indicating that the aggregates 
formed under this condition have a lower degree of 
packing of hydrophobic residues. 
Overall, the data provide structural information on two 
kinds of protofibrils formed by the same protein, and 
suggest the structural origin of cellular toxicity of non 
fibrillar aggregates. 
1. Chiti F. and Dobson C.M. (2006) Annu. Rev. Biochem. 
75, 333-366. 
2. Campioni S. et al. (2008) J. Mol. Biol. 379, 554-567. 
3. Marcon G. et al. (2005) J. Mol. Biol. 347, 323-335. 
4. Krishnan R. and Lindquist S.L. (2005) Nature 435, 
765-772. 
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Abnormal metabolism of the amyloid precursor protein, 
APP, through the amyloidogenic pathway results in the 
accumulation of heterogeneous Aβ peptides in the central 
nervous system, causing the onset of Alzheimer’s 
disease. Aβ and other different proteolytic fragments of 
APP are present in human plasma, and derive from 
circulating platelets. Platelets express APP isoforms 
similar to those found in neurons, and metabolise APP 
through ?- and β-secretases to produce soluble fragments 
sAPP?, sAPPβ and Aβ 1. Very little is known about the 
exact function of APP and of its proteolytic fragments in 
normal cellular metabolism. However, APP is expressed 
on the platelet membrane as an intact protein, suggesting 
that it may serve as a functional receptor. In this study we 
investigated the metabolism of APP in human platelets. 
We identified two different forms of APP expressed in 
human resting platelets. A 110-120 kDa soluble fragment 
(sAPP? and/or sAPPβ was stored into platelet ?-granules 
and was released upon platelet activation by several 
agonists, including thrombin. A 140 kDa full length intact 
protein, named APPFL, was found to be expressed on the 
platelet surface, and represented about ten percent of 
total platelet APP. APPFL underwent proteolysis upon 
stimulation of platelets with thrombin and other agonists. 
Agonist-induced proteolysis of APPFL occurred 
independently of platelet aggregation or secretion, but 
was inhibited in the presence of EDTA. Interestingly, 
proteolysis of APPFL, but not secretion of soluble APP 
fragments, was observed also upon incubation of 
platelets with the cell permeable calmodulin (CaM) 
antagonist W7. W7-induced APPFL proteolysis was time 
and dose-dependent, was not associated to platelet 
activation, and was prevented by preincubation with the 
metalloproteinase inhibitor GM6001 or with EDTA. In 
platelets, shedding of the extracellular domain of several 
membrane glycoproteins, including GPIb?, GPV, GPVI, 
and PECAM1, represents a recognized mechanism for 
receptor down-regulation. In all these cases, shedding is 
constitutively inhibited by CaM binding to the intracellular 
regions of the receptors, and occurs upon CaM 
dissociation with W72. Therefore, we screened APP 
sequence for CaM binding consensus sequences, and we 
identified two main potential sites. Co-
immunoprecipitation experiments have provided 
preliminary evidence for an association between APPFL
and CaM in intact platelets. Using a GST fusion protein 
containing the intracellular domain of APP, however, we 
have been unable to detect any specific association with 
purified CaM. Further studies are necessary to clarify this 
issue. Nevertheless, our results indicate a novel, CaM-
dependent mechanism for APP proteolysis in human 
platelets. 
1. Li Q.X. et al. (1999), J Leukoc Biol. 66, 567-74 
2. Khan J. et al. (1998) Cell 92, 809-818 
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Antarctic fish are highly cold adapted and remarkably 
stenothermal1, as a consequence of evolution of 
antifreeze glycoproteins and their higher catalytic 
efficiency of many enzymes at low temperatures2. For this 
reason, the study of enzymes in these poikilothermic 
species is of interest, especially in relation to the 
strategies adopted by these organisms to achieve a 
normal level of proteolysis at temperatures well below that 
of homeothermic species. In our studies on aspartic 
proteinases in notothenioids, a fish group endemic to 
Antarctica, we have focused our attention on pepsins 
because of their important nutritional role. Pepsins are a 
family of aspartic proteinases accomplishing important 
digestive functions in both invertebrates and vertebrates3.
Like other aspartic proteinases, pepsin is produced as a 
zymogen. The primary structure of the zymogen includes 
a signal peptide (or presequence) and the so-called 
propart, whose autocatalytic cleavage leads to the 
formation of the active enzyme4. To better understand the 
molecular mechanisms responsible for adaptation of food 
digestion at temperatures below 0 °C, we have produced 
the two T. bernacchii fish pepsin variants A1 and A2 by 
heterologous expression in E. coli. The enzymes were 
purified, and their biochemical properties were studied in 
comparison to pepsin A from porcine stomach. The 
properties of these two Antarctic isoenzymes were 
compared to porcine pepsin and found to be unique in a 
number of ways. Fish pepsins were found to be more 
temperature sensitive, generally less active at lower pH 
and more sensitive to inhibition by pepstatin than the 
mesophilic counterpart. The specificity of Antarctic fish 
pepsins was similar but not identical to pig pepsin, likely 
owing to changes in the sequence of fish enzymes near 
the active site. Gene duplication of Antarctic rock cod 
pepsins is the likely mechanism for adaptation to the 
harsh temperature environment in which these enzymes 
must function.  
1. Christina Cheng, C. H. & William Detrich, H. (2007) 
Philos Trans R Soc Lond B Biol Sci.
2. D'Avino, R., et al.  (1991) Springer-Verlag, Berlin. 
3. Kageyama, T. (2002) Cell Mol Life Sci. 59, 288-306. 
4. Kageyama, T et al. (1989)  J Biochem (Tokyo). 105,
15-22. 
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Glutamate synthases (GltS) catalyze the reductive transfer 
of the glutamine (L-Gln) amide group to the C2 carbon of 
2-oxoglutarate (2-OG) producing two molecules of L-Glu. 
They form with glutamine synthetase an essential 
pathway of ammonia assimilation in microorganisms, 
plants and lower animals. All GltS are complex Fe/S 
flavoproteins, which share a subunit or domain for the L-
Gln-dependent L-Glu synthesis from 2-OG. GltS tightly 
control and coordinate the partial reactions taking place in 
the α subunit of the NADPH-dependent GltS (αGltS, 
162.4 kDa) or the homologous plant-type ferredoxin-
dependent enzyme (FdGltS), namely: i. ammonia release 
from L-Gln at the glutaminase site in the N-terminal 
amidotransferase domain; ii. ammonia transfer through 
the 30 Å-long intramolecular tunnel to the synthase site 
where (iii) ammonia adds to bound 2-OG forming the 2-
iminoglutarate (2-IG) intermediate that is reduced by FMN 
at this site. The crystal structures revealed which residues 
may be important for the control of GltS reactions, which 
has been proposed to occur through conformational 
changes initiated by 2-OG binding and reduction of the 
FMN and 3Fe-4S cofactors at the synthase site, which 
are transmitted across the tunnel to activate glutamine 
hydrolysis and open the tunnel entry point. Among these 
residues, K937 of the synthase domain interacts with 2-
OG carbonyl oxygen potentially favoring ammonia 
addition and signaling 2-OG presence to the glutaminase 
site. M479 belongs to the central domain and is in van der 
Waals contact with both FMN and the [3Fe-4S] cluster in 
the synthase domain. Thus, M479 may modulate the 
redox properties of the cofactors and may signal the 
enzyme redox state. To determine the role of these 
residues, we engineered K937A and M479A substitutions 
in αGltS. The resulting αGltS variants have been co-
produced with a C-terminally His(6)-tagged form of βGltS 
for a rapid purification of the resulting K937A- and 
M479A-GltSHis. Both GltS variants have been 
successfully produced in E. coli and purified. Both species 
are indistinguishable from the wild-type enzyme with 
respect to stability and cofactor content. Steady-state 
kinetic studies of the K/A variant showed that K937 is 
essential for the synthesis of L-Glu at the synthase site, 
presumably by favoring ammonia addition to the carbonyl 
C of 2-OG. Indeed, sulfite titrations followed by 
backtitrations with 2-OG ruled out that K937 is important 
for 2-OG binding, but also revealed the lowering of the Kd
for the FMN-sulfite adduct, This property correlates with a 
10-fold increase of the NADPH oxidase activity of K937A-
GltSHis which has been shown to be quenched by 2-OG 
and L-Gln. The latter observation is of interest showing for 
the first time an effect of ligand binding to the glutaminase 
site on the properties of the synthase site. The M/A 
substitution led to only a 5-fold decrease of the turnover 
number with no detectable effect on the apparent affinity 
for the substrates and only a mild enhancement of the 
oxidase activity. Experiments are in progress in order to 
test the effect of the substitutions on the properties of the 
glutaminase site and on the coupling the glutaminase and 
synthase reactions. 
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Cytidine deaminase (CDA) has been the focus of several 
studies because it deaminates some cytosine nucleoside 
analogues used in chemotherapy leading to the loss of  
their pharmacological activity. Human CDA Y33 is part of 
a conserved region in most tetrameric CDAs and is 
probably involved in the contact between subunits and in 
the active site. By a series of site-directed mutagenesis 
on human CDA cDNA were obtained the mutants Y33G, 
Y33F and Y33S1  but in the prokaryotic expression 
system used, only Y33G produced a partially soluble 
protein without enzymatic activity. To correct the protein 
folding and therefore to increase the solubility and the 
activity of an enzyme expressed in an heterologous 
system low molecular weight compounds (osmolytes) that 
stabilize proteins in their native conformations2 are useful.  
In this work the effect of some osmolytes such as 
glycerol, DMSO, cyclodextrins, sorbitol (chemical 
chaperones), and some specific ligands of CDA 
(pharmacological chaperones), added to the culture 
medium during induction, was investigated with regard to 
protein content and specific activity of the CDAs protein 
mutated in the tyrosine 33 residue. At this purpose, each 
crude extracts containing 20 ?g of total proteins obtained 
by the titration of Y33G, Y33F and Y33S with each 
chaperone concentration, was subjected to immunoblot 
analysis with the polyclonal primary antibody anti-CDA 
and to enzymatic (CDA) activity determination by 
spectrophotometric assay3.
The results indicated that the use of glycerol and 
DMSO or the presence of substrates (cytidine) or 
inhibitors (uridine, 5-fluoro-zebularine, 6-[3,5(cytidyl) 
acryloyl amino] hexanoic acid) of human CDA increased 
the content and the specific activity of the Y33G mutant 
enzyme. Other osmolytes such as cyclodextrins and 
sorbitol had no effect on the protein stability. The 
presence of glycerol in culture media increased the 
protein content of the other mutant CDA Y33F but not the 
specific activity, whereas the chemical and 
pharmacological chaperones had no effect on Y33S 
mutant CDA. Finally,  on the purified  Y33G mutant CDA,  
a kinetic characterization was performed and the effect of 
temperature on the protein stability was also investigated.  
1. Vincenzetti S. et al., (2008) Proteins: Structure, 
Function and Bioinformatics. 70, 144-156. 
2. Tatzel J. et al., (1996) EMBO J. 15,  6363-6373. 
3. Vincenzetti S. et al., (1996) Protein Expr. Purif. 8, 
247–253. 
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Cerato-populin (PoP) is an about 12.900 Da protein, 
produced by the Ascomycete Ceratocystis populicola 
(Cepop), the causal agent of poplar black canker. It  
belongs to Cerato-platanin Family, a fungal protein family 
characterized by high sequence similarity, presence of 
four cysteine residues forming two S-S bridges and 
involvement in biological recognition phenomena. 
The founder member of this protein family is cerato-
platanin (CP), a 120 amino acids protein, long since 
studied in our laboratories, produced by Ceratocystis 
platani (Cep) and involved in plane canker stain1. CP is 
located in Cep mycelial cell walls and is early released 
into the medium. It induces over-expression of defence-
related genes and reduction in Cep growth on plane 
leaves2. This protein has ability to self assemble in vitro
and CP aggregates seem to be involved in interactions 
with host.  
Furthermore, CP homologous proteins have been 
identified in other species of Ceratocystis, as C. 
populicola, C. cacaofunesta, C. variospora, C. fimbriata
clones from Coffea arabica, Mangifera indica, Fagus sp.,
Crotolaria juncea and Ipomea batatas. Among these 
proteins, PoP seems to be particularly interesting since its 
sequence has a homology of only 62% with that of CP 
and since Cepop attacks the poplar, an industrially and 
commercially important specie.  
PoP has been recently purified from Cepop liquid 
culture in low yield.  The secondary structure of PoP, 
determined by Circular Dicroism (CD), presents some 
similarities with CP 2D structure but it shows a larger 
percentage of helix which seems to be organized in a 
coiled coil structure. 
To improve functional and structural characterization, 
we are cloning pop gene in the yeast Pichia pastoris,
using pPIC9 extracellular expression vector. 
At the same time, we are studying if also PoP is able 
to self-aggregation like CP does. Aggregation studies are 
carried out incubating 1,3 mM PoP in 10% acetic acid and 
are monitored by ThioflavinT (ThT) fluorescence, Circular 
Dicroism and Atomic Force Microscopy. Actually we have 
found that POP self assembles in vitro forming ThT 
positive aggregates that show a morphology similar to 
that of CP aggregates. 
Recombinant PoP will allow us to deepen the study of 
PoP aggregation process, the biological activity both of 
the soluble protein and the aggregates and to compare it  
with those of CP, in order to understand the mechanism 
through which CP Family proteins interact with their 
respective hosts. At this respect the determination of 3D 
solution structure of CP is in project.  
1. Pazzagli L. et al (1999) J. Biol. Chem. 274, 24959-
24964. 
2. Fontana F. et al (2007) J. Plant Pathol.  In press. 
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Numerous data suggest that mitochondria are involved in 
the regulation of the skeletal muscle physiology and play 
a critical role in cell growth, proliferation, differentiation 
and death. In particular, mitochondrial activity is involved 
in the regulation of myoblast differentiation through 
myogenin expression, activity of myogenic factors and by 
control of c-Myc expression1,2. Furthermore, differentiation 
seems to be a program depending on both mitochondrial 
function and mitochondrial biogenesis as indicated by a 
rapid increase in mitochondrial mass/volume, mtDNA 
copy number, enzyme activities and mitochondrial mRNA 
levels within the first 48hrs of myoblasts differentiation3.
We have studied the changes in mitochondrial biogenesis 
and activity in murine myoblast cultures (C2C12 line) 
undergoing differentiation: myoblasts were grown, and 
induced to differentiate. Staining of mitochondria by Mito 
Tracker Green was used to evaluate their mass/volume 
by epifluorescence microscope. The Real time RT-PCR 
was used to study the expression level of PGC-1?, T-fam 
A and COX II, target genes for mitochondrial biogenesis 
and activity. The mitochondrial functionality was also 
tested by their ATP production and cytochrome c oxidase 
activity using HPLC, HPCE and spectrophotometer 
approaches respectively. These assays show that the 
mitochondrial biogenesis and activity significantly  
increase in differentiating myotubes, also compared to 
undifferentiated and quiescent cells. Intriguingly, using a 
proteomic approach, changes appear also in 
mitochondria proteomic pattern during differentiation. 
Indeed a significant number of new and up-regulated 
proteins were revealed in mitochondria isolated from 
myotubes compared to those isolated from myoblasts.  
Such data are also supported by a preliminary study 
where an increase of energy production during the 
differentiation, is observed. Thus, the mitochondrial 
biogenesis seems to be correlated to a change in cellular 
metabolism during myogenesis. 
1. Rochard P.,  Rodier A., Casas F., Cassar-Malek I., 
Marchal-Victorion S., Daury L., Wrutniak C. and 
Cabello G. (2000) J. Biol. Chem. 275, 2733-2744 
2. Seyer P., Grandemange S., Busson M., Carazo A., 
Gamaleri F., Pessemesse L., Casas F., Cabello G. 
and Wrutniak-Cabello C. (2006) J. Cell Physiol. 207, 
75-86 
3. Kraft C.S., LeMoine C.M., Lyons C.N., Michaud D., 
Mueller C.R. and Moyes C.D. (2006) Am. J. Physiol. 
Cell Physiol. 290, 1119-27. 
15.31 
PROTEOMIC APPROACH IN C2C12 MYOBLAST 
DIFFERENTIATION 
L. Casadei1, L.Vallorani1, A.M Gioacchini1, M. Guescini1,
S. Burattini2, A. D’Emilio2, L. Biagiotti2, E. Falcieri2,3, V. 
Stocchi1
1
Dipartimento di Scienze Biomolecolari,  Università degli 
Studi di Urbino “Carlo Bo” Urbino, Italia 
2
Dipartimento SUNT, Università degli Studi di Urbino 
“Carlo Bo” Urbino, Italia 
3
IGM, CNR, Istituti Ortopedici Rizzoli, Bologna, Italia 
Skeletal muscle cell differentiation is a multistage process 
that has been studied extensively over the years1-3. Even 
if great improvements have been made in defining 
biological process undergoing skeletal muscle 
differentiation, many molecular and biochemical 
mechanisms need still to be clarified. 
To provide further evidence in understanding this 
process, we compared 2-DE gels obtained from 
differentiating C2C12  cells.  
We studied  cells at the undifferentiated stage (T0), at 
intermediate (T3 -T5) and high (T7) differentiation stages, 
analyzing, for each condition, morphological and 
proteomic changes. We also identified the proteins that 
showed statistically significant changes by a ESI-Q-Tof 
mass spectrometer. In this way we have identified 26 
specific phase proteins, some of which overlooked in 
skeletal muscle development. Furthermore, the discovery 
of myogenesis correlated proteins, which are known to be 
involved in the apoptotic process, suggests a link 
between apoptosis and differentiation. Intriguingly, many 
heat shock proteins at high level of expression suggest a 
relationship between differentiation and cellular stress.  
1. Delgado I., Huang X., Jones S., Zhang L., Hatcher R., 
Gao B. and Zhang P., (2003) Genomics 82 , 109-21.  
2. Tomczak K.K., Marinescu V.D., Ramoni M.F., 
Sanoudou D., Montanaro F., Han M., Kunkel L.M., 
Kohane I.S., Beggs A.H., (2004) Faseb J. 18, 403-
405. 
3. Tannu N.S., Rao V.K., Chaudhary R.M., Giorgianni F., 
Saeed A.E., Gao Y. and Raghow R. (2004) Mol. Cell. 
Proteomics 3, 1065-82. 
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Ochratoxin A (OTA) is a mycotoxin produced by the fungi 
Aspergillus and Penicillum. It is a secondary metabolite 
found as a contaminant in a variety of very common 
foods: mostly cereals and grain products. Because of its 
very prolonged half life in blood the human exposure to 
this contaminant is of relevant importance, in particular 
because OTA was found to be cancerogenic, nephrotoxic, 
teratogenic neurotoxic and immunotoxic in several 
species of animal experiments1. Despite its toxicity, the 
mechanisms underlying these various toxic effects of 
OTA have not been still elucidated in detail. 
The aim of this study was to gain more insight into the 
molecular changes that occur after oral exposure to OTA 
in kidney that is the target organ of the toxin injury.  
Kidney protein extracts were obtained from mice fed 
OTA and analysed by 2D electrophoresis. Comparative 
image analysis of five replicates highlighted the 
differentially expressed proteins, which were identified by 
peptide mass fingerprint on Voyager-DE Pro MALDI-TOF 
or by MS/MS analysis on ESI-Q-TOF (Q-STAR). The 
exposure to OTA modified the expression of some 
cytoskeleton proteins (up-regulation of Vimentin and 
Tropomyosin and down-regulation of Spectrin 2); 
moreover some proteins involved in the cellular 
metabolism (up-regulation of Adenylate Kinase 3, 
Glyceraldehyde 3-phosphate Dehydrogenase and ET 
Flavoprotein Dehydrogenase; down-regulation of 
Bisphosphate 3’-Nucleotidase 1, V-ATPase H+, Malate 
Dehydrogenase and Isocitrate Dehydrogenase) and in 
protein homeostasis (up-regulation of Calreticulin; down-
regulation of the Elongation Factor 1-??1 and 
Homogentisate 1,2- dioxygenase), as well as some 
proteins with antioxidant functions (up-regulation of 
Phosphotriesterase; down-regulation of HSPD1 Protein 
and Glutathione Synthetase) were affected by the 
treatment of prolonged (8 weeks) OTA intoxication at sub-
acute doses (0.5 mg/kg body weight).  
The results show that the OTA toxicity is exploited by 
altering protein synthesis, cellular  metabolism and cell 
cycle; by a general rearrangement of the cytoskeleton  
proteins and by depleting some of the proteins involved in 
the protection of the cell from oxidative damage. 
1. Pfohl-Leszkowicz A., Manderville R.A., Ochratoxin A: 
an overview on toxicity and carcinogenicity in animals 
ans humans, Mol. Nutr. Food Res. 2007,51,61-69 
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Bcps constitute a group of antioxidant enzymes, 
belonging to the Prx family, that are widely distributed in 
bacteria, plants and fungi. These proteins can contain two 
conserved cysteines within the CXXXXC motif. Recent 
studies demonstrated that while the role of the first 
cysteine is well defined, being the catalytic peroxidatic 
cysteine in all the members of this protein family, data on 
the function of the second cysteine are controversial and 
require further investigation.1
Here we report on the functional and structural 
characterization of Bcp1, an archaeal Bcp isolated from 
Sulfolobus solfataricus, which presents two conserved 
cysteine residues at positions 45 and 50. Functional 
studies revealed that this enzyme carries out the catalytic 
reaction using an atypical 2-Cys mechanism, where 
Cys45 is the peroxidatic and Cys50 is the resolving 
cysteine. The X-ray structure of the double mutant 
C45S/C50S, representative of the fully reduced enzyme 
state, was determined at a resolution of 2.15 Å, showing a 
Trx fold similar to that of other Prx family members. 
Superposition with a structural homologue in the oxidized 
state provided for the first time a detailed description of 
the structural rearrangement necessary for a member of 
the Bcp family to perform the catalytic reaction. From this 
structural analysis it emerges that a significant 
conformational change from a fully folded to a locally 
unfolded form is required to form the intramolecular 
disulfide bond upon oxidation, according to the proposed 
reaction mechanism. Two residues, namely Arg53 and 
Asp54, which play a key role in this rearrangement, were 
also identified. 
1. Wood Z. A., Schröder E., Harris J. R. and Poole L. B. 
(2003). Trends Biochem. Sci. 28, 32–40. 
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The mixed-lineage leukemia (MLL) gene, located on 
chromosome 11q23, is involved in numerous 
chromosomal aberrations associated with human 
leukemia. At least 50% of cases of infant acute 
lymphoblastic leukemia (ALL) harbor the balanced 
translocation t(4;11)(q21;q23), which fuses the genomic 
sequences encoding the N-terminal portion of MLL to 
sequences encoding the C-terminus of AF4, on 
chromosome 4q21.3-5. This translocation is the hallmark 
of a high-risk ALL that has a very poor prognosis. MLL
translocation breakpoints cluster between exon 8 and 12; 
the AF4 breakpoint usually lies within exon 4. The 
resulting fusion gene encodes an in-frame MLL–AF4 
fusion protein (usual MLL-AF4 chimera) that exerts 
oncogenic activity. We identified a different MLL-AF4 
fusion protein (novel MLL-AF4 chimera) in a 5-month-old 
child affected by ALL1. The translocation junction of the 
novel fusion gene falls between MLL exon 9 and AF4 
exon 11, and the resulting novel MLL-AF4 chimera lacks 
part of the putative AF4 transcriptional activating domain. 
In an attempt to identify MLL-AF4 molecular partners, we 
cloned cDNAs encoding the usual and novel chimeras to 
produce Flag-tagged recombinant proteins. Using 
functional proteomics, we identified several proteins that 
interact with human AF4. These include MED7, MED23, 
CDK9 and YWHAQ. The first three are directly involved in 
RNA pol II transcription activation mechanisms. YWHAQs 
are ubiquitous proteins that exert a remarkably 
widespread effect on cellular functions, including cell-
cycle control and apoptosis2. To evaluate whether MLL-
AF4 oncoproteins could bind these four AF4 interactors, 
we transiently expressed recombinant flagged chimeras 
in HEK-293 cells and affinity-immunoprecipitated them 
using anti-Flag monoclonal antibody. We found that both 
chimeras bind YWHAQ, MED7 and CDK9, the latter being 
a negative regulator of the transcriptional activator 
function of AF43. Only the most frequent fusion protein 
binds MED23. Therefore, chimeras gain the ability to bind 
specific AF4 partners that may influence gene expression 
at transcriptional level. These preliminary data suggest 
that a gain-of-function pathomechanism might explain the 
oncogenic properties of MLL-AF4 chimeras. 
1. Pane F, Intrieri M, Izzo B, Quintarelli C, Vitale D, 
Migliorati R, Sebastio L, Salvatore F, Blood. 2002 
Dec 1; 100(12): 4247-8. 
2. Mackintosh C.,Biochem J, 2004 Jul 15; 381 (Pt 2): 
329-42. 
3. Bitoun E, Oliver PL, Davies KE. Hum Mol Genet. 2007 
Jan 1;16(1):92-106. 
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The world incidence of food allergy is estimated to be as 
high as 6% in children and approximately 3-4% in adults. 
The majority of plant food allergens can be grouped into 
four protein superfamilies: prolamins (comprising the 2S 
albumin seed storage proteins and nonspecific lipid 
transfer proteins), cupins, profilins, and proteins related to 
the major birch pollen allergen Bet v 1. Seed storage 
proteins are synthesized in developing plant embryos 
during seed germination and play an important biological 
role as a source of nitrogen and sulfur for germination. 
Ses i 2 is the major allergen from white sesame seeds 
and belongs to the 2S albumin family. In this work, we 
have purified Ses i 2 in sufficiently large amounts (10-30 
mg) for subsequent chemical, conformational and stability 
characterization. 
Ses i 2 was purified to homogeneity (> 98%) in two 
consecutive chromatographic steps, involving size-
exclusion chromatography on a sephacryl HR-100 column 
and semi-preparative RP-HPLC on a C18 coulmn. 
Reduction and carboxamidomethylation of Cys-residues 
allowed us to establish that mature Ses i 2 is composed 
of a light (LC) and heavy (HC) chain held together by 
three disulfides, while two extra disulfides are present in 
the HC. Peptide mass fingerprint analysis of LC and HC 
with S. aureus V8 protease, combined with a MASCOT 
search, allowed us to unambiguously identify all the 
peptide masses of the proteolytic fragments as originating 
from the precursor protein of the Ses i 2 allergen from 
Sesamum indicum (Swiss-Prot entry code: Q9XHP1). 
Notably, the abundance of Cys (10.6%), Arg (13.8%), Met 
(16%), and Gln (17%) in the mature Ses i 2 (containing 94 
amino acids) is much higher than that normally observed 
in natural proteins. The structural model of Ses i 2, 
obtained by homology on the NMR structure of napin from 
Brassica napus (PDB code 1sm7), revealed that Ses i 2 is 
arranged in a four-helix bundle topology. 
Ses i 2 possess an extraordinarily high stability to 
heat, Gnd-HCl, low pH, and proteases. In particular, at 
both pH 2.0 and 7.0, Ses i 2 structure exhibits only a 
partial unfolding even at high temperatures (e.g., 90°C). 
In the presence of Gnd-HCl, Ses i 2 reversibly unfolds 
with a [Gnd-HCl]1/2 of 6.8 M. Strikingly, Ses i 2 is fully 
resistant to the combined action of low pH and pepsin in 
simulated gastric fluid, while in simulated intestinal fluid it 
is only partially trimmed at the N- and C-termini by trypsin 
and chymotrypsin, leaving a compact and folded protein 
structure. Quite surprisingly, Ses i 2 inhibits the amidolytic 
activity of thrombin, a key enzyme in blood coagulation, 
with an IC50 value of 1.60±0.05 ?M. 
Altogether, our results indicate that Ses i 2 may 
preserve its structure from the degradation in the 
gastrointestinal tract and this behaviour may be crucial to 
sensitise the mucosal immune system in the gut. 
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alpha-Synuclein is a 140-residue protein, of unknown 
function, involved in several neurodegenerative disorders, 
such as Parkinson disease. Recently, a wide interest has 
risen around the putative interaction between alpha-
synuclein and polyunsaturated fatty acids. Indeed, lipids 
are able to trigger multimerization of the protein in vitro
and in cultured cells and alpha-synuclein is implicated in 
fatty acid uptake and metabolism. Docosahexaenoic acid 
is one of the main fatty acids in cerebral grey matter; it is 
dynamically released following phospholipid hydrolysis 
and it has been found in high levels in brains areas with 
alpha-synuclein inclusions from patients affected by 
Parkinson disease. Debated and unresolved questions 
regard the nature of the molecular interaction between 
alpha-synuclein and docosahexaenoic acid and the effect 
of the protein on the fatty acid aggregated state. We 
report a detailed characterization of the complex formed 
by alpha-synuclein and docosahexaenoic acid, analyzing 
the physical state of the lipid and the conformation 
adopted by the protein upon binding to the fatty acid by 
biophysical and biochemical methods. Docosahexaenoic 
acid is prone to assemble in vesicles with a large size 
distribution. Turbidity measurements, fluorescence 
studies and transmission electron microscopy have 
shown that alpha-synuclein disrupts the vesicles, 
stabilizing micellar forms of the fatty acid. Upon binding to 
docosahexaenoic acid micelles, alpha-synuclein acquires 
alpha-helical conformation in a simple two-state transition. 
Furthermore, proteolysis experiments by proteinase K 
and trypsin have allowed to define that only the first 70 
amino acid residues of the polypeptide chain are strictly 
involved. In the presence of docosahexaenoic acid 
micelles, alpha-synuclein is highly prone to aggregate and 
form amyloid fibril. A thorough understanding of the role 
of lipids in protein structural transition and aggregation 
process should provide insights into the implication of 
lipids in amyloid formation in vivo.
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The tetratricopeptide repeat (TPR) is a 34-amino acid ?-
helical motif that occurs in a great number of proteins 
from all kingdoms of life. In this type of proteins there are 
three or more  TPR motifs in tandem arrays that function 
to mediate protein-protein interaction in a myriad of 
biological processes1. The repetitive and elongated nature 
of TPR proteins causes them to differ radically in their 
folding from normal globular proteins. As matter of fact, 
TPR proteins fold by a 1-D Ising model and are 
dominated by short-range interactions, whereas globular 
proteins fold by the typical two-state mechanism and 
exhibit complex topologies that frequently have numerous 
long-range interactions2,3. Based on a statistical analysis 
of TPR sequences, Regan and co-workers designed a 
idealized, consensus TPR modules which can be 
combined to create TPR proteins, named Consensus
TPR number of repeats (e.g. CTPR2, CTPR3)4. We want 
to investigate the folding mechanism of repeat proteins 
using the consensus TPR comprised of different number 
of tandem repeats by ensemble and single molecule 
FRET. These experiments require homogenously labelled 
proteins with fluorescent dyes. In order to obtain CTPR 
variants in which fluorescence donor and acceptor pairs 
are incorporated at different, specific positions, we use a 
semi-synthetic strategy which combines solid phase 
peptide synthesis and protein expression techniques5.
1. D’Andrea L. D. and Regan L. (2003) trends in 
Biochemical Science 28(12), 655-661 
2. Main E. R. et al. (2005) Curr. Opin. Struct. Biol. 15(4), 
464-471 
3. Kajander T. et al. (2005) J. Am. Chem. Soc. 127 (29), 
10188 -10190 
4. Main E. R. et al. (2003) Structure 11, 497-508 
5. Muir T.W., et al. (1998) Proc. Natl. Acad. Sci. USA 95, 
6705-6710 
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Rop (repressor of primer) is a small dimeric protein of E. 
coli with a stable four helix bundle structure.  
Protein engineering of Rop has been used: 1- to 
introduce a heme binding site into the four helix bundle 
scaffold; 2- to create a new three helix bundle molecular 
scaffold.  
1- Heme ligands were introduced in the hydrophobic 
core of an engineered monomeric rop (rop-S55) in two 
different layers of the heptad repeat. Mutants rop-
L63M/F121H (layer 1) and rop-L56H/L113H (layer 3) 
were found to bind heme with a KD of 1.1±0.2 and 
0.47±0.07 ?M respectively. The unfolding of heme-bound 
and –free mutants in the presence of guanidine 
hydrochloride was monitored by both circular dichroism 
and fluorescence spectroscopy and the total free energy 
change resulted 0.5 kcal/mol higher in the case of heme 
bound rop-L56H/L113H respect to rop-L63M/F121H. 
Heme binding resulted also to increase ΔG by 1.4 and 1.8 
kcal/mol in rop-L63M/F121H and rop-L56H/L113H 
respectively. 
Spectroelectrochemical titrations allowed to calculate 
redox potentials of-154±2 mV in rop-56H/113H and –
87.5±1.2 mV in rop-L63M/F121H.  
The mutant designed to bind heme in a more 
hydrophobic environment (layer 3) resulted to have a 
tighter binding, a higher stability and a more negative 
redox potential than the mutant designed to bind heme in 
layer 1 demonstrating the possibility to control the 
properties of heme binding of rop by protein engineering. 
2- The last helix of the monomeric ROP protein was 
removed by PCR and the resulting protein was purified. 
The far-UV circular dichroism spectrum showed a high 
helical content. Thermal and chemical unfolding were 
monitored and the stability of the mutant was found to be 
very similar to a synthetic three helix bundle peptide. 
Analysis in gel filtration and native electrophoresis 
showed a dimeric behaviour of the protein due to the 
presence of a disulphide bridge. Molecular modeling was 
used to predict the structure of the protein according to th 
experimental data. 
The results suggest that it is possible by protein 
engineering to turn Rop into a redox protein with 
controlled properties and to create new molecular 
scaffolds for the introduction of new functions. 
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Angiogenesis is a remodeling process characterized by 
the sprouting of new blood vessels from pre-existing 
ones. It occurs during embryogenesis and to a limited 
extent in the adult, for example in the female reproductive 
system, in physiological wound healing and in 
pathological disease processes such as cancer1. Vascular 
endothelial growth factor (VEGF) is a homodimeric 
protein and has been characterized as a prime regulator 
of angiogenesis and vasculogenesis; when cells lose the 
ability to control the synthesis of VEGF, angiogenic 
disease ensues2. In vitro studies show that VEGF is a 
potent and specific angiogenic factor involved in the 
development of the vascular system and in the 
differentiation of endothelial cells3. VEGF biological 
function is mediated through binding to two receptor 
tyrosine kinases: the kinase domain receptor (KDR) and 
the Fms-like tyrosine kinase (Flt-1), which are localized on 
the cell surface of various endothelial cell types. This 
binding activates signal transduction and can regulate 
both physiological and pathological angiogenesis4. VEGF 
and its receptors are in fact overexpressed in pathological 
angiogenesis, making this system a potential target for 
therapeutic and diagnostic applications5, 6.
The extracellular portion of VEGF receptors is 
comprised of 7 immunoglobulin-like domains that is a 
common feature of membrane-anchored proteins; 
deletion studies have shown that the ligand binding 
function resides within the first three domains of Flt-1 and 
in domains 2 and 3 of KDR. Both VEGF receptors contain 
several putative N-glycosylation sites and apparent 
molecular weights of the mature proteins suggest that 
both receptors are extensively glycosylated. Anyway, 
glycosylation is not a prerequisite of high affinity binding 
of VEGF to its receptors7. Actually, no structural data are 
known on the extracellular portion of these receptors 
except for the second domain of Flt-18. So, our aim is the 
cloning and the expression of part of extracellular 
domains of both VEGF receptors for structural 
characterization and to be used in interaction studies with 
peptide ligands or small organic molecules. 
1. Folkman J. (1999) Nat. Med. 1, 27-31. 
2. Ferrara N. (2002) Semin. Oncol. 29, 10-14. 
3. Ferrara N. (1989) Biochem. Biophys. Res. Commun. 
161, 851-858. 
4. Neufeld G. et al. (1999) FASEB J. 13, 9-22. 
5. Ferrara N. and Davis-Smyth T. (1997) Endocrinol. 
Res. 18, 4-25. 
6. Ferrara N. (2000) Curr. Opin. Biotechnol. 11, 617-624. 
7. Millauer B. et al. (1993) Cell 72, 835-846. 
8. Wiesmann et al. ( 1997) Cell 91, 695-704.    
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The recently discovered globin-coupled sensors (GCS) 
are heme-containing two domain transducers, that 
mediate the cellular responses to metabolic and 
environmental stimuli, such as NO, CO and O2. In 
particular, the GCSs identified in the strict anaerobic -
Proteobacteria Geobacter sulfurreducens and Geobacter 
metalloreducens may be involved in sulfate/sulfur 
reduction. They are composed of 300 amino acid 
residues and characterised by a N-terminal globin domain 
(162 amino acids) and by a bundle of four 
transmembrane helices at C-terminal1.
Here, we present the X-ray three-dimensional 
structure of the globin domain of GCS from Geobacter 
sulfurreducens (Gs-GCS162), at 1.5 Å resolution. The 
crystal structure of ferric Gs-GCS162 was solved by MAD 
techniques (data collected at the synchrotron beamline 
ID23-1, ESRF, Grenoble, France), based on the heme Fe 
atom anomalous scattering.  
The Gs-GCS162 fold is a variant of the classical 
globin fold of myoglobin and hemoglobin, spanning 
helices A through H, with an additional Z helix at the N-
terminus. The Gs-GCS162 displays a six-coordinated 
heme and is one of the first examples of bishistidyl 
hexacoordinated GCS. Strikingly, the distal heme-
coordination is provided by a His residue located at the 
E11 topological site, an unprecedented feature within 
globins. 
1. Freitas T.A., Hou S. & Alam M. (2003) FEBS Lett. 
552, 99-104. 
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Thrombin exerts either procoagulant and anticoagulant 
functions in hemostasis. The procoagulant role entails 
conversion of fibrinogen into fibrin and platelets activation, 
while anticoagulant role regards the activation of protein 
C. The most effective modulator of thrombin function in 
solution is Na+, that triggers the transition of the enzyme 
from an anticoagulant (slow) form to a procoagulant (fast) 
form. The Na+-bound (fast) form displays procoagulant 
properties, since it cleaves more specifically fibrinogen 
and protease-activated receptor 1, whereas the Na+-free 
(slow) form is anticoagulant because it retains the normal 
activity toward protein C, but is unable to promote 
acceptable hydrolysis of procoagulant substrates. Several 
crystal structures of the enzyme with and without Na+
bound have been recently reported, but none of these 
seem to fully account for the different biochemical 
properties of the two forms. 
Conformational studies were conducted by far- and 
near-UV circular dichroism (CD) and quenching of 
fluorescence; stability studies were carried out by 
recording the fluorescence changes of thrombin upon 
urea-induced-unfolding; the conformational flexibility of 
thrombin allosteric forms were probed by limited 
proteolysis with chymotrypsin; the accessibility of the 
binding sites of the enzyme in the fast or slow form was 
probed by using synthetic analogs of the N-terminal 
domain of hirudin. 
In this work, the effect of Na+ binding on the 
conformational, stability, and molecular recognition 
properties of thrombin in solution was investigated. The 
binding of Na+ reduces the CD signal in the far-UV 
region, while increasing the intensity of the near-UV CD 
and fluorescence spectra. These spectroscopic changes 
have been assigned to perturbations in the environment 
of aromatic residues at the level of the S2 and S3 sites. 
The Na+-bound form is more stable to urea-denaturation 
than the sodium-free form. Notably, the effects of cation 
binding on thrombin conformation and stability are 
specific for Na+ and parallel the affinity order of 
monovalent cations for the enzyme. The Na+-bound form 
is even more resistant to limited proteolysis by subtilisin, 
at the level of the 148-loop, suggestive of the more rigid 
conformation this segment assumes in the fast form. 
Finally, we have used hirudin fragment 1-47 as a 
molecular probe of the conformation of thrombin 
recognition sites in the fast and slow form. From the 
effects of amino acid substitutions on the affinity of 
fragment 1-47 for the enzyme allosteric forms, we 
conclude that the specificity sites of thrombin in the Na+-
bound form are in a more open and permissible 
conformation, compared to the more closed structure they 
adopt in the slow form. Our results indicate that the 
binding of sodium to thrombin serves to stabilize the 
enzyme into a more open and rigid conformation. 
1. De Filippis V., De Dea E., Lucatello F. and Frasson R. 
(2005) Biochem J. 390, 485-492. 
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Human serum albumin (HSA), the most prominent protein 
in plasma, is best known for its exceptional ligand binding 
capacity, the most strongly bound compounds being 
hydrophobic organic anions of medium size, long chain 
fatty acids, heme and bilirubin. Moreover, HSA 
abundance (its concentration being 45 mg/mL, in the 
serum of human adults) makes it an important 
determinant of the pharmacokinetic behavior of many 
drugs. The conformational adaptability of HSA involves 
more than the immediate vicinity of the binding site(s), 
affecting both the structure and the ligand binding 
properties of the whole HSA molecule that displays 
ligand-dependent allosteric conformational transition(s)1.
Here, we report the heme binding properties of a 
truncated form of HSA, encompassing domains I and II.
The truncated sequence fully contains the primary binding 
sites for heme and warfarin, and the secondary ibuprofen 
binding site.  
Results obtained demonstrate that the truncated form 
of HSA include the heme binding site and shows 
magnetic and optical properties quite similar to the full 
length form of HSA. 
1. Ascenzi P., Bocedi A., Notari S., Fanali G., Fesce R. 
and Fasano M. (2006) MINI REV. MED. CHEM. 6, 
483-489. 
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Non steroidal antiinflammatory drug (NSAIDs) because of 
their analgesic and anti-inflammatory properties are used 
to treat both rheumatoid arthritis (RA) and osteoarthritis 
(OA). Their mechanism of action is generally attributed to 
the inhibition of cyclooxygenases (COXs) (Vane, 1971). 
Recent evidences suggest that NSAIDs could play other 
important roles such as chemopreventive activity for colon 
cancer, apoptotic action and other functions mediated 
through COX-independent mechanism (Tegeder, 2001). 
The aim of the present study is to investigate if and how 
NSAIDs  could play a role in the modulation of the 
expression and activity of matrix metalloproteinases 
(MMPs) produced by rheumatoid synovial cells. It is well 
known that MMPs act on the cartilage and extracellular 
matrix leading to the progressive joint destruction 
occurring in RA and OA. Synovial cells were obtained 
from patients with RA and characterised for CD90 
content. Cultures of confluent cells were treated with IL1?
and/or test drugs (5-25 uM) for 24-48h. Expression of 
MMP-1, 2, 3, 9 and TIMP-1 was monitored by 
zymography, western blotting and enzymatic analysis 
using fluorogenic synthetic peptides as substrate. 
Semiquantitative analysis of mRNA expression was also 
performed. All tested NSAIDs showed , with different 
extent the ability to down-regulate the expression of 
proMMPs.TIMP-1 production remained in each case 
unaffected, At the same time the ability of proMMP-2 to 
convert in its active form was inhibited in a concentrantion 
dependent manner.  These COX-independent 
mechanisms suggest to further investigate new potential 
role of different NSAIDs as therapeutic agents, in the light 
of their good tolerability on long term and reduced side-
effects. 
1. Vane JR (1971) Nature, 231; 232-235 
2. Tegeder I et al (2001) The Faseb Journal, 15; 2057-
2072
3. Manicourt D.H. et al. (1995) Arthritis Rheum; 38: 
1031-1039.  
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Similarly to other clotting factors, in vivo thrombin is 
mainly present as a zymogen, prothrombin. Activation of 
prothrombin occurs via proteolytic cleavage by factor Xa, 
generating prethrombin-2 (PreT-2), the smallest single-
chain intermediate precursor of alpha-thrombin, which is 
subsequently cleaved to produce the mature enzyme. 
Among several different expression systems developed 
so far, production of thrombin in E. coli has demonstrated 
as a convenient method to produce active human 
thrombin in reasonably high yields. Human thrombin 
(hThb) contains four disulfide bridges and is glycosylated 
at Asn60g. Recombinant alpha-thrombin obtained in E. 
coli (rThb) lacks glycosylation and it has being widely 
used by numerous research groups for structural and 
functional studies. However, no detailed characterisation 
of wild-type rPreT-2 and rThb has been reported in the 
literature. 
With the aim to fill this gap, we have carried out a 
thorough chemical, conformational, stability, and 
functional characterisation of rPreT-2 and rThb expressed 
in E. coli and compared the mature recombinant thrombin 
with the natural enzyme. PreT-2 cDNA was expressed in 
E. coli under the control of T7 polymerase promoter. 
rPreT-2 formed intracellular inclusion bodies from which 
the protein was refolded in a reverse-dilution renaturation 
process. After centrifugation, soluble rPreT-2 was purified 
to homogeneity by heparin-sepharose affinity 
chromatography, with a final yield as high as 12%. Highly 
pure (> 95%) rThb was obtained after activation of rPreT-
2 with Echis carinatus snake venom and subsequent 
purification by affinity chromatography. The major results 
obtained in this work can be summarised as follows: 1) 
the disulfide bond topology of rThb, established by 
peptide mass fingerprint analysis, is the same as that of 
the natural hThb; 2) rThb and hThb share a common 3D 
structure, as deduced from far- and near-UV CD and 
fluorescence spectroscopy; 3) the kinetic constants (Km 
and kcat) for the hydrolysis of the chromogenic substrate 
D-Phe-Pro-Arg-pNA are identical for both rThb and hThb; 
4) both rThb and hThb display identical affinities for Na+
ion (an allosteric modulator of thrombin), full-length 
hirudin (the most potent and selective thrombin inhibitor 
known so far) and its N- and C-terminal fragments Hir(1-
47) and Hir(48-64); 4) rThb ([urea]1/2 = 2.6±0.1 M) is less 
stable than hThb ([urea]1/2 = 3.2±0.1 M) to urea-induced 
unfolding; 5) rPreT-2 and rThb display significant 
differences in the far-UV CD and fluorescence spectra; 6) 
active rThb is more stable than rPreT-2 ([urea]1/2 = 
2.1±0.1 M); 7) rPreT-2 binds full-length hirudin with an 
affinity 7x106 fold lower than rThb. 
Our results indicate that the lack of glycosylation in 
rThb selectively affects the stability of the recombinant 
enzyme, while keeping the functional and ligand-binding 
properties of the natural enzyme unchanged. 
15.45 
REDOX PROTEOMICS OF 3’-NITRO-TYROSINE-
CONTAINING PROTEINS IN UREMIC PLASMA 
Piroddi M1, Pilolli F1, Palmese A2, Amoresano A2, Pucci 
P2 and Galli F1
1
 Dipartimento di Medicina Interna , Sezione di Biochimica 
Applicata e Scienze della Nutrizione Università di 
Perugia. 
2
 CEINGE Biotecnologie Avanzate scarl e Dipartimento di 
Chimica Organica e Biochimica Università Federico II, 
Napoli. 
Oxidative and nitrosative stress may cause post 
translational changes in plasma proteins that have been 
described to accumulate in inflammatory and 
degenerative conditions. 3’-Nitro-Tyrosine (3NTyr) has 
been so far suggested to represent one of the main 
protein changes occurring by the sustained exposure to 
nitric oxide derived species formed during inflammatory 
cell activation.  
However, current analysis methods applied to human 
plasma have missed the exact identification of proteins 
containing this post-translational change, thereby 
providing incomplete and unverified information, and 
ultimately limited clinical value.  
In this study we used a LC-MS/MS analysis method 
recently developed by some of us1 that combined with an 
immuno-purification step2, allows the direct identification 
of 3NT-containing proteins in human plasma. A clinical 
application of this analysis was performed in chronic renal 
failure patients on regular hemodialysis (HD) therapy that 
are notoriously affected by chronic inflammation and were 
tentatively identified to accumulate protein nitration 
hallmarks3.
The specificity of the LC-MS/MS analysis method 
proposed in this study is based on the chemoselective 
labelling with DNS of 3’-amino-Tyr-containing peptides 
produced after trypsin digestion by the reduction with 
Na2S2O4 and the immunopurification step was 
demonstrated to be a pre-requisite to achieve sensitivity 
in this redox-proteomics analysis of human plasma 
proteins. 
This method was successfully applied to the 
qualitative analysis of 3NT-containing proteins with 
different relative abundance and molecular mass, in 
plasma and dialysis fluids of HD patients. This analysis 
method can be used also to identify the number and 
position of Tyr residues affected by this post-translational 
change in individual proteins. Semi-quantitative data 
obtained with this procedure clearly show that healthy 
control plasma contains much less nitrated peptides, and 
these findings were in agreement with lower levels of 
biochemical indices of oxidative stress and inflammation. 
Further studies are in progress to apply this assay 
procedure to a more extensive identification of 3NT-
containing proteins in plasma of HD patients and also in 
other chronic diseases associated with oxidative stress 
and inflammation. 
1. Amoresano et al Anal. Chem. 2007 
2. Piroddi et al in preparation 
3. Mitrogianni et al Am. J. Kid  Dis. 2004 
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Bovine pancreatic ribonuclease A is monomeric in its native 
state, but forms three-dimensional (3D) domain-swapped 
dimers, trimers, tetramers, and larger oligomers by 
lyophilization from 40% acetic acid solutions1, according to 
the method of Crestfield, Stein and Moore2. The same 
oligomers form if the protein is subjected to a thermally-
induced oligomerization procedure lacking the lyophilization 
step3. Several studies have been performed to determine 
which are the structural determinants that promote RNase A 
oligomerization; these studies have been accompanied by 
others performed on BS-RNase, a member of the RNase 
superfamily that displays more than 80% of sequence 
identity with RNase A, and is found in bull semen. The 
seminal variant is dimeric in nature for the presence of two 
intersubunit antiparallel disulphide bonds, and about 70% of 
its native molecules swap their N-terminal ends 4. It has been 
recently found that the R80S-BS-RNase mutant lowers its 
swapping propensity to about 30% if the residue 80 mutation 
is accompanied by the substitution of the 16-22 loop 
(connecting the N-terminal domain with the core of the 
protein) of the seminal enzyme with the loop present in 
RNase A 5.
Considering that in RNase A the residue present in 80 
is serine, we tried the opposite mutation in the pancreatic 
enzyme to see if this could induce a significant increase in 
the aggregation propensity of the pancreatic enzyme 
through 3D domain swapping. The S80R-RNase A 
mutant was produced, sequenced,  purified and analyzed. 
No significant loss of stability, structural features or 
enzymatic activity were detected. The aggregation 
propensity of the mutant was then studied, in parallel with 
that of the wild type, using either the ‘classical’ acetic acid 
lyophilization method or the thermally-induced 
oligomerization. All results obtained to date indicate that 
the aggregation propensity of the S80R-RNase A mutant 
is higher than the w.t., and that that of the species formed 
through the N-terminus swapping significantly increase 
their yield  in the mutant with respect to the w.t. enzyme. 
Invesitgations on the stability of the dimeric species 
produced by the mutant with respect to the stability of the 
w.t. are presently under study, while the future goal will be 
to see if the more basic oligomers of the S80R RNase A 
mutant may show increased biological activities with 
respect to the ones displayed by the omologous 
oligomers formed by the wild type1.
1. Libonati M. and Gotte G. (2004) Biochem J 380, 311-
327
2. Crestfield A. M., Stein W. H. and Moore S. (1962) 
Arch Biochem Biophys Suppl 1, 217-222 
3. Gotte G., Vottariello F. and Libonati M. (2003) J Biol 
Chem 278, 10763-10769. 
4. D’Alessio G., Di Donato A., Piccoli R. and  Russo N. 
(2001) Methods Ezymol. 341, 248-263 
5. Ercole C., Spadaccini R., Alfano C., Tancredi T. and 
Picone, D. (2007)  Biochemistry 46, 2227-2232 
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Snake venom on evenomation has many toxicological 
effects that eventually leads to death in human, however 
these toxins contained in venoms are undoubtely proven 
to be useful to human. 
Venom from  Echis Carinatus has been reported to be 
active on plasma proteins. It is reported that it contain 
proteases. 
These proteases affect various physiological 
functions: platelet aggregation, blood coagulation, 
fibrinolysis and complement system. In particular the 
ecarin is active as prothrombin activators1.
We studied and identified the properties of Echis 
Carinatus proteases in comparison with other snake 
venom proteases that are active on plasma. 
In addition we carried out an experiment to compare 
ecarin activity with thrombin activity on depleted plasma. 
An appropriate ratio concentration between Echis 
Carinatus and plasma was used for this assay in SDS-
PAGE. 
We observed venom activity on plasma, in particular 
changes which occurred in the bands that we analysed 
with Total Lab. This we studied using whole plasma and 
depleted plasma. 
Plasmatic changes that occurred was studied after 
pre-incubation with venom in a different times of 0’, 10’, 
20’,30’,40’,50’ and 60’. 
The 2D Image of the various spots detected were then 
analysed using Image Master Platinum to evaluated the 
changes that occurred in the plasma proteins 
In conclusion using a proteomic approach we 
observed that Echis Carinatus venom contains proteases 
that are active on plasma proteins. 
1. Manjunatha Kini R. Pathophysiol Haemost Thromb. 
2005;34:200-204. 
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Transferrins (Tfs) belongs to a family of iron-binding 
glycoproteins. The different proteins of the Tf family have 
been subdivided on the basis of their amino acid 
sequence, biological function and location. Lactoferrin 
(Lf), is expressed and secreted from glandular epithelial 
cells and from mature neutrophiles of mammalian, and it 
is an important component of the aspecific host defence 
or natural immunity1. Serum transferrin (sTf) is 
synthesized by the liver of mammals and secreted into 
the blood; its primary function is iron transport. 
Ovotransferrin (Otrf), instead, is synthesized by avians
and displays both iron transport and protective functions2.
A 17-mer sequence Y679–K695 present near the C-
terminus of human (hLf) and bovine (bLf) lactoferrin 
shows 90% homology and 60% identity with the 
sequence of the reactive site of the cystatins, which are 
competitive inhibitors of papain-like cysteine proteases3.
The same sequence is present, though with lower 
homology, in Otrf and, with even lower homology, in sTf. 
Parasites synthesize papain-like cysteine proteases that 
are relevant for the virulence and pathogenicity of 
parasites, being involved in several aspects of the 
parasite life cycle4, it is therefore possible that the 
antiparasitic activity of Lf could be due to parasitic papain-
like cysteine protease inhibition.  
In this study we have investigated the kinetic 
parameters of Tfs inhibition of the parasitic papain-like 
cysteine protease type I from Leishmania infantum and 
Trypanosoma cruzii. bLf, hLf and Otrf inhibit papain and 
the parasitic proteases. The inhibition of such cysteine 
proteases by these proteins conforms to a competitive 
mechanism. KI values for bLf and hLf inhibition of L. 
infantum protease and T. cruzi (KI = 3.1 nM) are lower 
than those for papain (KI = 24 nM). The inhibition of 
cysteine proteases by Otrf is still present, although much 
lower than that displayed by the mammalian proteins (KI =
6.0 ?M. On the contrary, sTf does not display any 
inhibition, according to its different role in mammals. 
Moreover, SDS-PAGE shows that bLf, hLf and Otrf are 
easily degraded by papain during the assay incubation 
time and it is likely that a cystatin-like peptide is 
generated from protease hydrolysis to competitively 
inhibit the protease itself. The unequivocal identification of 
this peptide is presently under investigation by HPLC-
Mass Spectroscopy technique. 
These data strongly support the hypothesis that Lf 
antiparasitic activity could be due, at least partially, to the 
inhibition of parasitic proteases. 
1. Valenti P. & Antonini G., Cell. Mol. Life Sci. 62, 2576–
2587 (2005) 
2. Giansanti F. et al.Biochem Cell Biol.85:150-155 
(2007).
3. Katanuma N. et al., Adv Enzyme Regul. 43,393-410 
(2003 
4. Smith B.O. et al., J Biol Chem. 281:5821-5828 (2006) 
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The tumor suppressor p53 and the cellular oncogene 
mdm2 have been identified as key signal integrator 
molecules. Alterations in their phosphorylation status can 
abolish their function resulting in uncontrolled cell growth. 
Several CK1 isoforms have been shown to phosphorylate 
p53. Whereas CK1? is able to phosphorylate p53 only in 
vitro, CK1δ and ? phosphorylate p53 in vitro and in 
cultured cells. CK1δ/?-mediated phosphorylation has been 
reported to occur at serines 4, 6 and 9 of murine p53 
(Knippschild, 1997), whereas phosphorylation of human 
p53 at serine 9 and threonine 18 by CK1δ/? seems to 
require prior phosphorylation by other kinases of serine 6 
and 15, respectively (Sakaguchi, 2000). 
These somewhat conflicting observations prompted us 
to assay a series of peptides encompassing residues 1-
28 of human p53 protein as substrates for different CK1 
isoforms. Phosphorylation assays with radiolabelled ATP 
show that only the CK1 delta phosphorylates p53 
peptides, albeit with low efficiency (Km?4mM). In the case 
of full length human p53 GST-fusion protein, both CK1 
alpha and delta are able to phosphorylate the protein with 
Km in the low nM range.   
In the peptide model, mutation of S15 and S20 to 
alanines results in a very low radioactivity incorporation, 
suggesting a major implication of these residues as the 
main target of CK1 delta. Phospho-aminoacid analysis, 
moreover, rules out the involvement of threonine 18 in 
CK1δ-mediated phosphorylation. To further analyze the 
residues phosphorylated in the p53 peptide, we have 
performed solid-phase Edman degradation: S15 alone 
accounts for about 80% of the whole radioactivity 
incorporated; a much lower but significant 
phosphorylation of S9 as well as traces of radioactivity in 
correspondence of S6 and S9 are found.  
At present we are working on the full length p53 
protein to compare its phosphorylation pattern to that of 
the peptides and to gain information about remote 
docking sites responsible for the dramatic increase in Km 
observed with the protein as compare to the peptides. 
Knippschild U. et al., Oncogene 15 (1997), 1727-1736 
Sakaguchi K. et al., J. Biol. Chem. 275 (2000), 9278-9283 
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In the last decades, bacterial, yeast, and animal cells 
have been exploited as factories for the production of 
therapeutic proteins. More recently, molecular farming 
has rapidly pushed towards plants for producing 
recombinant proteins. Expression of therapeutic proteins 
in plants is safe and extremely cost-effective. Unlike 
microbial fermentation, plants are indeed capable of 
introducing post-translational modifications and, unlike 
production systems based on mammalian cell cultures, 
they are devoid of human infective viruses and prions. 
In this study, Nicotiana benthamiana was used as a 
novel expression system for the production of human 
interleukin-6 (hIL-6) and human granulocyte-macrophage 
colony-stimulating factor (hGM-CSF), two protein drugs of 
outstanding pharmacological interest. DNA coding 
sequence for mature hIL6 protein was fused with an 
extensin target peptide sequence at the 5'-position and a 
6xHis tag at the 3'-position. Construct with a double 35S 
promoter and a 35S terminator was inserted in pBin32 
vector. Plants of Nicotiana benthamiana were transiently 
transformed by Agrobacterium tumefaciens and green 
leaves were collected 6 days after transformation. 
Immunoblotting analysis showed that the recombinant 
proteins were efficiently accumulated in transgenic plants, 
with expression levels of about 0.1-0.2%, calculated on 
the total soluble proteins in leaves. The presence of 
multiple species of hIL-6 and hGM-CSF at different 
molecular weights is the result of heterogeneous N- and 
O-linked in vivo glycosylation. After extraction, the 
recombinant proteins were purified to homogeneity by 
combining several chromatographic steps and the purity 
of the protein samples was ascertained by RP-HPLC and 
IEF/SDS 2D gel-electrophoresis. 
By using peptide mass fingerprint analysis on 
Coomassie-stained electrophoretic bands, we isolated 
several tryptic peptides covering 26 and 48% of the entire 
sequence of hGM-CSF and hIL-6, respectively. This 
allowed us to unambiguously identify the two recombinant 
proteins. In vitro functional analysis were performed on a 
cell proliferation assay using a human growth factor-
dependent TF-1 cell line suggesting that the recombinant 
proteins expressed in N. benthamiana are biologically 
active, with a ED50 value of 0.02-0.05 ng/mL for hGM-
CSF and 0.10-0.25 ng/mL for hIL6. 
Our results demonstrate that Nicotiana benthamiana
is a suitable eukaryotic expression system for producing 
in reasonable yields correctly glycosylated proteins of 
therapeutic interest.  
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Keratoepithelin (KE), also known as Big-h3, TGF-?-
induced protein h3 or RGD_CAP, is an extracellular 
matrix protein highly conserved among all the vertebrate 
species so far analyzed. It is encoded by the gene BIGH3 
(also known as TGFBI) that was discovered in a search 
for genes induced by transforming growth factor ? (TGF-
?). KE is expressed in various tissues and organ systems, 
such as cornea, skin, bone, tendon and kidney, where it 
interconnects the extracellular matrix proteins to resident 
cells binding collagens, fibronectin and integrins. In a 
recent work we have also detected KE, by 
immunofluorescence experiments, in the perimysium and 
endomysium of skeletal muscle fibers1. KE is formed by 
four domains in close succession, discovered in the insect 
cell adhesion molecule fasciclin I and thus named FAS1 
domains. This kind of domains has been identified within 
Eukarya in Plantae, Fungi and Animalia. Many studies 
have shown a role of KE in 5q31-linked human autosomal 
dominant corneal dystrophies, such as granular corneal 
dystrophy (GCD) and lattice corneal dystrophy (LCD) 
characterised by the formation of amyloid-like or granular 
deposits of KE within the corneal stroma2. It has been 
proposed that some missense mutations found into the 
BIGH3 gene may trigger KE misfolding, eventually 
resulting in the deposition and/or fibrillation of KE mutant 
protein3. To verify this hypothesis, we have cloned and 
recombinantly expressed domain FAS1-4 of human KE,  
and analysed its structural properties and stability by 
circular dichroism and fluorescence spectroscopy. We 
have introduced into this domain a point-mutation found in 
patients affected by lattice corneal dystrophy (LCD) type I, 
namely L518R, and we have compared the biochemical 
properties of wild-type and mutant FAS1-4 domains. 
Amyloid protein aggregation is a prominent feature of 
many neurodegenerative diseases, such as Alzheimer's, 
Huntington's and Parkinson's diseases as well as 
spongiform encephalopathies. KE and the study of its 
amyloidogenicity may represent an attractive model for 
the analysis of protein misfolding and aggregation 
phenomena.  
1. Sciandra F. et al.(2008) Matrix Biol.  27(4), 360-70. 
2. Munier, F.L. et al. (1997) Nat. Genet.  15, 247-251.  
3. Clout, N.J. et al. (2003) Structure 11, 197-203.  
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Dystroglycan (DG) is a membrane receptor belonging to 
the complex of glycoproteins associated to dystrophin. 
DG is formed by two subunits, alpha-DG, an extracellular 
matrix protein highly glycosylated, and beta-DG, a 
transmembrane protein resulting from a post-translational 
cleavage, which are held together by non-covalent 
interactions. The association between alpha-DG and 
beta-DG results in a contact between the extracellular 
matrix and the cytoskeleton, and it is crucial to maintain 
the integrity of the plasma membrane. In inherited 
neuromuscular diseases such as Duchenne and Becker 
muscular dystrophies, disruption or even a weakening of 
the interaction between the two DG subunits, due to a 
reduction or a complete loss of one or both DG subunits, 
causes sarcolemmal instability and necrosis of muscular 
fibers. Interestingly, Western blot experiments carried out 
on tissue extracts from patients affected by such diseases 
revealed the proteolytic fragment of beta-DG missing its 
extra-cellular domain and showing an apparent molecular 
weight of 30 kDa that was originally discovered in breast 
cancer cell lines1. It was demonstrated that the 30 kDa 
beta-DG fragment is produced by a matrix 
metalloproteinase activity resulting in the shedding of all 
or part of the beta-DG ectodomain2. The 30 kDa beta-DG 
fragment was also detected in other pathological 
conditions such as Fukuyama-type congenital dystrophy, 
sarcoglycanopathy, ischemic injury, osteoarthritis, as well 
as in healthy tissues such as peripheral nerve, bladder, 
lung, kidney and skin. Although many studies have been 
focused on the 30 kDa beta-DG fragment produced by 
matrix metalloproteinase activity, the molecular 
mechanism of the enzymatic digestion of beta-DG 
extracellular domain is still elusive; for this reason we 
have carried out an in vitro enzymatic digestion of the 
recombinant extracellular domain of beta-DG, beta-
DG(654-750) with the metalloproteinase MMP-9, and 
characterised the reaction both kinetically and 
thermodynamically. Moreover, we have analysed the 
reaction products using a combined approach based on 
SDS-PAGE and HPLC-ESI-IT mass spectrometry. Thus 
we were able to identify the exact beta-DG peptide bond 
primarily cleaved by MMP-9, localized between the amino 
acidic positions 716-717.  
1. Losasso C. et al. (2000) FEBS Lett. 484, 194-198. 
2. Yamada, H. et al. (2001) Hum. Mol. Genet. 10, 1563-
1569. 
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Among the variety of proteins found to be able to form 
amyloid fibrils in vivo and in vitro, human lysozyme is a 
very interesting case1. Some lysozyme  variants, in fact, 
have been proved to be responsible for abnormal fibril 
deposition in familial non-neuropathic systemic 
amyloidosis. Moreover, wild type lysozyme itself has been 
demonstrated to form in vitro amyloid fibrils highly similar 
to the pathological ones. In order to understand the 
mechanism of aggregation of both variant and wild type 
lysozyme, experimental conditions have been tuned to 
allow the in vitro formation of lysozyme amyloid fibrils. 
Unfortunately, due to the extreme stability of all lysozyme 
variants (midpoint of thermal denaturation is between 55 
and 80 C under physiological conditions), fibrils have 
been formed under mild and high denaturant conditions, 
including high temperature, low pH, moderate 
concentration of denaturant or high pressure. Except for 
an overall fibrillar morphology, lysozyme fibrils formed 
under different conditions have never been shown to 
share the same amyloid structure. Here, human lysozyme 
fibrils have been formed under two sets of conditions, at 
low and neutral pH. Their amyloid nature has been 
confirmed by thioflavin T assay, transmission electron 
microscopy and X-ray diffraction. Interestingly, FTIR 
analysis revealed a significant difference in the fibrils 
structure and fibrils dissociation experiments confirmed a 
different conformational stability for the two kinds of fibrils. 
This study clearly indicates that aggregation conditions 
promote the formation of amyloid fibrils with different 
structure and stability due to different rearrangements of 
lysozyme polypeptide chain into the core of amyloid 
fibrils. Such differences in amyloid conformations could 
arise from the properties of the amino acid sequence of 
lysozyme in each condition or could be driven by kinetic 
factors. Moreover, the structure of the precursor protein 
may also lead to different folds of the lysozyme 
polypeptide chain in the beta-sheet core of fibrils. 
1. Dumoulin M., Kumita J.R., Dobson C.M. (2006) Acc. 
Chem. Res. 2006 39, 603-610. 
15.54 
NOVEL ANTIBACTERIAL PEPTIDES ISOLATED FROM 
THE EUROPEAN PAPER WASP, POLISTES 
DOMINULUS (HYMENOPTERA, VESPOIDEA) 
E. Pagni1, B. Pantera1, L. Carresi2, G. Mastrobuoni3, S. 
Turillazzi4, G. Cappugi1 and L. Pazzagli1
1
Dipartimento di Scienze Biochimiche, Università di 
Firenze, Firenze, Italia 
2
Dipartimento Biotecnologie Agrarie, Università di 
Firenze, Firenze, Italia 
3
Centro Interdipartimentale Spettrometria di Massa, 
Università di Firenze, Firenze, Italia 
4
Dipartimento di Biologia Animale e Genetica, Università 
di Firenze, Italia 
Insects have very efficient defense mechanisms against 
pathogens and parasites. Their systemic antimicrobial 
response is mainly based on the synthesis of 
antimicrobial peptides (AMPs) by the fat body and certain 
blood cells and on the release of these factors into the 
hemolymph after bacterial challenge. AMPs can also be 
produced as a local response in the epithelia such as 
tracheal epithelium, gut lining and salivary glands. On the 
basis of their structural features, AMPs are classified into 
three classes (1): (i) linear peptides, devoid of cysteines 
and forming ?-helices, such as cecropins; (ii) peptides 
with an over-representation in proline and/or glycine 
residues; (iii) peptides stabilized by intramolecular 
disulfide bonds, such as defensins. Here we report the 
isolation of two constitutive antibacterial peptides from the 
larval saliva of the social wasp  Polistes dominulus, a very 
common specie in Europe. This secretion has an 
alimentary function but it is also important for the infection 
prevention in the social insect community. Microbiological 
tests proved that larval saliva of Polistes dominulus has
an antibiotic activity against Bacillus subtilis, Gram +, and 
Escherichia coli, Gram - (2). The antimicrobial peptides 
were purified by reversed-phase HPLC and characterized 
by peptide sequencing and mass spectrometry. The first 
one has a molecular weight of 2279.50 Da, is formed from 
21 aminoacids, it is rich in proline and its sequence has 
been completely determined. Unfortunately the synthetic 
form of this molecule had no antibacterial activity and it 
was probably not correctly structured: we think that 
treatment with proline cis-trans-isomerase inducing the 
isomerization of the proline peptide bond(s) can allow the 
activation of the synthetic peptide. The second peptide, 
with a mass of 3700,54 Da, has been only partially 
sequenced and belongs to the group of defensins, 
because of the presence of six cysteine residues. It 
shows some similarities with a putative defensin of the 
dipter Culicoides sonorensis, but a definitive 
characterization of this molecule awaits further work. 
1. Bulet et al. (1999) Dev. Comp. Immunol. 23: 329-44. 
2. Turillazzi et al. (2004) Insect. Soc. 51: 1-3. 
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Mycobacterium tuberculosis (MTB) is one of the most 
devastating human microbial pathogens. It invades and 
multiplies in both phagocytes and epithelial cells. In MTB, 
adherence to epithelial cells is mediated by the heparin-
binding haemagglutinin adhesin, HBHA1. This protein binds 
to heparan sulphate proteoglycans on the surface of 
epithelial cells and is, therefore, responsible for extra-
pulmonary dissemination of tuberculosis2. Binding to target 
epithelial cells involves the C-terminal lysine-rich domain of 
the protein, which is exposed at the mycobacterial cell 
surface2. However, despite the interest of HBHA both as a 
potential antigen against tuberculosis  and as a diagnostic 
tool, no structural data are so far available, nor detailed 
information on the protein oligomerization state have yet 
been provided. We here present a biophysical 
characterization and the low resolution structure by Small 
Angle X-ray Scattering (SAXS) of both the full length HBHA 
and a truncated form, here denoted as HBHADC, which 
lacks the C-terminal heparin-binding domain (residues 161-
199)4. We have cloned, expressed and purified both HBHA 
and HBHADC to study their molecular properties and 
oligomerisation, a key event for bacterial haemagglutination5.
Circular dichroism studies have provided an experimental 
evidence that HBHA presents a coiled coil domain, like 
predicted by sequence analysis6. To validate this result, we 
performed chemical denaturation, using urea as a 
denaturating agent, of HBHADC. The urea denaturation 
profile of HBHADC is characteristic of a two-state helix-coil 
transition with a peculiarly low urea Cm, a characteristic 
which is typical of coiled coil systems. By performing cross-
linking experiments using both glutaraldehyde and bis-
sulfosuccinnimidyl-suberate (BS3) as cross-linking agents, 
we evidenced that HBHA is dimeric in solution. Small Angle 
X-ray Scattering (SAXS) experiments on both HBHA and 
HBHADC confirmed the dimeric nature of these proteins[5].
The experimental Rg and Dmax values showed that HBHA 
exhibits an elongated shape. The increase of both Rg and 
Dmax of the full-length protein compared to HBHADC 
suggests peripheral location of the C-terminal of HBHA. This 
is consistent with the role attributed to HBHA C-termini in 
epithelial cell adhesion. Furthermore, our data suggest that, 
like for other known systems, the coiled-coil nature of the N-
terminal region of HBHA is responsible for dimerization, 
which may be regarded as a process that leads to enhanced 
affinity to epithelial cells and improves cell adhesion.  
1. Pethe K., et al.  (2001) Nature 412, 190-194 
2. Menozzi . F.D. et al. (1998) PNAS 95,12625-12630 
3. Pethe K et al. (2002)  PNAS 99, 10759-10764 
4. Svergun, D. I. (1999) Biophys J 76, 2879-2886 
5. Esposito C et al.  (2008) J Bac 190, 4749-53 
6. Delogu G. and Brennan M.J. (1999) J Bacteriol 181,
7464-7469 
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Nucleoside hydrolases (NHs) comprise a superfamily of 
structurally related metalloproteins with a unique ?-sheet 
topology1. Functionally, NHs are glicosidases that 
hydrolyse the N-glycosidic bond of ?-ribonucleosides, 
forming the free purine/pyrimidine base and ribose. All 
characterised members impose a stringent specificity for 
the ribose moiety, but exhibit variability in their preference 
for the nature of the nucleic base1. Sequence alignments 
highlight a recurring N-terminal DXDXXXDD motif as a 
hallmark of NH activity.  
To elucidate  the mechanisms by which 
hyperthermophilic enzymes acquire their unusual 
thermostability and to increase our knowledge on the 
structure of NH we have chosen as experimental model 
system NH from Sulfolobus solfataricus, (SsNH) an 
hyperthermophilic archaeon optimally growing at 87°C. 
The analysis of the complete sequenced genome of  S. 
solfataricus  revealed  two open reading frames 
(SSO0505 and SSO2243) encoding two proteins, the 
citosine-uridine preferring nucleoside hydrolase (SsCU-
NH) and  the adenosine-inosine-guanosine preferring 
nucleoside hydrolase (SsIAG-NH). The genes were 
amplified by PCR, ligated into the plasmid pET-22b(+) 
and expressed in E. coli BL21. The purified recombinant 
proteins were enzymatically active, thermophilic and 
thermostable. The enzymes are characterized by a 
subunit of  35 kDa. SsCU-NH is a homotetramer of 140 
kDa that recognizes only pyrimidine nucleosides as 
substrates. On the other hand, SsIAG-NH is a homodimer 
of 70 kDa  specific for purine nucleosides. To obtain 
information about the flexible regions of the protein 
exposed to the solvent, SsCU-NH and SsIAG-NH were 
subjected to limited  proteolysis. Finally, the structures of 
the two enzymes provided insight into substrate specificity 
and proteolytic analyses as well as into mechanisms of 
thermal stability. Molecular model analysis reveals that 
the overall structure and the position of catalytically 
important residues in the calcium and ribose binding are 
conserved while the base-binding pocket reflects the 
difference in substrate specificity between SsCU-NH and 
SsIAG-NH strongly supporting the hypothesis that SsIAG-
NH and SsCU-NH are the same enzyme whose active 
site was partially modified to specifically recognize purine 
or pyrimidine. The evaluation of the models allowed to 
state that a higher compactness of the structure and the 
presence of clusters of hydrophobic residues such as Ile 
and Leu at the subunit interfaces, enhance protein 
thermostability of both enzymes whereas the presence of 
an intersubunit disulfide bridge in SsIAG-NH appears to 
be more relevant to obtain higher enzyme stability. These 
are the first example of nucleoside hydrolases reported in 
Archaea.
1. Versées W. and  Steyaert J. (2003) Curr. Opin. Struct. 
Biol. 13, 731–738. 
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Amyloid fibrils are ordered protein structures generated 
by molecular self-assembly (“molecular Lego”). Being 
resistant to proteases, detergents and mechanical stress 
and stable under a variety of conditions, amyloid fibrils 
are optimal tools for the construction of novel nanoscale 
biomaterials.  
We used amyloid fibrils as a scaffold for the 
production of enzymatically active polymers, named 
“catalytic fibrils”, generated by functionalizing a 
fibrillogenic polypeptide with an enzyme. This was 
achieved by genetically fusing glutathione S-transferase 
(GST), an enzyme widely used for biotechnological 
applications, to the Apolipoprotein A-I (ApoA-I) 
fibrillogenic domain, to generate a bifunctional chimeric 
protein consisting of a fibrillogenic and a catalytic moiety.  
The fibrillogenic domain of ApoA-I (90-100 residue 
long) corresponds to the N-terminal region of the protein. 
In ApoA-I variants associated to amyloidosis, this domain 
is released and generates amyloid fibrils in various 
organs and tissues. Recently, we were able to produce a 
recombinant version of the 93-residue N-terminal 
polypeptide, named [1-93]ApoA-I1, previously extracted 
from cardiac amyloid fibrils of patients affected by 
amyloidosis2. It was found to be a natively unfolded  
polypeptide1 with high propensity to generate fibrils as its 
natural counterpart.  
This polypeptide was fused to GST. The fusion protein 
GST-[1-93]ApoA-I was expressed, isolated and 
characterized. It was found to fully retain GST catalytic 
activity and to have high propensity to aggregate in 
fibrillar structures, as indicated by tests for protein 
aggregation in amyloid-like structures. Upon incubation 
for 3 weeks at pH 6.4, almost all the protein molecules 
generated insoluble aggregates. AFM analysis showed 
the presence of straight fibrils and fibril networks.  
Fibrils were loaded on a polypropilene-based filter and 
tested for enzymatic activity by injecting through the 
fibrillar matrix a reaction mixture containing GST 
substrates. Spectrophotometric analyses of the flow-
through demonstrated that fibrils were enzymatically 
active. The enzymatic activity of catalytic fibrils was found 
to be time-dependent and stable over time.  
Our findings show that a fibrillar matrix, generated by 
self-assembly of a bifunctional chimeric protein, is 
catalytically active and reusable over time. It may 
represent a novel nanoscale catalytically active 
biomaterial. 
1. S. Di Gaetano et al., (2006) Biochem. Biophys. Res. 
Commun. 351, 223-228. 
2. L. Obici et al., (1999) Am. J. Pathol. 155, 695-702. 
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The growing emergency of multi-drug resistant bacteria is 
a global concern:  a number Gram-positive and Gram-
negative bacteria have developed resistance against 
most traditional, as well as new generation antibiotics. 
Therefore, the  demand for new antibiotics urges 
researchers and pharmaceutical companies to consider 
new antimicrobial agents. Among these, antimicrobial 
peptides turned out to be particularly interesting, in 
consideration of their peculiar mechanism of action, which 
is specifically targeted to bacterial membrane. 
Nonetheless, pharmaceutical companies have shown a 
general reluctance to the development of peptide drugs, 
which can be explained by a number of problems related 
to development of peptide as drugs, including their short 
half life produced by rapid proteolysis.  
We recently identified a non-natural peptide 
sequence, showing a strong antimicrobial activity1. This 
peptide (QKKIRVRLSA; called M6) was synthesized in 
the branched Multiple Antigen Peptide form, that we had 
previously demonstrated to induce general peptide 
resistance to proteolysis, making this kind of molecules 
very suitable for in vivo use2-3. The branched peptide M6 
was characterized for its activity against a number of 
bacteria showing a strong specificity for Gram negative 
species. The peptide resulted particularly active against 
Escherichia coli, Pseudomonas Aeruginosa, Klebsiella 
pneumoniae and some other enterobacteriacee, including 
multi-drug resistant clinical isolates. We also 
demonstrated that M6 showed a poor toxicity for 
eukaryotic cells, it bound LPS and DNA and it did not 
produce appreciable haemolysis even upon prolonged 
incubation. Moreover, we evaluated M6 acute toxicity 
(LD50 around 125 mg/Kg for i.p. administration) and we 
also demonstrated that it is not immunogenic upon 
repeated injections in animals4.
We report here on M6 in vivo activity in models of 
sepsis induced in mice by E. coli and P. aeruginosa. 
These experiments showed that the peptide can prevent 
animal death and can neutralize sepsis symptoms when 
used in doses comparable to traditional antibiotics and 
compatible with a clinical use.  
These results make the branched M6 peptide a strong 
candidate for the development of a new antibacterial 
drug. 
1. Pini et al. Antimicrob Agents Chemother. 
2005;49:2665-72. 
2. Bracci et al. J Biol Chem. 2003;278:46590-5. 
3. Falciani et al. Chem Biol Drug Des. 2007;69:216-21 
4. Pini et al. J Pept Sci. 2007;13:393-9. 
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Cholesterol oxidase (CO, EC 1.1.3.6) is a bifunctional 
FAD-containing flavoenzyme catalyzing the oxidation and 
isomerization of cholesterol to cholest-4-en-3-one1. CO 
from Brevibacterium sterolicum (BCO) possesses the 
cofactor covalently linked to the apoprotein moiety; its 3-D 
structure shows a putative “oxygen-tunnel” extending 
from the surface of the molecule to the buried active site 
cavity. This tunnel is blocked from direct access by the 
side chain of R477, which adopts two alternative 
structural conformations, corresponding to an “open 
tunnel” and to a “closed tunnel” forms: E311 and E475 
seem to modulate the conformational change. The 
residues A204, G309 and I423 also participate to the 
tunnel formation. To assess the role of these residues on 
the oxygen accessibility/reactivity of BCO, a number of 
mutants were prepared by SDM, over-expressed in E. coli
and characterized.
Mutants involving substitutions of residues E311 and 
R477 show the most significant modifications of the 
kinetic properties. The conservative substitutions E311Q 
and R477K resulted in a 50?fold decrease in the kcat
value for the dehydrogenation reaction with respect to the 
wild?type BCO; the elimination of the charge (E311L and 
R477A BCO mutants) quite completely abolished the 
enzymatic activity. Substitution of E475 affected mainly 
the isomerization reaction, whereas mutations at positions 
204, 309 and 423 marginally modified the enzymatic 
activitiy. Furthermore, the midpoint redox potential of 
BCO mutants were modified to a limited extent (?40 mV) 
by the substitutions introduced. 
Concerning the oxidative half-reaction, wild?type BCO 
shows a saturation behaviour of the observed re-oxidation 
rate constant of the reduced form with increasing oxygen 
concentration2. This behaviour was proposed to arise 
from an “interconversion” between the two conformations 
of the residues gating the putative oxygen channel in the 
reduced enzyme form2. Interestingly, the BCO mutants at 
position E311 show a linear dependence of the rate of 
reoxidation with O2 concentration, pointing to the 
elimination of the “interconversion” process. Furthermore, 
the rate of reoxidation is significantly decreased for 
E311Q and R477K BCO mutants.  
In conclusion, our results suggest that reactivity of 
BCO with regard to dioxygen is finely tuned by the 
interaction of E311 with the E475?R477 couple. The 
present findings on a flavooxidase support the notion that 
the presence of specific channels is a common theme in 
enzymes that act on dioxygen. 
1. Sampson N.S. and Vrielink A. (2003) Acc. Chem. Res. 
36, 713-722. 
2. Pollegioni, L., Wels, G., Pilone, M.S., and Ghisla, S. 
(1999) Eur. J. Biochem. 264, 140?151. 
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The aggregation process of wild type human lysozyme at 
pH 3.0 and 60 °C has been analyzed by characterizing a 
series of distinct species formed on the aggregation 
pathway, specifically the amyloidogenic monomeric 
precursor protein, the oligomeric soluble prefibrillar 
aggregates and the polimeric mature fibrils. Particular 
attention was focused on the analysis of the structural 
properties of prefibrillar aggregates, since recent studies 
have shown that the oligomers formed by lysozyme prior 
to the appearance of mature amyloid fibrils are toxic to 
living cells. Here, soluble oligomers of human lysozyme 
have been purified, and then analyzed by a range of 
techniques including binding to fluorescent probes such 
as Thioflavin T and ANS, Fourier-transform infrared 
spectroscopy and controlled proteolysis. Oligomers were 
isolated after 5 days of incubation of the protein: they 
appear as spherical particles with a diameter of 8-17 nm 
when observed by transmission electron microscopy. 
Unlike the monomeric protein, oligomers have solvent-
exposed hydrophobic patches able to bind the fluorescent 
probe ANS. FTIR spectra are indicative of highly 
misfolded species when compared with monomeric 
lysozyme, with a prevalence of random structure, but with 
significant element of the ?-sheet structure that is 
characteristic of the mature fibrils. Moreover, the 
oligomeric lysozyme aggregates are more susceptible to 
proteolysis with pepsin than both the monomeric protein 
and the mature fibrils, indicating further the lack of 
organized structure. In summary, this study shows that 
the soluble lysozyme oligomers are structurally flexible 
species, present at low concentration even during the 
initial phases of aggregation. Their dynamic and non-
native conformational features are likely to confer on them 
the ability to interact inappropriately with a variety of 
cellular targets including cellular membranes generating 
the toxicity that is observed experimentally.  
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Beta2-glycoprotein I (?2-GpI) is the principal target of 
autoantibodies in the antiphospholipid syndrome (APS) 
and it is abundant in human plasma (0.1-0.2 mg/ml). 
Although the exact physiological function has not been 
fully elucidated, earlier studies suggest that ?2-GpI may 
function as a mild anticoagulant by binding the 
phospholipids surface on platelets and thus inhibiting the 
initiation of the contact pathway1. More recent data 
provide evidence that ?2-GpI exerts both anticoagulant 
and procoagulant activities through binding to factor XI, 
von Willebrand factor, and alpha-thrombin2,3.
With the aim to better understand the role of Beta2-
GpI in haemostasis, we have investigated the effect of 
physiological concentrations of this protein on thrombin-
mediated hydrolysis of protease-activated receptors PAR-
1 and PAR-4, and platelet aggregation. 
Gel-filtered platelets (220000/?l) were activated in the 
presence of human alpha-thrombin (1 nM) and the 
change in transmittance at 350 nm was recorded in the 
presence of increasing concentrations of ?2-GpI (0-2 ?M). 
?2-GPI inhibited thrombin-induced platelet activation up to 
60%, with an IC50 value of 0.34±0.03 ?M. 
Cytofluorometric determination of uncleaved PAR-1, 
carried out with the anti-PAR1 MoAb Span-12 incubated 
with thrombin activated platelets, yielded an IC50 value of 
0.35±0.05 ?M, indicating that inhibition of platelet 
aggregation by Beta2-GpI is caused by the inhibitory 
activity that this protein exerts on thrombin-mediated 
PAR-1 hydrolysis in intact platelets. 
Next, we tested the effect of Beta2-GpI on the 
hydrolysis of the synthetic peptides PAR-1(38-60) and 
PAR-4(44-66) by thrombin. Our data indicate that Beta2-
GpI inhibits PAR-1(38-60) cleavage by thrombin in a 
dose-dependent manner, with a IC50 value of 0.35±0.04 
?M. Conversely, the efficiency of PAR-4(44-66) hydrolysis 
by thrombin was not affected by ?2-GpI. Finally, we have 
also shown that ?2-GpI inhibits the hydrolysis by thrombin 
of the chromogenic substrate (D)-Phe-Pro-Arg-pNA, with 
an IC50 of 0.43±0.02 ?M, whereas it is uneffective on the 
cleavage of (D)-Val-Leu-Arg-pNA, suggesting that binding 
of ?2-GpI induce allosterically some modifications in the 
active site of thrombin. 
Altogether, our results demonstrate that the proposed 
anticoagulant function of ?2-GpI in haemostasis unfolds 
by inhibiting PAR-1-dependent platelet aggregation. 
1. Schousboe, I. (1985) Blood 66, 1086-1091. 
2. Miyakis S., Giannakopoulos B., and Krilis S. A. (2004) 
Thrombosis Research 114, 335-346. 
3. Rahgozar S., Yang Q., Giannakopoulos B., Yan X., 
Miyakis S., and Krilis S. A. (2007) Arthritis & 
Rheumatism 56, 605-613. 
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Serine proteases play a pivotal role in many different, 
important biological processes, including digestion, 
inflammation, cell differentiation and blood coagulation. The 
results of protein engineering studies accumulated so far 
indicate that mutation of the amino acids at the active site 
of some of these enzymes dramatically decrease or even 
abolish their catalytic function, while the 3D structure of the 
resulting mutants remains essentially unchanged. Relevant 
examples in this field are the mutation of the catalytic 
Asp102 with Asn in trypsin and that of the catalytic Ser195 
with Ala in human alpha-thrombin. 
Recently, the Asp102Asn mutant (D102N) of human 
alpha-thrombin has been produced and its 
crystallographic structure solved at high resolution1. As 
expected, the hydrolytic activity is decreased by 16x103
fold, compared to that of the wild-type enzyme. Quite 
surprisingly, the 3D structure is significantly 
compromised1, especially in the Na+-binding site and in 
the primary specificity site, assuming a self-inhibited 
conformation, with the active site occluded. Importantly, it 
was proposed that the structural features of the D102N 
represent genuine properties of the inactive slow form 
(S*), captured during the crystallization process. 
According to a widely accepted model: S* ⇔ S ⇔ F, 
thrombin exists in equilibrium between a low populated (< 
1%) and inactive slow form (S*) and a highly populated 
and active slow form (S). The binding of Na+ converts the 
S form into the fully active fast form (F).  
To discriminate as to whether the unique structure of 
the D102N mutant pertains to the inactive slow form (S*) 
of the wild type thrombin or it is the results of the mutation 
Asp102Asn, the overall conformational properties of the 
mutant in solution were investigated by using several 
different ligands/inhibitors mapping different regions of the 
enzyme. In particular, the specificity sites were probed by 
full-length hirudin, its N-terminal domain Hir(1-47) and p-
aminobenzamidine, while exosite-1 was probed by the C-
terminal hirudin tail Hir(48-64). Our results show that 
D102N binds Na+ with an affinity six-fold lower than that 
of the wild type thrombin and that D102N assumes a 
more closed conformation, with the recognition sites not 
readily accessible for ligand binding, in agreement with 
the crystal structure of D102N. However, D102N is not a 
dead enzyme, devoid of any ligand binding properties. In 
the presence of sub-saturating concentrations of Na+ 
and/or Hir(48-64) it can assume a more open 
conformation, resembling that of the wild-type enzyme. 
Our findings highlight the extraordinary structural plasticity 
of thrombin molecule and demonstrate that even a single 
isosteric amino acid replacement, like D102N, can cause 
dramatic and unpredictable changes in the resulting 
mutant structure. 
1. Pineda A.O., Chen Z.W., Bah A., Garvey L. C., 
Mathews S. F., and Di Cera  E. (2006) J.B.C. 281, 
32922-32928. 
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The AF4 gene is one of the most common MLL fusion 
partner in the chromosomal translocations that often 
causes acute lymphoblastic leukaemia (ALL) 1. The AF4 
gene is expressed in many types of tissues and mainly in 
the haematopoietic cells2. The AF4 protein is an ALF 
protein. It contains three regions that are conserved in the 
ALF family1,3: the N-terminal homology domain, the ALF 
domain, and the C-terminal homology domain. AF4 also 
contains a transactivation domain4 and a nuclear 
localization signal3. The ALF homology domain seems to 
promote AF4 proteasomal degradation through its 
interaction with SIAH ubiquitin ligases (1). Although AF4 
has been studied for over a decade, little is known about 
its function. A murine AF4 knockout model demonstrated 
that AF4 is required for normal lymphocyte development5.
In a previous study of the functional role of AF4 in 
eukaryotic cells, we identified, using a proteomic strategy, 
about 60 proteins that interact with human AF4. The 
network of interactions strongly suggested that AF4 is a 
transcriptional activator. We verified, by co-
immunoprecipitation and western blot, the molecular 
interaction between AF4 and four of the proteins we 
identified, namely, CDK9, MED7, MED23, and 14-3-3 θ.
The first three are directly involved in RNA pol II 
transcription activation mechanisms. In particular, murine 
AF4 positively regulates CDK9 kinase, which directs Pol II 
transcriptional elongation1. CDK9 also phosphorylates 
and down-regulates AF4 activity1. The 14-3-3s are 
ubiquitous proteins that control the cellular localization of 
phosphorylated target proteins. 14-3-3 θ could be 
involved in the regulation of AF4 activity perhaps via 
nucleo-cytoplasmic shuttling. To evaluate how these 
interactions might influence the AF4 transactivation 
potential, we restricted the AF4 regions responsible for 
interaction with CDK9 and with 14-3-3 θ. We found that 
the 14-3-3 θ binding domain is located in an AF4 region 
usually conserved in MLL-AF4 chimeras. The CDK9 
binding region is in the AF4 N-terminal domain, which is 
absent from the MLL-AF4 oncoprotein, thus depriving the 
latter of a potential downregulation site. Oncogenic MLL-
AF4 chimeras usually lack this domain that could be 
involved in the down-regulation of the AF4 transactivation 
potential. Therefore, a gain-of-function pathogenic 
mechanism might explain the leukaemia phenotypes 
associated to the t(4;11)(q21;q23) translocations. 
1. Bitoun E.et al. (2007) Hum. Mol. Genet. 16, 92-106. 
2. Frestedt, J. L. et al. (1996) Genet Anal. 12,147-9. 
3. Nilson, I., et al. (1997) Br. J. Haematol. 98,157-69. 
4. Prasad, R. et al. (1995) Proc. Natl. Acad. Sci. 92,
12160-4. 
5. Isnard, P. et al. (2000) Blood. 96, 705-10. 
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Although the general mechanisms of seed germination 
have extensively been studied, some aspects are still 
obscure. For example, it has not been elucidated yet how 
the growing seedling contrasts possible pathogenic 
attacks.  During the first steps of germination (i.e. 0 – 24 
hours) Lupinus albus, a legume seed, releases various 
kinds of proteins outside the seeds. Aims of the present 
work were to characterize the polypeptides accumulated 
into the germinating medium by 2D electrophoresis and 
mass spectrometry and to study the expression levels of 
mRNAs coding for the most abundant proteins released 
from the seed during time course, carried out by RT-
qPCR. 
The full set of results obtained indicate that the 
release of polypeptides in the germination medium is not 
caused by a passive leakage from the seed but rather it is 
driven by a specific mechanism. The 2D electrophoretic 
patterns appeared relatively simple in term of 
composition, being formed by only about 60 spots. The 
majority of them (66%) have been identified by mass 
spectrometry, whereas for the remaining polypeptide 
chains no attribution has been possible. The 
characterized proteins all belong to protein functional 
classes directly or indirectly involved in defense 
mechanisms. The most abundant protein found in the 
germinating medium was chitinase (about 50% of all the 
proteins loaded on the electrophoretic gel). The other 
main proteins were conglutin γ (Cγ), a tetrameric 
glycoprotein of 200 kDa sharing a high similarity with 
tomato xylanase inhibitor and a number of peptides 
ascribable to vicilin, a seed storage protein, whose 
peptides generated from its proteolysis during 
germinations have been proved to have antimicrobial 
activity1. Subsequently, the expression levels of vicilin, 
chitinase and conglutin γ genes were analyzed by a newly 
set-up RT-qPCR using seed germinating in different 
conditions, including the use of elicitor substances known 
to be involved in the pathogenic-related protein 
biosynthesis. As result, vicilin was not expressed at 
germination, whereas chitinase gene was strongly 
activated in all conditions. Conglutin genes were also 
expressed, but under different stimuli.  
By and large, this work demonstrates that a legume 
seed is able to actively defend itself with preexisting and 
newly synthesized proteins from pathogen attacks during 
the early step of germination. 
1. Marcus et al. (1999) Plant J. 19, 699-710. 
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Conglutin γ is a glycoprotein which constitutes about 6 % 
of lupin seed proteins. It shows insulin-binding capacity 
with a measured Kd of about 10
-5 M 1. Moreover, the 
protein was found to decrease plasma glucose 
concentration in glucose overload experiments on rats: it 
is not known whether the two events are related. 
Moreover, conglutin γ can be responsible of allergic 
reactions in sensitive subjects2. Therefore, it is crucial to 
investigate the metabolic fate of this dietary protein, 
including its resistance to proteolysis and intestinal 
absorption, as already shown for other orally-
administered proteins, especially allergens and protein 
inhibitors, which were found intact in sera or tissues3,4. To 
this purpose, we used Caco-2 cell monolayers which are 
suitable in vitro models to mimic certain aspects of human 
intestinal epithelium. 
Absorption experiments were carried out 21 days after 
initial cell seeding, using a well consolidated protocol5.
The undigested and pepsin-trypsin-digested protein 
aliquots were added to the apical chamber and 
basolateral and apical media were collected after 2 hours. 
Cell monolayer integrity was monitored measuring the 
trans-epithelial electrical resistance during the whole 
experiment. The samples from apical and basolateral 
sides were analysed by SDS-PAGE and Western-Blot, 
using chemiluminescence enhancement. 
These experiments showed that undigested conglutin 
γ can pass through the Caco-2 cell monolayer, being 
present both in the apical and also in the basolateral side. 
The digested protein could not be revealed, owing to its 
hydrolysis and loss of immunoreactivity. Parallel 
experiments on conglutin γ susceptibility to proteolysis 
with various enzymes showed that the protein is 
susceptible to hydrolysis uniquely upon destabilisation of 
its native conformation at very low pH values. 
These results confirm the possibility of absorption of 
conglutin γ through Caco-2 cells in intact form, opening 
the way to further studies on the bioactivity of this protein. 
1. Magni C. et al. (2004) J. Nutr. Biochem. 15, 646-650. 
2. Magni C. et al. (2005) J. Agric. Food Chem. 53, 2275-
2281. 
3. Weangsripanaval T. et al. (2005) J. Nutr. 135, 1738-
1744. 
4. Billings P.C. et al. (1992) Cancer Lett. 62, 191-197. 
5. Duranti M. et al. (1994) Eur. J. Biochem. 222, 387- 
393. 
6. Moreno F.J. et al. (2006) J. Agric. Food Chem. 54, 
8631-8639. 
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The trehalose/maltose-binding protein (MalE1) is one 
component of trehalose and maltose uptake system in the 
thermophilic organism T. thermophilus. MalE1 is a 
monomeric 48 kDa protein belonging to the class of 
sugar-binding proteins. Proteins isolated from 
thermophilic microorganisms are particularly heat-
resistant. By spectroscopic techniques is possible to 
follow the thermal denaturation process1 when these 
proteins unfold at temperatures below or close to 100°C, 
but in the case they have a Tm above 100°C is necessary 
to study the unfolding process in the presence of high 
pressure or destabilizing agents. MalE1 belongs to the 
latter case, its great thermostability was compromised 
only in the presence of SDS. In this work we used 
Fourier-infrared (FT-IR) spectroscopy and in-silico
methodologies for investigating the structural stability 
properties of MalE1. The protein was studied at neutral 
p2H in the absence and in the presence of maltose or 
SDS as well as at p2H 9.8. Infrared spectra analysis 
indicated that MalE1 is a protein predominantly in ?-helix 
conformation with a minor content of β-structure. This 
finding is confirmed by the model obtained by homology 
modelling method. At neutral p2H the protein is extremely 
thermostable. In particular, the protein preserves its ?-
helical conformation even when maintained for prolonged 
time at 99.5°C. The high thermostability of the ?-helices is 
maintained also at p2H 9.8 and it is even higher at p2H 7.5 
in the presence of maltose. On the other hand, the data 
showed that at high temperatures β-sheet undergo some 
structural rearrangement, phenomenon that resulted 
reversible when the temperature was lowered. The 
presence of SDS modified slightly the secondary structure 
of MalE1 and decreased the protein thermostability. In the 
presence of the detergent a temperature-dependent loss 
of ?-helices and β-sheet took place but β-sheet 
rearrangement was not observed. The infrared data, 
corroborated by the inspection of the 3D structure of 
MalE1, suggest that hydrophobic interactions may play an 
important role in the high thermostability of MalE1. 
1. Herman P., Staiano M., Marabotti A., Varriale A., Scire 
A., Tanfani F., Vecer J., Rossi M. and D'Auria S. 
(2006) Proteins 63, 754-767. 
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The assembly of proteins into highly organized fibrillar 
aggregates is a key process in biology1, biotechnology2
and human disease3. It has been shown that proteins 
retain a small, yet significant propensity to aggregate 
when they are folded into compact globular structures and 
this may be physiologically relevant, particularly when 
considering that proteins spend most of their lifespan into 
such compact states. Proteins from the acylphosphatase-
like structural family have been shown to aggregate via 
different mechanisms, with some members forming 
native-like aggregates as a first step of their aggregation 
process and others requiring unfolding as a first 
necessary step. The acylphosphatase from the 
archeobacterium Sulfolobus solfataricus (Sso AcP) has 
been demonstrated to aggregate via native-like 
oligomers4. These aggregates retain enzymatic activity 
and do not show typical β-amyloid features, such as 
extensive β-sheet structure, thioflavin T or Congo Red 
binding. The enzymatic activity is subsequently lost when 
the aggregates undergo a structural reorganization that 
convert them into amyloid-like protofibrils4. Here we show 
that assembly of folded Sso AcP molecules into native-
like aggregates is prevented by single-point mutations 
that introduce structural protections within one of the most 
flexible region of the protein, the peripheral edge β-
strand-4. The resulting mutants do not form native-like 
aggregates, but can still form thioflavin T-binding and β-
structured protofibrils, albeit more slowly than the wild-
type protein. The kinetic data of folding, unfolding and 
aggregation show that formation of the protofibrils 
proceeds via an alternative mechanism that is 
independent of the transient formation of native-like 
aggregates. 
1. Fowler D.M. et al. (2007) Trends Biochem.Sci. 32 (5), 
217-224. 
2. Hamada D. et al. (2004) Trends Biotechnol. 22, 93-97. 
3. Chiti, F. and Dobson, C.M. (2006) Annu.Rev.Biochem. 
75, 333-366. 
4. Plakoutsi G. et al. (2005) J.Mol.Biol. 351, 910-922. 
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The purpose of this study was to investigate the possible 
utilisation of classic proteomic approach for studying the 
plasma protein changes exercise-induced in race horses. 
It is well known that physical exercise can cause 
qualitative and quantitative modifications of plasma 
protein content due to hormonal changes, muscle 
damage, immune system activation, oxidative stress and 
metabolic adaptation.  
The proteomic approach enables both the large-scale 
identification of proteins and the comparison of protein 
levels and could be an important tool to investigate the 
physiological and pathological processes induced by 
physical stress. Plasma is a rich collection of information 
about factors occurring at the same time and it represents 
the most convenient sample to collect and investigate in 
vivo exercising athletes. Numerous biomedical studies 
have demonstrated that plasma protein levels can be 
used for diagnosis and prognosis of diseases and can 
help to define biochemical mechanisms not yet 
completely understood1.
For this study we used seven horses which had taken 
part in endurance race. Plasma samples were collected at 
rest, immediately after race, 24 hours after ad 48 hours 
after and stored at -80 °C in anti-protease cocktail until 
analysis. 
To find out the more convenient procedure, plasma 
were analysed in triplicate both individually (from each 
horse at each time) and by pooling plasma from all horses 
at each time.  
15 ?l of plasma were treated in 2% Chaps, 2,3% DTE 
at 95°C for 5 min and then diluited in rehydratation buffer 
(8 M urea, 2 M thiourea, 2% CHAPS, 30 mM Tris, 100 
mM DTT and 0,8% anfolyte). IPG strip, 17 cm long, pH 3–
10 and pH 4-7 (Bio-Rad, Hercules, CA, USA) were 
rehydrated overnight at 50 V, and focused in Protean IEF 
Cell (Bio-Rad). The Second dimension was on a 9/16% 
poly-acrylamide gradient after reduction (5 mM TBP) and 
alkylation (2.5% IAA) in rehydratation buffer (375mM 
TRIS-HCl pH 8.8, 6 M urea, 2% SDS, 20% glicerol). 
Gels were stained with colloidal Coomassie blue G-
250 and to imaging using the Bio-Rad GS-800™ 
calibrated densitometer. The comparative analysis was 
performed by with PD-QUEST (BioRad, Hercules, CA). 
2D obtained from plasma pooled were analysed and 
matched in the same matchset. While a different matchset 
were performed to analyse gels from individually sample. 
With both the procedures we found significant differences 
of spot intensity among all times tested. At the moment we 
are not able to discuss the mining of these variations 
because MS identification of the spots are still in progress. 
This preliminary result suggest the possible use of 2D 
electrophoresis to identify modification of plasma protein 
pattern induced by physical exercise, despite of the 
complessity of biological matrix used 
1. H.J. Issaq, Z. Xiao, T.D. Veenstra (2007) Chem. Rev. 
107: 3601-3620. 
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ANALYSIS OF HORSE SYNOVIAL FLUID BY TWO-
DIMENSIONAL GEL ELECTROPHORESIS: A PILOT 
STUDY. 
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Chiaradia 
Dipartimento di Patologia Diagnostica e Clinica 
Veterinaria – Università di Perugia-Perugia-Italy  
Synovial fluid (SF) reflects the patho-physiological 
condition affecting joints because it represents a dynamic 
reservoir for protein originating from synovial tissue and 
cartilage. We focused our attention on equine 
Osteochondrosis (OC), a pathology with multifactorial 
ethiology1,2. The specific alteration of chondrocyte 
metabolism as well as ultrastructural modification of extra-
cellular matrix that can cause OC have not been yet 
completely described. The aim of this study was to 
analyse, by using the proteomic approach, SF collected 
from normal and OC affected joints of horses in order to 
define both the protein reference map of horse synovial 
fluid and to characterise the differential protein expression 
during disease. Proteomic analysis of SF may provide a 
minimally invasive opportunity to analyse disease-related 
proteins and might become a valuable tool in diagnosing 
and monitoring different articular diseases. 
For this pilot study we used horses admitted to the 
Veterinary Teaching Hospital of Perugia. SF samples 
were obtained from hock and fetlock joints with OC after 
clinical evaluation. Synovial proteins diluited in 
rehydratation buffer (8 M urea, 2 M thiourea, 2-4% 
CHAPS, 40 mM Tris, 100 mM DTT and 0,8% anfolyte) 
were focused on IPG strips, 17cm long, pH 3–10 and pH 
4-7, in Protean IEF Cell. The Second dimension was 
performed on 9-16% poly-acrylamide gradient gel in Dalt-
six system (Amersham Pharmacia Biotech) after 
reduction with 5 mM TBP and alkylation with 2.5% 
Iodoacetamide in rehydratation buffer (375 mM TRIS-HCl 
pH 8.8, 6 M urea, 2% SDS, 20% glicerol). Gels were 
stained with colloidal Coomassie blue G-250 and to 
imaging using the Bio-Rad GS-800™ calibrated 
densitometer. The comparative analysis was  performed 
by with PD QUEST (BioRad, Hercules, CA).  
At first, we optimised 2D protocols in order to obtain 
the better resolution of protein spots by varying 
experimental conditions including protein loading, pH 
range, % chaps, and precipitation steps. The pI of most 
proteins ranges between pH 4 and pH 7. As a 
consequence, this range was chosen for comparative 
analysis between maps obtained from OC and control 
joint. Not significant differences were found by comparing 
2D protein profile of hock and fetlock. However, by 
comparing 2-D gel obtained from OC and control SF we 
found differentially expressed proteins that are at the 
moment under MS investigation. Although, results are still 
in progress they could improve the diagnosis and the 
understanding of osteoarticular diseases. 
1. Fukui N., Purple C.R., Sandell L.J. (2001). Curr. 
Rheumatol. Rep. 3 (6): 496-505. 
2. McIlwraith W.C. (1996). In McIlwraith W.C.; Trotter 
G.W. ”Joint Disease in the horse”, W.B.Saunders 
Company, Philadelphia, cap. 3: pp.40-70. 
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STRUCTURAL AND FUNCTIONAL PROPERTIES OF 
"ZERO-LENGTH" RIBONUCLEASE A OLIGOMERS 
F. Vottariello, C. Costanzo, G. Gotte, and M. Libonati 
Dipartimento di Scienze Morfologico-Biomediche, 
Sezione di Chimica Biologica, Facoltà di Medicina e 
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Many ribonucleases were found to be endowed with 
remarkable biological activities, among which particularly 
interesting is an in vitro and in vivo cytotoxic action 
against tumor cells1.
This is not the case for native monomeric RNase A, 
which is devoid of any biological action. On the contrary, 
RNase A aggregated oligomers obtained through 3D 
domain swapping after lyophilization of 40% acetic acid 
solutions of the enzyme, showed to be able to degrade 
double-stranded RNA and to be cytotoxic2.
The most important limit for the practical use of the 
domain swapped RNase A oligomeric species is their 
metastability. 
To avoid this limitation the new strategy proposed by 
Simons et al. 3 was used to oligomerize the enzyme: 
RNase A, dissolved in ddH2O and lyophilized, was then 
maintained under high vacuum at 85 °C for four-six days. 
This treatment allows the protein to form a new inter-
chain peptide bond through an acidic and a basic residue, 
with the loss of a water molecule. 
In this way dimers, but also trimers and higher-order 
oligomers can be formed. They result to be covalently 
linked, but without the use of crosslinkers, and therefore 
without eterologous spacer(s) present in the reaction 
products. For this reason these species can be called 
‘zero-length’ RNase A oligomers. 
The species produced maintain their catalytic activity 
against ssRNA and acquire a significant activity against 
dsRNA, similar to the activity shown in the past by the 
omologous 3D domain swapped RNase A oligomers2.
The various ‘zero-length’ oligomers have been 
chromatographically purified using different techniques 
and each species showed to be composed by not a 
single, but different isoforms, contrarily to what was 
asserted by Simons et al. 3. This result was confirmed by 
several methods: electrophoresis under non denaturing 
conditions, measurements of the amino-groups remaining 
in the dimer(s) after the reaction, and site-directed 
mutagenesis.  
Investigations on the biological (antitumor) activity that  
the ‘zero-length’ RNase A oligomers may have acquired  
are presently under study. 
1. Leland P. A. and Raines R. T. (2001) Chem. Biol.  8,  
405-413. 
2. Libonati M. and Gotte G. (2004) Biochem. J. 380, 311-
327. 
3. Simons, B. L., Kaplan H., Fournier S. M., Cyr T. and 
Hefford M. A. (2007)  Proteins 66, 183-195. 
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ON THE MECHANISM OF L-LACTATE OXIDATION 
CATALYZED BY FLAVOCYTOCHROME B2: A 
COMBINED FIRST PRINCIPLE MOLECULAR 
DYNAMICS AND SITE DIRECTED MUTAGENESIS 
STUDY. 
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Flavocytochrome b2 (Fcb2) catalyzes the oxidation of L-
lactate (Lac) to pyruvate (Pyr) in its C-terminal 
flavodehydrogenase (FDH) domain (residues 100-486). 
The N-terminal heme b2 domain (residues 1-99) mediates 
electron transfer from FMN bound to the FDH domain to 
Cyt c. The FDH domain, a (β/α)8 barrel, is the prototype of 
a family of α-hydroxy acid dehydrogenases/ oxidases. In 
spite of decades of work by several top laboratories 
world-wide, for none of these enzymes the mechanism of 
α-hydroxy acid oxidation has been clarified. To contribute 
to this issue, we have carried out first principles quantum 
mechanical molecular dynamics simulations on models of 
the Fcb2 active site. A stable active site-Lac model 
complex was only obtained with Lac bound as per a 
hydride transfer (HT) mechanism, with Lac αH pointing 
toward FMN N(5) position and the αOH hydrogen H-
bonded to H373 N?. The subsequent simulation of the 
reaction complemented and extended the available 
information on the Fcb2-catalyzed reaction yielding an 
atomistic level description of the process. The simulations 
also revealed an unexpected role of a crystallographic 
water (Wat609) and of a third shell residue (S371), both 
conserved in the Fcb2 family of enzymes. Wat609 forms 
a S371-Wat609-D282-H373 H-bonded chain and 
appeared to modulate the acid-base properties of H373. 
This residue initiates substrate oxidation by abstracting 
the Lac αOH proton and shuttles between the neutral and 
the positively charged forms in the oxidized and reduced 
enzyme, respectively. To test the hypothesis, we 
produced the S371A variants of the full-length Fcb2 and 
of its FDH domain. S371A-FDH was produced in E. coli
as the non reconstitutable apoprotein, while S371A-Fcb2 
incorporated only 0.3 mol FMN per mol indicating an 
unexpected structural role of S371. The S371A 
substitution caused a 20-fold decrease of both V and 
V/Klac entirely attributable to a decrease of the rate of the 
enzyme reductive half reaction (kred), as shown by the 
analysis of the primary kinetic isotope effects on Lac 
oxidation. It had no effect on the pH dependence of V and 
V/KLac, but it caused a 10-fold increase of the Kd of the 
FMN-N(5)/sulfite adduct. The data support the hypothesis 
that the S371A substitution prevents the positioning of 
Wat609, thus lowering the proton affinity of H373. As a 
result the rate of Lac oxidation decreases due to: (i) the 
lower tendency of H373 to abstract the substrate proton 
and initiate the reaction, and (ii) the lower stabilization of 
the reduced anionic FMN cofactor by the protonated 
H373. A positively charged H373 is also required to 
stabilize the FMN-N(5)-sulfite complex, mimicking the 
reduced form, explaining the increased Kd of the sulfite 
complex in S371A-Fcb2. Beside providing information on 
the Fcb2 class of enzymes, this study shows the power of 
combining computational and experimental approaches to 
gain insight on how enzymes work. 
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FUNCTIONAL CHARACTERIZATION OF A 
PSYCHROPHILIC THIOREDOXIN SYSTEM 
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The preservation of the redox state of intracellular 
proteins is mainly regulated by the thioredoxin system 
which is composed by two proteins, named thioredoxin 
(Trx) and thioredoxin reductase (TrxR), respectively. 
Indeed, the reduction of oxidised protein targets by the 
thioredoxin system involves the reversible and alternate 
oxidation/reduction of a conserved disulphide bridge 
present in both components of this enzymatic system. In 
this abstract we report the purification procedure and the 
biochemical characterization of Trx and TrxR isolated 
from the Antarctic psychrophilic eubacterium 
Pseudoalteromonas haloplanktis (Ph). 
PhTrxR and PhTrx were isolated from P. haloplanktis 
cells collected after 3 days of growth in LB-broth at 4°C; 
the two proteins were purified from the cell homogenate 
by conventional chromatographic steps. The PhTrxR 
activity was determined by the DTNB reduction method in 
the presence of NADPH as electrons donor, whereas the 
PhTrx was identified by a nephelometric assay, using 
DTT as electrons donor and human insulin as protein 
substrate. 
The flavo-enzyme PhTrxR is organised as a 
homodimer, the molecular mass of the subunit being 35 
kDa; vice versa, PhTrx is a monomer with a molecular 
mass of 12 kDa.  
The functional characterisation of the psychrophilic 
thioredoxin system included the study of the effect of 
temperature on the activity and stability of both proteins. 
In particular, PhTrxR showed the maximum value of kcat
at 30°C; beyond this temperature, the enzymic activity 
decreased. In the 5-30°C temperature interval the energy 
of activation (Ea) value of this reaction was calculated as 
31 kJ/mol. A thermal denaturation profile of PhTrxR 
obtained to fluorescence melting measurements revealed 
a Tm of 55°C, a value quite high considering the 
psychrophilic origin of this enzyme. The effect of 
temperature on the PhTrx activity was maximum at 25°C; 
in the 0-25°C interval the Ea of the reaction was 
calculated as 53 kJ/mol. Surprisingly, this protein was 
found very resistant to heat inactivation, the t1/2 at 95°C 
being 263 min. These overall results support the 
hypothesis that the structures of PhTrxR and PhTrx are 
characterised by a localized rather than a global flexibility, 
a typical property of the psychrophilic enzymes. An in 
vitro reconstituted PhTrx-PhTrxR system showed a lower 
Ea of the redox reaction catalysed by PhTrxR, hence 
making thermodynamically more favourable electrons 
transfer. 
The effect of increasing concentration of different 
monovalent cations on PhTrxR activity has also been 
investigated. Among the considered cations, the presence 
of 0.5 M Na+ provoked a 6 fold increase of the activity 
with respect the control. This apparent halophilicity of 
PhTrxR is common to other enzymes isolated from 
psychrophilic sources. 
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RETINOIC ACID BIOSYNTHESIS IS INHIBITED BY 
ESTROGEN
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The striking influence of retinoic acid on differentiation of 
epithelial cells and its efficacy to suppress cell 
proliferation1,2 prompted studies aimed to clarify its 
molecular mechanisms and its homeostasis in normal and 
malignant cells. Several dehydrogenases are involved in 
the conversion of retinol to retinoic acid. Furthermore, 
retinoic acid deficiency has been demonstrated in tumor 
epithelial cells and ascribed to the lack of cellular retinol 
binding protein (CRBP) and/or to the inactivity of 
retinol/retinaldehyde dehydrogenase enzyme system3,4.
Our studies on the biosynthesis of retinoic acid in 
normal mammary epithelial cells (HMEC) have revealed 
the crucial role of the xanthine dehydrogenase (XDH) 
enzyme in the conversion of retinol/retinaldehyde to 
retinoic acid and the necessary participation of CRBP in 
this process. In MCF7 and MDA-MB231 cells, both 
lacking CRBP, retinol oxidation to retinoic acid by XDH 
could not be observed. However, XDH catalyzes 
retinaldehyde conversion to retinoic acid, albeit less 
actively than in HMEC 5.
Estrogens affected both XDH expression and activity 
in both normal and tumor mammary epithelial cells. 
Estradiol, added to MCF7 and MDA-MB231 cell cultures 
at concentrations varying from 10 pM to 100 nM, exerted 
in fact a marked inhibitory effect on the XDH-driven 
retinaldehyde oxidation, with the enzyme activity dropping 
to 14-66% of that observed in control cell cultures. The 
XDH protein content was also reduced to 40% by 100 nM 
estradiol. 
This evidence suggests that estrogens have a 
profound negative on retinol-retinoic acid homeostasis 
and consequently are primary regulators of cell 
differentiation.  
1. Sporn M.B., Clamon G.H., Dunlop N.M., Newton D.L., 
Smith J.M., Saffiotti U. (1975) Nature 253, 47-50.  
2. Lotan R. (1980) Biochim Biophys Acta 605, 33-91.  
3. Kuppumbatti YS, Bleiweiss IJ, Mandeli JP, Waxman 
S, Mira-Y-Lopez R. (200) J Natl Cancer Inst 92, 475-
480
4. Rexer BN, Zheng WL, Ong DE. (2001) Cancer Res. 
61, 7065-7070. 
5. Taibi G., Di Gaudio F., Nicotra C.M.A. (2008) J Enz 
Inhib Med Chem 23(3), 317-327 
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REDOX REGULATION OF ANOIKIS: REACTIVE 
OXYGEN SPECIES AS ESSENTIAL MEDIATORS OF 
CELL SURVIVAL 
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Proper attachment to the extracellular matrix (ECM) is 
essential for ensuring survival of adherent non-trasformed 
cells. The loss of integrin-mediated cell-ECM contact 
results in an apoptotic process termed anoikis. However, 
the underlying mechanisms involved in regulation of cell 
survival are not fully understood. We demonstrate that in 
epithelial cells reactive oxygen species (ROS), produced 
through the involvement of the small GTPase Rac-1 upon 
integrin engagement, exert a mandatory role in 
transducing a pro-survival signal that ensures cells to 
escape from anoikis. In particular, we show that ROS are 
responsible for the redox-mediated activation of the Src 
kinase that trans-phosphorylates EGFR in a ligand-
independent manner, culminating in the ERK- and Akt-
induced degradation of the pro-apoptotic protein Bim. 
These evidence underline a fundamental role of ROS-
mediated Src regulation in ensuring anoikis protection. 
Furthermore, we investigated the possible involvement of 
ROS in anchorage-independent growth and in anoikis 
resistance of metastatic cancer cells. By the comparison 
between untransformed prostate epithelial cells (RWPE-
1) and metastatic prostate carcinoma cells (PC3), we 
observed that PC3, which exhibit higher amount of 
intracellular ROS with respect to untrasformed cells, are 
resistant to anoikis and lack suicidal pathways. As a 
consequence of ROS increase, Src is constitutively 
oxidized/activated in metastatic cells, granting for a 
constitutive Src-dependent trans-phosphorylation of 
EGFR and activation of pro-survival pathways. 
Antioxidant treatment of PC3 cells or transfection with the 
dominant negative form of  Rac-1 or with redox-
insensitive mutants of Src, completely abolish the trans-
phosphorylation of EGFR and the resistance to anoikis, 
thus restoring the apoptogenic stimuli. Hence, our data 
highlight the crucial role of the Rac-dependent redox 
signalling in ensuring tumour cells resistance to anoikis, 
proposing the ROS-mediated Src activation as an 
essential step to promote cancer cell survival.  
16.3  
S1P1 RECEPTOR NEGATIVELY REGULATES PDGF-
DEPENDENT PROLIFERATION OF C2C12 
MYOBLASTS.  
C. Donati, P. Nincheri, F. Cencetti, C. Bernacchioni, E. 
Rapizzi, P. Bruni 
Dipartimento di Scienze Biochimiche, Università di 
Firenze, Firenze, Italia 
It is becoming increasingly apparent that numerous 
growth factors acting via receptor tyrosine kinases require 
regulation of sphingosine 1-phosphate (S1P) metabolism 
and signalling to accomplish their biological response1.
Actually S1P was initially described as a bioactive 
sphingolipid generated intracellularly in response to 
PDGF, implicated in its mitogenic signalling2. More 
recently, S1P1 receptor has been found critically involved 
in the chemotactic response elicited in vascular smooth 
muscle cells as well as in endothelial cells3. However, 
although PDGF is known to stimulate myoblast 
proliferation little information is presently available on its 
molecular mechanism of action. To fill at least in part this 
gap, in this study the role of S1P1 in the mitogenic action 
of PDGF in C2C12 cells has been examined. 
Unexpectedly, when S1P1, but not S1P2 or S1P3, 
expression was down-regulated by antisense 
oligonucleotide administration the stimulation of 
radioactive thymidine incorporation induced by 30 ng/ml 
PDGF was enhanced, suggesting that in these cells the 
cross-talk between PDGF and S1P1 attenuates the 
mitogenic signalling downstream of PDGF receptor. This 
hypothesis was supported by the potentiation of PDGF 
mitogenic response detected after the specific silencing of 
S1P1, and by the selective inhibition of S1P1 with (R)-3-
Amino-(3-hexylphenylamino)-4-oxobutylphosphonic acid. 
In addition, in line with these findings, the overexpression 
of S1P1 was capable of strongly attenuating the PDGF-
stimulated DNA synthesis.  
Since the cross-talk between PDGF receptors and 
S1P1 not necessarily implicates the growth factor-
directed S1P formation, we also examined the effect of 
PDGF on the activity of sphingosine kinase (SK), which 
catalyzes the synthesis of S1P. Interestingly, the 
enzymatic activity was found to be rapidly enhanced by 
PDGF. Moreover, selective inhibition of SK by 2-(p-
hydroxyanilino)-4-(p-chlorophenyl)thiazole enhanced the 
mitogenic action exerted by PDGF. These results are in 
favour of a unique inhibitory role of SK/S1P1 axis in the 
mitogenic response to PDGF. 
1. Pyne NJ and Pyne S (2008) Biochim. Biophys. Acta, 
Epub ahead of print 
2. Tolan D et al. (1999) Cell. Signal. 11, 349-354  
3. Waters CM et al (2006) FASEB J. 20, 509-511 
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The X-linked Inhibitor of Apoptosis Protein (XIAP) is 
overexpressed in several malignant cells, where it 
prevents apoptosis by binding to and blocking the 
activation of caspases-3, -7, and -91. Human XIAP (479 
residues) is composed of three tandem-repeated BIR 
domains (BIR1-3), and by a C-terminal RING domain1.
Smac-DIABLO, the natural antagonist of XIAP, binds 
through its N-terminal sequence AVPI to the same 
surface groove, in the BIR domains, that binds 
caspases3,4. Synthetic compounds, mimicking such 
tetrapeptide motif, effectively block the interaction 
between IAP and active caspases, thus triggering 
apoptosis2. Peptidomimetics based on an 
azabicyclo[x.y.0]alkane scaffolds,  have been shown to 
bind the BIR3 domain of XIAP with ?M to nM affinities, 
thus presenting interesting features for drug lead 
optimization3. Here we report a study on three newly 
synthesized Smac-mimetics, which have been 
characterized in their complexes with XIAP BIR3 domain 
through X-ray crystallography and molecular 
modelling/docking simulations. Based on analysis of the 
crystal structures, we show that specific substitutions at 
the 4-position of the azabicyclo[5.3.0]alkane scaffold 
results in sizeable effects on the peptidomimetic/BIR3 
domain affinity. By means of functional, biophysical and 
simulative approaches we also propose that the same 
Smac-mimetics can bind XIAP BIR2 domain at a location 
structurally related to the BIR3 domain AVPI binding 
groove. Details of the XIAP/Smac-mimetic recognition 
principles highlighted by this study are discussed at the 
light of the drug-like profile of the three (potentially pro-
apoptotic) compounds developed, that show improved 
performance in ADMET tests. 
1. La Casse, et al. (1998) Oncogene 17, 3247–3259; 
2. Sun, H., et al. (2004) J. Am. Chem. Soc. 126,16686 -
16687; 
3. Mastrangelo, E., et al. (2008) submitted to JBC;
4. Sun, H., et al. (2007) J. Am.Chem. Soc. 129, 15279-
15294. 
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Transforming growth factor-? (TGF?) is a cytokine endowed 
with multiple biological effects. In skeletal myoblasts, TGF?
inhibits myogenic differentiation1 while it promotes their 
transdifferentiation into myofibroblasts2, thereby favouring 
muscle fibrogenesis. The molecular mechanisms by which 
TGF? evokes its biological response are quite complex. It 
has been demonstrated that the canonical SMAD-dependent 
signalling pathway is implicated in the negative regulation of 
myogenic transcription factors such as MyoD and MEF2 1,
however the signalling downstream of TGF? responsible for 
differentiation of myogenic cells into myofibroblasts is largely 
unknown. In the last ten years the bioactive sphingolipid 
sphingosine 1-phosphate (S1P) has received increasing 
attention owing to its multiple biological effects, the 
complexity of its signalling, mediated by at least five GPCR 
and the discovery that the regulation of its metabolism is 
exploited by a number of growth factors and cytokines. 
Our previous studies performed in C2C12 mouse 
myoblasts have established that S1P accelerates 
myogenic differentiation3. Moreover, sphingosine kinase-1 
(SphK1), which catalyzes S1P biosynthesis, is required 
for myogenic differentiation triggered by the shift of 
confluent cells to low-serum medium4, indicating that 
SphK/S1P axis plays a key role in the regulation of 
biological response of these cells. 
Recent studies have established the occurrence of a 
bidirectional cross-talk between the TGFβ-S1P regulated 
signalling pathways). 
To gain insights into the mechanism of action of TGFβ
in skeletal muscle cells here the effect of TGFβ on SphK 
has been examined together with its possible implication 
in the biological action of the cytokine. 
Our results show that TGFβ exerts a biphasic effect 
on SphK activity in C2C12 cells, inhibiting the enzymatic 
activity within the first 4 h of incubation but enhancing it at 
more prolonged times of incubation (18-72 h). TGFβ up-
regulates mRNA and protein content of SphK1, without 
influencing SphK subcellular localization. Moreover, 
TGF?-dependent regulation of SphK1 appears to be 
implicated in the pro-fibrotic effect of the cytokine, since 
pharmacological inhibition of SphK1 or its  down-
regulation by specific siRNA, attenuated the biological 
response to TGF?. Finally, the pro-fibrotic effect of TGFβ
relied on S1P3 receptor engagement, being it mimicked 
by FTY720P, which does not activate S1P2 and blunted 
by siRNA specific for S1P3. 
This study demonstrates that SphK/S1P axis is 
exploited by TGF? to transform skeletal C2C12 myoblasts 
into myofibroblasts.  
1. Liu et al. Genes Dev 15, 2950 (2001) 
2. Li et al. Am J Pathol. 164, 1007 (2004) 
3. Donati et al. FASEB J 19, 449 (2005) 
4. Meacci et al J Cell Physiol. 214, 210 (2008) 
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Cardenolides are steroid glycosides used clinically for their 
cardiotonic effects that act by binding to the Na+/K+-
ATPase. Na+/K+ ATPase has been shown to possess an 
interesting role as signal transducer, demonstrating its 
involvement also in normal and cancer cell proliferation and 
other biological processes1. Thus, besides their cardiotonic 
property, cardiac glycosides have been shown to exert 
potential antitumor activity2. Here, we evaluated the anti-
tumor potential of four cardiotonic steroids, isolated from 
Periploca graeca L.3. Two are 17β-cardenolides 
(compounds 4 and 5), one is a 17α-cardenolide (6), and 
another one is the aglycon of a 17β-cardenolide (2). All 
tested cardenolides inhibited in a nanomolar range of 
doses U937 (monocytic leukaemia) and PC3 (prostate 
adeno carcinoma) cell growth. The antiproliferative potency 
ascending order was 4> 5> 6> 2, compound 4 being more 
effective than ouabain, the cardenolide used as a positive 
control. The antiproliferative potency of test compounds 
paralleled, at least in part, their capability to inhibit porcine 
cerebral cortex Na+/K+-ATPase. The differences in the 
kinetics of inhibition of U937 and PC3 cell growth, 
suggested that cardenolides evoked different responses in 
these two cell lines. Accordingly, 24h following treatment, 
PC3 cells underwent apoptosis (30% hypodiploid cells vs 
3% control cells), whereas U937 cells arrested in G2/M. 
Apoptotic cell death was detectable in U937 cells only after 
72 h. The apoptotic mode of cell death in PC3 was 
confirmed by the occurrence of phosphatidylserine 
externalization, a hallmark of early apoptosis, loss of 
mitochondrial potential, and cytochrome c release. 
Apoptosis was caspase-dependent as the pan-caspase 
inhibitor, Z-VAD fmk, reverted almost completely 
cardenolide-induced PC3 cell death. Moreover, proteolytic 
cleavage of caspase 3 (assessed WB analysis) also 
occurred.  
Tumor necrosis factor (TNF)–related apoptosis-
inducing ligand (TRAIL) is a promising therapeutic agent 
that induces apoptosis selectively in cancer cells4.
Unfortunately, several cancer cells, including U937, are 
resistant to TRAIL. Interestingly, we found that compound 
4 sensitized U937 cells to TRAIL-induced apoptosis. The 
effect is largely mediated by up-regulation of the death 
receptor 5 (DR5) at both RNA and protein levels. 
However, the possibility that other mechanisms might 
also contribute to the observed cardenolide-induced 
sensitization to TRAIL should be considered. In particular, 
as we found that compound 4 induced changes of 
membrane fluidity, cardenolides might facilitate DR5 
clustering and subsequent death-inducing signaling 
complex formation. 
1. Xie Z. et al., Mol Interv, 2003 3:157; 2. Lopez-Lazaro, 
Expert Opinion Ther. Targets, 2007, 11: 1043; 3. 
Spera et al., 2007; 4. Kimberley FC and Screaton GR, 
Cell Research, 2004. 
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CAMPTOTHECIN INDUCES S-PHASE ARREST AND 
APOPTOSIS  IN MG63 OSTEOSARCOMA CELLS 
A. De Blasio, R. Di Fiore, C. Messina, P. Di Fazio, G. 
Costa, A. Attanzio and  R. Vento, 
Dipartimento di Scienze Biochimiche Università di 
Palermo, Policlinico, via Del Vespro 129 Palermo, Italia 
Osteosarcoma is an extremely aggressive neoplasm that 
commonly occurs in children and adolescents. Most of 
osteosarcoma tumors display a broad range of genetic 
and molecular alterations involving disregulation of the 
major signaling pathways. Mutations in tumor suppressor 
genes as p53 and/or RB, are usually detected in the 
majority of osteosarcoma cells and further molecular 
alterations are frequently discovered. In particular, MG63 
osteosarcoma cell line is characterized by loss of Tp53 
expression 1 and by the presence of 
hyperphosphorylated/inactive pRb form 2, which is 
responsible for both the loss of the G1/S checkpoint and 
the altered cell proliferation. Here, we evaluated the 
effects of  camptothecin (CPT) in MG63 human 
osteosarcoma cells with the aim of contributing to the 
understanding of the basic biology of osteosarcoma and 
to devise more targeted therapeutic strategies. CPT is a 
genototoxic drug that directly inhibits topoisomerase I by 
inducing double strand breaks in chromosomal DNA, with 
the maximum toxicity during the S phase of the cell cycle. 
Here, we have shown by flow cytometric analysis that 200 
nM CPT induced a progressive cell cycle arrest in S 
phase. This effect appeared 6 h after the treatment and 
lasted approximately 24 h. No entry in G2-M phase was 
observed as confirmed by the inhibition of BrdU 
incorporation into DNA. Moreover, after 48 h of  
treatment, a significant percentage of cells accumulated 
in subG0/G1 phase suggesting apoptotic events. 
Apoptotic cell death was confirmed by flow cytometric 
analysis of annexin V/ PI staining. Western blotting 
analysis of cyclins A and E and of pRb phosphorylation 
status showed a strong increase of these proteins  after 6 
h treatment, followed  by the progressive lowering to their  
basal levels after 24-48 h of treatment. At the same time, 
we observed a potent increase in both E2F-1 level and its 
phosphorylated form, accompanied by high levels of p73. 
These results suggest a scenario where DNA damage 
induced by CPT in MG63 cells, blocks DNA replication 
fork progression, thus activating S-phase checkpoint and 
thereafter inducing apoptosis. Although the exact 
mechanism responsible for this S phase checkpoint 
activation followed by apoptosis has to be clearly defined, 
we hypothesize that the checkpoint kinases (CHK1-2; 
ATM/ATR) could be primarily involved and that they could  
act by activating p73 and E2F-1 phosphorylation.     
1. Matsui TA et al (2006) Carcinogenesis 27, 1768-77 
2. De Blasio A et al (2005) FEBS Lett. 31, 615-20 
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PROLONGED  TREATMENT OF HUMAN 
OSTEOSARCOMA MG63 CELLS WITH 3AB INDUCES 
THE PRODUCTION OF TUMOR INITIATING CELLS 
R. Di Fiore,  R. Drago-Ferrante,  P. Carta, G. Augello,                                       
A. Santulli,  R. Vento, 
Dipartimento di Scienze Biochimiche Università di 
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Recent evidences suggest that a number of human 
malignancies contain an organized cell hierarchy where a 
minor population of Tumor Initiating Cells (TICs) is 
responsible for tumor growth1. These TICs  are endowed 
with high self-renewing capacity, propensity to 
differentiate into actively proliferating tumor cells and high 
resistance to chemotherapy. Ours previous studies have 
demonstrated that prolonged exposure of human 
osteosarcoma MG63 cells to 3AB, a canonical PARP 
inhibitor, induces the appearence of a cell population, 
characterized by both the CD133+ expression and a 
marked reduction in cell volume, containing a potentially 
stem-like phenotype.  
In this study we indicate these cells as TICs and we 
show that, respect to the wild type MG63 cells, TICs 
possess a greater ability of self-renewing and a higher 
proliferative potential. 
To compare the ability of MG63 cells and TICs to 
generate spherical clones and to self-renew, both cell 
types were grown in the 1% methylcellulose medium in 
ultra low attachment plates and after 6 and 12 days of 
culturing, the colonies were quantitated by inverted phase 
contrast microscopy. We have demonstrated that both 
cell types were capable of forming spheres, but those 
formed by TICs were more numerous and larger than 
those formed by MG63 cells. Growth curves have shown 
that TICs possess a higher proliferative output than 
MG63. Moreover, analysis of cell cycle regulators by 
western-blotting assay have shown that, respect to MG63 
cells, TICs are characterized by a greater level of 
inactive/hyperphosphorylated pRb form, a higher level of 
E2F1, cyclins D1, E, A, and B1 and a much higher activity 
of CDC2 kinase. In conclusion, we have demonstrated  
that TICs possess some characteristics of stem cells, 
which include the ability for self-renewal and high 
proliferative potential. 
1. Liu J.C. et al (2007) Cancer Res. 67, 8671-81.
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THE MECHANISM BY WHICH HISTONE 
DEACETYLASE INHIBITORS SENSITIZE HEPATOMA 
AND COLON CANCER CELLS TO TRAIL-INDUCED 
APOPTOSIS 
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Introduction: Histone deacetylase inhibitors (HDACIs) 
represent a new and promising class of anti-tumor drugs 
that influence gene expression by enhancing acetylation 
of histones in specific chromatin domains and induce 
apoptosis in several tumor cell types.  
It has been recently shown that HDACIs are capable 
of sensitizing tumor cells that display resistance to TRAIL-
mediated apoptosis. However, the molecular mechanisms 
that account for this sensitization have not been fully 
elucidated.  
Our study provides evidence that human hepatoma 
and colon cancer cells can be potently sensitized by 
HDACIs to TRAIL-induced apoptosis through increasing 
the expression of the death receptor DR5 together with 
downregulation of some antiapoptotic factors such as c-
Flip, NF-kB and Akt. 
Materials and methods: Apoptosis was assessed 
either by flow cytometry or AO/EB staining. DISC 
precipitation was performed using biotin-tagged 
recombinant TRAIL. Knockdown of c-Flip was obtained 
using a specific siRNA. Protein levels were evaluated by 
western blot analysis. The DNA binding of NF-kB subunits 
was assessed using the Trans-AM NF-kB ELISA assay.  
Results: Our study shows that both human hepatoma 
HepG2 and colon cancer HT-29 cells are resistant to the 
effect of soluble recombinant TRAIL. Low doses of 
different types of HDACIs (1 ?M SAHA, 0.2 ?M ITF2357 
and 10 nM TSA) potently sensitized both the cell lines to 
TRAIL-induced apoptosis resulting in a marked 
synergistic effect.  
The sensitization determined by HDACIs, in particular 
by 1?M SAHA, seems to be mainly correlated with the 
increasing effect in the expression of TRAIL receptor DR5 
and down-regulation of c-Flip, an inhibitor of caspase-8 
activity. 
Analysis of the TRAIL death-inducing signalling 
complex (DISC) confirmed that SAHA provokes up-
regulation of DR5 together with the recruitment and 
activation of caspase-8. 
Treatment with combinations SAHA/TRAIL decreased 
the level of NF-kB. Consequently, also the levels of a 
number of antiapoptotic factors, such as IAP-2, XIAP, 
survivin and Bcl-XL, declined because their expression is 
stimulated by NF-kB.  
Combined treatment also caused downregulation of 
Akt and inhibition of  Bad phosphorylation.  
These effects led to activation of both caspase-9 and 
caspase-3 with the consequent cleavage of NF-kB and 
Akt and induction of cell death.  
Taken together, our data suggest that combination 
HDACIs/TRAIL might represent a novel strategy to target 
defensive systems in tumor cells and open new 
perspectives in tumor therapy.   
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THE SYNTHETIC CANNABINOID WIN55,212-2 
SYNERGIZES WITH THE DEATH RECEPTOR LIGAND 
TRAIL TO INDUCE APOPTOTIC EFFECTS IN HEPG2 
HEPATOMA CELLS. 
O. Pellerito, P. Portanova, M. Giuliano, G. Calvaruso, R. 
Vento and G. Tesoriere
Dipartimento di Scienze Biochimiche, Università degli 
Studi di Palermo, Palermo, Italia 
TNF-related apoptosis-inducing ligand (TRAIL), a 
member of the TNF superfamily, is of special interest for 
cancer therapy since this factor has been shown to 
predominantly kill tumor cells, while it seems to be almost 
ineffective in normal cells. However, many cancer cells 
fail to undergo apoptosis in response to TRAIL treatment, 
thus combination therapies have been developed for 
tumor-cell sensitization towards TRAIL.  
Cannabinoids, the active constituents of Cannabis 
sativa, are known to exert a wide range of central and 
peripheral effects. In recent years, numerous studies 
have evidenced the role of cannabinoids in the regulation 
of cell death and survival, focusing their antiproliferative 
effects in various tumors. Recently, we have 
demonstrated that WIN, a synthetic cannabinoid receptor 
agonist, induces a clear apoptotic effect in hepatoma 
HepG2 cells which is accompanied by up-regulation of 
Bcl-2 family proapoptotic members and down-regulation 
of survival factors. In this study we examined whether 
sub-optimal doses of WIN sensitized HepG2 cells to 
TRAIL and whether combinations of the two drugs 
induced synergistic cytotoxic effects in these cells. 
Furthermore, the underlying mechanisms were 
investigated.  
Western blotting analysis demonstrated that WIN up-
regulated the expression of death receptor DR5 and 
decreased that of decoy receptor DcR2, which is 
correlated with TRAIL resistance. Following the variations 
in the level of these proteins, HepG2 cells, which are 
resistant to TRAIL death pathway, became sensitive to 
this compounds. In fact, treatment of HepG2 cells with 10 
mM WIN and 50 ng/ml TRAIL for 24 h resulted in a 
reduction of cell viability of about 80%, assessed with 
both MTT assay and cytofluorimetric analysis while the 
two compounds, when employed alone, did not show any 
cytotoxicity.  
The addition of TRAIL to WIN-treated HepG2 cells 
also induced a marked decrease in the level of FLIPL with 
the consequent activation of caspase-8. Moreover, pAKT, 
whose level decreased after WIN treatment, became no 
more detectable when the cells were co-treated with the 
two compounds. The consequence of all these events 
was cell destruction through the activation of executive 
caspases.  
In our opinion, a relevant role in the apoptotic pathway 
induced by the combination of WIN and TRAIL is played 
by the transcription factor PPAR-g, whose activation is an 
early event in WIN-induced apoptosis and that seems to 
be responsible for up-regulation of DR5 receptor. 
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REVERSINE SELECTIVELY INDUCES CELL DEATH IN 
TUMOR CELLS 
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Reversine is a synthetic 2,6-distribuited purine1, which 
has been shown to increase cell plasticity with the ability 
to reprogram lineage-committed cells to a more primitive 
multipotent state.  In particular, reversine-treated dermal 
fibroblasts could be then induced to differentiate to 
skeletal muscle both in vitro and in vivo2.  Nevertheless, 
reversine mechanism of action is still not fully 
demonstrated, although it has been shown that the 
molecule inhibits MEK1, nonmuscle myosin II heavy 
chain3, and aurora kinases.  Although it is still unclear if 
these effects are strictly related to de-differentiation, it is 
now quite clear that the molecule inhibits cell growth.  
Thus, it has been already reported that reversine inhibits 
cell growth and colony formation in tumor cells.  
Surprisingly and remarkably, in our hands, treatment of 
several types of cancer cells (including neuroblastoma, 
fibrosarcoma, and glioblastoma cancer stem cells) with 
reversine at micromolar concentration, not only inhibited 
tumor cells growth, but extensively induced cell death.  
On the other hand, we did not observe the same lethal 
effects on normal cells (including human and murine 
primary dermal fibroblast, murine myoblasts, rat and 
human mesenchymal stem cells, and murine 
mesangioblasts), but only a reversible cell growth arrest.  
Moreover, we found that tumor cells seem to undergo 
different death pathways.  In fact, while neuroblastoma 
SK-N-BE cells revealed all the canonical signs of 
apoptosis (chromatin condensation, caspase 3 
activation), we could not find the same evidences in 
fibrosarcoma cells HT1080.  Nevertheless, cell cycle 
analysis and morphological features, after reversine 
treatment, seem to point out that cell death may be due to 
mitotic catastrophe, which may be caspase dependent or 
independent.  In fact, reversine treatment leads to the 
formation of large cells with several micronuclei, possibly 
due to the aberrant chromosome segregation and the 
inhibition of cytokinesis. Reversine inhibition of aurora 
kinase and nonmuscle myosin II heavy chain, which hold 
crucial roles in the correct mitotic division, may result in 
the observed effects.  Cell cycle analysis shows that 
reversine induces endoreplication, but while normal cells 
can control this effect and block cells in G1 phase, tumor 
cells, where G1 checkpoint is de-regulated, keep cycling 
to a point where micronucleated polyploid populations 
start to die.  
1. P. G. Schultz et al. JACS 126 (2004) 410-411. 
2. L. Anastasia et al. Cell Death Differ 12 (2006) 2042-
51. 
3. P.G. Schultz et al PNAS (2007) 104(25)10482-7. 
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UPSTREAM STIMULATING FACTOR 1 (USF1) IS 
INVOLVED IN THE TRANSCRIPTIONAL ACTIVATION 
OF THE HUMAN ALDOLASE C GENE IN PC12 CELLS 
DURING NEURONAL DIFFERENTIATION INDUCED BY 
NGF
A. Mancini1, L. Serio2, A. D’Angelo2, P. Buono1, 2,3,4 and F. 
Salvatore2,4
1
Fondazione SDN per la ricerca e l’alta formazione in 
Diagnostica Nucleare IRCCS, Napoli 
2
Ceinge 
Biotecnologie Avanzate, Napoli; 
3
Dipartimento di Studi 
delle Istituzioni e dei Sistemi Territoriali, Università 
Parthenope, Napoli
 4
Dipartimento di Biochimica e 
Biotecnologie Mediche, Università Federico II, Napoli. 
Aldolase C is the brain-specific isoform of fructose 1-6 
bisphosphate aldolase. We previously identified two 
distinct regions in the human aldolase C gene promoter. 
The proximal region (-164/+1), located just upstream from 
the main transcriptional start site, that drives low levels of 
the brain-specific expression of aldolase C messenger; 
and the distal region (-1190/-164) that contains various 
binding sites for transcriptional activators. In the distal 
region, we identified a functional binding site for the 
neuronal transcriptional activator NGFI-B,  which is 
involved in the c-AMP-induced activations of transcription 
of the human aldolase C gene1,2. Here we report the 
functional characterization of a novel transcriptional 
activator that is involved in transcription of the aldolase C 
gene during neuronal differentiation. The expression of 
endogenous aldolase C messenger increased by about 4-
fold in PC12 cells treated with 100 ng/ml nerve growth 
factor (NGF) for 1 day, and reached maximal levels (9-
fold) after 14 days of treatment. Using different constructs 
containing complete and deleted regions of the human 
aldolase C gene promoter, we carried out transient 
transfection experiments in PC12 cells untreated and 
treated for 3 days with 100 ng/ml NGF. These 
experiments revealed a novel cis-acting element, 
“element E”, in the distal promoter region (-241/-235), that 
drives aldolase C gene up-regulation during NGF 
treatment. We demonstrate that the transcriptional 
activator USF1 binds to element E. NGF treatment for 3 
days induced translocation of USF1 from the cytoplasm to 
the nucleus of PC12 cells, and activated aldolase C gene 
expression. Further experiments are in progress to 
elucidate if USF1 phosphorylation is involved 
transcriptional activation of aldolase C.  
1. Buono P et al, (1997) Biochem. Journal, 323,245-250  
2. Buono P et al, (2002) Gene, 291,115-121  
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Introduction. Classical Osteogenesis Imperfecta (OI) is a 
bone dysplasia caused by mutations in the COL1A1 or 
COL1A2 genes coding for the a chains of type I collagen. 
Several years ago, we generated the only knock in 
murine model for the dominant non-lethal form of this 
disorder, the BrtlIV mouse, reproducing a typical glycine 
substitution in the a1 chain of type I collagen (G349C) 
and the moderately severe outcome of Type IV OI. To 
further investigate the molecular and cellular basis of this 
adaptation we evaluated in vitro the proliferation and 
differentiation potential of mesenchymal stem cells 
(MSCs) from WT and Brtl mice towards osteoblasts and 
adipocytes.  
Methods. Femora, tibiae and column from 2 months 
old WT and BrtlIV mice were dissected and cleaned from 
soft tissues. MSCs collected from marrow flushing and 
bone crushing were isolated by plastic adhesion and used 
at passage 0 and 1. Cellular proliferation was evaluate 
after 6 days of culture both counting and using the 
CellTiter 96 AQueous One Solution Reagent kit 
(Promega). Colony forming unit-Fibroblasts (CFU-F) 
number was evaluated by means of limiting dilution assay 
and staining with Giemsa. Differentiation into adipocytes 
was induced by 10-8 M dexamethasone, 10 mg/mL insulin, 
0.5 mM isobutylmethylxanthine, 125 mM indomethacin; 
while differentiation into osteoblasts was induced by 10-8 
M dexamethasone, 10 mM b-glycerol phosphate, 0.2 mM 
ascorbic acid 2-phosphate. Culture dishes were then 
stained with Oil Red O and Von Kossa, respectively for 
adipocytes and osteoblasts identification. 
Results. The proliferation of mesenchymal stem cells 
from BrtlIV mice, determined as Cell doubling number, 
was statistically higher than that of WT MSCs after 6 days 
of culture (p<0.05). No difference was detected in the 
CFU-F number between mutant and WT MSCs both from 
tibia/femora and column. The number of adipocytes 
colonies detected in the MSCs from mutant mice were 
statistically higher than from WT animals (p<0.05). The 
ability of WT and mutant MSCs to differentiate into 
osteoblasts was assayed by quantify the area of dark 
brown mineralized extracellular matrix. MSCs from both 
genotypes deposited mineral, but the mineralized area in 
mutant cells was statistically lower than in WT (p<0.05).  
Conclusion. Our data show that at 2 months (the age 
at which the phenotype is most severe) the Brtl bone  
shows an increased MSCs proliferation strongly directed 
to adipogenic differentiation and a decrease in the 
osteoblasts differentiation. These results let us to 
hypothesize an alteration in the cellular differentiation 
signal pathway for our murine model. 
Work Supported by: Fondazione Cariplo 2007 to A.F.; 
MIUR 2006050235 to A. F.; Progetto Regione Lombardia 
2007 to A. F.; EuroGrow LSHM-CT-2007-037471 to A. R..  
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Previously we reported that brief exposure of HL60 cells 
to a mixture of 5-chloro-2-methyl-4-isothiazolin-3-one 
(CMI) and 2-methyl-4-isothiazolin-3-one (MI) shifts the 
cells into a state of oxidative stress that induces apoptosis 
and necrosis1. The aim of this study was to evaluate the 
participation of Ca2+ in apoptosis or necrosis induced by 
CMI/MI treatment in HL60 cells. We used the intracellular 
calcium chelator 1,2-bis-(2-aminophenoxy)-ethane-
N,N,N',N'-tetraacetic acid acetoxymethyl ester (BAPTA-
AM) to investigate the relationships among intracellular 
calcium, changes Δ?m, and induction of apoptosis or 
necrosis in HL60 cells exposed to CMI/MI. 
HL60 cells were exposed to both apoptotic and necrotic 
doses of CMI/MI (0.001-0.1%) for 10 min. Using time-
course (0-3 h), we performed all the analyses using flow 
cytometry: cytoplamic calcium levels, mitochondrial 
calcium levels, changes in mitochondrial transmembrane 
potential (δΨm) were assessed by FuraRed AM, Rhod-2 
and Rhodamine 123 (Rhod123) respectively. Apoptosis 
and necrosis were evaluated as previously described1.
The addition of CMI/MI to Fura Red-AM-loaded HL60 
cells in the absence of extracellular Ca2+ induced a rapid 
and sustained increase in intracellular Ca2+ in a dose-
dependent manner. In CMI/MI-treated cells the 
subsequent addition of thapsigargin, an inhibitor of ER 
Ca2+-ATPase that discharges intracellular Ca2+ stores, did 
not cause a further increase of Ca2+ levels, indicating that 
the ER had already released its Ca2+. A slight increase in 
fluorescence was observed in the presence of external 
calcium, suggesting that the primary source of Ca2+ is 
most likely the ER, the primary site of Ca2+ storage in 
eukaryotic cells. Using Rhod-2-AM, we showed that the  
rapid increase in cytosolic calcium induced by CMI/MI 
was followed by mitochondrial calcium increase. BAPTA-
AM reduced necrosis and secondary necrosis and  the 
loss of δΨm induced by necrotic doses of CMI/MI, by 
switching from necrosis to apoptosis, but did not protect 
against CMI/MI-induced apoptosis, mitochondrial calcium 
uptake and mitochondrial hyperpolarization. Our results 
show that CMI/MI induces early perturbation of calcium 
homeostasis, increasing cytosolic and mitochondrial 
calcium and depleting the intracellular endoplasmic 
reticulum (ER) stores. These findings suggest that 
increased cytoplasmic calcium does not have a causal 
role in the induction of apoptosis, while cross-talk 
between the ER and mitochondria could be responsible 
for the induction of apoptosis, while necrosis is associated 
with cytoplasmic calcium overload.  
1. Di Stefano A et al, (2006) Biochim. Biophys. Acta 
1763: 214-225 
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Stem cell based repletion of scarred myocardial tissue 
and regeneration of cardiomyocytes have been proposed 
as a potential treatment of ventricular dysfunction. Tissue-
engineering is a new strategy to regenerate the infarcted 
myocardium. This new discipline combines isolated 
functioning cells and biodegradable 3-dimensional 
polymeric scaffolds. The scaffold temporary provides the 
biomechanical support for the cells until they produce 
their own extracellular matrix. Because tissue-engineering 
constructs contain living cells, they may have the potential 
for growth and cellular self repair and remodeling. In the 
present study, using a heterotopic heart transplantation 
animal model, we examined whether the implantation of a 
hyaluronan-based non-woven scaffold with bone-marrow 
mesenchymal stem cells (MSCs) would result in the 
formation of alternative cardiac tissue that could replace 
the scar and improve cardiac function after myocardial 
infarction in rat heart. Rat hearts were explanted after 
cardiac arrest by cold cardioplegic solution infusion and 
left pneumonectomy and left coronary descending artery 
ligation were performed on the bench. The heart-lung 
block was transplanted into the abdomen of a receiving 
syngenic rat performing an end-to-side aorta-aorta 
anastomosis. After two weeks we measured the cardiac 
function of the heterotopic rat heart by M-Mode 
echocardiography . Immediately after, a pocket of 3 mm2
was made in the thickness of the ventricular wall at the 
level of the post-infarction scar. The scaffold, previously 
engineered for 3 weeks with rat bone-marrow MSCs, was 
introduced into the pocket and the myocardial edges 
sutured with few stitches. Two weeks later we evaluated 
cardiac function of the transplanted heart and we 
sacrificed the rats for histological analysis. Our results 
showed that after two weeks the scaffold fibres had not 
been substantially degraded. MSCs delivered through the 
scaffold were mostly migrated to the surrounding infarcted  
and found close to small sized vessels. Some of them 
were still close to the scaffold fibres and expressed 
cardiac-troponin-I. Scar tissue was moderated in the 
engrafted region and capillary density was found 
increased in the scar area of treated hearts compared to 
non-treated one. Also, the left ventricular shortening 
fraction was slightly improved when compared to that 
measured just before construct implantation. Therefore, 
this study suggests that post-infarction myocardial 
remodelling can be favourably affected by the grafting of 
MSCs delivered through a hyaluronan-based non-woven 
scaffold. This research was founded by a grant of 
Compagnia di San Paolo, Turin, Italy
16.16 
REACTIVE OXIGEN  SPECIES MEDIATE HIF-1? –
INDUCED SURVIVAL  IN METASTATIC MELANOMA  
M Calvani , M. Parri, E Giannoni, G. Comito, and 
P.Chiarugi  
Department of Biochemical Sciences , University of 
Florence 
Hypoxia, a common feature of solid tumors, is a major 
obstacle in the development of effective cancer 
chemotherapy often decreasing the efficacy of 
chemotherapic drugs in several solid tumors. The hypoxic 
environment is able to maintain an anti-apoptotic potential 
through the activation of critical genes associated with 
drug resistance and the overexpression of prosurvival 
proteins as Bcl-2. Hypoxia inducible factor1? (HIF1?) is 
the master regulator of hypoxic response and its 
overexpression and enhanced transcriptional activity are 
linked to tumour initiation and progression by inducing 
expression of genes mediating angiogenesis and motility, 
as well as tumor metabolism and survival. Increased level 
of HIF-1? are associated with resistance to therapy in 
head and neck, ovarian, esophageal and prostate cancer, 
thus suggesting that HIF-1? is a key contributor involved 
in drug resistance acquired by hypoxia. Beside inducing a 
glycolytic shift of tumour cells, hypoxia also paradoxically 
increases the intracellular level of reactive oxygen 
species (ROS) such as superoxide and hydrogen 
peroxide. Mitochondria appear to be their main source, 
although hypoxia may affect the intracellular redox state 
through NADPH oxidase engagement by autocrine 
growth factor production. 
We observed that 1% hypoxia increases the 
resistance of human Hs29-4T metastatic melanoma to 
conventional chemotherapy with etoposide, mediating a 
signalling leading to  tumor cells survival. The aim of our 
work is to identify the role of the redox component  of this 
pro-survival spur in hypoxia signalling. In melanoma cells 
hypoxia leads to a strong and sustained increase of 
intracellular ROS, indicating mitochondria as the main 
source. Mitochondria-derived ROS are both necessary 
and sufficient to stabilize and activate HIF-1? both in 
normoxic and hypoxic conditions. In addition, inhibition of  
HIF-1?  with specific siRNA, as well as inhibition of ROS 
production impairing mitochondrial source (rotenone) or 
NADPH oxidase (DPI), rescue the hypoxic protection from 
etoposide-induced apoptosis. Moreover VEGF and VEGF 
receptor neutralizing antibodies fully abrogate hypoxia-
induced survival, thus suggesting a participation of VEGF 
signalling to sustain survival. Again, removal of 
mitochondria-derived ROS abrogates VEGF downstream 
signalling and survival. We therefore propose hypoxia-
derived ROS as key modulators of the HIF-1? and VEGF-
mediated resistance to chemotherapy of metastatic 
melanoma. 
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THE ACTIVITY OF CYTOSOLIC NADH/CYTO-C 
ELECTRON TRANSPORT SYSTEM IN APOPTOTIC 
HeLa CELLS
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The endogenous pathway of programmed cell death is 
characterized by the release from mitochondria of 
apoptotic reducing factors included the cytochrome c 
(cyto-c). The presence of cyto-c into the cytosol is 
required for the formation of apoptosome, responsible for 
the activation of caspases cascade. However, the release 
of cyto-c from mitochondria promotes an impairement of 
the respiratory chain which entity is directly linked to the 
amount of cyto-c released. Some Authors indicate that 
almost all the cyto-c is released with a drastic drop in the 
energy content of the cell due to impairement or the 
absence of respiration. This makes the problem of the 
source of energy required for the correct execution of 
apoptosis. Indeed, in the early stages of apoptosis, 
mitochondria continue to maintains a membrane potential. 
In the absence of energy apoptosis is converted in 
necrosis. We have shown the existence in liver cells of a 
rotenone and myxothiazol insensitive cytosolic 
NADH/cyto-c electron transport pathway. This system is 
activated only in the presence of catalytic amounts of 
cyto-c outside mitochondria, promotes the oxidation of 
exogenous substrates present in the cytosol and 
generates in mitochondria an electrochemical proton 
gradient useful for ATP synthesis. In 1998 we proposed 
that in apoptosis, cyto-c molecules released into the 
cytosol other than to partecipate to the formation of the 
apoptosome, activate the cytosolic NADH/cyto-c system 
with the generation of a mitochondrial membrane 
potential which contributes to the synthesis of ATP 
utilized by the apoptotic program. In this report we show 
that in homogenate of HeLa cells, induced to apoptosis 
with staurosporin, the oxidation of both NADH and cyto-c 
is greatly increased in support to the activation of 
NADH/cyto-c system. Mitochondria from apoptotic HeLa 
cells oxidize cyto-c and generate a membrane potential at 
higher rate than those from control cells. Relevant is the 
finding that the cytosol of both control and staurosporin 
treated cells promotes the reduction of added cyto-c and 
the reduction rate is further increased in the presence of 
oxidized NAD. This indicates that in apoptotic cells but 
also in control cells the presence of catalytic amounts of 
cyto-c outside the mitochondria may activate the 
NADH/cyto-c system to promote the oxidation of cytosolic 
substrates. The results obtained in reconstituted system 
made of cytosol and isolated mitochondria are consistent 
with this view. Patho-physiological implications of the 
activity of the NADH/cyto-c electron transport pathway will 
be discussed. 
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EXOGENOUS DELIVERY AND MOLECULAR 
EVOLUTION: PEPTIDES BASED ON C
?
-METHYLATED 
?-AMINO ACIDS AS ASYMMETRIC CATALYSTS IN 
THE SYNTHESES OF SIMPLE SUGARS 
F. Formaggio,1 A. Moretto,1 C. Toniolo,1 Q. B. 
Broxterman,2 A. L. Weber,3 S. Pizzarello4
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It is known that chiral amino acids, as well as their 
dipeptides, may catalyze the asymmetric condensation of 
glycolaldehyde in water. On the basis of the particularly 
large erythrose enantiomeric excesses (ee) obtained 
when utilizing the chiral L-Val-L-Val catalyst and given the 
possibility of an abundant delivery of other types of amino 
acids to the early Earth, we have studied the catalytic 
effect on this synthesis of the peptides based on C?-
methylated ?-amino acids, such as Iva (isovaline or C?-
methyl, C?-aminobutyric acid) and C?-methylvaline, 
(?Me)Val, that are abundant in meteorites.  
Results of the catalysis experiments showed the all 
C?-methylated peptides to the tetramer level exhibit 
significant chiral influence on the synthesis of tetroses 
and mimic the effect of the L-Val-L-Val catalyst in having 
a larger erythrose ee than threose ee, as well as in their 
configuration relationship with the sugars (the product 
erythrose acquires ee of configuration opposite to that of 
the catalyst in case of peptides, while it is the same for 
amino acids). Interestingly, the largest ee (45% for 
erythrose) was obtained with the Iva homo-tetrapeptide 
under mild conditions. The homo-dipeptides of both Iva 
and (?Me)Val also produced a significant ee (41% for 
erythrose) that appears to increase with time. 
Because C?-methylated amino acids are non-racemic 
in meteorites, do not racemize in aqueous environments, 
and are known to be (310)-helix formers in peptides with 
as few as four residues, these results suggest that 
meteoritic, C?-methylated, ?-amino acids may have 
contributed to molecular evolution upon delivery to the 
early Earth by catalytically transferring their asymmetry to 
other prebiotic molecules. 
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BACKBONE NMR ASSIGNMENT AND PRELIMINARY 
STRUCTURAL ANALYSIS OF T. brucei GRX3 
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Glutaredoxins (Grxs) were first discovered as glutathione-
dependent reductants for ribonucleotide reductase1 which 
is essential for DNA synthesis in all aerobic organisms. 
Today, Grxs are recognized as versatile regulatory 
proteins with multiple functions in health and disease2.
The so called monothiol Grxs belong to a recently 
discovered class with a CGFS consensus, in contrast to 
the ‘classical’ dithiol motif with a CPYC active site. 
Monothiol Grxs are found either as single domain proteins 
or in multidomain proteins together with thioredoxin 
and/or dithiol glutaredoxin entities3. Until now, neither the 
physiological reductant(s) nor substrates of monothiol 
Grxs are definitely proved, and their functional role is 
largely unknown. Nevertheless, the extent of conservation 
of these proteins amongst prokaryotes and eukaryotes, 
and the poor viability of some knock-outs, suggest a 
decisive importance in central processes within the cells, 
and a role which is not redundant with dithiol 
glutaredoxins. 
Trypanosoma brucei is the causative agent of African 
sleeping sickness. African trypanosomes have a unique 
thiol metabolism based on the dithiol trypanothione 
[bis(glutathionyl)spermidine]. Enzymes of this parasite-
specific redox metabolism are therefore attractive 
antiparasitic drug targets4. The genome of T. brucei
encodes three genes for monothiol Grxs. Grx1 and Grx2 
are single domain monothiol glutaredoxins, while 
monothiol T. brucei Grx3 contains an additional N-
terminal thioredoxin-like domain. We determined the first 
and as yet only high resolution structure for a single 
domain Grx5, and we have now chosen the two-domain T. 
brucei Grx3 as our next target for structure determination. 
We  obtained the full backbone assignment of the 24 kDa 
protein and a preliminary structural analysis, based on 
chemical shift data, will be presented here. Furthermore, 
we show that the cysteines in the two putative active sites 
behave differently with respect to pH changes and 
oxidation, which could be relevant for the function of the 
protein. 
1. Holmgren, A. (1976) Proc. Natl. Acad. Sci. USA 73,
2275-2279. 
2. Lillig, C.H. and Holmgren, A. (2007) Antioxid. Redox 
Signal. 9, 25-47. 
3. Herrero, E. and  De la Torre-Ruiz, M.A. (2007)  Cell. 
Mol. Life Sci. 64, 1518-1530. 
4. Krauth-Siegel R.L.,Bauer H., and Schirmer R.H. 
(2005)  Angew. Chem. Int. Ed. 44, 690 – 715. 
5. Fladvad M., Bellanda M., Fernandes A.P., Mammi S., 
Vlamis-Gardikas A., Holmgren A. and Sunnerhagen M. 
(2005) J. Biol. Chem. 280, 24553-24561. 
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REACTIVE OXYGEN SPECIES HIF-1? INDUCED 
SURVIVAL IN METASTATIC MELANOMA 
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Florence 
Hypoxia, a common feature of solid tumors, is a major 
obstacle in the development of effective cancer 
chemotherapy often decreasing the efficacy of 
chemotherapic drugs in several solid tumors. The hypoxic 
environment is able to maintain an anti-apoptotic potential 
through the activation of critical genes associated with 
drug resistance and the overexpression of prosurvival 
proteins as Bcl-2. Hypoxia inducible factor1? (HIF1?) is 
the master regulator of hypoxic response and its 
overexpression and enhanced transcriptional activity are 
linked to tumour initiation and progression by inducing 
expression of genes mediating angiogenesis and motility, 
as well as tumor metabolism and survival. Increased level 
of HIF-1? are associated with resistance to therapy in 
head and neck, ovarian, esophageal and prostate cancer, 
thus suggesting that HIF-1? is a key contributor involved 
in drug resistance acquired by hypoxia. Besides inducing 
a glycolytic shift of tumour cells, hypoxia also 
paradoxically increases the intracellular level of reactive 
oxygen species (ROS) such as superoxide and hydrogen 
peroxide. Mitochondria appear to be their main source, 
although hypoxia may affect the intracellular redox state 
through NADPH oxidase engagement by autocrine 
growth factor production. 
We observed that 1% hypoxia increases the 
resistance of human Hs29-4T metastatic melanoma to 
conventional chemotherapy with etoposide, mediating a 
signalling leading to tumor cells survival. The aim of our 
work is to identify the role of the redox   component of this 
pro-survival spur in hypoxia signalling. In melanoma cells 
hypoxia leads to a strong and sustained increase of 
intracellular ROS, indicating mitochondria as the main 
source. Mitochondria-derived ROS are both necessary 
and sufficient to stabilize and activate HIF-1? both in 
normoxic and hypoxic conditions. In addition, inhibition of 
HIF-1? with specific siRNA, as well as inhibition of ROS 
production impairing mitochondrial source (rotenone) or 
NADPH oxidase (DPI), rescues the hypoxic protection 
from etoposide-induced apoptosis. Moreover VEGF and 
VEGF receptor neutralizing antibodies fully abrogate 
hypoxia-induced survival, thus suggesting a participation 
of VEGF signalling to sustain survival. Again, removal of 
mitochondria-derived ROS abrogates VEGF downstream 
signalling and survival. We therefore propose hypoxia-
derived ROS as key modulators of the HIF-1? and VEGF-
mediated resistance to chemotherapy of metastatic 
melanoma. 
SCI.4 
POSSIBLE ROLE OF OXIDATIVE STRESS IN THE 
PATHOGENESIS OF CHRONIC VENOUS 
INSUFFICIENCY. PRELIMINARY RESULTS OF A 
POPULATION STUDY 
C. Cervellati, E. Franzoni, E. Masotti, E. Cremonini, A. 
Guariento, C.M. Bergamini 
Dipartimento di Biochimica e Biologia Molecolare, 
Università di Ferrara 
BACKGROUND: It is now appreciated that Oxidative 
Stress (OS) is involved in the pathogenesis of the lesions 
in certain chronic arterial diseases (as in 
atherosclerosis)1. In contrast, little information  is available 
on the  implication of oxidant species in pathologies 
affecting the venous system. OBJECTIVES:  The aim of 
our population study was to evaluate whether OS could 
have role in the onset of chronic venous insufficiency 
(CVI), one of the most spread and severe venous 
diseases. 
METHODS: For this study we have selected 2 
samples of women from a total of 350 patients attending a 
Vascular Surgery Clinics: the first group included 71 
women devoid of any type of pharmacologic intervention; 
the second consisted of 65 subjects who either intensively 
or occasionally used medicals. Both samples were 
subdivided in 3 groups: healthy; patients with varicose 
veins; and patients with diagnosed CVI.  Sera from all 
subjects were employed for colorimetric assessment of 
Oxidant Power (PO) given by hydroperoxides 
concentration measured by D-Roms test and total 
antioxidant power (TAP), determined through a ferric 
reduction (FRAP) technique.   
RESULTS: In the first sample a slight, but not 
significant (p>0.05), increase in Oxidant and Antioxidant 
power is observed in ill with respect to healthy subjects. 
The average values of both parameters are higher in 
patients with CVI than those with varixes. The use of 
medications appears to indistinctly increase PO (p<0.001) 
in healthy, varixes and CVI groups while the increment in 
TAP is only significant in CVI patients.  
DISCUSSION: Our preliminary results are not 
consistent with an implication of OS in pathogenesis of 
CVI. Indeed, the progression of venous disease, from the 
mild varicous veins to the severe CVI is not accompanied 
by an increase of OS. Interestingly, the use of medicals 
for the cure of this venous disease seems to improve the 
antioxidant defense.  
1. Behl C. et. al. Molecular Pharmacology 1997; 51:535–
41
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In recent years porphyrin-based photosensitizers have 
experienced enormous interest due to their potential use 
in photodynamic antitumoral theraphy (PDT). However, 
insolubility of many porphyrins derivatives in aqueous 
solution causes serious problems in biological application. 
Poly(ethylene glycol) (PEG) conjugation is one of the 
delivery systems that have been employed to increase 
solubility, bioavailability and pharmacokinetics of many 
drugs.  
In the present study, we have conjugated 
pheophorbide (Pba) to a new orthogonally protected 
bifunctional PEG (M.W. = 5000 Da), followed by the 
addition of a fluorescent moiety to the other extremity of 
the polymeric chain to analyze its cellular trafficking. 
Alternatively, a galactose unit was also added since 
glycoconjugation can be a potentially effective strategy for 
targeting photosensitizers toward tumor cells. The 
biological activity of Pba and PEG-Pba have been initially 
evaluated in a number of different cancer cells, including 
HeLa, HepG2, MCF7 and B78. Both porphyrins induced a 
strong dose-dependent PDT effect with IC50 values up to 
800 nM. At high doses of porhyrin (>800 nM for Peg-Pba 
or >100 nM for Pba) the treated cells were found to die by 
apoptosis or necrosis, as indicated by FACS and caspase 
3/7 assays. At lower doses the porphyrins, the FACS 
analyses showed that the cells were arrested in the G2/M 
phase. Moreover, the fact that both porphyrins induced in 
the treated cells the formation of relatively high levels of 
malondialdehyde (MDA) suggests that these compounds 
cause peroxydation of the membrane phospholipids.  
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Integramide A, an efficient inhibitor of the coupled 
reaction of HIV-1 integrase, is a 16-mer linear peptide 
characterized by 9 C?-methylated ?-amino acids (5 Iva, 
isovaline, and 4 Aib, ?-aminoisobutyric acid, residues) 
that was isolated from fungal extracts of Dendrodochium 
sp. The amino acid sequence was fully elucidated by the 
Merck group a few years ago.1 On the other hand, the 
chiral sequence was only partially determined. In 
particular, the precise stereochemistry of the Iva14-Iva15
dipeptide (known to contain one D- and one L-residue) 
near the C-terminus was not reported. 
To solve this unsettled issue and to assess 
integramide A primary structure-bioactivity relationship we 
performed by solution methods the total chemical 
independent syntheses of both L-D and D-L 16-mer 
diastereomers and compared their properties with those 
of the natural inhibitor. For an unambiguous, complete 
stereochemical assignment of integramide A we relied 
heavily on HPLC and NMR techniques. Our results clearly 
indicate that the chirality sequence of the Iva14-Iva15
dipeptide of the natural product is L-D. The two 
integramide A diastereomers were also evaluated as 
inhibitors of HIV-1 integrase in the coupled reaction of 
proviral DNA into the host cell DNA. 
1. Singh S. B., Herath K., Guan Z., Zink D. L., 
Dombrowski A. W., Polishook J. D., Silverman K. C., 
Lingham R. B., Felock P. J., Hazuda D. J. (2003) Org. 
Lett. 4, 1431-1434. 
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Trichogin GA IV is the most extensively investigated 
member of the class of lipopeptaibols that are linear 
peptide antibiotics of fungal origin, characterized by the 
presence of a variable, but remarkable, number of Aib 
residues, a fatty acyl group at the N-terminus, and a 1,2-
amino alcohol at the C-terminus. 
Several analogues of trichogin GA IV with amino acid 
substitutions or deletions were designed which allowed 
determination of the minimal inhibition concentration 
against Gram-positive and Gram-negative bacteria and 
various pathogenic fungal cells. The natural peptide 
exhibits a specific activity against S. aureus and only a 
marginal hemolytic effect. Interestingly, trichogin GA IV is 
active also against several methicillin-resistant S. aureus 
strains. Studies on synthetic analogues demonstrated that 
substitution of the C-terminal leucinol by Leu-OMe, or 
substitution of one Aib residues by the EPR label TOAC 
do not perturb significantly the biological activity of the 
peptide. On the other hand, removal of  3 or 7 N-terminal 
residues eliminated any antibacterial activity. Finally, 
studies of proteolytic degradation on trichogin GA IV and 
analogues where the 3 Aib residues are replaced by Leu 
demonstrated that the presence of  several non-coded 
Aib residues endows the natural peptaibol with 
remarkable resistance to proteolysis. The present results 
indicate that trichogin GA IV is a promising lead 
compound for the development of new, selective and 
protease-resistant, antibacterial drugs. 
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PBLs possess a complex dopaminergic system. Indeed, 
they express tyrosine hydroxylase and store 
catecholamines into vesicles that are released through a 
synaptic-like mechanism1. They possess transporters like 
DAT and VMAT, therefore they can internalize 
dopamine2.
PBLs are easy to obtain from patients with little 
discomfort and may represent sensitive cellular sensors 
to be used for the evaluation of gene expression 
modification in physiological and pathological conditions, 
providing a unique and easily available biological model 
for integrated studies of gene expression in humans3.
Our final purpose will be that of using lymphocytes as 
a source to look for biomarkers of Parkinson’s disease. 
As a preliminary study we wanted to better understand 
which are the proteins whose level change in response to 
pharmacological doses of dopamine, to detect probable 
biochemical pathways “sensitive” to dopamine. 
To this purpose, we treated a T-cell model (human T 
cell leukemia Jurkat cells) with 50 ?M dopamine and 700 
U/ml catalase, in order to correct for aspecific effects due 
to auto-oxidation of dopamine in the extracellular space. 
The differential analysis of the proteome was performed 
using 2D-electrophoresis. Our maps were rich in proteins 
with basic and acidic pI. Moreover, lymphocytes have 
many plasma membrane proteins, whose hydrophobicity 
could prevent the proteins to enter the IEF gel. To 
overcome this limit and to obtain a more complete 
analysis, we also separated proteins with ion-exchange 
chromatography and we further analyzed the different 
fractions by classical SDS-PAGE. 
1. Cosentino M., Fietta A.M., Ferrari M., et al. (2007) 
Blood 109, 632-642. 
2. Marazziti D., Baroni S., Dell'Osso M.C., Masala I., 
Fabbrini L., Betti L., Giannaccini G., Dell'osso B., 
Lucacchini A. (2008) Neurochem Res. 33, 1011-6. 
3. Borro M., Gentile G., Stigliano A., Misiti S., Toscano 
V. and Simmaco M. (2007) Clin. Exp. Immunol. 150, 
494-501.  
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Posttranslational modifications of lens crystallin, 
consequent to aging or diseases such as diabetes, lead to 
lens opacification and cataract formation1. Cataract is seen 
as a conformational disorder where unfolding or 
destabilization of the crystallin proteins drives their 
aggregation. Alpha-crystallin is the major structural protein 
within the eye lens and is therefore predominant in the 
aggregates. 
Under mildly denaturing conditions in vitro, bovine 
alpha-crystallin assembles into fibrillar structures2. The 
crystallins conversion into fibrils under destabilizing 
conditions suggests that this process could contribute to 
the development of cataract with aging. 
Carnosine (ß-alanyl-histidine) is present in long-lived 
tissues in high amounts and has been shown to delay 
aging of cultured cells3, to disaggregate glycated alpha-
crystallin and to have potential biological and therapeutic 
significance. 
In the present study we examined the ability of L and 
D-carnosine to affect the alpha-crystallin amyloid fibril 
formation under destabilizing conditions and its property 
in dissolving preformed fibrils. Morphological changes of 
whole lens, dissected from Rattus norvegicus, under 
organ culture were examined after treatment with 
guanidine hydrochloride and in the presence of carnosine. 
The observed dose and time dependent lens opacification 
was prevented in the presence of carnosine. Interestingly 
carnosine addition to already damaged lenses provided a 
significant recovery. 
Studies on conformational stability of alpha-crystallin 
have been carried out in the presence of guanidine and 
increasing temperature, by calorimetric (DSC) microscopic 
(AFM) and fluorescence analyses. The observed formation 
of fibrillar structures and aggregates of alpha-crystallin was 
reversed in the presence of carnosine. 
Either considering alpha-crystallin alone or the more 
complex model of lens organ culture, the presence of 
carnosine prevented fibrils formation and disassembled 
already formed fibrils restoring most of lens transparency. 
Protein misfolding is particularly relevant in the lens 
opacification, but it’s possible to counteract this process 
using agents with the common feature protein structures 
stabilization4.
1. Yan, H., Harding, J.J. Mol. Vis. 2006, 12, 205. 
2. Meehan, S., Berry, Y., Luisi, B., Dobson, C. M., 
Carver, J. A., MacPheea, C. E. J. Biol. Chem. 2004, 
279, 3413. 
3. McFarland, G.A., Holliday, R. Exp. Cell. Res. 1994, 
212, 167. 
4. Attanasio F., Cascio C., Fisichella S., Nicoletti V.G., 
Pignataro B., Savarino A., Rizzarelli E. (2007) 
Trehalose effects on alpha-crystallin aggregates. 
BBRC, 354, 899-905. 
SCI.10 
ANTIOXIDANT AND ANTIPROLIFERATIVE ACTIVITY 
OF SEEDS FROM BETA VULGARIS CICLA
P. Ninfalia, M. Blasaa, L. Gennaria, D. Angelinoa, A. 
Croceb, M. Felletti b, C. Buondelmontea, S. Dominicia, L. 
Giorgic, A. Corallinib
aDipartimento di Scienze Biomolecolari, c Istituto di 
Scienze Chimiche” F.Bruner”, Università di Urbino “Carlo 
Bo”, Urbino, bIstituto di Genetica e Microbiologia, 
Università di Ferrara, Ferrara, Italia. 
Seeds of several plants contain a large number of 
chemical compounds which could be examined for useful 
phytochemicals. These compounds probably function in 
the protection of seeds from microbial degradation until 
conditions are favourable for germination. Given the 
easily availability of seeds from food plants in horticulture, 
these seeds are now currently evaluated for isolation of 
phytocomplexes and pure phytochemicals to be used for 
pharmaceutical and nutritional purposes. 
This report focuses on the antioxidant and 
antiproliferative activity of seeds from Beta vulgaris cicla.
Values for total phenolics, flavonoids and antioxidant 
capacity were determined in the raw seed powder and 
after each step of organic extraction and  preparative 
chromatography on Sepadex LH 20 and RP 18 silica 
media. A phytocomplex, labelled P2, with remarkable 
antioxidant capacity and antiproliferating activity was 
obtained. P2 was tested for growth inhibition of cancer 
cell lines: MCF-7, RKO and G401. The most responsive 
cells were RKO which showed a 50% proliferating 
inhibition with 60 ug/ml phenolic concentration. The main 
phytochemical present in P2, vitexin-2-O-rhamnoside, a 
glucoside of the flavone apigenine, was not able alone to 
exploit the antiproliferating effect showed by P2. The 
number of apoptotic cells evaluated cytofluorimetrically 
was 10% only thus suggesting an effect of P2 on some 
cell cycle regulatory proteins and not on the apoptotic 
mechanism. 
P2 resulted bioavailable by searching with an HPLC 
method, the aglicone apigenine in the blood and liver of 
mice which received 5% P2 in food for 5 days. Flavonoid 
presence in mice plasma was also confirmed by an 
ELISA assay based on specific antibodies previously 
developed in mouse  by creation of haptens to obtain a 
proper immune response. 
The results show that Beta vulgaris cicla seeds are an 
excellent source for phytochemicals of potential utility in 
chemoprevention and for preparation of antioxidant 
nutraceutical products. 
SCI.11 
STUDIES ON MYCOBACTERIUM TUBERCULOSIS
GLUTAMYL-tRNA SYNTHETASE
S. Paravisi, M. A. Vanoni 
Dipartimento di Scienze Biomolecolari e Biotecnologie, 
Università degli Studi di Milano, Milano, Italy.  
Mycobacterium tuberculosis glutamyl-tRNA synthetase 
(Mt-GluRS) is an essential enzyme which provides Glu-
tRNAGlu for protein biosynthesis and for that of δ-
aminolevulinic acid (ALA), the first common precursor of 
tetrapyrrole biosynthesis.  
Soluble recombinant protein was obtained in large 
amounts and purified to homogeneity. The catalytic 
properties of Mt-GluRS are being investigated using the 
well characterized  E. coli GluRS (Ec-GluRS) as a 
reference in order to highlight peculiar properties of the M. 
tuberculosis enzyme. The steady-state kinetic parameters 
of Mt-GluRS reaction were found to be similar to those 
exhibited by other GluRS  except for a higher value of the 
Km for L-Glu (2.7 mM instead of 0.1 mM for Ec-GluRS). 
The enzyme reaction mechanism and the Glu-AMP 
intermediate formation was studied by using a 
colorimetric method for pyrophosphate (PPi) detection, 
[3H]-labelled ATP and chromatographic separation of 
reaction components and by monitoring the [32P]-PPi-ATP 
exchange reaction. Mt-GluRS was shown to catalyze the 
formation of Glu-AMP only in the presence of bound 
tRNAGlu as reported for GluRS from other sources. 
Among the several GluRS substrate and product analogs 
tested, only the reaction product PPi and the Glu-AMP 
analog glutamol-AMP (GOM) had an effect on GluRS 
activity.  PPi was a non competitive inhibitor with respect 
to ATP, in agreement with the observed [32P]-PPi-ATP 
exchange. GOM was a competitive inhibitor with respect 
to both L-Glu and ATP (Ki 3.9 and 1.5 ?M, respectively) 
suggesting random binding of these substrates to the 
enzyme•tRNA complex. At variance with other GluRS, Mt-
GluRS was found to catalyze the hydrolysis of ATP to 
ADP+Pi in the absence of tRNA and Glu, although at a 
rate of 5.1 min-1, corresponding to only 4% of the turnover 
rate of the physiological reaction. 
Analysis of M. tuberculosis genome revealed the 
absence of genes encoding Gln-tRNAGln synthetase 
indicating that Mt-GluRS belongs to the class of the non 
discriminating GluRS, which misacylate tRNAGln with L-Glu 
forming Glu-tRNAGln. The misacylation is corrected by the 
specific amidotransferase generating Gln-tRNAGln. Genes 
encoding the amidotransferase have indeed been identified 
in M. tuberculosis genome. However, the overexpression of 
Mt-GluRS in E. coli, which expresses a Gln-tRNAGln
synthetase and lacks the amidotransferase, was not toxic, 
raising the question of the tRNA specificity of Mt-GluRS. 
Genome analyses indicated that in M. tuberculosis ALA 
is formed from Glu-tRNAGlu by glutamyl-tRNA reductase 
(GluTR), in the presence of NADPH, and glutamate 1-
semialdehyde aminomutase in the so-called C5 pathway. 
Thus, we tested the hypothesis of the possible formation of 
a complex between GluRS and GluTR, which would 
commit Glu-tRNAGlu to tetrapyrrole biosynthesis as 
opposed to protein synthesis. By affinity chromatography 
with immobilized His-tagged forms of GluRS or of GluTR as 
the bait to fish out the second enzyme, we obtained data 
consistent with complex formation. 
SCI.12 
STRUCTURE, STABILITY AND DYNAMICS OF A 
MESOPHILIC-PSYCROPHILIC PAIR  
I. Russo Krauss1, A. Merlino1, I. Castellano2, E. De 
Vendittis2, M. Conte1, A. Vergara1,3, F. Sica1,3
1 Dipartimento di Chimica, Università degli Studi di Napoli 
“Federico II”, Napoli, Italia, 2 Dipartimento di Biochimica e 
Biotecnologie Mediche, Università degli Studi di Napoli 
“Federico II”, Napoli, Italia, 3 Istituto di Biostrutture e 
Bioimmagini, CNR, Napoli, Italia 
Superoxide dismutases are a family of metalloenzymes 
that catalyse the dismutation of superoxide anion radicals 
into molecular oxygen and hydrogen peroxide. Here, we 
present the first crystal structure of a cold-active iron 
superoxide dismutase, from the antarctic eubacterium 
Pseudoalteromonas haloplanktis (PhSOD)1-2. The 
structural information is combined with a characterization 
of stability and dynamics of the enzyme and with a 
comparative study with the mesophilic counterpart from E. 
coli (EcSOD)3, which shares the same number of 
residues and a very high sequence identity with PhSOD 
(70%). The temperature- and denaturant-induced 
unfolding of PhSOD and EcSOD have been studied by 
circular dichroism (CD) and fluorescence measurements. 
The denaturation temperature at the transition midpoint of 
PhSOD is comparable to that of EcSOD, and higher than 
that expected for a psychrophilic enzyme. On the 
contrary, the values of the denaturant concentration at the 
transition midpoint are in line with the 
psychrophilic/mesophilic origin of the two proteins. 
PhSOD and EcSOD share a large structural similarity: 
conserved tertiary structure and arrangement of two 
monomers, almost identical total number of inter- and 
intramolecular hydrogen bonds and salt bridges, polar 
and non polar surface, number of internal cavities. 
However, the cold-adapted protein shows an increased 
flexibility of the active site residues with respect to its 
mesophilic homologue.  
These data provide an additional support for the 
hypothesis that cold-adapted enzymes achieve efficient 
catalysis at low temperatures by increasing active site 
flexibility. Our results also illustrate how fine structural 
modifications can alter enzyme active site flexibility, 
without compromising the overall protein structure and 
stability. 
1. Castellano, I. et al. (2006) Biochimie 88 (10), 1377-89. 
2. Merlino, A. et al. (2008) Protein and Peptide Letters,
15 (4), 415-418. 
3. Lah, M. S. et al., (1995) Biochemistry 34 (5), 1646-
1660
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